SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Metlife Investors USA Separate Account A, et al. – ‘N-4’ on 11/18/14

On:  Tuesday, 11/18/14, at 10:51am ET   ·   Accession #:  1193125-14-416298   ·   File #s:  811-03365, 333-200323

Previous ‘N-4’:  ‘N-4’ on 11/17/14   ·   Next:  ‘N-4’ on 4/30/15   ·   Latest:  ‘N-4/A’ on 6/7/16   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/18/14  Metlife Investors USA Sep Acct A  N-4                   19:2.1M                                   RR Donnelley/FABrighthouse Separate Account A 2 Classes/Contracts

Registration Statement for a Separate Account (Unit Investment Trust)   —   Form N-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: N-4         Metlife Investment Portfolio Architect/Sm/           530   3.09M 
 2: EX-99.1(II)  Mli Usa Board Resolutions and Plan of Merger          9     33K 
 3: EX-99.1(III)  Micc Board Resolutions                               2     13K 
18: EX-99.10    Consent of Independent Registered Public               1     10K 
                          Accounting Firm (Deloitte & Touche LLP)                
19: EX-99.13    Powers of Attorney                                    15     71K 
 4: EX-99.3(I)(B)  Amendment to Distribution and Principal             2     13K 
                          Underwriting Agreement                                 
 5: EX-99.4(XVI)  Merger Endorsement                                   1     11K 
 6: EX-99.5     Form of Variable Annuity Application                   6     37K 
 7: EX-99.6(I)  Copy of Certificate of Incorporation and Amendment     5     21K 
 8: EX-99.6(II)  Copy of By-Laws of the Company                       15     53K 
10: EX-99.8 (III)(C)  Amendment to Participation Agreement With        5     20K 
                          American Funds Insurance Series                        
11: EX-99.8 (IV)  Amendment to Participation Agreement With           20     90K 
                          Blackrock Variable Series Funds, Inc.                  
16: EX-99.8 (IX)  Amendment to Participation Agreement With Van       27     93K 
                          Eck Vip Trust                                          
12: EX-99.8 (V)  Amendment to Participation Agreement With Ivy        30    102K 
                          Funds Var Insurance Portfolios                         
13: EX-99.8 (VI)(C)  Amendment to Participation Agreement With         7     30K 
                          Legg Mason Partners Var Equity Trust                   
14: EX-99.8 (VII)(B)  Amendment to Participation Agreement With        3     15K 
                          Pimco Variable Insurance Trust                         
15: EX-99.8 (VIII)(B)  Amendment to Participation Agreement With       5     21K 
                          the Universal Institutional Funds Inc.                 
 9: EX-99.8(I)(D)  Amendment to Participation Agreement With Met       4     17K 
                          Investors Series Trust                                 
17: EX-99.9     Opinion of Counsel                                     2     13K 


N-4   —   Metlife Investment Portfolio Architect/Sm/
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
5Index of Special Terms
6Highlights
7Free Look
8Fee Tables and Examples
"Withdrawal Charge
"Note 1
"Note 2
131. the Annuity Contract
142. Purchase
"Purchase Payments
"Termination for Low Account Value
15Allocation of Purchase Payments
16Accumulation Units
"Account Value
"Replacement of Contracts
17Owning Multiple Contracts
"3. Investment Options
20Investment Portfolios That Are Funds-of-Funds
21Transfers
"General
22Transfers By Telephone or Other Means
"Restrictions on Frequent Transfers
24Restrictions on Large Transfers
26Dollar Cost Averaging Program (DCA)
"Automatic Rebalancing Program
27Voting Rights
"4. Expenses
"Product Charges
28Account Fee
29Reduction or Elimination of the Withdrawal Charge
"Premium and Other Taxes
30Transfer Fee
"Income Taxes
"Investment Portfolio Expenses
"5. Annuity Payments (The Income Phase)
"Annuity Date
"Annuity Payments
31Annuity Options
32Variable Annuity Payments
33Fixed Annuity Payments
"6. Access to Your Money
34Systematic Withdrawal Program
35Suspension of Payments or Transfers
"7. Performance
"8. Death Benefit
"Upon Your Death
36Standard Death Benefit (Account Value)
"Optional Death Benefit - Return of Premium
"General Death Benefit Provisions
37Spousal Continuation
"Death of the Annuitant
38Controlled Payout
"9. Federal Income Tax Status
"Non-Qualified Contracts
40Death Benefits
"Taxation of Payments in Annuity Form
41Qualified Contracts
45Withdrawals
4710. Other Information
"MetLife USA
"The Separate Account
48Distributor
"Selling Firms
49Additional Compensation for Selected Selling Firms
50Requests and Elections
51Good Order
"Ownership
"Owner
52Beneficiary
"Annuitant
"Legal Proceedings
"Financial Statements
53Table of Contents of the Statement of Additional Information
"Company
"Independent Registered Public Accounting Firm
"Custodian
"Distribution
"Calculation of Performance Information
"Total Return
"Historical Unit Values
"Annuity Provisions
"Variable Annuity
"Fixed Annuity
"Legal or Regulatory Restrictions on Transactions
"Additional Federal Tax Considerations
54Appendix A
"Participating Investment Portfolios
60Appendix B
"Death Benefit Example
65Reporting Agencies
67Mortality and Expense Guarantee
70Generation-Skipping Transfer Tax
72Report of Independent Registered Public Accounting Firm
74American Funds
79Invesco V.I
83Mist
99Oppenheimer Va
131Uif U.S. Real Estate Sub-Account
137FTVIPT Franklin Small Cap Value Securities Sub-Account
139Ftvipt
"Invesco V.I. Equity and Income Sub-Account
141LMPVET ClearBridge Variable Appreciation Sub-Account
143Lmpvet
"LMPVET Variable Lifestyle Allocation 70% Sub-Account
145MIST American Funds Balanced Allocation Sub-Account
147MIST BlackRock Large Cap Core Sub-Account
149MIST Invesco Comstock Sub-Account
151MIST Lord Abbett Bond Debenture Sub-Account
153MIST MetLife Defensive Strategy Sub-Account
155MIST Oppenheimer Global Equity Sub-Account
159MSF Barclays Aggregate Bond Index Sub-Account
161Msf
163MSF MetLife Mid Cap Stock Index Sub-Account
165MSF Neuberger Berman Genesis Sub-Account
167Oppenheimer VA Core Bond Sub-Account
169Pioneer VCT Equity Income Sub-Account
171T. Rowe Price Prime Reserve Sub-Account
178Mergers
193MSF Met/Artisan Mid Cap Value Sub-Account
195Pioneer VCT
224Item 8. Financial Statements and Supplementary Data
226Consolidated Balance Sheets
227Consolidated Statements of Operations
228Consolidated Statements of Comprehensive Income (Loss)
229Consolidated Statements of Stockholders' Equity
"Accumulated Other Comprehensive Income (Loss)
"Balance at December 31,
230Consolidated Statements of Cash Flows
232Notes to the Consolidated Financial Statements
2331. Business, Basis of Presentation and Summary of Significant Accounting Policies (Continued)
"Separate Accounts
236Retained earnings
237Insurance
238Other Policy-Related Balances
239Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles
240Reinsurance
242Investments
243Mortgage Loans
"Policy Loans
244Short-Term Investments
"Other Invested Assets
"Other invested assets consist principally of the following:
245Derivatives
247Fair Value
"Goodwill
248Income Tax
250Other Revenues
268Dac
274Related Party Reinsurance Transactions
277Fixed Maturity Securities
279Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities
282Equity Securities
285Recorded Investment
290Securities Lending
292Variable Interest Entities
293CSEs
295Net investment income
296Net Investment Gains (Losses)
298Related Party Investment Transactions
303Net Derivative Gains (Losses)
312Recurring Fair Value Measurements
315Securities, Short-term Investments and Long-term Debt of CSEs
316U.S
"U.S. Treasury and Agency Securities
318Separate Account Assets
322Direct and Assumed Guaranteed Minimum Benefits
333Nonrecurring Fair Value Measurements
336Premiums, Reinsurance and Other Receivables
"PABs
337Long-term debt
"Other Liabilities
"Separate account liabilities
339Balance at December 31, 2012
340Return of capital
351Insolvency Assessments
"Other assets
353Equity
355Schedule I
356Schedule II
360Schedule III
362Schedule IV
376Other limited partnership interests
392Voba
424Securities and Short-term Investments
426Non-redeemable preferred stock
429Direct Guaranteed Minimum Benefits
496Assumed Guaranteed Minimum Benefits
512Other Information
"Item 24. Financial Statements and Exhibits
515Item 25. Directors and Officers of the Depositor
518Item 26. Persons Controlled by or Under Common Control With the Depositor or Registrant
525Item 27. Number of Contract Owners
"Item 28. Indemnification
"Item 29. Principal Underwriters
527Item 30. Location of Accounts and Records
"Item 31. Management Services
"Item 32. Undertakings
N-41st Page of 530TOCTopPreviousNextBottomJust 1st
 

As filed with the Securities and Exchange Commission on November 18, 2014 File Nos. 333- 811-03365 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Pre-Effective Amendment No. [] Post-Effective Amendment No. [] and REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 Amendment No. 560 [x] (Check Appropriate Box or Boxes) MetLife Investors USA Separate Account A (Exact Name of Registrant) MetLife Insurance Company USA (Name of Depositor) 11225 North Community House Road Charlotte, NC 28277 (Address of Depositor's Principal Executive Offices) (Zip Code) Depositor's Telephone Number, including Area Code (800) 989-3752 (Name and Address of Agent for Service) Eric T. Steigerwalt President MetLife Insurance Company USA 11225 North Community House Road Charlotte, NC 28277 COPIES TO: W. Thomas Conner Reed Smith LLP 1301 K Street, N.W. Washington, D.C. 20005-3373 APPROXIMATE DATE OF PROPOSED PUBLIC OFFERING As soon as possible after the effective date of this registration statement. The Registrant hereby amends this registration statement on such dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine. TITLE OF SECURITIES BEING REGISTERED Interest in a separate account under individual flexible premium deferred variable annuity contracts.
N-42nd Page of 530TOC1stPreviousNextBottomJust 2nd
THE VARIABLE ANNUITY CONTRACT ISSUED BY METLIFE INSURANCE COMPANY USA AND METLIFE INVESTORS USA SEPARATE ACCOUNT A METLIFE INVESTMENT PORTFOLIO ARCHITECT\SM\ - STANDARD VERSION METLIFE INVESTMENT PORTFOLIO ARCHITECT\SM\ - C SHARE OPTION NOVEMBER 19, 2014 This prospectus describes the flexible premium deferred variable annuity contract offered by MetLife Insurance Company USA (MetLife USA or we or us). The contract is offered for individuals and some tax qualified and non-tax qualified retirement plans. The annuity contract has 81 investment choices - a Fixed Account that offers an interest rate guaranteed by us, and 80 Investment Portfolios listed below. IF YOU SELECT THE C SHARE OPTION, THE FIXED ACCOUNT IS NOT AVAILABLE AS AN INVESTMENT CHOICE. AMERICAN FUNDS INSURANCE SERIES (Reg. TM) (CLASS 4): American Funds Global Small Capitalization Fund BLACKROCK VARIABLE SERIES FUNDS, INC. (CLASS III): BlackRock Global Allocation V.I. Fund IVY FUNDS VARIABLE INSURANCE PORTFOLIOS: Ivy Funds VIP Asset Strategy Fund LEGG MASON PARTNERS VARIABLE EQUITY TRUST (CLASS II): Permal Alternative Select VIT Portfolio MET INVESTORS SERIES TRUST (CLASS B OR, AS NOTED, CLASS C): AllianceBernstein Global Dynamic Allocation Portfolio Allianz Global Investors Dynamic Multi-Asset Plus Portfolio American Funds (Reg. TM) Growth Portfolio (Class C) AQR Global Risk Balanced Portfolio BlackRock Global Tactical Strategies Portfolio BlackRock High Yield Portfolio Clarion Global Real Estate Portfolio ClearBridge Aggressive Growth Portfolio Goldman Sachs Mid Cap Value Portfolio Harris Oakmark International Portfolio Invesco Balanced-Risk Allocation Portfolio Invesco Comstock Portfolio Invesco Mid Cap Value Portfolio Invesco Small Cap Growth Portfolio JPMorgan Core Bond Portfolio JPMorgan Global Active Allocation Portfolio JPMorgan Small Cap Value Portfolio Loomis Sayles Global Markets Portfolio Lord Abbett Bond Debenture Portfolio Met/Artisan International Portfolio Met/Eaton Vance Floating Rate Portfolio Met/Franklin Low Duration Total Return Portfolio Met/Templeton International Bond Portfolio MetLife Balanced Plus Portfolio MetLife Multi-Index Targeted Risk Portfolio MFS (Reg. TM) Emerging Markets Equity Portfolio MFS (Reg. TM) Research International Portfolio Morgan Stanley Mid Cap Growth Portfolio Oppenheimer Global Equity Portfolio PanAgora Global Diversified Risk Portfolio PIMCO Inflation Protected Bond Portfolio PIMCO Total Return Portfolio Pioneer Fund Portfolio Pioneer Strategic Income Portfolio Pyramis (Reg. TM) Government Income Portfolio Pyramis (Reg. TM) Managed Risk Portfolio Schroders Global Multi-Asset Portfolio T. Rowe Price Large Cap Value Portfolio Third Avenue Small Cap Value Portfolio WMC Large Cap Research Portfolio 1
N-43rd Page of 530TOC1stPreviousNextBottomJust 3rd
METROPOLITAN SERIES FUND (CLASS B, OR AS NOTED, CLASS G): Baillie Gifford International Stock Portfolio Barclays Aggregate Bond Index Portfolio (Class G) BlackRock Bond Income Portfolio BlackRock Capital Appreciation Portfolio BlackRock Large Cap Value Portfolio BlackRock Money Market Portfolio Jennison Growth Portfolio Loomis Sayles Small Cap Core Portfolio Met/Dimensional International Small Company Portfolio MetLife Mid Cap Stock Index Portfolio (Class G) MetLife Stock Index Portfolio (Class G) MFS (Reg. TM) Value Portfolio MSCI EAFE (Reg. TM) Index Portfolio (Class G) Neuberger Berman Genesis Portfolio Russell 2000 (Reg. TM) Index Portfolio (Class G) T. Rowe Price Large Cap Growth Portfolio T. Rowe Price Small Cap Growth Portfolio (Class G) Van Eck Global Natural Resources Portfolio Western Asset Management Strategic Bond Opportunities Portfolio Western Asset Management U.S. Government Portfolio WMC Core Equity Opportunities Portfolio PIMCO VARIABLE INSURANCE TRUST (CLASS M): PIMCO CommodityRealReturn (Reg. TM) Strategy Portfolio PIMCO Emerging Markets Bond Portfolio PIMCO Unconstrained Bond Portfolio THE UNIVERSAL INSTITUTIONAL FUNDS, INC. (CLASS II): Global Infrastructure Portfolio VAN ECK VIP TRUST (CLASS S): Van Eck VIP Long/Short Equity Index Fund MET INVESTORS SERIES TRUST - ASSET ALLOCATION PORTFOLIOS: American Funds (Reg. TM) Moderate Allocation Portfolio (Class C) American Funds (Reg. TM) Balanced Allocation Portfolio (Class C) American Funds (Reg. TM) Growth Allocation Portfolio (Class C) MetLife Asset Allocation 100 Portfolio (Class B) SSgA Growth and Income ETF Portfolio (Class B) SSgA Growth ETF Portfolio (Class B) METROPOLITAN SERIES FUND - ASSET ALLOCATION PORTFOLIOS (CLASS B): MetLife Asset Allocation 20 Portfolio MetLife Asset Allocation 40 Portfolio MetLife Asset Allocation 60 Portfolio MetLife Asset Allocation 80 Portfolio Please read this prospectus before investing and keep it on file for future reference. It contains important information about the MetLife USA Variable Annuity Contract. To learn more about the MetLife USA Variable Annuity Contract, you can obtain a copy of the Statement of Additional Information (SAI) dated November 19, 2014. The SAI has been filed with the Securities and Exchange Commission (SEC) and is legally a part of the prospectus. The SEC maintains a Web site (http://www.sec.gov) that contains the SAI, material incorporated by reference, and other information regarding companies that file electronically with the SEC. The Table of Contents of the SAI is on Page 52 of this prospectus. For a free copy of the SAI, call us at (800) 343-8496, visit our website at WWW.METLIFEINVESTORS.COM, or write to us at: 11225 North Community House Road, Charlotte, NC 28277. The contracts: o are not bank deposits o are not FDIC insured o are not insured by any federal government agency o are not guaranteed by any bank or credit union o may be subject to loss of principal THE SECURITIES AND EXCHANGE COMMISSION HAS NOT APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. November 19, 2014 2
N-44th Page of 530TOC1stPreviousNextBottomJust 4th
TABLE OF CONTENTS PAGE [Download Table] INDEX OF SPECIAL TERMS.................. 5 HIGHLIGHTS.............................. 5 FEE TABLES AND EXAMPLES................. 7 1. THE ANNUITY CONTRACT................. 12 2. PURCHASE............................. 13 Purchase Payments.................. 13 Termination for Low Account Value.. 13 Allocation of Purchase Payments.... 14 Free Look.......................... 14 Accumulation Units................. 15 Account Value...................... 15 Replacement of Contracts........... 15 Owning Multiple Contracts.......... 16 3. INVESTMENT OPTIONS................... 16 Investment Portfolios That Are Funds-of-Funds................... 19 Transfers.......................... 20 Asset Allocation Program - Blueprint Models................. 23 Dollar Cost Averaging Program (DCA)............................ 25 Automatic Rebalancing Program...... 25 Voting Rights...................... 26 Substitution of Investment Options. 26 4. EXPENSES............................. 26 Product Charges.................... 26 Account Fee........................ 27 Withdrawal Charge.................. 27 Reduction or Elimination of the Withdrawal Charge................ 28 Premium and Other Taxes............ 28 Transfer Fee....................... 29 Income Taxes....................... 29 Investment Portfolio Expenses...... 29 5. ANNUITY PAYMENTS (THE INCOME PHASE)................. 29 Annuity Date....................... 29 Annuity Payments................... 29 [Download Table] Annuity Options.................... 30 Variable Annuity Payments.......... 31 Fixed Annuity Payments............. 32 6. ACCESS TO YOUR MONEY................. 32 Systematic Withdrawal Program...... 33 Suspension of Payments or Transfers........................ 34 7. PERFORMANCE.......................... 34 8. DEATH BENEFIT........................ 34 Upon Your Death.................... 34 Standard Death Benefit (Account Value)........................... 35 Optional Death Benefit - Return of Premium.......................... 35 General Death Benefit Provisions... 35 Spousal Continuation............... 36 Death of the Annuitant............. 36 Controlled Payout.................. 37 9. FEDERAL INCOME TAX STATUS............ 37 Non-Qualified Contracts............ 37 Qualified Contracts................ 40 10. OTHER INFORMATION................... 46 MetLife USA........................ 46 The Separate Account............... 46 Distributor........................ 47 Selling Firms...................... 47 Requests and Elections............. 49 Ownership.......................... 50 Legal Proceedings.................. 51 Financial Statements............... 51 TABLE OF CONTENTS OF THE STATEMENT OF ADDITIONAL INFORMATION.................. 52 APPENDIX A.............................. A-1 Participating Investment Portfolios....................... A-1 APPENDIX B.............................. B-1 Death Benefit Example.............. B-1 3
N-45th Page of 530TOC1stPreviousNextBottomJust 5th
INDEX OF SPECIAL TERMS Because of the complex nature of the contract, we have used certain words or terms in this prospectus which may need an explanation. We have identified the following as some of these words or terms. The page that is indicated here is where we believe you will find the best explanation for the word or term. These words and terms are in italics on the indicated page. PAGE Account Value............................................................ 15 Accumulation Phase....................................................... 12 Accumulation Unit........................................................ 15 Annuitant................................................................ 51 Annuity Date............................................................. 29 Annuity Options.......................................................... 30 Annuity Payments......................................................... 29 Annuity Service Center................................................... 6 Annuity Units............................................................ 30 Beneficiary.............................................................. 51 Business Day............................................................. 14 Contract Year............................................................ 13 Fixed Account............................................................ 12 Free Look................................................................ 14 Good Order............................................................... 50 Income Phase............................................................. 12 Investment Portfolios.................................................... 16 Joint Owners............................................................. 50 Owner.................................................................... 50 Purchase Payment......................................................... 13 Separate Account......................................................... 46 4
N-46th Page of 530TOC1stPreviousNextBottomJust 6th
HIGHLIGHTS The variable annuity contract that we are offering is a contract between you, the Owner, and us, the insurance company, where you agree to make at least one Purchase Payment to us and we agree to make a series of Annuity Payments at a later date. The contract has a maximum issue age and you should consult with your registered representative. The contract provides a means for investing on a tax-deferred basis in our Fixed Account and the Investment Portfolios. The contract is intended for retirement savings or other long-term investment purposes. When you purchase the contract, you can choose an optional death benefit and fixed and variable income options. We are obligated to pay all money we owe under the contracts, including death benefits and income payments. Any such amount that exceeds the assets in the Separate Account is paid from our general account, subject to our financial strength and claims-paying ability and our long-term ability to make such payments, and is not guaranteed by any other party. (See "Other Information - The Separate Account".) The contract allows you to select one of two different charge structures, referred to as a class, based on your specific situation. The two classes of the contract are the Standard Version and the C Share Option. Each class imposes different mortality and expense charges, and the Standard Version of the contract imposes a withdrawal charge. Depending on your expectations and preferences, you can choose the class that best meets your needs. Prior to issuance, you must select either: o The Standard Version of the contract, which imposes a withdrawal charge on withdrawals equal to a maximum of 7% of each Purchase Payment, reducing over five years, and a mortality and expense charge that is lower than the mortality and expense charge of the C Share Option; or o The C Share Option, which imposes no withdrawal charge but has a mortality and expense charge that is higher than the mortality and expense charge of the Standard Version. If you elect the C Share Option, you may make withdrawals from your contract, including a complete withdrawal, at any time without paying a withdrawal charge, whereas you would need to wait until the sixth Contract Year (i.e., the Contract Year starting on the day after your fifth contract anniversary) under the Standard Version to make a complete withdrawal without a withdrawal charge. However, the C Share Option has a higher mortality and expense charge for the duration of the contract whereas under the Standard Version the withdrawal charge is reduced to 0% after five complete years from the receipt of each Purchase Payment. Which class of the contract is appropriate for you will depend on your particular circumstances, for example the size and timing of Purchase Payments and withdrawals you expect to make. In addition, the Fixed Account is not available if you select the C Share Option. You should carefully consider which of the two classes is appropriate for you. The contract, like all deferred annuity contracts, has two phases: the Accumulation Phase and the Income Phase. During the Accumulation Phase, earnings accumulate on a tax-deferred basis and are taxed as income when you make a withdrawal. For the Standard Version, if you make a withdrawal during the Accumulation Phase, we may assess a withdrawal charge of up to 7%. (There are no withdrawal charges for the C Share Option.) Certain withdrawals, depending on the amount and timing, may negatively impact the guarantees provided by your contract. You should carefully consider whether a withdrawal under a particular circumstance will have any negative impact to your guarantees. The impact of withdrawals generally on your guarantees is discussed in the corresponding sections of the prospectus describing such guarantees. The Income Phase occurs when you or a designated payee begin receiving regular Annuity Payments from your contract. You and the Annuitant (the person on whose life we base Annuity Payments) do not have to be the same, unless you purchase a tax qualified contract. You can have Annuity Payments made on a variable basis, a fixed basis, or a combination of both. If you choose variable Annuity Payments, the amount of the variable Annuity Payments will depend upon the investment performance of the Investment Portfolio(s) you select for the Income Phase. If you choose fixed Annuity Payments, the amount of each payment will not change during the Income Phase. TAX DEFERRAL AND QUALIFIED PLANS. The contracts are offered for individuals and some tax qualified and non-tax qualified retirement plans. For any tax qualified account (e.g., an IRA), the tax deferred accrual feature is provided by the tax qualified retirement plan. Therefore, there 5
N-47th Page of 530TOC1stPreviousNextBottomJust 7th
should be reasons other than tax deferral for acquiring the contract within a qualified plan. (See "Federal Income Tax Status.") STATE VARIATIONS. Contracts issued in your state may provide different features and benefits from, and impose different costs than, those described in this prospectus because of state law variations. These differences include, among other things, Free Look rights, age issuance limitations, transfer rights and limitations, the right to reject Purchase Payments, the right to assess transfer fees, and the requirements for unisex annuity rates. However, please note that the maximum fees and charges for all features and benefits are set forth in the fee table in this prospectus. This prospectus describes all the material features of the contract. If you would like to review a copy of the contract and any endorsements, contact our Annuity Service Center. FREE LOOK. You may cancel the contract within 10 days after receiving it (or whatever period is required in your state). If you mail your cancellation request, the request must be postmarked by the appropriate day; if you deliver your cancellation request by hand, it must be received by us by the appropriate day. Unless otherwise required by state law, you will receive whatever your contract is worth on the day that we receive your cancellation request and we will not deduct a withdrawal charge. The amount you receive may be more or less than your Purchase Payment depending upon the performance of the Investment Portfolios (and, for the Standard Version, any interest credited by the Fixed Account, if applicable). You bear the risk of any decline in Account Value. We do not refund any charges or deductions assessed during the Free Look period. We will return your Purchase Payment if required by law. TAX PENALTY. The earnings in your contract are not taxed until you take money out of your contract. If you take money out of a Non-Qualified Contract during the Accumulation Phase, for tax purposes any earnings are deemed to come out first. If you are younger than 59 1/2 when you take money out, you may be charged a 10% federal tax penalty on those earnings. Payments during the Income Phase are considered partly a return of your original investment until your investment is returned. NON-NATURAL PERSONS AS OWNERS. If the Owner of a non-qualified annuity contract is not a natural person (e.g., a corporation, partnership or certain trusts), gains under the contract are generally not eligible for tax deferral. The Owner of this contract can be a natural person, a trust established for the exclusive benefit of a natural person, a charitable remainder trust or other trust arrangement (if approved by us). The Owner of this contract can also be a Beneficiary of a deceased person's contract that is an Individual Retirement Account or non-qualified deferred annuity. A contract generally may have two Owners (both of whom must be individuals). The contract is not available to corporations or other business organizations, except to the extent an employer is the purchaser of a SEP contract. Subject to state approval, certain retirement plans qualified under the Internal Revenue Code may purchase the contract. If a non-natural person is the Owner of a Non-Qualified Contract, the distribution on death rules under the Internal Revenue Code may require payment to begin earlier than expected and may impact the usefulness of the optional Return of Premium death benefit. NON-NATURAL PERSONS AS BENEFICIARIES. Naming a non-natural person, such as a trust or estate, as a Beneficiary under the contract will generally eliminate the Beneficiary's ability to stretch the contract or a spousal Beneficiary's ability to continue the contract and the death benefits. INQUIRIES. If you need more information, please contact our ANNUITY SERVICE CENTER at: MetLife Investors Distribution Company P.O. Box 10366 Des Moines, Iowa 50306-0366 (800) 343-8496 ELECTRONIC DELIVERY. As an Owner you may elect to receive electronic delivery of current prospectuses related to this contract, prospectuses and annual and semi-annual reports for the Investment Portfolios and other contract related documents. Contact us at WWW.METLIFEINVESTORS.COM for more information and to enroll. 6
N-48th Page of 530TOC1stPreviousNextBottomJust 8th
FEE TABLES AND EXAMPLES THE FOLLOWING TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY WHEN BUYING, OWNING, AND SURRENDERING THE CONTRACT. THE FIRST TABLE DESCRIBES THE FEES AND EXPENSES THAT YOU WILL PAY AT THE TIME THAT YOU BUY THE CONTRACT, SURRENDER THE CONTRACT, OR TRANSFER ACCOUNT VALUE BETWEEN INVESTMENT OPTIONS. STATE PREMIUM TAXES OF 0% TO 3.5% MAY ALSO BE DEDUCTED. -------------------------------------------------------------------------------- OWNER TRANSACTION EXPENSES TABLE [Download Table] WITHDRAWAL CHARGE METLIFE INVESTMENT PORTFOLIO ARCHITECT 7% - STANDARD VERSION (Note 1) (as a percentage of Purchase Payments) METLIFE INVESTMENT PORTFOLIO ARCHITECT None - C SHARE OPTION (as a percentage of Purchase Payments) TRANSFER FEE (Note 2) $25 $0 (First 12 per year) -------------------------------------------------------------------------------- Note 1. For the Standard Version of the contract, if an amount withdrawn is determined to include the withdrawal of prior Purchase Payments, a withdrawal charge may be assessed. Withdrawal charges are calculated in accordance with the following. (See "Expenses - Withdrawal Charge.") [Download Table] Number of Complete Years from Withdrawal Charge Receipt of Purchase Payment (% of Purchase Payment) ------------------------------- ------------------------ 0 7 1 7 2 6 3 6 4 5 5 and thereafter 0 Note 2. There is no charge for the first 12 transfers in a Contract Year; thereafter the fee is $25 per transfer. MetLife USA is currently waiving the transfer fee, but reserves the right to charge the fee in the future. 7
N-49th Page of 530TOC1stPreviousNextBottomJust 9th
THE NEXT TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CONTRACT, NOT INCLUDING INVESTMENT PORTFOLIO FEES AND EXPENSES. -------------------------------------------------------------------------------- [Download Table] ACCOUNT FEE (Note 1) $30 SEPARATE ACCOUNT ANNUAL EXPENSES (Note 2) (referred to as Separate Account Product Charges) (as a percentage of average Account Value in the Separate Account) [Download Table] METLIFE INVESTMENT PORTFOLIO ARCHITECT ---------------------------------------- - STANDARD ---------------------------------------- VERSION ---------------------------------------- Mortality and Expense Charge 0.85% Administration Charge 0.25% ---- Total Separate Account Annual Expenses 1.10% Optional Death Benefit - Return of 0.25% Premium Total Separate Account Annual Expenses Including Charge for Optional Death 1.35% Benefit METLIFE INVESTMENT PORTFOLIO ARCHITECT ---------------------------------------- - C SHARE ---------------------------------------- OPTION ---------------------------------------- Mortality and Expense Charge 1.10% Administration Charge 0.25% ---- Total Separate Account Annual Expenses 1.35% Optional Death Benefit - Return of 0.25% Premium Total Separate Account Annual Expenses Including Charge for Optional Death 1.60% Benefit -------------------------------------------------------------------------------- Note 1. An account fee of $30 is charged on the last day of each Contract Year if the Account Value is less than $50,000. Different policies apply during the Income Phase of the contract. (See "Expenses.") Note 2. Certain charges may not apply during the Income Phase of the contract. (See "Expenses.") 8
N-410th Page of 530TOC1stPreviousNextBottomJust 10th
-------------------------------------------------------------------------------- THE NEXT TABLE SHOWS THE MINIMUM AND MAXIMUM TOTAL OPERATING EXPENSES CHARGED BY THE INVESTMENT PORTFOLIOS THAT YOU MAY PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CONTRACT. CERTAIN INVESTMENT PORTFOLIOS MAY IMPOSE A REDEMPTION FEE IN THE FUTURE. MORE DETAIL CONCERNING EACH INVESTMENT PORTFOLIO'S FEES AND EXPENSES IS CONTAINED IN THE PROSPECTUSES FOR THE INVESTMENT PORTFOLIOS. [Download Table] Minimum Maximum ------- ------- Total Annual Portfolio Expenses 0.57% 2.94% (expenses that are deducted from investment portfolio assets, including management fees, 12b-1/service fees, and other expenses) -------------------------------------------------------------------------------- FOR INFORMATION CONCERNING COMPENSATION PAID FOR THE SALE OF THE CONTRACTS, SEE "OTHER INFORMATION - DISTRIBUTOR." 9
N-411th Page of 530TOC1stPreviousNextBottomJust 11th
EXAMPLES THESE EXAMPLES ARE INTENDED TO HELP YOU COMPARE THE COST OF INVESTING IN THE CONTRACT WITH THE COST OF INVESTING IN OTHER VARIABLE ANNUITY CONTRACTS. THESE COSTS INCLUDE CONTRACT OWNER TRANSACTION EXPENSES, CONTRACT FEES, SEPARATE ACCOUNT ANNUAL EXPENSES, AND INVESTMENT PORTFOLIO FEES AND EXPENSES. THE EXAMPLES ASSUME THAT YOU INVEST $10,000 IN THE CONTRACT FOR THE TIME PERIODS INDICATED. THE EXAMPLES ALSO ASSUME THAT YOUR INVESTMENT HAS A 5% RETURN EACH YEAR AND ASSUME: (A) MAXIMUM AND (B) MINIMUM FEES AND EXPENSES OF ANY OF THE INVESTMENT PORTFOLIOS (BEFORE ANY WAIVER AND/OR REIMBURSEMENT). ALTHOUGH YOUR ACTUAL COSTS MAY BE HIGHER OR LOWER, BASED ON THESE ASSUMPTIONS, YOUR COSTS WOULD BE: METLIFE INVESTMENT PORTFOLIO ARCHITECT - STANDARD VERSION CHART 1. Chart 1 assumes you select the optional Return of Premium death benefit, which is the most expensive way to purchase the contract. (1) IF YOU SURRENDER YOUR CONTRACT AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ------------ ------------ ------------ ------------ maximum (a)$1,158 (a)$1,919 (a)$2,756 (a)$4,658 minimum (b)$921 (b)$1,220 (b)$1,612 (b)$2,475 (2) IF YOU DO NOT SURRENDER YOUR CONTRACT OR IF YOU ANNUITIZE AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ---------- ------------ ------------ ------------ maximum (a)$458 (a)$1,379 (a)$2,306 (a)$4,658 minimum (b)$221 (b)$680 (b)$1,162 (b)$2,475 CHART 2. Chart 2 assumes that you do not select the optional Return of Premium death benefit, which is the least expensive way to purchase the contract. (1) IF YOU SURRENDER YOUR CONTRACT AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ------------ ------------ ------------ ------------ maximum (a)$1,133 (a)$1,847 (a)$2,641 (a)$4,451 minimum (b)$897 (b)$1,145 (b)$1,485 (b)$2,214 (2) IF YOU DO NOT SURRENDER YOUR CONTRACT OR IF YOU ANNUITIZE AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ---------- ------------ ------------ ------------ maximum (a)$433 (a)$1,307 (a)$2,191 (a)$4,451 minimum (b)$197 (b)$605 (b)$1,035 (b)$2,214 10
N-412th Page of 530TOC1stPreviousNextBottomJust 12th
METLIFE INVESTMENT PORTFOLIO ARCHITECT - C SHARE OPTION CHART 1. Chart 1 assumes you select the optional Return of Premium death benefit, which is the most expensive way to purchase the contract. (1) IF YOU SURRENDER, DO NOT SURRENDER OR IF YOU ANNUITIZE YOUR CONTRACT AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ---------- ------------ ------------ ------------ maximum (a)$483 (a)$1,450 (a)$2,421 (a)$4,860 minimum (b)$246 (b)$756 (b)$1,288 (b)$2,730 CHART 2. Chart 2 assumes that you do not select the optional Return of Premium death benefit, which is the least expensive way to purchase the contract. (1) IF YOU SURRENDER, DO NOT SURRENDER OR IF YOU ANNUITIZE YOUR CONTRACT AT THE END OF THE APPLICABLE TIME PERIOD: [Download Table] Time Periods 1 year 3 years 5 years 10 years ---------- ------------ ------------ ------------ maximum (a)$458 (a)$1,379 (a)$2,306 (a)$4,658 minimum (b)$221 (b)$680 (b)$1,162 (b)$2,475 The Examples should not be considered a representation of past or future expenses or annual rates of return of any Investment Portfolio. Actual expenses and annual rates of return may be more or less than those assumed for the purpose of the Examples. Condensed financial information (Accumulation Unit value information) is not available because the contract was not offered for sale prior to November 19, 2014, and therefore there are no Accumulation Units outstanding as of the date of this prospectus. 11
N-413th Page of 530TOC1stPreviousNextBottomJust 13th
1. THE ANNUITY CONTRACT This prospectus describes the Variable Annuity Contract offered by us. The variable annuity contract is a contract between you as the Owner, and us, the insurance company, where we promise to pay an income to you, in the form of Annuity Payments, beginning on a designated date that you select. Until you decide to begin receiving Annuity Payments, your annuity is in the ACCUMULATION PHASE. Once you begin receiving Annuity Payments, your contract switches to the INCOME PHASE. The contract benefits from tax deferral. Tax deferral means that you are not taxed on earnings or appreciation on the assets in your contract until you take money out of your contract. For any tax qualified account (e.g., an IRA), the tax deferred accrual feature is provided by the tax qualified retirement plan. Therefore, there should be reasons other than tax deferral for acquiring the contract within a qualified plan. (See "Federal Income Tax Status.") The contract is called a variable annuity because you can choose among the Investment Portfolios and, depending upon market conditions, you can make or lose money in any of these portfolios. If you select the variable annuity portion of the contract, the amount of money you are able to accumulate in your contract during the Accumulation Phase depends upon the investment performance of the Investment Portfolio(s) you select. The amount of the Annuity Payments you receive during the Income Phase from the variable annuity portion of the contract also depends, in part, upon the investment performance of the Investment Portfolio(s) you select for the Income Phase. We do not guarantee the investment performance of the variable annuity portion. You bear the full investment risk for all amounts allocated to the variable annuity portion. In most states, the Standard Version of the contract also contains a FIXED ACCOUNT option (contact your registered representative regarding your state; the Fixed Account is not available with the C Share Option). The Fixed Account is part of our general account and offers an interest rate that is guaranteed by us. The minimum interest rate depends on the date your contract is issued but will not be less than 1%. Your registered representative can tell you the current and minimum interest rates that apply. Because of exemptive and exclusionary provisions, interests in the Fixed Account have not been registered under the Securities Act of 1933, and neither the Fixed Account nor the general account has been registered as an investment company under the Investment Company Act of 1940. Therefore, although the Standard Version of the contract makes interests in the Fixed Account generally available for allocation of Purchase Payments and Account Value (subject to limitations - see, for example, "Purchase Payments - Allocation of Purchase Payments" and "Investment Options - Transfers - General"), for securities law purposes the descriptions of the Fixed Account in this prospectus do not consitute an offer to sell, or a solicitation of an offer to buy, Fixed Account interests. If you select the Fixed Account, your money will be placed with our other general account assets, and the amount of money you are able to accumulate in your contract during the Accumulation Phase depends upon the total interest credited to your contract. The Fixed Account is part of our general account. Our general account consists of all assets owned by us other than those in the Separate Account and our other separate accounts. We have sole discretion over the investment of assets in the general account. If you select a fixed Annuity Payment option during the Income Phase, payments are made from our general account assets. All guarantees as to Purchase Payments or Account Value allocated to the Fixed Account, interest credited to the Fixed Account, and fixed Annuity Payments are subject to our financial strength and claims-paying ability. The amount of the Annuity Payments you receive during the Income Phase from a fixed Annuity Payment option of the contract will remain level for the entire Income Phase. (Please see "Annuity Payments (The Income Phase)" for more information.) As Owner of the contract, you exercise all interests and rights under the contract. You can change the Owner at any time, subject to our underwriting rules (see "Death Benefit" for information on how a change of ownership may affect the death benefit). The contract may be owned generally by Joint Owners (limited to two natural persons). We provide more information on this under "Other Information - Ownership." All contract provisions will be interpreted and administered in accordance with the requirements of the Internal Revenue Code (the "Code"). Any Code references to 12
N-414th Page of 530TOC1stPreviousNextBottomJust 14th
"spouses" include those persons who are married spouses under state law, regardless of sex. 2. PURCHASE The contract may not be available for purchase through your broker dealer ("selling firm") during certain periods. There are a number of reasons why the contract periodically may not be available, including that the insurance company wants to limit the volume of sales of the contract. You may wish to speak to your registered representative about how this may affect your purchase. For example, you may be required to submit your purchase application in Good Order prior to or on a stipulated date in order to purchase a contract, and a delay in such process could result in your not being able to purchase a contract. In addition, the optional death benefit rider described in this prospectus may not be available through your selling firm, which you may also wish to discuss with your registered representative. Your selling firm may offer the contract with a lower maximum issue age for the contract than other selling firms. We reserve the right to reject any application. PURCHASE PAYMENTS A PURCHASE PAYMENT is the money you give us to invest in the contract. The initial Purchase Payment is due on the date the contract is issued. You may also be permitted to make subsequent Purchase Payments. Initial and subsequent Purchase Payments are subject to certain requirements. These requirements are explained below. We may restrict your ability to make subsequent Purchase Payments. The manner in which subsequent Purchase Payments may be restricted is discussed below. GENERAL REQUIREMENTS FOR PURCHASE PAYMENTS. The following requirements apply to initial and subsequent Purchase Payments: o The minimum initial Purchase Payment we will accept is $10,000. o If you want to make an initial Purchase Payment of $1 million or more, or a subsequent Purchase Payment that would cause your total Purchase Payments to exceed $1 million, you will need our prior approval. o The minimum subsequent Purchase Payment is $500 unless you have elected an electronic funds transfer program approved by us, in which case the minimum subsequent Purchase Payment is $100 per month. o We will accept a different amount if required by federal tax law. o We reserve the right to refuse Purchase Payments made via a personal check in excess of $100,000. Purchase Payments over $100,000 may be accepted in other forms, including, but not limited to, EFT/wire transfers, certified checks, corporate checks, and checks written on financial institutions. The form in which we receive a Purchase Payment may determine how soon subsequent disbursement requests may be fulfilled. (See "Access to Your Money.") o We will not accept Purchase Payments made with cash, money orders, or travelers checks. RESTRICTIONS ON SUBSEQUENT PURCHASE PAYMENTS. We may restrict your ability to make subsequent Purchase Payments. We will notify you in advance if we impose restrictions on subsequent Purchase Payments. You and your financial representative should carefully consider whether our ability to restrict subsequent Purchase Payments is consistent with your investment objectives. o We reserve the right to reject any Purchase Payment and to limit future Purchase Payments. This means that we may restrict your ability to make subsequent Purchase Payments for any reason, subject to applicable requirements in your state. We may make certain exceptions to restrictions on subsequent Purchase Payments in accordance with our established administrative procedures. TERMINATION FOR LOW ACCOUNT VALUE We may terminate your contract by paying you the Account Value in one sum if, prior to the Annuity Date, you do not make Purchase Payments for two consecutive Contract Years, the total amount of Purchase Payments made, less any partial withdrawals, is less than $2,000 or any lower amount required by federal tax laws, and the Account Value on or after the end of such two year period is less than $2,000. (A CONTRACT YEAR is defined as a one-year period starting on the date the contract is issued and on each contract anniversary thereafter.) Accordingly, no contract will be terminated due solely to negative investment performance. Federal tax law may impose additional restrictions on our right to cancel your Traditional IRA, Roth IRA, SEP, or other Qualified Contract. We will not terminate any contract that includes a guaranteed death benefit if at the time the termination would otherwise occur, the guaranteed amount under any 13
N-415th Page of 530TOC1stPreviousNextBottomJust 15th
death benefit is greater than the Account Value. For all other contracts, we reserve the right to exercise this termination provision, subject to obtaining any required regulatory approvals. ALLOCATION OF PURCHASE PAYMENTS When you purchase a contract, we will allocate your Purchase Payment to the Fixed Account and/or any of the Investment Portfolios you have selected. You may not choose more than 40 Investment Portfolios (including the Fixed Account) at the time your initial Purchase Payment is allocated. The Fixed Account is not available if you selected the C Share Option. Each allocation must be at least $500 and must be in whole numbers. Your selling firm may make one or more of the Investment Portfolios unavailable when you apply for the contract. However, after your contract has been issued, all of the Investment Portfolios are available for Purchase Payments or Account Value transfers. Please be aware that your registered representative may not be able to provide you any information or answer any questions you may have about the Investment Portfolio(s) that your selling firm does make unavailable. Therefore, for transactions involving such Investment Portfolio(s), you may need to contact us directly, as described in the "Other Information - Requests and Elections" section. Any such transfer will be counted for purposes of any applicable transfer fee. (See "Expenses-Transfer Fee.") We have reserved the right to restrict payments to the Fixed Account if any of the following conditions exist: o the credited interest rate on the Fixed Account is equal to the guaranteed minimum rate indicated in your contract; or o your Account Value in the Fixed Account equals or exceeds our published maximum for Fixed Account allocation (currently, there is no limit; we will notify you of any such maximum allocation limit); or o a transfer was made out of the Fixed Account within the previous 180 days. Once we receive your Purchase Payment and the necessary information (or a designee receives a payment and the necessary information in accordance with the designee's administrative procedures), we will issue your contract and allocate your first Purchase Payment within 2 Business Days. A BUSINESS DAY is each day that the New York Stock Exchange is open for business. A Business Day closes at the close of normal trading on the New York Stock Exchange, usually 4:00 p.m. Eastern Time. If you do not give us all of the information we need, we will contact you to get it before we make any allocation. If for some reason we are unable to complete this process within 5 Business Days, we will either send back your money or get your permission to keep it until we get all of the necessary information. (See "Other Information - Requests and Elections.") If you make additional Purchase Payments, we will allocate them in the same way as your first Purchase Payment unless you tell us otherwise. However, if you make an additional Purchase Payment while a Dollar Cost Averaging (DCA) program is in effect, we will not allocate the additional Purchase Payment to the DCA program, unless you tell us to do so. Instead, unless you give us other instructions, we will allocate the additional Purchase Payment directly to the same destination Investment Portfolios you selected under the DCA program. (See "Investment Options - Dollar Cost Averaging Program.") You may change your allocation instructions at any time by notifying us in writing, by calling us or by Internet. You may not choose more than 40 Investment Portfolios (including the Fixed Account) at the time you submit a subsequent Purchase Payment. The Fixed Account is not available if you select the C Share Option. If you wish to allocate the payment to more than 40 Investment Portfolios (including the Fixed Account, if available), we must have your request to allocate future Purchase Payments to more than 40 Investment Portfolios on record before we can apply your subsequent Purchase Payment to your chosen allocation. If there are Joint Owners, unless we are instructed to the contrary, we will accept allocation instructions from either Joint Owner. FREE LOOK If you change your mind about owning this contract, you can cancel it within 10 days after receiving it (or the period required in your state). We ask that you submit your request to cancel in writing, signed by you, to our Annuity Service Center. When you cancel the contract within this FREE LOOK period, we will not assess a withdrawal charge. Unless otherwise required by state law, you will receive back whatever your contract is worth on the day we receive your request. This may be more or less than your Purchase Payment depending upon the performance of the Investment Portfolios (and, for the Standard Version, any interest credited by the Fixed Account, if applicable) according to your Purchase Payment allocation during the Free Look period. This means that you bear the risk of any decline in the value of your contract due to Investment 14
N-416th Page of 530TOC1stPreviousNextBottomJust 16th
Portfolio performance during the Free Look period. We do not refund any charges or deductions assessed during the Free Look period. In certain states, we are required to give you back your Purchase Payment if you decide to cancel your contract during the Free Look period. ACCUMULATION UNITS The portion of your Account Value allocated to the Separate Account will go up or down depending upon the investment performance of the Investment Portfolio(s) you choose. In order to keep track of this portion of your Account Value, we use a unit of measure we call an ACCUMULATION UNIT. (An Accumulation Unit works like a share of a mutual fund.) In addition to the investment performance of the Investment Portfolio, the deduction of Separate Account charges also affects an Investment Portfolio's Accumulation Unit Value, as explained below. Every Business Day as of the close of the New York Stock Exchange (generally 4:00 p.m. Eastern Time), we determine the value of an Accumulation Unit for each of the Investment Portfolios by multiplying the Accumulation Unit value for the immediately preceding Business Day by a factor for the current Business Day. The factor is determined by: 1) dividing the net asset value per share of the Investment Portfolio at the end of the current Business Day, plus any dividend or capital gains per share declared on behalf of the Investment Portfolio as of that day, by the net asset value per share of the Investment Portfolio for the previous Business Day, and 2) multiplying it by one minus the Separate Account product charges (including any rider charge for the Return of Premium death benefit) for each day since the last Business Day and any charges for taxes. The value of an Accumulation Unit may go up or down from day to day. When you make a Purchase Payment, we credit your contract with Accumulation Units. The number of Accumulation Units credited is determined by dividing the amount of the Purchase Payment allocated to an Investment Portfolio by the value of the Accumulation Unit for that Investment Portfolio. Purchase Payments and transfer requests are credited to a contract on the basis of the Accumulation Unit value next determined after receipt of a Purchase Payment or transfer request. Purchase Payments or transfer requests received before the close of the New York Stock Exchange will be credited to your ------ contract that day, after the New York Stock Exchange closes. Purchase Payments or transfer requests received after the close of the New York Stock Exchange, ----- or on a day when the New York Stock Exchange is not open, will be treated as received on the next day the New York Stock Exchange is open (the next Business Day). EXAMPLE: On Monday we receive an additional Purchase Payment of $5,000 from you before 4:00 p.m. Eastern Time. You have told us you want this to go to the MetLife Asset Allocation 60 Portfolio. When the New York Stock Exchange closes on that Monday, we determine that the value of an Accumulation Unit for the MetLife Asset Allocation 60 Portfolio is $12.50. We then divide $5,000 by $12.50 and credit your contract on Monday night with 400 Accumulation Units for the MetLife Asset Allocation 60 Portfolio. ACCOUNT VALUE ACCOUNT VALUE is equal to the sum of your interests in the Investment Portfolios and the Fixed Account. Your interest in each Investment Portfolio is determined by multiplying the number of Accumulation Units for that portfolio by the value of the Accumulation Unit. REPLACEMENT OF CONTRACTS EXCHANGE PROGRAMS. From time to time we may offer programs under which certain fixed or variable annuity contracts previously issued by us or one of our affiliates may be exchanged for the contracts offered by this prospectus. Currently, with respect to exchanges from certain of our variable annuity contracts to this contract, an existing contract is eligible for exchange if a withdrawal from, or surrender of, the contract would not trigger a withdrawal charge (certain restrictions may apply if the existing contract has living benefits). The Account Value of a Standard Version of this contract attributable to the exchanged assets will not be subject to any withdrawal charge (there are no withdrawal charges for the C Share Option). Any additional Purchase Payments contributed to the new contract will be subject to all fees and charges, including the withdrawal charge described in this prospectus. You should carefully consider whether an exchange is appropriate for you by comparing the death benefits, living benefits, and other guarantees provided by the contract you currently own to the benefits and guarantees that would be provided by the new contract offered by this prospectus. Then, you should compare the 15
N-417th Page of 530TOC1stPreviousNextBottomJust 17th
fees and charges (for example, the death benefit charges, the living benefit charges, and the mortality and expense charge) of your current contract to the fees and charges of the new contract, which may be higher than your current contract. The programs we offer will be made available on terms and conditions determined by us, and any such programs will comply with applicable law. We believe the exchanges will be tax free for federal income tax purposes; however, you should consult your tax adviser before making any such exchange. OTHER EXCHANGES. Generally you can exchange one variable annuity contract for another in a tax-free exchange under Section 1035 of the Internal Revenue Code. Before making an exchange, you should compare both annuities carefully. If you exchange another annuity for the one described in this prospectus, unless the exchange occurs under one of our exchange programs as described above, you might have to pay a withdrawal charge on your old annuity, and there will be a new withdrawal charge period for the Standard Version this contract (there is no withdrawal charge period for the C Share Option). Other charges may be higher (or lower) and the benefits may be different. Also, because we will not issue the contract until we have received the initial premium from your existing insurance company, the issuance of the contract may be delayed. Generally, it is not advisable to purchase a contract as a replacement for an existing variable annuity contract. Before you exchange another annuity for our contract, ask your registered representative whether the exchange would be advantageous, given the contract features, benefits and charges. OWNING MULTIPLE CONTRACTS You may be considering purchasing this contract when you already own a variable annuity contract. You should carefully consider whether purchasing an additional contract in this situation is appropriate for you by comparing the features of the contract you currently own, including the death benefits, living benefits, and other guarantees provided by the contract, to the features of this contract. You should also compare the fees and charges of your current contract to the fees and charges of this contract, which may be higher than your current contract. You may also wish to discuss purchasing a contract in these circumstances with your registered representative. 3. INVESTMENT OPTIONS The contract offers 80 INVESTMENT PORTFOLIOS, which are listed below. Additional Investment Portfolios may be available in the future. YOU SHOULD READ THE PROSPECTUSES FOR THESE FUNDS CAREFULLY. YOU CAN OBTAIN COPIES OF THE FUND PROSPECTUSES BY CALLING OR WRITING TO US AT: METLIFE INSURANCE COMPANY USA, ANNUITY SERVICE CENTER, P.O. BOX 10366, DES MOINES, IOWA 50306-0366, (800) 343-8496. YOU CAN ALSO OBTAIN INFORMATION ABOUT THE FUNDS (INCLUDING A COPY OF THE STATEMENT OF ADDITIONAL INFORMATION) BY ACCESSING THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV. APPENDIX A CONTAINS A SUMMARY OF ADVISERS, SUBADVISERS, AND INVESTMENT OBJECTIVES FOR EACH INVESTMENT PORTFOLIO. The investment objectives and policies of certain of the Investment Portfolios may be similar to the investment objectives and policies of other mutual funds that certain of the portfolios' investment advisers manage. Although the objectives and policies may be similar, the investment results of the Investment Portfolios may be higher or lower than the results of such other mutual funds. The investment advisers cannot guarantee, and make no representation, that the investment results of similar funds will be comparable even though the funds may have the same investment advisers. Shares of the Investment Portfolios may be offered to insurance company separate accounts of both variable annuity and variable life insurance contracts and to qualified plans. Due to differences in tax treatment and other considerations, the interests of various Owners participating in, and the interests of qualified plans investing in the Investment Portfolios may conflict. The Investment Portfolios will monitor events in order to identify the existence of any material irreconcilable conflicts and determine what action, if any, should be taken in response to any such conflict. CERTAIN PAYMENTS WE RECEIVE WITH REGARD TO THE INVESTMENT PORTFOLIOS. An investment adviser (other than our affiliate MetLife Advisers, LLC) or subadviser of an Investment Portfolio, or its affiliates, may make 16
N-418th Page of 530TOC1stPreviousNextBottomJust 18th
payments to us and/or certain of our affiliates. These payments may be used for a variety of purposes, including payment of expenses for certain administrative, marketing, and support services with respect to the contracts and, in our role as an intermediary, with respect to the Investment Portfolios. We and our affiliates may profit from these payments. These payments may be derived, in whole or in part, from the advisory fee deducted from Investment Portfolio assets. Contract Owners, through their indirect investment in the Investment Portfolios, bear the costs of these advisory fees (see the Investment Portfolios' prospectuses for more information). The amount of the payments we receive is based on a percentage of assets of the Investment Portfolios attributable to the contracts and certain other variable insurance products that we and our affiliates issue. These percentages differ and some advisers or subadvisers (or their affiliates) may pay us more than others. These percentages currently range up to 0.50%. Additionally, an investment adviser (other than our affiliate MetLife Advisers, LLC) or subadviser of an Investment Portfolio or its affiliates may provide us with wholesaling services that assist in the distribution of the contracts and may pay us and/or certain of our affiliates amounts to participate in sales meetings. These amounts may be significant and may provide the adviser or subadviser (or its affiliate) with increased access to persons involved in the distribution of the contracts. We and/or certain of our affiliated insurance companies have joint ownership interests in our affiliated investment adviser, MetLife Advisers, LLC, which is formed as a "limited liability company." Our ownership interests in MetLife Advisers, LLC entitle us to profit distributions if the adviser makes a profit with respect to the advisory fees it receives from the Investment Portfolios. We will benefit accordingly from assets allocated to the Investment Portfolios to the extent they result in profits to the adviser. (See the prospectsues for the Investment Portfolios for information on the management fees paid by the Investment Portfolios and the Statement of Additional Information for the Investment Portfolios for information on the management fees paid by the adviser to the subadvisers.) Certain Investment Portfolios have adopted a Distribution Plan under Rule 12b-1 of the Investment Company Act of 1940. An Investment Portfolio's 12b-1 Plan, if any, is described in more detail in the Investment Portfolio's prospectus. Any payments we receive pursuant to those 12b-1 Plans are paid to us or our distributor. (See "Distributor" for more information.) Payments under an Investment Portfolio's 12b-1 Plan decrease the Investment Portfolio's investment return. We select the Investment Portfolios offered through this contract based on a number of criteria, including asset class coverage, the strength of the adviser's or subadviser's reputation and tenure, brand recognition, performance, and the capability and qualification of each investment firm. Another factor we consider during the selection process is whether the Investment Portfolio's adviser or subadviser is one of our affiliates or whether the Investment Portfolio, its adviser, its subadviser(s), or an affiliate will make payments to us or our affiliates. In this regard, the profit distributions we receive from our affiliated investment adviser are a component of the total revenue that we consider in configuring the features and investment choices available in the variable insurance products that we and our affiliated insurance companies issue. Since we and our affiliated insurance companies may benefit more from the allocation of assets to portfolios advised by our affiliates than to those that are not, we may be more inclined to offer portfolios advised by our affiliates in the variable insurance products we issue. We review the Investment Portfolios periodically and may remove an Investment Portfolio or limit its availability to new Purchase Payments and/or transfers of Account Value if we determine that the Investment Portfolio no longer meets one or more of the selection criteria, and/or if the Investment Portfolio has not attracted significant allocations from contract Owners. In some cases, we have included Investment Portfolios based on recommendations made by selling firms. These selling firms may receive payments from the Investment Portfolios they recommend and may benefit accordingly from the allocation of Account Value to such Investment Portfolios. WE DO NOT PROVIDE ANY INVESTMENT ADVICE AND DO NOT RECOMMEND OR ENDORSE ANY PARTICULAR INVESTMENT PORTFOLIO. YOU BEAR THE RISK OF ANY DECLINE IN THE ACCOUNT VALUE OF YOUR CONTRACT RESULTING FROM THE PERFORMANCE OF THE INVESTMENT PORTFOLIOS YOU HAVE CHOSEN. We make certain payments to American Funds Distributors, Inc., principal underwriter for the American 17
N-419th Page of 530TOC1stPreviousNextBottomJust 19th
Funds Insurance Series (Reg. TM). (See "Other Information - Distributor.") AMERICAN FUNDS INSURANCE SERIES (Reg. TM) (CLASS 4) American Funds Insurance Series (Reg. TM) is a mutual fund with multiple portfolios. Capital Research and Management Company is the investment adviser to each portfolio. The following Class 4 portfolio is available under the contract: American Funds Global Small Capitalization Fund BLACKROCK VARIABLE SERIES FUNDS, INC. (CLASS III) BlackRock Variable Series Funds, Inc. is a mutual fund with multiple portfolios. BlackRock Advisors, LLC. is the manager of the portfolios. The following Class III portfolio is available under the contract: BlackRock Global Allocation V.I. Fund IVY FUNDS VARIABLE INSURANCE PORTFOLIOS Ivy Funds Variable Insurance Portfolios is a mutual fund with multiple portfolios. Waddell & Reed Investment Management Company is the investment manager for each portfolio. The following Class A portfolio is available under the contract: Ivy Funds VIP Asset Strategy Fund LEGG MASON PARTNERS VARIABLE EQUITY TRUST (CLASS II) Legg Mason Partners Variable Equity Trust is a mutual fund with multiple portfolios. Legg Mason Partners Fund Advisor, LLC is the investment adviser to each portfolio. Legg Mason Partners Fund Advisor, LLC has engaged subadvisers to provide investment advice for the individual Investment Portfolios. (See Appendix A for the names of the subadvisers.) The following Class II portfolio is available under the contract: Permal Alternative Select VIT Portfolio MET INVESTORS SERIES TRUST (CLASS B OR, AS NOTED, CLASS C) Met Investors Series Trust is a mutual fund with multiple portfolios. MetLife Advisers, LLC (MetLife Advisers), an affiliate of MetLife, is the investment manager of Met Investors Series Trust. MetLife Advisers has engaged subadvisers to provide investment advice for the individual Investment Portfolios. (See Appendix A for the names of the subadvisers.) The following Class B or, as noted, Class C portfolios are available under the contract: AllianceBernstein Global Dynamic Allocation Portfolio Allianz Global Investors Dynamic Multi-Asset Plus Portfolio American Funds (Reg. TM) Growth Portfolio (Class C) AQR Global Risk Balanced Portfolio BlackRock Global Tactical Strategies Portfolio BlackRock High Yield Portfolio Clarion Global Real Estate Portfolio ClearBridge Aggressive Growth Portfolio Goldman Sachs Mid Cap Value Portfolio Harris Oakmark International Portfolio Invesco Balanced-Risk Allocation Portfolio Invesco Comstock Portfolio Invesco Mid Cap Value Portfolio Invesco Small Cap Growth Portfolio JPMorgan Core Bond Portfolio JPMorgan Global Active Allocation Portfolio JPMorgan Small Cap Value Portfolio Loomis Sayles Global Markets Portfolio Lord Abbett Bond Debenture Portfolio Met/Artisan International Portfolio Met/Eaton Vance Floating Rate Portfolio Met/Franklin Low Duration Total Return Portfolio Met/Templeton International Bond Portfolio MetLife Balanced Plus Portfolio MetLife Multi-Index Targeted Risk Portfolio MFS (Reg. TM) Emerging Markets Equity Portfolio MFS (Reg. TM) Research International Portfolio Morgan Stanley Mid Cap Growth Portfolio Oppenheimer Global Equity Portfolio PanAgora Global Diversified Risk Portfolio PIMCO Inflation Protected Bond Portfolio PIMCO Total Return Portfolio Pioneer Fund Portfolio Pioneer Strategic Income Portfolio Pyramis (Reg. TM) Government Income Portfolio Pyramis (Reg. TM) Managed Risk Portfolio Schroders Global Multi-Asset Portfolio T. Rowe Price Large Cap Value Portfolio Third Avenue Small Cap Value Portfolio WMC Large Cap Research Portfolio METROPOLITAN SERIES FUND (CLASS B, OR AS NOTED, CLASS G) Metropolitan Series Fund is a mutual fund with multiple portfolios. MetLife Advisers is the investment adviser to the portfolios. MetLife Advisers has engaged subadvisers to provide investment advice for the individual Investment Portfolios. (See Appendix A for the names of the subadvisers.) The following Class B, or as noted, Class G portfolios are available under the contract: Baillie Gifford International Stock Portfolio 18
N-420th Page of 530TOC1stPreviousNextBottomJust 20th
Barclays Aggregate Bond Index Portfolio (Class G) BlackRock Bond Income Portfolio BlackRock Capital Appreciation Portfolio BlackRock Large Cap Value Portfolio BlackRock Money Market Portfolio Jennison Growth Portfolio Loomis Sayles Small Cap Core Portfolio Met/Dimensional International Small Company Portfolio MetLife Mid Cap Stock Index Portfolio (Class G) MetLife Stock Index Portfolio (Class G) MFS (Reg. TM) Value Portfolio MSCI EAFE (Reg. TM) Index Portfolio (Class G) Neuberger Berman Genesis Portfolio Russell 2000 (Reg. TM) Index Portfolio (Class G) T. Rowe Price Large Cap Growth Portfolio T. Rowe Price Small Cap Growth Portfolio (Class G) Van Eck Global Natural Resources Portfolio Western Asset Management Strategic Bond Opportunities Portfolio Western Asset Management U.S. Government Portfolio WMC Core Equity Opportunities Portfolio PIMCO VARIABLE INSURANCE TRUST (CLASS M) PIMCO Variable Insurance Trust is a mutual fund with multiple portfolios. Pacific Investment Management Company LLC is the investment adviser to each portfolio. The following Class M portfolios are available under the contract: PIMCO CommodityRealReturn (Reg. TM) Strategy Portfolio PIMCO Emerging Markets Bond Portfolio PIMCO Unconstrained Bond Portfolio THE UNIVERSAL INSTITUTIONAL FUNDS, INC. (CLASS II) The Universal Institutional Funds, Inc. is a mutual fund with multiple portfolios. The Portfolios are managed by Morgan Stanley Investment Management Inc. The following Class II portfolio is available under the contract: Global Infrastructure Portfolio VAN ECK VIP TRUST (CLASS S) Van Eck VIP Trust is a mutual fund with multiple portfolios. Van Eck Associates Corporation serves as investment adviser to the portfolios. The following Class S portfolio is available under the contract. Van Eck VIP Long/Short Equity Index Fund MET INVESTORS SERIES TRUST - ASSET ALLOCATION PORTFOLIOS In addition to the portfolios listed above under Met Investors Series Trust, the following portfolios are available under the contract: American Funds (Reg. TM) Moderate Allocation Portfolio (Class C) American Funds (Reg. TM) Balanced Allocation Portfolio (Class C) American Funds (Reg. TM) Growth Allocation Portfolio (Class C) MetLife Asset Allocation 100 Portfolio (Class B) SSgA Growth and Income ETF Portfolio (Class B) SSgA Growth ETF Portfolio (Class B) METROPOLITAN SERIES FUND - ASSET ALLOCATION PORTFOLIOS: In addition to the portfolios listed above under Metropolitan Series Fund, the following Class B portfolios are available under the contract: MetLife Asset Allocation 20 Portfolio MetLife Asset Allocation 40 Portfolio MetLife Asset Allocation 60 Portfolio MetLife Asset Allocation 80 Portfolio INVESTMENT PORTFOLIOS THAT ARE FUNDS-OF-FUNDS The following Investment Portfolios available within Met Investors Series Trust and Metropolitan Series Fund are "funds of funds": American Funds (Reg. TM) Balanced Allocation Portfolio American Funds (Reg. TM) Growth Allocation Portfolio American Funds (Reg. TM) Moderate Allocation Portfolio BlackRock Global Tactical Strategies Portfolio MetLife Asset Allocation 20 Portfolio MetLife Asset Allocation 40 Portfolio MetLife Asset Allocation 60 Portfolio MetLife Asset Allocation 80 Portfolio MetLife Asset Allocation 100 Portfolio MetLife Balanced Plus Portfolio MetLife Multi-Index Targeted Risk Portfolio Pyramis (Reg. TM) Managed Risk Portfolio SSgA Growth and Income ETF Portfolio SSgA Growth ETF Portfolio 19
N-421st Page of 530TOC1stPreviousNextBottomJust 21st
"Fund of funds" Investment Portfolios invest substantially all of their assets in other portfolios or, with respect to the SSgA Growth and Income ETF Portfolio and the SSgA Growth ETF Portfolio, other exchange-traded funds ("Underlying ETFs"). Therefore, each of these Investment Portfolios will bear its pro rata share of the fees and expenses incurred by the underlying portfolios or Underlying ETFs in which it invests in addition to its own management fees and expenses. This will reduce the investment return of each of the fund of funds Investment Portfolios. The expense levels will vary over time, depending on the mix of underlying portfolios or Underlying ETFs in which the fund of funds Investment Portfolio invests. Contract Owners may be able to realize lower aggregate expenses by investing directly in the underlying portfolios and Underlying ETFs instead of investing in the fund of funds Investment Portfolios, if such underlying portfolios or Underlying ETFs are available under the contract. However, no Underlying ETFs and only some of the underlying portfolios are available under the contract. TRANSFERS GENERAL. You can transfer a portion of your Account Value among the Fixed Account (not available if you selected the C Share Option) and the Investment Portfolios. The contract provides that you can make a maximum of 12 transfers every year and that each transfer is made without charge. We measure a year from the anniversary of the day we issued your contract. We currently allow unlimited transfers but reserve the right to limit this in the future. We may also limit transfers in circumstances of frequent or large transfers, or other transfers we determine are or would be to the disadvantage of other contract Owners. (See "Restrictions on Frequent Transfers" and "Restrictions on Large Transfers" below.) We also may be required to suspend the right to transfers in certain circumstances (see "Access to Your Money - Suspension of Payments or Transfers"). We are not currently charging a transfer fee, but we reserve the right to charge such a fee in the future. If such a charge were to be imposed, it would be $25 for each transfer over 12 in a year. The transfer fee will be deducted from the Investment Portfolio or Fixed Account from which the transfer is made. However, if the entire interest in an account is being transferred, the transfer fee will be deducted from the amount which is transferred. You can make a transfer to or from any Investment Portfolio or the Fixed Account (not available if you selected the C Share Option), subject to the limitations below. All transfers made on the same Business Day will be treated as one transfer. Transfers received before the close of trading on the New York Stock Exchange will take effect as of the end of the Business Day. The following apply to any transfer: o Your request for transfer must clearly state which Investment Portfolio(s) or the Fixed Account (not available if you selected the C Share Option) are involved in the transfer. o Your request for transfer must clearly state how much the transfer is for. o The minimum amount you can transfer is $500 from an Investment Portfolio, or your entire interest in the Investment Portfolio, if less (this does not apply to pre-scheduled transfer programs). o The minimum amount that may be transferred from the Fixed Account is $500, or your entire interest in the Fixed Account. Transfers out of the Fixed Account during the Accumulation Phase are limited to the greater of: (a) 25% of the Fixed Account value at the beginning of the Contract Year, or (b) the amount transferred out of the Fixed Account in the prior Contract Year. Currently we are not imposing these restrictions on transfers out of the Fixed Account, but we have the right to reimpose them at any time. You should be aware that, if transfer restrictions are imposed, it may take a while (even if you make no additional Purchase Payments or transfers into the Fixed Account) to make a complete transfer of your Account Value from the Fixed Account. When deciding whether to invest in the Fixed Account (not available if you select the C Share Option) it is important to consider whether the transfer restrictions fit your risk tolerance and time horizon. o You may not make a transfer to more than 40 investment portfolios (including the Fixed Account-not available if you selected the C Share Option) at any time if the request is made by telephone to our voice response system or by Internet. A request to transfer to more than 40 investment portfolios (including the Fixed Account, if available) may be made by calling or writing our Annuity Service Center. During the Accumulation Phase, to the extent permitted by applicable law, during times of drastic economic or market conditions, we may suspend the transfer privilege 20
N-422nd Page of 530TOC1stPreviousNextBottomJust 22nd
temporarily without notice and treat transfer requests based on their separate components (a redemption order with simultaneous request for purchase of another Investment Portfolio). In such a case, the redemption order would be processed at the source Investment Portfolio's next determined Accumulation Unit value. However, the purchase of the new Investment Portfolio would be effective at the next determined Accumulation Unit value for the new Investment Portfolio only after we receive the proceeds from the source Investment Portfolio, or we otherwise receive cash on behalf of the source Investment Portfolio. For transfers during the Accumulation Phase, we have reserved the right to restrict transfers to the Fixed Account if any one of the following conditions exist: o the credited interest rate on the Fixed Account is equal to the guaranteed minimum rate indicated in your contract; or o your Account Value in the Fixed Account equals or exceeds our published maximum for Fixed Account allocation (currently, there is no limit; we will notify you of any such maximum allocation limit); or o a transfer was made out of the Fixed Account within the previous 180 days. During the Income Phase, you cannot make transfers from a fixed Annuity Payment option to the Investment Portfolios. You can, however, make transfers during the Income Phase from the Investment Portfolios to a fixed Annuity Payment option and among the Investment Portfolios. TRANSFERS BY TELEPHONE OR OTHER MEANS. You may elect to make transfers by telephone, Internet or other means acceptable to us. To elect this option, you must first provide us with a notice or agreement in Good Order. If you own the contract with a Joint Owner, unless we are instructed otherwise, we will accept instructions from either you or the other Owner. (See "Other Information - Requests and Elections.") All transfers made on the same day will be treated as one transfer. A transfer will be made as of the end of the Business Day when we receive a notice containing all the required information necessary to process the request. We will consider telephone and Internet requests received after the close of the New York Stock Exchange (generally 4:00 p.m. Eastern Time), or on a day when the New York Stock Exchange is not open, to be received on the next day the New York Stock Exchange is open (the next Business Day). PRE-SCHEDULED TRANSFER PROGRAM. There are certain programs that involve transfers that are pre-scheduled. When a transfer is made as a result of such a program, we do not count the transfer in determining the applicability of any transfer fee and certain minimums do not apply. The current pre-scheduled transfers are made in conjunction with the following: Dollar Cost Averaging and Automatic Rebalancing Programs. RESTRICTIONS ON FREQUENT TRANSFERS. Frequent requests from contract Owners to transfer Account Value may dilute the value of an Investment Portfolio's shares if the frequent trading involves an attempt to take advantage of pricing inefficiencies created by a lag between a change in the value of the securities held by the portfolio and the reflection of that change in the portfolio's share price ("arbitrage trading"). Frequent transfers involving arbitrage trading may adversely affect the long-term performance of the Investment Portfolios, which may in turn adversely affect contract Owners and other persons who may have an interest in the contracts (E.G., Annuitants and Beneficiaries). We have policies and procedures that attempt to detect and deter frequent transfers in situations where we determine there is a potential for arbitrage trading. Currently, we believe that such situations may be presented in the international, small-cap, and high-yield Investment Portfolios (i.e., the American Funds Global Small Capitalization Fund, Baillie Gifford International Stock Portfolio, BlackRock Global Allocation V.I. Fund, BlackRock High Yield Portfolio, Clarion Global Real Estate Portfolio, Global Infrastructure Portfolio, Harris Oakmark International Portfolio, Invesco Small Cap Growth Portfolio, Ivy Funds VIP Asset Strategy Fund, JPMorgan Small Cap Value Portfolio, Loomis Sayles Global Markets Portfolio, Loomis Sayles Small Cap Core Portfolio, Lord Abbett Bond Debenture Portfolio, Met/Artisan International Portfolio, Met/Dimensional International Small Company Portfolio, Met/Eaton Vance Floating Rate Portfolio, Met/Templeton International Bond Portfolio, MFS (Reg. TM) Emerging Markets Equity Portfolio, MFS (Reg. TM) Research International Portfolio, MSCI EAFE (Reg. TM) Index Portfolio, Neuberger Berman Genesis Portfolio, Oppenheimer Global Equity Portfolio, PIMCO Emerging Markets Bond Portfolio, Pioneer Strategic Income 21
N-423rd Page of 530TOC1stPreviousNextBottomJust 23rd
Portfolio, Russell 2000 (Reg. TM) Index Portfolio, T. Rowe Price Small Cap Growth Portfolio, Third Avenue Small Cap Value Portfolio, Van Eck Global Natural Resources Portfolio, and Western Asset Management Strategic Bond Opportunities Portfolio), and we monitor transfer activity in those portfolios (the "Monitored Portfolios"). In addition, as described below, we treat all American Funds Insurance Series (Reg. TM) portfolios ("American Funds portfolios") as Monitored Portfolios. We employ various means to monitor transfer activity, such as examining the frequency and size of transfers into and out of the Monitored Portfolios within given periods of time. For example, we currently monitor transfer activity to determine if, for each category of international, small-cap, and high-yield portfolios, in a 12-month period there were: (1) six or more transfers involving the given category; (2) cumulative gross transfers involving the given category that exceed the current Account Value; and (3) two or more "round-trips" involving the given category. A round-trip generally is defined as a transfer in followed by a transfer out within the next seven calendar days or a transfer out followed by a transfer in within the next seven calendar days, in either case subject to certain other criteria. WE DO NOT BELIEVE THAT OTHER INVESTMENT PORTFOLIOS PRESENT A SIGNIFICANT OPPORTUNITY TO ENGAGE IN ARBITRAGE TRADING AND THEREFORE DO NOT MONITOR TRANSFER ACTIVITY IN THOSE PORTFOLIOS. We may change the Monitored Portfolios at any time without notice in our sole discretion. As a condition to making their portfolios available in our products, American Funds requires us to treat all American Funds portfolios as Monitored Portfolios under our current frequent transfer policies and procedures. Further, American Funds requires us to impose additional specified monitoring criteria for all American Funds portfolios available under the contract, regardless of the potential for arbitrage trading. We are required to monitor transfer activity in American Funds portfolios to determine if there were two or more transfers in followed by transfers out, in each case of a certain dollar amount or greater, in any 30-day period. A first violation of the American Funds monitoring policy will result in a written notice of violation; each additional violation will result in the imposition of a six-month restriction, during which period we will require all transfer requests to or from an American Funds portfolio to be submitted with an original signature. Further, as Monitored Portfolios, all American Funds portfolios also will be subject to our current frequent transfer policies, procedures and restrictions (described below), and transfer restrictions may be imposed upon a violation of either monitoring policy. Our policies and procedures may result in transfer restrictions being applied to deter frequent transfers. Currently, when we detect transfer activity in the Monitored Portfolios that exceeds our current transfer limits, we require future transfer requests to or from any Monitored Portfolios under that contract to be submitted with an original signature. A first occurrence will result in the imposition of this restriction for a six month period; a second occurrence will result in the permanent imposition of the restriction. Transfers made under a Dollar Cost Averaging Program, a rebalancing program or, if applicable, any asset allocation program described in this prospectus are not treated as transfers when we monitor the frequency of transfers. The detection and deterrence of harmful transfer activity involves judgments that are inherently subjective, such as the decision to monitor only those Investment Portfolios that we believe are susceptible to arbitrage trading or the determination of the transfer limits. Our ability to detect and/or restrict such transfer activity may be limited by operational and technological systems, as well as our ability to predict strategies employed by Owners to avoid such detection. Our ability to restrict such transfer activity also may be limited by provisions of the contract. Accordingly, there is no assurance that we will prevent all transfer activity that may adversely affect Owners and other persons with interests in the contracts. We do not accommodate frequent transfers in any Investment Portfolio and there are no arrangements in place to permit any contract Owner to engage in frequent transfers; we apply our policies and procedures without exception, waiver, or special arrangement. The Investment Portfolios may have adopted their own policies and procedures with respect to frequent transfers in their respective shares, and we reserve the right to enforce these policies and procedures. For example, Investment Portfolios may assess a redemption fee (which we reserve the right to collect) on shares held for a relatively short period. The prospectuses for the Investment Portfolios describe any such policies and procedures, which may be more or less restrictive than the policies and procedures we have adopted. Although we may not have the contractual authority or the operational capacity to apply the frequent transfer policies and procedures of the Investment Portfolios, we have entered into a written agreement, as required by SEC regulation, with each Investment Portfolio 22
N-424th Page of 530TOC1stPreviousNextBottomJust 24th
or its principal underwriter that obligates us to provide to the Investment Portfolio promptly upon request certain information about the trading activity of individual contract Owners, and to execute instructions from the Investment Portfolio to restrict or prohibit further purchases or transfers by specific contract Owners who violate the frequent transfer policies established by the Investment Portfolio. In addition, contract Owners and other persons with interests in the contracts should be aware that the purchase and redemption orders received by the Investment Portfolios generally are "omnibus" orders from intermediaries, such as retirement plans or separate accounts funding variable insurance contracts. The omnibus orders reflect the aggregation and netting of multiple orders from individual Owners of variable insurance contracts and/or individual retirement plan participants. The omnibus nature of these orders may limit the Investment Portfolios in their ability to apply their frequent transfer policies and procedures. In addition, the other insurance companies and/or retirement plans may have different policies and procedures or may not have any such policies and procedures because of contractual limitations. For these reasons, we cannot guarantee that the Investment Portfolios (and thus contract Owners) will not be harmed by transfer activity relating to other insurance companies and/or retirement plans that may invest in the Investment Portfolios. If an Investment Portfolio believes that an omnibus order reflects one or more transfer requests from contract Owners engaged in frequent trading, the Investment Portfolio may reject the entire omnibus order. In accordance with applicable law, we reserve the right to modify or terminate the transfer privilege at any time. We also reserve the right to defer or restrict the transfer privilege at any time that we are unable to purchase or redeem shares of any of the Investment Portfolios, including any refusal or restriction on purchases or redemptions of their shares as a result of their own policies and procedures on frequent transfers (even if an entire omnibus order is rejected due to the frequent transfers of a single contract Owner). You should read the Investment Portfolio prospectuses for more details. RESTRICTIONS ON LARGE TRANSFERS. Large transfers may increase brokerage and administrative costs of the Investment Portfolios and may disrupt portfolio management strategy, requiring an Investment Portfolio to maintain a high cash position and possibly resulting in lost investment opportunities and forced liquidations. We do not monitor for large transfers to or from Investment Portfolios except where the portfolio manager of a particular Investment Portfolio has brought large transfer activity to our attention for investigation on a case-by-case basis. For example, some portfolio managers have asked us to monitor for "block transfers" where transfer requests have been submitted on behalf of multiple contract Owners by a third party such as an investment adviser. When we detect such large trades, we may impose restrictions similar to those described above where future transfer requests from that third party must be submitted in writing with an original signature. A first occurrence will result in the imposition of this restriction for a six-month period; a second occurrence will result in the permanent imposition of the restriction. ASSET ALLOCATION PROGRAM - BLUEPRINT MODELS The Blueprint Models are not offered by this prospectus and are not a part of your contract. The Blueprint Models are separate asset allocation guidance we make available in connection with the contract, at no additional charge to you, to help you allocate your Purchase Payments and Account Value among the available Investment Options, as described below.This service may be terminated at any time. At the time the contract is issued, and at any time you change or update your investment allocations, your default investment allocation for Purchase Payments and automatic rebalancing will be set in accordance with the investment allocation you select. You are not required to use a Blueprint Model to select your investment allocation. You may choose to use the suggested allocations in one or more Blueprint Models or any combination of Blueprint Models and individual Investment Options. Please note a Blueprint Model is not an investment portfolio: by selecting a Blueprint Model, you are investing directly in the individual underlying portfolios for that Blueprint Model. At any time after the contract is issued, you may transfer Account Value or change the investment allocation for future Purchase Payments and automatic rebalancing. There are no investment allocation restrictions associated with using the Blueprint Models. Asset allocation, in general, is an investment strategy intended to optimize the selection of investment portfolios for a given level of risk tolerance, in order to attempt to maximize returns and limit the effects of market volatility. Asset allocation strategies reflect the theory that 23
N-425th Page of 530TOC1stPreviousNextBottomJust 25th
diversification among asset classes can help reduce volatility and potentially enhance returns over the long term. An asset class refers to a category of investments having similar characteristics, such as stocks and other equities, bonds and other fixed income investments, alternative investments, and cash equivalents. There are further divisions within asset classes, for example, divisions according to the size of the issuer (large cap, mid cap, small cap), the type of issuer (government, municipal, corporate, etc.) or the location of the issuer (domestic, foreign, etc.). If you elect to use the Blueprint Models, our affiliate MetLife Advisers, LLC (MetLife Advisers), an investment adviser registered under the Investment Advisers Act of 1940, will serve as your investment adviser, but solely for the purpose of developing and updating the Blueprint Models. MetLife Advisers currently follows the recommendations of an independent third-party consultant in providing this service. From time to time, MetLife Advisers may select a different consultant, to the extent permitted under applicable law. MetLife Advisers also serves as the investment adviser to certain Investment Options available under the contract and receives compensation for those services. (See "Investment Options-Certain Payments We Receive with Regard to the Investment Options," "Investment Options-Met Investors Series Trust," and "Investment Options-Metropolitan Series Fund.") However, MetLife Advisers receives no compensation for services it performs in developing and updating the Blueprint Models. It is your responsibility to select or change your investment allocations among the Investment Options. Your registered representative can provide you with information that may assist you in selecting and allocating among the Investment Options. Once you select the Investment Option allocations, these selections will remain unchanged until you elect to revise them. Although the Blueprint Models are generally designed to maximize investment returns and reduce volatility for a given level of risk, there is no guarantee that a Blueprint Model will not lose money or experience volatility. A Blueprint Model may fail to perform as intended, or may perform worse than any single Investment Option or asset class, or a different combination of Investment Options. In addition, any Blueprint Model is subject to all of the risks associated with its underlying Investment Options. If, from time to time, MetLife Advisers changes the Blueprint Models, any flows of money into and out of underlying Investment Options resulting from such changes may generate higher brokerage and administrative costs for those portfolios, or such changes may disrupt an Investment Option's management strategy. If you elect to use the Blueprint Models, you can choose to allocate your Purchase Payments among one or more specified allocations of Investment Options MetLife Advisers provides. Each Blueprint Model is a set of target allocation percentages for certain Investment Options. There currently are 14 Blueprint Models, designed to achieve different levels of risk tolerance and return potential (generally, asset classes and sub-classes with higher potential returns have greater risk of losses and experience greater volatility). You may elect to change your allocations as your tolerance for risk and/or your needs and objectives change. In consultation with your registered representative, you may determine a different allocation better meets your risk tolerance and time horizons. There is no fee to change your Investment Option allocations, and currently we allow unlimited transfers without charge during the Accumulation Phase (see "Expenses - Transfer Fee"). MetLife Advisers, through its consultant as described above, periodically reviews the Blueprint Models (typically annually) and may find that asset allocations within a particular Blueprint Model may need to be changed. Similarly, the principal investments, investment style, or investment manager of an Investment Option may change such that it is no longer appropriate for a Blueprint Model, or it may become appropriate for a Blueprint Model. Also, from time to time, we may change the Investment Options available under the contract. (See "Investment Options.") As a result of the periodic review and/or any changes in available Investment Options, each Blueprint Model may change and asset classes or sub-classes may be added or deleted. We will provide notice regarding any such changes, and you, in consultation with your registered representative, may wish to revise your investment allocations based on these Blueprint Model and Investment Option changes. You are not required to make any changes, and if you take no action your current allocations will continue in effect. Our affiliates, including MetLife Advisers, receive greater compensation and/or profits from certain Investment Options than we receive from other portfolios. Therefore, it is conceivable that MetLife Advisers may have an incentive to develop Blueprint Models in such a way that larger allocations will be made to more profitable 24
N-426th Page of 530TOC1stPreviousNextBottomJust 26th
portfolios. Also, MetLife Advisers, in its capacity as investment adviser to certain of the Investment Options, may believe that certain portfolios it manages may benefit from additional assets or could be harmed by redemptions. As a fiduciary, MetLife Advisers legally is obligated to disregard these incentives. In addition, MetLife Advisers believes that following the recommendations of an independent third-party to develop and update the Blueprint Models may reduce or eliminate the potential for MetLife Advisers to be influenced by these competing interests. As described above, from time to time, MetLife Advisers may select a different consultant to provide these recommendations, to the extent permitted under applicable law. For more information about MetLife Advisers and its role in making the Blueprint Models available, please see the disclosure document, which is available to you at no charge, containing information from Part II of its Form ADV, the SEC investment adviser registration form. Your registered representative can provide you this disclosure document, or you can request a copy by writing to MetLife Advisers, LLC, c/o MetLife Investors USA Insurance Company, P.O. Box 10366, Des Moines, Iowa 50306-0366. We may perform certain administrative functions on behalf of our affiliate, MetLife Advisers; however, we are not registered as an investment adviser and are not providing any investment advice in making the Blueprint Models available. DOLLAR COST AVERAGING PROGRAM (DCA) We offer a dollar cost averaging (DCA) program which is described below. By allocating amounts on a regular schedule as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations. The dollar cost averaging program is available only during the Accumulation Phase. We reserve the right to modify, terminate or suspend the dollar cost averaging program. There is no additional charge for participating in the dollar cost averaging program. If you participate in the dollar cost averaging program, the transfers made under the program are not taken into account in determining any transfer fee. We may, from time to time, offer other dollar cost averaging programs which have terms different from those described in this prospectus. We will terminate your participation in a dollar cost averaging program when we receive notification of your death. This program allows you to systematically transfer a set amount each month from the Fixed Account (not available if you selected the C Share Option) or from a money market Investment Portfolio to any of the other available Investment Portfolio(s) you select. We provide certain exceptions from our normal Fixed Account restrictions to accommodate the dollar cost averaging program. These transfers are made on a date you select or, if you do not select a date, on the date that a Purchase Payment or Account Value is allocated to the dollar cost averaging program. However, transfers will be made on the 1st day of the following month for Purchase Payments or Account Value allocated to the dollar cost averaging program on the 29th, 30th, or 31st day of a month. If you make an additional Purchase Payment while a Dollar Cost Averaging (DCA) program is in effect, we will not allocate the additional payment to the DCA program unless you tell us to do so. Instead, unless you previously provided different allocation instructions for future Purchase Payments or provide new allocation instructions with the payment, we will allocate the additional Purchase Payment directly to the same destination Investment Portfolios you selected under the DCA program. Any Purchase Payments received after the DCA program has ended will be allocated as described in "Purchase - Allocation of Purchase Payments." If you make such an addition to your existing DCA program, the DCA transfer amount will not be increased; however, the number of months over which transfers are made is increased, unless otherwise elected in writing. You can terminate the program at any time, at which point transfers under the program will stop. AUTOMATIC REBALANCING PROGRAM Once your money has been allocated to the Investment Portfolios, the performance of each portfolio may cause your allocation to shift. You can direct us to automatically rebalance your contract to return to your original percentage allocations by selecting our Automatic Rebalancing Program. You can tell us whether to rebalance monthly, quarterly, semi-annually or annually. An automatic rebalancing program is intended to transfer Account Value from those portfolios that have increased in value to those that have declined or not increased as much in value. Over time, this method of investing may help you "buy low and sell high," although there can be no assurance that this objective will be achieved. Automatic 25
N-427th Page of 530TOC1stPreviousNextBottomJust 27th
rebalancing does not guarantee profits, nor does it assure that you will not have losses. We will measure the rebalancing periods from the anniversary of the date we issued your contract. If the dollar cost averaging program is in effect, rebalancing allocations will be based on your current DCA allocations. If you are not participating in the dollar cost averaging program, we will make allocations based upon your current Purchase Payment allocations, unless you tell us otherwise. The Automatic Rebalancing Program is available only during the Accumulation Phase. There is no additional charge for participating in the Automatic Rebalancing Program. If you participate in the Automatic Rebalancing Program, the transfers made under the program are not taken into account in determining any transfer fee. We will terminate your participation in the Automatic Rebalancing Program when we receive notification of your death. EXAMPLE: Assume that you want your initial Purchase Payment split between 2 Investment Portfolios. You want 50% to be in the American Funds (Reg. TM) Moderate Allocation Portfolio and 50% to be in the American Funds (Reg. TM) Balanced Allocation Portfolio. Over the next 2 1/2 months the American Funds (Reg. TM) Balanced Allocation Portfolio outperforms the American Funds (Reg. TM) Moderate Allocation Portfolio. At the end of the first quarter, the American Funds (Reg. TM) Balanced Allocation Portfolio now represents 60% of your holdings because of its increase in value. If you have chosen to have your holdings rebalanced quarterly, on the first day of the next quarter, we will sell some of your units in the American Funds (Reg. TM) Balanced Allocation Portfolio to bring its value back to 50% and use the money to buy more units in the American Funds (Reg. TM) Moderate Allocation Portfolio to increase those holdings to 50%. VOTING RIGHTS We are the legal owner of the Investment Portfolio shares. However, we believe that when an Investment Portfolio solicits proxies in conjunction with a vote of shareholders, we are required to obtain from you and other affected Owners instructions as to how to vote those shares. When we receive those instructions, we will vote all of the shares we own in proportion to those instructions. This will also include any shares that we own on our own behalf. The effect of this proportional voting is that a small number of contract Owners may control the outcome of a vote. Should we determine that we are no longer required to comply with the above, we will vote the shares in our own right. SUBSTITUTION OF INVESTMENT OPTIONS If investment in the Investment Portfolios or a particular Investment Portfolio is no longer possible, in our judgment becomes inappropriate for purposes of the contract, or for any other reason in our sole discretion, we may substitute another Investment Portfolio or Investment Portfolios without your consent. The substituted Investment Portfolio may have different fees and expenses. Substitution may be made with respect to existing investments or the investment of future Purchase Payments, or both. However, we will not make such substitution without any necessary approval of the Securities and Exchange Commission and applicable state insurance departments. Furthermore, we may close Investment Portfolios to allocation of Purchase Payments or Account Value, or both, at any time in our sole discretion. 4. EXPENSES There are charges and other expenses associated with the contract that reduce the return on your investment in the contract. These charges and expenses are: PRODUCT CHARGES SEPARATE ACCOUNT PRODUCT CHARGES. Each day, we make a deduction for our Separate Account product charges (which consist of the mortality and expense charge, the administration charge and the charges related to the optional Return of Premium death benefit rider). We do this as part of our calculation of the value of the Accumulation Units and the Annuity Units (I.E., during the Accumulation Phase and the Income Phase - although death benefit charges no longer continue in the Income Phase). MORTALITY AND EXPENSE CHARGE. For the Standard Version of the contract, we assess a daily mortality and expense charge that is equal, on an annual basis, to 0.85% of the average daily net asset value of each Investment Portfolio. For the C Share Option, we assess a daily mortality and expense charge that is equal, on an annual basis, to 1.10% of the average daily net asset value of each Investment Portfolio. This charge compensates us for mortality risks we assume, including making Annuity Payments that will not change based on our actual mortality experience and, for the 26
N-428th Page of 530TOC1stPreviousNextBottomJust 28th
Standard Version of the contract, waiving withdrawal charges in the event of the Owner's death during the Accumulation Phase. The charge also compensates us for expense risks we assume to cover contract maintenance expenses. These expenses may include issuing contracts, maintaining records, making and maintaining subaccounts available under the contract and performing accounting, regulatory compliance, and reporting functions. This charge also compensates us for costs associated with the establishment and administration of the contract, including programs like transfers and dollar cost averaging. If the mortality and expense charge is inadequate to cover the actual expenses of mortality, maintenance, and administration, we will bear the loss. If the charge exceeds the actual expenses, we will add the excess to our profit and it may be used to finance distribution expenses or for any other purpose. ADMINISTRATION CHARGE. This charge is equal, on an annual basis, to 0.25% of the average daily net asset value of each Investment Portfolio. This charge, together with the account fee (see below), is for the expenses associated with the administration of the contract. Some of these expenses are: issuing contracts, maintaining records, providing accounting, valuation, regulatory and reporting services, as well as expenses associated with marketing, sale and distribution of the contracts. DEATH BENEFIT RIDER CHARGE. If you select the Return of Premium death benefit, we will deduct a charge that compensates us for the costs and risks we assume in providing the benefit. This charge (assessed during the Accumulation Phase) is equal, on an annual basis, to 0.25% of the average daily net asset value of each Investment Portfolio. ACCOUNT FEE During the Accumulation Phase, every Contract Year on your contract anniversary (the anniversary of the date when your contract was issued), we will deduct $30 from your contract as an account fee for the prior Contract Year if your Account Value is less than $50,000. If you make a complete withdrawal from your contract, the full account fee will be deducted from the Account Value regardless of the amount of your Account Value. During the Accumulation Phase, the account fee is deducted pro rata from the Investment Portfolios. This charge is for administrative expenses (see above). This charge cannot be increased. A pro rata portion of the charge will be deducted from the Account Value on the Annuity Date if this date is other than a contract anniversary. If your Account Value on the Annuity Date is at least $50,000, then we will not deduct the account fee. After the Annuity Date, the charge will be collected monthly out of the Annuity Payment, regardless of the size of your contract. WITHDRAWAL CHARGE If you selected the C Share Option, no withdrawal charges apply. For the Standard Version, we impose a withdrawal charge to reimburse us for contract sales expenses, including commissions and other distribution, promotion, and acquisition expenses. During the Accumulation Phase, you can make a withdrawal from your contract (either a partial or a complete withdrawal). If the amount you withdraw is determined to include the withdrawal of any of your prior Purchase Payments, a withdrawal charge is assessed against each Purchase Payment withdrawn. To determine what portion (if any) of a withdrawal is subject to a withdrawal charge, amounts are withdrawn from your contract in the following order: 1. Earnings in your contract (earnings are equal to your Account Value, less Purchase Payments not previously withdrawn); then 2. The free withdrawal amount described below (deducted from Purchase Payments not previously withdrawn, in the order such Purchase Payments were made, with the oldest Purchase Payment first, as described below); then 3. Purchase Payments not previously withdrawn, in the order such Purchase Payments were made: the oldest Purchase Payment first, the next Purchase Payment second, etc. until all Purchase Payments have been withdrawn. The withdrawal charge is calculated at the time of each withdrawal in accordance with the following: 27
N-429th Page of 530TOC1stPreviousNextBottomJust 29th
[Download Table] Number of Complete Years from Withdrawal Charge Receipt of Purchase Payment (% of Purchase Payment) ------------------------------ ------------------------ 0 7 1 7 2 6 3 6 4 5 5 and thereafter 0 For a partial withdrawal, the withdrawal charge is deducted from the remaining Account Value, if sufficient. If the remaining Account Value is not sufficient, the withdrawal charge is deducted from the amount withdrawn. If the Account Value is smaller than the total of all Purchase Payments, the withdrawal charge only applies up to the Account Value. We do not assess the withdrawal charge on any payments paid out as Annuity Payments or as death benefits. In addition, we will not assess the withdrawal charge on required minimum distributions from Qualified Contracts in order to satisfy federal income tax rules or to avoid required federal income tax penalties. This exception only applies to amounts required to be distributed from this contract. We do not assess the withdrawal charge on earnings in your contract. NOTE: For tax purposes, earnings from Non-Qualified Contracts are considered to come out first. FREE WITHDRAWAL AMOUNT. The free withdrawal amount for each Contract Year after the first (there is no free withdrawal amount in the first Contract Year) is equal to 10% of your total Purchase Payments, less the total free withdrawal amount previously withdrawn in the same Contract Year. Also, we currently will not assess the withdrawal charge on amounts withdrawn during the first Contract Year under the Systematic Withdrawal Program. Any unused free withdrawal amount in one Contract Year does not carry over to the next Contract Year. REDUCTION OR ELIMINATION OF THE WITHDRAWAL CHARGE GENERAL. We may elect to reduce or eliminate the amount of the withdrawal charge when the contract is sold under circumstances which reduce our sales expenses. Some examples are: if there is a large group of individuals that will be purchasing the contract, or if a prospective purchaser already had a relationship with us. NURSING HOME OR HOSPITAL CONFINEMENT RIDER. We will not impose a withdrawal charge if, after you have owned the contract for one year, you or your Joint Owner becomes confined to a nursing home and/or hospital for at least 90 consecutive days or confined for a total of at least 90 days if there is no more than a 6-month break in confinement and the confinements are for related causes. The confinement must begin after the first contract anniversary and you must have been the Owner continuously since the contract was issued (or have become the Owner as the spousal Beneficiary who continues the contract). The confinement must be prescribed by a physician and be medically necessary. You must exercise this right no later than 90 days after you or your Joint Owner exits the nursing home or hospital. This waiver terminates on the Annuity Date. We will not accept additional payments once this waiver is used. There is no charge for this rider. This rider is not available in Massachusetts and South Dakota. TERMINAL ILLNESS RIDER. After the first contract anniversary, we will waive the withdrawal charge if you or your Joint Owner are terminally ill and not expected to live more than 12 months; a physician certifies to your illness and life expectancy; you were not diagnosed with the terminal illness as of the date we issued your contract; and you have been the Owner continuously since the contract was issued (or have become the Owner as the spousal Beneficiary who continues the contract). This waiver terminates on the Annuity Date. We will not accept additional payments once this waiver is used. There is no charge for this rider. This rider is not available in Massachusetts. The Nursing Home or Hospital Confinement rider and the Terminal Illness rider are not available for Owners who are age 81 or older (on the contract issue date). Additional conditions and requirements apply to the Nursing Home or Hospital Confinement rider and the Terminal Illness rider. They are specified in the rider(s) that are part of your contract. PREMIUM AND OTHER TAXES We reserve the right to deduct from Purchase Payments, account balances, withdrawals, death benefits or income payments any taxes relating to the contracts (including, but not limited to, premium taxes) paid by us to any government entity. Examples of these taxes include, but are not limited to, premium tax, generation-skipping transfer 28
N-430th Page of 530TOC1stPreviousNextBottomJust 30th
tax or a similar excise tax under federal or state tax law which is imposed on payments we make to certain persons and income tax withholdings on withdrawals and income payments to the extent required by law. Premium taxes generally range from 0 to 3.5%, depending on the state. We will, at our sole discretion, determine when taxes relate to the contracts. We may, at our sole discretion, pay taxes when due and deduct that amount from the account balance at a later date. Payment at an earlier date does not waive any right we may have to deduct amounts at a later date. It is our current practice not to charge premium taxes until Annuity Payments begin. TRANSFER FEE We currently allow unlimited transfers without charge during the Accumulation Phase. However, we have reserved the right to limit the number of transfers to a maximum of 12 per year without charge and to charge a transfer fee of $25 for each transfer greater than 12 in any year. We are currently waiving the transfer fee, but reserve the right to charge it in the future. The transfer fee is deducted from the Investment Portfolio or Fixed Account from which the transfer is made. However, if the entire interest in an account is being transferred, the transfer fee will be deducted from the amount which is transferred. If the transfer is part of a pre-scheduled transfer program, it will not count in determining the transfer fee. INCOME TAXES We reserve the right to deduct from the contract for any income taxes which we incur because of the contract. In general, we believe under current federal income tax law, we are entitled to hold reserves with respect to the contract that offset Separate Account income. If this should change, it is possible we could incur income tax with respect to the contract, and in that event we may deduct such tax from the contract. At the present time, however, we are not incurring any such income tax or making any such deductions. INVESTMENT PORTFOLIO EXPENSES There are deductions from and expenses paid out of the assets of each Investment Portfolio, which are described in the Investment Portfolio prospectuses. These deductions and expenses are not charges under the terms of the contract, but are represented in the share values of each Investment Portfolio. 5. ANNUITY PAYMENTS (THE INCOME PHASE) ANNUITY DATE Under the contract you can receive regular income payments (referred to as ANNUITY PAYMENTS). You can choose the month and year in which those payments begin. We call that date the ANNUITY DATE. Your Annuity Date must be the first day of a calendar month and must be at least 30 days after we issue the contract. When you purchase the contract, the Annuity Date will be the later of the first day of the calendar month after the Annuitant's 90th birthday or 10 years from the date your contract was issued. You can change or extend the Annuity Date at any time before the Annuity Date with 30 days prior notice to us (subject to restrictions that may apply in your state, restrictions imposed by your selling firm, and our current established administrative procedures). PLEASE BE AWARE THAT ONCE YOUR CONTRACT IS ANNUITIZED, YOU ARE INELIGIBLE TO RECEIVE THE DEATH BENEFIT YOU HAVE SELECTED. ANNUITY PAYMENTS You (unless another payee is named) will receive the Annuity Payments during the Income Phase. The Annuitant is the natural person(s) whose life we look to in the determination of Annuity Payments. During the Income Phase, you have the same investment choices you had just before the start of the Income Phase. At the Annuity Date, you can choose whether payments will be: o fixed Annuity Payments, or o variable Annuity Payments, or o a combination of both. If you don't tell us otherwise, your Annuity Payments will be based on the investment allocations that were in place just before the start of the Income Phase. If you choose to have any portion of your Annuity Payments based on the Investment Portfolio(s), the dollar amount of your initial payment will vary and will depend upon three things: 1) the value of your contract in the Investment Portfolio(s) just before the start of the Income Phase, 29
N-431st Page of 530TOC1stPreviousNextBottomJust 31st
2) the assumed investment return (AIR) (you select) used in the annuity table for the contract, and 3) the Annuity Option elected. Subsequent variable Annuity Payments will vary with the performance of the Investment Portfolios you selected. (For more information, see "Variable Annuity Payments" below.) At the time you choose an Annuity Option, you select the AIR, which must be acceptable to us. Currently, you can select an AIR of 3% or 4%. You can change the AIR with 30 days notice to us prior to the Annuity Date. If you do not select an AIR, we will use 3%. If the actual performance exceeds the AIR, your variable Annuity Payments will increase. Similarly, if the actual investment performance is less than the AIR, your variable Annuity Payments will decrease. Your variable Annuity Payment is based on ANNUITY UNITS. An Annuity Unit is an accounting device used to calculate the dollar amount of Annuity Payments. (For more information, see "Variable Annuity Payments" below.) When selecting an AIR, you should keep in mind that a lower AIR will result in a lower initial variable Annuity Payment, but subsequent variable Annuity Payments will increase more rapidly or decline more slowly as changes occur in the investment experience of the Investment Portfolios. On the other hand, a higher AIR will result in a higher initial variable Annuity Payment than a lower AIR, but later variable Annuity Payments will rise more slowly or fall more rapidly. A transfer during the Income Phase from a variable Annuity Payment option to a fixed Annuity Payment option may result in a reduction in the amount of Annuity Payments. If you choose to have any portion of your Annuity Payments be a fixed Annuity Payment, the dollar amount of each fixed Annuity Payment will not change, unless you make a transfer from a variable Annuity Payment option to the fixed Annuity Payment that causes the fixed Annuity Payment to increase. Please refer to the "Annuity Provisions" section of the Statement of Additional Information for more information. Annuity Payments are made monthly (or at any frequency permitted under the contract) unless you have less than $5,000 to apply toward an Annuity Option. In that case, we may provide your Annuity Payment in a single lump sum instead of Annuity Payments. Likewise, if your Annuity Payments would be or become less than $100 a month, we have the right to change the frequency of payments so that your Annuity Payments are at least $100. ANNUITY OPTIONS You can choose among income plans. We call those ANNUITY OPTIONS. You can change your Annuity Option at any time before the Annuity Date with 30 days notice to us. If you do not choose an Annuity Option, Option 2, which provides a life annuity with 10 years of guaranteed Annuity Payments, will automatically be applied. You can choose one of the following Annuity Options or any other Annuity Option acceptable to us. After Annuity Payments begin, you cannot change the Annuity Option. If more than one frequency is permitted under your contract, choosing less frequent payments will result in each Annuity Payment being larger. Annuity options that guarantee that payments will be made for a certain number of years regardless of whether the Annuitant or joint Annuitant are alive (such as Options 2 and 4 below) result in Annuity Payments that are smaller than Annuity Options without such a guarantee (such as Options 1 and 3 below). For Annuity Options with a designated period, choosing a shorter designated period will result in each Annuity Payment being larger. OPTION 1. LIFE ANNUITY. Under this option, we will make Annuity Payments so long as the Annuitant is alive. We stop making Annuity Payments after the Annuitant's death. It is possible under this option to receive only one Annuity Payment if the Annuitant dies before the due date of the second payment or to receive only two Annuity Payments if the Annuitant dies before the due date of the third payment, and so on. OPTION 2. LIFE ANNUITY WITH 10 YEARS OF ANNUITY PAYMENTS GUARANTEED. Under this option, we will make Annuity Payments so long as the Annuitant is alive. If, when the Annuitant dies, we have made Annuity Payments for less than ten years, we will then continue to make Annuity Payments to the Beneficiary for the rest of the 10 year period. OPTION 3. JOINT AND LAST SURVIVOR ANNUITY. Under this option, we will make Annuity Payments so long as the Annuitant and a second person (joint Annuitant) are both alive. When either Annuitant dies, we will continue to 30
N-432nd Page of 530TOC1stPreviousNextBottomJust 32nd
make Annuity Payments, so long as the survivor continues to live. We will stop making Annuity Payments after the last survivor's death. OPTION 4. JOINT AND LAST SURVIVOR ANNUITY WITH 10 YEARS OF ANNUITY PAYMENTS GUARANTEED. Under this option, we will make Annuity Payments so long as the Annuitant and a second person (joint Annuitant) are both alive. When either Annuitant dies, we will continue to make Annuity Payments, so long as the survivor continues to live. If, at the last death of the Annuitant and the joint Annuitant, we have made Annuity Payments for less than ten years, we will then continue to make Annuity Payments to the Beneficiary for the rest of the 10 year period. OPTION 5. PAYMENTS FOR A DESIGNATED PERIOD. We currently offer an Annuity Option under which fixed or variable monthly Annuity Payments are made for a selected number of years as approved by us, currently not less than 10 years. This Annuity Option may be limited or withdrawn by us in our discretion. We may require proof of age or sex of an Annuitant before making any Annuity Payments under the contract that are measured by the Annuitant's life. If the age or sex of the Annuitant has been misstated, the amount payable will be the amount that the Account Value would have provided at the correct age or sex. Once Annuity Payments have begun, any underpayments will be made up in one sum with the next Annuity Payment. Any overpayments will be deducted from future Annuity Payments until the total is repaid. A commutation feature (a feature that allows the Owner to receive a lump sum of the present value of future Annuity Payments) is available under the variable Payments for a Designated Period Annuity Option (Option 5).You may not commute the fixed Payments for a Designated Period Annuity Option or any option involving a life contingency, whether fixed or variable, prior to the death of the last surviving Annuitant. Upon the death of the last surviving Annuitant, the Beneficiary may choose to continue receiving income payments or to receive the commuted value of the remaining guaranteed payments. For variable Annuity Options, the calculation of the commuted value will be done using the AIR applicable to the contract. (See "Annuity Payments" above.) For fixed Annuity Options, the calculation of the commuted value will be done using the then current Annuity Option rates. There may be tax consequences resulting from the election of an Annuity Payment option containing a commutation feature (I.E., an Annuity Payment option that permits the withdrawal of a commuted value). (See "Federal Income Tax Status.") Due to underwriting, administrative or Internal Revenue Code considerations, there may be limitations on payments to the survivor under Options 3 and 4 and/or the duration of the guarantee period under Options 2, 4, and 5. Tax rules with respect to decedent contracts may prohibit the election of Joint and Last Survivor Annuity Options (or income types) and may also prohibit payments for as long as the Owner's life in certain circumstances. In addition to the Annuity Options described above, we may offer an additional payment option that would allow your Beneficiary to take distribution of the Account Value over a period not extending beyond his or her life expectancy. Under this option, annual distributions would not be made in the form of an annuity, but would be calculated in a manner similar to the calculation of required minimum distributions from IRAs. (See "Federal Income Tax Status.") We intend to make this payment option available to both Qualified Contracts and Non-Qualified Contracts. In the event that you purchased the contract as a Qualified Contract, you must take distribution of the Account Value in accordance with the minimum required distribution rules set forth in applicable tax law. (See "Federal Income Tax Status.") Under certain circumstances, you may satisfy those requirements by electing an Annuity Option. You may choose any death benefit available under the contract, but certain other contract provisions and programs will not be available. Upon your death, if Annuity Payments have already begun, the death benefit would be required to be distributed to your Beneficiary at least as rapidly as under the method of distribution in effect at the time of your death. VARIABLE ANNUITY PAYMENTS The Adjusted Contract Value (the Account Value, less any applicable premium taxes, account fee, and any prorated rider charge) is determined on the annuity calculation date, which is a Business Day no more than five (5) Business Days before the Annuity Date. The first variable Annuity Payment will be based upon the Adjusted Contract Value, the Annuity Option elected, the Annuitant's age, the Annuitant's sex (where permitted by law), and the appropriate variable Annuity Option table. Your annuity rates will not be less than those guaranteed in your contract at the time of purchase for the assumed investment return 31
N-433rd Page of 530TOC1stPreviousNextBottomJust 33rd
and Annuity Option elected. If, as of the annuity calculation date, the then current variable Annuity Option rates applicable to this class of contracts provide a first Annuity Payment greater than that which is guaranteed under the same Annuity Option under this contract, the greater payment will be made. The dollar amount of variable Annuity Payments after the first payment is determined as follows: o The dollar amount of the first variable Annuity Payment is divided by the value of an Annuity Unit for each applicable Investment Portfolio as of the annuity calculation date. This establishes the number of Annuity Units for each payment. The number of Annuity Units for each applicable Investment Portfolio remains fixed during the annuity period, provided that transfers among the Investment Portfolios will be made by converting the number of Annuity Units being transferred to the number of Annuity Units of the Investment Portfolio to which the transfer is made, and the number of Annuity Units will be adjusted for transfers to a fixed Annuity Option. Please see the Statement of Additional Information for details about making transfers during the Annuity Phase. o The fixed number of Annuity Units per payment in each Investment Portfolio is multiplied by the Annuity Unit value for that Investment Portfolio for the Business Day for which the Annuity Payment is being calculated. This result is the dollar amount of the payment for each applicable Investment Portfolio, less any account fee. The account fee will be deducted pro rata out of each Annuity Payment. o The total dollar amount of each variable Annuity Payment is the sum of all Investment Portfolio variable Annuity Payments. ANNUITY UNIT. The initial Annuity Unit value for each Investment Portfolio of the Separate Account was set by us. The subsequent Annuity Unit value for each Investment Portfolio is determined by multiplying the Annuity Unit value for the immediately preceding Business Day by the net investment factor (see the Statement of Additional Information for a definition) for the Investment Portfolio for the current Business Day and multiplying the result by a factor for each day since the last Business Day which represents the daily equivalent of the AIR you elected. FIXED ANNUITY PAYMENTS The Adjusted Contract Value (defined above under "Variable Annuity Payments") on the day immediately preceding the Annuity Date will be used to determine a fixed Annuity Payment. The Annuity Payment will be based upon the Annuity Option elected, the Annuitant's age, the Annuitant's sex (where permitted by law), and the appropriate Annuity Option table. Your annuity rates will not be less than those guaranteed in your contract at the time of purchase. If, as of the annuity calculation date, the then current Annuity Option rates applicable to this class of contracts provide an Annuity Payment greater than that which is guaranteed under the same Annuity Option under this contract, the greater payment will be made. You may not make a transfer from the fixed Annuity Option to the variable Annuity Option. 6. ACCESS TO YOUR MONEY You (or in the case of a death benefit, your Beneficiary) can have access to the money in your contract: (1) by making a withdrawal (either a partial or a complete withdrawal); (2) by electing to receive Annuity Payments; or (3) when a death benefit is paid to your Beneficiary. Under most circumstances, withdrawals can only be made during the Accumulation Phase. You may establish a withdrawal plan under which you can receive substantially equal periodic payments in order to comply with the requirements of Sections 72(q) or (t) of the Code. Premature modification or termination of such payments may result in substantial penalty taxes. (See "Federal Income Tax Status.") When you make a complete withdrawal, you will receive the withdrawal value of the contract. The withdrawal value of the contract is the Account Value of the contract at the end of the Business Day when we receive a written request for a withdrawal: o less any applicable withdrawal charge; o less any premium or other tax; and o less any account fee. 32
N-434th Page of 530TOC1stPreviousNextBottomJust 34th
Unless you instruct us otherwise, any partial withdrawal will be made pro rata from the Fixed Account and the Investment Portfolio(s) you selected. Under most circumstances the amount of any partial withdrawal must be for at least $500, or your entire interest in the Investment Portfolio or Fixed Account. We require that after a partial withdrawal is made you keep at least $2,000 in the contract. If the withdrawal would result in the Account Value being less than $2,000 after a partial withdrawal, we will treat the withdrawal request as a request for a full withdrawal. We will pay the amount of any withdrawal from the Separate Account within seven days of when we receive the request in Good Order unless the suspension of payments or transfers provision is in effect. We may withhold payment of withdrawal proceeds if any portion of those proceeds would be derived from a contract Owner's check that has not yet cleared (I.E., that could still be dishonored by the contract Owner's banking institution). We may use telephone, fax, Internet or other means of communication to verify that payment from the contract Owner's check has been or will be collected. We will not delay payment longer than necessary for us to verify that payment has been or will be collected. Contract Owners may avoid the possibility of delay in the disbursement of proceeds coming from a check that has not yet cleared by providing us with a certified check. How to withdraw all or part of your Account Value: o You must submit a request to our Annuity Service Center. (See "Other Information - Requests and Elections.") o If you would like to have the withdrawal charge waived under the Nursing Home or Hospital Confinement Rider or the Terminal Illness Rider, you must provide satisfactory evidence of confinement to a nursing home or hospital or terminal illness. (See "Expenses - Reduction or Elimination of the Withdrawal Charge.") o You must state in your request whether you would like to apply the proceeds to a payment option (otherwise you will receive the proceeds in a lump sum and may be taxed on them). o We have to receive your withdrawal request in our Annuity Service Center prior to the Annuity Date or Owner's death. There are limits to the amount you can withdraw from certain qualified plans including Qualified and TSA plans. (See "Federal Income Tax Status.") INCOME TAXES, TAX PENALTIES AND CERTAIN RESTRICTIONS MAY APPLY TO ANY WITHDRAWAL YOU MAKE. DIVORCE. A withdrawal made pursuant to a divorce or separation instrument is subject to the same withdrawal charge provisions as described in "Expenses - Withdrawal Charge," if permissible under tax law (there are no withdrawal charges if you selected the C Share Option). In addition, the withdrawal will reduce the Account Value and the death benefit. The withdrawal could have a significant negative impact on the optional Return of Premium death benefit. SYSTEMATIC WITHDRAWAL PROGRAM You may elect the Systematic Withdrawal Program at any time. We do not assess a charge for this program. This program provides an automatic payment to you of up to 10% of your total Purchase Payments each year. You can receive payments monthly or quarterly, provided that each payment must amount to at least $100 (unless we consent otherwise). We reserve the right to change the required minimum systematic withdrawal amount. If the New York Stock Exchange is closed on a day when the withdrawal is to be made, we will process the withdrawal on the next Business Day. While the Systematic Withdrawal Program is in effect you can make additional withdrawals. However, such withdrawals plus the systematic withdrawals will be considered when determining the applicability of any withdrawal charge. (For a discussion of the withdrawal charge, see "Expenses" above.) We will terminate your participation in the Systematic Withdrawal Program when we receive notification of your death. INCOME TAXES, TAX PENALTIES AND CERTAIN RESTRICTIONS MAY APPLY TO SYSTEMATIC WITHDRAWALS. 33
N-435th Page of 530TOC1stPreviousNextBottomJust 35th
SUSPENSION OF PAYMENTS OR TRANSFERS We may be required to suspend or postpone payments for withdrawals or transfers for any period when: o the New York Stock Exchange is closed (other than customary weekend and holiday closings); o trading on the New York Stock Exchange is restricted; o an emergency exists, as determined by the Securities and Exchange Commission, as a result of which disposal of shares of the Investment Portfolios is not reasonably practicable or we cannot reasonably value the shares of the Investment Portfolios; or o during any other period when the Securities and Exchange Commission, by order, so permits for the protection of Owners. We have reserved the right to defer payment for a withdrawal or transfer from the Fixed Account for the period permitted by law, but not for more than six months. Federal laws designed to counter terrorism and prevent money laundering might, in certain circumstances, require us to block an Owner's ability to make certain transactions and thereby refuse to accept any requests for transfers, withdrawals, surrenders, or death benefits until instructions are received from the appropriate regulator. We may also be required to provide additional information about you and your contract to government regulators. 7. PERFORMANCE We periodically advertise subaccount performance relating to the Investment Portfolios. We will calculate performance by determining the percentage change in the value of an Accumulation Unit by dividing the increase (decrease) for that unit by the value of the Accumulation Unit at the beginning of the period. This performance number reflects the deduction of the Separate Account product charges (including certain death benefit rider charges) and the Investment Portfolio expenses. It does not reflect the deduction of any applicable account fee, withdrawal charge, or applicable optional rider charges. The deduction of these charges would reduce the percentage increase or make greater any percentage decrease. Any advertisement will also include total return figures which reflect the deduction of the Separate Account product charges (including certain death benefit rider charges), account fee, withdrawal charges, applicable optional rider charges, and the Investment Portfolio expenses. For periods starting prior to the date the contract was first offered, the performance will be based on the historical performance of the corresponding Investment Portfolios for the periods commencing from the date on which the particular Investment Portfolio was made available through the Separate Account. In addition, the performance for the Investment Portfolios may be shown for the period commencing from the inception date of the Investment Portfolios. These figures should not be interpreted to reflect actual historical performance of the Separate Account. We may, from time to time, include in our advertising and sales materials performance information for funds or investment accounts related to the Investment Portfolios and/or their investment advisers or subadvisers. Such related performance information also may reflect the deduction of certain contract charges. We may also include in our advertising and sales materials tax deferred compounding charts and other hypothetical illustrations, which may include comparisons of currently taxable and tax deferred investment programs, based on selected tax brackets. We may advertise using illustrations with historical performance of specific Investment Portfolios or with a hypothetical rate of return (which rate will not exceed 12%) or a combination of historical and hypothetical returns. These illustrations will reflect the deduction of all applicable charges including the portfolio expenses of the underlying Investment Portfolios. You should know that for any performance we illustrate, future performance will vary and results shown are not necessarily representative of future results. 8. DEATH BENEFIT UPON YOUR DEATH If you die during the Accumulation Phase, we will pay a death benefit to your Beneficiary (or Beneficiaries). This death benefit is described below. The death benefit is determined as of the end of the Business Day on which we receive both due proof of death and an election for the payment method. Until the Beneficiary (or the first Beneficiary if there are multiple Beneficiaries) submits the necessary documentation in Good Order, the Account Value attributable to his/her portion of the death benefit 34
N-436th Page of 530TOC1stPreviousNextBottomJust 36th
remains in the Investment Portfolios and is subject to investment risk. Where there are multiple Beneficiaries, any guaranteed death benefit will only be determined as of the time the first Beneficiary submits the necessary documentation in Good Order. For the optional Return of Premium death benefit, if the guaranteed death benefit payable is an amount that exceeds the Account Value on the day it is determined, we will apply to the contract's Account Value an amount equal to the difference between the death benefit payable and the Account Value, in accordance with the current allocation of the Account Value. If the Optional Return of Premium death benefit was not elected, the amount of the death benefit payable to the first Beneficiary is that Beneficiary's portion of the Account Value. If the optional Return of Premium death benefit was elected, the amount of the death benefit payable to the first Beneficiary is that Beneficiary's portion of the greater of 1) the Account Value or 2) the guaranteed death benefit amount, each determined as of the date of his/her claim in Good Order.The remaining death benefit amounts are held in the Investment Portfolios until each of the other Beneficiaries submits the necessary documentation in Good Order to claim his/her death benefit (see "General Death Benefit Provisions" below) and are subject to investment risk until we receive his/her necessary documentation . If you have a Joint Owner, the death benefit will be paid when the first Owner dies. Upon the death of either Owner, the surviving Joint Owner will be the primary Beneficiary. Any other Beneficiary designation will be treated as a contingent Beneficiary, unless instructed otherwise. If a non-natural person owns the contract, the Annuitant will be deemed to be the Owner in determining the death benefit. If there are Joint Owners, the age of the oldest Owner will be used to determine the death benefit amount. If we are presented with notification of your death before any requested transaction is completed (including transactions under a dollar cost averaging program, the Automatic Rebalancing Program, the Systematic Withdrawal Program, or the Automated Required Minimum Distribution Program), we will cancel the request. As described above, the death benefit will be determined when we receive both due proof of death and an election for the payment method. STANDARD DEATH BENEFIT (ACCOUNT VALUE) The death benefit will be equal to the Account Value as of the end of the Business Day on which we receive both due proof of death and an election for the payment method. OPTIONAL DEATH BENEFIT - RETURN OF PREMIUM If you select the Return of Premium death benefit rider, the death benefit will be the greater of: (1) the Account Value; or (2) total Purchase Payments, reduced proportionately by the percentage reduction in Account Value attributable to each partial withdrawal (including any applicable withdrawal charge). If the Owner is a natural person and the Owner is changed to someone other than a spouse, the death benefit amount will be determined as defined above; however, subsection (2) will be changed to provide as follows: "the Account Value as of the effective date of the change of Owner, increased by Purchase Payments received after the date of the change of Owner, reduced proportionately by the percentage reduction in Account Value attributable to each partial withdrawal (including any applicable withdrawal charge) made after such date." In the event that a Beneficiary who is the spouse of the Owner elects to continue the contract in his or her name after the Owner dies, the death benefit amount under the Return of Premium death benefit will be determined in accordance with (1) or (2) above. (See Appendix B for examples of the Return of Premium death benefit.) GENERAL DEATH BENEFIT PROVISIONS As described above, the death benefit is determined as of the end of the Business Day on which we receive both due proof of death and an election for the payment method. Until a Beneficiary submits the necessary documentation in Good Order, the Account Value attributable to his/her portion of the death benefit remains in the Investment Portfolios and is subject to investment risk. This risk is borne by the Beneficiary. If the Beneficiary under a Qualified Contract is the Annuitant's spouse, the tax law generally allows distributions to begin by the year in which the Annuitant 35
N-437th Page of 530TOC1stPreviousNextBottomJust 37th
would have reached 70 1/2 (which may be more or less than five years after the Annuitant's death). A Beneficiary must elect the death benefit to be paid under one of the payment options (unless the Owner has previously made the election). The entire death benefit must be paid within five years of the date of death unless the Beneficiary elects to have the death benefit payable under an Annuity Option. The death benefit payable under an Annuity Option must be paid over the Beneficiary's lifetime or for a period not extending beyond the Beneficiary's life expectancy. For Non-Qualified Contracts, payment must begin within one year of the date of death. For Qualified Contracts, payment must begin no later than the end of the calendar year immediately following the year of death. We may also offer a payment option, for both Non-Qualified Contracts and certain Qualified Contracts, under which your Beneficiary may receive payments, over a period not extending beyond his or her life expectancy, under a method of distribution similar to the distribution of required minimum distributions from Individual Retirement Accounts. If this option is elected, we will issue a new contract to your Beneficiary in order to facilitate the distribution of payments. Your Beneficiary may choose any optional death benefit available under the new contract. Upon the death of your Beneficiary, the death benefit would be required to be distributed to your Beneficiary's beneficiary at least as rapidly as under the method of distribution in effect at the time of your Beneficiary's death. (See "Federal Income Tax Status.") To the extent permitted under the tax law, and in accordance with our procedures, your designated Beneficiary is permitted under our procedures to make additional Purchase Payments consisting of monies which are direct transfers (as permitted under tax law) from other Qualified Contracts or Non-Qualified Contracts, depending on which type of contract you own, held in the name of the decedent. Any such additional Purchase Payments would be subject to applicable withdrawal charges. Your Beneficiary is also permitted to choose some of the optional benefits available under the contract, but certain contract provisions or programs may not be available. If a lump sum payment is elected and all the necessary requirements are met, the payment will be made within seven days. Payment to the Beneficiary under an Annuity Option may only be elected during the 60-day period beginning with the date we receive due proof of death. If the Owner or a Joint Owner, who is not the Annuitant, dies during the Income Phase, any remaining payments under the Annuity Option elected will continue at least as rapidly as under the method of distribution in effect at the time of the Owner's death. Upon the death of the Owner or a Joint Owner during the Income Phase, the Beneficiary becomes the Owner. SPOUSAL CONTINUATION If the primary Beneficiary is the spouse of the Owner, upon the Owner's death, the Beneficiary may elect to continue the contract in his or her own name. Upon such election, the Account Value will be adjusted upward (but not downward) to an amount equal to the death benefit amount determined upon such election and receipt of due proof of death of the Owner. Any excess of the death benefit amount over the Account Value will be allocated to each applicable Investment Portfolio and/or the Fixed Account in the ratio that the Account Value in the Investment Portfolio and/or the Fixed Account bears to the total Account Value. The terms and conditions of the contract that applied prior to the Owner's death will continue to apply, including the ability to make Purchase Payments, with certain exceptions described in the contract. For purposes of the death benefit on the continued contract, the death benefit is calculated in the same manner as it was prior to continuation except that all values used to calculate the death benefit are reset on the date the spouse continues the contract. Spousal continuation will not satisfy minimum required distribution rules for Qualified Contracts other than IRAs (see "Federal Income Tax Status"). All contract provisions will be interpreted and administered in accordance with the requirements of the Code. Any Internal Revenue Code reference to "spouses" includes those persons who are married spouses under state law, regardless of sex. DEATH OF THE ANNUITANT If the Annuitant, not an Owner or Joint Owner, dies during the Accumulation Phase, you automatically become the Annuitant. You can select a new Annuitant if you do not want to be the Annuitant (subject to our then current underwriting standards). However, if the Owner is a non- natural person (for example, a trust), then the death of the 36
N-438th Page of 530TOC1stPreviousNextBottomJust 38th
primary Annuitant will be treated as the death of the Owner, and a new Annuitant may not be named. Upon the death of the Annuitant after Annuity Payments begin, the death benefit, if any, will be as provided for in the Annuity Option selected. Death benefits will be paid at least as rapidly as under the method of distribution in effect at the Annuitant's death. CONTROLLED PAYOUT You may elect to have the death benefit proceeds paid to your Beneficiary in the form of Annuity Payments for life or over a period of time that does not exceed your Beneficiary's life expectancy. This election must be in writing in Good Order. You may revoke the election only in writing in Good Order. Upon your death, the Beneficiary cannot revoke or modify your election. The Controlled Payout is only available to Non-Qualified Contracts. 9. FEDERAL INCOME TAX STATUS INTRODUCTION The following information on taxes is a general discussion of the subject. It is not intended as tax advice. The Internal Revenue Code (the Code) and the provisions of the Code that govern the contract are complex and subject to change. The applicability of federal income tax rules may vary with your particular circumstances. This discussion does not include all the federal income tax rules that may affect you and your contract. Nor does this discussion address other federal tax consequences (such as estate and gift taxes, sales to foreign individuals or entities), or state or local tax consequences, which may affect your investment in the contract. As a result, you should always consult a tax adviser for complete information and advice applicable to your individual situation. You are responsible for determining whether your purchase of a contract, withdrawals, income payments and any other transactions under your contract satisfy applicable tax law. We are not responsible for determining if your employer's plan or arrangement satisfies the requirements of the Code and/or the Employee Retirement Income Security Act of 1974 (ERISA). We do not expect to incur federal, state or local income taxes on the earnings or realized capital gains attributable to the Separate Account. However, if we do incur such taxes in the future, we reserve the right to charge amounts allocated to the Separate Account for these taxes. To the extent permitted under federal tax law, we may claim the benefit of the corporate dividends received deduction and of certain foreign tax credits attributable to taxes paid by certain of the Investment Portfolios to foreign jurisdictions. Any Code reference to "spouse" includes those persons who are married spouses under state law, regardless of sex. NON-QUALIFIED CONTRACTS A "Non-Qualified Contract" discussed here assumes the contract is an annuity contract for federal income tax purposes, but the contract is not held in a tax qualified "plan" defined by the Code. Tax qualified plans include arrangements described in Code Sections 401(a), 401(k), 403(a), 403(b) or tax sheltered annuities (TSA), 408 or "IRAs" (including SEP and SIMPLE IRAs), 408A or "Roth IRAs" or 457(b) or governmental 457(b) plans. Contracts owned through such plans are referred to below as "Qualified Contracts." INVESTOR CONTROL In certain circumstances, Owners of variable annuity Non-Qualified Contracts have been considered to be the owners of the assets of the underlying Separate Account for federal income tax purposes due to their ability to exercise investment control over those assets. When this is the case, the contract Owners have been currently taxed on income and gains attributable to the variable account assets. There is little guidance in this area, and some features of the contract, such as the number of Investment Portfolios available and the flexibility of the contract Owner to allocate Purchase Payments and transfer amounts among the Investment Portfolios have not been addressed in public rulings. While we believe that the contract does not give the contract Owner investment control over Separate Account assets, we reserve the right to modify the contract as necessary to prevent a contract Owner from being treated as the owner of the Separate Account assets supporting the contract. ACCUMULATION Generally, an Owner of a Non-Qualified Contract is not taxed on increases in the value of the contract until there is a distribution from the contract, either as surrenders, partial withdrawals, or income payments. This deferral of taxation on accumulated value in the contract is limited to contracts owned by or held for the benefit of "natural persons." A contract will be treated as held by a natural 37
N-439th Page of 530TOC1stPreviousNextBottomJust 39th
person even if the nominal Owner is a trust or other entity which holds the contract as an agent for a natural person. In contrast, a contract owned by other than a "natural person," such as a corporation, partnership, trust, or other entity, will be taxed currently on the increase in accumulated value in the contract in the year earned. Note that in this regard, an employer which is the Owner of an annuity contract under a non-qualified deferred compensation arrangement for its employees would be considered a non-natural Owner and the annual increase in the Account Value would be subject to current income taxation. SURRENDERS OR WITHDRAWALS - EARLY DISTRIBUTION If you take a withdrawal from your contract, or surrender your contract prior to the date you commence taking annuity or "income" payments (the "Annuity Starting Date"), the amount you receive will be treated first as coming from earnings (and thus subject to income tax) and then from your Purchase Payments (which are not subject to income tax). If the accumulated value is less than your Purchase Payments upon surrender of your contract, you might be able to claim the loss on your federal income taxes as a miscellaneous itemized deduction. The portion of any withdrawal or distribution from an annuity contract that is subject to income tax will also be subject to a 10% federal income tax penalty for "early" distribution if such withdrawal or distribution is taken prior to you reaching age 59 1/2, unless the distribution was made: (a) on account of your death or disability, (b) as part of a series of substantially equal periodic payments payable for your life or joint lives of you and your designated Beneficiary, or (c) under certain immediate income annuities providing for substantially equal payments made at least annually. If you receive systematic payments that you intend to qualify for the "substantially equal periodic payments" exception noted above, any modifications (except due to death or disability) to your payment before age 59 1/2 or within five years after beginning these payments, whichever is later, will result in the retroactive imposition of the 10% federal income tax penalty with interest. Such modifications may include additional Purchase Payments or withdrawals (including tax-free transfers or rollovers of income payments) from the contract. If your contract has been purchased with an Optional Two Year Withdrawal Feature or is for a guaranteed period only (term certain) annuity, and is terminated as a result of the exercise of the withdrawal feature, the taxable portion of the payment will generally be the excess of the proceeds received over your remaining after-tax Purchase Payment. For Non-Qualified Contracts, amounts received under the exercise of a partial withdrawal may be fully includible in taxable income. The entire amount of the withdrawal could be treated as taxable income. Exercise of either withdrawal feature may adversely impact the amount of subsequent payments which can be treated as a nontaxable return of investment. TREATMENT OF SEPARATE ACCOUNT CHARGES It is possible that at some future date the Internal Revenue Service (IRS) may consider that contract charges attributable to certain guaranteed death benefits are to be treated as distributions from the contract to pay for such non-annuity benefits. Currently, these charges are considered to be an intrinsic part of the contract and we do not report these as taxable income. However, if this treatment changes in the future, the charge could also be subject to a 10% federal income tax penalty as an early distribution, as described above. AGGREGATION If you purchase two or more deferred annuity contracts from us (or our affiliates) during the same calendar year (after October 21, 1988), the law requires that all such contracts must be treated as a single contract for purposes of determining whether any payments not received as an annuity (e.g., withdrawals) will be includible in income. Aggregation could affect the amount of a withdrawal that is taxable and subject to the 10% federal income tax penalty described above. Since the IRS may require aggregation in other circumstances as well, you should consult a tax adviser if you are purchasing more than one annuity contract from the same insurance company in a single calendar year. Aggregation does not affect distributions paid in the form of an annuity (see "Taxation of Payments in Annuity Form" below). EXCHANGES/TRANSFERS The annuity contract may be exchanged in whole or in part for another annuity contract or a long-term care insurance policy. The exchange for another annuity contract may be a tax-free transaction provided that, among other prescribed IRS conditions, no amounts are distributed from either 38
N-440th Page of 530TOC1stPreviousNextBottomJust 40th
contract involved in the exchange for 180 days following the date of the exchange - other than Annuity Payments made for life, joint lives, or for a term of 10 years or more. Otherwise, a withdrawal or "deemed" distribution may be includible in your taxable income (plus a 10% federal income tax penalty) to the extent that the accumulated value of your annuity exceeds your investment in the contract (your "gain"). The opportunity to make partial annuity exchanges was provided by the IRS in 2011 and some ramifications of such an exchange remain unclear. If the annuity contract is exchanged in part for an additional annuity contract, a distribution from either contract may be taxable to the extent of the combined gain attributable to both contracts, or only to the extent of your gain in the contract from which the distribution is paid. It is not clear whether this guidance applies to a partial exchange involving long-term care contracts. Consult your tax adviser prior to a partial exchange. A transfer of ownership of the contract, or the designation of an Annuitant or other Beneficiary who is not also the contract Owner, may result in income or gift tax consequences to the contract Owner. You should consult your tax adviser if you are considering such a transfer or assignment. DEATH BENEFITS The death benefit is taxable to the recipient in the same manner as if paid to the contract Owner (under the rules for withdrawals or income payments, whichever is applicable). After your death, any death benefit determined under the contract must be distributed according to certain rules. The method of distribution that is required depends on whether you die before or after the Annuity Starting Date. If you die on or after the Annuity Starting Date, the remaining portion of the interest in the contract must be distributed at least as rapidly as under the method of distribution being used as of the date of death. If you die before the Annuity Starting Date, the entire interest in the contract must be distributed within five (5) years after the date of death, or as periodic payments over a period not extending beyond the life or life expectancy of the designated Beneficiary (provided such payments begin within one year of your death). Your designated Beneficiary is the person to whom benefit rights under the contract pass by reason of death; the Beneficiary must be a natural person in order to elect a periodic payment option based on life expectancy or a period exceeding five years. Additionally, if the annuity is payable to (or for the benefit of) your surviving spouse, that portion of the contract may be continued with your spouse as the Owner. For contracts owned by a non-natural person, the required distribution rules apply upon the death of the Annuitant. If there is more than one Annuitant of a contract held by a non-natural person, then such required distributions will be triggered by the death of the first co-Annuitant. TAXATION OF PAYMENTS IN ANNUITY FORM When payments are received from the contract in the form of an annuity, normally the Annuity Payments are taxable as ordinary income to the extent that payments exceed the portion of the payment determined by applying the exclusion ratio to the entire payment. The exclusion ratio of a contract is determined at the time the contract's accumulated value is converted to an annuity form of distribution. Generally, the applicable exclusion ratio is your investment in the contract divided by the total payments you are expected to receive based on IRS rules which consider such factors, such as the form of annuity and mortality. The excludable portion of each Annuity Payment is the return of investment in the contract and it is excludable from your taxable income until your investment in the contract is fully recovered. We will make this calculation for you. However, it is possible that the IRS could conclude that the taxable portion of income payments under a Non-Qualified Contract is an amount greater - or less - than the taxable amount determined by us and reported by us to you and the IRS. Once you have recovered the investment in the contract, further Annuity Payments are fully taxable. If you die before your investment in the contract is fully recovered, the balance may be deducted on your last tax return, or if Annuity Payments continue after your death, the balance may be deducted by your Beneficiary. The IRS has not furnished explicit guidance as to how the excludable amount is to be determined each year under variable income annuities that permit transfers between a fixed annuity option and variable investment options, as well as transfers between investment options after the Annuity Starting Date. Once Annuity Payments have 39
N-441st Page of 530TOC1stPreviousNextBottomJust 41st
commenced, you may not be able to make transfer withdrawals to another Non-Qualified Contract or a long-term care contract in a tax-free exchange. If you receive payments that you intend to qualify for the "substantially equal periodic payments" exception noted above, any modifications (except due to death or disability) to your payment before age 59 1/2 or within five years after beginning these payments, whichever is later, will result in the retroactive imposition of the 10% federal income tax penalty with interest. Such modifications may include additional Purchase Payments or withdrawals (including tax-free transfers or rollovers of income payments) from the contract. If the contract allows, you may elect to convert less than the full value of your contract to an annuity form of pay-out (i.e., "partial annuitization"). In this case, your investment in the contract will be pro-rated between the annuitized portion of the contract and the deferred portion. An exclusion ratio will apply to the Annuity Payments as described above, provided the annuity form you elect is payable for at least 10 years or for the life of one or more individuals. 3.8% TAX ON NET INVESTMENT INCOME Federal tax law imposes a 3.8% Medicare tax on the lesser of: (1) the taxpayer's "net investment income," (from non-qualified annuities, interest, dividends, and other investments, offset by specified allowable deductions), or (2) the taxpayer's modified adjusted gross income in excess of a specified income threshold ($250,000 for married couples filing jointly, $125,000 for married couples filing separately, and $200,000 otherwise). "Net investment income" in Item 1 above does not include distributions from tax qualified plans, (i.e., arrangements described in Code Sections 401(a), 403(a), 403(b), 408, 408A, or 457(b)), but such income will increase modified adjusted gross income in Item 2 above. You should consult your tax adviser regarding the applicability of this tax to income under your annuity contract. PUERTO RICO TAX CONSIDERATIONS The Puerto Rico Internal Revenue Code of 2011 (the "2011 PR Code") taxes distributions from Non-Qualified Contracts differently than in the U.S. Distributions that are not in the form of an annuity (including partial surrenders and period certain payments) are treated under the 2011 PR Code first as a return of investment. Therefore, a substantial portion of the amounts distributed generally will be excluded from gross income for Puerto Rico tax purposes until the cumulative amount paid exceeds your tax basis. The amount of income on annuity distributions in annuity form (payable over your lifetime) is also calculated differently under the 2011 PR Code. Since the U.S. source income generated by a Puerto Rico bona fide resident is subject to U.S. income tax and the IRS issued guidance in 2004 which indicated that the income from an annuity contract issued by a U.S. life insurer would be considered U.S. source income, the timing of recognition of income from an annuity contract could vary between the two jurisdictions. Although the 2011 PR Code provides a credit against the Puerto Rico income tax for U.S. income taxes paid, an individual may not get full credit because of the timing differences. You should consult with a personal tax adviser regarding the tax consequences of purchasing an annuity contract and/or any proposed distribution, particularly a partial distribution or election to annuitize if you are a resident of Puerto Rico. QUALIFIED CONTRACTS INTRODUCTION The contract may be purchased through certain types of retirement plans that receive favorable treatment under the Code ("tax qualified plans"). Tax-qualified plans include arrangements described in Code Sections 401(a), 401(k), 403(a), 403(b) or tax sheltered annuities (TSA), 408 or "IRAs" (including SEP and SIMPLE IRAs), 408A or "Roth IRAs" or 457 (b) or 457(b) governmental plans. Extensive special tax rules apply to qualified plans and to the annuity contracts used in connection with these plans. Therefore, the following discussion provides only general information about the use of the contract with the various types of qualified plans. Adverse tax consequences may result if you do not ensure that contributions, distributions and other transactions with respect to the contract comply with the law. The rights to any benefit under the plan will be subject to the terms and conditions of the plan itself as well as the terms and conditions of the contract. We exercise no control over whether a particular retirement plan or a particular contribution to the plan satisfies the 40
N-442nd Page of 530TOC1stPreviousNextBottomJust 42nd
applicable requirements of the Code, or whether a particular individual is entitled to participate or benefit under a plan. All qualified plans and arrangements receive tax deferral under the Code. Since there are no additional tax benefits in funding such retirement arrangements with an annuity, there should be reasons other than tax deferral for acquiring the annuity within the plan. Such non-tax benefits may include additional insurance benefits, such as the availability of a guaranteed income for life. A contract may also be available in connection with an employer's non-qualified deferred compensation plan and qualified governmental excess benefit arrangement to provide benefits to certain employees in the plan. The tax rules regarding these plans are complex. We do not provide tax advice. Please consult your tax adviser about your particular situation. ACCUMULATION The tax rules applicable to qualified plans vary according to the type of plan and the terms and conditions of the plan itself. Both the amount of the contribution that may be made and the tax deduction or exclusion that you may claim for that contribution are limited under qualified plans. See the SAI for a description of qualified plan types and annual current contribution limitations, which are subject to change from year-to-year. Purchase payments or contributions to IRAs or tax qualified retirement plans of an employer may be taken from current income on a before tax basis or after tax basis. Purchase payments made on a "before tax" basis entitle you to a tax deduction or are not subject to current income tax. Purchase payments made on an "after tax" basis do not reduce your taxable income or give you a tax deduction. Contributions may also consist of transfers or rollovers as described below which are not subject to the annual limitations on contributions. The contract will accept as a single Purchase Payment a transfer or rollover from another IRA or rollover from an eligible retirement plan of an employer (i.e., 401(a), 401(k), 403(a), 403(b), or governmental 457(b) plan). It will also accept a rollover or transfer from a SIMPLE IRA after the taxpayer has participated in such arrangement for at least two years. As part of the single Purchase Payment, the IRA contract will also accept an IRA contribution subject to the Code limits for the year of purchase. For income annuities established as "pay-outs" of SIMPLE IRAs, the contract will only accept a single Purchase Payment consisting of a transfer or rollover from another SIMPLE IRA. For income annuities established in accordance with a distribution option under a retirement plan of an employer (e.g., 401(a), 401(k), 403(a), 403(b), or 457(b) plan), the contract will only accept as its single Purchase Payment a transfer from such employer retirement plan. TAXATION OF ANNUITY DISTRIBUTIONS If contributions are made on a "before tax" basis, you generally pay income taxes on the full amount of money you withdraw as well as income earned under the contract. Withdrawals attributable to any after-tax contributions are your basis in the contract and not subject to income tax (except for the portion of the withdrawal allocable to earnings). Under current federal income tax rules, the taxable portion of distributions under annuity contracts and qualified plans (including IRAs) is not eligible for the reduced tax rate applicable to long-term capital gains and qualifying dividends. If you meet certain requirements, your Roth IRA, Roth 403(b) and Roth 401(k) earnings are free from federal income taxes. With respect to IRA contracts, we will withhold a portion of the taxable amount of your withdrawal for income taxes, unless you elect otherwise. The amount we withhold is determined by the Code. WITHDRAWALS PRIOR TO AGE 59 1/2 A taxable withdrawal or distribution from a qualified plan which is subject to income tax may also be subject to a 10% federal income tax penalty for "early" distribution if taken prior to age 59 1/2, unless an exception described below applies. The penalty rate is 25% for SIMPLE plan contracts if the distribution occurs within the first 2 years of your participation in the plan. These exceptions include distributions made: (a) on account of your death or disability, or (b) as part of a series of substantially equal periodic payments payable for your life or joint lives of you and your designated Beneficiary and you are separated from employment. 41
N-443rd Page of 530TOC1stPreviousNextBottomJust 43rd
If you receive systematic payments that you intend to qualify for the "substantially equal periodic payments" exception noted above, any modifications (except due to death or disability) to your payment before age 59 1/2 or within five years after beginning these payments, whichever is later, will result in the retroactive imposition of the 10% federal income tax penalty with interest. Such modifications may include additional Purchase Payments or withdrawals (including tax-free transfers or rollovers of income payments) from the contract. In addition, a withdrawal or distribution from a Qualified Contract other than an IRA (including SEPs and SIMPLEs) will avoid the penalty if: (1) the distribution is on separation from employment after age 55; (2) the distribution is made pursuant to a qualified domestic relations order (QDRO); (3) the distribution is to pay deductible medical expenses; or (4) if the distribution is to pay IRS levies (and made after December 31, 1999). The 10% federal income tax penalty on early distribution does not apply to governmental 457(b) plan contracts. However, it does apply to distributions from 457(b) plans of employers which are state or local governments to the extent that the distribution is attributable to rollovers accepted from other types of eligible retirement plans. In addition to death, disability and as part of a series of substantially equal periodic payments as indicated above, a withdrawal or distribution from an IRA (including SEPs and SIMPLEs and Roth IRAs) will avoid the penalty: (1) if the distribution is to pay deductible medical expenses; (2) if the distribution is to pay IRS levies (and made after December 31, 1999); (3) if the distribution is used to pay for medical insurance (if you are unemployed), qualified higher education expenses, or for a qualified first time home purchase up to $10,000. Other exceptions may be applicable under certain circumstances and special rules may be applicable in connection with the exceptions enumerated above. COMMUTATION FEATURES UNDER INCOME PAYMENT TYPES Please be advised that the tax consequences resulting from the election of an income payment types containing a commutation feature (a feature that allows the Owner to receive a lump sum of the present value of future Annuity Payments) are uncertain and the IRS may determine that the taxable amount of income payments and withdrawals received for any year could be greater than or less than the taxable amount reported by us. The exercise of the commutation feature also may result in adverse tax consequences including: o The imposition of a 10% federal income tax penalty on the taxable amount of the commuted value, if the taxpayer has not attained age 59 1/2 at the time the withdrawal is made. This 10% federal income tax penalty is in addition to the ordinary income tax on the taxable amount of the commuted value. o The retroactive imposition of the 10% federal income tax penalty on income payments received prior to the taxpayer attaining age 59 1/2. o The possibility that the exercise of the commutation feature could adversely affect the amount excluded from federal income tax under any income payments made after such commutation. A payee should consult with his or her own tax adviser prior to electing to annuitize the contract and prior to exercising any commutation feature under an income payment type. ROLLOVERS Your contract is non-forfeitable (i.e., not subject to the claims of your creditors) and non-transferable (i.e., you may not transfer it to someone else). Nevertheless, contracts held in certain employer plans subject to ERISA may be transferred in part pursuant to a QDRO. Under certain circumstances, you may be able to transfer amounts distributed from your contract to another eligible retirement plan or IRA. For 457(b) plans maintained by non-governmental employers, if certain conditions are met, amounts may be transferred into another 457(b) plan maintained by a non-governmental employer. You may make rollovers and direct transfers into your SIMPLE IRA annuity contract from another SIMPLE IRA annuity contract or account. No other rollovers or transfers can be made to your SIMPLE IRA. Rollovers and direct transfers from a SIMPLE IRA can only be made to another SIMPLE IRA or account during the first two years that you participate in the SIMPLE IRA plan. After this two year 42
N-444th Page of 530TOC1stPreviousNextBottomJust 44th
period, rollovers and transfers may be made from your SIMPLE IRA into a Traditional IRA or account, as well as into another SIMPLE IRA. Generally, a distribution may be eligible for rollover. Certain types of distributions cannot be rolled over, such as distributions received on account of: (a) minimum distribution requirements, or (b) financial hardship. 20% WITHHOLDING ON ELIGIBLE ROLLOVER DISTRIBUTIONS For certain qualified employer plans, we are required to withhold 20% of the taxable portion of your withdrawal that constitutes an "eligible rollover distribution" for federal income taxes. The amount we withhold is determined by the Code. You may avoid withholding if you assign or transfer a withdrawal from this contract directly into another qualified plan or IRA. Similarly, you may be able to avoid withholding on a transfer into this contract from an existing qualified plan you may have with another provider by arranging to have the transfer made directly to us. For taxable withdrawals that are not "eligible rollover distributions," the Code requires different withholding rules which determine the withholding amounts. DEATH BENEFITS The death benefit is taxable to the recipient in the same manner as if paid to the contract Owner or plan participant (under the rules for withdrawals or income payments, whichever is applicable). Distributions required from a Qualified Contract following your death depend on whether you die before you had converted your contract to an annuity form and started taking Annuity Payments (your Annuity Starting Date). If you die on or after your Annuity Starting Date, the remaining portion of the interest in the contract must be distributed at least as rapidly as under the method of distribution being used as of the date of death. If you die before your Annuity Starting Date, the entire interest in the contract must be distributed within five (5) years after the date of death, or as periodic payments over a period not extending beyond the life or life expectancy of the designated Beneficiary (provided such payments begin within one year of your death). Your designated Beneficiary is the person to whom benefit rights under the contract pass by reason of death; the Beneficiary must be a natural person in order to elect a periodic payment option based on life expectancy or a period exceeding five years. For required minimum distributions following the death of the Annuitant of a Qualified Contract, the five-year rule is applied without regard to calendar year 2009. For instance, for a contract Owner who died in 2007, the five-year period would end in 2013 instead of 2012. The required minimum distribution rules are complex, so consult your tax adviser because the application of these rules to your particular circumstances may have been impacted by the 2009 required minimum distribution waiver. Additionally, if the annuity is payable to (or for the benefit of) your surviving spouse, that portion of the contract may be continued with your spouse as the Owner. If your spouse is your Beneficiary, and your contract permits, your spouse may delay the start of these payments until December 31 of the year in which you would have reached age 70 1/2. If your spouse is your Beneficiary, your spouse may be able to rollover the death proceeds into another eligible retirement plan in which he or she participates, if permitted under the receiving plan. Alternatively, if your spouse is your sole Beneficiary, he or she may elect to rollover the death proceeds into his or her own IRA. If your Beneficiary is not your spouse and your plan and contract permit, your Beneficiary may be able to rollover the death proceeds via a direct trustee-to-trustee transfer into an inherited IRA. However, a non-spouse Beneficiary may not treat the inherited IRA as his or her own IRA. Additionally, for contracts issued in connection with qualified plans subject to ERISA, the spouse or ex-spouse of the Owner may have rights in the contract. In such a case, the Owner may need the consent of the spouse or ex-spouse to change annuity options or make a withdrawal from the contract. REQUIRED MINIMUM DISTRIBUTIONS Generally, you must begin receiving retirement plan withdrawals by April 1 following the latter of: (a) the calendar year in which you reach age 70 1/2, or (b) the calendar year you retire, provided you do not own more than 5% of your employer. 43
N-445th Page of 530TOC1stPreviousNextBottomJust 45th
For IRAs (including SEPs and SIMPLEs), you must begin receiving withdrawals by April 1 of the year after you reach age 70 1/2 even if you have not retired. A tax penalty of 50% applies to the amount by which the required minimum distribution exceeds the actual distribution. You may not satisfy minimum distributions for one employer's qualified plan (i.e., 401(a), 403(a), 457(b)) with distributions from another qualified plan of the same or a different employer. However, an aggregation rule does apply in the case of IRAs (including SEPs and SIMPLEs) or 403(b) plans. The minimum required distribution is calculated with respect to each IRA, but the aggregate distribution may be taken from any one or more of your IRAs/SEPs. Similarly, the amount of required minimum distribution is calculated separately with respect to each 403(b) arrangement, but the aggregate amount of the required distribution may be taken from any one or more of your 403(b) plan contracts. For SIMPLE IRAs, the aggregate amount of the required distribution may be taken from any one or more of your SIMPLE IRAs. Complex rules apply to the calculation of these withdrawals. In general, income tax regulations permit income payments to increase based not only with respect to the investment experience of the Investment Portfolios but also with respect to actuarial gains. The regulations also require that the value of benefits under a deferred annuity including certain death benefits in excess of contract value must be added to the amount credited to your account in computing the amount required to be distributed over the applicable period. We will provide you with additional information regarding the amount that is subject to minimum distribution under this rule. You should consult your own tax adviser as to how these rules affect your own distribution under this rule. If you intend to receive your minimum distributions which are payable over the joint lives of you and a Beneficiary who is not your spouse (or over a period not exceeding the joint life expectancy of you and your non-spousal Beneficiary), be advised that federal tax rules may require that payments be made over a shorter period or may require that payments to the Beneficiary be reduced after your death to meet the minimum distribution incidental benefit rules and avoid the 50% excise tax. You should consult your own tax adviser as to how these rules affect your own contract. Required minimum distribution rules that apply to other types of IRAs while you are alive do not apply to Roth IRAs. However, in general, the same rules with respect to minimum distributions required to be made to a Beneficiary after your death under other IRAs do apply to Roth IRAs. ADDITIONAL INFORMATION REGARDING IRAS PURCHASE PAYMENTS. Traditional IRA Purchase Payments (except for permissible rollovers and direct transfers) are generally not permitted after you attain age 70 1/2. Except for permissible rollovers and direct transfers, Purchase Payments for individuals are limited in the aggregate to the lesser of 100% of compensation or the deductible amount established each year under the Code. A Purchase Payment up to the deductible amount can also be made for a non-working spouse provided the couple's compensation is at least equal to their aggregate contributions. Individuals age 50 and older are permitted to make additional "catch-up" contributions if they have sufficient compensation. If you or your spouse are an active participant in a retirement plan of an employer, your deductible contributions may be limited. If you exceed Purchase Payment limits you may be subject to a tax penalty. Roth IRA Purchase Payments for individuals are non-deductible (made on an "after tax" basis) and are limited to the lesser of 100% of compensation or the annual deductible IRA amount. Individuals age 50 and older can make an additional "catch-up" Purchase Payment each year (assuming the individual has sufficient compensation). You may contribute up to the annual Purchase Payment limit if your modified adjusted gross income does not exceed certain limits. You can contribute to a Roth IRA after age 70 1/2. If you exceed Purchase Payment limits, you may be subject to a tax penalty. WITHDRAWALS. If and to the extent that Traditional IRA Purchase Payments are made on an "after tax" basis, withdrawals would be included in income except for the portion that represents a return of non-deductible Purchase Payments. This portion is generally determined based upon the ratio of all non-deductible Purchase Payments to the total value of all your Traditional IRAs (including SEP IRAs and SIMPLE IRAs). We withhold a portion of the amount of your withdrawal for income taxes, unless you elect otherwise. The amount we withhold is determined by the Code. 44
N-446th Page of 530TOC1stPreviousNextBottomJust 46th
Generally, withdrawal of earnings from Roth IRAs are free from federal income tax if: (1) they are made at least five taxable years after your first Purchase Payment to a Roth IRA; and (2) they are made on or after the date you reach age 59 1/2 and upon your death, disability or qualified first-home purchase (up to $10,000). Withdrawals from a Roth IRA are made first from Purchase Payments and then from earnings. We may be required to withhold a portion of your withdrawal for income taxes, unless you elect otherwise. The amount will be determined by the Code. CONVERSION. Traditional IRAs may be converted to Roth IRAs. Except to the extent you have non-deductible contributions, the amount converted from an existing Traditional IRA into a Roth IRA is taxable. Generally, the 10% federal income tax penalty does not apply. However, the taxable amount to be converted must be based on the fair market value of the entire annuity contract being converted into a Roth IRA. Such fair market value, in general, is to be determined by taking into account the value of all benefits in addition to the Account Value; as well as adding back certain loads and charges incurred during the prior twelve month period. Your contract may include such benefits and applicable charges. Accordingly, if you are considering such conversion of your annuity contract, please consult your tax adviser. The taxable amount may exceed the Account Value at the date of conversion. A Roth IRA contract may also be re-characterized as a Traditional IRA, if certain conditions are met. Please consult your tax adviser. DISTINCTION FOR PUERTO RICO CODE An annuity contract may be purchased by an employer for an employee under a qualified pension, profit sharing, stock bonus, annuity, or a "cash or deferred" arrangement plan established pursuant to Section 1081.01 of the 2011 PR Code. To be tax qualified under the 2011 PR Code, a plan must comply with the requirements of Section 1081.01(a) of the 2011 PR Code which includes certain participation requirements, among other requirements. A trust created to hold assets for a qualified plan is exempt from tax on its investment income. CONTRIBUTIONS. The employer is entitled to a current income tax deduction for contributions made to a qualified plan, subject to statutory limitations on the amount that may be contributed each year. The plan contributions by the employer are not required to be included in the current income of the employee. DISTRIBUTIONS. Any amount received or made available to the employee under the qualified plan is includible in the gross income of the employee in the taxable year in which received or made available. In such case, the amount paid or contributed by the employer shall not constitute consideration paid by the employee for the contract for purposes of determining the amount of Annuity Payments required to be included in the employee's gross income. Thus, amounts actually distributed or made available to any employee under the qualified plan will be included in their entirety in the employee's gross income. Lump-sum proceeds from a Puerto Rico qualified retirement plan due to separation from service will generally be taxed at a 20% capital gain tax rate to be withheld at the source. A special rate of 10% may apply instead, if the plan satisfies the following requirements: (1) the plan's trust is organized under the laws of Puerto Rico, or has a Puerto Rico resident trustee and uses such trustee as paying agent; and (2) 10% of all plan's trust assets (calculated based on the average balance of the investments of the trust) attributable to participants who are Puerto Rico residents must be invested in "property located in Puerto Rico" for a three-year period. If these two requirements are not satisfied, the distribution will generally be subject to the 20% tax rate. The three-year period includes the year of the distribution and the two immediately preceding years. In the case of a defined contribution plan that maintains separate accounts for each participant, the described 10% investment requirement may be satisfied in the accounts of a participant that chooses to invest in such fashion rather than at the trust level. Property located in Puerto Rico includes shares of stock of a Puerto Rico registered investment company, fixed or variable annuities issued by a domestic insurance company or by a foreign insurance corporation that derives more than 80% of its gross income from sources within Puerto Rico, and bank deposits. The PR 2011 Code does not impose a penalty tax in cases of early (premature) distributions from a qualified plan. ROLLOVER. Deferral of the recognition of income continues upon the receipt of a distribution by a participant from a qualified plan, if the distribution is contributed to another qualified retirement plan or traditional individual retirement account for the employee's benefit no later than sixty (60) days after the distribution. 45
N-447th Page of 530TOC1stPreviousNextBottomJust 47th
ERISA CONSIDERATIONS. In the context of a Puerto Rico qualified retirement plan trust, the IRS has recently held that the transfer of assets and liabilities from a qualified retirement plan trust under the Code to that type of plan would generally be treated as a distribution includible in gross income for U.S. income tax purposes even if the Puerto Rico retirement plan is a plan described in ERISA Section 1022(i)(1). By contrast, a transfer from a qualified retirement plan trust under the Code to a Puerto Rico qualified retirement plan trust that has made an election under ERISA Section 1022(i)(2) is not treated as a distribution from the transferor plan for U.S. income tax purposes because a Puerto Rico retirement plan that has made an election under ERISA Section 1022(i)(2) is treated as a qualified retirement plan for purposes Code Section 401(a). The IRS has determined that the above described rules prescribing the inclusion in income of transfers of assets and liabilities to a Puerto Rico retirement plan trust described in ERISA Section 1022(i)(1) would be applicable to transfers taking effect after December 31, 2012. Similar to the IRS in Revenue Ruling 2013-17, the U.S. Department of Labor issued DOL Technical Release No. 2013-04 on September 18, 2013, providing that, where the Secretary of Labor has authority to regulate with respect to the provisions of ERISA dealing with the use of the term "spouse," spouse will be read to refer to any individuals who are lawfully married under any state law, including same-sex spouses, and without regard to whether their state of domicile recognizes same-sex marriage. Thus, for ERISA purposes as well as Federal tax purposes, an employee benefit plan participant who marries a person of the same sex in a jurisdiction that recognizes same-sex marriage will continue to be treated as married even if the couple moves to a jurisdiction, like Puerto Rico, that does not recognize same-sex marriage. 10. OTHER INFORMATION METLIFE USA MetLife Insurance Company USA is a stock life insurance company originally chartered in Connecticut in 1863 and currently subject to the laws of the State of Delaware. MetLife USA was previously known as MetLife Insurance Company of Connecticut but changed its name to MetLife Insurance Company USA when it changed its state of domicile from Connecticut to Delaware on November 14, 2014. MetLife USA is licensed to conduct business in all states of the United States, except New York, and in the District of Columbia, Puerto Rico, Guam, the U.S. and British Virgin Islands and the Bahamas. The company is a wholly-owned subsidiary of MetLife, Inc., a publicly-traded company. MetLife, Inc., through its subsidiaries and affiliates, is a leading provider of insurance and financial services to individuals and institutional customers. The company's executive offices are located at 11225 North Community House Road, Charlotte, NC 28277. Prior to November 17, 2014, the contract was issued by MetLife Investors USA Insurance Company (MetLife Investors). On November, 14, 2014, following the close of business MetLife Investors merged into MetLife USA and MetLife USA replaced MetLife Investors as the issuer of the contract. THE SEPARATE ACCOUNT We have established a SEPARATE ACCOUNT, MetLife Investors USA Separate Account A (Separate Account), to hold the assets that underlie the contracts. The Board of Directors of MetLife Investors USA Insurance Company (MetLife Investors) adopted a resolution to establish the Separate Account under Delaware insurance law on May 29, 1980. On November 14, 2014, following the close of business MetLife Investors merged into MetLife USA and the Separate Account became a separate account of MetLife USA. We have registered the Separate Account with the Securities and Exchange Commission as a unit investment trust under the Investment Company Act of 1940. The Separate Account is divided into subaccounts. The Separate Account's assets are solely for the benefit of those who invest in the Separate Account and no one else, including our creditors. The assets of the Separate Account are held in our name on behalf of the Separate Account and legally belong to us. All the income, gains and losses (realized or unrealized) resulting from these assets are credited to or charged against the contracts issued from this Separate Account without regard to our other business. We reserve the right to transfer assets of the Separate Account to another account, and to modify the structure or operation of the Separate Account, subject to necessary regulatory approvals. If we do so, we will notify you of any such changes and we guarantee that the modification will not affect your Account Value. We are obligated to pay all money we owe under the contracts - such as death benefits and income payments - even if that amount exceeds the assets in the Separate Account. Any such amount that exceeds the assets in the 46
N-448th Page of 530TOC1stPreviousNextBottomJust 48th
Separate Account is paid from our general account. Any amount under any optional death benefit or optional Guaranteed Withdrawal Benefit that exceeds the assets in the Separate Account is also paid from our general account. Benefit amounts paid from the general account are subject to our financial strength and claims paying ability and our long term ability to make such payments. We issue other annuity contracts and life insurance policies where we pay all money we owe under those contracts and policies from our general account. MetLife USA is regulated as an insurance company under state law, which generally includes limits on the amount and type of investments in our general account. However, there is no guarantee that we will be able to meet our claims paying obligations; there are risks to purchasing any insurance product. The investment advisers to certain of the Investment Portfolios offered with the contracts or with other variable annuity contracts issued through the Separate Account may be regulated as Commodity Pool Operators. While it does not concede that the Separate Account is a commodity pool, MetLife USA has claimed an exclusion from the definition of the term "commodity pool operator" under the Commodities Exchange Act (CEA), and is not subject to registration or regulation as a pool operator under the CEA. DISTRIBUTOR We have entered into a distribution agreement with our affiliate, MetLife Investors Distribution Company (Distributor), 1095 Avenue of the Americas, New York, NY 10036, for the distribution of the contracts. Distributor is a member of the Financial Industry Regulatory Authority (FINRA). FINRA provides background information about broker-dealers and their registered representatives through FINRA BrokerCheck. You may contact the FINRA BrokerCheck Hotline at 1-800-289-9999, or log on to www.finra.org. An investor brochure that includes information describing FINRA BrokerCheck is available through the Hotline or on-line. Distributor, and in certain cases, we, have entered into selling agreements with other affiliated and unaffiliated selling firms for the sale of the contracts. We pay compensation to Distributor for sales of the contracts by selling firms. We also pay amounts to Distributor that may be used for its operating and other expenses, including the following sales expenses: compensation and bonuses for the Distributor's management team, advertising expenses, and other expenses of distributing the contracts. Distributor's management team and registered representatives also may be eligible for non-cash compensation items that we may provide jointly with Distributor. Non-cash items include conferences, seminars and trips (including travel, lodging and meals in connection therewith), entertainment, merchandise and other similar items. All of the Investment Portfolios make payments to Distributor under their distribution plans in consideration of services provided and expenses incurred by Distributor in distributing shares of the Investment Portfolios. (See the Investment Portfolio prospectuses for more information.) These payments range from 0.15% to 0.55% of Separate Account assets invested in the particular Investment Portfolio. We pay American Funds Distributors, Inc., principal underwriter for the American Funds Insurance Series, a percentage of Purchase Payments allocated to the following portfolios for the services it provides in marketing the portfolios' shares in connection with the contract: the American Funds Global Small Capitalization Fund, the American Funds (Reg. TM) Growth Portfolio, the American Funds (Reg. TM) Moderate Allocation Portfolio, the American Funds (Reg. TM) Balanced Allocation Portfolio, and the American Funds (Reg. TM) Growth Allocation Portfolio. SELLING FIRMS As noted above, Distributor, and in certain cases, we, have entered into selling agreements with affiliated and unaffiliated selling firms for the sale of the contracts. Affiliated selling firms include MetLife Securities, Inc. (MetLife Securities) and New England Securities Corporation. All selling firms receive commissions, and they may also receive some form of non-cash compensation. Certain selected selling firms receive additional compensation (described below under "Additional Compensation for Selected Selling Firms"). These commissions and other incentives or payments are not charged directly to contract Owners or the Separate Account. We intend to recoup commissions and other sales expenses through fees and charges deducted under the contract or from our general account. A portion of the payments made to selling firms may be passed on to their sales representatives in accordance with the selling firms' internal compensation programs. Those programs may also include other types of cash and non-cash compensation and other benefits. Registered representatives of the selling firms may also receive non-cash compensation, pursuant to their firm's guidelines, directly from us or Distributor. 47
N-449th Page of 530TOC1stPreviousNextBottomJust 49th
COMPENSATION PAID TO SELLING FIRMS. We and Distributor pay compensation to all affiliated and unaffiliated selling firms in the form of commissions and may also provide certain types of non-cash compensation. The maximum commission payable for contract sales and additional Purchase Payments by selling firms is 5.25% of Purchase Payments. Some selling firms may elect to receive a lower commission when a Purchase Payment is made, along with annual trail commissions beginning in year two up to 1.00% of Account Value (less Purchase Payments received within the previous 12 months) for so long as the contract remains in effect or as agreed in the selling agreement. We also pay commissions when a contract Owner elects to begin receiving regular income payments (referred to as "Annuity Payments"). (See "Annuity Payments - The Income Phase.") Distributor may also provide non-cash compensation items that we may provide jointly with Distributor. Non-cash items may include expenses for conference or seminar trips, certain gifts, prizes, and awards. With respect to the contracts, the compensation paid to affiliated selling firms is generally not expected to exceed, on a present value basis, the aggregate amount of compensation that is paid by Distributor to all other selling firms as noted above. SALES BY OUR AFFILIATES. As previously noted, we and Distributor may offer the contracts through retail selling firms that are affiliates of ours. The amount of compensation the affiliated selling firms pass on to their sales representatives is determined in accordance with their own internal compensation programs. These programs may also include other types of cash compensation, such as bonuses, equity awards (such as stock options), training allowances, supplementary salary, financing arrangements, marketing support, medical and other insurance benefits, retirement benefits, non-qualified deferred compensation plans and other benefits. Sales representatives of our affiliates must meet a minimum level of sales production in order to maintain their agent status with us. Sales representatives can meet the minimum level of sales production through sales of proprietary and/or non-proprietary products. (Proprietary products are those issued by us or our affiliates.) However, sales representatives can meet a lower alternative minimum level of sales production if the sales representative focuses on sales of proprietary products. Therefore, a sales representative may have an incentive to favor the sale of proprietary products. Moreover, because the managers who supervise the representatives receive a higher level of compensation based on sales of proprietary products, these sales managers have an incentive to promote the sale of proprietary products. Sales representatives of our affiliates receive cash payments for the products they sell and service based upon a "gross dealer concession" model. Gross dealer concession may also be credited when the contract is annuitized. The amount of gross dealer concession credited upon annuitization depends on several factors, including the number of years the contract has been in force. Sales representatives of our affiliates are entitled to part or all of the gross dealer concession. The percentage to which a representative is entitled is determined by a sliding-scale formula that takes into account the total amount of proprietary and non-proprietary products sold and serviced by the representative. Sales representatives of our affiliates and their managers may be eligible for additional cash compensation, such as bonuses and expense allowances (that may be tied to sales of specific products), equity awards (such as stock options), training allowances, supplemental compensation, product level add-ons controlled at the local and company levels, financing arrangements, special loan repayment options, marketing support, medical and other insurance benefits, and retirement benefits and other benefits. Since some of this additional compensation, in particular, life insurance, disability and retirement benefits, is based primarily on the amount of proprietary products sold, sales representatives and their managers have an incentive to favor the sale of proprietary products. Sales representatives who meet certain productivity, persistency, and length of service standards and/or their managers may be eligible for additional cash compensation. Moreover, managers may be eligible for additional cash compensation based on the sales production of the sales representatives that the manager supervises. The business unit responsible for the operation of our distribution system is also eligible to receive an amount of compensation. Ask your registered representative for further information about what payments your registered representative and the selling firm for which he or she works may receive in connection with your purchase of a contract. ADDITIONAL COMPENSATION FOR SELECTED SELLING FIRMS. We and Distributor have entered into distribution arrangements with certain selected selling firms. Under these arrangements we and Distributor may pay additional compensation to selected selling firms, including marketing allowances, introduction fees, persistency payments, 48
N-450th Page of 530TOC1stPreviousNextBottomJust 50th
preferred status fees and industry conference fees. Marketing allowances are periodic payments to certain selling firms, the amount of which depends on cumulative periodic (usually quarterly) sales of our insurance contracts (including the contracts offered by this prospectus) and may also depend on meeting thresholds in the sale of certain of our insurance contracts (other than the contracts offered by this prospectus). They may also include payments we make to cover the cost of marketing or other support services provided for or by registered representatives who may sell our products. Introduction fees are payments to selling firms in connection with the addition of our products to the selling firm's line of investment products, including expenses relating to establishing the data communications systems necessary for the selling firm to offer, sell and administer our products. Persistency payments are periodic payments based on Account Values of our variable insurance contracts (including Account Values of the contracts) or other persistency standards. Preferred status fees are paid to obtain preferred treatment of the contracts in selling firms' marketing programs, which may include marketing services, participation in marketing meetings, listings in data resources and increased access to their sales representatives. Industry conference fees are amounts paid to cover in part the costs associated with sales conferences and educational seminars for selling firms' sales representatives. We and Distributor have entered into such distribution agreements with the unaffiliated selling firms identified in the Statement of Additional Information. We and Distributor may enter into similar arrangements with affiliated selling firms, such as MetLife Securities and New England Securities Corporation. The additional types of compensation discussed above are not offered to all selling firms. The terms of any particular agreement governing compensation may vary among selling firms and the amounts may be significant. The prospect of receiving, or the receipt of, additional compensation as described above may provide selling firms and/or their sales representatives with an incentive to favor sales of the contracts over other variable annuity contracts (or other investments) with respect to which selling firm does not receive additional compensation, or lower levels of additional compensation. You may wish to take such payment arrangements into account when considering and evaluating any recommendation relating to the contracts. For more information about any such additional compensation arrangements, ask your registered representative. (See the Statement of Additional Information - "Distribution" for a list of selling firms that received compensation during 2013, as well as the range of additional compensation paid.) REQUESTS AND ELECTIONS We will treat your request for a contract transaction, or your submission of a Purchase Payment, as received by us if we receive a request conforming to our administrative procedures or a payment at our Annuity Service Center before the close of regular trading on the New York Stock Exchange on that day. We will treat your submission of a Purchase Payment as received by us if we receive a payment at our Annuity Service Center (or a designee receives a payment in accordance with the designee's administrative procedures) before the close of regular trading on the New York Stock Exchange on that day. If we receive the request, or if we (or our designee) receive the payment, after the close of trading on the New York Stock Exchange on that day, or if the New York Stock Exchange is not open that day, then the request or payment will be treated as received on the next day when the New York Stock Exchange is open. Our Annuity Service Center is located at P.O. Box 10366, Des Moines, IA 50306-0366. If you send your Purchase Payments or transaction requests to an address other than the one we have designated for receipt of such Purchase Payments or requests, we may return the Purchase Payment to you, or there may be a delay in applying the Purchase Payment or transaction to your contract. Requests for service may be made: o Through your registered representative o By telephone at (800) 343-8496, between the hours of 7:30AM and 5:30PM Central Time Monday through Thursday and 7:30AM and 5:00PM Central Time on Friday o In writing to our Annuity Service Center o By fax at (515) 457-4400 or o By Internet at www.metlifeinvestors.com Some of the requests for service that may be made by telephone or Internet include transfers of Account Value (see "Investment Options - Transfers - Transfers By Telephone or Other Means") and changes to the allocation of future Purchase Payments (see "Purchase - Allocation of Purchase Payments"). We may from time to time permit requests for other types of transactions to be made by telephone or Internet. All transaction requests must be in Good Order. Contact us for further information. Some 49
N-451st Page of 530TOC1stPreviousNextBottomJust 51st
selling firms may restrict the ability of their registered representatives to convey transaction requests by telephone or Internet on your behalf. We will use reasonable procedures such as requiring certain identifying information, tape recording the telephone instructions, and providing written confirmation of the transaction, in order to confirm that instructions communicated by telephone, fax, Internet or other means are genuine. Any telephone, fax or Internet instructions reasonably believed by us to be genuine will be your responsibility, including losses arising from any errors in the communication of instructions. As a result of this policy, you will bear the risk of loss. If we do not employ reasonable procedures to confirm that instructions communicated by telephone, fax or Internet are genuine, we may be liable for any losses due to unauthorized or fraudulent transactions. All other requests and elections under your contract must be in writing signed by the proper party, must include any necessary documentation and must be received at our Annuity Service Center to be effective. If acceptable to us, requests or elections relating to Beneficiaries and Ownership will take effect as of the date signed unless we have already acted in reliance on the prior status. We are not responsible for the validity of any written request or action. GOOD ORDER. A request or transaction generally is considered in GOOD ORDER if it complies with our administrative procedures and the required information is complete and accurate. A request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet as described above) along with all forms, information and supporting legal documentation necessary to effect the transaction. This information and documentation generally includes to the extent applicable to the transaction: your completed application; your contract number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Investment Portfolios affected by the requested transaction; the signatures of all contract Owners (exactly as indicated on the contract), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that we may require, including any spousal or Joint Owner's consents. With respect to Purchase Payments, Good Order also generally includes receipt by us of sufficient funds to effect the purchase. We may, in our sole discretion, determine whether any particular transaction request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have any questions, you should contact us or your registered representative before submitting the form or request. TELEPHONE AND COMPUTER SYSTEMS. Telephone and computer systems may not always be available. Any telephone or computer system, whether it is yours, your service provider's, your agent's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may delay or prevent our processing of your request. Although we have taken precautions to help our systems handle heavy use, we cannot promise complete reliability under all circumstances. If you experience technical difficulties or problems, you should make your transaction request in writing to our Annuity Service Center. CONFIRMING TRANSACTIONS. We will send out written statements confirming that a transaction was recently completed. Unless you inform us of any errors within 60 days of receipt, we will consider these communications to be accurate and complete. OWNERSHIP OWNER. You, as the OWNER of the contract, have all the interest and rights under the contract. These rights include the right to: o change the Beneficiary. o change the Annuitant before the Annuity Date (subject to our underwriting and administrative rules). o assign the contract (subject to limitation). o change the payment option. o exercise all other rights, benefits, options and privileges allowed by the contract or us. The Owner is as designated at the time the contract is issued, unless changed. Any change of Owner is subject to our underwriting rules in effect at the time of the request. JOINT OWNER. The contract can be owned by JOINT OWNERS, limited to two natural persons. Upon the death of either Owner, the surviving Owner will be the primary 50
N-452nd Page of 530TOC1stPreviousNextBottomJust 52nd
Beneficiary. Any other Beneficiary designation will be treated as a contingent Beneficiary unless otherwise indicated. BENEFICIARY. The BENEFICIARY is the person(s) or entity you name to receive any death benefit. The Beneficiary is named at the time the contract is issued unless changed at a later date. Unless an irrevocable Beneficiary has been named, you can change the Beneficiary at any time before you die. If Joint Owners are named, unless you tell us otherwise, the surviving Joint Owner will be the primary Beneficiary. Any other Beneficiary designation will be treated as a contingent Beneficiary (unless you tell us otherwise). ABANDONED PROPERTY REQUIREMENTS. Every state has unclaimed property laws which generally declare non-ERISA annuity contracts to be abandoned after a period of inactivity of three to five years from the contract's maturity date or the date the death benefit is due and payable. For example, if the payment of a death benefit has been triggered, but, if after a thorough search, we are still unable to locate the Beneficiary of the death benefit, or the Beneficiary does not come forward to claim the death benefit in a timely manner, the death benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. (Escheatment is the formal, legal name for this process.) However, the state is obligated to pay the death benefit (without interest) if your Beneficiary steps forward to claim it with the proper documentation. To prevent your contract's proceeds from being paid to the state's abandoned or unclaimed property office, it is important that you update your Beneficiary designations, including addresses, if and as they change. Please call (800) 343-8496 to make such changes. ANNUITANT. The ANNUITANT is the natural person(s) on whose life we base Annuity Payments. You can change the Annuitant at any time prior to the Annuity Date, unless an Owner is not a natural person. Any reference to Annuitant includes any joint Annuitant under an Annuity Option. The Owner and the Annuitant do not have to be the same person except as required under certain sections of the Internal Revenue Code. ASSIGNMENT. You can assign a Non-Qualified Contract at any time during your lifetime. We will not be bound by the assignment until the written notice of the assignment is recorded by us. We will not be liable for any payment or other action we take in accordance with the contract before we record the assignment. AN ASSIGNMENT MAY BE A TAXABLE EVENT. If the contract is issued pursuant to a qualified plan, there may be limitations on your ability to assign the contract. LEGAL PROCEEDINGS In the ordinary course of business, MetLife USA, similar to other life insurance companies, is involved in lawsuits (including class action lawsuits), arbitrations and other legal proceedings. Also, from time to time, state and federal regulators or other officials conduct formal and informal examinations or undertake other actions dealing with various aspects of the financial services and insurance industries. In some legal proceedings involving insurers, substantial damages have been sought and/or material settlement payments have been made. It is not possible to predict with certainty the ultimate outcome of any pending legal proceeding or regulatory action. However, MetLife USA does not believe any such action or proceeding will have a material adverse effect upon the Separate Account or upon the ability of MetLife Investors Distribution Company to perform its contract with the Separate Account or of MetLife USA to meet its obligations under the contracts. FINANCIAL STATEMENTS Our financial statements and the financial statements of the Separate Account have been included in the SAI. 51
N-453rd Page of 530TOC1stPreviousNextBottomJust 53rd
TABLE OF CONTENTS OF THE STATEMENT OF ADDITIONAL INFORMATION Company Independent Registered Public Accounting Firm Custodian Distribution Reduction or Elimination of the Withdrawal Charge Calculation of Performance Information Total Return Historical Unit Values Reporting Agencies Annuity Provisions Variable Annuity Fixed Annuity Mortality and Expense Guarantee Legal or Regulatory Restrictions on Transactions Additional Federal Tax Considerations Financial Statements 52
N-454th Page of 530TOC1stPreviousNextBottomJust 54th
APPENDIX A PARTICIPATING INVESTMENT PORTFOLIOS Below are the advisers and subadvisers and investment objectives of each Investment Portfolio available under the contract. The fund prospectuses contain more complete information, including a description of the investment objectives, policies, restrictions and risks. THERE CAN BE NO ASSURANCE THAT THE INVESTMENT OBJECTIVES WILL BE ACHIEVED. AMERICAN FUNDS INSURANCE SERIES (CLASS 4) AMERICAN FUNDS GLOBAL SMALL CAPITALIZATION FUND ADVISER: Capital Research and Management Company INVESTMENT OBJECTIVE: The American Funds Global Small Capitalization Fund seeks long-term growth of capital. BLACKROCK VARIABLE SERIES FUNDS, INC. (CLASS III) BLACKROCK GLOBAL ALLOCATION V.I. FUND ADVISER: BlackRock Investment Management, LLC. INVESTMENT OBJECTIVE: The BlackRock Global Allocation V.I. Fund seeks both capital appreciation and current income. IVY FUNDS VARIABLE INSURANCE PORTFOLIOS IVY FUNDS VIP ASSET STRATEGY FUND ADVISER: Ivy Investment Management Company (IICO) INVESTMENT OBJECTIVE:The Ivy Funds VIP Asset Strategy Fund seeks to provide total return. LEGG MASON PARTNERS VARIABLE EQUITY TRUST (CLASS II) PERMAL ALTERNATIVE SELECT VIT PORTFOLIO ADVISER: Permal Asset Management LLC SUBADVISERS: Apex Capital, LLC; River Canyon Fund Management LLC; and TT International. TRADING ADVISOR: BH-DG Systematic Trading LLP INVESTMENT OBJECTIVE: The Permal Alternative Select VIT Portfolio seeks to provide investors with long-term capital appreciation. MET INVESTORS SERIES TRUST (CLASS B, OR AS NOTED, CLASS C) Unless otherwise noted, the following portfolios are manged by our affiliate, MetLife Advisers, LLC. ALLIANCEBERNSTEIN GLOBAL DYNAMIC ALLOCATION PORTFOLIO SUBADVISER: AllianceBernstein L.P. INVESTMENT OBJECTIVE: The AllianceBernstein Global Dynamic Allocation Portfolio seeks capital appreciation and current income. ALLIANZ GLOBAL INVESTORS DYNAMIC MULTI-ASSET PLUS PORTFOLIO SUBADVISER: Allianz Global Investors U.S. LLC INVESTMENT OBJECTIVE: The Allianz Global Investors Dynamic Multi-Asset Plus Portfolio seeks total return. AMERICAN FUNDS (Reg. TM) GROWTH PORTFOLIO (CLASS C) ADVISERS: MetLife Advisers, LLC and Capital Research and Management Company INVESTMENT OBJECTIVE: The American Funds (Reg. TM) Growth Portfolio seeks to achieve growth of capital. AQR GLOBAL RISK BALANCED PORTFOLIO SUBADVISER: AQR Capital Management, LLC INVESTMENT OBJECTIVE: The AQR Global Risk Balanced Portfolio seeks total return. BLACKROCK GLOBAL TACTICAL STRATEGIES PORTFOLIO SUBADVISER: BlackRock Financial Management, Inc. INVESTMENT OBJECTIVE: The BlackRock Global Tactical Strategies Portfolio seeks capital appreciation and current income. A-1
N-455th Page of 530TOC1stPreviousNextBottomJust 55th
BLACKROCK HIGH YIELD PORTFOLIO SUBADVISER: BlackRock Financial Management, Inc. INVESTMENT OBJECTIVE: The BlackRock High Yield Portfolio seeks to maximize total return, consistent with income generation and prudent investment management. CLARION GLOBAL REAL ESTATE PORTFOLIO SUBADVISER: CBRE Clarion Securities LLC INVESTMENT OBJECTIVE: The Clarion Global Real Estate Portfolio seeks total return through investment in real estate securities, emphasizing both capital appreciation and current income. CLEARBRIDGE AGGRESSIVE GROWTH PORTFOLIO SUBADVISER: ClearBridge Investments, LLC INVESTMENT OBJECTIVE: The ClearBridge Aggressive Growth Portfolio seeks capital appreciation. GOLDMAN SACHS MID CAP VALUE PORTFOLIO SUBADVISER: Goldman Sachs Asset Management, L.P. INVESTMENT OBJECTIVE: The Goldman Sachs Mid Cap Value Portfolio seeks long-term capital appreciation. HARRIS OAKMARK INTERNATIONAL PORTFOLIO SUBADVISER: Harris Associates L.P. INVESTMENT OBJECTIVE: The Harris Oakmark International Portfolio seeks long-term capital appreciation. INVESCO BALANCED-RISK ALLOCATION PORTFOLIO SUBADVISER: Invesco Advisers, Inc. INVESTMENT OBJECTIVE: The Invesco Balanced-Risk Allocation Portfolio seeks total return. INVESCO COMSTOCK PORTFOLIO SUBADVISER: Invesco Advisers, Inc. INVESTMENT OBJECTIVE: The Invesco Comstock Portfolio seeks capital growth and income. INVESCO MID CAP VALUE PORTFOLIO SUBADVISER: Invesco Advisers, Inc. INVESTMENT OBJECTIVE: The Invesco Mid Cap Value Portfolio seeks high total return by investing in equity securities of mid-sized companies. INVESCO SMALL CAP GROWTH PORTFOLIO SUBADVISER: Invesco Advisers, Inc. INVESTMENT OBJECTIVE: The Invesco Small Cap Growth Portfolio seeks long-term growth of capital. JPMORGAN CORE BOND PORTFOLIO SUBADVISER: J.P. Morgan Investment Management Inc. INVESTMENT OBJECTIVE: The JPMorgan Core Bond Portfolio seeks to maximize total return. JPMORGAN GLOBAL ACTIVE ALLOCATION PORTFOLIO SUBADVISER: J.P. Morgan Investment Management Inc. INVESTMENT OBJECTIVE: The JPMorgan Global Active Allocation Portfolio seeks capital appreciation and current income. JPMORGAN SMALL CAP VALUE PORTFOLIO SUBADVISER: J.P. Morgan Investment Management Inc. INVESTMENT OBJECTIVE: The JPMorgan Small Cap Value Portfolio seeks long-term capital growth. LOOMIS SAYLES GLOBAL MARKETS PORTFOLIO SUBADVISER: Loomis, Sayles & Company, L.P. INVESTMENT OBJECTIVE: The Loomis Sayles Global Markets Portfolio seeks high total investment return through a combination of capital appreciation and income. LORD ABBETT BOND DEBENTURE PORTFOLIO SUBADVISER: Lord, Abbett & Co. LLC INVESTMENT OBJECTIVE: The Lord Abbett Bond Debenture Portfolio seeks high current income and the opportunity for capital appreciation to produce a high total return. MET/ARTISAN INTERNATIONAL PORTFOLIO SUBADVISER: Artisan Partners Limited Partnership INVESTMENT OBJECTIVE: The Met/Artisan International Portfolio seeks maximum long-term capital growth. MET/EATON VANCE FLOATING RATE PORTFOLIO SUBADVISER: Eaton Vance Management INVESTMENT OBJECTIVE: The Met/Eaton Vance Floating Rate Portfolio seeks a high level of current income. A-2
N-456th Page of 530TOC1stPreviousNextBottomJust 56th
MET/FRANKLIN LOW DURATION TOTAL RETURN PORTFOLIO SUBADVISER: Franklin Advisers, Inc. INVESTMENT OBJECTIVE: The Met/Franklin Low Duration Total Return Portfolio seeks a high level of current income, while seeking preservation of shareholders' capital. MET/TEMPLETON INTERNATIONAL BOND PORTFOLIO SUBADVISER: Franklin Advisers, Inc. INVESTMENT OBJECTIVE: The Met/Templeton International Bond Portfolio seeks current income with capital appreciation and growth of income. METLIFE BALANCED PLUS PORTFOLIO SUBADVISER - OVERLAY PORTION: Pacific Investment Management Company LLC INVESTMENT OBJECTIVE: The MetLife Balanced Plus Portfolio seeks a balance between a high level of current income and growth of capital, with a greater emphasis on growth of capital. METLIFE MULTI-INDEX TARGETED RISK PORTFOLIO SUBADVISER - OVERLAY PORTION: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The MetLife Multi-IndeTargeted Risk Portfolio seeks a balance between growth of capital and current income, with a greater emphasis on growth of capital. MFS (Reg. TM) EMERGING MARKETS EQUITY PORTFOLIO SUBADVISER: Massachusetts Financial Services Company INVESTMENT OBJECTIVE: The MFS (Reg. TM) Emerging Markets Equity Portfolio seeks capital appreciation. MFS (Reg. TM) RESEARCH INTERNATIONAL PORTFOLIO SUBADVISER: Massachusetts Financial Services Company INVESTMENT OBJECTIVE: The MFS (Reg. TM) Research International Portfolio seeks capital appreciation. MORGAN STANLEY MID CAP GROWTH PORTFOLIO SUBADVISER: Morgan Stanley Investment Management Inc. INVESTMENT OBJECTIVE: The Morgan Stanley Mid Cap Growth Portfolio seeks capital appreciation. OPPENHEIMER GLOBAL EQUITY PORTFOLIO SUBADVISER: OppenheimerFunds, Inc. INVESTMENT OBJECTIVE: The Oppenheimer Global Equity Portfolio seeks capital appreciation. PANAGORA GLOBAL DIVERSIFIED RISK PORTFOLIO SUBADVISER: PanAgora Asset Management, Inc. INVESTMENT OBJECTIVE: The PanAgora Global Diversified Risk Portfolio seeks total return. PIMCO INFLATION PROTECTED BOND PORTFOLIO SUBADVISER: Pacific Investment Management Company LLC INVESTMENT OBJECTIVE: The PIMCO Inflation Protected Bond Portfolio seeks maximum real return, consistent with preservation of capital and prudent investment management. PIMCO TOTAL RETURN PORTFOLIO SUBADVISER: Pacific Investment Management Company LLC INVESTMENT OBJECTIVE: The PIMCO Total Return Portfolio seeks maximum total return, consistent with the preservation of capital and prudent investment management. PIONEER FUND PORTFOLIO SUBADVISER: Pioneer Investment Management, Inc. INVESTMENT OBJECTIVE: The Pioneer Fund Portfolio seeks reasonable income and capital growth. PIONEER STRATEGIC INCOME PORTFOLIO SUBADVISER: Pioneer Investment Management, Inc. INVESTMENT OBJECTIVE: The Pioneer Strategic Income Portfolio seeks a high level of current income. PYRAMIS (Reg. TM) GOVERNMENT INCOME PORTFOLIO SUBADVISER: Pyramis Global Advisors, LLC INVESTMENT OBJECTIVE: The Pyramis (Reg. TM) Government Income Portfolio seeks a high level of current income, consistent with preservation of principal. A-3
N-457th Page of 530TOC1stPreviousNextBottomJust 57th
PYRAMIS (Reg. TM) MANAGED RISK PORTFOLIO SUBADVISER: Pyramis Global Advisors, LLC INVESTMENT OBJECTIVE: The Pyramis (Reg. TM) Managed Risk Portfolio seeks total return. SCHRODERS GLOBAL MULTI-ASSET PORTFOLIO SUBADVISERS: Schroder Investment Management North America Inc. and Schroder Investment Management North America Limited INVESTMENT OBJECTIVE: The Schroders Global Multi-Asset Portfolio seeks capital appreciation and current income. T. ROWE PRICE LARGE CAP VALUE PORTFOLIO SUBADVISER: T. Rowe Price Associates, Inc. INVESTMENT OBJECTIVE: The T. Rowe Price Large Cap Value Portfolio seeks long-term capital appreciation by investing in common stocks believed to be undervalued. Income is a secondary objective. THIRD AVENUE SMALL CAP VALUE PORTFOLIO SUBADVISER: Third Avenue Management LLC INVESTMENT OBJECTIVE: The Third Avenue Small Cap Value Portfolio seeks long-term capital appreciation. WMC LARGE CAP RESEARCH PORTFOLIO SUBADVISER: Wellington Management Company, LLP INVESTMENT OBJECTIVE: The WMC Large Cap Research Opportunities Portfolio seeks long-term capital appreciation. METROPOLITAN SERIES FUND (CLASS B, OR AS NOTED, CLASS G) Unless otherwise noted, the following portfolios are manged by our affiliate, MetLife Advisers, LLC. BAILLIE GIFFORD INTERNATIONAL STOCK PORTFOLIO SUBADVISER: Baillie Gifford Overseas Limited INVESTMENT OBJECTIVE: The Baillie Gifford International Stock Portfolio seeks long-term growth of capital. BARCLAYS AGGREGATE BOND INDEX PORTFOLIO SUBADVISER: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The Barclays Aggregate Bond Index Portfolio seeks to track the performance of the Barclays U.S. Aggregate Bond Index. BLACKROCK BOND INCOME PORTFOLIO SUBADVISER: BlackRock Advisors, LLC INVESTMENT OBJECTIVE: The BlackRock Bond Income Portfolio seeks a competitive total return primarily from investing in fixed-income securities. BLACKROCK CAPITAL APPRECIATION PORTFOLIO SUBADVISER: BlackRock Advisors, LLC INVESTMENT OBJECTIVE: The BlackRock Capital Appreciation Portfolio seeks long-term growth of capital. BLACKROCK LARGE CAP VALUE PORTFOLIO SUBADVISER: BlackRock Advisors, LLC INVESTMENT OBJECTIVE: The BlackRock Large Cap Value Portfolio seeks long-term growth of capital. BLACKROCK MONEY MARKET PORTFOLIO SUBADVISER: BlackRock Advisors, LLC INVESTMENT OBJECTIVE: The BlackRock Money Market Portfolio seeks a high level of current income consistent with preservation of capital. An investment in the BlackRock Money Market Portfolio is not insured or guaranteed by the Federal Deposit Insurance Company or any other government agency. Although the BlackRock Money Market Portfolio seeks to preserve the value of your investment at $100 per share, it is possible to lose money by investing in the BlackRock Money Market Portfolio. During extended periods of low interest rates, the yields of the BlackRock Money Market Portfolio may become extremely low and possibly negative. JENNISON GROWTH PORTFOLIO SUBADVISER: Jennison Associates LLC INVESTMENT OBJECTIVE: The Jennison Growth Portfolio seeks long-term growth of capital. LOOMIS SAYLES SMALL CAP CORE PORTFOLIO SUBADVISER: Loomis, Sayles & Company, L.P. INVESTMENT OBJECTIVE: The Loomis Sayles Small Cap Core Portfolio seeks long-term capital growth from investments in common stocks or other equity securities. A-4
N-458th Page of 530TOC1stPreviousNextBottomJust 58th
MET/DIMENSIONAL INTERNATIONAL SMALL COMPANY PORTFOLIO SUBADVISER: Dimensional Fund Advisors LP INVESTMENT OBJECTIVE: The Met/Dimensional International Small Company Portfolio seeks long-term capital appreciation. METLIFE MID CAP STOCK INDEX PORTFOLIO (CLASS G) SUBADVISER: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The MetLife Mid Cap Stock Index Portfolio seeks to track the performance of the Standard & Poor's MidCap 400 (Reg. TM) Composite Stock Price Index. METLIFE STOCK INDEX PORTFOLIO SUBADVISER: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The MetLife Stock Index Portfolio seeks to track the performance of the Standard & Poor's 500 (Reg. TM) Composite Stock Price Index. MFS (Reg. TM) VALUE PORTFOLIO SUBADVISER: Massachusetts Financial Services Company INVESTMENT OBJECTIVE: The MFS (Reg. TM) Value Portfolio seeks capital appreciation. MSCI EAFE (Reg. TM) INDEX PORTFOLIO (CLASS G) SUBADVISER: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The MSCI EAFE (Reg. TM) Index Portfolio seeks to track the performance of the MSCI EAFE (Reg. TM) Index. NEUBERGER BERMAN GENESIS PORTFOLIO SUBADVISER: Neuberger Berman Management LLC INVESTMENT OBJECTIVE: The Neuberger Berman Genesis Portfolio seeks high total return, consisting principally of capital appreciation. RUSSELL 2000 (Reg. TM) INDEX PORTFOLIO (CLASS G) SUBADVISER: MetLife Investment Management, LLC INVESTMENT OBJECTIVE: The Russell 2000 (Reg. TM) Index Portfolio seeks to track the performance of the Russell 2000 (Reg. TM) Index. T. ROWE PRICE LARGE CAP GROWTH PORTFOLIO SUBADVISER: T. Rowe Price Associates, Inc. INVESTMENT OBJECTIVE: The T. Rowe Price Large Cap Growth Portfolio seeks long-term growth of capital. T. ROWE PRICE SMALL CAP GROWTH PORTFOLIO (CLASS G) SUBADVISER: T. Rowe Price Associates, Inc. INVESTMENT OBJECTIVE: The T. Rowe Price Small Cap Growth Portfolio seeks long-term capital growth. VAN ECK GLOBAL NATURAL RESOURCES PORTFOLIO SUBADVISER: Van Eck Associates Corporation INVESTMENT OBJECTIVE: The Van Eck Global Natural Resources Portfolio seeks long-term capital appreciation with income as a secondary consideration. WESTERN ASSET MANAGEMENT STRATEGIC BOND OPPORTUNITIES PORTFOLIO SUBADVISER: Western Asset Management Company INVESTMENT OBJECTIVE: The Western Asset Management Strategic Bond Opportunities Portfolio seeks to maximize total return consistent with preservation of capital. WESTERN ASSET MANAGEMENT U.S. GOVERNMENT PORTFOLIO SUBADVISER: Western Asset Management Company INVESTMENT OBJECTIVE: The Western Asset Management U.S. Government Portfolio seeks to maximize total return consistent with preservation of capital and maintenance of liquidity. WMC CORE EQUITY OPPORTUNITIES PORTFOLIO SUBADVISER: Wellington Management Company, LLP INVESTMENT OBJECTIVE: The WMC Core Equity Opportunities Portfolio seeks to provide a growing stream of income over time and, secondarily, long-term capital appreciation and current income. PIMCO VARIABLE INSURANCE TRUST (CLASS M) Unless otherwise noted, the following portfolios are manged by Pacific Investment Management Company LLC. PIMCO COMMODITYREALRETURN (Reg. TM) STRATEGY PORTFOLIO INVESTMENT OBJECTIVE: The PIMCO CommodityRealReturn (Reg. TM) Strategy Portfolio seeks maximum real return, consistent with prudent investment management. A-5
N-459th Page of 530TOC1stPreviousNextBottomJust 59th
PIMCO EMERGING MARKETS BOND PORTFOLIO INVESTMENT OBJECTIVE: The PIMCO Emerging Markets Bond Portfolio seeks maximum total return, consistent with preservation of capital and prudent investment management. PIMCO UNCONSTRAINED BOND PORTFOLIO INVESTMENT OBJECTIVE: The PIMCO Unconstrained Bond Portfolio seeks maximum long-term return, consistent with preservation of capital and prudent investment management. THE UNIVERSAL INSTITUTIONAL FUNDS, INC. (CLASS II) GLOBAL INFRASTRUCTURE PORTFOLIO ADVISER: Morgan Stanley Investment Management Inc. SUBADVISERS: Morgan Stanley Investment Management Company; Morgan Stanley Investment Management Limited INVESTMENT OBJECTIVE: The Global Infrastructure Portfolio seeks both capital appreciation and current income. VAN ECK VIP TRUST (CLASS S) VAN ECK VIP LONG/SHORT EQUITY INDEX FUND ADVISER: Van Eck Associates Corporation INVESTMENT OBJECTIVE: The Van Eck VIP Long/Short Equity Index Fund seeks total return. MET INVESTORS SERIES TRUST - ASSET ALLOCATION PORTFOLIOS In addition to the Met Investors Series Trust portfolios listed above, the following portfolios managed by MetLife Advisers, LLC are available under the contract: AMERICAN FUNDS (Reg. TM) MODERATE ALLOCATION PORTFOLIO (CLASS C) INVESTMENT OBJECTIVE: The American Funds (Reg. TM) Moderate Allocation Portfolio seeks a high total return in the form of income and growth of capital, with a greater emphasis on income. AMERICAN FUNDS (Reg. TM) BALANCED ALLOCATION PORTFOLIO (CLASS C) INVESTMENT OBJECTIVE: The American Funds (Reg. TM) Balanced Allocation Portfolio seeks a balance between a high level of current income and growth of capital, with a greater emphasis on growth of capital. AMERICAN FUNDS (Reg. TM) GROWTH ALLOCATION PORTFOLIO (CLASS C) INVESTMENT OBJECTIVE: The American Funds (Reg. TM) Growth Allocation Portfolio seeks growth of capital. METLIFE ASSET ALLOCATION 100 PORTFOLIO (CLASS B) INVESTMENT OBJECTIVE: The MetLife Asset Allocation 100 Portfolio seeks growth of capital. SSGA GROWTH AND INCOME ETF PORTFOLIO (CLASS B) SUBADVISER: SSgA Funds Management, Inc. INVESTMENT OBJECTIVE: The SSgA Growth and Income ETF Portfolio seeks growth of capital and income. SSGA GROWTH ETF PORTFOLIO (CLASS B) SUBADVISER: SSgA Funds Management, Inc. INVESTMENT OBJECTIVE: The SSgA Growth ETF Portfolio seeks growth of capital. METROPOLITAN SERIES FUND - ASSET ALLOCATION PORTFOLIOS (CLASS B) In addition to the Metropolitan Series Fund portfolios listed above, the following Class B portfolios managed by MetLife Advisers, LLC are available under the contract: METLIFE ASSET ALLOCATION 20 PORTFOLIO INVESTMENT OBJECTIVE: The MetLife Asset Allocation 20 Portfolio seeks a high level of current income, with growth of capital as a secondary objective. METLIFE ASSET ALLOCATION 40 PORTFOLIO INVESTMENT OBJECTIVE: The MetLife Asset Allocation 40 Portfolio seeks high total return in the form of income and growth of capital, with a greater emphasis on income. METLIFE ASSET ALLOCATION 60 PORTFOLIO INVESTMENT OBJECTIVE: The MetLife Asset Allocation 60 Portfolio seeks a balance between a high level of current income and growth of capital, with a greater emphasis on growth of capital. METLIFE ASSET ALLOCATION 80 PORTFOLIO INVESTMENT OBJECTIVE: The MetLife Asset Allocation 80 Portfolio seeks growth of capital. A-6
N-460th Page of 530TOC1stPreviousNextBottomJust 60th
APPENDIX B DEATH BENEFIT EXAMPLE The purpose of these examples is to illustrate the operation of the optional Return of Premium death benefit. The investment results shown are hypothetical and are not representative of past or future performance. Actual investment results may be more or less than those shown and will depend upon a number of factors, including the investment allocation made by a contract Owner and the investment experience of the Investment Portfolios chosen. THE EXAMPLES DO NOT REFLECT THE DEDUCTION OF FEES AND EXPENSES, WITHDRAWAL CHARGES (NOT APPLICABLE IF YOU SELECTED THE C SHARE OPTION) OR INCOME TAXES AND TAX PENALTIES. RETURN OF PREMIUM DEATH BENEFIT The purpose of this example is to show how partial withdrawals reduce the Return of Premium death benefit proportionately by the percentage reduction in Account Value attributable to each partial withdrawal. [Enlarge/Download Table] DATE AMOUNT ------------------------------ ------------------------- A Initial Purchase Payment 12/1/2014 $100,000 B Account Value 12/1/2015 $104,000 (First Contract Anniversary) C Death Benefit As of 12/1/2015 $104,000 (= greater of A and B) D Account Value 12/1/2016 $ 90,000 (Second Contract Anniversary) E Death Benefit 12/1/2016 $100,000 (= greater of A and D) F Withdrawal 12/2/2016 $ 9,000 G Percentage Reduction in Account 12/2/2016 10% Value (= F/D) H Account Value after Withdrawal 12/2/2016 $ 81,000 (= D-F) I Purchase Payments Reduced for As of 12/2/2016 $ 90,000 Withdrawal (= A-(A x G)) J Death Benefit 12/2/2016 $ 90,000 (= greater of H and I) Notes to Example ---------------- Purchaser is age 60 at issue. The Account Values on 12/1/2016 and 12/2/2016 are assumed to be equal prior to the withdrawal. B-1
N-461st Page of 530TOC1stPreviousNextBottomJust 61st
STATEMENT OF ADDITIONAL INFORMATION INDIVIDUAL VARIABLE DEFERRED ANNUITY CONTRACT ISSUED BY METLIFE INVESTORS USA SEPARATE ACCOUNT A AND METLIFE INSURANCE COMPANY USA METLIFE INVESTMENT PORTFOLIO ARCHITECT/SM/ - STANDARD VERSION METLIFE INVESTMENT PORTFOLIO ARCHITECT/SM/ - C SHARE OPTION THIS IS NOT A PROSPECTUS. THIS STATEMENT OF ADDITIONAL INFORMATION SHOULD BE READ IN CONJUNCTION WITH THE PROSPECTUS DATED NOVEMBER 19, 2014, FOR THE INDIVIDUAL VARIABLE DEFERRED ANNUITY CONTRACT THAT IS DESCRIBED HEREIN. THE PROSPECTUS CONCISELY SETS FORTH INFORMATION THAT A PROSPECTIVE INVESTOR OUGHT TO KNOW BEFORE INVESTING. FOR A COPY OF THE PROSPECTUS WRITE US AT: P.O. BOX 10366, DES MOINES, IOWA 50306-0366, OR CALL (800) 343-8496. THIS STATEMENT OF ADDITIONAL INFORMATION IS DATED NOVEMBER 19, 2014. SAI-1114IPAUSA 1
N-462nd Page of 530TOC1stPreviousNextBottomJust 62nd
TABLE OF CONTENTS PAGE [Download Table] COMPANY................................. 3 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.................................... 3 CUSTODIAN............................... 3 DISTRIBUTION............................ 3 Reduction or Elimination of the Withdrawal Charge................ 4 CALCULATION OF PERFORMANCE INFORMATION.. 5 Total Return....................... 5 Historical Unit Values............. 5 Reporting Agencies................. 5 ANNUITY PROVISIONS...................... 6 Variable Annuity................... 6 Fixed Annuity...................... 7 Mortality and Expense Guarantee.... 7 Legal or Regulatory Restrictions on Transactions.................. 7 ADDITIONAL FEDERAL TAX CONSIDERATIONS... 8 FINANCIAL STATEMENTS.................... 11 2
N-463rd Page of 530TOC1stPreviousNextBottomJust 63rd
COMPANY Effective following the close of business on November 14, 2014, MetLife Investors USA Insurance Company, a wholly-owned subsidiary of MetLife Insurance Company of Connecticut, MetLife Investors Insurance Company and Exeter Reassurance Company, Ltd. were merged into MetLife Insurance Company of Connecticut, and MetLife Insurance Company of Connecticut was then renamed MetLife Insurance Company USA ("MetLife USA"). Simultaneously, MetLife USA changed its domicile from Connecticut to the state of Delaware. As a result of the merger, MetLife USA assumed legal ownership of all of the assets of these companies, including MetLife Investors USA Separate Account A and the assets held in the separate account. MetLife USA is now responsible for administering the contracts and paying any benefits due under the contracts. MetLife USA is a stock life insurance company originally chartered in Connecticut in 1863 and currently subject to the laws of the State of Delaware. MetLife USA is licensed to conduct business in all states of the United States, except New York, and in the District of Columbia, Puerto Rico, Guam, the U.S. and British Virgin Islands and the Bahamas. MetLife USA is a wholly-owned subsidiary of MetLife, Inc., a publicly-traded company. MetLife, Inc., through its subsidiaries and affiliates, is a leading provider of insurance and financial services to individuals and institutional customers. MetLife USA's principal executive offices are located at 11225 North Community House Road, Charlotte, NC 28277. INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The financial statements and financial highlights comprising each of the Sub-Accounts of MetLife Investors USA Separate Account A, included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements and financial highlights are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The consolidated financial statements and related financial statement schedules of MetLife Insurance Company of Connecticut and subsidiaries, included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements and financial statement schedules are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The financial statements of MetLife Investors Insurance Company ("MLI"), included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, independent auditors, as stated in their report appearing herein (which report expresses an unmodified opinion and includes an other matter paragraph related to MLI being a member of a controlled group). Such financial statements are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The financial statements of Exeter Reassurance Company, Ltd. ("Exeter"), included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, independent auditors, as stated in their report appearing herein (which report expresses an unmodified opinion and includes an emphasis of matter paragraph related to restatements of the statements of cash flows, and an other matters paragraph related to a change in Exeter's presentation of insurance liabilities and to Exeter being a member of a controlled group). Such financial statements are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The principal business address of Deloitte & Touche LLP is 30 Rockefeller Plaza, New York, New York 10112-0015. CUSTODIAN MetLife Insurance Company USA, 11225 North Community House Road, Charlotte, NC 28277, is the custodian of the assets of the Separate Account. The custodian has custody of all cash of the Separate Account and handles the collection of proceeds of shares of the underlying funds bought and sold by the Separate Account. DISTRIBUTION Information about the distribution of the contracts is contained in the prospectus. (See "Other Information.") Additional information is provided below. 3
N-464th Page of 530TOC1stPreviousNextBottomJust 64th
The contracts are offered to the public on a continuous basis. We anticipate continuing to offer the contracts, but reserve the right to discontinue the offering. MetLife Investors Distribution Company ("Distributor") serves as principal underwriter for the contracts. Distributor is a Missouri corporation and its home office is located at 1095 Avenue of the Americas, New York, NY 10036. In December 2004, MetLife Investors Distribution Company, which was then a Delaware corporation, was merged into General American Distributors, Inc., and the name of the surviving corporation was changed to MetLife Investors Distribution Company. Distributor is an indirect, wholly-owned subsidiary of MetLife, Inc. Distributor is registered as a broker-dealer with the Securities and Exchange Commission under the Securities Exchange Act of 1934 and is a member of the Financial Industry Regulatory Authority ("FINRA"). Distributor has entered into selling agreements with other broker-dealers ("selling firms") and compensates them for their services. Distributor (including its predecessor) received sales compensation with respect to all contracts issued from the Separate Account in the following amounts during the periods indicated: [Download Table] Aggregate Amount of Commissions Retained Aggregate Amount of by Distributor After Commissions Paid to Payments to Selling Fiscal year Distributor Firms ------------- --------------------- --------------------- 2013 $ 456,083,088 $0 2012 $ 689,121,186 $0 2011 $1,101,222,893 $0 Distributor passes through commissions to selling firms for their sales. In addition we pay compensation to Distributor to offset its expenses, including compensation costs, marketing and distribution expenses, advertising, wholesaling, printing, and other expenses of distributing the contracts. As noted in the prospectus, we and Distributor pay compensation to all selling firms in the form of commissions and certain types of non-cash compensation. We and Distributor may pay additional compensation to selected firms, including marketing allowances, introduction fees, persistency payments, preferred status fees and industry conference fees. The terms of any particular agreement governing compensation may vary among selling firms and the amounts may be significant. In view of the fact that the contracts are newly offered, no commissions were paid in connection with the contracts. REDUCTION OR ELIMINATION OF THE WITHDRAWAL CHARGE The amount of the withdrawal charge on the Investment Portfolio Architect contracts may be reduced or eliminated when sales of the contracts are made to individuals or to a group of individuals in a manner that results in savings of sales expenses. The entitlement to reduction of the withdrawal charge will be determined by the Company after examination of all the relevant factors such as: 1. The size and type of group to which sales are to be made will be considered. Generally, the sales expenses for a larger group are less than for a smaller group because of the ability to implement large numbers of contracts with fewer sales contacts. 2. The total amount of Purchase Payments to be received will be considered. Per contract sales expenses are likely to be less on larger Purchase Payments than on smaller ones. 3. Any prior or existing relationship with the Company will be considered. Per contract sales expenses are likely to be less when there is a prior existing relationship because of the likelihood of implementing the contract with fewer sales contacts. 4. There may be other circumstances, of which the Company is not presently aware, which could result in reduced sales expenses. If, after consideration of the foregoing factors, the Company determines that there will be a reduction in sales expenses, the Company may provide for a reduction or elimination of the withdrawal charge. The withdrawal charge may be eliminated when the contracts are issued to an officer, director or employee of the Company or any of its affiliates. In no event will any reduction or elimination of the withdrawal charge be permitted where the reduction or elimination will be unfairly discriminatory to any person. In lieu of a 4
N-465th Page of 530TOC1stPreviousNextBottomJust 65th
withdrawal charge waiver, we may provide an Account Value credit. CALCULATION OF PERFORMANCE INFORMATION TOTAL RETURN From time to time, the Company may advertise performance data. Such data will show the percentage change in the value of an Accumulation Unit based on the performance of an Investment Portfolio over a period of time, usually a calendar year, determined by dividing the increase (decrease) in value for that unit by the Accumulation Unit value at the beginning of the period. Any such advertisement will include total return figures for the time periods indicated in the advertisement. Such total return figures will reflect the deduction of the Separate Account product charges (including certain death benefit rider charges), the expenses for the underlying Investment Portfolio being advertised, and any applicable account fee or withdrawal charge. Premium taxes are not reflected. The deduction of such charges would reduce any percentage increase or make greater any percentage decrease. The hypothetical value of a contract purchased for the time periods described in the advertisement will be determined by using the actual Accumulation Unit values for an initial $1,000 Purchase Payment, and deducting any applicable account fee and any applicable sales charge to arrive at the ending hypothetical value. The average annual total return is then determined by computing the fixed interest rate that a $1,000 Purchase Payment would have to earn annually, compounded annually, to grow to the hypothetical value at the end of the time periods described. The formula used in these calculations is: P (1 + T)n = ERV Where: P = a hypothetical initial payment of $1,000 T = average annual total return n = number of years ERV = ending redeemable value at the end of the time periods used (or fractional portion thereof) of a hypothetical $1,000 payment made at the beginning of the 1, 5 or 10 year periods used. The Company may also advertise performance data which will be calculated in the same manner as described above but which will not reflect the deduction of a withdrawal charge. Premium taxes are not reflected. The deduction of such charges would reduce any percentage increase or make greater any percentage decrease. Owners should note that the investment results of each Investment Portfolio will fluctuate over time, and any presentation of the Investment Portfolio's total return for any period should not be considered as a representation of what an investment may earn or what the total return may be in any future period. HISTORICAL UNIT VALUES The Company may also show historical Accumulation Unit values in certain advertisements containing illustrations. These illustrations will be based on actual Accumulation Unit values. In addition, the Company may distribute sales literature which compares the percentage change in Accumulation Unit values for any of the against established market indices such as the Standard & Poor's 500 Composite Stock Price Index, the Dow Jones Industrial Average or other management investment companies which have investment objectives similar to the Investment Portfolio being compared. The Standard & Poor's 500 Composite Stock Price Index is an unmanaged, unweighted average of 500 stocks, the majority of which are listed on the New York Stock Exchange. The Dow Jones Industrial Average is an unmanaged, weighted average of thirty blue chip industrial corporations listed on the New York Stock Exchange. Both the Standard & Poor's 500 Composite Stock Price Index and the Dow Jones Industrial Average assume quarterly reinvestment of dividends. REPORTING AGENCIES The Company may also distribute sales literature which compares the performance of the Accumulation Unit values of the Contracts with the unit values of variable annuities issued by other insurance companies. Such information will be derived from the Lipper Variable Insurance Products Performance Analysis Service, the VARDS Report or from Morningstar. The Lipper Variable Insurance Products Performance Analysis Service is published by Lipper Analytical Services, Inc., a publisher of statistical data which currently tracks 5
N-466th Page of 530TOC1stPreviousNextBottomJust 66th
the performance of thousands of investment companies. The rankings compiled by Lipper may or may not reflect the deduction of asset-based insurance charges. The Company's sales literature utilizing these rankings will indicate whether or not such charges have been deducted. Where the charges have not been deducted, the sales literature will indicate that if the charges had been deducted, the ranking might have been lower. The VARDS Report is a monthly variable annuity industry analysis compiled by Variable Annuity Research & Data Service. The VARDS rankings may or may not reflect the deduction of asset-based insurance charges. In addition, VARDS prepares risk adjusted rankings, which consider the effects of market risk on total return performance. This type of ranking may address the question as to which funds provide the highest total return with the least amount of risk. Other ranking services may be used as sources of performance comparison, such as CDA/Weisenberger. Morningstar rates a variable annuity against its peers with similar investment objectives. Morningstar does not rate any variable annuity that has less than three years of performance data. ANNUITY PROVISIONS VARIABLE ANNUITY A variable annuity is an annuity with payments which: (1) are not predetermined as to dollar amount; and (2) will vary in amount in proportion to the amount that the net investment factor exceeds the assumed investment return selected. The Adjusted Contract Value (the Account Value, less any applicable premium taxes, account fee, and any prorated rider charge) will be applied to the applicable Annuity Table to determine the first Annuity Payment. The Adjusted Contract Value is determined on the annuity calculation date, which is a Business Day no more than five (5) Business Days before the Annuity Date. The dollar amount of the first variable Annuity Payment is determined as follows: The first variable Annuity Payment will be based upon the Annuity Option elected, the Annuitant's age, the Annuitant's sex (where permitted by law), and the appropriate variable Annuity Option table. Your annuity rates will not be less than those guaranteed in your contract at the time of purchase for the assumed investment return and Annuity Option elected. If, as of the annuity calculation date, the then current variable Annuity Option rates applicable to this class of contracts provide a first Annuity Payment greater than that which is guaranteed under the same Annuity Option under this contract, the greater payment will be made. The dollar amount of variable Annuity Payments after the first payment is determined as follows: 1. the dollar amount of the first variable Annuity Payment is divided by the value of an Annuity Unit for each applicable Investment Portfolio as of the annuity calculation date. This establishes the number of Annuity Units for each monthly payment. The number of Annuity Units for each applicable Investment Portfolio remains fixed during the annuity period, unless you transfer values from the Investment Portfolio to another Investment Portfolio; 2. the fixed number of Annuity Units per payment in each Investment Portfolio is multiplied by the Annuity Unit value for that Investment Portfolio for the Business Day for which the Annuity Payment is being calculated. This result is the dollar amount of the payment for each applicable Investment Portfolio, less any account fee. The account fee will be deducted pro rata out of each Annuity Payment. The total dollar amount of each variable Annuity Payment is the sum of all Investment Portfolio variable Annuity Payments. ANNUITY UNIT - The initial Annuity Unit value for each Investment Portfolio of the Separate Account was set by us. The subsequent Annuity Unit value for each Investment Portfolio is determined by multiplying the Annuity Unit value for the immediately preceding Business Day by the net investment factor for the Investment Portfolio for the current Business Day and multiplying the result by a factor for each day since the last Business Day which represents the daily equivalent of the AIR you elected. (1) the dollar amount of the first Annuity Payment is divided by the value of an Annuity Unit as of the Annuity Date. This establishes the number of Annuity Units for each monthly payment. The number of Annuity Units remains fixed during the Annuity Payment period. (2) the fixed number of Annuity Units is multiplied by the Annuity Unit value for the last valuation period of the 6
N-467th Page of 530TOC1stPreviousNextBottomJust 67th
month preceding the month for which the payment is due. This result is the dollar amount of the payment. NET INVESTMENT FACTOR - The net investment factor for each Investment Portfolio is determined by dividing A by B and multiplying by (1-C) where: A is (i) the net asset value per share of the portfolio at the end of the current Business Day; plus (ii) any dividend or capital gains per share declared on behalf of such portfolio that has an ex-dividend date as of the current Business Day. B is the net asset value per share of the portfolio for the immediately preceding Business Day. C is (i) the Separate Account product charges and for each day since the last Business Day. The daily charge is equal to the annual Separate Account product charges divided by 365; plus (ii) a charge factor, if any, for any taxes or any tax reserve we have established as a result of the operation of the Separate Account. Transfers During the Annuity Phase: o You may not make a transfer from the fixed Annuity Option to the variable Annuity Option; o Transfers among the subaccounts will be made by converting the number of Annuity Units being transferred to the number of Annuity Units of the subaccount to which the transfer is made, so that the next Annuity Payment if it were made at that time would be the same amount that it would have been without the transfer. Thereafter, Annuity Payments will reflect changes in the value of the new Annuity Units; and o You may make a transfer from the variable Annuity Option to the fixed Annuity Option. The amount transferred from a subaccount of the Separate Account will be equal to the product of "(a)" multiplied by "(b)" multiplied by "(c)", where (a) is the number of Annuity Units representing your interest in the subaccount per Annuity Payment; (b) is the Annuity Unit value for the subaccount; and (c) is the present value of $1.00 per payment period for the remaining annuity benefit period based on the attained age of the Annuitant at the time of transfer, calculated using the same actuarial basis as the variable annuity rates applied on the Annuity Date for the Annuity Option elected. Amounts transferred to the fixed Annuity Option will be applied under the Annuity Option elected at the attained age of the Annuitant at the time of the transfer using the fixed Annuity Option table. If at the time of transfer, the then current fixed Annuity Option rates applicable to this class of contracts provide a greater payment, the greater payment will be made. All amounts and Annuity Unit values will be determined as of the end of the Business Day on which the Company receives a notice. FIXED ANNUITY A fixed annuity is a series of payments made during the Annuity Phase which are guaranteed as to dollar amount by the Company and do not vary with the investment experience of the Separate Account. The Adjusted Contract Value on the day immediately preceding the Annuity Date will be used to determine the fixed annuity monthly payment. The monthly Annuity Payment will be based upon the Annuity Option elected, the Annuitant's age, the Annuitant's sex (where permitted by law), and the appropriate Annuity Option table. Your annuity rates will not be less than those guaranteed in your contract at the time of purchase. If, as of the annuity calculation date, the then current Annuity Option rates applicable to this class of contracts provide an Annuity Payment greater than that which is guaranteed under the same Annuity Option under this contract, the greater payment will be made. MORTALITY AND EXPENSE GUARANTEE The Company guarantees that the dollar amount of each Annuity Payment after the first Annuity Payment will not be affected by variations in mortality or expense experience. LEGAL OR REGULATORY RESTRICTIONS ON TRANSACTIONS If mandated under applicable law, the Company may be required to reject a premium payment. The Company may also be required to block a contract Owner's account and thereby refuse to pay any request for transfers, withdrawals, surrenders, death benefits or continue making Annuity Payments until instructions are received from the appropriate regulator. 7
N-468th Page of 530TOC1stPreviousNextBottomJust 68th
ADDITIONAL FEDERAL TAX CONSIDERATIONS NON-QUALIFIED CONTRACTS DIVERSIFICATION. In order for your Non-Qualified Contract to be considered an annuity contract for federal income tax purposes, we must comply with certain diversification standards with respect to the investments underlying the contract. We believe that we satisfy and will continue to satisfy these diversification standards. Failure to meet these standards would result in immediate taxation to contract Owners of gains under their contracts. Inadvertent failure to meet these standards may be correctable. CHANGES TO TAX RULES AND INTERPRETATIONS Changes to applicable tax rules and interpretations can adversely affect the tax treatment of your contract. These changes may take effect retroactively. We reserve the right to amend your contract where necessary to maintain its status as a variable annuity contract under federal tax law and to protect you and other contract Owners in the Investment Portfolios from adverse tax consequences. 3.8% INVESTMENT TAX The 3.8% investment tax applies to investment income earned in households making at least $250,000 ($200,000 single) and will result in the following top tax rates on investment income: [Download Table] Capital Gains Dividends Other ------------------ ----------- ---------- 23.8% 43.4% 43.4% The table above also incorporates the scheduled increase in the capital gains rate from 15% to 20%, and the scheduled increase in the dividends rate from 15% to 39.6%. QUALIFIED CONTRACTS Annuity contracts purchased through tax qualified plans are subject to limitations imposed by the Code and regulations as a condition of tax qualification. There are various types of tax qualified plans which have certain beneficial tax consequences for contract Owners and plan participants. TYPES OF QUALIFIED PLANS The following list includes individual account-type plans which may hold an annuity contract as described in the Prospectus. Except for Traditional IRAs, they are established by an employer for participation of its employees. IRA Established by an individual, or employer as part of an employer plan. SIMPLE Established by a for-profit employer with fewer than 100 employees, based on IRA accounts for each participant. SEP Established by a for-profit employer, based on IRA accounts for each participant. Employer only contributions. 401(K), 401(A) Established by for-profit employers, Section 501(c)(3) tax exempt and non-tax exempt entities, Indian Tribes. 403(B) TAX SHELTERED ANNUITY ("TSA") Established by Section 501(c)(3) tax exempt entities, public schools (K-12), public colleges, universities, churches, synagogues and mosques. 457(B) GOVERNMENTAL SPONSOR Established by state and local governments, public schools (K-12), public colleges and universities. 457(B) NON-GOVERNMENTAL SPONSOR Established by a tax-exempt entity. Under a non-governmental plan, which must be a tax-exempt entity under Section 501(c) of the Code, all such investments of the plan are owned by and are subject to the claims of the general creditors of the sponsoring employer. In general, all amounts received under a non-governmental Section 457(b) plan are taxable and are subject to federal income tax withholding as wages. ADDITIONAL INFORMATION REGARDING 457(B) PLANS A 457(b) plan may provide a one-time election to make special one-time "catch-up" contributions in one or more of the participant's last three taxable years ending before the participant's normal retirement age under the plan. 8
N-469th Page of 530TOC1stPreviousNextBottomJust 69th
Participants in governmental 457(b) plans may not use both the age 50 or older catch-up and the special one-time catch-up contribution in the same taxable year. In general, contribution limits with respect to elective deferral and to age 50 plus catch-up contributions are not aggregated with contributions under the other types of qualified plans for the purposes of determining the limitations applicable to participants. 403(A) If your benefit under the 403(b) plan is worth more than $5,000, the Code requires that your annuity protect your spouse if you die before you receive any payments under the annuity or if you die while payments are being made. You may waive these requirements with the written consent of your spouse. In general, designating a Beneficiary other than your spouse is considered a waiver and requires your spouse's written consent. Waiving these requirements may cause your monthly benefit to increase during your lifetime. Special rules apply to the withdrawal of excess contributions. ROTH ACCOUNT Individual or employee plan contributions made to certain plans on an after-tax basis. An IRA may be established as a Roth IRA, and 401(k), 403(b) and 457(b) plans may provide for Roth accounts. ERISA If your plan is subject to ERISA and you are married, the income payments, withdrawal provisions, and methods of payment of the death benefit under your contract may be subject to your spouse's rights as described below. Generally, the spouse must give qualified consent whenever you elect to: (a) choose income payments other than on a qualified joint and survivor annuity basis ("QJSA") (one under which we make payments to you during your lifetime and then make payments reduced by no more than 50% to your spouse for his or her remaining life, if any): or choose to waive the qualified pre-retirement survivor annuity benefit ("QPSA") (the benefit payable to the surviving spouse of a participant who dies with a vested interest in an accrued retirement benefit under the plan before payment of the benefit has begun); (b) make certain withdrawals under plans for which a qualified consent is required; (c) name someone other than the spouse as your Beneficiary; or (d) use your accrued benefit as security for a loan exceeding $5,000. Generally, there is no limit to the number of your elections as long as a qualified consent is given each time. The consent to waive the QJSA must meet certain requirements, including that it be in writing, that it acknowledges the identity of the designated Beneficiary and the form of benefit selected, dated, signed by your spouse, witnessed by a notary public or plan representative, and that it be in a form satisfactory to us. The waiver of the QJSA generally must be executed during the 180 day period (90 days for certain loans) ending on the date on which income payments are to commence, or the withdrawal or the loan is to be made, as the case may be. If you die before benefits commence, your surviving spouse will be your Beneficiary unless he or she has given a qualified consent otherwise. The qualified consent to waive the QPSA benefit and the Beneficiary designation must be made in writing that acknowledges the designated Beneficiary, dated, signed by your spouse, witnessed by a notary public or plan representative and in a form satisfactory to us. Generally, there is no limit to the number of Beneficiary designations as long as a qualified consent accompanies each designation. The waiver of and the qualified consent for the QPSA benefit generally may not be given until the plan year in which you attain age 35. The waiver period for the QPSA ends on the date of your death. If the present value of your benefit is worth $5,000 or less, your plan generally may provide for distribution of your entire interest in a lump sum without spousal consent. COMPARISON OF PLAN LIMITS FOR INDIVIDUAL CONTRIBUTIONS (1) IRA: elective contribution: $5,500; catch-up contribution: $1,000 (2) SIMPLE: elective contribution: $12,000; catch-up contribution: $2,500 (3) 401(K): elective contribution: $17,500; catch-up contribution: $5,500 (4) SEP/401(A): (employer contributions only) (5) 403(B) (TSA): elective contribution: $17,500; catch-up contribution: $5,500 (6) 457(B): elective contribution: $17,500; catch-up contribution: $5,500 9
N-470th Page of 530TOC1stPreviousNextBottomJust 70th
Dollar limits are for 2014 and subject to cost-of-living adjustments in future years. Employer-sponsored individual account plans (other than 457(b) plans) may provide for additional employer contributions not to exceed the greater of $52,000 or 25% of an employee's compensation for 2014. FEDERAL ESTATE TAXES While no attempt is being made to discuss the federal estate tax implications of the contract, you should bear in mind that the value of an annuity contract owned by a decedent and payable to a Beneficiary by virtue of surviving the decedent is included in the decedent's gross estate. Depending on the terms of the annuity contract, the value of the annuity included in the gross estate may be the value of the lump sum payment payable to the designated Beneficiary or the actuarial value of the payments to be received by the Beneficiary. Consult an estate planning adviser for more information. GENERATION-SKIPPING TRANSFER TAX Under certain circumstances, the Code may impose a "generation-skipping transfer tax" when all or part of an annuity contract is transferred to, or a death benefit is paid to, an individual two or more generations younger than the contract Owner. Regulations issued under the Code may require us to deduct the tax from your contract, or from any applicable payment, and pay it directly to the IRS. ANNUITY PURCHASE PAYMENTS BY NONRESIDENT ALIENS AND FOREIGN CORPORATIONS The discussion above provides general information regarding U.S. federal income tax consequences to annuity purchasers that are U.S. citizens or residents. Purchasers that are not U.S. citizens or residents will generally be subject to U.S. federal withholding tax on taxable distributions from annuity contracts at a 30% rate, unless a lower treaty rate applies. In addition, purchasers may be subject to state and/or municipal taxes and taxes that may be imposed by the purchaser's country of citizenship or residence. Prospective purchasers are advised to consult with a qualified tax adviser regarding U.S., state and foreign taxation with respect to an annuity contract purchase. 10
N-471st Page of 530TOC1stPreviousNextBottomJust 71st
FINANCIAL STATEMENTS The financial statements of MetLife Investors USA Separate Account A, the unaudited pro forma condensed combined financial statements of MetLife Insurance Company of Connecticut, giving effect to the merger on a pro forma basis, and the consolidated financial statements of MetLife Insurance Company of Connecticut, are included herein. Also included are the financial statements of MetLife Investors Insurance Company and Exeter Reassurance Company, Ltd. (affiliates of MetLife USA that were merged into MetLife USA effective as of November 14, 2014). The unaudited pro forma condensed combined financial statements of MetLife Insurance Company of Connecticut and the consolidated financial statements of MetLife Insurance Company of Connecticut should be considered only as bearing upon the ability of MetLife USA to meet its obligations under the contracts. 11
N-472nd Page of 530TOC1stPreviousNextBottomJust 72nd
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Contract Owners of MetLife Investors USA Separate Account A and Board of Directors of MetLife Investors USA Insurance Company We have audited the accompanying statements of assets and liabilities of MetLife Investors USA Separate Account A (the "Separate Account") of MetLife Investors USA Insurance Company (the "Company") comprising each of the individual Sub-Accounts listed in Note 2 as of December 31, 2013, the related statements of operations for the respective stated period in the year then ended, the statements of changes in net assets for the respective stated periods in the two years then ended, and the financial highlights in Note 8 for the respective stated periods in the five years then ended. These financial statements and financial highlights are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Separate Account is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Separate Account's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of investments owned as of December 31, 2013, by correspondence with the custodian or mutual fund companies. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the Sub-Accounts constituting the Separate Account of the Company as of December 31, 2013, the results of their operations for the respective stated period in the year then ended, the changes in their net assets for the respective stated periods in the two years then ended, and the financial highlights for the respective stated periods in the five years then ended, in conformity with accounting principles generally accepted in the United States of America. /s/ DELOITTE & TOUCHE LLP Certified Public Accountants Tampa, Florida March 27, 2014
N-473rd Page of 530TOC1stPreviousNextBottomJust 73rd
This page is intentionally left blank.
N-474th Page of 530TOC1stPreviousNextBottomJust 74th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES DECEMBER 31, 2013 [Enlarge/Download Table] AMERICAN FUNDS ALGER AMERICAN FUNDS AMERICAN FUNDS GLOBAL SMALL SMALL CAP GROWTH BOND GLOBAL GROWTH CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- ASSETS: Investments at fair value.............. $ 63,772,200 $ 146,158,384 $ 314,826,299 $ 124,184,057 Due from MetLife Investors USA Insurance Company................ -- -- -- -- ------------------- -------------------- ------------------- ------------------- Total Assets...................... 63,772,200 146,158,384 314,826,299 124,184,057 ------------------- -------------------- ------------------- ------------------- LIABILITIES: Accrued fees........................... -- 32 93 52 Due to MetLife Investors USA Insurance Company................ 1 1 3 2 ------------------- -------------------- ------------------- ------------------- Total Liabilities................. 1 33 96 54 ------------------- -------------------- ------------------- ------------------- NET ASSETS................................ $ 63,772,199 $ 146,158,351 $ 314,826,203 $ 124,184,003 =================== ==================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units..... $ 63,772,199 $ 146,137,922 $ 314,815,262 $ 124,172,760 Net assets from contracts in payout.... -- 20,429 10,941 11,243 ------------------- -------------------- ------------------- ------------------- Total Net Assets.................. $ 63,772,199 $ 146,158,351 $ 314,826,203 $ 124,184,003 =================== ==================== =================== =================== The accompanying notes are an integral part of these financial statements. 1
N-475th Page of 530TOC1stPreviousNextBottomJust 75th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] AMERICAN FUNDS AMERICAN FUNDS DWS I FEDERATED HIGH GROWTH GROWTH-INCOME INTERNATIONAL INCOME BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 856,560,270 $ 388,320,093 $ 18,592,801 $ 26,171 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- ------------------- Total Assets.................... 856,560,270 388,320,093 18,592,801 26,171 ------------------- -------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 64 100 7 5 Due to MetLife Investors USA Insurance Company.............. 2 3 -- -- ------------------- -------------------- ------------------- ------------------- Total Liabilities............... 66 103 7 5 ------------------- -------------------- ------------------- ------------------- NET ASSETS.............................. $ 856,560,204 $ 388,319,990 $ 18,592,794 $ 26,166 =================== ==================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 856,524,635 $ 388,260,143 $ 18,592,794 $ 26,166 Net assets from contracts in payout.. 35,569 59,847 -- -- ------------------- -------------------- ------------------- ------------------- Total Net Assets................ $ 856,560,204 $ 388,319,990 $ 18,592,794 $ 26,166 =================== ==================== =================== =================== FEDERATED FIDELITY VIP FIDELITY VIP FIDELITY VIP KAUFMAN ASSET MANAGER CONTRAFUND EQUITY-INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 44,909 $ 88,274,484 $ 611,972,984 $ 5,954,600 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- ------------------- Total Assets.................... 44,909 88,274,484 611,972,984 5,954,600 ------------------- -------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 2 1 45 -- Due to MetLife Investors USA Insurance Company.............. -- -- 13 -- ------------------- -------------------- ------------------- ------------------- Total Liabilities............... 2 1 58 -- ------------------- -------------------- ------------------- ------------------- NET ASSETS.............................. $ 44,907 $ 88,274,483 $ 611,972,926 $ 5,954,600 =================== ==================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 44,907 $ 88,274,483 $ 611,972,926 $ 5,954,600 Net assets from contracts in payout.. -- -- -- -- ------------------- -------------------- ------------------- ------------------- Total Net Assets................ $ 44,907 $ 88,274,483 $ 611,972,926 $ 5,954,600 =================== ==================== =================== =================== FIDELITY VIP FIDELITY VIP FUNDSMANAGER 50% FUNDSMANAGER 60% SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ASSETS: Investments at fair value............ $ 2,033,793,788 $ 4,031,523,824 Due from MetLife Investors USA Insurance Company.............. -- -- -------------------- ------------------- Total Assets.................... 2,033,793,788 4,031,523,824 -------------------- ------------------- LIABILITIES: Accrued fees......................... -- -- Due to MetLife Investors USA Insurance Company.............. -- -- -------------------- ------------------- Total Liabilities............... -- -- -------------------- ------------------- NET ASSETS.............................. $ 2,033,793,788 $ 4,031,523,824 ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 2,033,793,788 $ 4,031,523,824 Net assets from contracts in payout.. -- -- -------------------- ------------------- Total Net Assets................ $ 2,033,793,788 $ 4,031,523,824 ==================== =================== The accompanying notes are an integral part of these financial statements. 2
N-476th Page of 530TOC1stPreviousNextBottomJust 76th
The accompanying notes are an integral part of these financial statements. 3
N-477th Page of 530TOC1stPreviousNextBottomJust 77th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP GROWTH INDEX 500 MID CAP MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 165,968,439 $ 69,677,261 $ 446,581,951 $ 76,155,366 Due from MetLife Investors USA Insurance Company.............. -- -- 1 -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 165,968,439 69,677,261 446,581,952 76,155,366 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... -- 14 10 20 Due to MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Liabilities............... -- 14 10 20 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 165,968,439 $ 69,677,247 $ 446,581,942 $ 76,155,346 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 165,968,439 $ 69,677,247 $ 446,565,326 $ 76,155,346 Net assets from contracts in payout.. -- -- 16,616 -- -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 165,968,439 $ 69,677,247 $ 446,581,942 $ 76,155,346 ==================== ==================== ==================== ==================== FTVIPT FRANKLIN FIDELITY VIP FTVIPT FRANKLIN SMALL CAP VALUE FTVIPT MUTUAL OVERSEAS INCOME SECURITIES SECURITIES SHARES SECURITIES SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 5,925,521 $ 297,821,546 $ 128,048,986 $ 156,078,613 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 5,925,521 297,821,546 128,048,986 156,078,613 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... -- 75 2 41 Due to MetLife Investors USA Insurance Company.............. -- 1 1 1 -------------------- -------------------- -------------------- -------------------- Total Liabilities............... -- 76 3 42 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 5,925,521 $ 297,821,470 $ 128,048,983 $ 156,078,571 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 5,925,521 $ 297,781,830 $ 128,048,983 $ 156,068,938 Net assets from contracts in payout.. -- 39,640 -- 9,633 -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 5,925,521 $ 297,821,470 $ 128,048,983 $ 156,078,571 ==================== ==================== ==================== ==================== FTVIPT TEMPLETON FTVIPT TEMPLETON GLOBAL BOND FOREIGN SECURITIES SECURITIES SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 87,721,359 $ 254,683,432 Due from MetLife Investors USA Insurance Company.............. -- -- -------------------- -------------------- Total Assets.................... 87,721,359 254,683,432 -------------------- -------------------- LIABILITIES: Accrued fees......................... 64 18 Due to MetLife Investors USA Insurance Company.............. 2 -- -------------------- -------------------- Total Liabilities............... 66 18 -------------------- -------------------- NET ASSETS.............................. $ 87,721,293 $ 254,683,414 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 87,721,293 $ 254,675,740 Net assets from contracts in payout.. -- 7,674 -------------------- -------------------- Total Net Assets................ $ 87,721,293 $ 254,683,414 ==================== ==================== The accompanying notes are an integral part of these financial statements. 4
N-478th Page of 530TOC1stPreviousNextBottomJust 78th
The accompanying notes are an integral part of these financial statements. 5
N-479th Page of 530TOC1stPreviousNextBottomJust 79th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] INVESCO V.I. INVESCO V.I. INVESCO V.I. INVESCO V.I. AMERICAN FRANCHISE AMERICAN VALUE CORE EQUITY EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- --------------------- -------------------- ASSETS: Investments at fair value............ $ 163,724 $ 95,295,951 $ 249,706 $ 649,322,735 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- -------------------- --------------------- -------------------- Total Assets.................... 163,724 95,295,951 249,706 649,322,735 -------------------- -------------------- --------------------- -------------------- LIABILITIES: Accrued fees......................... 6 21 10 37 Due to MetLife Investors USA Insurance Company.............. 5 1 -- -- -------------------- -------------------- --------------------- -------------------- Total Liabilities............... 11 22 10 37 -------------------- -------------------- --------------------- -------------------- NET ASSETS.............................. $ 163,713 $ 95,295,929 $ 249,696 $ 649,322,698 ==================== ==================== ===================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 163,713 $ 95,295,929 $ 249,696 $ 649,301,613 Net assets from contracts in payout.. -- -- -- 21,085 -------------------- -------------------- --------------------- -------------------- Total Net Assets................ $ 163,713 $ 95,295,929 $ 249,696 $ 649,322,698 ==================== ==================== ===================== ==================== INVESCO V.I. INVESCO V.I. INVESCO V.I. JANUS ASPEN GLOBAL REAL ESTATE GROWTH AND INCOME INTERNATIONAL GROWTH GLOBAL RESEARCH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- -------------------- --------------------- ASSETS: Investments at fair value............ $ 29,993,352 $ 365,970,652 $ 281,999,222 $ 6,751 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- --------------------- -------------------- -------------------- --------------------- Total Assets.................... 29,993,352 365,970,652 281,999,222 6,751 --------------------- -------------------- -------------------- --------------------- LIABILITIES: Accrued fees......................... 28 37 14 3 Due to MetLife Investors USA Insurance Company.............. 1 2 2 -- --------------------- -------------------- -------------------- --------------------- Total Liabilities............... 29 39 16 3 --------------------- -------------------- -------------------- --------------------- NET ASSETS.............................. $ 29,993,323 $ 365,970,613 $ 281,999,206 $ 6,748 ===================== ==================== ==================== ===================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 29,993,323 $ 365,960,564 $ 281,990,432 $ 6,748 Net assets from contracts in payout.. -- 10,049 8,774 -- --------------------- -------------------- -------------------- --------------------- Total Net Assets................ $ 29,993,323 $ 365,970,613 $ 281,999,206 $ 6,748 ===================== ==================== ==================== ===================== LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH ALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- ASSETS: Investments at fair value............ $ 280,745,363 $ 129,253,621 Due from MetLife Investors USA Insurance Company.............. -- -- --------------------- -------------------- Total Assets.................... 280,745,363 129,253,621 --------------------- -------------------- LIABILITIES: Accrued fees......................... 160 56 Due to MetLife Investors USA Insurance Company.............. 3 2 --------------------- -------------------- Total Liabilities............... 163 58 --------------------- -------------------- NET ASSETS.............................. $ 280,745,200 $ 129,253,563 ===================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 280,734,965 $ 129,253,563 Net assets from contracts in payout.. 10,235 -- --------------------- -------------------- Total Net Assets................ $ 280,745,200 $ 129,253,563 ===================== ==================== The accompanying notes are an integral part of these financial statements. 6
N-480th Page of 530TOC1stPreviousNextBottomJust 80th
The accompanying notes are an integral part of these financial statements. 7
N-481st Page of 530TOC1stPreviousNextBottomJust 81st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] LMPVET LMPVET LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE APPRECIATION EQUITY INCOME LARGE CAP GROWTH LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 405,286,269 $ 191,169,763 $ 5,012,459 $ 6,893,046 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 405,286,269 191,169,763 5,012,459 6,893,046 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 46 108 68 91 Due to MetLife Investors USA Insurance Company.............. 2 2 1 1 -------------------- -------------------- -------------------- -------------------- Total Liabilities............... 48 110 69 92 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 405,286,221 $ 191,169,653 $ 5,012,390 $ 6,892,954 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 405,286,221 $ 191,162,626 $ 5,012,390 $ 6,892,954 Net assets from contracts in payout.. -- 7,027 -- -- -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 405,286,221 $ 191,169,653 $ 5,012,390 $ 6,892,954 ==================== ==================== ==================== ==================== LMPVET LMPVET INVESTMENT LMPVET LMPVET CLEARBRIDGE VARIABLE COUNSEL VARIABLE VARIABLE LIFESTYLE VARIABLE LIFESTYLE SMALL CAP GROWTH SOCIAL AWARENESS ALLOCATION 50% ALLOCATION 70% SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 112,499,086 $ 292,324 $ 44,101,424 $ 2,305,026 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- -------------------- -------------------- ------------------- Total Assets.................... 112,499,086 292,324 44,101,424 2,305,026 -------------------- -------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 65 38 23 27 Due to MetLife Investors USA Insurance Company.............. 1 -- -- -- -------------------- -------------------- -------------------- ------------------- Total Liabilities............... 66 38 23 27 -------------------- -------------------- -------------------- ------------------- NET ASSETS.............................. $ 112,499,020 $ 292,286 $ 44,101,401 $ 2,304,999 ==================== ==================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 112,499,020 $ 292,286 $ 44,101,401 $ 2,304,999 Net assets from contracts in payout.. -- -- -- -- -------------------- -------------------- -------------------- ------------------- Total Net Assets................ $ 112,499,020 $ 292,286 $ 44,101,401 $ 2,304,999 ==================== ==================== ==================== =================== LMPVET LMPVIT WESTERN VARIABLE LIFESTYLE ASSET VARIABLE GLOBAL ALLOCATION 85% HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT -------------------- --------------------- ASSETS: Investments at fair value............ $ 95,074,305 $ 104,740,529 Due from MetLife Investors USA Insurance Company.............. -- -- -------------------- --------------------- Total Assets.................... 95,074,305 104,740,529 -------------------- --------------------- LIABILITIES: Accrued fees......................... 21 77 Due to MetLife Investors USA Insurance Company.............. -- 1 -------------------- --------------------- Total Liabilities............... 21 78 -------------------- --------------------- NET ASSETS.............................. $ 95,074,284 $ 104,740,451 ==================== ===================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 95,074,284 $ 104,737,455 Net assets from contracts in payout.. -- 2,996 -------------------- --------------------- Total Net Assets................ $ 95,074,284 $ 104,740,451 ==================== ===================== The accompanying notes are an integral part of these financial statements. 8
N-482nd Page of 530TOC1stPreviousNextBottomJust 82nd
The accompanying notes are an integral part of these financial statements. 9
N-483rd Page of 530TOC1stPreviousNextBottomJust 83rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST ALLIANCEBERNSTEIN MFS VIT MFS VIT GLOBAL DYNAMIC INVESTORS TRUST NEW DISCOVERY MFS VIT RESEARCH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 25,959 $ 46,022 $ 63,838 $ 3,313,674,263 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets.................... 25,959 46,022 63,838 3,313,674,263 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 8 2 2 69 Due to MetLife Investors USA Insurance Company.............. -- -- 1 2 ------------------- -------------------- ------------------- -------------------- Total Liabilities............... 8 2 3 71 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 25,951 $ 46,020 $ 63,835 $ 3,313,674,192 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 25,951 $ 46,020 $ 63,835 $ 3,313,622,486 Net assets from contracts in payout.. -- -- -- 51,706 ------------------- -------------------- ------------------- -------------------- Total Net Assets................ $ 25,951 $ 46,020 $ 63,835 $ 3,313,674,192 =================== ==================== =================== ==================== MIST AMERICAN MIST AMERICAN MIST AMERICAN FUNDS BALANCED FUNDS GROWTH MIST AMERICAN FUNDS MODERATE ALLOCATION ALLOCATION FUNDS GROWTH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 3,430,387,069 $ 1,828,322,442 $ 632,386,712 $ 1,796,367,030 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- ------------------- ------------------- -------------------- Total Assets.................... 3,430,387,069 1,828,322,442 632,386,712 1,796,367,030 -------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 30 66 66 52 Due to MetLife Investors USA Insurance Company.............. 1 1 10 1 -------------------- ------------------- ------------------- -------------------- Total Liabilities............... 31 67 76 53 -------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 3,430,387,038 $ 1,828,322,375 $ 632,386,636 $ 1,796,366,977 ==================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 3,430,376,518 $ 1,827,667,872 $ 632,301,718 $ 1,796,362,961 Net assets from contracts in payout.. 10,520 654,503 84,918 4,016 -------------------- ------------------- ------------------- -------------------- Total Net Assets................ $ 3,430,387,038 $ 1,828,322,375 $ 632,386,636 $ 1,796,366,977 ==================== =================== =================== ==================== MIST AQR MIST BLACKROCK GLOBAL RISK GLOBAL TACTICAL BALANCED STRATEGIES SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 3,248,476,045 $ 5,457,878,842 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- -------------------- Total Assets.................... 3,248,476,045 5,457,878,842 ------------------- -------------------- LIABILITIES: Accrued fees......................... 68 78 Due to MetLife Investors USA Insurance Company.............. -- 3 ------------------- -------------------- Total Liabilities............... 68 81 ------------------- -------------------- NET ASSETS.............................. $ 3,248,475,977 $ 5,457,878,761 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 3,248,431,414 $ 5,457,828,462 Net assets from contracts in payout.. 44,563 50,299 ------------------- -------------------- Total Net Assets................ $ 3,248,475,977 $ 5,457,878,761 =================== ==================== The accompanying notes are an integral part of these financial statements. 10
N-484th Page of 530TOC1stPreviousNextBottomJust 84th
The accompanying notes are an integral part of these financial statements. 11
N-485th Page of 530TOC1stPreviousNextBottomJust 85th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST BLACKROCK MIST BLACKROCK MIST CLARION MIST CLEARBRIDGE HIGH YIELD LARGE CAP CORE GLOBAL REAL ESTATE AGGRESSIVE GROWTH II SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 265,149,930 $ 16,869,754 $ 182,674,017 $ 119,069,072 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets..................... 265,149,930 16,869,754 182,674,017 119,069,072 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 122 102 93 110 Due to MetLife Investors USA Insurance Company.............. 2 2 2 2 ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 124 104 95 112 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 265,149,806 $ 16,869,650 $ 182,673,922 $ 119,068,960 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 265,145,347 $ 16,869,650 $ 182,649,463 $ 119,068,960 Net assets from contracts in payout.. 4,459 -- 24,459 -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 265,149,806 $ 16,869,650 $ 182,673,922 $ 119,068,960 =================== ==================== =================== ==================== MIST MIST INVESCO MIST CLEARBRIDGE MIST GOLDMAN SACHS HARRIS OAKMARK BALANCED-RISK AGGRESSIVE GROWTH MID CAP VALUE INTERNATIONAL ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 451,710,663 $ 170,038,476 $ 693,983,315 $ 843,160,756 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets..................... 451,710,663 170,038,476 693,983,315 843,160,756 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 96 89 69 58 Due to MetLife Investors USA Insurance Company.............. 2 1 2 1 ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 98 90 71 59 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 451,710,565 $ 170,038,386 $ 693,983,244 $ 843,160,697 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 451,670,790 $ 170,001,706 $ 693,796,289 $ 843,160,697 Net assets from contracts in payout.. 39,775 36,680 186,955 -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 451,710,565 $ 170,038,386 $ 693,983,244 $ 843,160,697 =================== ==================== =================== ==================== MIST INVESCO MIST INVESCO COMSTOCK MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 443,562,037 $ 158,040,507 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- -------------------- Total Assets..................... 443,562,037 158,040,507 ------------------- -------------------- LIABILITIES: Accrued fees......................... 112 131 Due to MetLife Investors USA Insurance Company.............. 2 1 ------------------- -------------------- Total Liabilities................ 114 132 ------------------- -------------------- NET ASSETS.............................. $ 443,561,923 $ 158,040,375 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 443,532,010 $ 158,034,445 Net assets from contracts in payout.. 29,913 5,930 ------------------- -------------------- Total Net Assets................. $ 443,561,923 $ 158,040,375 =================== ==================== The accompanying notes are an integral part of these financial statements. 12
N-486th Page of 530TOC1stPreviousNextBottomJust 86th
The accompanying notes are an integral part of these financial statements. 13
N-487th Page of 530TOC1stPreviousNextBottomJust 87th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST JPMORGAN MIST INVESCO MIST JPMORGAN GLOBAL ACTIVE MIST JPMORGAN SMALL CAP GROWTH CORE BOND ALLOCATION SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 319,189,506 $ 311,869,966 $ 746,849,807 $ 27,866,760 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- ------------------- -------------------- ------------------- Total Assets..................... 319,189,506 311,869,966 746,849,807 27,866,760 -------------------- ------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 159 33 89 194 Due to MetLife Investors USA Insurance Company.............. 2 1 1 -- -------------------- ------------------- -------------------- ------------------- Total Liabilities................ 161 34 90 194 -------------------- ------------------- -------------------- ------------------- NET ASSETS.............................. $ 319,189,345 $ 311,869,932 $ 746,849,717 $ 27,866,566 ==================== =================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 319,132,725 $ 311,869,932 $ 746,849,717 $ 27,866,566 Net assets from contracts in payout.. 56,620 -- -- -- -------------------- ------------------- -------------------- ------------------- Total Net Assets................. $ 319,189,345 $ 311,869,932 $ 746,849,717 $ 27,866,566 ==================== =================== ==================== =================== MIST MIST MET/FRANKLIN MIST LOOMIS SAYLES MIST LORD ABBETT MET/EATON VANCE LOW DURATION GLOBAL MARKETS BOND DEBENTURE FLOATING RATE TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 180,595,879 $ 259,294,611 $ 83,115,922 $ 140,307,239 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets..................... 180,595,879 259,294,611 83,115,922 140,307,239 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 96 121 84 92 Due to MetLife Investors USA Insurance Company.............. 2 3 1 1 ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 98 124 85 93 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 180,595,781 $ 259,294,487 $ 83,115,837 $ 140,307,146 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 180,595,781 $ 259,067,107 $ 83,115,837 $ 140,307,146 Net assets from contracts in payout.. -- 227,380 -- -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 180,595,781 $ 259,294,487 $ 83,115,837 $ 140,307,146 =================== ==================== =================== ==================== MIST MET/TEMPLETON MIST METLIFE INTERNATIONAL BOND AGGRESSIVE STRATEGY SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 52,286,206 $ 659,971,556 Due from MetLife Investors USA Insurance Company.............. -- -- -------------------- -------------------- Total Assets..................... 52,286,206 659,971,556 -------------------- -------------------- LIABILITIES: Accrued fees......................... 66 51 Due to MetLife Investors USA Insurance Company.............. 1 1 -------------------- -------------------- Total Liabilities................ 67 52 -------------------- -------------------- NET ASSETS.............................. $ 52,286,139 $ 659,971,504 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 52,286,139 $ 659,913,190 Net assets from contracts in payout.. -- 58,314 -------------------- -------------------- Total Net Assets................. $ 52,286,139 $ 659,971,504 ==================== ==================== The accompanying notes are an integral part of these financial statements. 14
N-488th Page of 530TOC1stPreviousNextBottomJust 88th
The accompanying notes are an integral part of these financial statements. 15
N-489th Page of 530TOC1stPreviousNextBottomJust 89th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST METLIFE MIST METLIFE MIST METLIFE MIST METLIFE BALANCED PLUS BALANCED STRATEGY DEFENSIVE STRATEGY GROWTH STRATEGY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 6,454,727,036 $ 7,812,083,227 $ 1,972,799,230 $ 6,767,059,571 Due from MetLife Investors USA Insurance Company.............. -- -- -- 13 -------------------- ------------------- -------------------- ------------------- Total Assets..................... 6,454,727,036 7,812,083,227 1,972,799,230 6,767,059,584 -------------------- ------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 58 49 92 66 Due to MetLife Investors USA Insurance Company.............. 2 1 2 -- -------------------- ------------------- -------------------- ------------------- Total Liabilities................ 60 50 94 66 -------------------- ------------------- -------------------- ------------------- NET ASSETS.............................. $ 6,454,726,976 $ 7,812,083,177 $ 1,972,799,136 $ 6,767,059,518 ==================== =================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 6,454,591,334 $ 7,810,608,978 $ 1,972,521,631 $ 6,766,750,756 Net assets from contracts in payout.. 135,642 1,474,199 277,505 308,762 -------------------- ------------------- -------------------- ------------------- Total Net Assets................. $ 6,454,726,976 $ 7,812,083,177 $ 1,972,799,136 $ 6,767,059,518 ==================== =================== ==================== =================== MIST MIST METLIFE MIST METLIFE MULTI- MIST MFS EMERGING MFS RESEARCH MODERATE STRATEGY INDEX TARGETED RISK MARKETS EQUITY INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 3,631,779,081 $ 209,957,104 $ 456,076,979 $ 331,488,553 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- -------------------- ------------------- Total Assets..................... 3,631,779,081 209,957,104 456,076,979 331,488,553 ------------------- -------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 72 51 85 89 Due to MetLife Investors USA Insurance Company.............. 1 1 2 3 ------------------- -------------------- -------------------- ------------------- Total Liabilities................ 73 52 87 92 ------------------- -------------------- -------------------- ------------------- NET ASSETS.............................. $ 3,631,779,008 $ 209,957,052 $ 456,076,892 $ 331,488,461 =================== ==================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 3,631,343,957 $ 209,957,052 $ 456,043,852 $ 331,401,169 Net assets from contracts in payout.. 435,051 -- 33,040 87,292 ------------------- -------------------- -------------------- ------------------- Total Net Assets................. $ 3,631,779,008 $ 209,957,052 $ 456,076,892 $ 331,488,461 =================== ==================== ==================== =================== MIST MORGAN STANLEY MIST OPPENHEIMER MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ASSETS: Investments at fair value............ $ 244,579,293 $ 78,398,683 Due from MetLife Investors USA Insurance Company.............. -- 2 ------------------- ------------------- Total Assets..................... 244,579,293 78,398,685 ------------------- ------------------- LIABILITIES: Accrued fees......................... 57 112 Due to MetLife Investors USA Insurance Company.............. 2 -- ------------------- ------------------- Total Liabilities................ 59 112 ------------------- ------------------- NET ASSETS.............................. $ 244,579,234 $ 78,398,573 =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 244,579,234 $ 78,398,573 Net assets from contracts in payout.. -- -- ------------------- ------------------- Total Net Assets................. $ 244,579,234 $ 78,398,573 =================== =================== The accompanying notes are an integral part of these financial statements. 16
N-490th Page of 530TOC1stPreviousNextBottomJust 90th
The accompanying notes are an integral part of these financial statements. 17
N-491st Page of 530TOC1stPreviousNextBottomJust 91st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST PIMCO INFLATION MIST MIST MIST PIONEER PROTECTED BOND PIMCO TOTAL RETURN PIONEER FUND STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 821,456,212 $ 1,993,787,047 $ 297,755,838 $ 919,329,053 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- ------------------- ------------------- ------------------- Total Assets..................... 821,456,212 1,993,787,047 297,755,838 919,329,053 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 121 97 160 185 Due to MetLife Investors USA Insurance Company.............. 2 2 8 11 ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 123 99 168 196 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 821,456,089 $ 1,993,786,948 $ 297,755,670 $ 919,328,857 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 821,327,058 $ 1,993,490,223 $ 297,747,696 $ 919,316,926 Net assets from contracts in payout.. 129,031 296,725 7,974 11,931 ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 821,456,089 $ 1,993,786,948 $ 297,755,670 $ 919,328,857 =================== =================== =================== =================== MIST PYRAMIS MIST PYRAMIS MIST SCHRODERS MIST SSGA GROWTH GOVERNMENT INCOME MANAGED RISK GLOBAL MULTI-ASSET AND INCOME ETF SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 715,739,667 $ 78,417,297 $ 435,205,791 $ 1,578,178,756 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- ------------------- ------------------- ------------------- Total Assets..................... 715,739,667 78,417,297 435,205,791 1,578,178,756 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 109 67 101 77 Due to MetLife Investors USA Insurance Company.............. 1 1 1 2 ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 110 68 102 79 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 715,739,557 $ 78,417,229 $ 435,205,689 $ 1,578,178,677 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 715,457,516 $ 78,417,229 $ 435,205,689 $ 1,578,176,658 Net assets from contracts in payout.. 282,041 -- -- 2,019 ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 715,739,557 $ 78,417,229 $ 435,205,689 $ 1,578,178,677 =================== =================== =================== =================== MIST SSGA MIST T. ROWE PRICE GROWTH ETF LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ASSETS: Investments at fair value............ $ 509,607,946 $ 657,944,412 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- ------------------- Total Assets..................... 509,607,946 657,944,412 ------------------- ------------------- LIABILITIES: Accrued fees......................... 86 91 Due to MetLife Investors USA Insurance Company.............. 2 2 ------------------- ------------------- Total Liabilities................ 88 93 ------------------- ------------------- NET ASSETS.............................. $ 509,607,858 $ 657,944,319 =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 509,607,858 $ 657,632,896 Net assets from contracts in payout.. -- 311,423 ------------------- ------------------- Total Net Assets................. $ 509,607,858 $ 657,944,319 =================== =================== The accompanying notes are an integral part of these financial statements. 18
N-492nd Page of 530TOC1stPreviousNextBottomJust 92nd
The accompanying notes are an integral part of these financial statements. 19
N-493rd Page of 530TOC1stPreviousNextBottomJust 93rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MIST T. ROWE PRICE MIST THIRD AVENUE MSF BAILLIE GIFFORD MSF BARCLAYS MID CAP GROWTH SMALL CAP VALUE INTERNATIONAL STOCK AGGREGATE BOND INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 568,882,803 $ 330,702,076 $ 303,453,108 $ 162,571,949 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- ------------------- ------------------- -------------------- Total Assets..................... 568,882,803 330,702,076 303,453,108 162,571,949 ------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 55 112 57 98 Due to MetLife Investors USA Insurance Company.............. 1 2 4 2 ------------------- ------------------- ------------------- -------------------- Total Liabilities................ 56 114 61 100 ------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 568,882,747 $ 330,701,962 $ 303,453,047 $ 162,571,849 =================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 568,794,562 $ 330,531,309 $ 303,453,047 $ 162,571,849 Net assets from contracts in payout.. 88,185 170,653 -- -- ------------------- ------------------- ------------------- -------------------- Total Net Assets................. $ 568,882,747 $ 330,701,962 $ 303,453,047 $ 162,571,849 =================== =================== =================== ==================== MSF BLACKROCK MSF BLACKROCK MSF BLACKROCK MSF BLACKROCK BOND INCOME CAPITAL APPRECIATION LARGE CAP VALUE MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 57,252,064 $ 15,272,530 $ 3,792,927 $ 461,343,188 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets..................... 57,252,064 15,272,530 3,792,927 461,343,188 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 155 184 -- 292 Due to MetLife Investors USA Insurance Company.............. 2 4 1 6 ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 157 188 1 298 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 57,251,907 $ 15,272,342 $ 3,792,926 $ 461,342,890 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 57,243,808 $ 15,272,342 $ 3,792,926 $ 461,206,268 Net assets from contracts in payout.. 8,099 -- -- 136,622 ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 57,251,907 $ 15,272,342 $ 3,792,926 $ 461,342,890 =================== ==================== =================== ==================== MSF DAVIS MSF FRONTIER VENTURE VALUE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 658,561,619 $ 83,651,214 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- -------------------- Total Assets..................... 658,561,619 83,651,214 ------------------- -------------------- LIABILITIES: Accrued fees......................... 177 50 Due to MetLife Investors USA Insurance Company.............. 4 1 ------------------- -------------------- Total Liabilities................ 181 51 ------------------- -------------------- NET ASSETS.............................. $ 658,561,438 $ 83,651,163 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 658,275,863 $ 83,628,999 Net assets from contracts in payout.. 285,575 22,164 ------------------- -------------------- Total Net Assets................. $ 658,561,438 $ 83,651,163 =================== ==================== The accompanying notes are an integral part of these financial statements. 20
N-494th Page of 530TOC1stPreviousNextBottomJust 94th
The accompanying notes are an integral part of these financial statements. 21
N-495th Page of 530TOC1stPreviousNextBottomJust 95th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MSF MSF LOOMIS SAYLES MSF LOOMIS SAYLES MSF MET/ARTISAN JENNISON GROWTH SMALL CAP CORE SMALL CAP GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 585,624,287 $ 14,610,873 $ 226,834 $ 285,771,086 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- ------------------- -------------------- -------------------- Total Assets.................... 585,624,287 14,610,873 226,834 285,771,086 -------------------- ------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 66 98 32 73 Due to MetLife Investors USA Insurance Company.............. 2 2 -- 3 -------------------- ------------------- -------------------- -------------------- Total Liabilities............... 68 100 32 76 -------------------- ------------------- -------------------- -------------------- NET ASSETS.............................. $ 585,624,219 $ 14,610,773 $ 226,802 $ 285,771,010 ==================== =================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 585,280,529 $ 14,610,773 $ 226,802 $ 285,579,066 Net assets from contracts in payout.. 343,690 -- -- 191,944 -------------------- ------------------- -------------------- -------------------- Total Net Assets................ $ 585,624,219 $ 14,610,773 $ 226,802 $ 285,771,010 ==================== =================== ==================== ==================== MSF MET/DIMENSIONAL MSF METLIFE MSF METLIFE INTERNATIONAL SMALL CONSERVATIVE CONSERVATIVE TO MSF METLIFE COMPANY ALLOCATION MODERATE ALLOCATION MID CAP STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 66,162,529 $ 7,497,463 $ 7,732,407 $ 125,884,166 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- --------------------- -------------------- -------------------- -------------------- Total Assets.................... 66,162,529 7,497,463 7,732,407 125,884,166 --------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 106 55 31 87 Due to MetLife Investors USA Insurance Company.............. 4 -- -- 1 --------------------- -------------------- -------------------- -------------------- Total Liabilities............... 110 55 31 88 --------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 66,162,419 $ 7,497,408 $ 7,732,376 $ 125,884,078 ===================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 66,162,419 $ 7,497,408 $ 7,732,376 $ 125,884,078 Net assets from contracts in payout.. -- -- -- -- --------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 66,162,419 $ 7,497,408 $ 7,732,376 $ 125,884,078 ===================== ==================== ==================== ==================== MSF METLIFE MSF METLIFE MODERATE TO MODERATE ALLOCATION AGGRESSIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------- --------------------- ASSETS: Investments at fair value............ $ 44,655,438 $ 57,260,816 Due from MetLife Investors USA Insurance Company.............. -- -- -------------------- --------------------- Total Assets.................... 44,655,438 57,260,816 -------------------- --------------------- LIABILITIES: Accrued fees......................... 16 28 Due to MetLife Investors USA Insurance Company.............. 1 1 -------------------- --------------------- Total Liabilities............... 17 29 -------------------- --------------------- NET ASSETS.............................. $ 44,655,421 $ 57,260,787 ==================== ===================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 44,655,421 $ 57,260,787 Net assets from contracts in payout.. -- -- -------------------- --------------------- Total Net Assets................ $ 44,655,421 $ 57,260,787 ==================== ===================== The accompanying notes are an integral part of these financial statements. 22
N-496th Page of 530TOC1stPreviousNextBottomJust 96th
The accompanying notes are an integral part of these financial statements. 23
N-497th Page of 530TOC1stPreviousNextBottomJust 97th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] MSF METLIFE MSF MSF MSF MSCI STOCK INDEX MFS TOTAL RETURN MFS VALUE EAFE INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 561,274,528 $ 46,044,648 $ 260,474,139 $ 112,197,240 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- ------------------- ------------------- ------------------- Total Assets..................... 561,274,528 46,044,648 260,474,139 112,197,240 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 40 232 168 69 Due to MetLife Investors USA Insurance Company.............. 1 4 7 2 ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 41 236 175 71 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 561,274,487 $ 46,044,412 $ 260,473,964 $ 112,197,169 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 561,135,329 $ 46,044,412 $ 260,467,868 $ 112,197,169 Net assets from contracts in payout.. 139,158 -- 6,096 -- ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 561,274,487 $ 46,044,412 $ 260,473,964 $ 112,197,169 =================== =================== =================== =================== MSF NEUBERGER MSF MSF T. ROWE PRICE MSF T. ROWE PRICE BERMAN GENESIS RUSSELL 2000 INDEX LARGE CAP GROWTH SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 172,247,595 $ 141,070,551 $ 151,930,138 $ 10,522,855 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- ------------------- ------------------- ------------------- Total Assets..................... 172,247,595 141,070,551 151,930,138 10,522,855 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 133 91 66 42 Due to MetLife Investors USA Insurance Company.............. 2 2 1 -- ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 135 93 67 42 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 172,247,460 $ 141,070,458 $ 151,930,071 $ 10,522,813 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 172,210,991 $ 141,070,458 $ 151,902,711 $ 10,522,813 Net assets from contracts in payout.. 36,469 -- 27,360 -- ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 172,247,460 $ 141,070,458 $ 151,930,071 $ 10,522,813 =================== =================== =================== =================== MSF VAN ECK MSF WESTERN ASSET GLOBAL NATURAL MANAGEMENT RESOURCES U.S. GOVERNMENT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ASSETS: Investments at fair value............ $ 106,449,545 $ 291,870,510 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- ------------------- Total Assets..................... 106,449,545 291,870,510 ------------------- ------------------- LIABILITIES: Accrued fees......................... 45 121 Due to MetLife Investors USA Insurance Company.............. 1 1 ------------------- ------------------- Total Liabilities................ 46 122 ------------------- ------------------- NET ASSETS.............................. $ 106,449,499 $ 291,870,388 =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 106,449,499 $ 291,855,711 Net assets from contracts in payout.. -- 14,677 ------------------- ------------------- Total Net Assets................. $ 106,449,499 $ 291,870,388 =================== =================== The accompanying notes are an integral part of these financial statements. 24
N-498th Page of 530TOC1stPreviousNextBottomJust 98th
The accompanying notes are an integral part of these financial statements. 25
N-499th Page of 530TOC1stPreviousNextBottomJust 99th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2013 [Enlarge/Download Table] OPPENHEIMER VA NEUBERGER OPPENHEIMER VA GLOBAL STRATEGIC OPPENHEIMER VA BERMAN GENESIS CORE BOND INCOME MAIN STREET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 10,997 $ 8,649 $ 4,493 $ 104,043 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Assets.................... 10,997 8,649 4,493 104,043 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 6 3 1 4 Due to MetLife Investors USA Insurance Company.............. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Liabilities............... 6 3 1 4 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 10,991 $ 8,646 $ 4,492 $ 104,039 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 10,991 $ 8,646 $ 4,492 $ 104,039 Net assets from contracts in payout.. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................ $ 10,991 $ 8,646 $ 4,492 $ 104,039 =================== ==================== =================== ==================== OPPENHEIMER VA OPPENHEIMER VA PIONEER VCT PIONEER VCT MAIN STREET SMALL MONEY DISCIPLINED VALUE EMERGING MARKETS SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 123,045,425 $ 4,008 $ 2,003,215 $ 721,676 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- -------------------- ------------------- ------------------- -------------------- Total Assets.................... 123,045,425 4,008 2,003,215 721,676 -------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 18 8 78 92 Due to MetLife Investors USA Insurance Company.............. -- -- -- 1 -------------------- ------------------- ------------------- -------------------- Total Liabilities............... 18 8 78 93 -------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 123,045,407 $ 4,000 $ 2,003,137 $ 721,583 ==================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 123,045,407 $ 4,000 $ 2,003,137 $ 721,583 Net assets from contracts in payout.. -- -- -- -- -------------------- ------------------- ------------------- -------------------- Total Net Assets................ $ 123,045,407 $ 4,000 $ 2,003,137 $ 721,583 ==================== =================== =================== ==================== PIONEER VCT PIONEER VCT IBBOTSON EQUITY INCOME GROWTH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 637,916 $ 20,842,524 Due from MetLife Investors USA Insurance Company.............. -- -- ------------------- -------------------- Total Assets.................... 637,916 20,842,524 ------------------- -------------------- LIABILITIES: Accrued fees......................... 41 55 Due to MetLife Investors USA Insurance Company.............. 1 1 ------------------- -------------------- Total Liabilities............... 42 56 ------------------- -------------------- NET ASSETS.............................. $ 637,874 $ 20,842,468 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 637,874 $ 20,842,468 Net assets from contracts in payout.. -- -- ------------------- -------------------- Total Net Assets................ $ 637,874 $ 20,842,468 =================== ==================== The accompanying notes are an integral part of these financial statements. 26
N-4100th Page of 530TOC1stPreviousNextBottomJust 100th
The accompanying notes are an integral part of these financial statements. 27
N-4101st Page of 530TOC1stPreviousNextBottomJust 101st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF ASSETS AND LIABILITIES -- (CONCLUDED) DECEMBER 31, 2013 [Enlarge/Download Table] PIONEER VCT IBBOTSON PIONEER VCT PIONEER VCT T. ROWE PRICE MODERATE ALLOCATION MID CAP VALUE REAL ESTATE SHARES GROWTH STOCK SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 30,201,108 $ 71,900,108 $ 252,718 $ 8,339,192 Due from MetLife Investors USA Insurance Company.............. -- -- -- -- --------------------- -------------------- -------------------- -------------------- Total Assets.................... 30,201,108 71,900,108 252,718 8,339,192 --------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 44 65 64 -- Due to MetLife Investors USA Insurance Company.............. 1 1 1 -- --------------------- -------------------- -------------------- -------------------- Total Liabilities............... 45 66 65 -- --------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 30,201,063 $ 71,900,042 $ 252,653 $ 8,339,192 ===================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 30,201,063 $ 71,900,042 $ 252,653 $ 8,339,192 Net assets from contracts in payout.. -- -- -- -- --------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 30,201,063 $ 71,900,042 $ 252,653 $ 8,339,192 ===================== ==================== ==================== ==================== T. ROWE PRICE T. ROWE PRICE INTERNATIONAL STOCK PRIME RESERVE UIF U.S. REAL ESTATE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 655,401 $ 558,450 $ 100,974,984 Due from MetLife Investors USA Insurance Company.............. -- -- -- --------------------- -------------------- -------------------- Total Assets.................... 655,401 558,450 100,974,984 --------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... -- -- 6 Due to MetLife Investors USA Insurance Company.............. -- 1 1 --------------------- -------------------- -------------------- Total Liabilities............... -- 1 7 --------------------- -------------------- -------------------- NET ASSETS.............................. $ 655,401 $ 558,449 $ 100,974,977 ===================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 655,401 $ 558,449 $ 100,974,977 Net assets from contracts in payout.. -- -- -- --------------------- -------------------- -------------------- Total Net Assets................ $ 655,401 $ 558,449 $ 100,974,977 ===================== ==================== ==================== The accompanying notes are an integral part of these financial statements. 28
N-4102nd Page of 530TOC1stPreviousNextBottomJust 102nd
The accompanying notes are an integral part of these financial statements. 29
N-4103rd Page of 530TOC1stPreviousNextBottomJust 103rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] AMERICAN FUNDS ALGER AMERICAN FUNDS AMERICAN FUNDS GLOBAL SMALL SMALL CAP GROWTH BOND GLOBAL GROWTH CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 2,659,639 $ 3,543,665 $ 995,290 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 795,350 1,579,860 3,369,739 1,305,682 Administrative charges............... -- 361,049 700,854 239,013 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 795,350 1,940,909 4,070,593 1,544,695 ------------------- ------------------- ------------------- ------------------- Net investment income (loss).... (795,350) 718,730 (526,928) (549,405) ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 7,752,298 1,645,084 -- -- Realized gains (losses) on sale of investments........................ 715,762 105,489 3,982,592 1,957,425 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)..... 8,468,060 1,750,573 3,982,592 1,957,425 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 8,688,799 (7,601,790) 65,109,148 25,083,432 ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 17,156,859 (5,851,217) 69,091,740 27,040,857 ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 16,361,509 $ (5,132,487) $ 68,564,812 $ 26,491,452 =================== =================== =================== =================== AMERICAN FUNDS AMERICAN FUNDS DWS I FEDERATED HIGH GROWTH GROWTH-INCOME INTERNATIONAL INCOME BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 7,336,530 $ 4,748,193 $ 924,809 $ 1,732 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 9,466,721 4,415,548 235,774 357 Administrative charges............... 1,886,375 801,868 -- -- ------------------- ------------------- ------------------- ------------------- Total expenses..................... 11,353,096 5,217,416 235,774 357 ------------------- ------------------- ------------------- ------------------- Net investment income (loss).... (4,016,566) (469,223) 689,035 1,375 ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- -- -- Realized gains (losses) on sale of investments........................ 16,990,100 6,900,940 (490,812) -- ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)..... 16,990,100 6,900,940 (490,812) -- ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 182,361,798 89,831,743 2,799,643 (4) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 199,351,898 96,732,683 2,308,831 (4) ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 195,335,332 $ 96,263,460 $ 2,997,866 $ 1,371 =================== =================== =================== =================== FEDERATED FIDELITY VIP KAUFMAN ASSET MANAGER SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 1,335,776 ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 544 1,168,826 Administrative charges............... -- -- ------------------- ------------------- Total expenses..................... 544 1,168,826 ------------------- ------------------- Net investment income (loss).... (544) 166,950 ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 3,265 207,129 Realized gains (losses) on sale of investments........................ 351 599,116 ------------------- ------------------- Net realized gains (losses)..... 3,616 806,245 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 9,524 10,480,801 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 13,140 11,287,046 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 12,596 $ 11,453,996 =================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 30
N-4104th Page of 530TOC1stPreviousNextBottomJust 104th
The accompanying notes are an integral part of these financial statements. 31
N-4105th Page of 530TOC1stPreviousNextBottomJust 105th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP CONTRAFUND EQUITY-INCOME FUNDSMANAGER 50% FUNDSMANAGER 60% SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 5,646,134 $ 139,396 $ 19,057,686 $ 44,019,083 -------------------- -------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 6,566,916 80,957 24,306,286 75,257,193 Administrative charges................ 776,610 -- -- -- -------------------- -------------------- ------------------- -------------------- Total expenses...................... 7,343,526 80,957 24,306,286 75,257,193 -------------------- -------------------- ------------------- -------------------- Net investment income (loss)..... (1,697,392) 58,439 (5,248,600) (31,238,110) -------------------- -------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 159,570 370,347 10,771,735 140,760,703 Realized gains (losses) on sale of investments......................... 11,441,688 (2,721) -- 30,399,116 -------------------- -------------------- ------------------- -------------------- Net realized gains (losses)...... 11,601,258 367,626 10,771,735 171,159,819 -------------------- -------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments...................... 130,225,189 916,971 141,257,707 435,136,185 -------------------- -------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 141,826,447 1,284,597 152,029,442 606,296,004 -------------------- -------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 140,129,055 $ 1,343,036 $ 146,780,842 $ 575,057,894 ==================== ==================== =================== ==================== FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP GROWTH INDEX 500 MID CAP MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 427,133 $ 1,208,234 $ 1,103,058 $ 19,205 ------------------- ------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 2,006,872 883,110 4,345,498 1,616,530 Administrative charges................ -- -- 973,805 -- ------------------- ------------------- -------------------- -------------------- Total expenses...................... 2,006,872 883,110 5,319,303 1,616,530 ------------------- ------------------- -------------------- -------------------- Net investment income (loss)..... (1,579,739) 325,124 (4,216,245) (1,597,325) ------------------- ------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 101,698 659,971 52,528,266 -- Realized gains (losses) on sale of investments......................... 4,010,481 2,197,984 4,049,459 -- ------------------- ------------------- -------------------- -------------------- Net realized gains (losses)...... 4,112,179 2,857,955 56,577,725 -- ------------------- ------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 41,938,391 14,178,938 61,592,202 -- ------------------- ------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 46,050,570 17,036,893 118,169,927 -- ------------------- ------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 44,470,831 $ 17,362,017 $ 113,953,682 $ (1,597,325) =================== =================== ==================== ==================== FIDELITY VIP FTVIPT FRANKLIN OVERSEAS INCOME SECURITIES SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- INVESTMENT INCOME: Dividends............................. $ 73,625 $ 17,606,923 -------------------- ------------------- EXPENSES: Mortality and expense risk charges............................. 68,590 3,108,880 Administrative charges................ -- 695,083 -------------------- ------------------- Total expenses...................... 68,590 3,803,963 -------------------- ------------------- Net investment income (loss)..... 5,035 13,802,960 -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 20,183 -- Realized gains (losses) on sale of investments......................... (8,588) 335,927 -------------------- ------------------- Net realized gains (losses)...... 11,595 335,927 -------------------- ------------------- Change in unrealized gains (losses) on investments...................... 1,380,290 18,152,582 -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments...................... 1,391,885 18,488,509 -------------------- ------------------- Net increase (decrease) in net assets resulting from operations........... $ 1,396,920 $ 32,291,469 ==================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 32
N-4106th Page of 530TOC1stPreviousNextBottomJust 106th
The accompanying notes are an integral part of these financial statements. 33
N-4107th Page of 530TOC1stPreviousNextBottomJust 107th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] FTVIPT FRANKLIN FTVIPT TEMPLETON SMALL CAP VALUE FTVIPT MUTUAL FTVIPT TEMPLETON GLOBAL BOND SECURITIES SHARES SECURITIES FOREIGN SECURITIES SECURITIES SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 1,424,165 $ 3,049,245 $ 1,970,839 $ 11,451,561 -------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 1,177,277 1,657,493 1,284,267 2,597,751 Administrative charges................ 270,995 363,180 206,977 601,822 -------------------- -------------------- -------------------- -------------------- Total expenses...................... 1,448,272 2,020,673 1,491,244 3,199,573 -------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... (24,107) 1,028,572 479,595 8,251,988 -------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 1,837,932 -- -- 2,956,639 Realized gains (losses) on sale of investments......................... 1,498,054 1,531,390 527,295 (64,028) -------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 3,335,986 1,531,390 527,295 2,892,611 -------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 28,858,586 31,136,595 14,782,128 (10,624,497) -------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 32,194,572 32,667,985 15,309,423 (7,731,886) -------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 32,170,465 $ 33,696,557 $ 15,789,018 $ 520,102 ==================== ==================== ==================== ==================== INVESCO V.I. INVESCO V.I. INVESCO V.I. INVESCO V.I. AMERICAN FRANCHISE AMERICAN VALUE CORE EQUITY EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 610 $ 474,488 $ 3,195 $ 9,000,063 -------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 2,011 918,743 3,285 6,577,931 Administrative charges................ -- 208,813 -- 1,461,723 -------------------- -------------------- -------------------- -------------------- Total expenses...................... 2,011 1,127,556 3,285 8,039,654 -------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... (1,401) (653,068) (90) 960,409 -------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... -- -- -- -- Realized gains (losses) on sale of investments......................... 4,184 1,362,452 11,977 2,646,648 -------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 4,184 1,362,452 11,977 2,646,648 -------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 44,589 21,986,708 45,509 115,194,853 -------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 48,773 23,349,160 57,486 117,841,501 -------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 47,372 $ 22,696,092 $ 57,396 $ 118,801,910 ==================== ==================== ==================== ==================== INVESCO V.I. INVESCO V.I. GLOBAL REAL ESTATE GROWTH AND INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- INVESTMENT INCOME: Dividends............................. $ 1,116,085 $ 4,261,347 -------------------- ------------------- EXPENSES: Mortality and expense risk charges............................. 307,333 3,635,879 Administrative charges................ 69,997 813,892 -------------------- ------------------- Total expenses...................... 377,330 4,449,771 -------------------- ------------------- Net investment income (loss)..... 738,755 (188,424) -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... -- 2,944,746 Realized gains (losses) on sale of investments......................... 251,182 3,020,114 -------------------- ------------------- Net realized gains (losses)...... 251,182 5,964,860 -------------------- ------------------- Change in unrealized gains (losses) on investments...................... (841,038) 81,951,879 -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments...................... (589,856) 87,916,739 -------------------- ------------------- Net increase (decrease) in net assets resulting from operations........... $ 148,899 $ 87,728,315 ==================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 34
N-4108th Page of 530TOC1stPreviousNextBottomJust 108th
The accompanying notes are an integral part of these financial statements. 35
N-4109th Page of 530TOC1stPreviousNextBottomJust 109th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] LMPVET LMPVET INVESCO V.I. JANUS ASPEN CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE INTERNATIONAL GROWTH GLOBAL RESEARCH AGGRESSIVE GROWTH ALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 2,742,141 $ 73 $ 671,833 $ 1,655,948 -------------------- ------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 2,753,046 52 2,809,619 1,394,363 Administrative charges............... 625,200 -- 590,305 295,950 -------------------- ------------------- -------------------- -------------------- Total expenses..................... 3,378,246 52 3,399,924 1,690,313 -------------------- ------------------- -------------------- -------------------- Net investment income (loss)..... (636,105) 21 (2,728,091) (34,365) -------------------- ------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- 12,904,072 8,706,055 Realized gains (losses) on sale of investments........................ 1,305,822 120 4,957,428 1,486,711 -------------------- ------------------- -------------------- -------------------- Net realized gains (losses)...... 1,305,822 120 17,861,500 10,192,766 -------------------- ------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... 40,017,340 1,329 71,695,365 20,675,928 -------------------- ------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 41,323,162 1,449 89,556,865 30,868,694 -------------------- ------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 40,687,057 $ 1,470 $ 86,828,774 $ 30,834,329 ==================== =================== ==================== ==================== LMPVET LMPVET LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE APPRECIATION EQUITY INCOME LARGE CAP GROWTH LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 4,560,501 $ 2,745,187 $ 23,290 $ 103,406 -------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 4,021,644 1,903,271 70,000 87,700 Administrative charges............... 879,646 414,431 11,460 14,558 -------------------- -------------------- -------------------- -------------------- Total expenses..................... 4,901,290 2,317,702 81,460 102,258 -------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... (340,789) 427,485 (58,170) 1,148 -------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 12,586,231 -- 491,394 307,920 Realized gains (losses) on sale of investments........................ 1,266,391 646,901 254,029 158,693 -------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 13,852,622 646,901 745,423 466,613 -------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... 72,638,328 33,452,314 710,461 1,056,824 -------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 86,490,950 34,099,215 1,455,884 1,523,437 -------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 86,150,161 $ 34,526,700 $ 1,397,714 $ 1,524,585 ==================== ==================== ==================== ==================== LMPVET LMPVET INVESTMENT CLEARBRIDGE VARIABLE COUNSEL VARIABLE SMALL CAP GROWTH SOCIAL AWARENESS SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 40,622 $ 2,393 -------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 1,051,901 3,889 Administrative charges............... 224,160 717 -------------------- ------------------- Total expenses..................... 1,276,061 4,606 -------------------- ------------------- Net investment income (loss)..... (1,235,439) (2,213) -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 7,305,832 -- Realized gains (losses) on sale of investments........................ 1,558,761 8,209 -------------------- ------------------- Net realized gains (losses)...... 8,864,593 8,209 -------------------- ------------------- Change in unrealized gains (losses) on investments..................... 24,881,277 39,556 -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 33,745,870 47,765 -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 32,510,431 $ 45,552 ==================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 36
N-4110th Page of 530TOC1stPreviousNextBottomJust 110th
The accompanying notes are an integral part of these financial statements. 37
N-4111th Page of 530TOC1stPreviousNextBottomJust 111th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] LMPVET LMPVET LMPVET LMPVIT WESTERN VARIABLE LIFESTYLE VARIABLE LIFESTYLE VARIABLE LIFESTYLE ASSET VARIABLE GLOBAL ALLOCATION 50% ALLOCATION 70% ALLOCATION 85% HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- --------------------- INVESTMENT INCOME: Dividends............................ $ 873,351 $ 36,589 $ 1,460,852 $ 6,179,424 -------------------- ------------------- -------------------- --------------------- EXPENSES: Mortality and expense risk charges............................ 438,782 35,306 975,746 1,175,968 Administrative charges............... 98,604 6,498 219,274 249,397 -------------------- ------------------- -------------------- --------------------- Total expenses..................... 537,386 41,804 1,195,020 1,425,365 -------------------- ------------------- -------------------- --------------------- Net investment income (loss).... 335,965 (5,215) 265,832 4,754,059 -------------------- ------------------- -------------------- --------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- -- -- Realized gains (losses) on sale of investments........................ 294,643 164,204 1,739,917 97,460 -------------------- ------------------- -------------------- --------------------- Net realized gains (losses)..... 294,643 164,204 1,739,917 97,460 -------------------- ------------------- -------------------- --------------------- Change in unrealized gains (losses) on investments..................... 4,402,903 307,412 17,385,552 (303,455) -------------------- ------------------- -------------------- --------------------- Net realized and change in unrealized gains (losses) on investments..................... 4,697,546 471,616 19,125,469 (205,995) -------------------- ------------------- -------------------- --------------------- Net increase (decrease) in net assets resulting from operations.......... $ 5,033,511 $ 466,401 $ 19,391,301 $ 4,548,064 ==================== =================== ==================== ===================== MIST ALLIANCEBERNSTEIN MFS VIT MFS VIT GLOBAL DYNAMIC INVESTORS TRUST NEW DISCOVERY MFS VIT RESEARCH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 254 $ -- $ 188 $ 39,779,815 ------------------- -------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 323 581 798 36,599,907 Administrative charges............... -- -- -- 7,790,779 ------------------- -------------------- ------------------- -------------------- Total expenses..................... 323 581 798 44,390,686 ------------------- -------------------- ------------------- -------------------- Net investment income (loss).... (69) (581) (610) (4,610,871) ------------------- -------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 326 140 66,116,796 Realized gains (losses) on sale of investments........................ 292 1,680 993 6,931,021 ------------------- -------------------- ------------------- -------------------- Net realized gains (losses)..... 292 2,006 1,133 73,047,817 ------------------- -------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 5,877 12,769 14,560 213,779,983 ------------------- -------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 6,169 14,775 15,693 286,827,800 ------------------- -------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 6,100 $ 14,194 $ 15,083 $ 282,216,929 =================== ==================== =================== ==================== MIST AMERICAN MIST AMERICAN FUNDS BALANCED FUNDS GROWTH ALLOCATION ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 45,063,018 $ 16,505,934 ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 42,252,390 21,762,771 Administrative charges............... 8,199,489 4,137,682 ------------------- -------------------- Total expenses..................... 50,451,879 25,900,453 ------------------- -------------------- Net investment income (loss).... (5,388,861) (9,394,519) ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 202,636,315 91,077,385 Realized gains (losses) on sale of investments........................ 47,989,589 30,207,659 ------------------- -------------------- Net realized gains (losses)..... 250,625,904 121,285,044 ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 260,897,780 233,109,626 ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 511,523,684 354,394,670 ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 506,134,823 $ 345,000,151 =================== ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 38
N-4112th Page of 530TOC1stPreviousNextBottomJust 112th
The accompanying notes are an integral part of these financial statements. 39
N-4113th Page of 530TOC1stPreviousNextBottomJust 113th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MIST AMERICAN MIST AQR MIST BLACKROCK MIST AMERICAN FUNDS MODERATE GLOBAL RISK GLOBAL TACTICAL FUNDS GROWTH ALLOCATION BALANCED STRATEGIES SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 2,634,418 $ 29,195,296 $ 77,169,328 $ 71,277,628 ------------------- -------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 7,671,883 22,758,412 43,469,807 61,766,852 Administrative charges............... 1,480,530 4,420,275 9,245,161 13,128,334 ------------------- -------------------- ------------------- ------------------- Total expenses..................... 9,152,413 27,178,687 52,714,968 74,895,186 ------------------- -------------------- ------------------- ------------------- Net investment income (loss)..... (6,517,995) 2,016,609 24,454,360 (3,617,558) ------------------- -------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 29,294,729 96,296,087 143,800,114 115,215,891 Realized gains (losses) on sale of investments........................ 26,472,567 23,672,085 (12,389,834) 18,039,686 ------------------- -------------------- ------------------- ------------------- Net realized gains (losses)...... 55,767,296 119,968,172 131,410,280 133,255,577 ------------------- -------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 96,031,643 74,888,275 (347,099,092) 311,060,284 ------------------- -------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 151,798,939 194,856,447 (215,688,812) 444,315,861 ------------------- -------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 145,280,944 $ 196,873,056 $ (191,234,452) $ 440,698,303 =================== ==================== =================== =================== MIST BLACKROCK MIST BLACKROCK MIST CLARION MIST CLEARBRIDGE HIGH YIELD LARGE CAP CORE GLOBAL REAL ESTATE AGGRESSIVE GROWTH II SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 18,834,222 $ 200,349 $ 12,947,679 $ 651,867 ------------------- ------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 3,567,603 231,165 2,622,102 1,400,541 Administrative charges............... 670,423 38,903 472,278 257,443 ------------------- ------------------- -------------------- -------------------- Total expenses..................... 4,238,026 270,068 3,094,380 1,657,984 ------------------- ------------------- -------------------- -------------------- Net investment income (loss)..... 14,596,196 (69,719) 9,853,299 (1,006,117) ------------------- ------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 7,625,640 -- -- -- Realized gains (losses) on sale of investments........................ 2,016,699 843,040 (92,999) 5,873,060 ------------------- ------------------- -------------------- -------------------- Net realized gains (losses)...... 9,642,339 843,040 (92,999) 5,873,060 ------------------- ------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... (4,631,091) 3,552,916 (6,455,197) 19,911,595 ------------------- ------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 5,011,248 4,395,956 (6,548,196) 25,784,655 ------------------- ------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 19,607,444 $ 4,326,237 $ 3,305,103 $ 24,778,538 =================== =================== ==================== ==================== MIST CLEARBRIDGE MIST GOLDMAN SACHS AGGRESSIVE GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 804,033 $ 1,444,830 ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 4,918,827 2,210,823 Administrative charges............... 924,636 407,162 ------------------- -------------------- Total expenses..................... 5,843,463 2,617,985 ------------------- -------------------- Net investment income (loss)..... (5,039,430) (1,173,155) ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 5,739,462 Realized gains (losses) on sale of investments........................ 11,473,473 6,273,913 ------------------- -------------------- Net realized gains (losses)...... 11,473,473 12,013,375 ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 123,052,679 31,704,368 ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 134,526,152 43,717,743 ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 129,486,722 $ 42,544,588 =================== ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 40
N-4114th Page of 530TOC1stPreviousNextBottomJust 114th
The accompanying notes are an integral part of these financial statements. 41
N-4115th Page of 530TOC1stPreviousNextBottomJust 115th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MIST MIST INVESCO HARRIS OAKMARK BALANCED-RISK MIST INVESCO MIST INVESCO INTERNATIONAL ALLOCATION COMSTOCK MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------ ------------------- INVESTMENT INCOME: Dividends............................ $ 14,919,166 $ -- $ 4,115,774 $ 1,107,426 ------------------- ------------------- ------------------ ------------------- EXPENSES: Mortality and expense risk charges............................ 8,192,161 9,997,790 4,825,998 2,046,225 Administrative charges............... 1,525,990 2,160,902 964,548 375,754 ------------------- ------------------- ------------------ ------------------- Total expenses..................... 9,718,151 12,158,692 5,790,546 2,421,979 ------------------- ------------------- ------------------ ------------------- Net investment income (loss)..... 5,201,015 (12,158,692) (1,674,772) (1,314,553) ------------------- ------------------- ------------------ ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 8,370,113 -- -- Realized gains (losses) on sale of investments........................ 11,702,177 1,706,902 9,703,108 7,722,920 ------------------- ------------------- ------------------ ------------------- Net realized gains (losses)...... 11,702,177 10,077,015 9,703,108 7,722,920 ------------------- ------------------- ------------------ ------------------- Change in unrealized gains (losses) on investments..................... 134,182,838 4,078,692 101,696,056 30,620,411 ------------------- ------------------- ------------------ ------------------- Net realized and change in unrealized gains (losses) on investments..................... 145,885,015 14,155,707 111,399,164 38,343,331 ------------------- ------------------- ------------------ ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 151,086,030 $ 1,997,015 $ 109,724,392 $ 37,028,778 =================== =================== ================== =================== MIST JPMORGAN MIST INVESCO MIST JPMORGAN GLOBAL ACTIVE MIST JPMORGAN SMALL CAP GROWTH CORE BOND ALLOCATION SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------ ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 622,860 $ 920,373 $ 402,891 $ 180,697 ------------------- ------------------ ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 3,613,388 4,330,629 6,013,719 395,814 Administrative charges............... 684,045 828,654 1,323,733 65,410 ------------------- ------------------ ------------------- ------------------- Total expenses..................... 4,297,433 5,159,283 7,337,452 461,224 ------------------- ------------------ ------------------- ------------------- Net investment income (loss)..... (3,674,573) (4,238,910) (6,934,561) (280,527) ------------------- ------------------ ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 15,858,644 1,446,300 2,377,058 -- Realized gains (losses) on sale of investments........................ 8,726,778 23,440,529 52,966 1,241,336 ------------------- ------------------ ------------------- ------------------- Net realized gains (losses)...... 24,585,422 24,886,829 2,430,024 1,241,336 ------------------- ------------------ ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 67,501,884 (36,171,178) 53,369,009 6,048,540 ------------------- ------------------ ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 92,087,306 (11,284,349) 55,799,033 7,289,876 ------------------- ------------------ ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 88,412,733 $ (15,523,259) $ 48,864,472 $ 7,009,349 =================== ================== =================== =================== MIST LOOMIS SAYLES MIST LORD ABBETT GLOBAL MARKETS BOND DEBENTURE SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 4,375,048 $ 17,189,255 ------------------- ------------------ EXPENSES: Mortality and expense risk charges............................ 2,402,291 3,595,505 Administrative charges............... 452,881 629,148 ------------------- ------------------ Total expenses..................... 2,855,172 4,224,653 ------------------- ------------------ Net investment income (loss)..... 1,519,876 12,964,602 ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- Realized gains (losses) on sale of investments........................ 5,872,725 4,166,635 ------------------- ------------------ Net realized gains (losses)...... 5,872,725 4,166,635 ------------------- ------------------ Change in unrealized gains (losses) on investments..................... 18,236,473 (1,363,498) ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... 24,109,198 2,803,137 ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ 25,629,074 $ 15,767,739 =================== ================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 42
N-4116th Page of 530TOC1stPreviousNextBottomJust 116th
The accompanying notes are an integral part of these financial statements. 43
N-4117th Page of 530TOC1stPreviousNextBottomJust 117th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MIST MIST MET/FRANKLIN MET/EATON VANCE LOW DURATION MIST MET/TEMPLETON MIST METLIFE FLOATING RATE TOTAL RETURN INTERNATIONAL BOND AGGRESSIVE STRATEGY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 2,232,948 $ 893,838 $ 1,133,225 $ 4,474,444 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 900,105 1,094,957 716,202 8,137,841 Administrative charges............... 164,980 208,094 140,116 1,499,478 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 1,065,085 1,303,051 856,318 9,637,319 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... 1,167,863 (409,213) 276,907 (5,162,875) ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 265,827 -- 255,578 -- Realized gains (losses) on sale of investments........................ 105,627 31,429 (156,759) 8,803,988 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 371,454 31,429 98,819 8,803,988 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (202,111) 351,282 (752,953) 141,558,132 ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 169,343 382,711 (654,134) 150,362,120 ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 1,337,206 $ (26,502) $ (377,227) $ 145,199,245 =================== =================== =================== =================== MIST METLIFE MIST METLIFE MIST METLIFE MIST METLIFE BALANCED PLUS BALANCED STRATEGY DEFENSIVE STRATEGY GROWTH STRATEGY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 65,671,911 $ 149,909,646 $ 65,562,565 $ 84,984,230 ------------------- ------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 64,042,950 99,177,562 28,901,690 82,512,768 Administrative charges............... 13,798,627 18,629,342 5,413,398 15,126,933 ------------------- ------------------- ------------------- -------------------- Total expenses..................... 77,841,577 117,806,904 34,315,088 97,639,701 ------------------- ------------------- ------------------- -------------------- Net investment income (loss)..... (12,169,666) 32,102,742 31,247,477 (12,655,471) ------------------- ------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 106,085,395 -- 53,092,452 -- Realized gains (losses) on sale of investments........................ 3,300,639 83,827,637 61,751,261 48,996,687 ------------------- ------------------- ------------------- -------------------- Net realized gains (losses)...... 109,386,034 83,827,637 114,843,713 48,996,687 ------------------- ------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 560,925,735 1,085,370,764 8,150,548 1,250,387,461 ------------------- ------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 670,311,769 1,169,198,401 122,994,261 1,299,384,148 ------------------- ------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 658,142,103 $ 1,201,301,143 $ 154,241,738 $ 1,286,728,677 =================== =================== =================== ==================== MIST METLIFE MIST METLIFE MULTI-INDEX MODERATE STRATEGY TARGETED RISK SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 84,759,182 $ 471,631 ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 47,260,820 956,800 Administrative charges............... 8,890,601 213,949 ------------------- ------------------- Total expenses..................... 56,151,421 1,170,749 ------------------- ------------------- Net investment income (loss)..... 28,607,761 (699,118) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 6,497,219 3,615,891 Realized gains (losses) on sale of investments........................ 54,428,069 1,196 ------------------- ------------------- Net realized gains (losses)...... 60,925,288 3,617,087 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 327,287,238 7,257,662 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 388,212,526 10,874,749 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 416,820,287 $ 10,175,631 =================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 44
N-4118th Page of 530TOC1stPreviousNextBottomJust 118th
The accompanying notes are an integral part of these financial statements. 45
N-4119th Page of 530TOC1stPreviousNextBottomJust 119th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MIST MIST MFS EMERGING MFS RESEARCH MIST MORGAN STANLEY MIST OPPENHEIMER MARKETS EQUITY INTERNATIONAL MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 4,811,505 $ 8,275,334 $ 1,254,825 $ 190,049 ------------------- ------------------- ------------------- ------------------ EXPENSES: Mortality and expense risk charges............................ 5,795,261 4,320,197 2,442,024 579,669 Administrative charges............... 1,119,941 773,166 509,321 133,512 ------------------- ------------------- ------------------- ------------------ Total expenses..................... 6,915,202 5,093,363 2,951,345 713,181 ------------------- ------------------- ------------------- ------------------ Net investment income (loss)..... (2,103,697) 3,181,971 (1,696,520) (523,132) ------------------- ------------------- ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- -- -- Realized gains (losses) on sale of investments........................ 1,835,792 522,322 2,455,142 471,553 ------------------- ------------------- ------------------- ------------------ Net realized gains (losses)...... 1,835,792 522,322 2,455,142 471,553 ------------------- ------------------- ------------------- ------------------ Change in unrealized gains (losses) on investments..................... (28,154,915) 47,772,611 64,718,433 11,622,690 ------------------- ------------------- ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... (26,319,123) 48,294,933 67,173,575 12,094,243 ------------------- ------------------- ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ (28,422,820) $ 51,476,904 $ 65,477,055 $ 11,571,111 =================== =================== =================== ================== MIST PIMCO INFLATION MIST PIMCO MIST MIST PIONEER PROTECTED BOND TOTAL RETURN PIONEER FUND STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 20,321,139 $ 90,299,548 $ 8,345,878 $ 42,197,941 ------------------ ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 12,353,026 27,924,331 3,001,470 9,905,068 Administrative charges............... 2,311,558 5,148,777 661,711 2,187,565 ------------------ ------------------- ------------------- ------------------- Total expenses..................... 14,664,584 33,073,108 3,663,181 12,092,633 ------------------ ------------------- ------------------- ------------------- Net investment income (loss)..... 5,656,555 57,226,440 4,682,697 30,105,308 ------------------ ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 54,275,448 41,946,555 -- 2,413,486 Realized gains (losses) on sale of investments........................ (9,555,213) 338,113 4,614,621 934,646 ------------------ ------------------- ------------------- ------------------- Net realized gains (losses)...... 44,720,235 42,284,668 4,614,621 3,348,132 ------------------ ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (156,230,192) (175,186,613) 61,555,660 (32,752,219) ------------------ ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (111,509,957) (132,901,945) 66,170,281 (29,404,087) ------------------ ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ (105,853,402) $ (75,675,505) $ 70,852,978 $ 701,221 ================== =================== =================== =================== MIST PYRAMIS MIST PYRAMIS GOVERNMENT INCOME MANAGED RISK SUB-ACCOUNT SUB-ACCOUNT (a) ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 13,071,961 $ 598,784 ------------------- ------------------ EXPENSES: Mortality and expense risk charges............................ 9,769,937 286,383 Administrative charges............... 2,114,851 60,668 ------------------- ------------------ Total expenses..................... 11,884,788 347,051 ------------------- ------------------ Net investment income (loss)..... 1,187,173 251,733 ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 8,128,079 1,341,853 Realized gains (losses) on sale of investments........................ (5,369,602) (10,897) ------------------- ------------------ Net realized gains (losses)...... 2,758,477 1,330,956 ------------------- ------------------ Change in unrealized gains (losses) on investments..................... (56,847,411) 1,889,489 ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... (54,088,934) 3,220,445 ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ (52,901,761) $ 3,472,178 =================== ================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 46
N-4120th Page of 530TOC1stPreviousNextBottomJust 120th
The accompanying notes are an integral part of these financial statements. 47
N-4121st Page of 530TOC1stPreviousNextBottomJust 121st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MIST SCHRODERS MIST SSGA GROWTH MIST SSGA MIST T. ROWE PRICE GLOBAL MULTI-ASSET AND INCOME ETF GROWTH ETF LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 27,512 $ 38,910,462 $ 10,135,199 $ 9,703,207 -------------------- ------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 3,965,836 19,625,254 6,213,087 8,330,375 Administrative charges............... 856,921 3,878,354 1,204,388 1,098,308 -------------------- ------------------- -------------------- ------------------- Total expenses..................... 4,822,757 23,503,608 7,417,475 9,428,683 -------------------- ------------------- -------------------- ------------------- Net investment income (loss).... (4,795,245) 15,406,854 2,717,724 274,524 -------------------- ------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 1,183,030 36,548,485 17,541,690 -- Realized gains (losses) on sale of investments........................ 896,710 20,251,017 7,845,129 12,380,070 -------------------- ------------------- -------------------- ------------------- Net realized gains (losses)..... 2,079,740 56,799,502 25,386,819 12,380,070 -------------------- ------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... 31,029,531 92,923,301 44,458,197 154,938,541 -------------------- ------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 33,109,271 149,722,803 69,845,016 167,318,611 -------------------- ------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 28,314,026 $ 165,129,657 $ 72,562,740 $ 167,593,135 ==================== =================== ==================== =================== MIST T. ROWE PRICE MIST THIRD AVENUE MSF BAILLIE GIFFORD MSF BARCLAYS MID CAP GROWTH SMALL CAP VALUE INTERNATIONAL STOCK AGGREGATE BOND INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 1,085,760 $ 3,116,142 $ 35,486 $ 5,044,056 ------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 6,995,212 4,315,721 2,684,850 1,989,879 Administrative charges............... 1,307,457 772,929 516,484 370,173 ------------------- -------------------- -------------------- -------------------- Total expenses..................... 8,302,669 5,088,650 3,201,334 2,360,052 ------------------- -------------------- -------------------- -------------------- Net investment income (loss).... (7,216,909) (1,972,508) (3,165,848) 2,684,004 ------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 27,440,112 -- -- -- Realized gains (losses) on sale of investments........................ 16,686,809 14,422,998 1,385,436 (145,067) ------------------- -------------------- -------------------- -------------------- Net realized gains (losses)..... 44,126,921 14,422,998 1,385,436 (145,067) ------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... 116,792,789 71,078,415 31,198,214 (8,883,122) ------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 160,919,710 85,501,413 32,583,650 (9,028,189) ------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 153,702,801 $ 83,528,905 $ 29,417,802 $ (6,344,185) =================== ==================== ==================== ==================== MSF BLACKROCK MSF BLACKROCK BOND INCOME CAPITAL APPRECIATION SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 2,225,070 $ 106,239 ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 836,982 189,165 Administrative charges............... 131,860 29,512 ------------------- -------------------- Total expenses..................... 968,842 218,677 ------------------- -------------------- Net investment income (loss).... 1,256,228 (112,438) ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 1,413,627 -- Realized gains (losses) on sale of investments........................ 102,228 691,188 ------------------- -------------------- Net realized gains (losses)..... 1,515,855 691,188 ------------------- -------------------- Change in unrealized gains (losses) on investments..................... (4,322,733) 3,229,055 ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... (2,806,878) 3,920,243 ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ (1,550,650) $ 3,807,805 =================== ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 48
N-4122nd Page of 530TOC1stPreviousNextBottomJust 122nd
The accompanying notes are an integral part of these financial statements. 49
N-4123rd Page of 530TOC1stPreviousNextBottomJust 123rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MSF BLACKROCK MSF BLACKROCK MSF DAVIS MSF FRONTIER LARGE CAP VALUE MONEY MARKET VENTURE VALUE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (a) ------------------- ------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 47,745 $ -- $ 7,934,120 $ -- ------------------- ------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 45,976 6,753,002 8,428,727 758,287 Administrative charges............... -- 1,259,595 1,529,806 139,504 ------------------- ------------------- ------------------- -------------------- Total expenses..................... 45,976 8,012,597 9,958,533 897,791 ------------------- ------------------- ------------------- -------------------- Net investment income (loss).... 1,769 (8,012,597) (2,024,413) (897,791) ------------------- ------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 184,594 -- 10,467,525 -- Realized gains (losses) on sale of investments........................ 11,833 -- 30,055,792 1,222,819 ------------------- ------------------- ------------------- -------------------- Net realized gains (losses)..... 196,427 -- 40,523,317 1,222,819 ------------------- ------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 706,190 -- 130,538,788 14,503,587 ------------------- ------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 902,617 -- 171,062,105 15,726,406 ------------------- ------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 904,386 $ (8,012,597) $ 169,037,692 $ 14,828,615 =================== =================== =================== ==================== MSF MSF LOOMIS SAYLES MSF LOOMIS SAYLES MSF MET/ARTISAN JENNISON GROWTH SMALL CAP CORE SMALL CAP GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 1,077,074 $ 30,285 $ -- $ 1,930,028 ------------------- ------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 7,117,305 197,320 1,128 3,423,728 Administrative charges............... 1,294,771 33,017 283 587,956 ------------------- ------------------- ------------------- -------------------- Total expenses..................... 8,412,076 230,337 1,411 4,011,684 ------------------- ------------------- ------------------- -------------------- Net investment income (loss).... (7,335,002) (200,052) (1,411) (2,081,656) ------------------- ------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 5,112,106 1,002,384 -- -- Realized gains (losses) on sale of investments........................ 15,187,756 980,613 10,812 2,704,503 ------------------- ------------------- ------------------- -------------------- Net realized gains (losses)..... 20,299,862 1,982,997 10,812 2,704,503 ------------------- ------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 145,943,839 2,464,698 37,804 71,939,639 ------------------- ------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 166,243,701 4,447,695 48,616 74,644,142 ------------------- ------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 158,908,699 $ 4,247,643 $ 47,205 $ 72,562,486 =================== =================== =================== ==================== MSF MET/DIMENSIONAL MSF METLIFE INTERNATIONAL SMALL CONSERVATIVE COMPANY ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 1,008,312 $ 279,202 ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 786,753 132,606 Administrative charges............... 146,029 22,998 ------------------- ------------------- Total expenses..................... 932,782 155,604 ------------------- ------------------- Net investment income (loss).... 75,530 123,598 ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 1,576,427 45,703 Realized gains (losses) on sale of investments........................ 477,444 278,592 ------------------- ------------------- Net realized gains (losses)..... 2,053,871 324,295 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 11,472,763 (227,599) ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 13,526,634 96,696 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 13,602,164 $ 220,294 =================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 50
N-4124th Page of 530TOC1stPreviousNextBottomJust 124th
The accompanying notes are an integral part of these financial statements. 51
N-4125th Page of 530TOC1stPreviousNextBottomJust 125th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MSF METLIFE MSF METLIFE CONSERVATIVE TO MSF METLIFE MSF METLIFE MODERATE TO MODERATE ALLOCATION MID CAP STOCK INDEX MODERATE ALLOCATION AGGRESSIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- --------------------- INVESTMENT INCOME: Dividends............................ $ 192,977 $ 1,146,951 $ 854,751 $ 798,260 -------------------- ------------------- -------------------- --------------------- EXPENSES: Mortality and expense risk charges............................ 113,772 1,500,758 636,285 809,065 Administrative charges............... 19,027 212,206 107,040 136,956 -------------------- ------------------- -------------------- --------------------- Total expenses..................... 132,799 1,712,964 743,325 946,021 -------------------- ------------------- -------------------- --------------------- Net investment income (loss).... 60,178 (566,013) 111,426 (147,761) -------------------- ------------------- -------------------- --------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 79,641 3,264,955 348,738 -- Realized gains (losses) on sale of investments........................ 126,022 3,699,798 670,193 927,158 -------------------- ------------------- -------------------- --------------------- Net realized gains (losses)..... 205,663 6,964,753 1,018,931 927,158 -------------------- ------------------- -------------------- --------------------- Change in unrealized gains (losses) on investments..................... 395,866 23,599,476 5,244,250 10,180,246 -------------------- ------------------- -------------------- --------------------- Net realized and change in unrealized gains (losses) on investments..................... 601,529 30,564,229 6,263,181 11,107,404 -------------------- ------------------- -------------------- --------------------- Net increase (decrease) in net assets resulting from operations.......... $ 661,707 $ 29,998,216 $ 6,374,607 $ 10,959,643 ==================== =================== ==================== ===================== MSF METLIFE MSF MSF MSF MSCI STOCK INDEX MFS TOTAL RETURN MFS VALUE EAFE INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 8,570,152 $ 938,479 $ 1,008,807 $ 2,867,071 ------------------- -------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 7,336,639 565,222 2,492,653 1,277,623 Administrative charges............... 1,106,897 75,767 436,300 200,820 ------------------- -------------------- ------------------- -------------------- Total expenses..................... 8,443,536 640,989 2,928,953 1,478,443 ------------------- -------------------- ------------------- -------------------- Net investment income (loss).... 126,616 297,490 (1,920,146) 1,388,628 ------------------- -------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 7,693,711 -- 1,722,437 -- Realized gains (losses) on sale of investments........................ 15,797,044 439,651 3,468,253 1,008,944 ------------------- -------------------- ------------------- -------------------- Net realized gains (losses)..... 23,490,755 439,651 5,190,690 1,008,944 ------------------- -------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 106,939,595 5,520,960 43,048,658 15,456,919 ------------------- -------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 130,430,350 5,960,611 48,239,348 16,465,863 ------------------- -------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 130,556,966 $ 6,258,101 $ 46,319,202 $ 17,854,491 =================== ==================== =================== ==================== MSF NEUBERGER MSF BERMAN GENESIS RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 108,234 $ 1,470,662 ------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 1,557,555 1,497,893 Administrative charges............... 252,687 252,496 ------------------- ------------------- Total expenses..................... 1,810,242 1,750,389 ------------------- ------------------- Net investment income (loss).... (1,702,008) (279,727) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- Realized gains (losses) on sale of investments........................ 2,307,614 2,980,519 ------------------- ------------------- Net realized gains (losses)..... 2,307,614 2,980,519 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 36,584,374 32,072,788 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 38,891,988 35,053,307 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 37,189,980 $ 34,773,580 =================== =================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 52
N-4126th Page of 530TOC1stPreviousNextBottomJust 126th
The accompanying notes are an integral part of these financial statements. 53
N-4127th Page of 530TOC1stPreviousNextBottomJust 127th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] MSF VAN ECK MSF WESTERN ASSET MSF T. ROWE PRICE MSF T. ROWE PRICE GLOBAL NATURAL MANAGEMENT LARGE CAP GROWTH SMALL CAP GROWTH RESOURCES U.S. GOVERNMENT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 1,258 $ 19,657 $ 747,749 $ 5,946,946 -------------------- ------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 1,153,862 125,872 1,458,759 3,638,967 Administrative charges............... 208,703 12,195 281,714 760,986 -------------------- ------------------- ------------------- -------------------- Total expenses..................... 1,362,565 138,067 1,740,473 4,399,953 -------------------- ------------------- ------------------- -------------------- Net investment income (loss).... (1,361,307) (118,410) (992,724) 1,546,993 -------------------- ------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 476,803 -- -- Realized gains (losses) on sale of investments........................ 1,274,164 713,962 (2,668,683) 12,769 -------------------- ------------------- ------------------- -------------------- Net realized gains (losses)..... 1,274,164 1,190,765 (2,668,683) 12,769 -------------------- ------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 29,734,972 2,047,671 13,797,608 (8,825,000) -------------------- ------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 31,009,136 3,238,436 11,128,925 (8,812,231) -------------------- ------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 29,647,829 $ 3,120,026 $ 10,136,201 $ (7,265,238) ==================== =================== =================== ==================== OPPENHEIMER VA NEUBERGER OPPENHEIMER VA GLOBAL STRATEGIC OPPENHEIMER VA BERMAN GENESIS CORE BOND INCOME MAIN STREET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 30 $ 459 $ 226 $ 1,023 -------------------- ------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk charges............................ 83 124 62 1,303 Administrative charges............... -- -- -- -- -------------------- ------------------- -------------------- ------------------- Total expenses..................... 83 124 62 1,303 -------------------- ------------------- -------------------- ------------------- Net investment income (loss).... (53) 335 164 (280) -------------------- ------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 714 -- -- -- Realized gains (losses) on sale of investments........................ 35 (126) 8 1,403 -------------------- ------------------- -------------------- ------------------- Net realized gains (losses)..... 749 (126) 8 1,403 -------------------- ------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... 2,197 (342) (240) 23,373 -------------------- ------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 2,946 (468) (232) 24,776 -------------------- ------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 2,893 $ (133) $ (68) $ 24,496 ==================== =================== ==================== =================== OPPENHEIMER VA MAIN STREET OPPENHEIMER VA SMALL CAP MONEY SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 782,829 $ 1 ------------------- -------------------- EXPENSES: Mortality and expense risk charges............................ 1,229,635 103 Administrative charges............... 278,491 -- ------------------- -------------------- Total expenses..................... 1,508,126 103 ------------------- -------------------- Net investment income (loss).... (725,297) (102) ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 1,350,984 -- Realized gains (losses) on sale of investments........................ 4,979,504 -- ------------------- -------------------- Net realized gains (losses)..... 6,330,488 -- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... 30,298,071 -- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 36,628,559 -- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 35,903,262 $ (102) =================== ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 54
N-4128th Page of 530TOC1stPreviousNextBottomJust 128th
The accompanying notes are an integral part of these financial statements. 55
N-4129th Page of 530TOC1stPreviousNextBottomJust 129th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] PIONEER VCT PIONEER VCT PIONEER VCT DISCIPLINED VALUE EMERGING MARKETS EQUITY INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 33,900 $ 6,728 $ 13,722 -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 26,992 9,857 8,766 Administrative charges................ 5,310 1,825 1,488 -------------------- -------------------- -------------------- Total expenses...................... 32,302 11,682 10,254 -------------------- -------------------- -------------------- Net investment income (loss)..... 1,598 (4,954) 3,468 -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 92,595 -- -- Realized gains (losses) on sale of investments......................... 192,052 (140) 17,885 -------------------- -------------------- -------------------- Net realized gains (losses)...... 284,647 (140) 17,885 -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 226,657 (21,981) 119,241 -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 511,304 (22,121) 137,126 -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 512,902 $ (27,075) $ 140,594 ==================== ==================== ==================== PIONEER VCT IBBOTSON PIONEER VCT IBBOTSON PIONEER VCT GROWTH ALLOCATION MODERATE ALLOCATION MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 347,071 $ 683,149 $ 485,690 --------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 275,205 380,909 744,843 Administrative charges................ 49,137 73,997 163,063 --------------------- -------------------- -------------------- Total expenses...................... 324,342 454,906 907,906 --------------------- -------------------- -------------------- Net investment income (loss)..... 22,729 228,243 (422,216) --------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... -- -- -- Realized gains (losses) on sale of investments......................... 774,226 856,488 856,609 --------------------- -------------------- -------------------- Net realized gains (losses)...... 774,226 856,488 856,609 --------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 2,367,042 2,920,605 16,961,029 --------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 3,141,268 3,777,093 17,817,638 --------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 3,163,997 $ 4,005,336 $ 17,395,422 ===================== ==================== ==================== PIONEER VCT T. ROWE PRICE T. ROWE PRICE T. ROWE PRICE REAL ESTATE SHARES GROWTH STOCK INTERNATIONAL STOCK PRIME RESERVE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 5,332 $ 3,193 $ 6,278 $ 90 -------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk charges............................. 3,363 64,013 5,775 6,429 Administrative charges................ 610 -- -- -- -------------------- -------------------- -------------------- -------------------- Total expenses...................... 3,973 64,013 5,775 6,429 -------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... 1,359 (60,820) 503 (6,339) -------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 11,293 -- -- -- Realized gains (losses) on sale of investments......................... 6,764 357,589 10,324 -- -------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 18,057 357,589 10,324 -- -------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... (19,131) 2,047,793 71,247 -- -------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... (1,074) 2,405,382 81,571 -- -------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 285 $ 2,344,562 $ 82,074 $ (6,339) ==================== ==================== ==================== ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 56
N-4130th Page of 530TOC1stPreviousNextBottomJust 130th
The accompanying notes are an integral part of these financial statements. 57
N-4131st Page of 530TOC1stPreviousNextBottomJust 131st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF OPERATIONS -- (CONCLUDED) FOR THE YEAR ENDED DECEMBER 31, 2013 [Enlarge/Download Table] UIF U.S. REAL ESTATE SUB-ACCOUNT -------------------- INVESTMENT INCOME: Dividends.............................................................................................. $ 1,095,338 -------------------- EXPENSES: Mortality and expense risk charges............................................................................................. 1,166,803 Administrative charges................................................................................. 251,502 -------------------- Total expenses...................................................................................... 1,418,305 -------------------- Net investment income (loss)...................................................................... (322,967) -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions............................................................................ -- Realized gains (losses) on sale of investments......................................................................................... (34,211) -------------------- Net realized gains (losses)....................................................................... (34,211) -------------------- Change in unrealized gains (losses) on investments...................................................................................... 392,749 -------------------- Net realized and change in unrealized gains (losses) on investments...................................................................................... 358,538 -------------------- Net increase (decrease) in net assets resulting from operations........................................................................... $ 35,571 ==================== (a) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 58
N-4132nd Page of 530TOC1stPreviousNextBottomJust 132nd
This page is intentionally left blank.
N-4133rd Page of 530TOC1stPreviousNextBottomJust 133rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] ALGER SMALL CAP GROWTH AMERICAN FUNDS BOND SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (795,350) $ (722,308) $ 718,730 $ 1,653,836 Net realized gains (losses).... 8,468,060 11,906,761 1,750,573 253,909 Change in unrealized gains (losses) on investments...... 8,688,799 (5,650,965) (7,601,790) 2,948,249 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 16,361,509 5,533,488 (5,132,487) 4,855,994 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,617,076 1,749,806 11,875,043 21,553,499 Net transfers (including fixed account)..................... (2,035,008) (2,146,454) 11,294,017 6,190,229 Contract charges............... (8,421) (8,644) (1,263,411) (1,049,405) Transfers for contract benefits and terminations............. (4,789,042) (4,042,118) (9,827,827) (9,034,568) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (5,215,395) (4,447,410) 12,077,822 17,659,755 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 11,146,114 1,086,078 6,945,335 22,515,749 NET ASSETS: Beginning of year.............. 52,626,085 51,540,007 139,213,016 116,697,267 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 63,772,199 $ 52,626,085 $ 146,158,351 $ 139,213,016 ================ ================ ================ ================ AMERICAN FUNDS AMERICAN FUNDS GLOBAL GROWTH GLOBAL SMALL CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (526,928) $ (1,236,453) $ (549,405) $ (8,448) Net realized gains (losses).... 3,982,592 425,004 1,957,425 (334,212) Change in unrealized gains (losses) on investments...... 65,109,148 43,480,973 25,083,432 13,744,703 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 68,564,812 42,669,524 26,491,452 13,402,043 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 23,766,765 31,342,210 10,382,354 12,386,247 Net transfers (including fixed account)..................... (8,540,368) (1,972,607) (3,851,967) 1,926,520 Contract charges............... (2,337,645) (1,839,723) (874,487) (658,312) Transfers for contract benefits and terminations............. (17,922,689) (19,364,261) (6,349,695) (5,472,040) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (5,033,937) 8,165,619 (693,795) 8,182,415 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 63,530,875 50,835,143 25,797,657 21,584,458 NET ASSETS: Beginning of year.............. 251,295,328 200,460,185 98,386,346 76,801,888 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 314,826,203 $ 251,295,328 $ 124,184,003 $ 98,386,346 ================ ================ ================ ================ AMERICAN FUNDS GROWTH AMERICAN FUNDS GROWTH-INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (4,016,566) $ (4,250,325) $ (469,223) $ 406,074 Net realized gains (losses).... 16,990,100 1,880,290 6,900,940 800,760 Change in unrealized gains (losses) on investments...... 182,361,798 97,631,196 89,831,743 41,809,198 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 195,335,332 95,261,161 96,263,460 43,016,032 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 48,884,879 88,690,008 21,737,754 34,344,085 Net transfers (including fixed account)..................... (28,227,693) (11,631,864) (13,953,890) (9,765,377) Contract charges............... (6,793,715) (5,467,039) (2,765,946) (2,277,742) Transfers for contract benefits and terminations............. (49,304,587) (47,623,908) (25,784,839) (24,882,456) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (35,441,116) 23,967,197 (20,766,921) (2,581,490) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 159,894,216 119,228,358 75,496,539 40,434,542 NET ASSETS: Beginning of year.............. 696,665,988 577,437,630 312,823,451 272,388,909 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 856,560,204 $ 696,665,988 $ 388,319,990 $ 312,823,451 ================ ================ ================ ================ DWS I INTERNATIONAL SUB-ACCOUNT ----------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 689,035 $ 135,664 Net realized gains (losses).... (490,812) (950,927) Change in unrealized gains (losses) on investments...... 2,799,643 3,633,463 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 2,997,866 2,818,200 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 653,441 815,123 Net transfers (including fixed account)..................... (612,834) (890,959) Contract charges............... (1,860) (2,073) Transfers for contract benefits and terminations............. (1,377,035) (1,466,360) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,338,288) (1,544,269) ---------------- ---------------- Net increase (decrease) in net assets.............. 1,659,578 1,273,931 NET ASSETS: Beginning of year.............. 16,933,216 15,659,285 ---------------- ---------------- End of year.................... $ 18,592,794 $ 16,933,216 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 60
N-4134th Page of 530TOC1stPreviousNextBottomJust 134th
The accompanying notes are an integral part of these financial statements. 61
N-4135th Page of 530TOC1stPreviousNextBottomJust 135th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] FEDERATED HIGH INCOME BOND FEDERATED KAUFMAN SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 1,375 $ 2,033 $ (544) $ (620) Net realized gains (losses)..... -- (596) 3,616 3,375 Change in unrealized gains (losses) on investments....... (4) 1,882 9,524 5,499 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 1,371 3,319 12,596 8,254 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- -- -- Net transfers (including fixed account)...................... -- -- -- -- Contract charges................ -- -- -- -- Transfers for contract benefits and terminations.............. (113) (8,983) (1,113) (33,284) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (113) (8,983) (1,113) (33,284) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 1,258 (5,664) 11,483 (25,030) NET ASSETS: Beginning of year............... 24,908 30,572 33,424 58,454 ---------------- ---------------- ---------------- ----------------- End of year..................... $ 26,166 $ 24,908 $ 44,907 $ 33,424 ================ ================ ================ ================= FIDELITY VIP ASSET MANAGER FIDELITY VIP CONTRAFUND SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 166,950 $ 116,307 $ (1,697,392) $ (6,154) Net realized gains (losses)..... 806,245 304,655 11,601,258 2,083,421 Change in unrealized gains (losses) on investments....... 10,480,801 8,735,876 130,225,189 56,443,738 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 11,453,996 9,156,838 140,129,055 58,521,005 ---------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 1,646,197 2,107,703 46,614,319 63,383,760 Net transfers (including fixed account)...................... (2,338,518) (3,535,616) (6,126,568) (8,285,062) Contract charges................ (12,381) (13,367) (2,923,183) (2,022,747) Transfers for contract benefits and terminations.............. (8,115,163) (9,146,543) (36,834,423) (29,010,195) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (8,819,865) (10,587,823) 730,145 24,065,756 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 2,634,131 (1,430,985) 140,859,200 82,586,761 NET ASSETS: Beginning of year............... 85,640,352 87,071,337 471,113,726 388,526,965 ---------------- ----------------- ---------------- ----------------- End of year..................... $ 88,274,483 $ 85,640,352 $ 611,972,926 $ 471,113,726 ================ ================= ================ ================= FIDELITY VIP EQUITY-INCOME FIDELITY VIP FUNDSMANAGER 50% SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 (a) ---------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 58,439 $ 88,287 $ (5,248,600) $ 3,619,602 Net realized gains (losses)..... 367,626 240,155 10,771,735 1,127,805 Change in unrealized gains (losses) on investments....... 916,971 493,771 141,257,707 (985,620) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 1,343,036 822,213 146,780,842 3,761,787 ---------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 24,011 21,089 -- 381,250 Net transfers (including fixed account)...................... (72,869) (148,657) 1,474,414,428 440,849,283 Contract charges................ -- -- -- -- Transfers for contract benefits and terminations.............. (862,819) (661,322) (31,224,567) (1,169,235) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (911,677) (788,890) 1,443,189,861 440,061,298 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 431,359 33,323 1,589,970,703 443,823,085 NET ASSETS: Beginning of year............... 5,523,241 5,489,918 443,823,085 -- ---------------- ----------------- ---------------- ----------------- End of year..................... $ 5,954,600 $ 5,523,241 $ 2,033,793,788 $ 443,823,085 ================ ================= ================ ================= FIDELITY VIP FUNDSMANAGER 60% SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (31,238,110) $ (14,844,402) Net realized gains (losses)..... 171,159,819 16,912,548 Change in unrealized gains (losses) on investments....... 435,136,185 273,609,789 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 575,057,894 275,677,935 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 5,496,546 660,878 Net transfers (including fixed account)...................... -- 846,845,524 Contract charges................ -- -- Transfers for contract benefits and terminations.............. (145,663,704) (118,152,514) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (140,167,158) 729,353,888 ---------------- ---------------- Net increase (decrease) in net assets.............. 434,890,736 1,005,031,823 NET ASSETS: Beginning of year............... 3,596,633,088 2,591,601,265 ---------------- ---------------- End of year..................... $ 4,031,523,824 $ 3,596,633,088 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 62
N-4136th Page of 530TOC1stPreviousNextBottomJust 136th
The accompanying notes are an integral part of these financial statements. 63
N-4137th Page of 530TOC1stPreviousNextBottomJust 137th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] FIDELITY VIP GROWTH FIDELITY VIP INDEX 500 SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2013 2012 2013 2012 ----------------- ----------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (1,579,739) $ (1,080,859) $ 325,124 $ 419,770 Net realized gains (losses)..... 4,112,179 1,666,126 2,857,955 1,679,198 Change in unrealized gains (losses) on investments....... 41,938,391 16,522,108 14,178,938 6,239,811 ----------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 44,470,831 17,107,375 17,362,017 8,338,779 ----------------- ----------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 3,349,924 4,112,950 -- -- Net transfers (including fixed account)...................... (5,049,310) (4,169,183) (2,603,865) (1,951,671) Contract charges................ (22,025) (23,334) (23,942) (24,093) Transfers for contract benefits and terminations.............. (13,580,293) (12,203,205) (6,041,583) (5,440,312) ----------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (15,301,704) (12,282,772) (8,669,390) (7,416,076) ----------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 29,169,127 4,824,603 8,692,627 922,703 NET ASSETS: Beginning of year............... 136,799,312 131,974,709 60,984,620 60,061,917 ----------------- ----------------- ----------------- ---------------- End of year..................... $ 165,968,439 $ 136,799,312 $ 69,677,247 $ 60,984,620 ================= ================= ================= ================ FIDELITY VIP MID CAP FIDELITY VIP MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- -------------------------------------- 2013 2012 2013 2012 ---------------- ----------------- ------------------ ------------------ INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (4,216,245) $ (2,734,101) $ (1,597,325) $ (1,393,275) Net realized gains (losses)..... 56,577,725 26,034,787 -- -- Change in unrealized gains (losses) on investments....... 61,592,202 9,833,446 -- -- ---------------- ----------------- ------------------ ------------------ Net increase (decrease) in net assets resulting from operations............ 113,953,682 33,134,132 (1,597,325) (1,393,275) ---------------- ----------------- ------------------ ------------------ CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 45,946,288 64,821,528 1,482,045,626 1,295,167,554 Net transfers (including fixed account)...................... (13,593,184) 8,880,545 (1,474,484,969) (1,289,660,954) Contract charges................ (3,645,078) (2,508,522) (3,153) (3,912) Transfers for contract benefits and terminations.............. (20,912,658) (17,196,292) (3,464,232) (3,518,646) ---------------- ----------------- ------------------ ------------------ Net increase (decrease) in net assets resulting from contract transactions...... 7,795,368 53,997,259 4,093,272 1,984,042 ---------------- ----------------- ------------------ ------------------ Net increase (decrease) in net assets.............. 121,749,050 87,131,391 2,495,947 590,767 NET ASSETS: Beginning of year............... 324,832,892 237,701,501 73,659,399 73,068,632 ---------------- ----------------- ------------------ ------------------ End of year..................... $ 446,581,942 $ 324,832,892 $ 76,155,346 $ 73,659,399 ================ ================= ================== ================== FIDELITY VIP OVERSEAS FTVIPT FRANKLIN INCOME SECURITIES SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ------------------------------------ 2013 2012 2013 2012 ---------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 5,035 $ 35,712 $ 13,802,960 $ 11,781,681 Net realized gains (losses)..... 11,595 (91,435) 335,927 (143,328) Change in unrealized gains (losses) on investments....... 1,380,290 930,242 18,152,582 12,601,025 ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 1,396,920 874,519 32,291,469 24,239,378 ---------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 83,529 98,285 24,164,029 38,977,808 Net transfers (including fixed account)...................... (260,389) (2,174) 10,135,357 6,367,446 Contract charges................ (46) (60) (2,217,562) (1,667,113) Transfers for contract benefits and terminations.............. (535,530) (393,725) (19,716,164) (21,364,327) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (712,436) (297,674) 12,365,660 22,313,814 ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets.............. 684,484 576,845 44,657,129 46,553,192 NET ASSETS: Beginning of year............... 5,241,037 4,664,192 253,164,341 206,611,149 ---------------- ---------------- ----------------- ----------------- End of year..................... $ 5,925,521 $ 5,241,037 $ 297,821,470 $ 253,164,341 ================ ================ ================= ================= FTVIPT FRANKLIN SMALL CAP VALUE SECURITIES SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (24,107) $ (382,615) Net realized gains (losses)..... 3,335,986 82,294 Change in unrealized gains (losses) on investments....... 28,858,586 11,355,727 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 32,170,465 11,055,406 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 18,861,799 26,752,367 Net transfers (including fixed account)...................... (3,726,532) 831,747 Contract charges................ (1,067,656) (582,013) Transfers for contract benefits and terminations.............. (4,485,166) (2,467,131) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 9,582,445 24,534,970 ---------------- ---------------- Net increase (decrease) in net assets.............. 41,752,910 35,590,376 NET ASSETS: Beginning of year............... 86,296,073 50,705,697 ---------------- ---------------- End of year..................... $ 128,048,983 $ 86,296,073 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 64
N-4138th Page of 530TOC1stPreviousNextBottomJust 138th
The accompanying notes are an integral part of these financial statements. 65
N-4139th Page of 530TOC1stPreviousNextBottomJust 139th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] FTVIPT FTVIPT MUTUAL SHARES SECURITIES TEMPLETON FOREIGN SECURITIES SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ------------------------------------ 2013 2012 2013 2012 ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)..... $ 1,028,572 $ 828,209 $ 479,595 $ 905,498 Net realized gains (losses)...... 1,531,390 (351,542) 527,295 (666,651) Change in unrealized gains (losses) on investments........ 31,136,595 14,415,530 14,782,128 11,238,272 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............. 33,696,557 14,892,197 15,789,018 11,477,119 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners........... 7,934,359 13,759,082 1,244,169 6,029,850 Net transfers (including fixed account)....................... (3,863,825) (3,146,458) (3,114,726) 396,235 Contract charges................. (1,093,363) (879,739) (910,114) (813,888) Transfers for contract benefits and terminations............... (10,375,719) (13,377,390) (6,075,431) (5,310,132) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions....... (7,398,548) (3,644,505) (8,856,102) 302,065 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets............... 26,298,009 11,247,692 6,932,916 11,779,184 NET ASSETS: Beginning of year................ 129,780,562 118,532,870 80,788,377 69,009,193 ----------------- ----------------- ----------------- ----------------- End of year...................... $ 156,078,571 $ 129,780,562 $ 87,721,293 $ 80,788,377 ================= ================= ================= ================= FTVIPT TEMPLETON GLOBAL BOND SECURITIES INVESCO V.I. AMERICAN FRANCHISE SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ------------------------------------ 2013 2012 2013 2012 ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)..... $ 8,251,988 $ 9,308,296 $ (1,401) $ (1,969) Net realized gains (losses)...... 2,892,611 305,792 4,184 4,261 Change in unrealized gains (losses) on investments........ (10,624,497) 12,966,460 44,589 5,620 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............. 520,102 22,580,548 47,372 7,912 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners........... 31,796,531 55,695,235 -- 3 Net transfers (including fixed account)....................... 20,195,269 8,138,828 (8,489) 88,752 Contract charges................. (2,382,478) (1,598,059) -- -- Transfers for contract benefits and terminations............... (12,509,439) (7,739,164) (25,032) (36,838) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions....... 37,099,883 54,496,840 (33,521) 51,917 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets............... 37,619,985 77,077,388 13,851 59,829 NET ASSETS: Beginning of year................ 217,063,429 139,986,041 149,862 90,033 ----------------- ----------------- ----------------- ----------------- End of year...................... $ 254,683,414 $ 217,063,429 $ 163,713 $ 149,862 ================= ================= ================= ================= INVESCO V.I. AMERICAN VALUE INVESCO V.I. CORE EQUITY SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ------------------------------------- 2013 2012 2013 2012 ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)..... $ (653,068) $ (396,721) $ (90) $ (1,291) Net realized gains (losses)...... 1,362,452 295,908 11,977 9,182 Change in unrealized gains (losses) on investments........ 21,986,708 7,999,839 45,509 23,282 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............. 22,696,092 7,899,026 57,396 31,173 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners........... 11,493,142 15,070,411 -- -- Net transfers (including fixed account)....................... (396,972) (474,558) (15,058) (21,186) Contract charges................. (814,387) (538,047) -- -- Transfers for contract benefits and terminations............... (4,366,942) (2,285,953) (33,651) (45,739) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions....... 5,914,841 11,771,853 (48,709) (66,925) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets............... 28,610,933 19,670,879 8,687 (35,752) NET ASSETS: Beginning of year................ 66,684,996 47,014,117 241,009 276,761 ----------------- ----------------- ----------------- ----------------- End of year...................... $ 95,295,929 $ 66,684,996 $ 249,696 $ 241,009 ================= ================= ================= ================= INVESCO V.I. EQUITY AND INCOME SUB-ACCOUNT ------------------------------------ 2013 2012 ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)..... $ 960,409 $ 2,132,881 Net realized gains (losses)...... 2,646,648 987,347 Change in unrealized gains (losses) on investments........ 115,194,853 43,230,491 ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............. 118,801,910 46,350,719 ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners........... 67,597,697 83,668,907 Net transfers (including fixed account)....................... 8,022,603 (305,020) Contract charges................. (4,836,300) (3,578,432) Transfers for contract benefits and terminations............... (37,208,806) (43,547,842) ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions....... 33,575,194 36,237,613 ----------------- ----------------- Net increase (decrease) in net assets............... 152,377,104 82,588,332 NET ASSETS: Beginning of year................ 496,945,594 414,357,262 ----------------- ----------------- End of year...................... $ 649,322,698 $ 496,945,594 ================= ================= (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 66
N-4140th Page of 530TOC1stPreviousNextBottomJust 140th
The accompanying notes are an integral part of these financial statements. 67
N-4141st Page of 530TOC1stPreviousNextBottomJust 141st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] INVESCO V.I. GLOBAL REAL ESTATE INVESCO V.I. GROWTH AND INCOME SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 738,755 $ (159,936) $ (188,424) $ (39,401) Net realized gains (losses)..... 251,182 14,912 5,964,860 215,131 Change in unrealized gains (losses) on investments....... (841,038) 4,220,926 81,951,879 27,777,291 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 148,899 4,075,902 87,728,315 27,953,021 ----------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 6,235,134 6,088,001 41,201,557 55,614,326 Net transfers (including fixed account)...................... 1,699,930 615,737 (9,892,159) (3,884,258) Contract charges................ (265,363) (166,631) (3,013,438) (2,064,540) Transfers for contract benefits and terminations.............. (1,127,854) (777,696) (18,283,675) (15,726,767) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 6,541,847 5,759,411 10,012,285 33,938,761 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 6,690,746 9,835,313 97,740,600 61,891,782 NET ASSETS: Beginning of year............... 23,302,577 13,467,264 268,230,013 206,338,231 ----------------- ---------------- ---------------- ----------------- End of year..................... $ 29,993,323 $ 23,302,577 $ 365,970,613 $ 268,230,013 ================= ================ ================ ================= INVESCO V.I. INTERNATIONAL GROWTH JANUS ASPEN GLOBAL RESEARCH SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ------------------------------------ 2013 2012 2013 2012 ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (636,105) $ 51,882 $ 21 $ 1 Net realized gains (losses)..... 1,305,822 76,597 120 9 Change in unrealized gains (losses) on investments....... 40,017,340 24,064,007 1,329 896 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 40,687,057 24,192,486 1,470 906 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 29,193,980 45,143,565 -- -- Net transfers (including fixed account)...................... 6,799,837 6,206,236 -- -- Contract charges................ (2,450,016) (1,751,462) -- -- Transfers for contract benefits and terminations.............. (12,015,352) (8,106,175) (375) (3) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 21,528,449 41,492,164 (375) (3) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets.............. 62,215,506 65,684,650 1,095 903 NET ASSETS: Beginning of year............... 219,783,700 154,099,050 5,653 4,750 ----------------- ----------------- ----------------- ----------------- End of year..................... $ 281,999,206 $ 219,783,700 $ 6,748 $ 5,653 ================= ================= ================= ================= LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH VARIABLE ALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ------------------------------------ 2013 2012 2013 2012 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (2,728,091) $ (1,863,351) $ (34,365) $ 271,873 Net realized gains (losses)..... 17,861,500 9,957,799 10,192,766 (234,300) Change in unrealized gains (losses) on investments....... 71,695,365 19,162,336 20,675,928 12,653,901 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 86,828,774 27,256,784 30,834,329 12,691,474 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 26,964,170 26,101,454 7,542,551 10,482,501 Net transfers (including fixed account)...................... (1,165,621) (5,078,294) (2,438,406) (1,374,496) Contract charges................ (1,696,014) (1,164,246) (733,083) (563,153) Transfers for contract benefits and terminations.............. (17,174,971) (20,966,057) (10,398,584) (12,507,706) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 6,927,564 (1,107,143) (6,027,522) (3,962,854) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 93,756,338 26,149,641 24,806,807 8,728,620 NET ASSETS: Beginning of year............... 186,988,862 160,839,221 104,446,756 95,718,136 ---------------- ---------------- ---------------- ----------------- End of year..................... $ 280,745,200 $ 186,988,862 $ 129,253,563 $ 104,446,756 ================ ================ ================ ================= LMPVET CLEARBRIDGE VARIABLE APPRECIATION SUB-ACCOUNT ----------------------------------- 2013 2012 ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (340,789) $ 877,895 Net realized gains (losses)..... 13,852,622 276,468 Change in unrealized gains (losses) on investments....... 72,638,328 32,185,472 ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 86,150,161 33,339,835 ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 47,967,753 57,982,645 Net transfers (including fixed account)...................... 4,628,653 (4,101,720) Contract charges................ (3,067,660) (2,128,567) Transfers for contract benefits and terminations.............. (20,584,065) (19,581,184) ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 28,944,681 32,171,174 ---------------- ----------------- Net increase (decrease) in net assets.............. 115,094,842 65,511,009 NET ASSETS: Beginning of year............... 290,191,379 224,680,370 ---------------- ----------------- End of year..................... $ 405,286,221 $ 290,191,379 ================ ================= (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 68
N-4142nd Page of 530TOC1stPreviousNextBottomJust 142nd
The accompanying notes are an integral part of these financial statements. 69
N-4143rd Page of 530TOC1stPreviousNextBottomJust 143rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE EQUITY INCOME VARIABLE LARGE CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 427,485 $ 1,935,990 $ (58,170) $ (51,981) Net realized gains (losses).... 646,901 (1,496,446) 745,423 481,453 Change in unrealized gains (losses) on investments...... 33,452,314 13,043,194 710,461 353,548 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 34,526,700 13,482,738 1,397,714 783,020 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 27,050,110 30,792,673 648 1,459 Net transfers (including fixed account)..................... 8,008,781 2,474,161 (33,103) (256,108) Contract charges............... (1,307,320) (777,353) (17,152) (18,887) Transfers for contract benefits and terminations............. (12,039,748) (14,363,944) (647,971) (871,026) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 21,711,823 18,125,537 (697,578) (1,144,562) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 56,238,523 31,608,275 700,136 (361,542) NET ASSETS: Beginning of year.............. 134,931,130 103,322,855 4,312,254 4,673,796 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 191,169,653 $ 134,931,130 $ 5,012,390 $ 4,312,254 ================ ================ ================ ================ LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE LARGE CAP VALUE VARIABLE SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,148 $ 27,751 $ (1,235,439) $ (568,565) Net realized gains (losses).... 466,613 50,468 8,864,593 3,154,639 Change in unrealized gains (losses) on investments...... 1,056,824 510,271 24,881,277 5,466,771 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 1,524,585 588,490 32,510,431 8,052,845 ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 282,593 573,803 16,380,155 16,257,772 Net transfers (including fixed account)..................... 813,486 285,926 3,443,300 1,590,977 Contract charges............... (46,356) (36,742) (824,479) (481,813) Transfers for contract benefits and terminations............. (424,843) (504,347) (3,891,881) (3,103,064) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 624,880 318,640 15,107,095 14,263,872 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 2,149,465 907,130 47,617,526 22,316,717 NET ASSETS: Beginning of year.............. 4,743,489 3,836,359 64,881,494 42,564,777 ----------------- ---------------- ---------------- ---------------- End of year.................... $ 6,892,954 $ 4,743,489 $ 112,499,020 $ 64,881,494 ================= ================ ================ ================ LMPVET INVESTMENT LMPVET COUNSEL VARIABLE SOCIAL AWARENESS VARIABLE LIFESTYLE ALLOCATION 50% SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,213) $ (2,313) $ 335,965 $ 451,589 Net realized gains (losses).... 8,209 18,868 294,643 110,528 Change in unrealized gains (losses) on investments...... 39,556 26,419 4,402,903 2,456,921 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 45,552 42,974 5,033,511 3,019,038 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- -- 6,821,630 6,963,572 Net transfers (including fixed account)..................... 9,338 (49,856) 3,040,842 1,186,938 Contract charges............... (130) (173) (323,071) (208,041) Transfers for contract benefits and terminations............. (51,803) (204,989) (3,091,539) (2,607,174) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (42,595) (255,018) 6,447,862 5,335,295 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 2,957 (212,044) 11,481,373 8,354,333 NET ASSETS: Beginning of year.............. 289,329 501,373 32,620,028 24,265,695 ---------------- ----------------- ---------------- ---------------- End of year.................... $ 292,286 $ 289,329 $ 44,101,401 $ 32,620,028 ================ ================= ================ ================ LMPVET VARIABLE LIFESTYLE ALLOCATION 70% SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (5,215) $ 16,093 Net realized gains (losses).... 164,204 48,643 Change in unrealized gains (losses) on investments...... 307,412 296,816 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 466,401 361,552 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 120 3,120 Net transfers (including fixed account)..................... 208,852 (27,315) Contract charges............... (702) (796) Transfers for contract benefits and terminations............. (943,181) (849,995) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (734,911) (874,986) ---------------- ---------------- Net increase (decrease) in net assets.............. (268,510) (513,434) NET ASSETS: Beginning of year.............. 2,573,509 3,086,943 ---------------- ---------------- End of year.................... $ 2,304,999 $ 2,573,509 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 70
N-4144th Page of 530TOC1stPreviousNextBottomJust 144th
The accompanying notes are an integral part of these financial statements. 71
N-4145th Page of 530TOC1stPreviousNextBottomJust 145th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] LMPVET LMPVIT WESTERN ASSET VARIABLE LIFESTYLE ALLOCATION 85% VARIABLE GLOBAL HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 265,832 $ 362,338 $ 4,754,059 $ 5,165,628 Net realized gains (losses)..... 1,739,917 528,492 97,460 (68,307) Change in unrealized gains (losses) on investments....... 17,385,552 8,931,921 (303,455) 7,182,092 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 19,391,301 9,822,751 4,548,064 12,279,413 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 3,896,642 8,807,329 12,043,147 15,538,183 Net transfers (including fixed account)...................... (70,391) (793,785) 6,173,096 4,005,384 Contract charges................ (739,142) (611,650) (741,652) (516,554) Transfers for contract benefits and terminations.............. (7,221,465) (3,286,778) (9,054,116) (9,252,417) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (4,134,356) 4,115,116 8,420,475 9,774,596 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 15,256,945 13,937,867 12,968,539 22,054,009 NET ASSETS: Beginning of year............... 79,817,339 65,879,472 91,771,912 69,717,903 ---------------- ---------------- ---------------- ----------------- End of year..................... $ 95,074,284 $ 79,817,339 $ 104,740,451 $ 91,771,912 ================ ================ ================ ================= MFS VIT MFS VIT INVESTORS TRUST NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (69) $ (190) $ (581) $ (602) Net realized gains (losses)..... 292 2,707 2,006 4,349 Change in unrealized gains (losses) on investments....... 5,877 2,028 12,769 3,991 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 6,100 4,545 14,194 7,738 ---------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- -- -- Net transfers (including fixed account)...................... -- -- -- -- Contract charges................ -- -- -- -- Transfers for contract benefits and terminations.............. (637) (18,051) (9,835) (7,451) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (637) (18,051) (9,835) (7,451) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 5,463 (13,506) 4,359 287 NET ASSETS: Beginning of year............... 20,488 33,994 41,661 41,374 ---------------- ----------------- ---------------- ----------------- End of year..................... $ 25,951 $ 20,488 $ 46,020 $ 41,661 ================ ================= ================ ================= MIST ALLIANCEBERNSTEIN MFS VIT RESEARCH GLOBAL DYNAMIC ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (610) $ (299) $ (4,610,871) $ (31,735,651) Net realized gains (losses)..... 1,133 603 73,047,817 68,339 Change in unrealized gains (losses) on investments....... 14,560 6,684 213,779,983 215,787,760 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 15,083 6,988 282,216,929 184,120,448 ---------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- 248,776,609 748,915,629 Net transfers (including fixed account)...................... -- -- 93,377,580 331,990,410 Contract charges................ -- -- (43,781,572) (28,058,490) Transfers for contract benefits and terminations.............. (1,403) (1,975) (90,758,771) (52,503,657) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,403) (1,975) 207,613,846 1,000,343,892 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 13,680 5,013 489,830,775 1,184,464,340 NET ASSETS: Beginning of year............... 50,155 45,142 2,823,843,417 1,639,379,077 ---------------- ----------------- ---------------- ----------------- End of year..................... $ 63,835 $ 50,155 $ 3,313,674,192 $ 2,823,843,417 ================ ================= ================ ================= MIST AMERICAN FUNDS BALANCED ALLOCATION SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (5,388,861) $ 4,444,113 Net realized gains (losses)..... 250,625,904 60,128,154 Change in unrealized gains (losses) on investments....... 260,897,780 273,656,262 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 506,134,823 338,228,529 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 29,549,572 83,164,894 Net transfers (including fixed account)...................... (8,307,267) (60,456,373) Contract charges................ (37,993,157) (37,328,286) Transfers for contract benefits and terminations.............. (165,057,262) (132,325,623) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (181,808,114) (146,945,388) ---------------- ---------------- Net increase (decrease) in net assets.............. 324,326,709 191,283,141 NET ASSETS: Beginning of year............... 3,106,060,329 2,914,777,188 ---------------- ---------------- End of year..................... $ 3,430,387,038 $ 3,106,060,329 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 72
N-4146th Page of 530TOC1stPreviousNextBottomJust 146th
The accompanying notes are an integral part of these financial statements. 73
N-4147th Page of 530TOC1stPreviousNextBottomJust 147th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST MIST AMERICAN FUNDS GROWTH ALLOCATION AMERICAN FUNDS GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (9,394,519) $ (5,413,271) $ (6,517,995) $ (6,868,206) Net realized gains (losses).... 121,285,044 26,669,090 55,767,296 20,415,943 Change in unrealized gains (losses) on investments...... 233,109,626 175,144,743 96,031,643 67,309,082 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 345,000,151 196,400,562 145,280,944 80,856,819 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 19,707,302 52,400,148 14,629,823 17,133,976 Net transfers (including fixed account)..................... 66,168,229 (72,570,860) (37,937,636) (78,467,843) Contract charges............... (16,411,723) (15,855,986) (6,691,159) (6,678,966) Transfers for contract benefits and terminations............. (82,807,176) (62,098,994) (28,561,135) (20,470,993) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (13,343,368) (98,125,692) (58,560,107) (88,483,826) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 331,656,783 98,274,870 86,720,837 (7,627,007) NET ASSETS: Beginning of year.............. 1,496,665,592 1,398,390,722 545,665,799 553,292,806 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 1,828,322,375 $ 1,496,665,592 $ 632,386,636 $ 545,665,799 ================ ================ ================ ================ MIST MIST AMERICAN FUNDS MODERATE ALLOCATION AQR GLOBAL RISK BALANCED SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 --------------- --------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 2,016,609 $ 8,663,944 $ 24,454,360 $ (29,485,494) Net realized gains (losses).... 119,968,172 39,154,321 131,410,280 13,924,436 Change in unrealized gains (losses) on investments...... 74,888,275 103,394,103 (347,099,092) 257,592,013 --------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 196,873,056 151,212,368 (191,234,452) 242,030,955 --------------- --------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 17,989,884 43,856,551 299,929,057 1,010,258,029 Net transfers (including fixed account)..................... (30,931,042) (43,601,001) (449,932,361) 701,135,494 Contract charges............... (21,278,076) (21,439,772) (50,307,360) (34,472,373) Transfers for contract benefits and terminations............. (100,612,790) (79,167,097) (113,288,370) (63,766,725) --------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (134,832,024) (100,351,319) (313,599,034) 1,613,154,425 --------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 62,041,032 50,861,049 (504,833,486) 1,855,185,380 NET ASSETS: Beginning of year.............. 1,734,325,945 1,683,464,896 3,753,309,463 1,898,124,083 --------------- --------------- ---------------- ---------------- End of year.................... $ 1,796,366,977 $ 1,734,325,945 $ 3,248,475,977 $ 3,753,309,463 =============== =============== ================ ================ MIST MIST BLACKROCK GLOBAL TACTICAL STRATEGIES BLACKROCK HIGH YIELD SUB-ACCOUNT SUB-ACCOUNT ------------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (3,617,558) $ (58,135,263) $ 14,596,196 $ 13,623,467 Net realized gains (losses).... 133,255,577 130,203 9,642,339 5,023,228 Change in unrealized gains (losses) on investments...... 311,060,284 341,923,540 (4,631,091) 14,564,761 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 440,698,303 283,918,480 19,607,444 33,211,456 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 411,567,881 1,312,263,362 13,943,237 20,947,935 Net transfers (including fixed account)..................... (28,640,096) 557,379,957 (26,718,376) 17,699,162 Contract charges............... (73,176,143) (48,022,451) (2,612,849) (2,591,456) Transfers for contract benefits and terminations............. (149,396,119) (91,426,698) (16,046,952) (13,914,636) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 160,355,523 1,730,194,170 (31,434,940) 22,141,005 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 601,053,826 2,014,112,650 (11,827,496) 55,352,461 NET ASSETS: Beginning of year.............. 4,856,824,935 2,842,712,285 276,977,302 221,624,841 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 5,457,878,761 $ 4,856,824,935 $ 265,149,806 $ 276,977,302 ================ ================ ================ ================ MIST BLACKROCK LARGE CAP CORE SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (69,719) $ (98,467) Net realized gains (losses).... 843,040 204,327 Change in unrealized gains (losses) on investments...... 3,552,916 1,366,663 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 4,326,237 1,472,523 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 654,278 2,809,895 Net transfers (including fixed account)..................... (847,332) (1,633,705) Contract charges............... (180,167) (169,775) Transfers for contract benefits and terminations............. (1,522,513) (889,640) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,895,734) 116,775 ---------------- ---------------- Net increase (decrease) in net assets.............. 2,430,503 1,589,298 NET ASSETS: Beginning of year.............. 14,439,147 12,849,849 ---------------- ---------------- End of year.................... $ 16,869,650 $ 14,439,147 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 74
N-4148th Page of 530TOC1stPreviousNextBottomJust 148th
The accompanying notes are an integral part of these financial statements. 75
N-4149th Page of 530TOC1stPreviousNextBottomJust 149th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST MIST CLARION GLOBAL REAL ESTATE CLEARBRIDGE AGGRESSIVE GROWTH II SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 9,853,299 $ 648,569 $ (1,006,117) $ (1,256,766) Net realized gains (losses).... (92,999) (1,249,413) 5,873,060 1,264,699 Change in unrealized gains (losses) on investments...... (6,455,197) 35,559,210 19,911,595 14,507,523 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 3,305,103 34,958,366 24,778,538 14,515,456 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,804,117 7,794,423 1,347,767 4,262,148 Net transfers (including fixed account)..................... 14,576,022 (2,227,782) (5,985,835) 25,557,583 Contract charges............... (1,769,594) (1,587,295) (1,164,663) (1,131,367) Transfers for contract benefits and terminations............. (12,559,683) (9,066,811) (6,729,962) (5,149,785) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 2,050,862 (5,087,465) (12,532,693) 23,538,579 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 5,355,965 29,870,901 12,245,845 38,054,035 NET ASSETS: Beginning of year.............. 177,317,957 147,447,056 106,823,115 68,769,080 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 182,673,922 $ 177,317,957 $ 119,068,960 $ 106,823,115 ================ ================ ================= ================ MIST MIST CLEARBRIDGE AGGRESSIVE GROWTH GOLDMAN SACHS MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (5,039,430) $ (4,519,479) $ (1,173,155) $ (1,395,190) Net realized gains (losses).... 11,473,473 4,996,289 12,013,375 565,819 Change in unrealized gains (losses) on investments...... 123,052,679 43,727,000 31,704,368 21,341,212 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 129,486,722 44,203,810 42,544,588 20,511,841 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,418,106 8,612,510 1,260,840 2,591,780 Net transfers (including fixed account)..................... 52,077,391 (6,817,243) 158,750 (5,769,122) Contract charges............... (3,110,264) (2,555,203) (1,323,450) (1,125,130) Transfers for contract benefits and terminations............. (25,033,154) (16,051,172) (11,814,121) (7,693,862) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 29,352,079 (16,811,108) (11,717,981) (11,996,334) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 158,838,801 27,392,702 30,826,607 8,515,507 NET ASSETS: Beginning of year.............. 292,871,764 265,479,062 139,211,779 130,696,272 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 451,710,565 $ 292,871,764 $ 170,038,386 $ 139,211,779 ================ ================ ================= ================ MIST MIST HARRIS OAKMARK INTERNATIONAL INVESCO BALANCED-RISK ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 (b) ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 5,201,015 $ 91,453 $ (12,158,692) $ (1,415,511) Net realized gains (losses).... 11,702,177 (1,430,384) 10,077,015 6,907,824 Change in unrealized gains (losses) on investments...... 134,182,838 121,937,845 4,078,692 10,868,519 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 151,086,030 120,598,914 1,997,015 16,360,832 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 17,704,175 17,848,721 168,173,765 338,086,548 Net transfers (including fixed account)..................... 27,865,479 (30,313,737) 45,607,989 313,044,735 Contract charges............... (5,353,619) (4,604,462) (10,692,799) (1,295,053) Transfers for contract benefits and terminations............. (36,258,075) (26,450,720) (23,347,690) (4,774,645) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 3,957,960 (43,520,198) 179,741,265 645,061,585 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 155,043,990 77,078,716 181,738,280 661,422,417 NET ASSETS: Beginning of year.............. 538,939,254 461,860,538 661,422,417 -- ---------------- ----------------- ---------------- ---------------- End of year.................... $ 693,983,244 $ 538,939,254 $ 843,160,697 $ 661,422,417 ================ ================= ================ ================ MIST INVESCO COMSTOCK SUB-ACCOUNT ----------------------------------- 2013 2012 ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,674,772) $ (729,855) Net realized gains (losses).... 9,703,108 5,346,575 Change in unrealized gains (losses) on investments...... 101,696,056 43,146,332 ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 109,724,392 47,763,052 ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 20,478,377 22,458,903 Net transfers (including fixed account)..................... 11,030,539 19,211,409 Contract charges............... (3,417,107) (2,706,893) Transfers for contract benefits and terminations............. (23,713,080) (23,731,077) ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 4,378,729 15,232,342 ----------------- ---------------- Net increase (decrease) in net assets.............. 114,103,121 62,995,394 NET ASSETS: Beginning of year.............. 329,458,802 266,463,408 ----------------- ---------------- End of year.................... $ 443,561,923 $ 329,458,802 ================= ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 76
N-4150th Page of 530TOC1stPreviousNextBottomJust 150th
The accompanying notes are an integral part of these financial statements. 77
N-4151st Page of 530TOC1stPreviousNextBottomJust 151st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST INVESCO MID CAP VALUE MIST INVESCO SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,314,553) $ (1,633,191) $ (3,674,573) $ (3,709,725) Net realized gains (losses).... 7,722,920 2,663,619 24,585,422 18,783,431 Change in unrealized gains (losses) on investments...... 30,620,411 15,199,656 67,501,884 19,533,978 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 37,028,778 16,230,084 88,412,733 34,607,684 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,155,363 6,093,408 10,016,335 15,838,800 Net transfers (including fixed account)..................... (10,011,007) (3,393,066) 1,587,973 (5,702,899) Contract charges............... (1,678,656) (1,548,008) (2,269,655) (1,966,440) Transfers for contract benefits and terminations............. (7,603,595) (6,237,615) (19,026,821) (14,981,160) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (17,137,895) (5,085,281) (9,692,168) (6,811,699) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 19,890,883 11,144,803 78,720,565 27,795,985 NET ASSETS: Beginning of year.............. 138,149,492 127,004,689 240,468,780 212,672,795 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 158,040,375 $ 138,149,492 $ 319,189,345 $ 240,468,780 ================ ================ ================ ================ MIST MIST JPMORGAN CORE BOND JPMORGAN GLOBAL ACTIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 (b) ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (4,238,910) $ 3,581,213 $ (6,934,561) $ (253,669) Net realized gains (losses).... 24,886,829 5,226,825 2,430,024 1,691,655 Change in unrealized gains (losses) on investments...... (36,171,178) 2,725,888 53,369,009 7,508,587 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (15,523,259) 11,533,926 48,864,472 8,946,573 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,386,585 8,908,512 122,948,435 187,365,819 Net transfers (including fixed account)..................... 1,463,200 (2,442,719) 313,227,408 88,135,164 Contract charges............... (3,775,856) (4,085,255) (6,988,131) (274,498) Transfers for contract benefits and terminations............. (19,173,185) (16,768,257) (13,774,602) (1,600,923) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (19,099,256) (14,387,719) 415,413,110 273,625,562 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (34,622,515) (2,853,793) 464,277,582 282,572,135 NET ASSETS: Beginning of year.............. 346,492,447 349,346,240 282,572,135 -- ---------------- ---------------- ---------------- ---------------- End of year.................... $ 311,869,932 $ 346,492,447 $ 746,849,717 $ 282,572,135 ================ ================ ================ ================ MIST JPMORGAN SMALL CAP VALUE MIST LOOMIS SAYLES GLOBAL MARKETS SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- --------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (280,527) $ (218,746) $ 1,519,876 $ 1,268,388 Net realized gains (losses).... 1,241,336 283,760 5,872,725 2,390,289 Change in unrealized gains (losses) on investments...... 6,048,540 2,823,277 18,236,473 20,641,146 ---------------- ---------------- ---------------- --------------- Net increase (decrease) in net assets resulting from operations............ 7,009,349 2,888,291 25,629,074 24,299,823 ---------------- ---------------- ---------------- --------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 370,757 2,194,628 2,604,900 5,861,547 Net transfers (including fixed account)..................... (1,450,951) (541,359) (13,383,801) (8,628,678) Contract charges............... (290,764) (250,601) (1,759,667) (1,759,286) Transfers for contract benefits and terminations............. (1,786,801) (1,500,264) (10,275,135) (7,011,203) ---------------- ---------------- ---------------- --------------- Net increase (decrease) in net assets resulting from contract transactions...... (3,157,759) (97,596) (22,813,703) (11,537,620) ---------------- ---------------- ---------------- --------------- Net increase (decrease) in net assets.............. 3,851,590 2,790,695 2,815,371 12,762,203 NET ASSETS: Beginning of year.............. 24,014,976 21,224,281 177,780,410 165,018,207 ---------------- ---------------- ---------------- --------------- End of year.................... $ 27,866,566 $ 24,014,976 $ 180,595,781 $ 177,780,410 ================ ================ ================ =============== MIST LORD ABBETT BOND DEBENTURE SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 12,964,602 $ 14,699,205 Net realized gains (losses).... 4,166,635 1,754,535 Change in unrealized gains (losses) on investments...... (1,363,498) 11,202,166 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 15,767,739 27,655,906 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,945,951 4,758,094 Net transfers (including fixed account)..................... 3,690,479 2,066,753 Contract charges............... (1,551,965) (1,668,326) Transfers for contract benefits and terminations............. (27,568,008) (21,909,684) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (22,483,543) (16,753,163) ---------------- ---------------- Net increase (decrease) in net assets.............. (6,715,804) 10,902,743 NET ASSETS: Beginning of year.............. 266,010,291 255,107,548 ---------------- ---------------- End of year.................... $ 259,294,487 $ 266,010,291 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 78
N-4152nd Page of 530TOC1stPreviousNextBottomJust 152nd
The accompanying notes are an integral part of these financial statements. 79
N-4153rd Page of 530TOC1stPreviousNextBottomJust 153rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST MET/FRANKLIN MIST MET/EATON VANCE FLOATING RATE LOW DURATION TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 1,167,863 $ 893,371 $ (409,213) $ 118,242 Net realized gains (losses)..... 371,454 215,912 31,429 24,752 Change in unrealized gains (losses) on investments....... (202,111) 1,524,996 351,282 737,426 ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 1,337,206 2,634,279 (26,502) 880,420 ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 1,243,464 3,005,201 2,247,876 2,001,148 Net transfers (including fixed account)...................... 31,075,652 7,696,712 100,397,861 15,509,501 Contract charges................ (606,811) (455,891) (860,351) (372,941) Transfers for contract benefits and terminations.............. (4,130,678) (2,380,066) (5,061,682) (2,070,016) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 27,581,627 7,865,956 96,723,704 15,067,692 ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 28,918,833 10,500,235 96,697,202 15,948,112 NET ASSETS: Beginning of year............... 54,197,004 43,696,769 43,609,944 27,661,832 ----------------- ---------------- ----------------- ---------------- End of year..................... $ 83,115,837 $ 54,197,004 $ 140,307,146 $ 43,609,944 ================= ================ ================= ================ MIST MET/TEMPLETON INTERNATIONAL BOND MIST METLIFE AGGRESSIVE STRATEGY SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 276,907 $ 4,814,452 $ (5,162,875) $ (5,348,850) Net realized gains (losses)..... 98,819 (394,426) 8,803,988 (2,155,955) Change in unrealized gains (losses) on investments....... (752,953) 1,944,505 141,558,132 83,183,465 ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (377,227) 6,364,531 145,199,245 75,678,660 ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 293,635 1,816,115 6,117,615 14,730,577 Net transfers (including fixed account)...................... (1,527,452) 274,897 344,230 (36,687,365) Contract charges................ (704,031) (735,731) (4,668,056) (4,564,800) Transfers for contract benefits and terminations.............. (2,400,039) (1,811,827) (32,065,600) (28,804,866) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (4,337,887) (456,546) (30,271,811) (55,326,454) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. (4,715,114) 5,907,985 114,927,434 20,352,206 NET ASSETS: Beginning of year............... 57,001,253 51,093,268 545,044,070 524,691,864 ----------------- ---------------- ----------------- ---------------- End of year..................... $ 52,286,139 $ 57,001,253 $ 659,971,504 $ 545,044,070 ================= ================ ================= ================ MIST METLIFE BALANCED PLUS MIST METLIFE BALANCED STRATEGY SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (12,169,666) $ (51,515,645) $ 32,102,742 $ 38,994,505 Net realized gains (losses)..... 109,386,034 -- 83,827,637 19,597,212 Change in unrealized gains (losses) on investments....... 560,925,735 424,121,430 1,085,370,764 737,960,714 ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 658,142,103 372,605,785 1,201,301,143 796,552,431 ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 512,612,376 1,251,910,858 64,210,282 148,711,444 Net transfers (including fixed account)...................... 934,128,079 686,159,234 24,844,873 (193,862,187) Contract charges................ (75,280,741) (42,151,548) (69,900,438) (70,278,541) Transfers for contract benefits and terminations.............. (168,084,256) (87,089,575) (454,179,016) (399,975,900) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 1,203,375,458 1,808,828,969 (435,024,299) (515,405,184) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 1,861,517,561 2,181,434,754 766,276,844 281,147,247 NET ASSETS: Beginning of year............... 4,593,209,415 2,411,774,661 7,045,806,333 6,764,659,086 ----------------- ---------------- ----------------- ---------------- End of year..................... $ 6,454,726,976 $ 4,593,209,415 $ 7,812,083,177 $ 7,045,806,333 ================= ================ ================= ================ MIST METLIFE DEFENSIVE STRATEGY SUB-ACCOUNT ----------------------------------- 2013 2012 ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 31,247,477 $ 27,979,016 Net realized gains (losses)..... 114,843,713 40,608,351 Change in unrealized gains (losses) on investments....... 8,150,548 131,200,155 ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 154,241,738 199,787,522 ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 15,258,041 43,475,387 Net transfers (including fixed account)...................... (342,355,184) 24,870,720 Contract charges................ (21,496,345) (22,681,295) Transfers for contract benefits and terminations.............. (165,714,842) (141,326,271) ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (514,308,330) (95,661,459) ---------------- ----------------- Net increase (decrease) in net assets.............. (360,066,592) 104,126,063 NET ASSETS: Beginning of year............... 2,332,865,728 2,228,739,665 ---------------- ----------------- End of year..................... $ 1,972,799,136 $ 2,332,865,728 ================ ================= (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 80
N-4154th Page of 530TOC1stPreviousNextBottomJust 154th
The accompanying notes are an integral part of these financial statements. 81
N-4155th Page of 530TOC1stPreviousNextBottomJust 155th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST METLIFE GROWTH STRATEGY MIST METLIFE MODERATE STRATEGY SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (12,655,471) $ 1,381,851 $ 28,607,761 $ 37,131,263 Net realized gains (losses).... 48,996,687 (22,087,133) 60,925,288 22,204,509 Change in unrealized gains (losses) on investments...... 1,250,387,461 680,222,228 327,287,238 287,329,954 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 1,286,728,677 659,516,946 416,820,287 346,665,726 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 50,551,717 108,087,013 27,247,167 69,079,528 Net transfers (including fixed account)..................... 738,063,707 (246,783,276) (46,175,969) (27,530,545) Contract charges............... (53,238,434) (48,638,262) (35,004,574) (35,285,870) Transfers for contract benefits and terminations............. (370,695,161) (283,004,290) (214,831,807) (193,516,590) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 364,681,829 (470,338,815) (268,765,183) (187,253,477) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 1,651,410,506 189,178,131 148,055,104 159,412,249 NET ASSETS: Beginning of year.............. 5,115,649,012 4,926,470,881 3,483,723,904 3,324,311,655 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 6,767,059,518 $ 5,115,649,012 $ 3,631,779,008 $ 3,483,723,904 ================ ================ ================ ================ MIST METLIFE MULTI-INDEX TARGETED RISK MIST MFS EMERGING MARKETS EQUITY SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 (c) 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (699,118) $ (7,978) $ (2,103,697) $ (3,386,337) Net realized gains (losses).... 3,617,087 -- 1,835,792 1,870,263 Change in unrealized gains (losses) on investments...... 7,257,662 89,193 (28,154,915) 66,406,442 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 10,175,631 81,215 (28,422,820) 64,890,368 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 48,451,797 10,581,513 18,621,868 37,141,675 Net transfers (including fixed account)..................... 142,884,678 585,564 44,696,703 (611,099) Contract charges............... (796,188) -- (4,647,330) (4,426,432) Transfers for contract benefits and terminations............. (2,006,845) (313) (22,864,787) (17,976,417) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 188,533,442 11,166,764 35,806,454 14,127,727 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 198,709,073 11,247,979 7,383,634 79,018,095 NET ASSETS: Beginning of year.............. 11,247,979 -- 448,693,258 369,675,163 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 209,957,052 $ 11,247,979 $ 456,076,892 $ 448,693,258 ================ ================ ================ ================ MIST MIST MFS RESEARCH INTERNATIONAL MORGAN STANLEY MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 3,181,971 $ 858,851 $ (1,696,520) $ (2,043,749) Net realized gains (losses).... 522,322 (3,635,460) 2,455,142 158,086 Change in unrealized gains (losses) on investments...... 47,772,611 44,865,003 64,718,433 10,495,708 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 51,476,904 42,088,394 65,477,055 8,610,045 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,992,222 12,899,341 30,911,631 44,704,015 Net transfers (including fixed account)..................... (11,184,676) (5,504,513) (5,530,092) 10,647,959 Contract charges............... (2,476,702) (2,406,377) (2,046,240) (1,253,613) Transfers for contract benefits and terminations............. (23,934,709) (21,276,250) (10,333,215) (6,020,714) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (31,603,865) (16,287,799) 13,002,084 48,077,647 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 19,873,039 25,800,595 78,479,139 56,687,692 NET ASSETS: Beginning of year.............. 311,615,422 285,814,827 166,100,095 109,412,403 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 331,488,461 $ 311,615,422 $ 244,579,234 $ 166,100,095 ================ ================ ================ ================ MIST OPPENHEIMER GLOBAL EQUITY SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (523,132) $ (7,496) Net realized gains (losses).... 471,553 25,191 Change in unrealized gains (losses) on investments...... 11,622,690 1,707,146 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 11,571,111 1,724,841 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 974,476 93,332 Net transfers (including fixed account)..................... 59,782,304 42,419 Contract charges............... (334,651) (47,022) Transfers for contract benefits and terminations............. (3,578,136) (1,160,102) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 56,843,993 (1,071,373) ---------------- ---------------- Net increase (decrease) in net assets.............. 68,415,104 653,468 NET ASSETS: Beginning of year.............. 9,983,469 9,330,001 ---------------- ---------------- End of year.................... $ 78,398,573 $ 9,983,469 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 82
N-4156th Page of 530TOC1stPreviousNextBottomJust 156th
The accompanying notes are an integral part of these financial statements. 83
N-4157th Page of 530TOC1stPreviousNextBottomJust 157th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST PIMCO INFLATION PROTECTED BOND MIST PIMCO TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 5,656,555 $ 14,248,598 $ 57,226,440 $ 34,066,251 Net realized gains (losses).... 44,720,235 63,569,905 42,284,668 8,990,391 Change in unrealized gains (losses) on investments...... (156,230,192) (6,836,618) (175,186,613) 116,050,383 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (105,853,402) 70,981,885 (75,675,505) 159,107,025 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 7,816,286 37,089,098 23,558,528 78,337,791 Net transfers (including fixed account)..................... (33,502,041) 43,921,625 (36,143,738) (4,343,112) Contract charges............... (9,760,980) (10,805,997) (21,824,762) (22,953,383) Transfers for contract benefits and terminations............. (58,283,070) (56,743,134) (130,498,036) (116,536,293) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (93,729,805) 13,461,592 (164,908,008) (65,494,997) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. (199,583,207) 84,443,477 (240,583,513) 93,612,028 NET ASSETS: Beginning of year.............. 1,021,039,296 936,595,819 2,234,370,461 2,140,758,433 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 821,456,089 $ 1,021,039,296 $ 1,993,786,948 $ 2,234,370,461 ================ ================ ================= ================ MIST PIONEER FUND MIST PIONEER STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 4,682,697 $ 111,876 $ 30,105,308 $ 23,818,738 Net realized gains (losses).... 4,614,621 453,975 3,348,132 3,201,649 Change in unrealized gains (losses) on investments...... 61,555,660 15,646,585 (32,752,219) 39,967,597 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 70,852,978 16,212,436 701,221 66,987,984 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 28,240,878 44,864,297 95,062,807 151,288,040 Net transfers (including fixed account)..................... (4,702,128) 1,427,489 81,921,721 42,203,327 Contract charges............... (2,681,923) (1,901,589) (7,949,861) (6,040,609) Transfers for contract benefits and terminations............. (13,997,790) (9,026,061) (55,184,071) (49,923,251) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 6,859,037 35,364,136 113,850,596 137,527,507 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 77,712,015 51,576,572 114,551,817 204,515,491 NET ASSETS: Beginning of year.............. 220,043,655 168,467,083 804,777,040 600,261,549 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 297,755,670 $ 220,043,655 $ 919,328,857 $ 804,777,040 ================ ================ ================= ================ MIST PYRAMIS MIST PYRAMIS GOVERNMENT INCOME MANAGED RISK MIST SCHRODERS GLOBAL MULTI-ASSET SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------- ---------------------------------- 2013 2012 2013 (d) 2013 2012 (b) ---------------- ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,187,173 $ (10,117,810) $ 251,733 $ (4,795,245) $ 500,116 Net realized gains (losses).... 2,758,477 1,490,373 1,330,956 2,079,740 3,101,742 Change in unrealized gains (losses) on investments...... (56,847,411) 18,800,148 1,889,489 31,029,531 3,115,131 ---------------- ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (52,901,761) 10,172,711 3,472,178 28,314,026 6,716,989 ---------------- ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 63,436,489 302,268,640 11,152,445 68,362,808 102,099,034 Net transfers (including fixed account)..................... (213,162,045) 203,505,051 64,918,197 161,034,274 84,640,438 Contract charges............... (12,240,571) (8,518,130) (309,972) (4,470,986) (248,694) Transfers for contract benefits and terminations............. (38,279,793) (29,014,385) (815,619) (9,919,594) (1,322,606) ---------------- ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (200,245,920) 468,241,176 74,945,051 215,006,502 185,168,172 ---------------- ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (253,147,681) 478,413,887 78,417,229 243,320,528 191,885,161 NET ASSETS: Beginning of year.............. 968,887,238 490,473,351 -- 191,885,161 -- ---------------- ----------------- ---------------- ---------------- ---------------- End of year.................... $ 715,739,557 $ 968,887,238 $ 78,417,229 $ 435,205,689 $ 191,885,161 ================ ================= ================ ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 84
N-4158th Page of 530TOC1stPreviousNextBottomJust 158th
The accompanying notes are an integral part of these financial statements. 85
N-4159th Page of 530TOC1stPreviousNextBottomJust 159th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MIST SSGA GROWTH AND INCOME ETF MIST SSGA GROWTH ETF SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 15,406,854 $ 13,091,362 $ 2,717,724 $ 1,829,679 Net realized gains (losses).... 56,799,502 42,136,114 25,386,819 23,356,452 Change in unrealized gains (losses) on investments...... 92,923,301 98,280,740 44,458,197 28,469,195 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 165,129,657 153,508,216 72,562,740 53,655,326 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 11,860,244 46,035,006 5,978,512 21,002,248 Net transfers (including fixed account)..................... (37,705,533) (195,586) 6,512,325 (12,945,274) Contract charges............... (18,210,457) (18,086,953) (4,933,205) (4,790,029) Transfers for contract benefits and terminations............. (64,397,713) (50,499,266) (18,680,473) (17,887,141) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (108,453,459) (22,746,799) (11,122,841) (14,620,196) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 56,676,198 130,761,417 61,439,899 39,035,130 NET ASSETS: Beginning of year.............. 1,521,502,479 1,390,741,062 448,167,959 409,132,829 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 1,578,178,677 $ 1,521,502,479 $ 509,607,858 $ 448,167,959 ================ ================ ================= ================ MIST MIST T. ROWE PRICE LARGE CAP VALUE T. ROWE PRICE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 274,524 $ (196,934) $ (7,216,909) $ (7,430,645) Net realized gains (losses).... 12,380,070 (4,291,658) 44,126,921 66,125,790 Change in unrealized gains (losses) on investments...... 154,938,541 84,038,159 116,792,789 (7,225,269) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 167,593,135 79,549,567 153,702,801 51,469,876 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 7,988,896 11,676,417 4,862,681 13,185,984 Net transfers (including fixed account)..................... 4,058,593 (16,072,648) (21,028,467) (5,883,360) Contract charges............... (3,122,742) (2,725,048) (4,805,296) (4,454,613) Transfers for contract benefits and terminations............. (55,363,943) (42,677,000) (31,385,247) (25,927,937) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (46,439,196) (49,798,279) (52,356,329) (23,079,926) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. 121,153,939 29,751,288 101,346,472 28,389,950 NET ASSETS: Beginning of year.............. 536,790,380 507,039,092 467,536,275 439,146,325 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 657,944,319 $ 536,790,380 $ 568,882,747 $ 467,536,275 ================ ================ ================= ================ MIST MSF THIRD AVENUE SMALL CAP VALUE BAILLIE GIFFORD INTERNATIONAL STOCK SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ------------------------------------ 2013 2012 2013 2012 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,972,508) $ (4,874,313) $ (3,165,848) $ (13,133) Net realized gains (losses).... 14,422,998 4,677,378 1,385,436 (385,254) Change in unrealized gains (losses) on investments...... 71,078,415 44,432,620 31,198,214 847,778 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 83,528,905 44,235,685 29,417,802 449,391 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,497,715 6,340,050 1,422,162 3,449 Net transfers (including fixed account)..................... (16,141,981) (30,637,666) 282,688,482 78,870 Contract charges............... (2,257,569) (2,277,977) (2,205,156) (851) Transfers for contract benefits and terminations............. (24,465,425) (20,652,202) (10,455,850) (748,795) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (40,367,260) (47,227,795) 271,449,638 (667,327) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 43,161,645 (2,992,110) 300,867,440 (217,936) NET ASSETS: Beginning of year.............. 287,540,317 290,532,427 2,585,607 2,803,543 ---------------- ----------------- ---------------- ---------------- End of year.................... $ 330,701,962 $ 287,540,317 $ 303,453,047 $ 2,585,607 ================ ================= ================ ================ MSF BARCLAYS AGGREGATE BOND INDEX SUB-ACCOUNT ----------------------------------- 2013 2012 ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 2,684,004 $ 2,743,171 Net realized gains (losses).... (145,067) 313,783 Change in unrealized gains (losses) on investments...... (8,883,122) (228,315) ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (6,344,185) 2,828,639 ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 11,149,289 8,092,766 Net transfers (including fixed account)..................... 15,951,296 18,316,110 Contract charges............... (1,698,851) (1,557,565) Transfers for contract benefits and terminations............. (8,039,466) (6,300,163) ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 17,362,268 18,551,148 ----------------- ---------------- Net increase (decrease) in net assets.............. 11,018,083 21,379,787 NET ASSETS: Beginning of year.............. 151,553,766 130,173,979 ----------------- ---------------- End of year.................... $ 162,571,849 $ 151,553,766 ================= ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 86
N-4160th Page of 530TOC1stPreviousNextBottomJust 160th
The accompanying notes are an integral part of these financial statements. 87
N-4161st Page of 530TOC1stPreviousNextBottomJust 161st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MSF MSF BLACKROCK BOND INCOME BLACKROCK CAPITAL APPRECIATION SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,256,228 $ 421,147 $ (112,438) $ (164,210) Net realized gains (losses).... 1,515,855 610,488 691,188 625,272 Change in unrealized gains (losses) on investments...... (4,322,733) 1,764,307 3,229,055 1,002,738 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (1,550,650) 2,795,942 3,807,805 1,463,800 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,100,261 7,467,492 1,032,741 1,584,174 Net transfers (including fixed account)..................... 1,673,798 3,261,765 (69,939) (1,606,379) Contract charges............... (567,749) (523,968) (108,766) (99,934) Transfers for contract benefits and terminations............. (5,292,686) (4,651,283) (1,221,109) (858,701) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 913,624 5,554,006 (367,073) (980,840) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (637,026) 8,349,948 3,440,732 482,960 NET ASSETS: Beginning of year.............. 57,888,933 49,538,985 11,831,610 11,348,650 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 57,251,907 $ 57,888,933 $ 15,272,342 $ 11,831,610 ================ ================ ================ ================ MSF BLACKROCK LARGE CAP VALUE MSF BLACKROCK MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,769 $ 7,990 $ (8,012,597) $ (9,036,407) Net realized gains (losses).... 196,427 387,537 -- -- Change in unrealized gains (losses) on investments...... 706,190 (36,111) -- -- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 904,386 359,416 (8,012,597) (9,036,407) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 170,505 199,805 35,808,232 73,504,419 Net transfers (including fixed account)..................... 180,009 (190,041) (7,315,471) (7,665,689) Contract charges............... (147) (160) (5,349,795) (5,431,164) Transfers for contract benefits and terminations............. (439,359) (282,152) (122,897,380) (115,886,270) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (88,992) (272,548) (99,754,414) (55,478,704) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 815,394 86,868 (107,767,011) (64,515,111) NET ASSETS: Beginning of year.............. 2,977,532 2,890,664 569,109,901 633,625,012 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 3,792,926 $ 2,977,532 $ 461,342,890 $ 569,109,901 ================ ================ ================ ================ MSF FRONTIER MSF DAVIS VENTURE VALUE MID CAP GROWTH MSF JENNISON GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------- ---------------------------------- 2013 2012 2013 (d) 2013 2012 ---------------- ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,024,413) $ (5,420,518) $ (897,791) $ (7,335,002) $ (6,766,082) Net realized gains (losses).... 40,523,317 16,667,444 1,222,819 20,299,862 52,244,975 Change in unrealized gains (losses) on investments...... 130,538,788 50,920,457 14,503,587 145,943,839 (18,349,887) ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 169,037,692 62,167,383 14,828,615 158,908,699 27,129,006 ---------------- ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,918,436 14,661,575 339,204 3,447,603 10,762,342 Net transfers (including fixed account)..................... (37,323,562) (59,639,705) 73,026,037 (2,923,592) 213,225,860 Contract charges............... (4,862,149) (5,059,157) (461,156) (3,962,178) (3,408,013) Transfers for contract benefits and terminations............. (46,536,304) (38,956,468) (4,081,537) (38,611,159) (27,116,459) ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (82,803,579) (88,993,755) 68,822,548 (42,049,326) 193,463,730 ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 86,234,113 (26,826,372) 83,651,163 116,859,373 220,592,736 NET ASSETS: Beginning of year.............. 572,327,325 599,153,697 -- 468,764,846 248,172,110 ---------------- ---------------- ---------------- ---------------- ---------------- End of year.................... $ 658,561,438 $ 572,327,325 $ 83,651,163 $ 585,624,219 $ 468,764,846 ================ ================ ================ ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 88
N-4162nd Page of 530TOC1stPreviousNextBottomJust 162nd
The accompanying notes are an integral part of these financial statements. 89
N-4163rd Page of 530TOC1stPreviousNextBottomJust 163rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MSF MSF LOOMIS SAYLES SMALL CAP CORE LOOMIS SAYLES SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2013 2012 2013 2012 (b) ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (200,052) $ (204,728) $ (1,411) $ (109) Net realized gains (losses).... 1,982,997 586,780 10,812 1 Change in unrealized gains (losses) on investments...... 2,464,698 882,105 37,804 1,023 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 4,247,643 1,264,157 47,205 915 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 344,417 1,667,845 71,019 37,207 Net transfers (including fixed account)..................... (1,074,960) (236,709) 72,654 2,807 Contract charges............... (173,285) (146,127) (292) -- Transfers for contract benefits and terminations............. (1,065,267) (534,188) (4,711) (2) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (1,969,095) 750,821 138,670 40,012 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets............. 2,278,548 2,014,978 185,875 40,927 NET ASSETS: Beginning of year.............. 12,332,225 10,317,247 40,927 -- ---------------- ----------------- ---------------- ---------------- End of year.................... $ 14,610,773 $ 12,332,225 $ 226,802 $ 40,927 ================ ================= ================ ================ MSF MET/DIMENSIONAL MSF MET/ARTISAN MID CAP VALUE INTERNATIONAL SMALL COMPANY SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,081,656) $ (1,777,619) $ 75,530 $ 301,440 Net realized gains (losses).... 2,704,503 (3,905,883) 2,053,871 3,990,436 Change in unrealized gains (losses) on investments...... 71,939,639 26,191,820 11,472,763 3,392,556 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 72,562,486 20,508,318 13,602,164 7,684,432 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,406,731 4,670,705 946,915 2,031,164 Net transfers (including fixed account)..................... 15,760,862 (4,614,193) 2,187,268 (1,495,504) Contract charges............... (1,572,787) (1,472,349) (559,879) (519,052) Transfers for contract benefits and terminations............. (20,643,858) (17,348,925) (2,632,342) (2,307,911) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (4,049,052) (18,764,762) (58,038) (2,291,303) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets............. 68,513,434 1,743,556 13,544,126 5,393,129 NET ASSETS: Beginning of year.............. 217,257,576 215,514,020 52,618,293 47,225,164 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 285,771,010 $ 217,257,576 $ 66,162,419 $ 52,618,293 ================ ================ ================= ================ MSF METLIFE MSF METLIFE CONSERVATIVE ALLOCATION CONSERVATIVE TO MODERATE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2013 2012 2013 2012 ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 123,598 $ 152,780 $ 60,178 $ 85,571 Net realized gains (losses).... 324,295 493,943 205,663 122,762 Change in unrealized gains (losses) on investments...... (227,599) 57,363 395,866 444,706 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 220,294 704,086 661,707 653,039 ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- 26,093 -- 7,045 Net transfers (including fixed account)..................... (726,171) (539,314) 151,035 495,113 Contract charges............... (83,224) (83,156) (63,032) (61,615) Transfers for contract benefits and terminations............. (1,568,517) (848,031) (594,121) (660,740) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (2,377,912) (1,444,408) (506,118) (220,197) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. (2,157,618) (740,322) 155,589 432,842 NET ASSETS: Beginning of year.............. 9,655,026 10,395,348 7,576,787 7,143,945 ----------------- ---------------- ---------------- ---------------- End of year.................... $ 7,497,408 $ 9,655,026 $ 7,732,376 $ 7,576,787 ================= ================ ================ ================ MSF METLIFE MID CAP STOCK INDEX SUB-ACCOUNT ----------------------------------- 2013 2012 ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (566,013) $ (572,617) Net realized gains (losses).... 6,964,753 4,370,936 Change in unrealized gains (losses) on investments...... 23,599,476 8,138,980 ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 29,998,216 11,937,299 ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,805,517 5,096,199 Net transfers (including fixed account)..................... 9,018,341 (1,239,620) Contract charges............... (966,588) (736,669) Transfers for contract benefits and terminations............. (4,961,109) (3,873,437) ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 6,896,161 (753,527) ----------------- ---------------- Net increase (decrease) in net assets............. 36,894,377 11,183,772 NET ASSETS: Beginning of year.............. 88,989,701 77,805,929 ----------------- ---------------- End of year.................... $ 125,884,078 $ 88,989,701 ================= ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 90
N-4164th Page of 530TOC1stPreviousNextBottomJust 164th
The accompanying notes are an integral part of these financial statements. 91
N-4165th Page of 530TOC1stPreviousNextBottomJust 165th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MSF METLIFE MSF METLIFE MODERATE ALLOCATION MODERATE TO AGGRESSIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 111,426 $ 277,463 $ (147,761) $ 87,401 Net realized gains (losses).... 1,018,931 338,723 927,158 (18,329) Change in unrealized gains (losses) on investments...... 5,244,250 3,990,206 10,180,246 6,305,708 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 6,374,607 4,606,392 10,959,643 6,374,780 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 333,489 235,760 209,284 490,083 Net transfers (including fixed account)..................... 189,896 (2,028,081) (1,014,032) (857,665) Contract charges............... (368,244) (397,645) (511,319) (518,714) Transfers for contract benefits and terminations............. (3,563,775) (5,009,708) (4,103,646) (2,489,601) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (3,408,634) (7,199,674) (5,419,713) (3,375,897) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 2,965,973 (2,593,282) 5,539,930 2,998,883 NET ASSETS: Beginning of year.............. 41,689,448 44,282,730 51,720,857 48,721,974 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 44,655,421 $ 41,689,448 $ 57,260,787 $ 51,720,857 ================ ================ ================ ================ MSF METLIFE STOCK INDEX MSF MFS TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 126,616 $ (576,725) $ 297,490 $ 424,862 Net realized gains (losses).... 23,490,755 16,988,226 439,651 (156,072) Change in unrealized gains (losses) on investments...... 106,939,595 36,899,374 5,520,960 3,058,830 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 130,556,966 53,310,875 6,258,101 3,327,620 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 9,905,483 13,972,783 2,347,250 2,818,361 Net transfers (including fixed account)..................... 10,729,964 52,688,716 5,946,371 (315,421) Contract charges............... (3,364,435) (2,778,637) (195,752) (109,645) Transfers for contract benefits and terminations............. (33,312,519) (26,428,489) (3,656,176) (6,767,115) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (16,041,507) 37,454,373 4,441,693 (4,373,820) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 114,515,459 90,765,248 10,699,794 (1,046,200) NET ASSETS: Beginning of year.............. 446,759,028 355,993,780 35,344,618 36,390,818 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 561,274,487 $ 446,759,028 $ 46,044,412 $ 35,344,618 ================ ================ ================ ================ MSF MFS VALUE MSF MSCI EAFE INDEX SUB-ACCOUNT SUB-ACCOUNT --------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- --------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,920,146) $ 114,295 $ 1,388,628 $ 1,054,723 Net realized gains (losses).... 5,190,690 1,137,911 1,008,944 (680,643) Change in unrealized gains (losses) on investments...... 43,048,658 5,105,739 15,456,919 11,210,227 ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 46,319,202 6,357,945 17,854,491 11,584,307 ---------------- --------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,226,292 4,333,740 3,337,616 5,049,892 Net transfers (including fixed account)..................... 176,696,995 (2,214,337) 14,653,612 (493,052) Contract charges............... (1,727,489) (405,280) (946,782) (714,896) Transfers for contract benefits and terminations............. (12,316,297) (3,551,720) (4,106,316) (3,180,913) ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 165,879,501 (1,837,597) 12,938,130 661,031 ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 212,198,703 4,520,348 30,792,621 12,245,338 NET ASSETS: Beginning of year.............. 48,275,261 43,754,913 81,404,548 69,159,210 ---------------- --------------- ---------------- ---------------- End of year.................... $ 260,473,964 $ 48,275,261 $ 112,197,169 $ 81,404,548 ================ =============== ================ ================ MSF NEUBERGER BERMAN GENESIS SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,702,008) $ (124,305) Net realized gains (losses).... 2,307,614 (160,855) Change in unrealized gains (losses) on investments...... 36,584,374 1,235,418 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 37,189,980 950,258 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,534,745 1,660,390 Net transfers (including fixed account)..................... 130,824,603 (1,236,464) Contract charges............... (883,958) (14,681) Transfers for contract benefits and terminations............. (8,216,818) (827,588) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 123,258,572 (418,343) ---------------- ---------------- Net increase (decrease) in net assets.............. 160,448,552 531,915 NET ASSETS: Beginning of year.............. 11,798,908 11,266,993 ---------------- ---------------- End of year.................... $ 172,247,460 $ 11,798,908 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 92
N-4166th Page of 530TOC1stPreviousNextBottomJust 166th
The accompanying notes are an integral part of these financial statements. 93
N-4167th Page of 530TOC1stPreviousNextBottomJust 167th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] MSF MSF RUSSELL 2000 INDEX T. ROWE PRICE LARGE CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (279,727) $ (489,405) $ (1,361,307) $ (26,562) Net realized gains (losses).... 2,980,519 3,012,181 1,274,164 134,449 Change in unrealized gains (losses) on investments...... 32,072,788 8,632,997 29,734,972 129,142 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 34,773,580 11,155,773 29,647,829 237,029 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,036,517 4,246,140 1,216,598 3,080 Net transfers (including fixed account)..................... 17,108,088 16,541,440 125,845,085 255,979 Contract charges............... (979,907) (752,572) (670,738) (569) Transfers for contract benefits and terminations............. (4,618,795) (3,521,274) (5,610,315) (459,528) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 14,545,903 16,513,734 120,780,630 (201,038) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 49,319,483 27,669,507 150,428,459 35,991 NET ASSETS: Beginning of year.............. 91,750,975 64,081,468 1,501,612 1,465,621 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 141,070,458 $ 91,750,975 $ 151,930,071 $ 1,501,612 ================ ================ ================ ================ MSF MSF T. ROWE PRICE SMALL CAP GROWTH VAN ECK GLOBAL NATURAL RESOURCES SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (118,410) $ (120,658) $ (992,724) $ (1,735,261) Net realized gains (losses).... 1,190,765 1,108,096 (2,668,683) 5,438,424 Change in unrealized gains (losses) on investments...... 2,047,671 44,932 13,797,608 (1,471,349) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 3,120,026 1,032,370 10,136,201 2,231,814 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 217,643 162,113 944,635 3,689,394 Net transfers (including fixed account)..................... 76,680 (200,702) (11,189,728) 4,851,544 Contract charges............... (65,804) (62,062) (1,460,573) (1,484,490) Transfers for contract benefits and terminations............. (634,727) (622,866) (3,878,019) (3,724,214) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (406,208) (723,517) (15,583,685) 3,332,234 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 2,713,818 308,853 (5,447,484) 5,564,048 NET ASSETS: Beginning of year.............. 7,808,995 7,500,142 111,896,983 106,332,935 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 10,522,813 $ 7,808,995 $ 106,449,499 $ 111,896,983 ================ ================ ================ ================ MSF WESTERN ASSET MANAGEMENT U.S. GOVERNMENT NEUBERGER BERMAN GENESIS SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,546,993 $ 1,122,805 $ (53) $ (52) Net realized gains (losses).... 12,769 531,096 749 348 Change in unrealized gains (losses) on investments...... (8,825,000) 2,934,349 2,197 363 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (7,265,238) 4,588,250 2,893 659 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 17,581,036 39,776,656 -- -- Net transfers (including fixed account)..................... (7,036,962) 8,514,246 -- -- Contract charges............... (3,057,823) (2,890,949) -- -- Transfers for contract benefits and terminations............. (21,660,910) (22,207,896) (3) (1) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (14,174,659) 23,192,057 (3) (1) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (21,439,897) 27,780,307 2,890 658 NET ASSETS: Beginning of year.............. 313,310,285 285,529,978 8,101 7,443 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 291,870,388 $ 313,310,285 $ 10,991 $ 8,101 ================ ================ ================ ================ OPPENHEIMER VA CORE BOND SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 335 $ 311 Net realized gains (losses).... (126) (598) Change in unrealized gains (losses) on investments...... (342) 1,084 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (133) 797 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- -- Net transfers (including fixed account)..................... -- -- Contract charges............... -- -- Transfers for contract benefits and terminations............. (279) (1,889) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (279) (1,889) ---------------- ---------------- Net increase (decrease) in net assets.............. (412) (1,092) NET ASSETS: Beginning of year.............. 9,058 10,150 ---------------- ---------------- End of year.................... $ 8,646 $ 9,058 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 94
N-4168th Page of 530TOC1stPreviousNextBottomJust 168th
The accompanying notes are an integral part of these financial statements. 95
N-4169th Page of 530TOC1stPreviousNextBottomJust 169th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] OPPENHEIMER VA GLOBAL STRATEGIC INCOME OPPENHEIMER VA MAIN STREET SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 164 $ 199 $ (280) $ (512) Net realized gains (losses).... 8 54 1,403 4,748 Change in unrealized gains (losses) on investments...... (240) 229 23,373 10,567 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ (68) 482 24,496 14,803 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- -- -- -- Net transfers (including fixed account)..................... -- 5 -- -- Contract charges............... -- -- -- -- Transfers for contract benefits and terminations............. (2) -- (4,120) (38,440) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (2) 5 (4,120) (38,440) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (70) 487 20,376 (23,637) NET ASSETS: Beginning of year.............. 4,562 4,075 83,663 107,300 ---------------- ---------------- ---------------- ----------------- End of year.................... $ 4,492 $ 4,562 $ 104,039 $ 83,663 ================ ================ ================ ================= OPPENHEIMER VA MAIN STREET SMALL CAP OPPENHEIMER VA MONEY SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (725,297) $ (928,472) $ (102) $ (1,590) Net realized gains (losses).... 6,330,488 1,063,609 -- -- Change in unrealized gains (losses) on investments...... 30,298,071 13,086,051 -- -- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 35,903,262 13,221,188 (102) (1,590) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 7,423,119 7,613,898 -- -- Net transfers (including fixed account)..................... (9,338,929) (1,388,199) -- -- Contract charges............... (1,036,361) (862,843) -- -- Transfers for contract benefits and terminations............. (5,997,839) (3,986,210) (108,863) (154) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (8,950,010) 1,376,646 (108,863) (154) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 26,953,252 14,597,834 (108,965) (1,744) NET ASSETS: Beginning of year.............. 96,092,155 81,494,321 112,965 114,709 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 123,045,407 $ 96,092,155 $ 4,000 $ 112,965 ================ ================ ================ ================ PIONEER VCT DISCIPLINED VALUE PIONEER VCT EMERGING MARKETS SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,598 $ (11,306) $ (4,954) $ (11,558) Net realized gains (losses).... 284,647 39,918 (140) 25,278 Change in unrealized gains (losses) on investments...... 226,657 154,904 (21,981) 54,203 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 512,902 183,516 (27,075) 67,923 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,355 3,689 1,280 3,564 Net transfers (including fixed account)..................... (515,063) (8,654) 14,296 97,437 Contract charges............... (26,379) (24,154) (8,404) (8,283) Transfers for contract benefits and terminations............. (107,501) (53,735) (49,534) (75,321) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (646,588) (82,854) (42,362) 17,397 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. (133,686) 100,662 (69,437) 85,320 NET ASSETS: Beginning of year.............. 2,136,823 2,036,161 791,020 705,700 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 2,003,137 $ 2,136,823 $ 721,583 $ 791,020 ================ ================ ================= ================ PIONEER VCT EQUITY INCOME SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 3,468 $ 11,313 Net realized gains (losses).... 17,885 4,300 Change in unrealized gains (losses) on investments...... 119,241 22,355 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 140,594 37,968 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,835 3,646 Net transfers (including fixed account)..................... (47,268) 142,735 Contract charges............... (6,096) (5,521) Transfers for contract benefits and terminations............. (1,161) (1,130) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (51,690) 139,730 ---------------- ---------------- Net increase (decrease) in net assets.............. 88,904 177,698 NET ASSETS: Beginning of year.............. 548,970 371,272 ---------------- ---------------- End of year.................... $ 637,874 $ 548,970 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 96
N-4170th Page of 530TOC1stPreviousNextBottomJust 170th
The accompanying notes are an integral part of these financial statements. 97
N-4171st Page of 530TOC1stPreviousNextBottomJust 171st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] PIONEER VCT PIONEER VCT IBBOTSON GROWTH ALLOCATION IBBOTSON MODERATE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ---------------------------------- 2013 2012 2013 2012 ----------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 22,729 $ 19,019 $ 228,243 $ 255,252 Net realized gains (losses)..... 774,226 369,421 856,488 292,055 Change in unrealized gains (losses) on investments....... 2,367,042 1,375,293 2,920,605 2,023,933 ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 3,163,997 1,763,733 4,005,336 2,571,240 ----------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 85,890 641,966 148,361 195,281 Net transfers (including fixed account)...................... 268,913 (586,915) (864,929) 603,458 Contract charges................ (180,697) (176,884) (364,481) (347,432) Transfers for contract benefits and terminations.............. (1,602,862) (271,037) (1,164,852) (549,849) ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,428,756) (392,870) (2,245,901) (98,542) ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 1,735,241 1,370,863 1,759,435 2,472,698 NET ASSETS: Beginning of year............... 19,107,227 17,736,364 28,441,628 25,968,930 ----------------- ----------------- ---------------- ---------------- End of year..................... $ 20,842,468 $ 19,107,227 $ 30,201,063 $ 28,441,628 ================= ================= ================ ================ PIONEER VCT MID CAP VALUE PIONEER VCT REAL ESTATE SHARES SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ------------------------------------ 2013 2012 2013 2012 ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (422,216) $ (308,091) $ 1,359 $ 1,265 Net realized gains (losses)..... 856,609 (22,002) 18,057 26,262 Change in unrealized gains (losses) on investments....... 16,961,029 4,990,668 (19,131) 8,731 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 17,395,422 4,660,575 285 36,258 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 5,065,892 7,895,929 895 1,012 Net transfers (including fixed account)...................... (2,540,776) 302,978 17,963 3,518 Contract charges................ (481,800) (363,551) (2,841) (2,765) Transfers for contract benefits and terminations.............. (3,983,623) (5,196,081) (1,163) (52,356) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,940,307) 2,639,275 14,854 (50,591) ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets.............. 15,455,115 7,299,850 15,139 (14,333) NET ASSETS: Beginning of year............... 56,444,927 49,145,077 237,514 251,847 ----------------- ----------------- ----------------- ----------------- End of year..................... $ 71,900,042 $ 56,444,927 $ 252,653 $ 237,514 ================= ================= ================= ================= T. ROWE PRICE GROWTH STOCK T. ROWE PRICE INTERNATIONAL STOCK SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ---------------------------------- 2013 2012 2013 2012 ----------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (60,820) $ (47,423) $ 503 $ 2,166 Net realized gains (losses)..... 357,589 237,825 10,324 (5,645) Change in unrealized gains (losses) on investments....... 2,047,793 849,311 71,247 113,047 ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 2,344,562 1,039,713 82,074 109,568 ----------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 219,130 218,037 21,103 27,542 Net transfers (including fixed account)...................... (113,852) (456,841) (7,638) (158,822) Contract charges................ (1,536) (1,517) (151) (158) Transfers for contract benefits and terminations.............. (513,697) (410,744) (79,868) (43,778) ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (409,955) (651,065) (66,554) (175,216) ----------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 1,934,607 388,648 15,520 (65,648) NET ASSETS: Beginning of year............... 6,404,585 6,015,937 639,881 705,529 ----------------- ----------------- ---------------- ---------------- End of year..................... $ 8,339,192 $ 6,404,585 $ 655,401 $ 639,881 ================= ================= ================ ================ T. ROWE PRICE PRIME RESERVE SUB-ACCOUNT ---------------------------------- 2013 2012 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (6,339) $ (7,879) Net realized gains (losses)..... -- -- Change in unrealized gains (losses) on investments....... -- -- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (6,339) (7,879) ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 208 301 Net transfers (including fixed account)...................... (93,657) (199,272) Contract charges................ (155) (187) Transfers for contract benefits and terminations.............. (64,754) (43,573) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (158,358) (242,731) ---------------- ---------------- Net increase (decrease) in net assets.............. (164,697) (250,610) NET ASSETS: Beginning of year............... 723,146 973,756 ---------------- ---------------- End of year..................... $ 558,449 $ 723,146 ================ ================ (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 98
N-4172nd Page of 530TOC1stPreviousNextBottomJust 172nd
The accompanying notes are an integral part of these financial statements. 99
N-4173rd Page of 530TOC1stPreviousNextBottomJust 173rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY STATEMENTS OF CHANGES IN NET ASSETS -- (CONCLUDED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 [Enlarge/Download Table] UIF U.S. REAL ESTATE SUB-ACCOUNT ------------------------------------ 2013 2012 ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)............................................................... $ (322,967) $ (505,482) Net realized gains (losses)................................................................ (34,211) (531,267) Change in unrealized gains (losses) on investments.................................................................. 392,749 11,927,777 ----------------- ----------------- Net increase (decrease) in net assets resulting from operations....................................................................... 35,571 10,891,028 ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners..................................................................... 11,431,975 13,220,555 Net transfers (including fixed account)................................................................................. 5,853,586 684,788 Contract charges........................................................................... (713,884) (537,546) Transfers for contract benefits and terminations......................................................................... (6,390,221) (10,065,780) ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions................................................................. 10,181,456 3,302,017 ----------------- ----------------- Net increase (decrease) in net assets......................................................................... 10,217,027 14,193,045 NET ASSETS: Beginning of year.......................................................................... 90,757,950 76,564,905 ----------------- ----------------- End of year................................................................................ $ 100,974,977 $ 90,757,950 ================= ================= (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 100
N-4174th Page of 530TOC1stPreviousNextBottomJust 174th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS 1. ORGANIZATION MetLife Investors USA Separate Account A (the "Separate Account"), a separate account of MetLife Investors USA Insurance Company (the "Company"), was established by the Company's Board of Directors on May 29, 1980 to support operations of the Company with respect to certain variable annuity contracts (the "Contracts"). The Company is an indirect wholly-owned subsidiary of MetLife, Inc., a Delaware corporation. The Separate Account is registered as a unit investment trust under the Investment Company Act of 1940, as amended, and exists in accordance with the regulations of the Delaware Department of Insurance. In the second quarter of 2013, MetLife, Inc. announced its plans to merge into MetLife Insurance Company of Connecticut ("MICC"), as the surviving entity, two United States ("U.S.")-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company, which is expected to be renamed and domiciled in Delaware (the "Mergers"). The companies to be merged into MICC consist of the Company and MetLife Investors Insurance Company, each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. ("Exeter"), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. The Separate Account is divided into Sub-Accounts, each of which is treated as an individual accounting entity for financial reporting purposes. Each Sub-Account invests in shares of the corresponding portfolio, series, or fund (with the same name) of registered investment management companies (the "Trusts"), which are presented below: [Enlarge/Download Table] AIM Variable Insurance Funds (Invesco Variable Met Investors Series Trust ("MIST")* Insurance Funds) ("Invesco V.I.") Metropolitan Series Fund ("MSF")* American Funds Insurance Series ("American Funds") MFS Variable Insurance Trust ("MFS VIT") DWS Variable Series I ("DWS I") Neuberger Berman Equity Funds ("Neuberger Berman") Federated Insurance Series ("Federated") Oppenheimer Variable Account Funds Fidelity Variable Insurance Products ("Fidelity VIP") ("Oppenheimer VA") Franklin Templeton Variable Insurance Products Trust Pioneer Variable Contracts Trust ("Pioneer VCT") ("FTVIPT") T. Rowe Price Growth Stock Fund, Inc. Janus Aspen Series ("Janus Aspen") T. Rowe Price International Funds, Inc. Legg Mason Partners Variable Equity Trust T. Rowe Price Prime Reserve Fund, Inc. ("LMPVET") The Alger Portfolios ("Alger") Legg Mason Partners Variable Income Trust The Universal Institutional Funds, Inc. ("UIF") ("LMPVIT") * See Note 5 for a discussion of additional information on related party transactions. The assets of each of the Sub-Accounts of the Separate Account are registered in the name of the Company. Under applicable insurance law, the assets and liabilities of the Separate Account are clearly identified and distinguished from the Company's other assets and liabilities. The portion of the Separate Account's assets applicable to the Contracts is not chargeable with liabilities arising out of any other business the Company may conduct. 101
N-4175th Page of 530TOC1stPreviousNextBottomJust 175th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. LIST OF SUB-ACCOUNTS Purchase payments, less any applicable charges, applied to the Separate Account are invested in one or more Sub-Accounts in accordance with the selection made by the contract owner. The following Sub-Accounts had net assets as of December 31, 2013: [Enlarge/Download Table] Alger Small Cap Growth Sub-Account LMPVET ClearBridge Variable Large Cap Value American Funds Bond Sub-Account Sub-Account American Funds Global Growth Sub-Account LMPVET ClearBridge Variable Small Cap Growth American Funds Global Small Capitalization Sub-Account Sub-Account LMPVET Investment Counsel Variable Social American Funds Growth Sub-Account Awareness Sub-Account American Funds Growth-Income Sub-Account LMPVET Variable Lifestyle Allocation 50% DWS I International Sub-Account Sub-Account Federated High Income Bond Sub-Account LMPVET Variable Lifestyle Allocation 70% Federated Kaufman Sub-Account Sub-Account Fidelity VIP Asset Manager Sub-Account LMPVET Variable Lifestyle Allocation 85% Fidelity VIP Contrafund Sub-Account (a) Sub-Account Fidelity VIP Equity-Income Sub-Account LMPVIT Western Asset Variable Global High Yield Fidelity VIP FundsManager 50% Sub-Account Bond Sub-Account Fidelity VIP FundsManager 60% Sub-Account MFS VIT Investors Trust Sub-Account Fidelity VIP Growth Sub-Account MFS VIT New Discovery Sub-Account Fidelity VIP Index 500 Sub-Account MFS VIT Research Sub-Account Fidelity VIP Mid Cap Sub-Account MIST AllianceBernstein Global Dynamic Allocation Fidelity VIP Money Market Sub-Account (a) Sub-Account Fidelity VIP Overseas Sub-Account MIST American Funds Balanced Allocation FTVIPT Franklin Income Securities Sub-Account Sub-Account FTVIPT Franklin Small Cap Value Securities MIST American Funds Growth Allocation Sub-Account Sub-Account FTVIPT Mutual Shares Securities Sub-Account MIST American Funds Growth Sub-Account FTVIPT Templeton Foreign Securities Sub-Account MIST American Funds Moderate Allocation FTVIPT Templeton Global Bond Securities Sub-Account Sub-Account Invesco V.I. American Franchise Sub-Account MIST AQR Global Risk Balanced Sub-Account Invesco V.I. American Value Sub-Account MIST BlackRock Global Tactical Strategies Invesco V.I. Core Equity Sub-Account Sub-Account Invesco V.I. Equity and Income Sub-Account (a) MIST BlackRock High Yield Sub-Account (a) Invesco V.I. Global Real Estate Sub-Account MIST BlackRock Large Cap Core Sub-Account (a) Invesco V.I. Growth and Income Sub-Account (a) MIST Clarion Global Real Estate Sub-Account Invesco V.I. International Growth Sub-Account (a) MIST ClearBridge Aggressive Growth Sub-Account Janus Aspen Global Research Sub-Account MIST ClearBridge Aggressive Growth II LMPVET ClearBridge Variable Aggressive Growth Sub-Account (a) Sub-Account (a) MIST Goldman Sachs Mid Cap Value Sub-Account LMPVET ClearBridge Variable All Cap Value MIST Harris Oakmark International Sub-Account (a) Sub-Account MIST Invesco Balanced-Risk Allocation Sub-Account LMPVET ClearBridge Variable Appreciation MIST Invesco Comstock Sub-Account Sub-Account MIST Invesco Mid Cap Value Sub-Account LMPVET ClearBridge Variable Equity Income MIST Invesco Small Cap Growth Sub-Account (a) Sub-Account (a) MIST JPMorgan Core Bond Sub-Account LMPVET ClearBridge Variable Large Cap Growth MIST JPMorgan Global Active Allocation Sub-Account Sub-Account 102
N-4176th Page of 530TOC1stPreviousNextBottomJust 176th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. LIST OF SUB-ACCOUNTS -- (CONCLUDED) [Enlarge/Download Table] MIST JPMorgan Small Cap Value Sub-Account (a) MSF Met/Artisan Mid Cap Value Sub-Account (a) MIST Loomis Sayles Global Markets Sub-Account MSF Met/Dimensional International Small Company MIST Lord Abbett Bond Debenture Sub-Account (a) Sub-Account MIST Met/Eaton Vance Floating Rate Sub-Account MSF MetLife Conservative Allocation Sub-Account MIST Met/Franklin Low Duration Total Return MSF MetLife Conservative to Moderate Allocation Sub-Account Sub-Account MIST Met/Templeton International Bond Sub-Account MSF MetLife Mid Cap Stock Index Sub-Account (a) MIST MetLife Aggressive Strategy Sub-Account MSF MetLife Moderate Allocation Sub-Account MIST MetLife Balanced Plus Sub-Account MSF MetLife Moderate to Aggressive Allocation MIST MetLife Balanced Strategy Sub-Account Sub-Account MIST MetLife Defensive Strategy Sub-Account MSF MetLife Stock Index Sub-Account (a) MIST MetLife Growth Strategy Sub-Account MSF MFS Total Return Sub-Account (a) MIST MetLife Moderate Strategy Sub-Account MSF MFS Value Sub-Account (a) MIST MetLife Multi-Index Targeted Risk MSF MSCI EAFE Index Sub-Account (a) Sub-Account MSF Neuberger Berman Genesis Sub-Account (a) MIST MFS Emerging Markets Equity Sub-Account MSF Russell 2000 Index Sub-Account (a) MIST MFS Research International Sub-Account (a) MSF T. Rowe Price Large Cap Growth Sub-Account (a) MIST Morgan Stanley Mid Cap Growth Sub-Account (a) MSF T. Rowe Price Small Cap Growth Sub-Account (a) MIST Oppenheimer Global Equity Sub-Account MSF Van Eck Global Natural Resources Sub-Account MIST PIMCO Inflation Protected Bond Sub-Account MSF Western Asset Management U.S. Government MIST PIMCO Total Return Sub-Account (a) Sub-Account (a) MIST Pioneer Fund Sub-Account (a) Neuberger Berman Genesis Sub-Account MIST Pioneer Strategic Income Sub-Account (a) Oppenheimer VA Core Bond Sub-Account MIST Pyramis Government Income Sub-Account Oppenheimer VA Global Strategic Income MIST Pyramis Managed Risk Portfolio Sub-Account (b) Sub-Account MIST Schroders Global Multi-Asset Sub-Account Oppenheimer VA Main Street Sub-Account MIST SSgA Growth and Income ETF Sub-Account Oppenheimer VA Main Street Small Cap MIST SSgA Growth ETF Sub-Account Sub-Account (a) MIST T. Rowe Price Large Cap Value Sub-Account (a) Oppenheimer VA Money Sub-Account MIST T. Rowe Price Mid Cap Growth Sub-Account Pioneer VCT Disciplined Value Sub-Account MIST Third Avenue Small Cap Value Sub-Account (a) Pioneer VCT Emerging Markets Sub-Account MSF Baillie Gifford International Stock Sub-Account (a) Pioneer VCT Equity Income Sub-Account MSF Barclays Aggregate Bond Index Sub-Account (a) Pioneer VCT Ibbotson Growth Allocation Sub-Account MSF BlackRock Bond Income Sub-Account (a) Pioneer VCT Ibbotson Moderate Allocation MSF BlackRock Capital Appreciation Sub-Account (a) Sub-Account MSF BlackRock Large Cap Value Sub-Account Pioneer VCT Mid Cap Value Sub-Account MSF BlackRock Money Market Sub-Account (a) Pioneer VCT Real Estate Shares Sub-Account MSF Davis Venture Value Sub-Account (a) T. Rowe Price Growth Stock Sub-Account MSF Frontier Mid Cap Growth Sub-Account (b) T. Rowe Price International Stock Sub-Account MSF Jennison Growth Sub-Account (a) T. Rowe Price Prime Reserve Sub-Account MSF Loomis Sayles Small Cap Core Sub-Account UIF U.S. Real Estate Sub-Account MSF Loomis Sayles Small Cap Growth Sub-Account (a) This Sub-Account invests in two or more share classes within the underlying portfolio, series, or fund of the Trusts. (b) This Sub-Account began operations during the year ended December 31, 2013. 103
N-4177th Page of 530TOC1stPreviousNextBottomJust 177th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. PORTFOLIO CHANGES The following Sub-Accounts ceased operations during the year ended December 31, 2013: [Enlarge/Download Table] MIST American Funds International Sub-Account MIST MLA Mid Cap Sub-Account MIST Jennison Large Cap Equity Sub-Account MIST RCM Technology Sub-Account MIST Met/Franklin Mutual Shares Sub-Account MIST Turner Mid Cap Growth Sub-Account MIST Met/Franklin Templeton Founding Strategy MSF FI Value Leaders Sub-Account Sub-Account (MSF) Oppenheimer Global Equity Portfolio The operations of the Sub-Accounts were affected by the following changes that occurred during the year ended December 31, 2013: NAME CHANGES: [Enlarge/Download Table] Former Name New Name Invesco Van Kampen V.I. American Franchise Fund Invesco V.I. American Franchise Fund Invesco Van Kampen V.I. American Value Fund Invesco V.I. American Value Fund Invesco Van Kampen V.I. Equity and Income Fund Invesco V.I. Equity and Income Fund Invesco Van Kampen V.I. Growth and Income Fund Invesco V.I. Growth and Income Fund Janus Aspen Series Worldwide Portfolio Janus Aspen Series Global Research Portfolio Legg Mason ClearBridge Variable Aggressive Growth ClearBridge Variable Aggressive Growth Portfolio Portfolio Legg Mason ClearBridge Variable Appreciation ClearBridge Variable Appreciation Portfolio Portfolio Legg Mason ClearBridge Variable Equity Income ClearBridge Variable Equity Income Portfolio Builder Portfolio Legg Mason ClearBridge Variable Fundamental All ClearBridge Variable All Cap Value Portfolio Cap Value Portfolio Legg Mason ClearBridge Variable Large Cap Growth ClearBridge Variable Large Cap Growth Portfolio Portfolio Legg Mason ClearBridge Variable Large Cap Value ClearBridge Variable Large Cap Value Portfolio Portfolio Legg Mason ClearBridge Variable Small Cap Growth ClearBridge Variable Small Cap Growth Portfolio Portfolio Legg Mason Western Asset Variable Global High Yield Western Asset Variable Global High Yield Bond Bond Portfolio Portfolio (MIST) American Funds Bond Portfolio (MIST) JPMorgan Core Bond Portfolio (MIST) Dreman Small Cap Value Portfolio (MIST) JPMorgan Small Cap Value Portfolio (MIST) Janus Forty Portfolio (MIST) ClearBridge Aggressive Growth Portfolio II (MIST) Legg Mason ClearBridge Aggressive Growth (MIST) ClearBridge Aggressive Growth Portfolio Portfolio (MIST) Lord Abbett Mid Cap Value Portfolio (MIST) Invesco Mid Cap Value Portfolio (MIST) Met/Templeton Growth Portfolio (a) (MIST) Oppenheimer Global Equity Portfolio (a) (MIST) Van Kampen Comstock Portfolio (MIST) Invesco Comstock Portfolio (MSF) Barclays Capital Aggregate Bond Index (MSF) Barclays Aggregate Bond Index Portfolio Portfolio (MSF) BlackRock Legacy Large Cap Growth Portfolio (MSF) BlackRock Capital Appreciation Portfolio Oppenheimer Main Street Small- & Mid-Cap Fund/VA Oppenheimer Main Street Small Cap Fund/VA Pioneer Fundamental Value VCT Portfolio Pioneer Disciplined Value VCT Portfolio 104
N-4178th Page of 530TOC1stPreviousNextBottomJust 178th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. PORTFOLIO CHANGES -- (CONCLUDED) MERGERS: [Enlarge/Download Table] Former Portfolio New Portfolio (MIST) American Funds International Portfolio (MSF) Baillie Gifford International Stock Portfolio (MIST) Jennison Large Cap Equity Portfolio (MSF) Jennison Growth Portfolio (MIST) Met/Franklin Mutual Shares Portfolio (MSF) MFS Value Portfolio (MIST) Met/Franklin Templeton Founding Strategy (MIST) MetLife Growth Strategy Portfolio Portfolio (MIST) MLA Mid Cap Portfolio (MSF) Neuberger Berman Genesis Portfolio (MIST) RCM Technology Portfolio (MSF) T. Rowe Price Large Cap Growth Portfolio (MIST) Turner Mid Cap Growth Portfolio (MSF) Frontier Mid Cap Growth Portfolio (MSF) FI Value Leaders Portfolio (MSF) MFS Value Portfolio (MSF) Oppenheimer Global Equity Portfolio (a) (MIST) Met/Templeton Growth Portfolio (a) a) At the close of business on April 26, 2013, the (MSF) Oppenheimer Global Equity Portfolio merged with and into the (MIST) Met/Templeton Growth Portfolio. Concurrently, Oppenheimer Funds, Inc. became the subadviser of the (MIST) Met/Templeton Growth Portfolio, the portfolio's investment objective and principal investment strategies changed, and the portfolio's name was changed to (MIST) Oppenheimer Global Equity Portfolio. Pursuant to these changes, (MSF) Oppenheimer Global Equity Portfolio was deemed to be the accounting and performance survivor of the merger for financial reporting purposes, and therefore, the results of MIST Oppenheimer Global Equity Sub-Account presented in the financial statements reflect the historical results of MSF Oppenheimer Global Equity Sub-Account prior to the merger, and the combined results thereafter. 4. SIGNIFICANT ACCOUNTING POLICIES BASIS OF ACCOUNTING The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") applicable for variable annuity separate accounts registered as unit investment trusts. SECURITY TRANSACTIONS Security transactions are recorded on a trade date basis. Realized gains and losses on the sales of investments are computed on the basis of the average cost of the investment sold. Income from dividends and realized gain distributions are recorded on the ex-distribution date. SECURITY VALUATION A Sub-Account's investment in shares of a portfolio, series, or fund of the Trusts is valued at fair value based on the closing net asset value ("NAV") or price per share as determined by the Trusts as of the end of the year. All changes in fair value are recorded as changes in unrealized gains (losses) on investments in the statements of operations of the applicable Sub-Accounts. 105
N-4179th Page of 530TOC1stPreviousNextBottomJust 179th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. SIGNIFICANT ACCOUNTING POLICIES -- (CONTINUED) SECURITY VALUATION -- (CONCLUDED) The Separate Account defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Separate Account prioritizes the inputs to fair valuation techniques and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Separate Account has categorized its assets based on the priority of the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset's classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets that the Separate Account has the ability to access. Level 2 Observable inputs other than quoted prices in Level 1 that are observable either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market or prices for similar instruments. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets, representing the Separate Account's own assumptions about the assumptions a market participant would use in valuing the asset, and based on the best information available. Each Sub-Account invests in shares of open-end mutual funds which calculate a daily NAV based on the fair value of the underlying securities in their portfolios. As a result, and as required by law, shares of open-end mutual funds are purchased and redeemed at their quoted daily NAV as reported by the Trusts at the close of each business day. On that basis, the inputs used to value all shares held by the Separate Account, which are measured at fair value on a recurring basis, are classified as Level 2. There were no transfers between Level 1 and Level 2, and no activity in Level 3 during the year. FEDERAL INCOME TAXES The operations of the Separate Account form a part of the total operations of the Company and are not taxed separately. The Company is taxed as a life insurance company under the provisions of the Internal Revenue Code ("IRC"). Under the current provisions of the IRC, the Company does not expect to incur federal income taxes on the earnings of the Separate Account to the extent the earnings are credited under the Contracts. Accordingly, no charge is currently being made to the Separate Account for federal income taxes. The Company will periodically review the status of this policy in the event of changes in the tax law. A charge may be made in future years for any federal income taxes that would be attributable to the Contracts. ANNUITY PAYOUTS Net assets allocated to Contracts in the payout period are computed according to industry standard mortality tables. The assumed investment return is between 3.0 and 6.0 percent. The mortality risk is fully borne by the Company and may result in additional amounts being transferred into the Separate Account by the Company to cover greater longevity of annuitants than expected. Conversely, if amounts allocated exceed amounts required, transfers may be made to the Company. PURCHASE PAYMENTS Purchase payments received from contract owners by the Company are credited as accumulation units as of the end of the valuation period in which received, as provided in the prospectus of the Contracts, and are reported as contract transactions on the statements of changes in net assets of the applicable Sub-Accounts. 106
N-4180th Page of 530TOC1stPreviousNextBottomJust 180th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. SIGNIFICANT ACCOUNTING POLICIES -- (CONCLUDED) NET TRANSFERS Funds transferred by the contract owner into or out of Sub-Accounts within the Separate Account or into or out of the fixed account, which is part the Company's general account, are recorded on a net basis as net transfers in the statements of changes in net assets of the applicable Sub-Accounts. USE OF ESTIMATES The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported herein. Actual results could differ from these estimates. 5. EXPENSES AND RELATED PARTY TRANSACTIONS The following annual Separate Account charges paid to the Company, are asset-based charges assessed through a daily reduction in unit values, which are recorded as expenses in the accompanying statements of operations of the applicable Sub-Accounts: Mortality and Expense Risk -- The mortality risk assumed by the Company is the risk that those insured may die sooner than anticipated and therefore, the Company will pay an aggregate amount of death benefits greater than anticipated. The expense risk assumed is the risk that expenses incurred in issuing and administering the Contracts will exceed the amounts realized from the administrative charges assessed against the Contracts. In addition, the charge compensates the Company for the risk that the investor may live longer than estimated and the Company would be obligated to pay more in income payments than anticipated. Administrative -- The Company has responsibility for the administration of the Contracts and the Separate Account. Generally, the administrative charge is related to the maintenance, including distribution, of each contract and the Separate Account. Optional Death Benefit Rider -- For an additional charge, the total death benefit payable may be increased based on increases in account value of the Contracts. Distribution Expense -- The risk that surrender charges will be insufficient to cover the actual costs of distribution which includes commissions, fees, registration costs, direct and indirect selling expenses. Guaranteed Minimum Accumulation Benefit -- For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years. Earnings Preservation Benefit -- For an additional charge, the Company will provide this additional death benefit. The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2013: [Enlarge/Download Table] ---------------------------------------------------------------------------------------------------------------------------- Mortality and Expense Risk 0.70% - 2.05% ---------------------------------------------------------------------------------------------------------------------------- Administrative 0.10% - 0.25% ---------------------------------------------------------------------------------------------------------------------------- Optional Death Benefit Rider 0.15% - 0.35% ---------------------------------------------------------------------------------------------------------------------------- Distribution Expense 0.10% ---------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Accumulation Benefit 1.50% ---------------------------------------------------------------------------------------------------------------------------- Earnings Preservation Benefit 0.25% ---------------------------------------------------------------------------------------------------------------------------- The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract. The range of effective rates disclosed above excludes any waivers granted to certain Sub-Accounts. 107
N-4181st Page of 530TOC1stPreviousNextBottomJust 181st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. EXPENSES AND RELATED PARTY TRANSACTIONS -- (CONCLUDED) The following optional rider charges paid to the Company are charged at each contract anniversary date through the redemption of units and are recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts: Guaranteed Minimum Accumulation Benefit -- For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years. Lifetime Withdrawal Guarantee -- For an additional charge, the Company will guarantee minimum withdrawals for life regardless of market conditions. Guaranteed Withdrawal Benefit -- For an additional charge, the Company will guarantee minimum withdrawals regardless of market conditions. Guaranteed Minimum Income Benefit -- For an additional charge, the Company will guarantee a minimum payment regardless of market conditions. Enhanced Death Benefit -- For an additional charge, the Company will guarantee a death benefit equal to the greater of the account value or the higher of two death benefit bases. Enhanced Guaranteed Withdrawal Benefit -- For an additional charge, the Company will guarantee that at least the entire amount of purchase payments will be returned through a series of withdrawals without annuitizing. The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2013: [Enlarge/Download Table] ------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Accumulation Benefit 0.75% ------------------------------------------------------------------------------------------------------------------------- Lifetime Withdrawal Guarantee 0.50% - 1.80% ------------------------------------------------------------------------------------------------------------------------- Guaranteed Withdrawal Benefit 0.25% - 1.80% ------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Income Benefit 0.50% - 1.50% ------------------------------------------------------------------------------------------------------------------------- Enhanced Death Benefit 0.60% - 1.50% ------------------------------------------------------------------------------------------------------------------------- Enhanced Guaranteed Withdrawal Benefit 0.55% - 1.00% ------------------------------------------------------------------------------------------------------------------------- The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract. A contract maintenance fee ranging from $30 to $40 is assessed on an annual basis for Contracts with a value of less than $50,000. A transfer fee ranging from $0 to $25 may be deducted after twelve transfers are made in a contract year or, for certain contracts, 2% of the amount transferred from the contract value, if less. For certain contracts, an administrative charge is also assessed which ranges from $12 to $29.50 for each Sub-Account in which the contract owner invests (waived if purchase payments equal or exceed $2,000 in the year, or if the account value is $10,000 or more at year end). For other Contracts the administrative charge is $21.50 plus $2.50 for each Sub-Account selected, subject to the same waiver terms. In addition, the Contracts impose a surrender charge which ranges from 0% to 9% if the contract is partially or fully surrendered within the specified surrender charge period. For certain contracts, a transaction charge of the lesser of $10 or 2% of the surrender is imposed on surrenders and a $10 charge is assessed for annuitizations. For those contract owners who choose optional living benefit riders or certain optional death benefit riders, these charges range from 0.25% to 1.80% of the benefit base and are charged at each contract anniversary date. These charges are paid to the Company and recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts. MetLife Advisers, LLC, which acts in the capacity of investment adviser to the portfolios of the MIST and MSF Trusts, is an affiliate of the Company. 108
N-4182nd Page of 530TOC1stPreviousNextBottomJust 182nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2013 DECEMBER 31, 2013 ------------------------------- ------------------------------- COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- -------------- -------------- -------------- Alger Small Cap Growth Sub-Account......................... 1,953,805 57,250,154 8,367,037 6,625,484 American Funds Bond Sub-Account............................ 13,775,531 147,139,916 21,831,559 7,389,905 American Funds Global Growth Sub-Account................... 10,522,269 223,509,854 12,990,684 18,551,511 American Funds Global Small Capitalization Sub-Account..... 4,918,180 95,041,858 10,469,150 11,712,314 American Funds Growth Sub-Account.......................... 10,989,996 574,188,815 23,270,824 62,728,487 American Funds Growth-Income Sub-Account................... 7,704,764 274,807,285 11,909,004 33,145,087 DWS I International Sub-Account............................ 2,052,186 20,756,206 1,433,339 2,082,585 Federated High Income Bond Sub-Account..................... 3,660 25,725 1,732 468 Federated Kaufman Sub-Account.............................. 2,337 31,003 3,265 1,661 Fidelity VIP Asset Manager Sub-Account..................... 5,120,330 78,221,722 1,832,124 10,277,909 Fidelity VIP Contrafund Sub-Account........................ 17,856,406 423,701,254 46,928,007 47,735,664 Fidelity VIP Equity-Income Sub-Account..................... 255,672 5,773,353 567,078 1,049,969 Fidelity VIP FundsManager 50% Sub-Account.................. 169,341,698 1,893,521,701 1,448,712,994 -- Fidelity VIP FundsManager 60% Sub-Account.................. 341,365,269 3,336,110,670 184,779,786 215,424,352 Fidelity VIP Growth Sub-Account............................ 2,904,593 109,545,186 1,267,314 18,047,059 Fidelity VIP Index 500 Sub-Account......................... 374,026 48,066,934 1,890,733 9,575,024 Fidelity VIP Mid Cap Sub-Account........................... 12,544,437 367,482,168 75,428,895 19,321,498 Fidelity VIP Money Market Sub-Account...................... 76,155,366 76,155,366 264,136,300 261,640,341 Fidelity VIP Overseas Sub-Account.......................... 287,089 5,219,470 201,987 889,204 FTVIPT Franklin Income Securities Sub-Account.............. 18,532,766 277,580,598 34,739,012 8,570,345 FTVIPT Franklin Small Cap Value Securities Sub-Account..... 5,319,858 83,521,426 16,513,930 5,117,658 FTVIPT Mutual Shares Securities Sub-Account................ 7,215,840 124,287,971 5,389,350 11,759,291 FTVIPT Templeton Foreign Securities Sub-Account............ 5,088,246 75,734,816 4,034,851 12,411,337 FTVIPT Templeton Global Bond Securities Sub-Account........ 13,692,658 253,733,342 53,566,361 5,257,847 Invesco V.I. American Franchise Sub-Account................ 3,234 111,443 621 35,535 Invesco V.I. American Value Sub-Account.................... 4,830,003 62,389,211 9,919,898 4,658,110 Invesco V.I. Core Equity Sub-Account....................... 6,498 164,702 3,201 51,990 Invesco V.I. Equity and Income Sub-Account................. 35,060,599 485,126,865 47,241,462 12,705,837 Invesco V.I. Global Real Estate Sub-Account................ 2,012,977 28,050,116 9,597,854 2,317,229 Invesco V.I. Growth and Income Sub-Account................. 13,952,369 250,218,096 23,999,020 11,230,394 Invesco V.I. International Growth Sub-Account.............. 8,084,783 216,816,575 27,736,513 6,844,164 Janus Aspen Global Research Sub-Account.................... 173 4,105 73 426 LMPVET ClearBridge Variable Aggressive Growth Sub-Account.............................................. 10,526,694 173,680,862 31,834,893 14,731,303 LMPVET ClearBridge Variable All Cap Value Sub-Account...... 5,180,506 108,091,465 13,093,421 10,449,229 LMPVET ClearBridge Variable Appreciation Sub-Account....... 12,072,871 297,272,179 46,243,652 5,053,515 LMPVET ClearBridge Variable Equity Income Sub-Account...... 13,279,712 148,789,202 29,700,748 7,561,386 LMPVET ClearBridge Variable Large Cap Growth Sub-Account.............................................. 226,398 3,757,586 797,143 1,061,468 LMPVET ClearBridge Variable Large Cap Value Sub-Account.... 359,950 5,522,541 1,851,418 917,410 LMPVET ClearBridge Variable Small Cap Growth Sub-Account.............................................. 4,673,830 76,531,477 26,245,513 5,068,007 LMPVET Investment Counsel Variable Social Awareness Sub-Account.............................................. 9,442 232,386 10,822 55,604 LMPVET Variable Lifestyle Allocation 50% Sub-Account....... 3,101,366 37,754,389 9,234,898 2,451,069 LMPVET Variable Lifestyle Allocation 70% Sub-Account....... 164,059 1,810,549 239,158 979,283 LMPVET Variable Lifestyle Allocation 85% Sub-Account....... 5,758,589 66,979,732 3,730,962 7,599,475 LMPVIT Western Asset Variable Global High Yield Bond Sub-Account.............................................. 12,899,080 106,265,588 18,950,436 5,775,873 MFS VIT Investors Trust Sub-Account........................ 867 15,837 254 957 MFS VIT New Discovery Sub-Account.......................... 2,085 31,394 326 10,422 MFS VIT Research Sub-Account............................... 2,221 36,602 952 2,823 MIST AllianceBernstein Global Dynamic Allocation Sub-Account.............................................. 288,647,584 2,874,906,144 339,151,646 70,031,864 MIST American Funds Balanced Allocation Sub-Account........ 300,384,157 2,654,037,106 288,642,114 273,202,760 (a) For the period April 29, 2013 to December 31, 2013. 109
N-4183rd Page of 530TOC1stPreviousNextBottomJust 183rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS -- (CONTINUED) [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2013 DECEMBER 31, 2013 ------------------------------ ------------------------------ COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- ------------- ------------- -------------- MIST American Funds Growth Allocation Sub-Account.......... 156,668,590 1,261,388,927 187,273,795 118,934,248 MIST American Funds Growth Sub-Account..................... 50,753,348 408,915,751 57,650,347 93,433,662 MIST American Funds Moderate Allocation Sub-Account........ 162,126,988 1,481,324,840 132,089,031 168,608,325 MIST AQR Global Risk Balanced Sub-Account.................. 309,084,305 3,317,257,824 431,509,043 576,853,585 MIST BlackRock Global Tactical Strategies Sub-Account...... 493,925,687 4,834,010,333 498,847,226 226,893,346 MIST BlackRock High Yield Sub-Account...................... 30,167,540 248,786,488 75,760,990 84,974,024 MIST BlackRock Large Cap Core Sub-Account.................. 1,321,838 12,022,012 2,361,192 4,326,602 MIST Clarion Global Real Estate Sub-Account................ 16,471,958 186,042,092 33,695,540 21,791,337 MIST ClearBridge Aggressive Growth II Sub-Account.......... 1,236,585 87,905,039 25,671,132 39,209,879 MIST ClearBridge Aggressive Growth Sub-Account............. 34,402,945 285,713,931 64,106,785 39,794,082 MIST Goldman Sachs Mid Cap Value Sub-Account............... 9,595,851 125,486,222 24,251,997 31,403,632 MIST Harris Oakmark International Sub-Account.............. 36,800,509 503,074,943 71,257,624 62,098,633 MIST Invesco Balanced-Risk Allocation Sub-Account.......... 79,693,833 828,213,545 299,761,843 123,809,111 MIST Invesco Comstock Sub-Account.......................... 30,548,350 269,995,421 33,140,328 30,436,307 MIST Invesco Mid Cap Value Sub-Account..................... 7,049,086 100,237,071 7,632,318 26,084,710 MIST Invesco Small Cap Growth Sub-Account.................. 15,999,668 212,350,271 40,481,426 37,989,461 MIST JPMorgan Core Bond Sub-Account........................ 30,726,105 322,736,031 368,984,257 390,876,104 MIST JPMorgan Global Active Allocation Sub-Account......... 64,494,802 685,972,211 411,902,306 1,046,679 MIST JPMorgan Small Cap Value Sub-Account.................. 1,398,723 18,072,538 1,214,511 4,652,727 MIST Loomis Sayles Global Markets Sub-Account.............. 12,202,424 138,603,312 12,633,756 33,927,527 MIST Lord Abbett Bond Debenture Sub-Account................ 19,329,797 235,054,182 46,184,123 55,703,031 MIST Met/Eaton Vance Floating Rate Sub-Account............. 7,863,380 81,726,682 38,100,553 9,085,203 MIST Met/Franklin Low Duration Total Return Sub-Account.... 13,988,758 139,401,727 103,155,123 6,840,638 MIST Met/Templeton International Bond Sub-Account.......... 4,491,942 52,667,789 6,151,132 9,956,495 MIST MetLife Aggressive Strategy Sub-Account............... 49,251,609 505,233,905 31,238,424 66,673,079 MIST MetLife Balanced Plus Sub-Account..................... 545,623,587 5,483,698,749 1,326,655,191 29,363,967 MIST MetLife Balanced Strategy Sub-Account................. 595,887,355 6,184,791,946 179,740,906 582,662,431 MIST MetLife Defensive Strategy Sub-Account................ 166,200,441 1,713,481,836 126,802,565 556,770,928 MIST MetLife Growth Strategy Sub-Account................... 481,641,251 5,446,815,057 810,166,419 458,140,055 MIST MetLife Moderate Strategy Sub-Account................. 285,069,002 2,916,035,754 125,354,093 359,014,276 MIST MetLife Multi-Index Targeted Risk Sub-Account......... 18,679,458 202,610,249 191,498,331 48,099 MIST MFS Emerging Markets Equity Sub-Account............... 44,365,465 429,598,932 57,899,097 24,196,300 MIST MFS Research International Sub-Account................ 27,847,098 301,254,346 12,515,033 40,936,928 MIST Morgan Stanley Mid Cap Growth Sub-Account............. 15,499,415 162,566,616 20,430,987 9,125,428 MIST Oppenheimer Global Equity Sub-Account................. 3,800,227 65,786,011 61,353,234 5,032,293 MIST PIMCO Inflation Protected Bond Sub-Account............ 83,143,341 917,851,914 113,879,964 147,677,711 MIST PIMCO Total Return Sub-Account........................ 170,631,086 2,023,321,900 195,309,222 261,044,205 MIST Pioneer Fund Sub-Account.............................. 15,949,343 210,761,236 32,571,171 21,029,394 MIST Pioneer Strategic Income Sub-Account.................. 82,625,885 876,148,740 186,717,427 40,347,909 MIST Pyramis Government Income Sub-Account................. 69,421,888 747,414,598 57,541,272 248,471,876 MIST Pyramis Managed Risk Sub-Account (a).................. 7,404,844 76,527,808 77,271,884 733,179 MIST Schroders Global Multi-Asset Sub-Account.............. 37,615,021 401,061,129 226,828,734 15,434,410 MIST SSgA Growth and Income ETF Sub-Account................ 122,339,438 1,318,083,174 105,350,093 161,848,161 MIST SSgA Growth ETF Sub-Account........................... 39,535,139 399,830,404 57,552,201 48,415,555 MIST T. Rowe Price Large Cap Value Sub-Account............. 20,556,073 503,855,462 37,831,867 83,996,502 MIST T. Rowe Price Mid Cap Growth Sub-Account.............. 48,128,833 393,410,732 44,118,921 76,252,053 MIST Third Avenue Small Cap Value Sub-Account.............. 15,828,125 220,268,628 14,374,066 56,713,788 MSF Baillie Gifford International Stock Sub-Account........ 29,234,216 273,113,712 311,182,861 42,899,023 MSF Barclays Aggregate Bond Index Sub-Account.............. 15,178,976 166,570,569 38,878,822 18,832,470 MSF BlackRock Bond Income Sub-Account...................... 538,412 57,649,078 12,957,166 9,373,622 MSF BlackRock Capital Appreciation Sub-Account............. 403,724 10,024,567 2,229,406 2,708,887 MSF BlackRock Large Cap Value Sub-Account.................. 315,551 3,404,072 669,760 572,388 MSF BlackRock Money Market Sub-Account..................... 4,613,432 461,343,188 176,370,619 284,137,550 MSF Davis Venture Value Sub-Account........................ 15,402,597 420,921,811 31,456,149 105,816,524 MSF Frontier Mid Cap Growth Sub-Account (a)................ 2,404,461 69,147,627 81,218,276 13,293,468 (a) For the period April 29, 2013 to December 31, 2013. 110
N-4184th Page of 530TOC1stPreviousNextBottomJust 184th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS -- (CONCLUDED) [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2013 DECEMBER 31, 2013 ------------------------------ ------------------------------ COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- ------------- -------------- -------------- MSF Jennison Growth Sub-Account............................ 37,390,273 429,630,599 69,265,860 113,538,069 MSF Loomis Sayles Small Cap Core Sub-Account............... 46,607 10,168,424 3,048,297 4,215,033 MSF Loomis Sayles Small Cap Growth Sub-Account............. 14,168 188,007 211,819 74,553 MSF Met/Artisan Mid Cap Value Sub-Account.................. 1,091,073 231,985,737 27,383,064 33,513,723 MSF Met/Dimensional International Small Company Sub-Account.............................................. 3,950,002 55,914,922 10,427,096 8,833,121 MSF MetLife Conservative Allocation Sub-Account............ 626,354 6,754,260 919,266 3,127,833 MSF MetLife Conservative to Moderate Allocation Sub-Account.............................................. 599,876 6,335,265 483,309 849,587 MSF MetLife Mid Cap Stock Index Sub-Account................ 6,902,966 92,816,482 28,544,426 18,949,282 MSF MetLife Moderate Allocation Sub-Account................ 3,261,902 36,107,143 2,229,013 5,177,503 MSF MetLife Moderate to Aggressive Allocation Sub-Account.. 3,987,522 44,870,344 1,095,801 6,663,266 MSF MetLife Stock Index Sub-Account........................ 13,516,120 389,602,723 60,002,522 68,223,696 MSF MFS Total Return Sub-Account........................... 284,564 39,885,789 10,177,103 5,437,805 MSF MFS Value Sub-Account.................................. 14,761,892 212,369,045 193,949,379 28,267,507 MSF MSCI EAFE Index Sub-Account............................ 8,270,194 94,840,872 27,821,011 13,494,237 MSF Neuberger Berman Genesis Sub-Account................... 9,637,909 136,490,541 142,024,747 20,468,073 MSF Russell 2000 Index Sub-Account......................... 7,254,916 97,425,995 27,526,307 13,260,092 MSF T. Rowe Price Large Cap Growth Sub-Account............. 6,246,221 121,943,961 135,856,780 16,437,400 MSF T. Rowe Price Small Cap Growth Sub-Account............. 452,030 6,447,448 2,107,576 2,155,378 MSF Van Eck Global Natural Resources Sub-Account........... 7,538,920 111,407,740 11,063,333 27,639,732 MSF Western Asset Management U.S. Government Sub-Account.............................................. 24,419,140 293,673,478 28,293,902 40,921,526 Neuberger Berman Genesis Sub-Account....................... 170 6,315 744 84 Oppenheimer Main Street Small Cap Fund/VA Sub-Account...... 4,469,453 66,979,251 4,589,759 12,914,070 Oppenheimer VA Core Bond Sub-Account....................... 1,105 11,403 459 403 Oppenheimer VA Global Strategic Income Sub-Account......... 835 4,111 226 72 Oppenheimer VA Main Street Sub-Account..................... 3,330 68,347 1,023 5,420 Oppenheimer VA Money Sub-Account........................... 4,008 4,008 1 108,958 Pioneer VCT Disciplined Value Sub-Account.................. 140,183 1,349,515 138,952 691,311 Pioneer VCT Emerging Markets Sub-Account................... 29,182 698,961 114,121 161,395 Pioneer VCT Equity Income Sub-Account...................... 23,453 418,014 15,014 63,283 Pioneer VCT Ibbotson Growth Allocation Sub-Account......... 1,594,684 12,459,847 731,230 2,137,215 Pioneer VCT Ibbotson Moderate Allocation Sub-Account....... 2,404,547 20,332,710 858,176 2,875,809 Pioneer VCT Mid Cap Value Sub-Account...................... 3,154,897 54,265,442 2,889,298 5,251,801 Pioneer VCT Real Estate Shares Sub-Account................. 13,450 194,425 45,554 18,061 T. Rowe Price Growth Stock Sub-Account..................... 158,630 4,682,926 561,068 1,031,842 T. Rowe Price International Stock Sub-Account.............. 40,209 555,287 25,016 91,068 T. Rowe Price Prime Reserve Sub-Account.................... 558,450 558,450 508,210 672,907 UIF U.S. Real Estate Sub-Account........................... 6,415,183 102,746,012 16,458,164 6,599,672 (a) For the period April 29, 2013 to December 31, 2013. 111
N-4185th Page of 530TOC1stPreviousNextBottomJust 185th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] ALGER SMALL CAP GROWTH AMERICAN FUNDS BOND SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- --------------- -------------- Units beginning of year............ 4,795,545 5,212,661 7,687,811 6,703,194 Units issued and transferred from other funding options...... 231,164 325,189 2,005,667 2,184,489 Units redeemed and transferred to other funding options........... (639,591) (742,305) (1,331,533) (1,199,872) -------------- --------------- --------------- -------------- Units end of year.................. 4,387,118 4,795,545 8,361,945 7,687,811 ============== =============== =============== ============== AMERICAN FUNDS AMERICAN FUNDS GLOBAL GROWTH GLOBAL SMALL CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- -------------- Units beginning of year............ 8,485,913 8,205,329 3,385,796 3,080,674 Units issued and transferred from other funding options...... 1,261,036 1,718,893 652,214 863,669 Units redeemed and transferred to other funding options........... (1,413,396) (1,438,309) (662,267) (558,547) --------------- -------------- --------------- -------------- Units end of year.................. 8,333,553 8,485,913 3,375,743 3,385,796 =============== ============== =============== ============== AMERICAN FUNDS GROWTH AMERICAN FUNDS GROWTH-INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 4,113,319 3,976,212 2,745,842 2,773,925 Units issued and transferred from other funding options...... 453,387 749,508 297,744 440,944 Units redeemed and transferred to other funding options........... (629,462) (612,401) (461,701) (469,027) --------------- --------------- -------------- --------------- Units end of year.................. 3,937,244 4,113,319 2,581,885 2,745,842 =============== =============== ============== =============== [Enlarge/Download Table] DWS I INTERNATIONAL FEDERATED HIGH INCOME BOND SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 2,040,232 2,245,605 2,556 3,549 Units issued and transferred from other funding options...... 147,844 214,706 -- -- Units redeemed and transferred to other funding options........... (299,464) (420,079) (11) (993) --------------- --------------- --------------- --------------- Units end of year.................. 1,888,612 2,040,232 2,545 2,556 =============== =============== =============== =============== FEDERATED KAUFMAN FIDELITY VIP ASSET MANAGER SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 6,002 12,138 6,517,939 7,353,740 Units issued and transferred from other funding options...... -- -- 203,227 274,275 Units redeemed and transferred to other funding options........... (166) (6,136) (835,636) (1,110,076) --------------- --------------- --------------- --------------- Units end of year.................. 5,836 6,002 5,885,530 6,517,939 =============== =============== =============== =============== FIDELITY VIP CONTRAFUND FIDELITY VIP EQUITY-INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 15,604,750 15,588,853 400,352 460,289 Units issued and transferred from other funding options...... 4,408,947 2,218,180 5,137 3,099 Units redeemed and transferred to other funding options........... (2,296,246) (2,202,283) (63,929) (63,036) --------------- --------------- --------------- --------------- Units end of year.................. 17,717,451 15,604,750 341,560 400,352 =============== =============== =============== =============== [Enlarge/Download Table] FIDELITY VIP FUNDSMANAGER 50% FIDELITY VIP FUNDSMANAGER 60% SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 (a) 2013 2012 --------------- --------------- --------------- -------------- Units beginning of year............ 39,080,828 -- 345,636,001 272,464,191 Units issued and transferred from other funding options...... 123,377,437 39,341,051 492,775 86,542,932 Units redeemed and transferred to other funding options........... (3,504,235) (260,223) (12,977,090) (13,371,122) --------------- --------------- --------------- -------------- Units end of year.................. 158,954,030 39,080,828 333,151,686 345,636,001 =============== =============== =============== ============== FIDELITY VIP GROWTH FIDELITY VIP INDEX 500 SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 -------------- --------------- --------------- --------------- Units beginning of year............ 9,085,626 9,918,387 3,530,426 3,976,112 Units issued and transferred from other funding options...... 341,709 730,546 21,793 28,294 Units redeemed and transferred to other funding options........... (1,232,955) (1,563,307) (460,663) (473,980) -------------- --------------- --------------- --------------- Units end of year.................. 8,194,380 9,085,626 3,091,556 3,530,426 ============== =============== =============== =============== FIDELITY VIP MID CAP FIDELITY VIP MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 7,598,912 6,289,465 8,041,430 8,001,050 Units issued and transferred from other funding options...... 1,446,862 2,176,791 139,410,710 120,413,155 Units redeemed and transferred to other funding options........... (1,253,103) (867,344) (139,144,730) (120,372,775) --------------- --------------- --------------- --------------- Units end of year.................. 7,792,671 7,598,912 8,307,410 8,041,430 =============== =============== =============== =============== [Enlarge/Download Table] FTVIPT FRANKLIN FIDELITY VIP OVERSEAS INCOME SECURITIES SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 509,517 540,072 4,708,870 4,290,472 Units issued and transferred from other funding options...... 12,503 26,857 860,767 1,191,730 Units redeemed and transferred to other funding options........... (74,877) (57,412) (649,971) (773,332) --------------- --------------- --------------- --------------- Units end of year.................. 447,143 509,517 4,919,666 4,708,870 =============== =============== =============== =============== FTVIPT FRANKLIN FTVIPT MUTUAL SHARES SMALL CAP VALUE SECURITIES SECURITIES SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 8,321,925 5,710,847 5,768,385 5,952,328 Units issued and transferred from other funding options...... 2,576,537 3,738,614 550,522 965,771 Units redeemed and transferred to other funding options........... (1,714,039) (1,127,536) (841,541) (1,149,714) --------------- --------------- --------------- --------------- Units end of year.................. 9,184,423 8,321,925 5,477,366 5,768,385 =============== =============== =============== =============== FTVIPT TEMPLETON FTVIPT TEMPLETON FOREIGN SECURITIES GLOBAL BOND SECURITIES SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 2,730,167 2,720,421 11,067,808 8,104,261 Units issued and transferred from other funding options...... 184,075 444,001 3,547,855 4,284,150 Units redeemed and transferred to other funding options........... (457,225) (434,255) (1,664,761) (1,320,603) --------------- --------------- --------------- --------------- Units end of year.................. 2,457,017 2,730,167 12,950,902 11,067,808 =============== =============== =============== =============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 112
N-4186th Page of 530TOC1stPreviousNextBottomJust 186th
113
N-4187th Page of 530TOC1stPreviousNextBottomJust 187th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] INVESCO V.I. AMERICAN FRANCHISE INVESCO V.I. AMERICAN VALUE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- --------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- --------------- Units beginning of year............ 28,015 18,874 5,515,798 4,490,470 Units issued and transferred from other funding options...... 5 17,706 1,405,833 1,827,974 Units redeemed and transferred to other funding options........... (5,873) (8,565) (958,158) (802,646) ---------------- ---------------- ---------------- --------------- Units end of year.................. 22,147 28,015 5,963,473 5,515,798 ================ ================ ================ =============== INVESCO V.I. CORE EQUITY INVESCO V.I. EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ---------------------------------- 2013 2012 2013 2012 --------------- --------------- ---------------- ---------------- Units beginning of year............ 49,005 63,191 29,563,858 27,370,136 Units issued and transferred from other funding options...... 1 18 5,739,587 6,876,521 Units redeemed and transferred to other funding options........... (9,171) (14,204) (3,975,190) (4,682,799) --------------- --------------- ---------------- ---------------- Units end of year.................. 39,835 49,005 31,328,255 29,563,858 =============== =============== ================ ================ INVESCO V.I. GLOBAL REAL ESTATE INVESCO V.I. GROWTH AND INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2013 2012 2013 2012 ---------------- ---------------- ---------------- ---------------- Units beginning of year............ 2,556,360 1,863,096 13,407,203 11,777,382 Units issued and transferred from other funding options...... 1,352,296 1,078,991 2,432,918 3,449,278 Units redeemed and transferred to other funding options........... (654,076) (385,727) (2,040,267) (1,819,457) ---------------- ---------------- ---------------- ---------------- Units end of year.................. 3,254,580 2,556,360 13,799,854 13,407,203 ================ ================ ================ ================ [Enlarge/Download Table] INVESCO V.I. INTERNATIONAL GROWTH JANUS ASPEN GLOBAL RESEARCH SUB-ACCOUNT SUB-ACCOUNT --------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- -------------- -------------- --------------- Units beginning of year............ 8,127,475 6,481,068 769 769 Units issued and transferred from other funding options...... 1,760,912 2,444,775 -- -- Units redeemed and transferred to other funding options........... (987,033) (798,368) (48) -- -------------- -------------- -------------- --------------- Units end of year.................. 8,901,354 8,127,475 721 769 ============== ============== ============== =============== LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH VARIABLE ALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 11,687,754 11,855,614 3,081,671 3,213,146 Units issued and transferred from other funding options...... 2,702,461 2,474,667 316,163 465,469 Units redeemed and transferred to other funding options........... (2,411,214) (2,642,527) (475,543) (596,944) --------------- --------------- --------------- --------------- Units end of year.................. 11,979,001 11,687,754 2,922,291 3,081,671 =============== =============== =============== =============== LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE APPRECIATION VARIABLE EQUITY INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- -------------- Units beginning of year............ 7,908,912 7,021,537 9,055,914 8,013,455 Units issued and transferred from other funding options...... 1,753,644 2,091,600 2,599,732 2,895,083 Units redeemed and transferred to other funding options........... (1,058,149) (1,204,225) (1,411,492) (1,852,624) --------------- --------------- --------------- -------------- Units end of year.................. 8,604,407 7,908,912 10,244,154 9,055,914 =============== =============== =============== ============== [Enlarge/Download Table] LMPVET CLEARBRIDGE VARIABLE LMPVET CLEARBRIDGE VARIABLE LARGE CAP GROWTH LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 283,429 363,040 286,427 265,335 Units issued and transferred from other funding options...... 16,933 26,721 91,925 92,095 Units redeemed and transferred to other funding options........... (57,408) (106,332) (58,751) (71,003) --------------- --------------- -------------- --------------- Units end of year.................. 242,954 283,429 319,601 286,427 =============== =============== ============== =============== LMPVET CLEARBRIDGE VARIABLE LMPVET INVESTMENT COUNSEL SMALL CAP GROWTH VARIABLE SOCIAL AWARENESS SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 3,457,289 2,686,955 9,185 17,377 Units issued and transferred from other funding options...... 1,487,008 1,387,037 363 341 Units redeemed and transferred to other funding options........... (841,470) (616,703) (1,616) (8,533) --------------- --------------- -------------- --------------- Units end of year.................. 4,102,827 3,457,289 7,932 9,185 =============== =============== ============== =============== LMPVET VARIABLE LMPVET VARIABLE LIFESTYLE ALLOCATION 50% LIFESTYLE ALLOCATION 70% SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- -------------- -------------- --------------- Units beginning of year............ 1,699,443 1,414,982 162,342 219,583 Units issued and transferred from other funding options...... 532,901 529,688 12,965 1,501 Units redeemed and transferred to other funding options........... (220,911) (245,227) (53,912) (58,742) --------------- -------------- -------------- --------------- Units end of year.................. 2,011,433 1,699,443 121,395 162,342 =============== ============== ============== =============== [Enlarge/Download Table] LMPVET VARIABLE LIFESTYLE LMPVIT WESTERN ASSET VARIABLE ALLOCATION 85% GLOBAL HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------ 2013 2012 2013 2012 --------------- -------------- -------------- -------------- Units beginning of year............ 5,015,187 4,732,454 4,039,328 3,594,817 Units issued and transferred from other funding options...... 343,106 820,273 1,173,324 1,232,020 Units redeemed and transferred to other funding options........... (568,108) (537,540) (825,774) (787,509) --------------- -------------- -------------- -------------- Units end of year.................. 4,790,185 5,015,187 4,386,878 4,039,328 =============== ============== ============== ============== MFS VIT INVESTORS TRUST MFS VIT NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 3,616 7,050 4,161 4,939 Units issued and transferred from other funding options...... -- -- -- -- Units redeemed and transferred to other funding options........... (99) (3,434) (867) (778) --------------- --------------- --------------- --------------- Units end of year.................. 3,517 3,616 3,294 4,161 =============== =============== =============== =============== MIST ALLIANCEBERNSTEIN GLOBAL MFS VIT RESEARCH DYNAMIC ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 8,335 8,675 267,334,005 168,434,681 Units issued and transferred from other funding options...... 92 -- 49,782,034 116,824,775 Units redeemed and transferred to other funding options........... (295) (340) (30,859,953) (17,925,451) --------------- --------------- --------------- --------------- Units end of year.................. 8,132 8,335 286,256,086 267,334,005 =============== =============== =============== =============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 114
N-4188th Page of 530TOC1stPreviousNextBottomJust 188th
115
N-4189th Page of 530TOC1stPreviousNextBottomJust 189th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] MIST AMERICAN MIST AMERICAN FUNDS FUNDS BALANCED ALLOCATION GROWTH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 292,605,761 306,967,734 149,020,463 159,224,115 Units issued and transferred from other funding options...... 18,431,005 19,362,093 20,136,813 14,465,078 Units redeemed and transferred to other funding options........... (34,206,231) (33,724,066) (21,362,764) (24,668,730) --------------- --------------- -------------- --------------- Units end of year.................. 276,830,535 292,605,761 147,794,512 149,020,463 =============== =============== ============== =============== MIST AMERICAN FUNDS MIST AMERICAN FUNDS GROWTH MODERATE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- --------------- Units beginning of year............ 54,812,434 64,256,598 159,499,085 168,982,398 Units issued and transferred from other funding options...... 19,877,224 8,420,717 6,661,377 10,897,945 Units redeemed and transferred to other funding options........... (15,095,840) (17,864,881) (18,387,247) (20,381,258) --------------- -------------- --------------- --------------- Units end of year.................. 59,593,818 54,812,434 147,773,215 159,499,085 =============== ============== =============== =============== MIST AQR GLOBAL RISK MIST BLACKROCK GLOBAL BALANCED TACTICAL STRATEGIES SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 -------------- --------------- --------------- --------------- Units beginning of year............ 324,843,850 179,038,392 471,913,542 297,189,715 Units issued and transferred from other funding options...... 59,582,950 166,064,494 76,646,145 206,814,495 Units redeemed and transferred to other funding options........... (89,318,604) (20,259,036) (60,984,960) (32,090,668) -------------- --------------- --------------- --------------- Units end of year.................. 295,108,196 324,843,850 487,574,727 471,913,542 ============== =============== =============== =============== [Enlarge/Download Table] MIST BLACKROCK HIGH YIELD MIST BLACKROCK LARGE CAP CORE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 11,949,833 10,891,616 1,423,242 1,414,721 Units issued and transferred from other funding options...... 4,448,298 6,729,999 248,426 448,336 Units redeemed and transferred to other funding options........... (5,614,449) (5,671,782) (411,414) (439,815) --------------- --------------- -------------- --------------- Units end of year.................. 10,783,682 11,949,833 1,260,254 1,423,242 =============== =============== ============== =============== MIST CLEARBRIDGE MIST CLARION GLOBAL REAL ESTATE AGGRESSIVE GROWTH II SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- --------------- Units beginning of year............ 10,967,900 11,304,866 687,043 543,584 Units issued and transferred from other funding options...... 3,149,547 2,105,122 252,978 362,623 Units redeemed and transferred to other funding options........... (3,017,856) (2,442,088) (335,228) (219,164) --------------- -------------- --------------- --------------- Units end of year.................. 11,099,591 10,967,900 604,793 687,043 =============== ============== =============== =============== MIST CLEARBRIDGE MIST GOLDMAN SACHS AGGRESSIVE GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- --------------- -------------- Units beginning of year............ 33,802,849 35,764,496 8,486,283 9,263,271 Units issued and transferred from other funding options...... 12,353,599 7,911,776 2,123,717 1,124,342 Units redeemed and transferred to other funding options........... (9,856,765) (9,873,423) (2,670,616) (1,901,330) -------------- --------------- --------------- -------------- Units end of year.................. 36,299,683 33,802,849 7,939,384 8,486,283 ============== =============== =============== ============== [Enlarge/Download Table] MIST HARRIS OAKMARK MIST INVESCO INTERNATIONAL BALANCED-RISK ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- 2013 2012 2013 2012 (b) -------------- -------------- --------------- -------------- Units beginning of year............ 25,722,293 28,033,038 631,214,101 -- Units issued and transferred from other funding options...... 6,769,558 5,193,899 443,294,590 650,591,123 Units redeemed and transferred to other funding options........... (6,722,399) (7,504,644) (273,647,738) (19,377,022) -------------- -------------- --------------- -------------- Units end of year.................. 25,769,452 25,722,293 800,860,953 631,214,101 ============== ============== =============== ============== MIST INVESCO COMSTOCK MIST INVESCO MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 26,662,653 25,137,797 5,175,603 5,366,862 Units issued and transferred from other funding options...... 6,360,415 7,479,612 726,776 997,969 Units redeemed and transferred to other funding options........... (6,133,804) (5,954,756) (1,282,477) (1,189,228) --------------- --------------- --------------- --------------- Units end of year.................. 26,889,264 26,662,653 4,619,902 5,175,603 =============== =============== =============== =============== MIST INVESCO SMALL CAP GROWTH MIST JPMORGAN CORE BOND SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 13,528,657 13,942,780 31,242,391 32,528,572 Units issued and transferred from other funding options...... 3,270,520 3,212,680 69,538,044 7,302,721 Units redeemed and transferred to other funding options........... (3,796,043) (3,626,803) (71,340,945) (8,588,902) -------------- --------------- -------------- --------------- Units end of year.................. 13,003,134 13,528,657 29,439,490 31,242,391 ============== =============== ============== =============== [Enlarge/Download Table] MIST JPMORGAN GLOBAL ACTIVE ALLOCATION MIST JPMORGAN SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 (b) 2013 2012 --------------- --------------- --------------- -------------- Units beginning of year............ 269,034,003 -- 1,643,159 1,650,824 Units issued and transferred from other funding options...... 441,036,411 274,291,117 124,281 241,604 Units redeemed and transferred to other funding options........... (60,216,445) (5,257,114) (311,857) (249,269) --------------- --------------- --------------- -------------- Units end of year.................. 649,853,969 269,034,003 1,455,583 1,643,159 =============== =============== =============== ============== MIST LOOMIS SAYLES MIST LORD ABBETT GLOBAL MARKETS BOND DEBENTURE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------ 2013 2012 2013 2012 --------------- --------------- -------------- -------------- Units beginning of year............ 12,318,466 13,161,956 10,178,078 10,848,076 Units issued and transferred from other funding options...... 1,930,340 2,618,481 2,088,131 1,371,896 Units redeemed and transferred to other funding options........... (3,405,983) (3,461,971) (2,925,191) (2,041,894) --------------- --------------- -------------- -------------- Units end of year.................. 10,842,823 12,318,466 9,341,018 10,178,078 =============== =============== ============== ============== MIST MET/EATON VANCE MIST MET/FRANKLIN FLOATING RATE LOW DURATION TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------ 2013 2012 2013 2012 --------------- --------------- -------------- -------------- Units beginning of year............ 5,007,151 4,263,176 4,349,231 2,835,514 Units issued and transferred from other funding options...... 4,910,363 2,295,738 13,737,199 2,859,109 Units redeemed and transferred to other funding options........... (2,397,545) (1,551,763) (4,035,637) (1,345,392) --------------- --------------- -------------- -------------- Units end of year.................. 7,519,969 5,007,151 14,050,793 4,349,231 =============== =============== ============== ============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 116
N-4190th Page of 530TOC1stPreviousNextBottomJust 190th
117
N-4191st Page of 530TOC1stPreviousNextBottomJust 191st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] MIST MET/TEMPLETON MIST METLIFE INTERNATIONAL BOND AGGRESSIVE STRATEGY SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- 2013 2012 2013 2012 -------------- -------------- -------------- --------------- Units beginning of year............ 4,238,395 4,276,073 44,655,767 49,390,389 Units issued and transferred from other funding options...... 985,885 1,128,325 4,811,432 4,301,820 Units redeemed and transferred to other funding options........... (1,318,951) (1,166,003) (7,015,919) (9,036,442) -------------- -------------- -------------- --------------- Units end of year.................. 3,905,329 4,238,395 42,451,280 44,655,767 ============== ============== ============== =============== MIST METLIFE MIST METLIFE BALANCED PLUS BALANCED STRATEGY SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 438,994,467 257,076,022 550,560,779 592,824,603 Units issued and transferred from other funding options...... 154,477,158 208,342,594 36,007,453 38,366,523 Units redeemed and transferred to other funding options........... (46,374,998) (26,424,149) (67,366,811) (80,630,347) --------------- --------------- --------------- --------------- Units end of year.................. 547,096,627 438,994,467 519,201,421 550,560,779 =============== =============== =============== =============== MIST METLIFE MIST METLIFE DEFENSIVE STRATEGY GROWTH STRATEGY SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 178,585,503 186,262,512 407,576,342 446,977,194 Units issued and transferred from other funding options...... 12,195,405 36,676,249 80,860,643 23,060,082 Units redeemed and transferred to other funding options........... (50,200,387) (44,353,258) (53,560,238) (62,460,934) --------------- --------------- --------------- --------------- Units end of year.................. 140,580,521 178,585,503 434,876,747 407,576,342 =============== =============== =============== =============== [Enlarge/Download Table] MIST METLIFE MIST METLIFE MULTI-INDEX MODERATE STRATEGY TARGETED RISK SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------ 2013 2012 2013 2012 (c) -------------- --------------- -------------- -------------- Units beginning of year............ 266,549,696 281,377,647 11,094,386 -- Units issued and transferred from other funding options...... 19,283,696 27,689,670 150,360,164 11,117,372 Units redeemed and transferred to other funding options........... (38,726,315) (42,517,621) (7,504,407) (22,986) -------------- --------------- -------------- -------------- Units end of year.................. 247,107,077 266,549,696 153,950,143 11,094,386 ============== =============== ============== ============== MIST MFS MIST MFS EMERGING MARKETS EQUITY RESEARCH INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- -------------- Units beginning of year............ 38,352,212 37,004,554 21,667,563 22,841,018 Units issued and transferred from other funding options...... 12,177,917 9,475,344 2,142,621 3,053,885 Units redeemed and transferred to other funding options........... (8,906,952) (8,127,686) (4,193,701) (4,227,340) --------------- -------------- --------------- -------------- Units end of year.................. 41,623,177 38,352,212 19,616,483 21,667,563 =============== ============== =============== ============== MIST MORGAN STANLEY MIST OPPENHEIMER MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- -------------- Units beginning of year............ 12,225,316 8,735,505 500,711 559,531 Units issued and transferred from other funding options...... 3,100,228 4,900,360 3,443,548 38,793 Units redeemed and transferred to other funding options........... (2,225,641) (1,410,549) (816,539) (97,613) --------------- -------------- --------------- -------------- Units end of year.................. 13,099,903 12,225,316 3,127,720 500,711 =============== ============== =============== ============== [Enlarge/Download Table] MIST PIMCO MIST PIMCO INFLATION PROTECTED BOND TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 64,013,091 63,087,877 128,302,689 132,311,947 Units issued and transferred from other funding options...... 14,947,068 16,960,767 24,830,457 27,859,521 Units redeemed and transferred to other funding options........... (21,311,654) (16,035,553) (34,713,308) (31,868,779) -------------- --------------- -------------- --------------- Units end of year.................. 57,648,505 64,013,091 118,419,838 128,302,689 ============== =============== ============== =============== MIST PIONEER MIST PIONEER FUND STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 11,331,680 9,480,402 29,638,373 24,444,162 Units issued and transferred from other funding options...... 3,073,514 3,453,766 17,942,693 10,611,047 Units redeemed and transferred to other funding options........... (1,972,643) (1,602,488) (6,131,045) (5,416,836) -------------- --------------- -------------- --------------- Units end of year.................. 12,432,551 11,331,680 41,450,021 29,638,373 ============== =============== ============== =============== MIST PYRAMIS MIST PYRAMIS GOVERNMENT INCOME MANAGED RISK SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------- 2013 2012 2013 (d) -------------- --------------- -------------- Units beginning of year............ 88,599,553 45,618,019 -- Units issued and transferred from other funding options...... 20,394,869 64,826,342 7,910,133 Units redeemed and transferred to other funding options........... (39,506,061) (21,844,808) (616,086) -------------- --------------- -------------- Units end of year.................. 69,488,361 88,599,553 7,294,047 ============== =============== ============== [Enlarge/Download Table] MIST SCHRODERS MIST SSGA GLOBAL MULTI-ASSET GROWTH AND INCOME ETF SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 (b) 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 179,641,654 -- 118,446,237 120,297,977 Units issued and transferred from other funding options...... 254,720,312 184,349,381 8,842,539 17,478,592 Units redeemed and transferred to other funding options........... (59,100,608) (4,707,727) (16,853,399) (19,330,332) -------------- --------------- -------------- --------------- Units end of year.................. 375,261,358 179,641,654 110,435,377 118,446,237 ============== =============== ============== =============== MIST T. ROWE PRICE MIST SSGA GROWTH ETF LARGE CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 36,733,044 37,984,453 12,231,249 13,446,503 Units issued and transferred from other funding options...... 5,769,705 8,263,310 1,603,300 1,153,503 Units redeemed and transferred to other funding options........... (6,583,525) (9,514,719) (2,513,569) (2,368,757) -------------- --------------- -------------- --------------- Units end of year.................. 35,919,224 36,733,044 11,320,980 12,231,249 ============== =============== ============== =============== MIST T. ROWE PRICE MIST THIRD AVENUE MID CAP GROWTH SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 41,941,697 44,089,511 15,859,523 18,611,699 Units issued and transferred from other funding options...... 6,286,743 7,017,740 1,894,187 1,630,404 Units redeemed and transferred to other funding options........... (10,262,528) (9,165,554) (3,760,994) (4,382,580) -------------- --------------- -------------- --------------- Units end of year.................. 37,965,912 41,941,697 13,992,716 15,859,523 ============== =============== ============== =============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 118
N-4192nd Page of 530TOC1stPreviousNextBottomJust 192nd
119
N-4193rd Page of 530TOC1stPreviousNextBottomJust 193rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] MSF BAILLIE GIFFORD MSF BARCLAYS INTERNATIONAL STOCK AGGREGATE BOND INDEX SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- --------------- Units beginning of year............ 219,106 282,028 10,756,748 8,083,366 Units issued and transferred from other funding options...... 35,014,663 25,473 6,105,533 4,814,657 Units redeemed and transferred to other funding options........... (5,683,952) (88,395) (3,325,344) (2,141,275) --------------- -------------- --------------- --------------- Units end of year.................. 29,549,817 219,106 13,536,937 10,756,748 =============== ============== =============== =============== MSF BLACKROCK MSF BLACKROCK BOND INCOME CAPITAL APPRECIATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- 2013 2012 2013 2012 -------------- -------------- --------------- -------------- Units beginning of year............ 1,045,629 953,075 745,728 814,200 Units issued and transferred from other funding options...... 259,586 277,049 149,273 197,460 Units redeemed and transferred to other funding options........... (250,867) (184,495) (173,786) (265,932) -------------- -------------- --------------- -------------- Units end of year.................. 1,054,348 1,045,629 721,215 745,728 ============== ============== =============== ============== MSF BLACKROCK MSF BLACKROCK LARGE CAP VALUE MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 230,438 252,494 53,484,009 59,067,302 Units issued and transferred from other funding options...... 39,765 44,601 42,460,926 43,722,394 Units redeemed and transferred to other funding options........... (45,013) (66,657) (51,615,737) (49,305,687) --------------- --------------- -------------- --------------- Units end of year.................. 225,190 230,438 44,329,198 53,484,009 =============== =============== ============== =============== [Enlarge/Download Table] MSF FRONTIER MSF DAVIS VENTURE VALUE MID CAP GROWTH MSF JENNISON GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------------------- --------------- ------------------------------- 2013 2012 2013 (d) 2013 2012 --------------- --------------- --------------- --------------- -------------- Units beginning of year............ 41,401,029 48,368,185 -- 35,125,323 20,877,221 Units issued and transferred from other funding options...... 3,841,529 3,838,366 5,813,772 6,890,303 22,832,898 Units redeemed and transferred to other funding options........... (9,032,971) (10,805,522) (1,046,051) (9,441,429) (8,584,796) --------------- --------------- --------------- --------------- -------------- Units end of year.................. 36,209,587 41,401,029 4,767,721 32,574,197 35,125,323 =============== =============== =============== =============== ============== MSF LOOMIS SAYLES MSF LOOMIS SAYLES SMALL CAP CORE SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 (b) --------------- --------------- --------------- -------------- Units beginning of year............ 330,015 310,374 3,306 -- Units issued and transferred from other funding options...... 60,857 98,496 13,578 3,306 Units redeemed and transferred to other funding options........... (107,545) (78,855) (4,378) -- --------------- --------------- --------------- -------------- Units end of year.................. 283,327 330,015 12,506 3,306 =============== =============== =============== ============== MSF MET/ARTISAN MID CAP VALUE SUB-ACCOUNT ------------------------------- 2013 2012 -------------- --------------- Units beginning of year............ 13,419,571 14,599,235 Units issued and transferred from other funding options...... 2,613,526 1,633,041 Units redeemed and transferred to other funding options........... (2,907,307) (2,812,705) -------------- --------------- Units end of year.................. 13,125,790 13,419,571 ============== =============== [Enlarge/Download Table] MSF MET/DIMENSIONAL MSF METLIFE INTERNATIONAL SMALL COMPANY CONSERVATIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 3,203,412 3,336,605 735,694 850,770 Units issued and transferred from other funding options...... 832,391 791,959 51,604 73,579 Units redeemed and transferred to other funding options........... (827,252) (925,152) (230,263) (188,655) --------------- --------------- --------------- --------------- Units end of year.................. 3,208,551 3,203,412 557,035 735,694 =============== =============== =============== =============== MSF METLIFE CONSERVATIVE TO MSF METLIFE MODERATE ALLOCATION MID CAP STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 588,986 608,383 4,914,049 4,708,991 Units issued and transferred from other funding options...... 17,083 51,385 2,339,087 1,761,634 Units redeemed and transferred to other funding options........... (55,173) (70,782) (1,751,777) (1,556,576) --------------- --------------- --------------- --------------- Units end of year.................. 550,896 588,986 5,501,359 4,914,049 =============== =============== =============== =============== MSF METLIFE MSF METLIFE MODERATE ALLOCATION MODERATE TO AGGRESSIVE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ---------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 3,326,548 3,930,913 4,335,356 4,632,179 Units issued and transferred from other funding options...... 91,734 324,723 54,564 71,059 Units redeemed and transferred to other funding options........... (345,160) (929,088) (462,019) (367,882) --------------- --------------- --------------- --------------- Units end of year.................. 3,073,122 3,326,548 3,927,901 4,335,356 =============== =============== =============== =============== [Enlarge/Download Table] MSF METLIFE STOCK INDEX MSF MFS TOTAL RETURN MSF MFS VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------ ------------------------------ 2013 2012 2013 2012 2013 2012 -------------- -------------- -------------- -------------- -------------- -------------- Units beginning of year............ 29,109,224 25,347,914 730,405 826,212 3,025,966 3,145,406 Units issued and transferred from other funding options...... 6,636,730 14,585,302 213,323 113,713 11,667,337 433,811 Units redeemed and transferred to other funding options........... (7,121,566) (10,823,992) (129,604) (209,520) (2,553,425) (553,251) -------------- -------------- -------------- -------------- -------------- -------------- Units end of year.................. 28,624,388 29,109,224 814,124 730,405 12,139,878 3,025,966 ============== ============== ============== ============== ============== ============== MSF MSCI EAFE INDEX MSF NEUBERGER BERMAN GENESIS MSF RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------ ------------------------------ 2013 2012 2013 2012 2013 2012 --------------- -------------- -------------- -------------- -------------- -------------- Units beginning of year............ 7,172,234 6,390,970 626,194 647,811 5,078,788 3,926,223 Units issued and transferred from other funding options...... 3,468,301 2,557,262 8,992,058 169,024 2,243,147 3,452,677 Units redeemed and transferred to other funding options........... (1,830,889) (1,775,998) (1,598,077) (190,641) (1,486,434) (2,300,112) --------------- -------------- -------------- -------------- -------------- -------------- Units end of year.................. 8,809,646 7,172,234 8,020,175 626,194 5,835,501 5,078,788 =============== ============== ============== ============== ============== ============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 120
N-4194th Page of 530TOC1stPreviousNextBottomJust 194th
121
N-4195th Page of 530TOC1stPreviousNextBottomJust 195th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONCLUDED) FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012: [Enlarge/Download Table] MSF T. ROWE PRICE MSF T. ROWE PRICE LARGE CAP GROWTH SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- 2013 2012 2013 2012 -------------- -------------- --------------- -------------- Units beginning of year............ 39,346 44,809 380,162 417,381 Units issued and transferred from other funding options...... 18,370,073 21,120 74,979 41,453 Units redeemed and transferred to other funding options........... (3,721,339) (26,583) (98,222) (78,672) -------------- -------------- --------------- -------------- Units end of year.................. 14,688,080 39,346 356,919 380,162 ============== ============== =============== ============== MSF VAN ECK MSF WESTERN ASSET MANAGEMENT GLOBAL NATURAL RESOURCES U.S. GOVERNMENT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- --------------- Units beginning of year............ 7,200,491 6,910,683 17,244,875 16,038,241 Units issued and transferred from other funding options...... 1,538,360 2,301,818 4,180,259 6,048,090 Units redeemed and transferred to other funding options........... (2,460,184) (2,012,010) (5,007,641) (4,841,456) --------------- -------------- --------------- --------------- Units end of year.................. 6,278,667 7,200,491 16,417,493 17,244,875 =============== ============== =============== =============== NEUBERGER BERMAN GENESIS OPPENHEIMER VA CORE BOND SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- -------------- --------------- Units beginning of year............ 474 474 1,541 1,878 Units issued and transferred from other funding options...... -- -- -- -- Units redeemed and transferred to other funding options........... -- -- (48) (337) -------------- --------------- -------------- --------------- Units end of year.................. 474 474 1,493 1,541 ============== =============== ============== =============== [Enlarge/Download Table] OPPENHEIMER VA GLOBAL STRATEGIC INCOME OPPENHEIMER VA MAIN STREET SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2013 2012 2013 2012 --------------- --------------- -------------- --------------- Units beginning of year............ 443 443 14,959 22,109 Units issued and transferred from other funding options...... -- -- -- -- Units redeemed and transferred to other funding options........... -- -- (643) (7,150) --------------- --------------- -------------- --------------- Units end of year.................. 443 443 14,316 14,959 =============== =============== ============== =============== OPPENHEIMER VA MAIN STREET SMALL CAP OPPENHEIMER VA MONEY SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- -------------- --------------- --------------- Units beginning of year............ 5,041,901 4,964,464 20,150 20,177 Units issued and transferred from other funding options...... 643,815 773,448 -- -- Units redeemed and transferred to other funding options........... (1,030,426) (696,011) (19,427) (27) --------------- -------------- --------------- --------------- Units end of year.................. 4,655,290 5,041,901 723 20,150 =============== ============== =============== =============== PIONEER VCT DISCIPLINED VALUE PIONEER VCT EMERGING MARKETS SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2013 2012 2013 2012 -------------- --------------- --------------- -------------- Units beginning of year............ 229,721 238,409 49,333 48,427 Units issued and transferred from other funding options...... 2,035 15,082 8,618 17,770 Units redeemed and transferred to other funding options........... (61,099) (23,770) (11,263) (16,864) -------------- --------------- --------------- -------------- Units end of year.................. 170,657 229,721 46,688 49,333 ============== =============== =============== ============== [Enlarge/Download Table] PIONEER VCT PIONEER VCT EQUITY INCOME IBBOTSON GROWTH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 24,722 17,862 1,199,751 1,225,572 Units issued and transferred from other funding options...... 147 7,715 24,774 43,759 Units redeemed and transferred to other funding options........... (2,177) (855) (109,548) (69,580) --------------- --------------- --------------- --------------- Units end of year.................. 22,692 24,722 1,114,977 1,199,751 =============== =============== =============== =============== PIONEER VCT IBBOTSON MODERATE ALLOCATION PIONEER VCT MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 1,789,015 1,795,010 1,769,793 1,688,831 Units issued and transferred from other funding options...... 15,433 57,414 220,661 381,410 Units redeemed and transferred to other funding options........... (144,208) (63,409) (270,601) (300,448) --------------- --------------- --------------- --------------- Units end of year.................. 1,660,240 1,789,015 1,719,853 1,769,793 =============== =============== =============== =============== PIONEER VCT REAL ESTATE SHARES T. ROWE PRICE GROWTH STOCK SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2013 2012 2013 2012 --------------- --------------- --------------- --------------- Units beginning of year............ 10,700 12,968 66,302 73,401 Units issued and transferred from other funding options...... 1,372 2,570 6,234 5,154 Units redeemed and transferred to other funding options........... (673) (4,838) (9,965) (12,253) --------------- --------------- --------------- --------------- Units end of year.................. 11,399 10,700 62,571 66,302 =============== =============== =============== =============== [Enlarge/Download Table] T. ROWE PRICE INTERNATIONAL STOCK T. ROWE PRICE PRIME RESERVE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- --------------------------------- 2013 2012 2013 2012 ---------------- --------------- --------------- ---------------- Units beginning of year............ 45,736 59,337 40,746 54,384 Units issued and transferred from other funding options...... 1,435 2,844 30,026 24,475 Units redeemed and transferred to other funding options........... (5,811) (16,445) (39,029) (38,113) ---------------- --------------- --------------- ---------------- Units end of year.................. 41,360 45,736 31,743 40,746 ================ =============== =============== ================ UIF U.S. REAL ESTATE SUB-ACCOUNT -------------------------------- 2013 2012 --------------- --------------- Units beginning of year............ 2,343,331 2,367,197 Units issued and transferred from other funding options...... 692,925 610,442 Units redeemed and transferred to other funding options........... (505,065) (634,308) --------------- --------------- Units end of year.................. 2,531,191 2,343,331 =============== =============== (a) For the period July 23, 2012 to December 31, 2012. (b) For the period April 30, 2012 to December 31, 2012. (c) For the period November 12, 2012 to December 31, 2012. (d) For the period April 29, 2013 to December 31, 2013. 122
N-4196th Page of 530TOC1stPreviousNextBottomJust 196th
123
N-4197th Page of 530TOC1stPreviousNextBottomJust 197th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS The Company sells a number of variable annuity products which have unique combinations of features and fees, some of which directly affect the unit values of the Sub-Accounts. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns. The following table is a summary of unit values and units outstanding for the Contracts, net investment income ratios, and expense ratios, excluding expenses for the underlying portfolio, series, or fund, for the respective stated periods in the five years ended December 31, 2013: [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Alger Small Cap Growth 2013 4,387,118 14.41 - 14.70 63,772,199 Sub-Account 2012 4,795,545 10.89 - 11.09 52,626,085 2011 5,212,661 9.82 - 9.98 51,540,007 2010 5,634,931 10.28 - 10.44 58,325,342 2009 6,156,883 8.32 - 8.44 51,552,207 American Funds Bond 2013 8,361,945 15.94 - 18.68 146,158,351 Sub-Account 2012 7,687,811 16.60 - 19.27 139,213,016 2011 6,703,194 16.06 - 18.46 116,697,267 2010 5,183,483 15.43 - 17.57 86,203,052 2009 3,608,245 14.77 - 16.66 57,212,613 American Funds Global 2013 8,333,553 32.79 - 41.42 314,826,203 Growth Sub-Account 2012 8,485,913 25.98 - 32.35 251,295,328 2011 8,205,329 21.69 - 26.44 200,460,185 2010 7,470,107 24.36 - 29.30 202,441,649 2009 6,579,263 22.30 - 26.47 161,438,857 American Funds Global Small 2013 3,375,743 33.79 - 39.59 124,184,003 Capitalization Sub-Account 2012 3,385,796 26.85 - 31.14 98,386,346 2011 3,080,674 23.15 - 26.58 76,801,888 2010 2,578,008 29.19 - 33.17 80,582,925 2009 2,262,060 24.30 - 27.34 58,608,602 American Funds Growth 2013 3,937,244 168.83 - 257.41 856,560,204 Sub-Account 2012 4,113,319 132.79 - 199.62 696,665,988 2011 3,976,212 115.27 - 170.85 577,437,630 2010 3,717,676 123.22 - 180.08 568,813,924 2009 3,225,880 106.24 - 153.09 419,749,811 American Funds 2013 2,581,885 117.99 - 179.88 388,319,990 Growth-Income Sub-Account 2012 2,745,842 90.43 - 135.94 312,823,451 2011 2,773,925 78.78 - 116.75 272,388,909 2010 2,639,070 82.11 - 119.99 266,511,951 2009 2,398,146 75.40 - 108.65 219,689,912 DWS I International 2013 1,888,612 9.76 - 9.85 18,592,794 Sub-Account 2012 2,040,232 8.24 - 8.30 16,933,216 2011 2,245,605 6.92 - 6.97 15,659,285 2010 2,471,385 8.43 - 8.48 20,962,763 2009 2,700,348 8.41 - 8.46 22,845,161 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Alger Small Cap Growth 2013 -- 1.25 - 1.40 32.40 - 32.59 Sub-Account 2012 -- 1.25 - 1.40 10.93 - 11.09 2011 -- 1.25 - 1.40 (4.52) - (4.38) 2010 -- 1.25 - 1.40 23.54 - 23.73 2009 -- 1.25 - 1.40 43.49 - 43.70 American Funds Bond 2013 1.84 0.95 - 1.90 (4.00) - (3.08) Sub-Account 2012 2.64 0.95 - 1.90 3.38 - 4.37 2011 3.37 0.95 - 1.90 4.11 - 5.11 2010 3.44 0.95 - 1.90 4.44 - 5.44 2009 3.86 0.95 - 1.90 10.49 - 11.54 American Funds Global 2013 1.26 0.90 - 2.30 26.24 - 28.02 Growth Sub-Account 2012 0.94 0.90 - 2.30 7.06 - 21.40 2011 1.37 0.95 - 2.30 (10.95) - (9.75) 2010 1.56 0.95 - 2.30 9.21 - 10.69 2009 1.51 0.95 - 2.30 39.07 - 40.96 American Funds Global Small 2013 0.87 0.89 - 1.90 25.87 - 27.14 Capitalization Sub-Account 2012 1.35 0.89 - 1.90 2.91 - 17.13 2011 1.34 0.89 - 1.90 (20.66) - (19.86) 2010 1.75 0.89 - 1.90 20.11 - 21.33 2009 0.31 0.89 - 1.90 58.26 - 59.86 American Funds Growth 2013 0.93 0.89 - 2.30 27.15 - 28.95 Sub-Account 2012 0.81 0.89 - 2.30 1.85 - 16.84 2011 0.63 0.89 - 2.30 (6.45) - (5.12) 2010 0.77 0.89 - 2.30 15.98 - 17.63 2009 0.71 0.89 - 2.30 36.24 - 38.18 American Funds 2013 1.35 0.89 - 2.30 30.47 - 32.32 Growth-Income Sub-Account 2012 1.64 0.89 - 2.30 14.80 - 16.44 2011 1.60 0.89 - 2.30 (4.06) - (2.70) 2010 1.55 0.89 - 2.30 8.90 - 10.44 2009 1.74 0.89 - 2.30 28.26 - 30.08 DWS I International 2013 5.30 1.35 - 1.40 18.56 - 18.62 Sub-Account 2012 2.19 1.35 - 1.40 18.96 - 19.02 2011 1.83 1.35 - 1.40 (17.83) - (17.79) 2010 2.18 1.35 - 1.40 0.21 - 0.26 2009 4.39 1.35 - 1.40 31.67 - 31.73 124
N-4198th Page of 530TOC1stPreviousNextBottomJust 198th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 FOR THE YEAR ENDED DECEMBER 31 --------------------------------------------- ------------------------------------------------- UNIT VALUE INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) LOWEST TO NET INCOME LOWEST TO LOWEST TO UNITS HIGHEST ($) ASSETS ($) RATIO (%) HIGHEST (%) HIGHEST (%) ------------ --------------- -------------- ------------- ---------------- ---------------- Federated High Income Bond 2013 2,545 10.28 26,166 6.76 1.40 5.50 Sub-Account 2012 2,556 9.74 24,908 8.87 1.40 13.09 2011 3,549 8.62 30,572 8.62 1.40 3.71 2010 3,566 8.31 29,620 7.89 1.40 13.13 2009 3,582 7.34 26,300 8.35 1.40 50.72 Federated Kaufman 2013 5,836 7.70 44,907 -- 1.40 38.18 Sub-Account 2012 6,002 5.57 33,424 -- 1.40 15.65 (Commenced 3/15/2010) 2011 12,138 4.82 58,454 1.12 1.40 (14.47) 2010 14,184 5.63 79,874 -- 1.40 13.09 Fidelity VIP Asset Manager 2013 5,885,530 14.88 - 15.70 88,274,483 1.55 0.89 - 1.40 14.10 - 14.68 Sub-Account 2012 6,517,939 13.04 - 13.69 85,640,352 1.49 0.89 - 1.40 10.91 - 11.48 2011 7,353,740 11.75 - 12.28 87,071,337 1.88 0.89 - 1.40 (3.91) - (3.42) 2010 8,263,984 12.22 - 12.71 101,784,889 1.66 0.89 - 1.40 12.67 - 13.26 2009 9,345,424 10.84 - 11.23 102,112,475 2.38 0.89 - 1.40 27.32 - 27.96 Fidelity VIP Contrafund 2013 17,717,451 5.67 - 64.36 611,972,926 1.04 0.89 - 2.25 10.23 - 30.12 Sub-Account 2012 15,604,750 12.42 - 49.54 471,113,726 1.36 0.89 - 2.25 13.71 - 15.38 2011 15,588,853 10.76 - 43.00 388,526,965 1.01 0.89 - 2.25 (4.80) - (3.38) 2010 15,707,574 11.14 - 44.59 379,741,596 1.25 0.89 - 2.25 14.51 - 16.18 2009 15,955,996 9.59 - 38.44 313,576,644 1.44 0.89 - 2.25 32.65 - 34.50 Fidelity VIP Equity-Income 2013 341,560 17.43 5,954,600 2.41 1.40 26.37 Sub-Account 2012 400,352 13.80 5,523,241 2.96 1.40 15.67 2011 460,289 11.93 5,489,918 2.37 1.40 (0.43) 2010 530,175 11.98 6,350,751 1.75 1.40 13.56 2009 619,856 10.55 6,538,981 2.24 1.40 28.40 Fidelity VIP FundsManager 2013 158,954,030 12.73 - 12.88 2,033,793,788 1.55 1.90 - 2.05 12.57 - 12.74 50% Sub-Account 2012 39,080,828 11.31 - 11.42 443,823,085 2.69 1.90 - 2.05 1.76 - 4.11 (Commenced 7/23/2012) Fidelity VIP FundsManager 2013 333,151,686 12.05 - 12.16 4,031,523,824 1.16 1.90 - 2.05 16.21 - 16.38 60% Sub-Account 2012 345,636,001 10.37 - 10.45 3,596,633,088 1.53 1.90 - 2.05 9.33 - 9.49 (Commenced 10/15/2009) 2011 272,464,191 9.48 - 9.54 2,591,601,265 2.00 1.90 - 2.05 (4.01) - (3.87) 2010 118,824,451 9.88 - 9.93 1,176,598,687 2.72 1.90 - 2.05 11.32 - 11.49 2009 4,074,373 8.87 - 8.90 36,215,324 3.35 1.90 - 2.05 0.07 - 0.09 Fidelity VIP Growth 2013 8,194,380 20.10 - 21.07 165,968,439 0.29 0.89 - 1.40 34.44 - 35.13 Sub-Account 2012 9,085,626 14.95 - 15.59 136,799,312 0.59 0.89 - 1.40 13.09 - 13.67 2011 9,918,387 13.22 - 13.72 131,974,709 0.36 0.89 - 1.40 (1.19) - (0.68) 2010 10,951,340 13.38 - 13.81 147,385,504 0.28 0.89 - 1.40 22.44 - 23.08 2009 11,893,241 10.93 - 11.22 130,641,959 0.45 0.89 - 1.40 26.51 - 27.14 Fidelity VIP Index 500 2013 3,091,556 22.53 - 23.73 69,677,247 1.84 0.89 - 1.35 30.47 - 31.07 Sub-Account 2012 3,530,426 17.27 - 18.10 60,984,620 2.03 0.89 - 1.35 14.35 - 14.88 2011 3,976,112 15.10 - 15.76 60,061,917 1.87 0.89 - 1.35 0.67 - 1.14 2010 4,565,389 14.90 - 15.58 68,501,202 1.87 0.89 - 1.40 13.42 - 14.00 2009 5,300,313 13.22 - 13.67 70,079,047 2.52 0.89 - 1.35 24.91 - 25.48 125
N-4199th Page of 530TOC1stPreviousNextBottomJust 199th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Fidelity VIP Mid Cap 2013 7,792,671 52.90 - 61.01 446,581,942 Sub-Account 2012 7,598,912 39.68 - 45.33 324,832,892 2011 6,289,465 35.30 - 39.95 237,701,501 2010 4,364,581 40.36 - 45.24 187,246,537 2009 3,075,278 31.99 - 35.52 103,784,411 Fidelity VIP Money Market 2013 8,307,410 7.04 - 10.73 76,155,346 Sub-Account 2012 8,041,430 7.14 - 10.94 73,659,399 2011 8,001,050 7.23 - 11.14 73,068,632 2010 7,492,405 7.33 - 11.34 67,343,833 2009 6,126,543 7.41 - 11.53 50,572,988 Fidelity VIP Overseas 2013 447,143 12.41 - 14.19 5,925,521 Sub-Account 2012 509,517 9.62 - 11.02 5,241,037 2011 540,072 8.06 - 9.24 4,664,192 2010 593,728 9.85 - 11.30 6,266,276 2009 663,667 8.81 - 10.11 6,282,775 FTVIPT Franklin Income 2013 4,919,666 48.59 - 67.20 297,821,470 Securities Sub-Account 2012 4,708,870 43.62 - 59.54 253,164,341 2011 4,290,472 39.61 - 53.36 206,611,149 2010 3,722,732 39.56 - 52.61 176,548,647 2009 3,157,996 35.91 - 47.14 134,091,525 FTVIPT Franklin Small Cap 2013 9,184,423 13.56 - 14.30 128,048,983 Value Securities Sub-Account 2012 8,321,925 10.13 - 10.60 86,296,073 2011 5,710,847 8.71 - 9.04 50,705,697 2010 3,178,430 9.21 - 9.48 29,718,643 2009 1,787,114 7.31 - 7.46 13,205,263 FTVIPT Mutual Shares 2013 5,477,366 26.11 - 30.73 156,078,571 Securities Sub-Account 2012 5,768,385 20.75 - 24.19 129,780,562 2011 5,952,328 18.51 - 21.38 118,532,870 2010 5,431,435 19.07 - 21.81 110,507,146 2009 4,784,657 17.47 - 19.80 88,554,450 FTVIPT Templeton Foreign 2013 2,457,017 16.25 - 38.21 87,721,293 Securities Sub-Account 2012 2,730,167 13.46 - 31.61 80,788,377 2011 2,720,421 11.59 - 27.19 69,009,193 2010 2,782,005 13.20 - 30.95 79,683,759 2009 2,655,441 12.40 - 29.04 70,515,555 FTVIPT Templeton Global 2013 12,950,902 18.47 - 20.82 254,683,414 Bond Securities Sub-Account 2012 11,067,808 18.50 - 20.69 217,063,429 2011 8,104,261 16.36 - 18.15 139,986,041 2010 4,997,591 16.79 - 18.48 88,294,177 2009 2,853,081 14.93 - 16.31 44,636,060 Invesco V.I. American 2013 22,147 7.39 163,713 Franchise Sub-Account 2012 28,015 5.35 149,862 2011 18,874 4.77 90,033 2010 25,363 5.16 130,764 2009 26,829 4.36 117,046 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Fidelity VIP Mid Cap 2013 0.28 0.95 - 1.90 33.31 - 34.59 Sub-Account 2012 0.43 0.95 - 1.90 12.40 - 13.47 2011 0.03 0.95 - 1.90 (12.53) - (11.70) 2010 0.14 0.95 - 1.90 26.16 - 27.36 2009 0.54 0.95 - 1.90 37.12 - 38.43 Fidelity VIP Money Market 2013 0.02 0.89 - 2.05 (2.01) - (0.86) Sub-Account 2012 0.12 0.89 - 2.05 (1.93) - (0.76) 2011 0.09 0.89 - 2.05 (1.94) - (0.77) 2010 0.17 0.89 - 2.05 (1.82) - (0.65) 2009 0.71 0.89 - 2.05 (0.68) - (0.17) Fidelity VIP Overseas 2013 1.34 1.15 - 1.40 28.62 - 28.95 Sub-Account 2012 1.97 1.15 - 1.40 19.05 - 19.35 2011 1.35 1.15 - 1.40 (18.32) - (18.12) 2010 1.39 1.15 - 1.40 11.54 - 11.82 2009 2.17 1.15 - 1.40 24.78 - 25.09 FTVIPT Franklin Income 2013 6.33 0.95 - 2.25 11.41 - 12.86 Securities Sub-Account 2012 6.44 0.95 - 2.25 10.13 - 11.58 2011 5.75 0.95 - 2.25 0.11 - 1.42 2010 6.60 0.95 - 2.25 10.17 - 11.61 2009 8.01 0.95 - 2.25 32.58 - 34.31 FTVIPT Franklin Small Cap 2013 1.31 0.95 - 1.75 33.88 - 34.95 Value Securities Sub-Account 2012 0.78 0.95 - 1.75 16.32 - 17.26 2011 0.66 0.95 - 1.75 (5.43) - (4.67) 2010 0.73 0.95 - 1.75 26.00 - 27.01 2009 1.66 0.95 - 1.75 26.91 - 27.94 FTVIPT Mutual Shares 2013 2.10 0.95 - 1.90 25.85 - 27.05 Securities Sub-Account 2012 2.06 0.95 - 1.90 12.08 - 13.16 2011 2.42 0.95 - 1.90 (2.90) - (1.98) 2010 1.62 0.95 - 1.90 9.10 - 10.14 2009 2.02 0.95 - 1.90 23.67 - 24.86 FTVIPT Templeton Foreign 2013 2.38 1.55 - 2.30 20.18 - 21.08 Securities Sub-Account 2012 3.02 1.55 - 2.30 15.53 - 16.41 2011 1.71 1.55 - 2.30 (12.66) - (12.00) 2010 1.88 1.55 - 2.30 5.94 - 6.74 2009 3.05 1.55 - 2.30 33.93 - 34.94 FTVIPT Templeton Global 2013 4.75 0.95 - 1.75 (0.13) - 0.67 Bond Securities Sub-Account 2012 6.42 0.95 - 1.75 13.06 - 13.97 2011 5.46 0.95 - 1.75 (2.58) - (1.81) 2010 1.36 0.95 - 1.75 12.46 - 13.36 2009 14.21 0.95 - 1.75 16.62 - 17.56 Invesco V.I. American 2013 0.42 1.40 38.19 Franchise Sub-Account 2012 -- 1.40 12.14 2011 -- 1.40 (7.49) 2010 -- 1.40 18.18 2009 0.11 1.40 63.78 126
N-4200th Page of 530TOC1stPreviousNextBottomJust 200th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ ---------------- -------------- Invesco V.I. American Value 2013 5,963,473 15.53 - 16.44 95,295,929 Sub-Account 2012 5,515,798 11.80 - 12.39 66,684,996 2011 4,490,470 10.26 - 10.68 47,014,117 2010 2,673,648 10.35 - 10.70 28,139,044 2009 1,763,519 8.62 - 8.84 15,401,650 Invesco V.I. Core Equity 2013 39,835 6.27 249,696 Sub-Account 2012 49,005 4.92 241,009 2011 63,191 4.38 276,761 2010 88,640 4.44 393,933 2009 99,143 4.11 407,845 Invesco V.I. Equity and 2013 31,328,255 6.09 - 21.69 649,322,698 Income Sub-Account 2012 29,563,858 4.93 - 17.54 496,945,594 2011 27,370,136 4.44 - 15.75 414,357,262 2010 22,199,448 14.98 - 16.11 345,124,808 2009 17,747,381 13.63 - 14.52 249,400,082 Invesco V.I. Global Real 2013 3,254,580 8.95 - 9.48 29,993,323 Estate Sub-Account 2012 2,556,360 8.90 - 9.34 23,302,577 2011 1,863,096 7.08 - 7.38 13,467,264 2010 1,148,943 7.73 - 7.98 9,028,134 2009 704,385 6.71 - 6.88 4,786,308 Invesco V.I. Growth and 2013 13,799,854 9.57 - 36.41 365,970,613 Income Sub-Account 2012 13,407,203 7.24 - 27.48 268,230,013 2011 11,777,382 6.40 - 24.26 206,338,231 2010 9,061,763 6.63 - 25.06 160,437,278 2009 6,896,039 5.97 - 22.55 107,604,807 Invesco V.I. International 2013 8,901,354 9.17 - 34.47 281,999,206 Growth Sub-Account 2012 8,127,475 7.81 - 29.32 219,783,700 2011 6,481,068 6.86 - 25.68 154,099,050 2010 4,327,573 7.46 - 27.87 111,888,065 2009 2,818,925 6.70 - 24.98 65,315,391 Janus Aspen Global Research 2013 721 9.35 6,748 Sub-Account 2012 769 7.35 5,653 2011 769 6.17 4,750 2010 901 7.22 6,506 2009 999 6.29 6,285 LMPVET ClearBridge Variable 2013 11,979,001 15.00 - 25.98 280,745,200 Aggressive Growth 2012 11,687,754 10.38 - 17.75 186,988,862 Sub-Account 2011 11,855,614 8.94 - 15.09 160,839,221 2010 11,742,971 8.92 - 14.87 156,471,918 2009 11,503,827 7.29 - 12.01 123,705,924 LMPVET ClearBridge Variable 2013 2,922,291 37.21 - 48.58 129,253,563 All Cap Value Sub-Account 2012 3,081,671 28.81 - 37.11 104,446,756 2011 3,213,146 25.64 - 32.59 95,718,136 2010 3,100,875 27.97 - 35.07 99,528,233 2009 2,989,079 24.54 - 30.36 83,258,408 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- Invesco V.I. American Value 2013 0.57 0.95 - 1.75 31.61 - 32.67 Sub-Account 2012 0.68 0.95 - 1.75 15.03 - 15.96 2011 0.72 0.95 - 1.75 (0.92) - (0.12) 2010 0.80 0.95 - 1.75 20.06 - 21.03 2009 1.18 0.95 - 1.75 36.75 - 37.84 Invesco V.I. Core Equity 2013 1.36 1.40 27.45 Sub-Account 2012 0.91 1.40 12.29 2011 0.92 1.40 (1.44) 2010 0.95 1.40 8.02 2009 1.76 1.40 26.51 Invesco V.I. Equity and 2013 1.54 0.95 - 1.90 22.54 - 23.71 Income Sub-Account 2012 1.85 0.95 - 1.90 10.26 - 11.32 2011 1.69 0.95 - 1.90 (8.77) - (2.23) 2010 1.92 0.95 - 1.90 9.92 - 10.97 2009 2.82 0.95 - 1.90 20.19 - 21.33 Invesco V.I. Global Real 2013 3.98 0.95 - 1.75 0.66 - 1.47 Estate Sub-Account 2012 0.48 0.95 - 1.75 25.62 - 26.63 2011 4.22 0.95 - 1.75 (8.34) - (7.62) 2010 5.55 0.95 - 1.75 15.19 - 16.13 2009 -- 0.95 - 1.75 28.83 - 29.86 Invesco V.I. Growth and 2013 1.31 0.95 - 1.90 31.25 - 32.50 Income Sub-Account 2012 1.36 0.95 - 1.90 12.18 - 13.26 2011 1.13 0.95 - 1.90 (4.10) - (3.18) 2010 0.09 0.95 - 1.90 10.09 - 11.13 2009 3.60 0.95 - 1.90 21.78 - 22.94 Invesco V.I. International 2013 1.10 0.95 - 1.75 16.66 - 17.60 Growth Sub-Account 2012 1.38 0.95 - 1.75 13.25 - 14.16 2011 1.06 0.95 - 1.75 (8.60) - (7.87) 2010 2.01 0.95 - 1.75 10.66 - 11.55 2009 1.74 0.95 - 1.75 32.57 - 33.63 Janus Aspen Global Research 2013 1.21 0.89 27.29 Sub-Account 2012 0.89 0.89 19.01 2011 0.58 0.89 (14.50) 2010 0.61 0.89 14.80 2009 1.43 0.89 36.49 LMPVET ClearBridge Variable 2013 0.28 0.95 - 2.30 44.42 - 46.38 Aggressive Growth 2012 0.43 0.95 - 2.30 16.01 - 17.60 Sub-Account 2011 0.20 0.95 - 2.30 0.15 - 1.50 2010 0.15 0.95 - 2.30 22.17 - 23.83 2009 -- 0.95 - 2.30 31.51 - 33.30 LMPVET ClearBridge Variable 2013 1.40 0.95 - 2.30 29.16 - 30.92 All Cap Value Sub-Account 2012 1.72 0.95 - 2.30 12.35 - 13.89 2011 1.41 0.95 - 2.30 (8.32) - (7.08) 2010 1.79 0.95 - 2.30 13.96 - 15.50 2009 1.44 0.95 - 2.30 26.41 - 28.14 127
N-4201st Page of 530TOC1stPreviousNextBottomJust 201st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- LMPVET ClearBridge Variable 2013 8,604,407 38.78 - 51.73 405,286,221 Appreciation Sub-Account 2012 7,908,912 30.52 - 40.17 290,191,379 2011 7,021,537 26.94 - 34.98 224,680,370 2010 5,515,253 26.87 - 34.42 173,626,503 2009 4,134,838 24.41 - 30.85 116,657,409 LMPVET ClearBridge Variable 2013 10,244,154 12.44 - 20.09 191,169,653 Equity Income Sub-Account 2012 9,055,914 10.11 - 16.14 134,931,130 2011 8,013,455 9.06 - 14.28 103,322,855 2010 6,778,039 10.29 - 13.39 81,006,913 2009 6,144,958 9.34 - 12.06 64,946,351 LMPVET ClearBridge Variable 2013 242,954 18.99 - 21.53 5,012,390 Large Cap Growth 2012 283,429 14.10 - 15.86 4,312,254 Sub-Account 2011 363,040 11.99 - 13.38 4,673,796 2010 459,350 12.35 - 13.67 6,065,533 2009 557,417 11.50 - 12.63 6,818,703 LMPVET ClearBridge Variable 2013 319,601 19.77 - 22.45 6,892,954 Large Cap Value Sub-Account 2012 286,427 15.28 - 17.21 4,743,489 2011 265,335 13.42 - 15.00 3,836,359 2010 194,899 13.09 - 14.51 2,729,796 2009 196,692 12.23 - 13.45 2,559,454 LMPVET ClearBridge Variable 2013 4,102,827 22.63 - 31.63 112,499,020 Small Cap Growth 2012 3,457,289 15.75 - 21.71 64,881,494 Sub-Account 2011 2,686,955 13.50 - 18.35 42,564,777 2010 2,149,625 13.62 - 18.28 33,662,804 2009 1,757,714 11.13 - 14.74 21,966,842 LMPVET Investment Counsel 2013 7,932 34.52 - 37.64 292,286 Variable Social Awareness 2012 9,185 29.64 - 32.19 289,329 Sub-Account 2011 17,377 27.28 - 29.51 501,373 2010 17,424 27.81 - 29.97 510,680 2009 19,412 25.28 - 27.12 515,712 LMPVET Variable Lifestyle 2013 2,011,433 20.00 - 23.49 44,101,401 Allocation 50% Sub-Account 2012 1,699,443 17.68 - 20.56 32,620,028 2011 1,414,982 15.93 - 17.95 24,265,695 2010 769,522 16.05 - 17.94 13,086,823 2009 487,451 14.30 - 15.06 7,231,568 LMPVET Variable Lifestyle 2013 121,395 18.11 - 19.37 2,304,999 Allocation 70% Sub-Account 2012 162,342 15.15 - 16.14 2,573,509 2011 219,583 13.47 - 14.30 3,086,943 2010 236,121 13.81 - 14.60 3,395,287 2009 271,548 12.24 - 12.89 3,447,350 LMPVET Variable Lifestyle 2013 4,790,185 18.14 - 21.30 95,074,284 Allocation 85% Sub-Account 2012 5,015,187 14.61 - 17.00 79,817,339 2011 4,732,454 12.85 - 14.81 65,879,472 2010 4,289,092 13.41 - 15.30 62,035,149 2009 3,756,486 11.81 - 13.35 47,576,561 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- LMPVET ClearBridge Variable 2013 1.29 0.95 - 2.30 27.05 - 28.77 Appreciation Sub-Account 2012 1.75 0.95 - 2.30 13.30 - 14.85 2011 1.77 0.95 - 2.30 0.28 - 1.64 2010 1.83 0.95 - 2.30 10.07 - 11.56 2009 2.45 0.95 - 2.30 19.34 - 20.96 LMPVET ClearBridge Variable 2013 1.65 0.95 - 2.30 23.08 - 24.49 Equity Income Sub-Account 2012 3.04 0.95 - 2.30 11.60 - 12.99 2011 3.39 0.95 - 2.30 (2.15) - 6.69 2010 4.09 0.95 - 1.90 10.01 - 11.06 2009 3.37 0.95 - 1.90 20.32 - 21.47 LMPVET ClearBridge Variable 2013 0.51 1.50 - 2.30 34.72 - 35.80 Large Cap Growth 2012 0.66 1.50 - 2.30 17.60 - 18.55 Sub-Account 2011 0.42 1.50 - 2.30 (2.91) - (2.12) 2010 0.11 1.50 - 2.30 7.34 - 8.19 2009 0.27 1.50 - 2.30 39.14 - 40.27 LMPVET ClearBridge Variable 2013 1.77 1.50 - 2.30 29.36 - 30.40 Large Cap Value Sub-Account 2012 2.37 1.50 - 2.30 13.84 - 14.76 2011 2.82 1.50 - 2.30 2.57 - 3.39 2010 3.02 1.50 - 2.30 6.98 - 7.83 2009 1.95 1.50 - 2.30 21.66 - 22.65 LMPVET ClearBridge Variable 2013 0.05 0.95 - 2.30 43.71 - 45.66 Small Cap Growth 2012 0.42 0.95 - 2.30 16.70 - 18.29 Sub-Account 2011 -- 0.95 - 2.30 (0.91) - 0.43 2010 -- 0.95 - 2.30 22.34 - 24.00 2009 -- 0.95 - 2.30 39.53 - 41.42 LMPVET Investment Counsel 2013 0.83 1.50 - 1.90 16.47 - 16.94 Variable Social Awareness 2012 1.06 1.50 - 1.90 8.62 - 9.06 Sub-Account 2011 1.20 1.50 - 1.90 (1.89) - (1.51) 2010 1.24 1.50 - 1.90 10.04 - 10.48 2009 1.43 1.50 - 1.90 20.53 - 21.01 LMPVET Variable Lifestyle 2013 2.21 0.95 - 1.90 13.16 - 14.24 Allocation 50% Sub-Account 2012 2.95 0.95 - 1.90 10.96 - 12.02 2011 3.19 1.10 - 1.90 (0.73) - 0.07 2010 4.10 1.10 - 1.90 6.21 - 12.65 2009 5.06 1.50 - 1.90 29.83 - 30.35 LMPVET Variable Lifestyle 2013 1.41 1.50 - 1.90 19.53 - 20.01 Allocation 70% Sub-Account 2012 2.16 1.50 - 1.90 12.43 - 12.88 2011 1.88 1.50 - 1.90 (2.45) - (2.06) 2010 2.04 1.50 - 1.90 12.84 - 13.30 2009 3.60 1.50 - 1.90 30.41 - 30.93 LMPVET Variable Lifestyle 2013 1.66 0.95 - 1.90 24.12 - 25.30 Allocation 85% Sub-Account 2012 1.84 0.95 - 1.90 13.70 - 14.79 2011 1.55 0.95 - 1.90 (4.15) - (3.23) 2010 1.73 0.95 - 1.90 13.52 - 14.60 2009 2.64 0.95 - 1.90 29.99 - 31.22 128
N-4202nd Page of 530TOC1stPreviousNextBottomJust 202nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- LMPVIT Western Asset 2013 4,386,878 20.82 - 25.72 104,740,451 Variable Global High Yield 2012 4,039,328 20.05 - 24.44 91,771,912 Bond Sub-Account 2011 3,594,817 17.34 - 20.85 69,717,903 2010 3,170,899 17.44 - 20.70 61,092,507 2009 2,845,850 15.53 - 18.18 48,249,580 MFS VIT Investors Trust 2013 3,517 7.38 25,951 Sub-Account 2012 3,616 5.67 20,488 2011 7,050 4.82 33,994 2010 8,683 5.00 43,404 2009 11,563 4.56 52,758 MFS VIT New Discovery 2013 3,294 13.97 46,020 Sub-Account 2012 4,161 10.01 41,661 2011 4,939 8.38 41,374 2010 4,951 9.47 46,865 2009 6,461 7.04 45,491 MFS VIT Research Sub-Account 2013 8,132 7.85 63,835 2012 8,335 6.02 50,155 2011 8,675 5.20 45,142 2010 21,202 5.30 112,388 2009 23,944 4.64 111,057 MIST AllianceBernstein 2013 286,256,086 11.32 - 11.74 3,313,674,192 Global Dynamic Allocation 2012 267,334,005 10.40 - 10.66 2,823,843,417 Sub-Account 2011 168,434,681 9.68 - 9.75 1,639,379,077 (Commenced 5/2/2011) MIST American Funds 2013 276,830,535 11.83 - 12.78 3,430,387,038 Balanced Allocation 2012 292,605,761 10.22 - 10.89 3,106,060,329 Sub-Account 2011 306,967,734 9.22 - 9.69 2,914,777,188 2010 251,644,506 9.64 - 10.00 2,478,289,324 2009 147,529,141 8.80 - 9.00 1,315,175,709 MIST American Funds Growth 2013 147,794,512 11.83 - 12.67 1,828,322,375 Allocation Sub-Account 2012 149,020,463 9.68 - 10.24 1,496,665,592 2011 159,224,115 8.53 - 8.92 1,398,390,722 2010 155,386,301 9.17 - 9.47 1,454,861,016 2009 139,002,030 8.27 - 8.44 1,164,848,803 MIST American Funds Growth 2013 59,593,818 1.29 - 12.90 632,386,636 Sub-Account 2012 54,812,434 9.59 - 10.07 545,665,799 2011 64,256,598 8.36 - 8.69 553,292,806 2010 52,406,611 8.97 - 9.23 480,253,525 2009 30,278,080 7.76 - 7.90 238,097,827 MIST American Funds 2013 147,773,215 11.61 - 12.53 1,796,366,977 Moderate Allocation 2012 159,499,085 10.47 - 11.15 1,734,325,945 Sub-Account 2011 168,982,398 9.67 - 10.16 1,683,464,896 2010 143,876,667 9.88 - 10.25 1,452,175,003 2009 89,994,728 9.20 - 9.42 839,089,528 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- LMPVIT Western Asset 2013 6.19 0.95 - 2.30 3.85 - 5.27 Variable Global High Yield 2012 7.84 0.95 - 2.30 15.62 - 17.20 Bond Sub-Account 2011 8.38 0.95 - 2.30 (0.59) - 0.75 2010 9.47 0.95 - 2.30 12.31 - 13.83 2009 11.34 0.95 - 2.30 52.02 - 54.08 MFS VIT Investors Trust 2013 1.10 1.40 30.22 Sub-Account 2012 0.67 1.40 17.52 2011 0.90 1.40 (3.54) 2010 1.30 1.40 9.56 2009 1.77 1.40 25.15 MFS VIT New Discovery 2013 -- 1.40 39.55 Sub-Account 2012 -- 1.40 19.53 2011 -- 1.40 (11.51) 2010 -- 1.40 34.44 2009 -- 1.40 60.90 MFS VIT Research Sub-Account 2013 0.33 1.40 30.45 2012 0.79 1.40 15.63 2011 0.72 1.40 (1.83) 2010 0.92 1.40 14.29 2009 1.44 1.40 28.73 MIST AllianceBernstein 2013 1.28 0.90 - 2.35 8.56 - 10.15 Global Dynamic Allocation 2012 0.10 0.90 - 2.35 3.45 - 8.82 Sub-Account 2011 0.87 1.15 - 2.25 (3.18) - (2.47) (Commenced 5/2/2011) MIST American Funds 2013 1.37 1.00 - 2.35 15.78 - 17.35 Balanced Allocation 2012 1.69 1.00 - 2.35 10.88 - 12.39 Sub-Account 2011 1.26 1.00 - 2.35 (4.39) - (3.10) 2010 1.01 1.00 - 2.35 9.55 - 11.05 2009 -- 1.00 - 2.35 20.40 - 27.85 MIST American Funds Growth 2013 1.00 1.15 - 2.35 22.20 - 23.68 Allocation Sub-Account 2012 1.21 1.15 - 2.35 13.45 - 14.82 2011 1.10 1.15 - 2.35 (6.95) - (5.82) 2010 0.89 1.15 - 2.35 10.86 - 12.18 2009 -- 1.15 - 2.35 30.93 - 32.51 MIST American Funds Growth 2013 0.44 0.95 - 2.35 11.27 - 28.11 Sub-Account 2012 0.33 1.30 - 2.35 14.67 - 15.89 2011 0.35 1.30 - 2.35 (6.81) - (5.83) 2010 0.20 1.30 - 2.35 15.57 - 16.79 2009 -- 1.30 - 2.35 35.67 - 37.09 MIST American Funds 2013 1.65 1.00 - 2.35 10.88 - 12.39 Moderate Allocation 2012 2.04 1.00 - 2.35 8.25 - 9.73 Sub-Account 2011 1.54 1.00 - 2.35 (2.14) - (0.81) 2010 1.41 1.00 - 2.35 7.36 - 8.82 2009 -- 1.00 - 2.35 15.69 - 21.98 129
N-4203rd Page of 530TOC1stPreviousNextBottomJust 203rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST AQR Global Risk 2013 295,108,196 9.93 - 11.09 3,248,475,977 Balanced Sub-Account 2012 324,843,850 10.42 - 11.61 3,753,309,463 (Commenced 5/2/2011) 2011 179,038,392 10.54 - 10.62 1,898,124,083 MIST BlackRock Global 2013 487,574,727 10.92 - 11.35 5,457,878,761 Tactical Strategies 2012 471,913,542 10.13 - 10.38 4,856,824,935 Sub-Account 2011 297,189,715 9.51 - 9.58 2,842,712,285 (Commenced 5/2/2011) MIST BlackRock High Yield 2013 10,783,682 14.92 - 28.32 265,149,806 Sub-Account 2012 11,949,833 13.83 - 26.13 276,977,302 2011 10,891,616 12.03 - 21.28 221,624,841 2010 9,034,810 11.92 - 21.07 182,367,303 2009 5,656,394 16.02 - 18.43 100,278,538 MIST BlackRock Large Cap 2013 1,260,254 12.25 - 14.84 16,869,650 Core Sub-Account 2012 1,423,242 9.34 - 11.16 14,439,147 2011 1,414,721 8.42 - 9.34 12,849,849 2010 1,044,239 8.60 - 9.47 9,613,588 2009 613,169 7.82 - 8.54 5,078,728 MIST Clarion Global Real 2013 11,099,591 15.36 - 17.68 182,673,922 Estate Sub-Account 2012 10,967,900 15.19 - 17.23 177,317,957 2011 11,304,866 12.34 - 13.38 147,447,056 2010 9,934,760 13.39 - 14.36 139,330,754 2009 7,999,282 11.80 - 12.53 98,120,895 MIST ClearBridge Aggressive 2013 604,793 145.80 - 224.52 119,068,960 Growth II Sub-Account 2012 687,043 115.55 - 176.62 106,823,115 2011 543,584 96.27 - 146.05 68,769,080 2010 397,905 106.29 - 160.04 53,356,686 2009 192,470 99.16 - 121.06 21,865,637 MIST ClearBridge Aggressive 2013 36,299,683 10.84 - 13.77 451,710,565 Growth Sub-Account 2012 33,802,849 7.55 - 9.54 292,871,764 2011 35,764,496 6.45 - 7.78 265,479,062 2010 13,863,499 6.97 - 7.63 102,505,758 2009 12,110,468 5.76 - 6.24 73,409,292 MIST Goldman Sachs Mid Cap 2013 7,939,384 19.93 - 22.07 170,038,386 Value Sub-Account 2012 8,486,283 15.38 - 16.85 139,211,779 2011 9,263,271 13.34 - 14.45 130,696,272 2010 7,332,195 14.57 - 15.63 112,015,664 2009 6,218,018 12.01 - 12.74 77,628,353 MIST Harris Oakmark 2013 25,769,452 23.43 - 29.23 693,983,244 International Sub-Account 2012 25,722,293 18.33 - 22.61 538,939,254 2011 28,033,038 14.49 - 17.04 461,860,538 2010 23,589,953 17.23 - 20.14 459,739,197 2009 18,176,767 15.11 - 17.52 309,481,262 MIST Invesco Balanced-Risk 2013 800,860,953 1.04 - 1.06 843,160,697 Allocation Sub-Account 2012 631,214,101 1.04 - 1.05 661,422,417 (Commenced 4/30/2012) FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST AQR Global Risk 2013 2.09 0.90 - 2.35 (5.64) - (4.26) Balanced Sub-Account 2012 0.44 0.90 - 2.35 3.72 - 9.29 (Commenced 5/2/2011) 2011 3.00 1.15 - 2.25 1.94 - 2.70 MIST BlackRock Global 2013 1.36 0.90 - 2.35 7.75 - 9.32 Tactical Strategies 2012 -- 0.90 - 2.35 3.27 - 7.89 Sub-Account 2011 1.37 1.15 - 2.25 (4.84) - (4.14) (Commenced 5/2/2011) MIST BlackRock High Yield 2013 7.02 0.90 - 2.35 6.79 - 8.35 Sub-Account 2012 7.05 0.90 - 2.35 7.68 - 15.15 2011 6.52 1.20 - 2.35 (0.03) - 1.12 2010 5.88 1.20 - 2.35 5.99 - 14.28 2009 3.54 1.30 - 2.35 43.24 - 44.75 MIST BlackRock Large Cap 2013 1.28 0.90 - 2.30 31.12 - 32.97 Core Sub-Account 2012 1.07 0.90 - 2.30 (0.27) - 11.75 2011 0.92 1.55 - 2.30 (2.06) - (1.33) 2010 1.06 1.55 - 2.30 10.01 - 10.85 2009 1.34 1.55 - 2.30 16.49 - 17.35 MIST Clarion Global Real 2013 6.85 0.90 - 2.35 1.14 - 2.62 Estate Sub-Account 2012 2.03 0.90 - 2.35 9.18 - 24.35 2011 3.80 1.30 - 2.35 (7.78) - (6.80) 2010 7.76 1.30 - 2.35 13.41 - 14.61 2009 3.11 1.30 - 2.35 31.61 - 33.00 MIST ClearBridge Aggressive 2013 0.63 1.30 - 2.35 25.80 - 27.13 Growth II Sub-Account 2012 0.29 1.30 - 2.35 19.66 - 20.94 2011 1.69 1.30 - 2.35 (9.69) - (8.74) 2010 1.30 1.30 - 2.35 3.20 - 8.00 2009 -- 1.55 - 2.30 39.96 - 41.01 MIST ClearBridge Aggressive 2013 0.22 0.90 - 2.35 42.22 - 44.30 Growth Sub-Account 2012 0.02 0.90 - 2.35 3.28 - 17.38 2011 -- 0.95 - 2.35 (9.34) - 1.91 2010 -- 1.30 - 2.35 20.92 - 22.20 2009 -- 1.30 - 2.35 29.87 - 31.23 MIST Goldman Sachs Mid Cap 2013 0.89 1.30 - 2.35 29.57 - 30.94 Value Sub-Account 2012 0.59 1.30 - 2.35 15.36 - 16.58 2011 0.48 1.30 - 2.35 (8.46) - (7.50) 2010 0.92 1.30 - 2.35 21.35 - 22.63 2009 1.25 1.30 - 2.35 29.24 - 30.59 MIST Harris Oakmark 2013 2.44 0.95 - 2.35 27.46 - 29.26 International Sub-Account 2012 1.63 0.95 - 2.35 15.61 - 27.58 2011 -- 1.30 - 2.35 (16.24) - (15.36) 2010 1.82 1.30 - 2.35 13.71 - 14.92 2009 7.66 1.30 - 2.35 43.46 - 53.06 MIST Invesco Balanced-Risk 2013 -- 0.90 - 2.35 (0.50) - 0.95 Allocation Sub-Account 2012 0.55 0.90 - 2.35 3.03 - 4.04 (Commenced 4/30/2012) 130
N-4204th Page of 530TOC1stPreviousNextBottomJust 204th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 -------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- ------------- MIST Invesco Comstock 2013 26,889,264 14.36 - 22.42 443,561,923 Sub-Account 2012 26,662,653 10.86 - 16.72 329,458,802 2011 25,137,797 9.39 - 14.24 266,463,408 2010 21,172,822 9.76 - 14.59 230,561,318 2009 16,791,760 8.70 - 12.82 161,042,507 MIST Invesco Mid Cap Value 2013 4,619,902 30.27 - 38.39 158,040,375 Sub-Account 2012 5,175,603 23.78 - 29.73 138,149,492 2011 5,366,862 21.23 - 24.69 127,004,689 2010 4,351,943 22.57 - 25.97 108,323,379 2009 3,034,782 18.41 - 20.96 60,902,685 MIST Invesco Small Cap 2013 13,003,134 22.53 - 27.31 319,189,345 Growth Sub-Account 2012 13,528,657 16.44 - 19.61 240,468,780 2011 13,942,780 14.22 - 16.69 212,672,795 2010 11,943,258 14.70 - 16.99 186,610,558 2009 11,180,366 11.92 - 13.55 140,473,926 MIST JPMorgan Core Bond 2013 29,439,490 10.12 - 10.75 311,869,932 Sub-Account 2012 31,242,391 10.69 - 11.23 346,492,447 2011 32,528,572 10.43 - 10.84 349,346,240 2010 26,655,400 10.10 - 10.38 274,791,792 2009 14,305,838 9.74 - 9.92 141,146,685 MIST JPMorgan Global Active 2013 649,853,969 1.13 - 1.16 746,849,717 Allocation Sub-Account 2012 269,034,003 1.04 - 1.05 282,572,135 (Commenced 4/30/2012) MIST JPMorgan Small Cap 2013 1,455,583 18.28 - 20.23 27,866,566 Value Sub-Account 2012 1,643,159 14.04 - 15.36 24,014,976 2011 1,650,824 12.42 - 13.17 21,224,281 2010 1,677,961 14.14 - 14.87 24,426,974 2009 1,579,618 12.10 - 12.62 19,575,088 MIST Loomis Sayles Global 2013 10,842,823 15.69 - 17.47 180,595,781 Markets Sub-Account 2012 12,318,466 13.71 - 14.91 177,780,410 2011 13,161,956 12.01 - 12.74 165,018,207 2010 10,620,691 12.48 - 13.10 137,171,845 2009 7,198,911 10.47 - 10.88 77,383,467 MIST Lord Abbett Bond 2013 9,341,018 9.99 - 32.33 259,294,487 Debenture Sub-Account 2012 10,178,078 9.36 - 30.15 266,010,291 2011 10,848,076 8.39 - 26.88 255,107,548 2010 11,708,304 8.12 - 25.87 267,920,695 2009 11,953,991 7.27 - 23.06 245,913,998 MIST Met/Eaton Vance 2013 7,519,969 10.76 - 11.18 83,115,837 Floating Rate Sub-Account 2012 5,007,151 10.61 - 10.91 54,197,004 (Commenced 5/3/2010) 2011 4,263,176 10.13 - 10.30 43,696,769 2010 1,600,145 10.16 - 10.23 16,334,315 MIST Met/Franklin Low 2013 14,050,793 9.78 - 10.16 140,307,146 Duration Total Return 2012 4,349,231 9.92 - 10.14 43,609,944 Sub-Account 2011 2,835,514 9.70 - 9.78 27,661,832 (Commenced 5/2/2011) FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST Invesco Comstock 2013 1.07 0.90 - 2.35 32.25 - 34.18 Sub-Account 2012 1.22 0.90 - 2.35 5.55 - 17.40 2011 1.09 0.95 - 2.35 (3.76) - (2.39) 2010 1.45 0.95 - 2.35 12.19 - 13.80 2009 1.11 0.95 - 2.35 23.63 - 30.57 MIST Invesco Mid Cap Value 2013 0.74 0.90 - 2.35 27.28 - 29.14 Sub-Account 2012 0.40 0.90 - 2.35 2.26 - 13.21 2011 0.51 1.30 - 2.35 (5.93) - (4.94) 2010 0.55 1.30 - 2.35 22.62 - 23.91 2009 1.74 1.30 - 2.35 23.59 - 24.90 MIST Invesco Small Cap 2013 0.23 0.89 - 2.35 36.92 - 39.29 Growth Sub-Account 2012 -- 0.89 - 2.35 15.47 - 17.45 2011 -- 0.89 - 2.35 (3.37) - (1.73) 2010 -- 0.89 - 2.35 23.26 - 25.35 2009 -- 0.89 - 2.35 30.70 - 33.03 MIST JPMorgan Core Bond 2013 0.28 1.30 - 2.35 (5.04) - (4.05) Sub-Account 2012 2.57 1.30 - 2.35 2.47 - 3.55 2011 2.09 1.30 - 2.35 3.34 - 4.42 2010 1.64 1.30 - 2.35 3.63 - 4.73 2009 -- 1.30 - 2.35 9.52 - 10.67 MIST JPMorgan Global Active 2013 0.08 0.90 - 2.35 8.41 - 9.99 Allocation Sub-Account 2012 0.73 0.90 - 2.35 3.02 - 4.03 (Commenced 4/30/2012) MIST JPMorgan Small Cap 2013 0.69 0.90 - 2.30 30.22 - 31.71 Value Sub-Account 2012 0.84 0.90 - 2.30 2.73 - 13.98 2011 1.69 1.20 - 2.30 (12.17) - (11.43) 2010 0.82 1.20 - 2.30 16.82 - 17.83 2009 0.88 1.20 - 2.30 26.15 - 27.24 MIST Loomis Sayles Global 2013 2.41 0.95 - 2.35 14.41 - 16.02 Markets Sub-Account 2012 2.32 1.10 - 2.35 2.75 - 15.41 2011 2.32 1.30 - 2.35 (3.77) - (2.75) 2010 2.99 1.30 - 2.35 19.18 - 20.43 2009 1.95 1.30 - 2.35 37.54 - 39.00 MIST Lord Abbett Bond 2013 6.62 0.89 - 2.35 5.47 - 7.21 Debenture Sub-Account 2012 7.20 0.89 - 2.35 5.77 - 12.18 2011 5.92 0.89 - 2.35 2.04 - 3.90 2010 6.21 0.89 - 2.35 10.34 - 12.18 2009 7.17 0.89 - 2.35 33.60 - 35.91 MIST Met/Eaton Vance 2013 3.38 1.30 - 2.35 1.42 - 2.50 Floating Rate Sub-Account 2012 3.39 1.30 - 2.35 4.83 - 5.94 (Commenced 5/3/2010) 2011 1.99 1.30 - 2.30 (0.31) - 0.69 2010 -- 1.30 - 2.30 1.64 - 2.31 MIST Met/Franklin Low 2013 1.07 0.90 - 2.35 (1.19) - 0.25 Duration Total Return 2012 1.91 0.90 - 2.20 1.17 - 3.15 Sub-Account 2011 -- 1.20 - 2.35 (2.83) - (2.08) (Commenced 5/2/2011) 131
N-4205th Page of 530TOC1stPreviousNextBottomJust 205th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST Met/Templeton 2013 3,905,329 13.00 - 13.53 52,286,139 International Bond 2012 4,238,395 13.19 - 13.56 57,001,253 Sub-Account 2011 4,276,073 11.74 - 12.02 51,093,268 (Commenced 5/4/2009) 2010 2,982,596 12.04 - 12.22 36,302,425 2009 775,327 10.84 - 10.90 8,438,524 MIST MetLife Aggressive 2013 42,451,280 14.53 - 16.59 659,971,504 Strategy Sub-Account 2012 44,655,767 11.48 - 12.93 545,044,070 2011 49,390,389 10.07 - 10.98 524,691,864 2010 45,689,702 10.94 - 11.78 522,967,837 2009 41,343,573 9.62 - 10.23 412,402,731 MIST MetLife Balanced Plus 2013 547,096,627 11.51 - 11.96 6,454,726,976 Sub-Account 2012 438,994,467 10.30 - 10.55 4,593,209,415 (Commenced 5/2/2011) 2011 257,076,022 9.33 - 9.40 2,411,774,661 MIST MetLife Balanced 2013 519,201,421 14.02 - 16.02 7,812,083,177 Strategy Sub-Account 2012 550,560,779 12.02 - 13.53 7,045,806,333 2011 592,824,603 10.80 - 11.77 6,764,659,086 2010 546,381,907 11.25 - 12.12 6,437,293,439 2009 458,932,798 10.14 - 10.79 4,832,135,577 MIST MetLife Defensive 2013 140,580,521 13.08 - 14.94 1,972,799,136 Strategy Sub-Account 2012 178,585,503 12.28 - 13.82 2,332,865,728 2011 186,262,512 11.33 - 12.48 2,228,739,665 2010 167,912,074 11.40 - 12.39 2,003,850,499 2009 134,240,318 10.52 - 11.28 1,466,386,791 MIST MetLife Growth 2013 434,876,747 14.54 - 16.61 6,767,059,518 Strategy Sub-Account 2012 407,576,342 11.83 - 13.31 5,115,649,012 2011 446,977,194 10.46 - 11.40 4,926,470,881 2010 473,161,406 11.14 - 12.00 5,512,372,206 2009 490,302,032 9.88 - 10.51 5,026,063,304 MIST MetLife Moderate 2013 247,107,077 13.70 - 15.64 3,631,779,008 Strategy Sub-Account 2012 266,549,696 12.27 - 13.82 3,483,723,904 2011 281,377,647 11.18 - 12.19 3,324,311,655 2010 257,780,425 11.46 - 12.34 3,094,289,659 2009 201,975,022 10.44 - 11.11 2,188,428,006 MIST MetLife Multi-Index 2013 153,950,143 1.12 - 11.26 209,957,052 Targeted Risk Sub-Account 2012 11,094,386 1.01 11,247,979 (Commenced 11/12/2012) MIST MFS Emerging Markets 2013 41,623,177 10.29 - 12.45 456,076,892 Equity Sub-Account 2012 38,352,212 11.09 - 13.41 448,693,258 2011 37,004,554 9.55 - 11.54 369,675,163 2010 29,287,659 12.03 - 14.53 365,169,255 2009 18,534,256 9.96 - 12.02 189,762,080 MIST MFS Research 2013 19,616,483 15.39 - 18.44 331,488,461 International Sub-Account 2012 21,667,563 13.21 - 15.60 311,615,422 2011 22,841,018 11.58 - 13.42 285,814,827 2010 22,399,698 13.27 - 15.17 318,521,626 2009 21,694,779 12.19 - 13.75 281,155,296 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST Met/Templeton 2013 2.02 1.30 - 2.15 (1.11) - (0.27) International Bond 2012 10.26 1.30 - 2.05 11.96 - 12.80 Sub-Account 2011 6.86 1.30 - 2.20 (2.49) - (1.61) (Commenced 5/4/2009) 2010 0.51 1.30 - 2.20 11.07 - 12.08 2009 -- 1.30 - 2.20 8.40 - 9.00 MIST MetLife Aggressive 2013 0.75 0.90 - 2.35 26.50 - 28.35 Strategy Sub-Account 2012 0.64 0.90 - 2.35 2.91 - 15.40 2011 1.10 1.15 - 2.35 (7.96) - (6.85) 2010 1.18 1.15 - 2.35 13.80 - 15.17 2009 -- 1.15 - 2.35 29.56 - 31.13 MIST MetLife Balanced Plus 2013 1.19 0.90 - 2.35 11.71 - 13.34 Sub-Account 2012 -- 0.90 - 2.35 4.67 - 11.81 (Commenced 5/2/2011) 2011 0.27 1.15 - 2.25 (6.68) - (6.00) MIST MetLife Balanced 2013 2.01 0.90 - 2.35 16.65 - 18.35 Strategy Sub-Account 2012 2.15 0.90 - 2.35 3.72 - 12.62 2011 1.58 1.15 - 2.35 (3.98) - (2.82) 2010 2.05 1.15 - 2.35 10.96 - 12.28 2009 -- 1.15 - 2.35 25.35 - 26.87 MIST MetLife Defensive 2013 3.03 0.90 - 2.35 6.55 - 8.10 Strategy Sub-Account 2012 2.83 0.90 - 2.35 3.87 - 9.80 2011 2.22 1.00 - 2.35 (0.59) - 0.76 2010 3.05 1.00 - 2.35 8.32 - 9.80 2009 2.86 1.00 - 2.35 14.50 - 21.50 MIST MetLife Growth 2013 1.40 0.90 - 2.35 22.99 - 24.79 Strategy Sub-Account 2012 1.66 0.90 - 2.35 3.45 - 14.39 2011 1.54 1.15 - 2.35 (6.10) - (4.98) 2010 1.71 1.15 - 2.35 12.81 - 14.17 2009 -- 1.15 - 2.35 27.08 - 28.61 MIST MetLife Moderate 2013 2.38 0.90 - 2.35 11.57 - 13.20 Strategy Sub-Account 2012 2.66 0.90 - 2.35 3.72 - 11.10 2011 1.83 1.15 - 2.35 (2.43) - (1.26) 2010 2.46 1.15 - 2.35 9.79 - 11.12 2009 3.18 1.15 - 2.35 23.16 - 24.65 MIST MetLife Multi-Index 2013 0.55 1.15 - 2.25 4.04 - 11.65 Targeted Risk Sub-Account 2012 -- 1.15 - 2.00 2.56 - 2.68 (Commenced 11/12/2012) MIST MFS Emerging Markets 2013 1.07 0.90 - 2.35 (7.19) - (5.83) Equity Sub-Account 2012 0.75 0.90 - 2.35 3.96 - 17.77 2011 1.39 0.95 - 2.35 (20.59) - (19.48) 2010 0.97 0.95 - 2.35 20.79 - 22.49 2009 1.45 0.95 - 2.35 65.01 - 67.34 MIST MFS Research 2013 2.58 0.90 - 2.35 16.49 - 18.19 International Sub-Account 2012 1.89 0.90 - 2.35 6.35 - 15.60 2011 1.88 0.95 - 2.35 (12.79) - (11.56) 2010 1.70 0.95 - 2.35 8.83 - 10.35 2009 3.12 0.95 - 2.35 28.50 - 30.32 132
N-4206th Page of 530TOC1stPreviousNextBottomJust 206th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST Morgan Stanley Mid Cap 2013 13,099,903 2.79 - 24.94 244,579,234 Growth Sub-Account 2012 12,225,316 2.03 - 18.06 166,100,095 2011 8,735,505 1.88 - 16.63 109,412,403 2010 6,606,286 2.04 - 17.98 89,015,672 2009 5,166,934 9.84 - 11.09 54,290,087 MIST Oppenheimer Global 2013 3,127,720 21.72 - 27.49 78,398,573 Equity Sub-Account 2012 500,711 18.48 - 21.83 9,983,469 2011 559,531 15.55 - 17.64 9,330,001 2010 608,969 17.31 - 19.88 11,272,119 2009 672,213 15.23 - 17.32 10,903,654 MIST PIMCO Inflation 2013 57,648,505 13.13 - 15.33 821,456,089 Protected Bond Sub-Account 2012 64,013,091 14.82 - 17.05 1,021,039,296 2011 63,087,877 13.90 - 15.36 936,595,819 2010 52,467,468 12.81 - 13.99 711,162,874 2009 37,506,865 12.17 - 13.14 478,661,744 MIST PIMCO Total Return 2013 118,419,838 12.03 - 19.16 1,993,786,948 Sub-Account 2012 128,302,689 12.42 - 19.67 2,234,370,461 2011 132,311,947 11.50 - 18.11 2,140,758,433 2010 111,149,390 11.27 - 17.67 1,761,602,464 2009 71,654,403 10.54 - 16.44 1,055,450,302 MIST Pioneer Fund 2013 12,432,551 2.58 - 28.13 297,755,670 Sub-Account 2012 11,331,680 9.91 - 21.33 220,043,655 2011 9,480,402 9.11 - 19.29 168,467,083 2010 5,977,317 16.24 - 20.40 112,914,666 2009 3,239,380 14.30 - 17.72 53,308,711 MIST Pioneer Strategic 2013 41,450,021 2.53 - 31.43 919,328,857 Income Sub-Account 2012 29,638,373 13.34 - 31.23 804,777,040 2011 24,444,162 12.25 - 27.99 600,261,549 2010 17,115,149 12.17 - 27.26 419,601,867 2009 10,957,582 11.11 - 24.54 251,000,578 MIST Pyramis Government 2013 69,488,361 10.04 - 10.44 715,739,557 Income Sub-Account 2012 88,599,553 10.77 - 11.03 968,887,238 (Commenced 5/2/2011) 2011 45,618,019 10.69 - 10.77 490,473,351 MIST Pyramis Managed 2013 7,294,047 10.69 - 10.77 78,417,229 Risk Sub-Account (Commenced 4/29/2013) MIST Schroders Global 2013 375,261,358 1.14 - 1.17 435,205,689 Multi-Asset Sub-Account 2012 179,641,654 1.06 - 1.07 191,885,161 (Commenced 4/30/2012) MIST SSgA Growth and Income 2013 110,435,377 13.34 - 15.03 1,578,178,677 ETF Sub-Account 2012 118,446,237 12.09 - 13.24 1,521,502,479 2011 120,297,977 10.97 - 11.83 1,390,741,062 2010 85,827,962 11.20 - 11.84 995,772,752 2009 29,942,630 10.20 - 10.67 314,125,011 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST Morgan Stanley Mid Cap 2013 0.60 0.89 - 2.30 35.86 - 38.07 Growth Sub-Account 2012 -- 0.89 - 2.30 (4.93) - 8.58 2011 0.56 0.89 - 2.30 (9.04) - (7.49) 2010 0.01 0.89 - 2.30 17.15 - 30.84 2009 -- 0.95 - 2.30 53.69 - 55.79 MIST Oppenheimer Global 2013 0.35 0.90 - 2.30 24.22 - 25.97 Equity Sub-Account 2012 1.40 0.90 - 1.95 8.80 - 19.84 2011 1.79 0.95 - 1.95 (10.17) - (9.41) 2010 1.34 0.95 - 1.95 13.69 - 14.83 2009 2.29 0.95 - 1.95 37.10 - 38.48 MIST PIMCO Inflation 2013 2.20 0.90 - 2.35 (11.38) - (10.09) Protected Bond Sub-Account 2012 3.02 0.90 - 2.35 4.22 - 7.82 2011 1.62 1.20 - 2.35 8.56 - 9.82 2010 2.23 1.20 - 2.35 5.26 - 6.48 2009 3.18 1.20 - 2.35 15.31 - 16.64 MIST PIMCO Total Return 2013 4.27 0.89 - 2.35 (4.19) - (2.59) Sub-Account 2012 3.13 0.89 - 2.35 4.10 - 8.58 2011 2.62 0.89 - 2.35 (0.31) - 2.51 2010 3.20 0.89 - 2.35 5.65 - 7.45 2009 6.39 0.89 - 2.35 15.29 - 17.35 MIST Pioneer Fund 2013 3.15 0.90 - 2.30 9.33 - 31.88 Sub-Account 2012 1.45 0.90 - 2.30 0.85 - 9.54 2011 1.11 0.95 - 2.30 (11.94) - (5.45) 2010 0.78 0.95 - 2.30 13.47 - 15.12 2009 1.52 0.95 - 2.30 21.07 - 27.31 MIST Pioneer Strategic 2013 4.82 0.90 - 2.35 (0.94) - 1.21 Income Sub-Account 2012 4.73 0.90 - 2.35 6.09 - 10.56 2011 4.36 0.95 - 2.35 1.06 - 2.65 2010 4.58 0.95 - 2.20 5.21 - 11.12 2009 4.72 0.95 - 2.15 23.08 - 31.83 MIST Pyramis Government 2013 1.55 0.90 - 2.35 (6.74) - (5.37) Income Sub-Account 2012 0.02 0.90 - 2.35 0.74 - 1.96 (Commenced 5/2/2011) 2011 0.89 1.15 - 2.25 6.96 - 7.75 MIST Pyramis Managed 2013 1.65 1.15 - 2.25 4.66 - 5.43 Risk Sub-Account (Commenced 4/29/2013) MIST Schroders Global 2013 0.01 0.90 - 2.35 7.55 - 9.12 Multi-Asset Sub-Account 2012 1.49 0.90 - 2.35 5.01 - 6.03 (Commenced 4/30/2012) MIST SSgA Growth and Income 2013 2.51 0.90 - 2.35 10.31 - 11.92 ETF Sub-Account 2012 2.40 1.10 - 2.35 4.01 - 11.55 2011 1.70 1.15 - 2.35 (1.29) - (0.09) 2010 1.05 1.15 - 2.20 9.80 - 10.96 2009 0.78 1.15 - 2.20 22.17 - 23.97 133
N-4207th Page of 530TOC1stPreviousNextBottomJust 207th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ ---------------- -------------- MIST SSgA Growth ETF 2013 35,919,224 13.27 - 14.96 509,607,858 Sub-Account 2012 36,733,044 11.51 - 12.55 448,167,959 2011 37,984,453 10.24 - 11.04 409,132,829 2010 29,136,066 10.71 - 11.41 325,453,346 2009 16,443,398 9.67 - 10.11 163,291,494 MIST T. Rowe Price Large 2013 11,320,980 38.18 - 128.69 657,944,319 Cap Value Sub-Account 2012 12,231,249 28.88 - 96.83 536,790,380 2011 13,446,503 24.76 - 82.60 507,039,092 2010 14,212,118 26.09 - 86.60 558,423,606 2009 14,942,501 22.55 - 74.47 502,483,411 MIST T. Rowe Price Mid Cap 2013 37,965,912 13.67 - 15.54 568,882,747 Growth Sub-Account 2012 41,941,697 10.24 - 11.53 467,536,275 2011 44,089,511 9.22 - 10.28 439,146,325 2010 40,356,445 9.67 - 10.58 414,850,131 2009 31,597,201 7.75 - 8.40 258,174,943 MIST Third Avenue Small Cap 2013 13,992,716 21.87 - 26.40 330,701,962 Value Sub-Account 2012 15,859,523 16.91 - 20.06 287,540,317 2011 18,611,699 14.67 - 17.11 290,532,427 2010 18,793,984 16.49 - 18.91 327,520,477 2009 17,777,766 14.06 - 15.88 262,479,306 MSF Baillie Gifford 2013 29,549,817 4.51 - 15.12 303,453,047 International Stock 2012 219,106 3.96 - 13.35 2,585,607 Sub-Account 2011 282,028 3.36 - 11.37 2,803,543 2010 318,412 4.26 - 14.47 3,979,701 2009 337,655 4.02 - 13.77 3,955,132 MSF Barclays Aggregate 2013 13,536,937 1.71 - 18.22 162,571,849 Bond Index Sub-Account 2012 10,756,748 1.78 - 18.82 151,553,766 2011 8,083,366 1.73 - 18.28 130,173,979 2010 5,646,137 14.02 - 17.15 86,674,964 2009 2,010,364 13.73 - 16.32 29,893,966 MSF BlackRock Bond Income 2013 1,054,348 44.86 - 72.01 57,251,907 Sub-Account 2012 1,045,629 46.32 - 73.22 57,888,933 2011 953,075 44.15 - 68.69 49,538,985 2010 952,834 42.45 - 65.04 47,336,145 2009 911,026 40.15 - 60.57 42,636,576 MSF BlackRock Capital 2013 721,215 15.83 - 48.60 15,272,342 Appreciation Sub-Account 2012 745,728 12.04 - 36.54 11,831,610 2011 814,200 10.75 - 32.23 11,348,650 2010 601,185 12.06 - 35.71 9,563,155 2009 612,808 10.28 - 30.07 8,419,085 MSF BlackRock Large Cap 2013 225,190 16.80 - 17.73 3,792,926 Value Sub-Account 2012 230,438 12.89 - 13.54 2,977,532 2011 252,494 11.44 - 11.96 2,890,664 2010 253,453 11.33 - 11.79 2,872,585 2009 264,703 10.51 - 10.89 2,783,413 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST SSgA Growth ETF 2013 2.10 0.90 - 2.35 15.33 - 17.01 Sub-Account 2012 1.96 1.15 - 2.35 4.38 - 13.71 2011 1.56 1.15 - 2.35 (4.40) - (3.24) 2010 1.35 1.15 - 2.35 11.50 - 12.85 2009 0.93 1.15 - 2.20 26.29 - 28.66 MIST T. Rowe Price Large 2013 1.58 0.89 - 2.35 30.67 - 32.90 Cap Value Sub-Account 2012 1.50 0.89 - 2.35 6.92 - 17.22 2011 0.70 0.89 - 2.35 (6.24) - (4.62) 2010 1.11 0.89 - 2.35 14.30 - 16.29 2009 2.30 0.89 - 2.35 15.64 - 17.62 MIST T. Rowe Price Mid Cap 2013 0.21 1.30 - 2.35 33.41 - 34.82 Growth Sub-Account 2012 -- 1.30 - 2.35 11.03 - 12.21 2011 -- 1.30 - 2.35 (3.93) - (2.92) 2010 -- 1.30 - 2.35 24.72 - 26.05 2009 -- 1.30 - 2.35 42.11 - 43.59 MIST Third Avenue Small Cap 2013 0.99 0.89 - 2.35 29.37 - 31.64 Value Sub-Account 2012 -- 0.89 - 2.35 15.23 - 17.22 2011 1.10 0.89 - 2.35 (11.09) - (9.50) 2010 1.17 0.89 - 2.35 17.11 - 19.08 2009 1.15 0.89 - 2.35 23.51 - 25.70 MSF Baillie Gifford 2013 0.02 1.30 - 2.25 9.68 - 13.94 International Stock 2012 1.14 1.40 - 1.90 17.11 - 17.85 Sub-Account 2011 1.60 1.40 - 1.90 (21.63) - (20.99) 2010 1.41 1.40 - 1.90 4.85 - 5.74 2009 0.42 1.40 - 1.90 19.59 - 20.44 MSF Barclays Aggregate 2013 3.23 0.89 - 2.25 (4.74) - (3.19) Bond Index Sub-Account 2012 3.45 0.89 - 2.25 1.27 - 2.98 2011 3.22 0.89 - 2.25 4.77 - 6.56 2010 2.64 0.89 - 2.25 3.30 - 5.11 2009 3.64 0.89 - 2.15 2.27 - 4.24 MSF BlackRock Bond Income 2013 3.83 0.89 - 2.30 (3.17) - (1.65) Sub-Account 2012 2.54 0.89 - 2.30 3.74 - 6.59 2011 3.84 0.89 - 2.30 4.00 - 5.62 2010 3.77 0.89 - 2.30 5.72 - 7.38 2009 6.49 0.89 - 2.30 6.81 - 8.50 MSF BlackRock Capital 2013 0.79 0.89 - 2.30 31.17 - 33.03 Appreciation Sub-Account 2012 0.32 0.89 - 2.30 (0.88) - 13.35 2011 0.17 0.89 - 2.30 (11.01) - (9.75) 2010 0.22 0.89 - 2.30 17.10 - 18.76 2009 0.15 0.89 - 2.30 28.77 - 35.57 MSF BlackRock Large Cap 2013 1.38 0.89 - 1.35 30.28 - 30.88 Value Sub-Account 2012 1.61 0.89 - 1.35 12.74 - 13.27 2011 1.16 0.89 - 1.35 0.97 - 1.44 2010 1.09 0.89 - 1.35 7.75 - 8.26 2009 1.58 0.89 - 1.35 9.73 - 10.22 134
N-4208th Page of 530TOC1stPreviousNextBottomJust 208th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 -------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- ------------- MSF BlackRock Money Market 2013 44,329,198 2.36 - 25.88 461,342,890 Sub-Account 2012 53,484,009 9.33 - 25.53 569,109,901 2011 59,067,302 9.55 - 25.84 633,625,012 2010 51,015,018 9.77 - 26.15 553,885,805 2009 54,211,009 9.99 - 26.46 576,532,284 MSF Davis Venture Value 2013 36,209,587 16.00 - 52.55 658,561,438 Sub-Account 2012 41,401,029 12.26 - 39.65 572,327,325 2011 48,368,185 11.12 - 35.45 599,153,697 2010 46,415,423 11.87 - 37.27 606,785,200 2009 41,123,511 10.86 - 33.58 487,864,492 MSF Frontier Mid Cap 2013 4,767,721 16.33 - 18.08 83,651,163 Growth Sub-Account (Commenced 4/29/2013) MSF Jennison Growth 2013 32,574,197 3.93 - 19.82 585,624,219 Sub-Account 2012 35,125,323 2.91 - 14.55 468,764,846 2011 20,877,221 2.55 - 12.29 248,172,110 2010 20,230,170 2.57 - 12.42 243,817,657 2009 17,375,446 2.33 - 11.31 190,651,501 MSF Loomis Sayles Small Cap 2013 283,327 46.30 - 57.49 14,610,773 Core Sub-Account 2012 330,015 33.68 - 41.36 12,332,225 2011 310,374 30.16 - 36.63 10,317,247 2010 214,307 30.76 - 36.95 7,224,075 2009 73,444 25.33 - 29.40 1,990,671 MSF Loomis Sayles Small Cap 2013 12,506 17.15 - 18.50 226,802 Growth Sub-Account 2012 3,306 11.73 - 12.58 40,927 (Commenced 4/30/2012) MSF Met/Artisan Mid Cap 2013 13,125,790 19.41 - 55.03 285,771,010 Value Sub-Account 2012 13,419,571 14.54 - 40.57 217,257,576 2011 14,599,235 13.33 - 36.59 215,514,020 2010 15,163,945 12.80 - 34.58 213,857,206 2009 15,659,935 11.41 - 30.33 195,923,686 MSF Met/Dimensional 2013 3,208,551 19.88 - 21.38 66,162,419 International Small Company 2012 3,203,412 15.91 - 16.90 52,618,293 Sub-Account 2011 3,336,605 13.82 - 14.29 47,225,164 2010 2,082,274 16.89 - 17.28 35,750,236 2009 1,225,665 14.11 - 14.28 17,436,960 MSF MetLife Conservative 2013 557,035 12.93 - 13.63 7,497,408 Allocation Sub-Account 2012 735,694 12.67 - 13.27 9,655,026 2011 850,770 11.86 - 12.35 10,395,348 2010 830,223 11.74 - 12.15 9,998,191 2009 967,744 10.85 - 11.21 10,771,428 MSF MetLife Conservative to 2013 550,896 13.60 - 14.27 7,732,376 Moderate Allocation 2012 588,986 12.52 - 13.07 7,576,787 Sub-Account 2011 608,383 11.48 - 11.91 7,143,945 2010 782,775 11.60 - 11.97 9,257,856 2009 836,071 10.62 - 10.90 9,016,185 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MSF BlackRock Money Market 2013 -- 0.90 - 2.35 (2.32) - (0.37) Sub-Account 2012 -- 0.95 - 2.35 (2.34) - (0.74) 2011 -- 0.95 - 2.35 (2.32) - (0.94) 2010 -- 0.95 - 2.35 (2.32) - (0.64) 2009 0.25 1.00 - 2.35 (2.07) - (0.48) MSF Davis Venture Value 2013 1.27 0.89 - 2.35 30.43 - 32.52 Sub-Account 2012 0.72 0.89 - 2.35 1.16 - 11.86 2011 1.01 0.89 - 2.35 (11.86) - (4.88) 2010 0.87 0.89 - 2.35 9.22 - 11.01 2009 1.37 0.89 - 2.35 28.77 - 30.82 MSF Frontier Mid Cap 2013 -- 1.30 - 2.35 19.21 - 20.07 Growth Sub-Account (Commenced 4/29/2013) MSF Jennison Growth 2013 0.20 0.90 - 2.35 33.56 - 35.51 Sub-Account 2012 0.01 0.95 - 2.35 (4.12) - 14.17 2011 0.06 1.30 - 2.35 (2.11) - (0.86) 2010 0.38 1.30 - 2.35 8.74 - 10.07 2009 -- 1.30 - 2.35 36.32 - 38.02 MSF Loomis Sayles Small Cap 2013 0.23 1.20 - 2.30 37.49 - 39.01 Core Sub-Account 2012 -- 1.20 - 2.30 11.66 - 12.90 2011 -- 1.20 - 2.30 (1.94) - (0.86) 2010 -- 1.20 - 2.30 24.32 - 25.69 2009 -- 1.20 - 2.15 27.16 - 28.38 MSF Loomis Sayles Small Cap 2013 -- 0.90 - 1.50 46.17 - 47.05 Growth Sub-Account 2012 -- 0.90 - 1.50 (1.28) - (0.88) (Commenced 4/30/2012) MSF Met/Artisan Mid Cap 2013 0.77 0.89 - 2.35 33.34 - 35.64 Value Sub-Account 2012 0.80 0.89 - 2.35 8.98 - 10.87 2011 0.79 0.89 - 2.35 4.02 - 5.81 2010 0.59 0.89 - 2.35 12.09 - 14.02 2009 0.84 0.89 - 2.35 37.92 - 40.31 MSF Met/Dimensional 2013 1.72 0.90 - 2.30 24.70 - 26.46 International Small Company 2012 2.19 0.90 - 2.35 3.91 - 16.37 Sub-Account 2011 1.94 1.30 - 2.35 (18.19) - (17.33) 2010 1.30 1.30 - 2.35 19.74 - 21.01 2009 -- 1.30 - 2.35 39.40 - 40.87 MSF MetLife Conservative 2013 3.04 1.55 - 2.15 2.07 - 2.68 Allocation Sub-Account 2012 3.27 1.55 - 2.15 6.85 - 7.49 2011 2.37 1.55 - 2.15 1.06 - 1.66 2010 4.06 1.55 - 2.15 7.71 - 8.36 2009 3.20 1.55 - 2.25 17.85 - 18.68 MSF MetLife Conservative to 2013 2.53 1.55 - 2.10 8.62 - 9.22 Moderate Allocation 2012 2.95 1.55 - 2.10 9.13 - 9.74 Sub-Account 2011 2.14 1.55 - 2.10 (1.04) - (0.50) 2010 3.38 1.55 - 2.10 9.21 - 9.81 2009 3.07 1.55 - 2.10 21.11 - 21.78 135
N-4209th Page of 530TOC1stPreviousNextBottomJust 209th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 FOR THE YEAR ENDED DECEMBER 31 --------------------------------------------- -------------------------------------------------- UNIT VALUE INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) LOWEST TO NET INCOME LOWEST TO LOWEST TO UNITS HIGHEST ($) ASSETS ($) RATIO (%) HIGHEST (%) HIGHEST (%) ------------ --------------- -------------- ------------- ---------------- ----------------- MSF MetLife Mid Cap Stock 2013 5,501,359 2.64 - 28.20 125,884,078 1.00 0.89 - 2.35 29.67 - 31.97 Index Sub-Account 2012 4,914,049 2.01 - 21.37 88,989,701 0.82 0.89 - 2.35 14.53 - 16.55 2011 4,708,991 1.73 - 18.33 77,805,929 0.70 0.89 - 2.35 (4.50) - (2.76) 2010 3,443,301 15.77 - 18.85 59,472,935 0.76 0.89 - 2.20 23.19 - 25.17 2009 1,692,693 12.86 - 15.06 23,983,061 1.55 0.89 - 2.15 28.41 - 35.78 MSF MetLife Moderate 2013 3,073,122 13.90 - 14.77 44,655,421 2.00 1.55 - 2.25 15.36 - 16.17 Allocation Sub-Account 2012 3,326,548 12.05 - 12.71 41,689,448 2.39 1.55 - 2.25 10.71 - 11.49 2011 3,930,913 10.88 - 11.40 44,282,730 1.52 1.55 - 2.25 (3.55) - (2.89) 2010 4,192,524 11.28 - 11.74 48,715,861 2.53 1.55 - 2.25 10.65 - 11.44 2009 4,293,013 10.20 - 10.54 44,856,785 2.96 1.55 - 2.25 23.72 - 24.58 MSF MetLife Moderate to 2013 3,927,901 14.05 - 14.80 57,260,787 1.46 1.55 - 2.15 21.67 - 22.40 Aggressive Allocation 2012 4,335,356 11.55 - 12.09 51,720,857 1.91 1.55 - 2.15 12.92 - 13.60 Sub-Account 2011 4,632,179 10.23 - 10.65 48,721,974 1.43 1.55 - 2.15 (5.81) - (5.25) 2010 5,194,016 10.86 - 11.24 57,766,976 2.14 1.55 - 2.15 12.25 - 12.94 2009 5,328,120 9.67 - 9.95 52,562,753 2.53 1.55 - 2.15 26.35 - 27.11 MSF MetLife Stock Index 2013 28,624,388 6.28 - 69.33 561,274,487 1.68 0.89 - 2.90 28.14 - 30.85 Sub-Account 2012 29,109,224 4.82 - 52.98 446,759,028 1.55 0.89 - 2.90 12.30 - 14.73 2011 25,347,914 4.22 - 46.18 355,993,780 1.55 0.89 - 2.90 (1.15) - 0.94 2010 23,801,960 11.03 - 45.76 343,187,076 1.63 0.89 - 2.90 11.41 - 13.81 2009 21,150,594 9.85 - 40.20 281,243,641 2.10 0.89 - 2.90 23.01 - 26.75 MSF MFS Total Return 2013 814,124 46.24 - 71.07 46,044,412 2.31 0.89 - 2.30 16.06 - 17.94 Sub-Account 2012 730,405 41.41 - 60.26 35,344,618 2.78 0.89 - 2.15 2.75 - 10.59 2011 826,212 38.00 - 54.49 36,390,818 2.68 0.89 - 2.15 0.04 - 1.51 2010 929,202 37.99 - 53.68 40,676,709 2.91 0.89 - 2.15 7.53 - 9.10 2009 1,006,138 35.33 - 49.20 40,772,224 4.14 0.89 - 2.15 15.84 - 17.55 MSF MFS Value Sub-Account 2013 12,139,878 12.05 - 23.85 260,473,964 0.55 0.89 - 2.35 17.10 - 34.53 2012 3,025,966 14.12 - 17.78 48,275,261 1.94 0.89 - 2.30 3.00 - 15.61 2011 3,145,406 12.27 - 14.81 43,754,913 1.57 0.89 - 2.30 (1.43) - (0.04) 2010 3,234,649 12.33 - 14.90 45,430,281 1.32 0.89 - 2.30 8.89 - 10.44 2009 2,664,361 11.22 - 13.56 33,984,060 -- 0.89 - 2.30 18.08 - 19.75 MSF MSCI EAFE Index 2013 8,809,646 1.61 - 17.40 112,197,169 2.89 0.89 - 2.25 18.74 - 20.78 Sub-Account 2012 7,172,234 1.34 - 14.41 81,404,548 2.89 0.89 - 2.15 15.42 - 17.27 2011 6,390,970 1.15 - 12.29 69,159,210 2.23 0.89 - 2.15 (14.50) - (13.28) 2010 4,636,491 11.54 - 14.17 58,834,689 2.24 0.89 - 2.15 5.47 - 7.24 2009 2,230,107 10.94 - 13.21 27,098,496 3.30 0.89 - 2.15 26.95 - 35.25 MSF Neuberger Berman 2013 8,020,175 18.58 - 27.70 172,247,460 0.10 0.89 - 2.35 24.94 - 37.30 Genesis Sub-Account 2012 626,194 16.44 - 20.18 11,798,908 0.34 0.89 - 2.30 7.25 - 9.05 2011 647,811 15.96 - 18.50 11,266,993 0.73 0.89 - 1.95 (7.38) - 4.87 2010 578,563 16.81 - 17.64 9,730,049 0.51 0.89 - 1.35 19.95 - 20.50 2009 605,787 14.02 - 14.64 8,493,213 1.10 0.89 - 1.35 11.63 - 12.15 MSF Russell 2000 Index 2013 5,835,501 2.74 - 29.98 141,070,458 1.29 0.89 - 2.35 34.91 - 37.33 Sub-Account 2012 5,078,788 2.01 - 21.83 91,750,975 0.88 0.89 - 2.35 13.24 - 15.31 2011 3,926,223 1.75 - 18.93 64,081,468 0.84 0.89 - 2.35 (6.46) - (4.95) 2010 2,703,578 7.11 - 19.92 46,792,763 0.77 0.89 - 2.35 23.61 - 25.79 2009 1,108,328 5.68 - 15.83 15,337,009 1.65 0.89 - 2.20 24.25 - 26.62 136
N-4210th Page of 530TOC1stPreviousNextBottomJust 210th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MSF T. Rowe Price Large 2013 14,688,080 8.03 - 53.41 151,930,071 Growth Sub-Account 2012 39,346 35.99 - 39.07 1,501,612 2011 44,809 30.91 - 33.42 1,465,621 2010 40,496 31.93 - 34.38 1,365,647 2009 39,614 27.87 - 29.90 1,161,818 MSF T. Rowe Price Small Cap 2013 356,919 25.98 - 35.74 10,522,813 Growth Sub-Account 2012 380,162 18.41 - 24.95 7,808,995 2011 417,381 16.23 - 21.67 7,500,142 2010 465,332 16.01 - 21.48 8,285,648 2009 481,022 12.16 - 16.06 6,406,764 MSF Van Eck Global Natural 2013 6,278,667 16.43 - 17.17 106,449,499 Resources Sub-Account 2012 7,200,491 15.15 - 15.70 111,896,983 (Commenced 5/4/2009) 2011 6,910,683 15.07 - 15.51 106,332,935 2010 3,967,225 18.49 - 18.86 74,371,723 2009 1,195,095 14.65 - 14.80 17,635,926 MSF Western Asset 2013 16,417,493 14.93 - 19.52 291,870,388 Management U.S. Government 2012 17,244,875 15.42 - 19.89 313,310,285 Sub-Account 2011 16,038,241 15.32 - 19.49 285,529,978 2010 12,558,586 14.90 - 18.69 214,907,918 2009 8,573,371 14.46 - 17.89 140,925,866 Neuberger Berman Genesis 2013 474 23.21 10,991 Sub-Account 2012 474 17.11 8,101 2011 474 15.72 7,443 2010 571 15.16 8,663 2009 697 12.60 8,785 Oppenheimer VA Core Bond 2013 1,493 5.79 8,646 Sub-Account 2012 1,541 5.88 9,058 2011 1,878 5.41 10,150 2010 1,952 5.06 9,885 2009 12,533 4.61 57,756 Oppenheimer VA Global 2013 443 10.15 4,492 Strategic Income Sub-Account 2012 443 10.30 4,562 2011 443 9.20 4,075 2010 443 9.25 4,097 2009 1,786 8.16 14,575 Oppenheimer VA Main Street 2013 14,316 7.27 104,039 Sub-Account 2012 14,959 5.59 83,663 2011 22,109 4.85 107,300 2010 24,227 4.92 119,249 2009 28,105 4.30 120,826 Oppenheimer VA Main Street 2013 4,655,290 16.15 - 27.82 123,045,407 Small Cap Sub-Account 2012 5,041,901 11.62 - 19.97 96,092,155 2011 4,964,464 9.98 - 17.13 81,494,321 2010 4,127,208 10.35 - 17.72 70,331,777 2009 3,126,840 8.51 - 14.54 43,881,910 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MSF T. Rowe Price Large 2013 -- 0.89 - 2.35 26.10 - 37.93 Growth Sub-Account 2012 -- 1.50 - 1.90 16.43 - 16.90 2011 -- 1.50 - 1.90 (3.19) - (2.80) 2010 0.07 1.50 - 1.90 14.55 - 15.01 2009 0.32 1.50 - 1.90 40.35 - 40.91 MSF T. Rowe Price Small Cap 2013 0.22 0.89 - 2.15 41.11 - 43.27 Growth Sub-Account 2012 -- 0.89 - 2.15 13.43 - 15.14 2011 -- 0.89 - 2.15 (0.70) - 0.87 2010 -- 0.89 - 2.30 31.60 - 33.71 2009 0.12 0.89 - 2.30 35.49 - 37.73 MSF Van Eck Global Natural 2013 0.66 1.30 - 2.15 8.40 - 9.32 Resources Sub-Account 2012 -- 1.30 - 2.15 0.38 - 1.25 (Commenced 5/4/2009) 2011 1.10 1.30 - 2.20 (18.49) - (17.75) 2010 0.25 1.30 - 2.20 26.22 - 27.36 2009 -- 1.30 - 2.20 35.00 - 35.82 MSF Western Asset 2013 1.95 0.95 - 2.35 (3.21) - (1.84) Management U.S. Government 2012 1.85 0.95 - 2.35 0.64 - 2.07 Sub-Account 2011 1.20 0.95 - 2.35 2.83 - 4.28 2010 2.24 0.95 - 2.35 3.04 - 4.50 2009 4.06 0.95 - 2.35 1.67 - 3.10 Neuberger Berman Genesis 2013 0.32 0.89 35.68 Sub-Account 2012 0.21 0.89 8.84 2011 0.84 0.89 3.67 2010 -- 0.89 20.30 2009 -- 0.89 25.13 Oppenheimer VA Core Bond 2013 5.14 1.40 (1.49) Sub-Account 2012 4.67 1.40 8.75 2011 5.76 1.40 6.77 2010 4.81 1.40 9.87 2009 -- 1.40 8.09 Oppenheimer VA Global 2013 4.99 1.40 (1.52) Strategic Income Sub-Account 2012 5.95 1.40 11.95 2011 3.19 1.40 (0.55) 2010 16.19 1.40 13.38 2009 0.53 1.40 17.17 Oppenheimer VA Main Street 2013 1.10 1.40 29.94 Sub-Account 2012 0.86 1.40 15.24 2011 1.27 1.40 (1.40) 2010 1.11 1.40 14.49 2009 1.94 1.40 26.52 Oppenheimer VA Main Street 2013 0.70 0.95 - 1.75 38.19 - 39.29 Small Cap Sub-Account 2012 0.33 0.95 - 1.75 15.62 - 16.55 2011 0.36 0.95 - 1.75 (4.07) - (3.30) 2010 0.37 0.95 - 1.75 20.92 - 21.90 2009 0.52 0.95 - 1.75 34.52 - 35.58 137
N-4211th Page of 530TOC1stPreviousNextBottomJust 211th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Oppenheimer VA Money 2013 723 5.53 4,000 Sub-Account 2012 20,150 5.61 112,965 2011 20,177 5.69 114,709 2010 20,177 5.76 116,310 2009 20,177 5.84 117,917 Pioneer VCT Disciplined 2013 170,657 11.41 - 12.04 2,003,137 Value Sub-Account 2012 229,721 9.05 - 9.48 2,136,823 2011 238,409 8.34 - 8.68 2,036,161 2010 243,744 8.83 - 9.11 2,192,843 2009 223,412 8.19 - 8.44 1,867,892 Pioneer VCT Emerging 2013 46,688 14.71 - 16.31 721,583 Markets Sub-Account 2012 49,333 15.34 - 16.87 791,020 2011 48,427 14.01 - 15.29 705,700 2010 62,764 18.70 - 20.26 1,212,537 2009 60,035 16.18 - 17.74 1,020,914 Pioneer VCT Equity Income 2013 22,692 27.19 - 30.29 637,874 Sub-Account 2012 24,722 21.52 - 23.79 548,970 2011 17,862 19.96 - 21.90 371,272 2010 18,868 19.24 - 20.95 375,754 2009 20,833 16.12 - 17.79 354,460 Pioneer VCT Ibbotson Growth 2013 1,114,977 18.19 - 19.45 20,842,468 Allocation Sub-Account 2012 1,199,751 15.56 - 16.51 19,107,227 2011 1,225,572 14.18 - 14.93 17,736,364 2010 1,275,136 14.95 - 15.62 19,386,421 2009 1,257,274 13.28 - 13.78 16,934,322 Pioneer VCT Ibbotson 2013 1,660,240 17.16 - 18.76 30,201,063 Moderation Allocation 2012 1,789,015 15.09 - 16.33 28,441,628 Sub-Account 2011 1,795,010 13.82 - 14.81 25,968,930 2010 1,833,743 14.43 - 15.31 27,517,066 2009 1,818,031 12.95 - 13.60 24,317,338 Pioneer VCT Mid Cap Value 2013 1,719,853 37.64 - 45.45 71,900,042 Sub-Account 2012 1,769,793 28.91 - 34.56 56,444,927 2011 1,688,831 26.60 - 31.48 49,145,077 2010 1,493,349 28.81 - 33.76 46,621,818 2009 1,309,529 24.92 - 28.91 35,037,503 Pioneer VCT Real Estate 2013 11,399 21.20 - 23.46 252,653 Shares Sub-Account 2012 10,700 21.29 - 23.38 237,514 2011 12,968 18.70 - 20.38 251,847 2010 12,983 17.38 - 18.80 234,208 2009 16,034 13.78 - 14.80 228,918 T. Rowe Price Growth Stock 2013 62,571 133.27 8,339,192 Sub-Account 2012 66,302 96.60 6,404,585 2011 73,401 81.96 6,015,937 2010 85,875 83.50 7,170,858 2009 97,059 72.05 6,993,261 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Oppenheimer VA Money 2013 0.01 1.40 (1.38) Sub-Account 2012 0.01 1.40 (1.39) 2011 0.01 1.40 (1.37) 2010 0.03 1.40 (1.37) 2009 0.35 1.40 (1.07) Pioneer VCT Disciplined 2013 1.59 1.20 - 1.95 26.11 - 27.06 Value Sub-Account 2012 0.98 1.20 - 1.95 8.45 - 9.27 2011 0.72 1.20 - 1.95 (5.53) - (4.82) 2010 0.58 1.20 - 1.95 7.15 - 7.96 2009 0.70 1.20 - 2.15 13.26 - 14.34 Pioneer VCT Emerging 2013 0.92 1.20 - 1.95 (4.08) - (3.36) Markets Sub-Account 2012 0.21 1.20 - 1.95 9.49 - 10.32 2011 -- 1.20 - 1.95 (25.09) - (24.53) 2010 0.32 1.20 - 1.95 13.38 - 14.23 2009 0.63 1.20 - 2.15 70.32 - 71.96 Pioneer VCT Equity Income 2013 2.29 1.20 - 1.95 26.35 - 27.30 Sub-Account 2012 3.87 1.20 - 1.95 7.83 - 8.65 2011 2.00 1.20 - 1.95 3.73 - 4.51 2010 2.07 1.20 - 1.95 16.93 - 17.81 2009 3.38 1.20 - 2.15 11.47 - 12.53 Pioneer VCT Ibbotson Growth 2013 1.76 1.20 - 1.95 16.95 - 17.83 Allocation Sub-Account 2012 1.76 1.20 - 1.95 9.72 - 10.55 2011 1.94 1.20 - 1.95 (5.14) - (4.42) 2010 1.88 1.20 - 1.95 12.55 - 13.39 2009 2.87 1.20 - 1.95 30.11 - 31.09 Pioneer VCT Ibbotson 2013 2.31 1.20 - 2.20 13.71 - 14.85 Moderation Allocation 2012 2.47 1.20 - 2.20 9.14 - 10.25 Sub-Account 2011 2.49 1.20 - 2.20 (4.21) - (3.25) 2010 2.53 1.20 - 2.20 11.44 - 12.56 2009 3.10 1.20 - 2.20 28.59 - 29.89 Pioneer VCT Mid Cap Value 2013 0.74 0.95 - 1.95 30.19 - 31.50 Sub-Account 2012 0.84 0.95 - 1.95 8.67 - 9.77 2011 0.64 0.95 - 1.95 (7.66) - (6.73) 2010 0.87 0.95 - 1.95 15.62 - 16.78 2009 1.29 0.95 - 1.95 22.85 - 24.08 Pioneer VCT Real Estate 2013 2.16 1.20 - 1.95 (0.42) - 0.33 Shares Sub-Account 2012 2.11 1.20 - 1.95 13.84 - 14.70 2011 2.24 1.20 - 1.95 7.64 - 8.45 2010 2.42 1.20 - 1.95 26.06 - 27.01 2009 4.81 1.20 - 1.95 29.02 - 29.98 T. Rowe Price Growth Stock 2013 0.04 0.89 37.97 Sub-Account 2012 0.18 0.89 17.86 2011 0.02 0.89 (1.85) 2010 0.06 0.89 15.89 2009 0.21 0.89 41.98 138
N-4212th Page of 530TOC1stPreviousNextBottomJust 212th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INVESTORS USA INSURANCE COMPANY NOTES TO THE FINANCIAL STATEMENTS -- (CONCLUDED) 8. FINANCIAL HIGHLIGHTS -- (CONCLUDED) [Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- T. Rowe Price International 2013 41,360 15.85 655,401 Stock Sub-Account 2012 45,736 13.99 639,881 2011 59,337 11.89 705,529 2010 68,117 13.68 932,126 2009 72,797 12.06 877,970 T. Rowe Price Prime Reserve 2013 31,743 17.59 558,449 Sub-Account 2012 40,746 17.75 723,146 2011 54,384 17.91 973,756 2010 70,013 18.06 1,264,618 2009 76,856 18.22 1,400,475 UIF U.S. Real Estate 2013 2,531,191 27.80 - 60.27 100,974,977 Sub-Account 2012 2,343,331 27.76 - 59.62 90,757,950 2011 2,367,197 24.43 - 51.96 76,564,905 2010 2,327,750 23.50 - 49.52 68,963,648 2009 2,542,094 18.43 - 38.47 56,466,102 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- T. Rowe Price International 2013 0.97 0.89 13.26 Stock Sub-Account 2012 1.21 0.89 17.66 2011 1.20 0.89 (13.11) 2010 1.13 0.89 13.46 2009 2.49 0.89 50.86 T. Rowe Price Prime Reserve 2013 0.01 0.89 (0.87) Sub-Account 2012 0.01 0.89 (0.88) 2011 0.01 0.89 (0.87) 2010 0.01 0.89 (0.87) 2009 0.22 0.89 (0.70) UIF U.S. Real Estate 2013 1.09 0.95 - 1.90 0.13 - 1.09 Sub-Account 2012 0.85 0.95 - 1.90 13.65 - 14.74 2011 0.85 0.95 - 1.90 3.93 - 4.92 2010 2.15 0.95 - 1.90 27.52 - 28.73 2009 3.31 0.95 - 1.90 25.93 - 27.14 1 These amounts represent the dividends, excluding distributions of capital gains, received by the Sub-Account from the underlying portfolio, series, or fund, net of management fees assessed by the fund manager, divided by the average net assets, regardless of share class, if any. These ratios exclude those expenses, such as mortality and expense risk charges, that are assessed against contract owner accounts either through reductions in the unit values or the redemption of units. The investment income ratio is calculated for each period indicated or from the effective date through the end of the reporting period. The recognition of investment income by the Sub-Account is affected by the timing of the declaration of dividends by the underlying fund or portfolio in which the Sub-Account invests. The investment income ratio is calculated as a weighted average ratio since the Sub-Account may invest in two or more share classes, within the underlying portfolio, series, or fund of the Trusts which may have unique investment income ratios. 2 These amounts represent annualized contract expenses of each of the applicable Sub-Accounts, consisting primarily of mortality and expense risk charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying portfolio, series, or fund have been excluded. 3 These amounts represent the total return for the period indicated, including changes in the value of the underlying portfolio, series, or fund, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. The total return is presented as a range of minimum to maximum returns, based on the minimum and maximum returns within each product grouping of the applicable Sub-Account. 139
N-4213th Page of 530TOC1stPreviousNextBottomJust 213th
This page is intentionally left blank.
N-4214th Page of 530TOC1stPreviousNextBottomJust 214th
MetLife Insurance Company of Connecticut Unaudited Pro Forma Condensed Combined Financial Statements In the second quarter of 2013, MetLife, Inc. announced its plans to merge three U.S.-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company (the "Mergers"). The companies to be merged are MetLife Insurance Company of Connecticut, MetLife Investors USA Insurance Company ("MLI-USA"), a wholly-owned subsidiary of MetLife Insurance Company of Connecticut, and MetLife Investors Insurance Company ("MLIIC"), each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. ("Exeter"), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. MetLife Insurance Company of Connecticut, which is expected to be renamed and domiciled in Delaware, will be the surviving company. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Effective January 1, 2014, following receipt of New York State Department of Financial Services approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also, effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with an affiliate all existing New York insurance policies and annuity contracts that include a separate account feature. Following the Mergers and subject to certain regulatory approvals, MetLife Insurance Company of Connecticut will likely enter into transactions to transfer to one or more affiliates certain business that is currently reinsured by Exeter. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. The unaudited pro forma condensed combined financial statements and accompanying notes present the impact of the Mergers as a transaction among entities under common control which is more fully described in the notes to the unaudited pro forma condensed combined financial statements. Transactions among entities under common control are prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). The unaudited pro forma condensed combined financial statements include historical audited amounts as of December 31, 2013 and for the years ended December 31, 2013, 2012 and 2011, for MetLife Insurance Company of Connecticut and its subsidiaries, including MLI-USA (collectively "MICC"), MLIIC and Exeter. The unaudited pro forma condensed combined financial statements give effect to the Mergers as if they had occurred (i) on December 31, 2013 for purposes of the unaudited pro forma condensed combined balance sheet and (ii) on January 1, 2011 for purposes of the unaudited pro forma condensed combined statements of operations for the years ended December 31, 2013, 2012 and 2011. The historical financial information has been adjusted in the unaudited pro forma condensed combined financial statements to give effect to pro forma events that are directly attributable to the Mergers, factually supportable, and are expected to have a continuing impact on the combined results. It is likely that the actual adjustments reflected in the final accounting, that will consider additional available information, will differ from the pro forma adjustments and it is possible the differences may be material. The unaudited pro forma condensed combined financial statements should be read in conjunction with the accompanying notes. In addition, the unaudited proforma condensed combined financial statements were derived from and should be read in conjunction with the audited historical consolidated financial statements of MICC included in MetLife Insurance Company of Connecticut's Annual Report on Form 10-K for the year ended December 31, 2013, as revised by MetLife Insurance Company of Connecticut's Current Report on Form 8-K filed on October 27, 2014, as well as the audited historical balance sheets of MLIIC as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity and cash flows for each of the three years in the period ended December 31, 2013 together with the notes thereto and balance sheets of Exeter as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity and cash flows for each of the three years in the period ended December 31, 2013 together with the notes thereto, as restated on October 27, 2014 and as revised on November 7, 2014, are included as Exhibits 99.1 and 99.2, respectively, to the Current Report on Form 8-K/A ("Amendment No. 2") with which this financial information is filed as Exhibit 99.3. 1
N-4215th Page of 530TOC1stPreviousNextBottomJust 215th
The unaudited pro forma condensed combined financial statements are presented for informational purposes only and are not intended to reflect the results of operations or the financial position of the combined company that would have resulted had the Mergers been effective as of and during the periods presented or the results that may be obtained by the combined company in the future. The unaudited pro forma condensed combined financial statements as of and for the periods presented do not reflect future events that are not directly attributable to the Mergers and that may occur after the Mergers, including, but not limited to, expense efficiencies or revenue enhancements arising from the Mergers or management actions. Future results may vary significantly from the results reflected in the unaudited pro forma condensed combined financial statements. 2
N-4216th Page of 530TOC1stPreviousNextBottomJust 216th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Unaudited Pro Forma Condensed Combined Balance Sheet December 31, 2013 (In millions, except per share data) [Enlarge/Download Table] Historical ----------------------------- MetLife Exeter Investors Reassurance Insurance Company Reinsurance Other Pro Forma MICC Company Ltd. Adjustments Adjustments Notes Combined -------- --------- ----------- ----------- ----------- ----------- --------- Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value............................ $ 45,252 $ 2,250 $ 1,321 $ (695) $ -- 3(c) $ 48,128 Equity securities available-for-sale, at estimated fair value............... 418 45 -- -- -- 463 Mortgage loans, net; at estimated fair value................................. 7,718 286 -- -- -- 8,004 Policy loans............................ 1,219 27 -- -- -- 1,246 Real estate and real estate joint ventures.............................. 754 -- -- -- -- 754 Other limited partnership interests..... 2,130 32 -- -- -- 2,162 Short-term investments, principally at estimated fair value.................. 2,107 75 2,781 (7) -- 3(c) 4,956 Derivative assets....................... -- -- 2,376 -- (2,376) 4(a) -- Funds withheld at interest.............. -- -- 2,694 -- (2,694) 4(a) -- Other invested assets, principally at 3(a)-(c), estimated fair value.................. 2,555 68 -- (2,768) 4,570 4(a), 5(a) 4,425 -------- ------- ------- ------- ------- -------- Total investments..................... 62,153 2,783 9,172 (3,470) (500) 70,138 Cash and cash equivalents, principally at estimated fair value................. 746 24 630 (604) -- 3(a), (c) 796 Accrued investment income................ 542 26 94 (29) (2) 3(c), 5(a) 631 Premiums, reinsurance and other receivables............................. 20,609 1,829 646 (3,170) -- 3(a)-(c) 19,914 Deferred policy acquisition costs and value of business acquired.............. 4,730 291 160 707 -- 3(b), (c) 5,888 Current income tax recoverable........... 192 9 197 -- -- 398 Deferred income tax recoverable.......... -- -- 1,529 -- (1,529) 4(b) -- Goodwill................................. 493 -- -- -- 33 4(c) 526 Other assets............................. 794 110 -- 34 (33) 3(b), 4(c) 905 Separate account assets.................. 97,780 12,033 -- -- -- 109,813 -------- ------- ------- ------- ------- -------- Total assets.......................... $188,039 $17,105 $12,428 $(6,532) $(2,031) $209,009 ======== ======= ======= ======= ======= ======== Liabilities and Stockholders' Equity Liabilities Future policy benefits................... 3(b), (c), $ 27,991 $ 501 $ 2,747 $(1,455) $ 12 4(d) $ 29,796 Policyholder account balances............ 33,453 2,748 2,489 (1,262) -- 3(c) 37,428 Other policy-related balances............ 3(b), (c), 3,164 102 2,170 (2,973) 4 4(d) 2,467 Policyholder dividends payable........... -- -- 16 -- (16) 4(d) -- Payables for collateral under securities loaned and other transactions............................ 6,451 266 -- -- 197 4(e) 6,914 Long-term debt........................... 2,251 -- 575 -- (500) 5(a) 2,326 Deferred income tax liability............ 1,385 192 -- 272 (1,529) 3(b), 4(b) 320 Derivative liabilities................... -- -- 2,648 -- (2,648) 4(f) -- 3(a)-(c), 4(e), 4(f), Other liabilities........................ 6,776 94 553 (1,560) 2,449 5(a) 8,312 Separate account liabilities............. 97,780 12,033 -- -- -- 109,813 -------- ------- ------- ------- ------- -------- Total liabilities..................... 179,251 15,936 11,198 (6,978) (2,031) 197,376 -------- ------- ------- ------- ------- -------- Stockholders' Equity Preferred stock.......................... -- -- -- -- -- -- Common stock, par value $2.50 per share.. 86 6 -- -- -- 92 Additional paid-in capital............... 6,737 636 4,126 -- -- 11,499 Retained earnings (accumulated deficit).. 1,076 504 (2,965) 506 -- 3(b) (879) Accumulated other comprehensive income (loss).................................. 889 23 69 (60) -- 3(c) 921 -------- ------- ------- ------- ------- -------- Total stockholders' equity............ 8,788 1,169 1,230 446 -- 11,633 -------- ------- ------- ------- ------- -------- Total liabilities and stockholders' equity............................... $188,039 $17,105 $12,428 $(6,532) $(2,031) $209,009 ======== ======= ======= ======= ======= ======== See accompanying notes to unaudited pro forma condensed combined financial statements. 3
N-4217th Page of 530TOC1stPreviousNextBottomJust 217th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Unaudited Pro Forma Condensed Combined Statement of Operations For the Year End December 31, 2013 (In millions) [Enlarge/Download Table] Historical ----------------------------- MetLife Exeter Investors Reassurance Insurance Company Reinsurance Other Pro Forma MICC Company Ltd. Adjustments Adjustments Notes Combined ------- --------- ----------- ----------- ----------- --------------- --------- Revenues Premiums............................ $ 606 $ 29 $ 59 $ (5) $ -- 3(b) $ 689 Universal life and investment-type product policy fees................ 2,336 202 587 (177) -- 3(b), (c) 2,948 Net investment income............... 2,852 114 35 (16) (2) 3(c), 5(a) 2,983 Fees on ceded reinsurance and other.............................. -- 90 -- -- (90) 4(g) -- Other revenues...................... 592 -- 2 (74) 90 3(b), (c), 4(g) 610 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities..... (9) -- -- -- -- (9) Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)...... (11) -- -- -- -- (11) Other net investment gains (losses)......................... 102 1 (57) 59 (45) 3(c), 5(b) 60 ------- ----- ------ ----- ---- ------ Total net investment gains (losses)....................... 82 1 (57) 59 (45) 40 Net derivative gains (losses)..... (1,052) (442) 1,935 375 -- 3(c) 816 ------- ----- ------ ----- ---- ------ Total revenues.................. 5,416 (6) 2,561 162 (47) 8,086 ------- ----- ------ ----- ---- ------ Expenses Policyholder benefits and claims.... 1,707 48 1,380 (44) 27 3(b), (c), 4(h) 3,118 Interest credited to policyholder account balances................... 1,037 113 17 (17) -- 3(c) 1,150 Policyholder dividends.............. -- -- 27 -- (27) 4(h) -- Goodwill impairment................. 66 -- -- -- -- 66 Other expenses...................... 1,659 (11) 101 215 (2) 3(b)-(d), 5(a) 1,962 ------- ----- ------ ----- ---- ------ Total expenses.................. 4,469 150 1,525 154 (2) 6,296 ------- ----- ------ ----- ---- ------ Income (loss) from continuing operations before provision for income tax......................... 947 (156) 1,036 8 (45) 1,790 Provision for income tax expense (benefit).......................... 227 (67) 364 3 (16) 3(e), 5(c) 511 ------- ----- ------ ----- ---- ------ Income from continuing operations, net of income tax.................. $ 720 $ (89) $ 672 $ 5 $(29) $1,279 ======= ===== ====== ===== ==== ====== See accompanying notes to unaudited pro forma condensed combined financial statements. 4
N-4218th Page of 530TOC1stPreviousNextBottomJust 218th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Unaudited Pro Forma Condensed Combined Statement of Operations For the Year End December 31, 2012 (In millions) [Enlarge/Download Table] Historical ---------------------------- MetLife Exeter Investors Reassurance Insurance Company Reinsurance Other Pro Forma MICC Company Ltd. Adjustments Adjustments Notes Combined ------ --------- ----------- ----------- ----------- -------------- --------- Revenues Premiums.......................... $1,261 $ 11 $ 950 $ (888) $ -- 3(b),(c) $1,334 Universal life and investment- type product policy fees........ 2,261 198 548 (183) -- 3(b),(c) 2,824 Net investment income............. 2,952 113 21 (2) (26) 3(c), 5(a) 3,058 Fees on ceded reinsurance and other........................... -- 93 -- -- (93) 4(g) -- Other revenues.................... 511 -- 23 (24) 93 3(c), 4(g) 603 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities............ (52) (2) -- -- -- (54) Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)......................... 3 -- -- -- -- 3 Other net investment gains (losses)....................... 201 (2) 42 (37) -- 3(c) 204 ------ ---- ------- ------- ---- ------ Total net investment gains (losses)..................... 152 (4) 42 (37) -- 153 Net derivative gains (losses)....................... 1,003 329 (3,677) 1,432 -- 3(c) (913) ------ ---- ------- ------- ---- ------ Total revenues................. 8,140 740 (2,093) 298 (26) 7,059 ------ ---- ------- ------- ---- ------ Expenses Policyholder benefits and claims.......................... 2,389 100 1,812 (1,001) 30 3(b),(c), 4(h) 3,330 Interest credited to policyholder account balances................ 1,147 118 17 (17) -- 3(c) 1,265 Policyholder dividends............ -- -- 30 -- (30) 4(h) -- Goodwill impairment............... 394 -- -- -- -- 394 Other expenses.................... 2,720 229 206 (709) (26) 3(b)-(d), 5(a) 2,420 ------ ---- ------- ------- ---- ------ Total expenses................. 6,650 447 2,065 (1,727) (26) 7,409 ------ ---- ------- ------- ---- ------ Income (loss) from continuing operations before provision for income tax.................. 1,490 293 (4,158) 2,025 -- (350) Provision for income tax expense (benefit)............... 372 94 (1,455) 709 -- 3(e), 5(c) (280) ------ ---- ------- ------- ---- ------ Income (loss) from continuing operations, net of income tax............................. $1,118 $199 $(2,703) $ 1,316 $ -- $ (70) ====== ==== ======= ======= ==== ====== See accompanying notes to unaudited pro forma condensed combined financial statements. 5
N-4219th Page of 530TOC1stPreviousNextBottomJust 219th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Unaudited Pro Forma Condensed Combined Statement of Operations For the Year End December 31, 2011 (In millions) [Enlarge/Download Table] Historical ---------------------------- MetLife Exeter Investors Reassurance Insurance Company Reinsurance Other Pro Forma MICC Company Ltd. Adjustments Adjustments Notes Combined ------ --------- ----------- ----------- ----------- -------------- --------- Revenues Premiums........................... $1,828 $ 7 $ 72 $ (9) $ -- 3(b) $1,898 Universal life and investment-type product policy fees.............. 1,956 204 433 (136) -- 3(b),(c) 2,457 Net investment income.............. 3,074 114 17 3 (9) 3(c), 5(a) 3,199 Fees on ceded reinsurance and other............................ -- 104 -- -- (104) 4(g) -- Other revenues..................... 508 -- 44 (55) 104 3(b),(c), 4(g) 601 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities...................... (42) -- -- -- -- (42) Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss).......................... (5) -- -- -- -- (5) Other net investment gains (losses)........................ 82 (5) (1) -- -- 76 ------ ---- ---- ----- ----- ------ Total net investment gains (losses)...................... 35 (5) (1) -- -- 29 Net derivative gains (losses)..... 1,096 326 230 (787) -- 3(c) 865 ------ ---- ---- ----- ----- ------ Total revenues.................. 8,497 750 795 (984) (9) 9,049 ------ ---- ---- ----- ----- ------ Expenses Policyholder benefits and claims... 2,660 59 309 (88) 31 3(b),(c), 4(h) 2,971 Interest credited to policyholder account balances................. 1,189 127 16 (16) -- 3(c) 1,316 Policyholder dividends............. -- -- 31 -- (31) 4(h) -- Other expenses..................... 2,981 259 170 (101) (9) 3(b)-(d), 5(a) 3,300 ------ ---- ---- ----- ----- ------ Total expenses.................. 6,830 445 526 (205) (9) 7,587 ------ ---- ---- ----- ----- ------ Income (loss) from continuing operations before provision for income tax....................... 1,667 305 269 (779) -- 1,462 Provision for income tax expense (benefit)........................ 493 90 94 (272) -- 3(e), 5(c) 405 ------ ---- ---- ----- ----- ------ Income (loss) from continuing operations, net of income tax.... $1,174 $215 $175 $(507) $ -- $1,057 ====== ==== ==== ===== ===== ====== See accompanying notes to unaudited pro forma condensed combined financial statements. 6
N-4220th Page of 530TOC1stPreviousNextBottomJust 220th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS 1. Description of Transaction In the second quarter of 2013, MetLife, Inc. announced its plans to merge three U.S.-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company (the "Mergers"). The companies to be merged are MetLife Insurance Company of Connecticut, MetLife Investors USA Insurance Company ("MLI-USA"), a wholly-owned subsidiary of MetLife Insurance Company of Connecticut, and MetLife Investors Insurance Company ("MLIIC"), each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. ("Exeter"), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. MetLife Insurance Company of Connecticut, which is expected to be renamed and domiciled in Delaware, will be the surviving company. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Effective January 1, 2014, following receipt of New York State Department of Financial Services approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also, effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with an affiliate all existing New York insurance policies and annuity contracts that include a separate account feature. Following the Mergers and subject to certain regulatory approvals, MetLife Insurance Company of Connecticut will likely enter into transactions to transfer to one or more affiliates certain business that is currently reinsured by Exeter. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. 2. Basis of Presentation The Mergers represent a transaction among entities under common control. Transactions among entities under common control are accounted for as if the transaction occurred at the beginning of the earliest date presented and prior years are retrospectively adjusted to furnish comparative information similar to the pooling method. The unaudited pro forma condensed combined financial statements include historical amounts derived from the audited financial statements as of December 31, 2013 and for the years ended December 31, 2013, 2012 and 2011, for MetLife Insurance Company of Connecticut and its subsidiaries, including MLI-USA (collectively "MICC"), MLIIC and Exeter. The unaudited pro forma condensed combined financial statements give effect to the Mergers as if they had occurred (i) on December 31, 2013 for purposes of the unaudited pro forma condensed combined balance sheet and (ii) on January 1, 2011 for purposes of the unaudited pro forma condensed combined statements of operations for the years ended December 31, 2013, 2012 and 2011. The unaudited pro forma condensed combined financial statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and presented in accordance with the requirements of Article 11 of Regulation S-X published by the U.S. Securities and Exchange Commission. In accordance with Article 11 of Regulation S-X, discontinued operations have been excluded from the presentation of the unaudited pro forma condensed combined statements of operations. The historical financial information has been adjusted in the unaudited pro forma condensed combined financial statements to give effect to pro forma events that are directly attributable to the Mergers, factually supportable, and are expected to have a continuing impact on the combined results. The unaudited pro forma condensed combined financial statements exclude the effects of adjustments that rely on highly judgmental estimates including how historical management practices and operating decisions may or may not have changed as a result of the Mergers. The unaudited pro forma condensed combined financial statements are presented for informational purposes only and are not intended to reflect the results of operations or the financial position of the combined company that 7
N-4221st Page of 530TOC1stPreviousNextBottomJust 221st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS -- (CONTINUED) would have resulted had the Mergers been effective during the periods presented or the results that may be obtained by the combined company in the future. These unaudited pro forma condensed combined financial statements should be read in conjunction with the audited historical consolidated financial statements of MICC included in MetLife Insurance Company of Connecticut's Annual Report on Form 10-K for the year ended December 31, 2013, as revised by MetLife Insurance Company of Connecticut's Current Report on Form 8-K filed on October 27, 2014, as well as the audited historical balance sheets of MLIIC as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity and cash flows for each of the three years in the period ended December 31, 2013 together with the notes thereto and balance sheets of Exeter as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity and cash flows for each of the three years in the period ended December 31, 2013 together with the notes thereto, as restated on October 27, 2014 and as revised on November 7, 2014, are included as Exhibits 99.1 and 99.2, respectively, to the Current Report on Form 8-K/A ("Amendment No. 2") with which this financial information is filed as Exhibit 99.3. 3. Reinsurance Adjustments In connection with the Mergers, adjustments have been included for new and planned reinsurance agreements, for the recapture of certain reinsurance agreements and to eliminate non-recurring bank fees. The total of the reinsurance adjustments at December 31, 2013 resulted in changes to total assets of ($6,532) million, total liabilities of ($6,978) million, and total stockholders' equity of $446 million and for the years ended December 31, 2013, 2012 and 2011 resulted in changes to total revenues of $162 million, $298 million and ($984) million, respectively, and to total expenses of $154 million, ($1,727) million, and ($205) million, respectively. (a)Adjustment to increase total assets and total liabilities by $97 million to record a new reinsurance agreement. Effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with Metropolitan Life Insurance Company, an affiliate, all existing New York insurance policies and annuity contracts that include a separate account feature. The new reinsurance agreement was entered into in connection with MetLife Insurance Company of Connecticut withdrawing its license to issue insurance policies and annuity contracts in New York. (b)Adjustment to eliminate reinsurance transactions among the merging companies. The adjustments at December 31, 2013 include: changes of ($4,045) million to total assets, ($4,551) million to total liabilities and $506 million to retained earnings. The adjustments for the years ended December 31, 2013, 2012 and 2011 include: reductions to total revenue of $73 million, $0 and $12 million, respectively, and changes to other expenses of $208 million, ($690) million and ($61) million, respectively. (c)Adjustment to reflect planned reinsurance transactions to transfer to one or more affiliates certain business that is currently reinsured by Exeter. The adjustments at December 31, 2013 include: reductions of $2,584 million to total assets, $2,524 million to total liabilities and $60 million to accumulated other comprehensive income (loss). The adjustments for the years ended December 31, 2013, 2012 and 2011 include: changes to total revenue of $235 million, $298 million and ($972) million, respectively, and reductions to other expenses of $37 million, $1,018 million and $119 million, respectively. (d)Adjustment to eliminate from other expenses non-recurring credit facility usage fees for letters of credit, which were held to collateralize assumed liabilities and which were canceled when Exeter re-domesticated to Delaware of $17 million, $19 million and $25 million, for the years ended December 31, 2013, 2012 and 2011, respectively. (e)Adjustment for the income tax impact for all reinsurance adjustments at the federal statutory tax rate of 35%. 8
N-4222nd Page of 530TOC1stPreviousNextBottomJust 222nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS -- (CONTINUED) 4. Reclassification Adjustments Reclassification adjustments, included in other adjustments, are reflected herein to conform the presentation of Exeter's and MLIIC's financial statements to the presentation of MICC's financial statements. (a)Adjustment to reclassify derivative assets of $2,376 million and funds withheld at interest of $2,694 million to other invested assets. (b)Adjustment to net deferred income tax recoverable of $1,529 million with deferred income tax liability. (c)Adjustment to reclassify goodwill of $33 million from other assets to goodwill. (d)Adjustment to reclassify policyholder dividends payable of $12 million and $4 million to future policy benefits and other policy-related balances, respectively. (e)Adjustment to reclassify cash collateral on deposit of $197 million from other liabilities to payables for collateral under securities loaned and other transactions. (f)Adjustment to reclassify derivative liabilities of $2,648 million to other liabilities. (g)Adjustment to reclassify fees on ceded reinsurance and other of $90 million, $93 million and $104 million to other revenues for the years ended December 31, 2013, 2012 and 2011, respectively. (h)Adjustment to reclassify policyholder dividends of $27 million, $30 million and $31 million to policyholder benefits and claims for the years ended December 31, 2013, 2012 and 2011, respectively. 5. Other Adjustments The following other pro forma adjustments have been recorded in the unaudited pro forma condensed combined financial statements. (a)Adjustments to eliminate related party debt transactions among the merging entities. The adjustments at December 31, 2013 include: reductions of $2 million to accrued investment income and other liabilities and reductions of $500 million to other invested assets and long-term debt. The adjustments for the year ended December 31, 2013, 2012 and 2011 include: reductions of $2 million, $26 million and $9 million, respectively, to net investment income and other expenses. (b)Adjustment to eliminate related party investment gains for the year ended December 31, 2013. The non-recurring gains were recorded in connection with establishing a custodial account when MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. (c)Adjustment for the income tax impact for all other adjustments at the federal statutory tax rate of 35%. 6. Forward Looking Statements These unaudited pro forma condensed combined financial statements may be deemed to be forward looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements are identified by words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. Such statements may include, but are not limited to statements about the benefits of the Mergers, including future financial and operating results, the combined company's plans, objectives, expectations and intentions and other statements that are not historical facts. These forward looking statements are based largely on management's expectations and are subject to a number of risks and uncertainties. Actual results could differ materially from these forward looking statements. 9
N-4223rd Page of 530TOC1stPreviousNextBottomJust 223rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS -- (CONTINUED) 7. Subsequent Event On February 14, 2014, a subsidiary of MetLife Insurance Company of Connecticut entered into a definitive agreement to sell its wholly-owned subsidiary, MetLife Assurance Limited ("MAL"). Beginning in the first quarter of 2014, MICC will account for and report MAL as discontinued operations. These unaudited pro forma condensed combined financial statements exclude the impact of the MAL disposition as the transaction does not meet the significant subsidiary conditions of Article 11 of Regulation S-X and is not directly attributable to the Mergers. The transaction is expected to close in the second quarter of 2014, subject to regulatory approvals and satisfaction of other closing conditions. 10
N-4224th Page of 530TOC1stPreviousNextBottomJust 224th
Item 8. Financial Statements and Supplementary Data Index to Consolidated Financial Statements, Notes and Schedules [Enlarge/Download Table] Page ---- Report of Independent Registered Public Accounting Firm............................................ 2 Financial Statements at December 31, 2013 and 2012 and for the Years Ended December 31, 2013, 2012 and 2011: Consolidated Balance Sheets....................................................................... 3 Consolidated Statements of Operations............................................................. 4 Consolidated Statements of Comprehensive Income (Loss)............................................ 5 Consolidated Statements of Stockholders' Equity................................................... 6 Consolidated Statements of Cash Flows............................................................. 7 Notes to the Consolidated Financial Statements.................................................... 9 Note 1 -- Business, Basis of Presentation and Summary of Significant Accounting Policies...... 9 Note 2 -- Segment Information................................................................. 29 Note 3 -- Dispositions........................................................................ 35 Note 4 -- Insurance........................................................................... 36 Note 5 -- Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy- Related Intangibles......................................................................... 42 Note 6 -- Reinsurance......................................................................... 46 Note 7 -- Investments......................................................................... 53 Note 8 -- Derivatives......................................................................... 76 Note 9 -- Fair Value.......................................................................... 88 Note 10 -- Goodwill........................................................................... 114 Note 11 -- Debt............................................................................... 116 Note 12 -- Equity............................................................................. 117 Note 13 -- Other Expenses..................................................................... 122 Note 14 -- Income Tax......................................................................... 123 Note 15 -- Contingencies, Commitments and Guarantees.......................................... 126 Note 16 -- Related Party Transactions......................................................... 130 Note 17 -- Subsequent Events.................................................................. 130 Financial Statement Schedules at December 31, 2013 and 2012 and for the Years Ended December 31, 2013, 2012 and 2011: Schedule I -- Consolidated Summary of Investments -- Other Than Investments in Related Parties.... 132 Schedule II -- Condensed Financial Information (Parent Company Only).............................. 133 Schedule III -- Consolidated Supplementary Insurance Information.................................. 137 Schedule IV -- Consolidated Reinsurance........................................................... 139 1
N-4225th Page of 530TOC1stPreviousNextBottomJust 225th
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of MetLife Insurance Company of Connecticut: We have audited the accompanying consolidated balance sheets of MetLife Insurance Company of Connecticut and subsidiaries (the "Company") as of December 31, 2013 and 2012, and the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2013. Our audits also included the financial statement schedules listed in the Index to Consolidated Financial Statements, Notes and Schedules. These consolidated financial statements and financial statement schedules are the responsibility of the Company's management. Our responsibility is to express an opinion on the consolidated financial statements and financial statement schedules based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of MetLife Insurance Company of Connecticut and subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein. /s/ DELOITTE & TOUCHE LLP New York, New York March 28, 2014 (October 27, 2014 as to Note 17) 2
N-4226th Page of 530TOC1stPreviousNextBottomJust 226th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Balance Sheets December 31, 2013 and 2012 (In millions, except share and per share data) [Enlarge/Download Table] 2013 2012 ----------- ----------- Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $43,477 and $46,005, respectively)................................................... $ 45,252 $ 50,968 Equity securities available-for-sale, at estimated fair value (cost: $397 and $311, respectively)........................................................................ 418 317 Mortgage loans (net of valuation allowances of $34 and $35, respectively; includes $1,598 and $2,666, respectively, at estimated fair value, relating to variable interest entities)................................................................... 7,718 9,157 Policy loans........................................................................... 1,219 1,216 Real estate and real estate joint ventures............................................. 754 708 Other limited partnership interests.................................................... 2,130 1,848 Short-term investments, principally at estimated fair value............................ 2,107 2,576 Other invested assets, principally at estimated fair value............................. 2,555 2,970 ----------- ----------- Total investments.................................................................... 62,153 69,760 Cash and cash equivalents, principally at estimated fair value.......................... 746 895 Accrued investment income (includes $9 and $13, respectively, relating to variable interest entities).................................................................... 542 575 Premiums, reinsurance and other receivables............................................. 20,609 21,927 Deferred policy acquisition costs and value of business acquired........................ 4,730 3,746 Current income tax recoverable.......................................................... 192 135 Goodwill................................................................................ 493 559 Other assets............................................................................ 794 826 Separate account assets................................................................. 97,780 86,114 ----------- ----------- Total assets......................................................................... $ 188,039 $ 184,537 =========== =========== Liabilities and Stockholders' Equity Liabilities Future policy benefits.................................................................. $ 27,991 $ 27,583 Policyholder account balances........................................................... 33,453 36,976 Other policy-related balances........................................................... 3,164 3,138 Payables for collateral under securities loaned and other transactions.................. 6,451 8,399 Long-term debt (includes $1,461 and $2,559, respectively, at estimated fair value, relating to variable interest entities)............................................... 2,251 3,350 Deferred income tax liability........................................................... 1,385 1,870 Other liabilities (includes $7 and $13, respectively, relating to variable interest entities)............................................................................. 6,776 6,547 Separate account liabilities............................................................ 97,780 86,114 ----------- ----------- Total liabilities.................................................................... 179,251 173,977 ----------- ----------- Contingencies, Commitments and Guarantees (Note 15) Stockholders' Equity Common stock, par value $2.50 per share; 40,000,000 shares authorized; 34,595,317 shares issued and outstanding at December 31, 2013 and 2012........................... 86 86 Additional paid-in capital.............................................................. 6,737 6,718 Retained earnings....................................................................... 1,076 1,356 Accumulated other comprehensive income (loss)........................................... 889 2,400 ----------- ----------- Total stockholders' equity........................................................... 8,788 10,560 ----------- ----------- Total liabilities and stockholders' equity........................................... $ 188,039 $ 184,537 =========== =========== See accompanying notes to the consolidated financial statements. 3
N-4227th Page of 530TOC1stPreviousNextBottomJust 227th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Operations For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 --------- --------- --------- Revenues Premiums............................................................. $ 606 $ 1,261 $ 1,828 Universal life and investment-type product policy fees............... 2,336 2,261 1,956 Net investment income................................................ 2,852 2,952 3,074 Other revenues....................................................... 592 511 508 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities....... (9) (52) (42) Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss).................. (11) 3 (5) Other net investment gains (losses)................................. 102 201 82 --------- --------- --------- Total net investment gains (losses)............................... 82 152 35 Net derivative gains (losses)....................................... (1,052) 1,003 1,096 --------- --------- --------- Total revenues.................................................. 5,416 8,140 8,497 --------- --------- --------- Expenses Policyholder benefits and claims..................................... 1,707 2,389 2,660 Interest credited to policyholder account balances................... 1,037 1,147 1,189 Goodwill impairment.................................................. 66 394 -- Other expenses....................................................... 1,659 2,720 2,981 --------- --------- --------- Total expenses.................................................. 4,469 6,650 6,830 --------- --------- --------- Income (loss) from continuing operations before provision for income tax................................................................ 947 1,490 1,667 Provision for income tax expense (benefit)........................... 227 372 493 --------- --------- --------- Income (loss) from continuing operations, net of income tax.......... 720 1,118 1,174 Income (loss) from discontinued operations, net of income tax........ -- 8 -- --------- --------- --------- Net income (loss).................................................... $ 720 $ 1,126 $ 1,174 ========= ========= ========= See accompanying notes to the consolidated financial statements. 4
N-4228th Page of 530TOC1stPreviousNextBottomJust 228th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Comprehensive Income (Loss) For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ----------- --------- --------- Net income (loss).................................................... $ 720 $ 1,126 $ 1,174 Other comprehensive income (loss): Unrealized investment gains (losses), net of related offsets........ (2,094) 850 2,074 Unrealized gains (losses) on derivatives............................ (204) 4 347 Foreign currency translation adjustments............................ 28 88 (16) ----------- --------- --------- Other comprehensive income (loss), before income tax................. (2,270) 942 2,405 Income tax (expense) benefit related to items of other comprehensive income (loss)...................................................... 759 (313) (851) ----------- --------- --------- Other comprehensive income (loss), net of income tax................. (1,511) 629 1,554 ----------- --------- --------- Comprehensive income (loss).......................................... $ (791) $ 1,755 $ 2,728 =========== ========= ========= See accompanying notes to the consolidated financial statements. 5
N-4229th Page of 530TOC1stPreviousNextBottomJust 229th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Stockholders' Equity For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] Accumulated Other Comprehensive Income (Loss) --------------------------------------------- Net Foreign Additional Unrealized Other-Than- Currency Total Common Paid-in Retained Investment Temporary Translation Stockholders' Stock Capital Earnings Gains (Losses) Impairments Adjustments Equity ------ ---------- ----------- -------------- ----------- ----------- ------------- Balance at December 31, 2010 (1).................. $ 86 $ 6,719 $ 424 $ 393 $ (51) $ (125) $ 7,446 Dividend paid to MetLife.... (517) (517) Capital contribution........ 1 1 Return of capital (Note 12). (47) (47) Net income (loss)........... 1,174 1,174 Other comprehensive income (loss), net of income tax. 1,591 (23) (14) 1,554 ------ --------- ----------- ----------- ---------- --------- ----------- Balance at December 31, 2011 86 6,673 1,081 1,984 (74) (139) 9,611 Dividend of subsidiary (Note 3).................. (347) (347) Dividend paid to MetLife.... (504) (504) Capital contribution........ 45 45 Net income (loss)........... 1,126 1,126 Other comprehensive income (loss), net of income tax (2)................... 503 36 90 629 ------ --------- ----------- ----------- ---------- --------- ----------- Balance at December 31, 2012 86 6,718 1,356 2,487 (38) (49) 10,560 Dividend paid to MetLife.... (1,000) (1,000) Capital contribution........ 19 19 Net income (loss)........... 720 720 Other comprehensive income (loss), net of income tax. (1,549) 12 26 (1,511) ------ --------- ----------- ----------- ---------- --------- ----------- Balance at December 31, 2013 $ 86 $ 6,737 $ 1,076 $ 938 $ (26) $ (23) $ 8,788 ====== ========= =========== =========== ========== ========= =========== -------- (1)Includes amounts related to prior period adjustments to Retained Earnings of ($33) million. See Note 1. (2)Includes amounts related to dividend of subsidiary. See Notes 3 and 12. See accompanying notes to the consolidated financial statements. 6
N-4230th Page of 530TOC1stPreviousNextBottomJust 230th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Cash Flows For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ----------- ----------- ----------- Cash flows from operating activities Net income (loss)...................................................................... $ 720 $ 1,126 $ 1,174 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization expenses............................................... 33 31 37 Amortization of premiums and accretion of discounts associated with investments, net. (167) (168) (152) (Gains) losses on investments and derivatives and from sales of businesses, net...... 1,108 (1,043) (1,160) (Income) loss from equity method investments, net of dividends or distributions...... (78) (42) (23) Interest credited to policyholder account balances................................... 1,037 1,147 1,189 Universal life and investment-type product policy fees............................... (2,336) (2,261) (1,956) Goodwill impairment.................................................................. 66 394 -- Change in fair value option securities............................................... -- (602) (1,483) Change in accrued investment income.................................................. 77 66 51 Change in premiums, reinsurance and other receivables................................ (1,355) (1,197) (1,202) Change in deferred policy acquisition costs and value of business acquired, net...... (553) 182 (207) Change in income tax................................................................. 213 630 537 Change in other assets............................................................... 1,836 1,499 1,386 Change in insurance-related liabilities and policy-related balances.................. 1,144 1,863 1,958 Change in other liabilities.......................................................... 847 804 406 Other, net........................................................................... 141 53 67 ----------- ----------- ----------- Net cash provided by (used in) operating activities.................................... 2,733 2,482 622 ----------- ----------- ----------- Cash flows from investing activities Sales, maturities and repayments of: Fixed maturity securities........................................................... 18,718 14,394 17,348 Equity securities................................................................... 67 50 168 Mortgage loans...................................................................... 2,292 1,447 993 Real estate and real estate joint ventures.......................................... 104 72 26 Other limited partnership interests................................................. 153 223 256 Purchases of: Fixed maturity securities........................................................... (15,841) (15,706) (17,127) Equity securities................................................................... (133) (58) (27) Mortgage loans...................................................................... (882) (807) (1,357) Real estate and real estate joint ventures.......................................... (201) (225) (72) Other limited partnership interests................................................. (363) (341) (378) Cash received in connection with freestanding derivatives............................ 111 414 397 Cash paid in connection with freestanding derivatives................................ (720) (335) (478) Dividend of subsidiary............................................................... -- (53) -- Issuances of loans to affiliates..................................................... (500) -- (430) Net change in policy loans........................................................... (3) (13) (13) Net change in short-term investments................................................. 471 (155) (1,347) Net change in other invested assets.................................................. (47) (54) (12) Other, net........................................................................... 3 -- 1 ----------- ----------- ----------- Net cash provided by (used in) investing activities.................................... $ 3,229 $ (1,147) $ (2,052) ----------- ----------- ----------- See accompanying notes to the consolidated financial statements. 7
N-4231st Page of 530TOC1stPreviousNextBottomJust 231st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Cash Flows -- (Continued) For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ----------- ----------- ----------- Cash flows from financing activities Policyholder account balances: Deposits............................................................................... $ 13,770 $ 14,785 $ 20,496 Withdrawals............................................................................ (15,899) (15,493) (19,404) Net change in payables for collateral under securities loaned and other transactions.... (1,948) 320 (24) Long-term debt repaid................................................................... (1,009) (482) (385) Financing element on certain derivative instruments..................................... (29) 180 129 Return of capital....................................................................... -- -- (47) Dividends on common stock............................................................... (1,000) (504) (517) ----------- ----------- ----------- Net cash provided by (used in) financing activities....................................... (6,115) (1,194) 248 ----------- ----------- ----------- Effect of change in foreign currency exchange rates on cash and cash equivalents balances. 4 9 (1) ----------- ----------- ----------- Change in cash and cash equivalents....................................................... (149) 150 (1,183) Cash and cash equivalents, beginning of year.............................................. 895 745 1,928 ----------- ----------- ----------- Cash and cash equivalents, end of year.................................................... $ 746 $ 895 $ 745 =========== =========== =========== Supplemental disclosures of cash flow information Net cash paid (received) for: Interest............................................................................... $ 194 $ 232 $ 406 =========== =========== =========== Income tax............................................................................. $ (1) $ (226) $ (47) =========== =========== =========== Non-cash transactions: Disposal of subsidiary: (1) Assets disposed........................................................................ $ -- $ 4,857 $ -- Liabilities disposed................................................................... -- (4,567) -- ----------- ----------- ----------- Net assets disposed.................................................................... -- 290 -- Cash disposed.......................................................................... -- (53) -- Dividend of interests in subsidiary.................................................... -- (237) -- ----------- ----------- ----------- (Gain) loss on dividend of interests in subsidiary..................................... $ -- $ -- $ -- =========== =========== =========== Capital contribution from MetLife, Inc.................................................. $ 19 $ 45 $ -- =========== =========== =========== Real estate and real estate joint ventures acquired in satisfaction of debt............. $ -- $ 50 $ 5 =========== =========== =========== -------- (1)See Note 3. See accompanying notes to the consolidated financial statements. 8
N-4232nd Page of 530TOC1stPreviousNextBottomJust 232nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements 1. Business, Basis of Presentation and Summary of Significant Accounting Policies Business "MICC" or the "Company" refers to MetLife Insurance Company of Connecticut, a Connecticut corporation incorporated in 1863, and its subsidiaries, including MetLife Investors USA Insurance Company ("MLI-USA"). MetLife Insurance Company of Connecticut is a wholly-owned subsidiary of MetLife, Inc. ("MetLife"). The Company offers individual annuities, individual life insurance, and institutional protection and asset accumulation products. The Company is organized into two segments: Retail and Corporate Benefit Funding. In the second quarter of 2013, MetLife announced its plans to merge three U.S.-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company (the "Mergers"). The companies to be merged are MetLife Insurance Company of Connecticut, MLI-USA and MetLife Investors Insurance Company ("MLIIC"), each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. ("Exeter"), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. MetLife Insurance Company of Connecticut, which is expected to be renamed and domiciled in Delaware, will be the surviving entity. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Effective January 1, 2014, following receipt of New York State Department of Financial Services ("Department of Financial Services") approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with Metropolitan Life Insurance Company ("MLIC"), an affiliate, all existing New York insurance policies and annuity contracts that include a separate account feature. As a result of the reinsurance agreements, MetLife Insurance Company of Connecticut recorded a reinsurance recoverable, included in premiums, reinsurance and other receivables, of $545 million and a funds withheld liability, included in other liabilities, of $97 million, and transferred cash and investments of $448 million to MLIC. On December 31, 2013, MetLife Insurance Company of Connecticut deposited investments with an estimated fair market value of $6.3 billion into a custodial account, which became restricted to secure MetLife Insurance Company of Connecticut's remaining New York policyholder liabilities not covered by such reinsurance on January 1, 2014. In anticipation of establishing the custodial account with qualifying investments, MetLife Insurance Company of Connecticut transferred investments with an estimated fair value of $739 million and cash of $12 million to MLIC and received from MLIC qualifying investments with an estimated fair value of $751 million in the fourth quarter of 2013. See Note 7. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company's business and operations. Actual results could differ from estimates. 9
N-4233rd Page of 530TOC1stPreviousNextBottomJust 233rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Consolidation The accompanying consolidated financial statements include the accounts of MetLife Insurance Company of Connecticut and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities ("VIEs") for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated. Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity. Discontinued Operations The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. In order to qualify for a discontinued operation, the operations and cash flows of the component have been or will be eliminated from the ongoing operations of the Company, and the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction. Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if: . such separate accounts are legally recognized; . assets supporting the contract liabilities are legally insulated from the Company's general account liabilities; . investments are directed by the contractholder; and . all investment performance, net of contract fees and assessments, is passed through to the contractholder. The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company's general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account. Unit-linked separate account investments that are directed by contractholders but do not meet one or more of the other above criteria are included in fair value option ("FVO") securities. See Note 3. 10
N-4234th Page of 530TOC1stPreviousNextBottomJust 234th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company's revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees in the statements of operations. Reclassifications Certain amounts in the prior years' consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as discussed throughout the Notes to the Consolidated Financial Statements. Adjustments to Prior Periods During the fourth quarter of 2013, the Company determined to adjust certain prior period results to correct the following: . Certain prior years' acquisition costs related to variable annuity sales were incorrectly allocated to an affiliate. Such costs, net of deferred policy acquisition costs ("DAC"), were $57 million, $66 million, and $52 million for 2012, 2011 and 2010, respectively. . A DAC recoverability write-off of $111 million associated with term life and universal life secondary guarantees business sold in 2012 was not recorded as of December 31, 2012. . The fair value of a bifurcated embedded derivative associated with a reinsurance agreement was overstated by $23 million for 2011. . Policyholder benefits and claims and other expenses were overstated in 2012 by $6 million and $23 million, respectively, due to an adjustment in the modeling of dynamic lapses in certain variable annuity products. . Tax valuation allowances were understated by $22 million for 2012. . A non-cash transaction relating to a pension closeout sale was incorrectly recorded as an increase of $312 million in net cash provided by operating activities with an offsetting impact on net cash used in investing activities for 2011. Management evaluated the materiality of these adjustments quantitatively and qualitatively and concluded that they were not material to any prior periods' annual or quarterly financial statements, however, unadjusted amounts as of December 31, 2012 would have had a significant effect on the results of operations for 2013 if they were recorded in 2013. Accordingly, the Company has revised its previously reported financial statements for prior annual periods for the items listed above, including the related tax impacts, as detailed below. The effects of the adjustments were immaterial to quarterly financial information reported in each of the interim condensed consolidated financial statements in 2012 and 2013, since the most significant adjustments occurred in the fourth quarter of 2012. As a result, such previously reported quarterly financial information has not been adjusted, and we do not plan to amend prior quarterly filings. 11
N-4235th Page of 530TOC1stPreviousNextBottomJust 235th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The impact of the adjustments is shown in the tables below: [Enlarge/Download Table] December 31, 2012 ------------------- As Previously As Consolidated Balance Sheets Reported Adjusted -------------------------------------------------------------------- ---------- -------- (In millions) Assets Premiums, reinsurance and other receivables...................... $ 22,143 $ 21,927 Deferred policy acquisition costs and value of business acquired. $ 3,793 $ 3,746 Other assets..................................................... $ 822 $ 826 Total assets..................................................... $184,796 $184,537 Liabilities Future policy benefits........................................... $ 27,585 $ 27,583 Deferred income tax liability.................................... $ 1,938 $ 1,870 Total liabilities................................................ $174,047 $173,977 Stockholders' Equity Retained earnings................................................ $ 1,545 $ 1,356 Total stockholders' equity....................................... $ 10,749 $ 10,560 Total liabilities and stockholders' equity....................... $184,796 $184,537 [Enlarge/Download Table] December 31, --------------------------------------- 2012 2011 ------------------- ------------------- As As Previously As Previously As Consolidated Statements of Operations Reported Adjusted Reported Adjusted --------------------------------------------------------------------- ---------- -------- ---------- -------- (In millions) Revenues Net derivative gains (losses)..................................... $ 980 $1,003 $1,119 $1,096 Total revenues.................................................... $8,117 $8,140 $8,520 $8,497 Expenses Policyholder benefits and claims.................................. $2,395 $2,389 $2,660 N/A Other expenses.................................................... $2,575 $2,720 $2,915 $2,981 Total expenses.................................................... $6,511 $6,650 $6,764 $6,830 Income (loss) from continuing operations before provision for income tax................................................................ $1,606 $1,490 $1,756 $1,667 Provision for income tax expense (benefit)........................... $ 391 $ 372 $ 523 $ 493 Income (loss) from continuing operations, net of income tax.......... $1,215 $1,118 $1,233 $1,174 Net income (loss).................................................... $1,223 $1,126 $1,233 $1,174 [Enlarge/Download Table] December 31, --------------------------------------- 2012 2011 ------------------- ------------------- As As Previously As Previously As Consolidated Statements of Comprehensive Income (Loss) Reported Adjusted Reported Adjusted ------------------------------------------------------ ---------- -------- ---------- -------- (In millions) Net income (loss)......................... $1,223 $1,126 $1,233 $1,174 Comprehensive income (loss)............... $1,852 $1,755 $2,787 $2,728 12
N-4236th Page of 530TOC1stPreviousNextBottomJust 236th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) [Download Table] As Previously As Consolidated Statements of Stockholders' Equity Reported Adjusted ----------------------------------------------- ---------- -------- (In millions) Retained Earnings Balance at December 31, 2010........... $ 457 $ 424 Net income (loss)..................... $ 1,233 $ 1,174 Balance at December 31, 2011........... $ 1,173 $ 1,081 Net income (loss)..................... $ 1,223 $ 1,126 Balance at December 31, 2012........... $ 1,545 $ 1,356 Total Stockholders' Equity Balance at December 31, 2010........... $ 7,479 $ 7,446 Balance at December 31, 2011........... $ 9,703 $ 9,611 Balance at December 31, 2012........... $10,749 $10,560 [Enlarge/Download Table] December 31, - --------------------------------------- 2012 2011 ------------------ ------------------- As As Previously As Previously As Consolidated Statements of Cash Flows Reported Adjusted Reported Adjusted ------------------------------------------------------------------- ---------- -------- ---------- -------- (In millions) Cash flows from operating activities Net income (loss)................................................ $ 1,223 $ 1,126 $ 1,233 $ 1,174 (Gains) losses on investments and derivatives and from sales of businesses, net................................................ $(1,020) $(1,043) $ (1,183) $ (1,160) Change in premiums, reinsurance and other receivables............ $(1,229) $(1,197) $ (1,288) $ (1,202) Change in deferred policy acquisition costs and value of business acquired, net......................................... $ 69 $ 182 $ (187) $ (207) Change in income tax............................................. $ 649 $ 630 $ 567 $ 537 Change in other assets........................................... $ 1,503 $ 1,499 N/A N/A Change in insurance-related liabilities and policy-related balances....................................................... $ 1,865 $ 1,863 $ 2,307 $ 1,958 Other, net....................................................... N/A N/A $ 30 $ 67 Net cash provided by (used in) operating activities.............. N/A N/A $ 934 $ 622 Cash flows from investing activities Purchases of fixed maturity securities........................... N/A N/A $(17,439) $(17,127) Net cash provided by (used in) investing activities.............. N/A N/A $ (2,364) $ (2,052) 13
N-4237th Page of 530TOC1stPreviousNextBottomJust 237th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Summary of Significant Accounting Policies The following are the Company's significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies. [Enlarge/Download Table] -------------------------------------------------------------------------------------------------------- Accounting Policy Note -------------------------------------------------------------------------------------------------------- Insurance 4 -------------------------------------------------------------------------------------------------------- Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles 5 -------------------------------------------------------------------------------------------------------- Reinsurance 6 -------------------------------------------------------------------------------------------------------- Investments 7 -------------------------------------------------------------------------------------------------------- Derivatives 8 -------------------------------------------------------------------------------------------------------- Fair Value 9 -------------------------------------------------------------------------------------------------------- Goodwill 10 -------------------------------------------------------------------------------------------------------- Income Tax 14 -------------------------------------------------------------------------------------------------------- Litigation Contingencies 15 Insurance Future Policy Benefit Liabilities and Policyholder Account Balances The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are "locked in" upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. Liabilities for universal and variable life secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments. The assumptions used in estimating the secondary guarantee liabilities are consistent with those used for amortizing DAC and are thus subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of appropriate underlying equity indices, such as the Standard & Poor's Ratings Services ("S&P") 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. 14
N-4238th Page of 530TOC1stPreviousNextBottomJust 238th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur. Policyholder account balances ("PABs") relate to contract or contract features where the Company has no significant insurance risk. The Company issues directly and assumes through reinsurance, certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits ("GMDBs"), the portion of guaranteed minimum income benefits ("GMIBs") that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits ("GMWBs"). Guarantees accounted for as embedded derivatives in PABs include the non life-contingent portion of GMWBs, guaranteed minimum accumulation benefits ("GMABs") and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Other Policy-Related Balances Other policy-related balances include policy and contract claims, unearned revenue liabilities, premiums received in advance and policyholder dividends due and unpaid. The liability for policy and contract claims generally relates to incurred but not reported death, disability, and long-term care ("LTC") claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company's estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made. The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product's estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees. 15
N-4239th Page of 530TOC1stPreviousNextBottomJust 239th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company accounts for the prepayment of premiums on its individual life, group life and health contracts as premiums received in advance and applies the cash received to premiums when due. Recognition of Insurance Revenues and Deposits Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are provided to recognize profits over the estimated lives of the insurance policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into earnings in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments. Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term. Deposits related to universal life-type and investment-type products are credited to PABs. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related PABs. Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include: . incremental direct costs of contract acquisition, such as commissions; . the portion of an employee's total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed; . other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and . in limited circumstances, the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits. All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred. Value of business acquired ("VOBA") is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is 16
N-4240th Page of 530TOC1stPreviousNextBottomJust 240th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections. DAC and VOBA are amortized as follows: ----------------------------------------------------------------------------- Products: In proportion to the following over estimated lives of the contracts: ----------------------------------------------------------------------------- . Nonparticipating and Historic actual and expected future non-dividend-paying traditional gross premiums. contracts (primarily term insurance) ----------------------------------------------------------------------------- . Participating, dividend-paying Actual and expected future gross traditional contracts margins. ----------------------------------------------------------------------------- . Fixed and variable universal life Actual and expected future gross contracts profits. . Fixed and variable deferred annuity contracts ----------------------------------------------------------------------------- See Note 5 for additional information on DAC and VOBA amortization. The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes. The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder's initial account balance is increased by an amount equal to a specified percentage of the customer's deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements to determine the recoverability of the asset. Value of distribution agreements acquired ("VODA") is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired ("VOCRA") is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 30 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired. Reinsurance For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company's obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. 17
N-4241st Page of 530TOC1stPreviousNextBottomJust 241st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established. Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. The Company withholds the funds rather than transferring the underlying investments and, as a result, records funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. 18
N-4242nd Page of 530TOC1stPreviousNextBottomJust 242nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Investments Net Investment Income and Net Investment Gains (Losses) Income on investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein. Fixed Maturity and Equity Securities The majority of the Company's fixed maturity and equity securities are classified as available-for-sale ("AFS") and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) ("OCI"), net of policyholder-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income on fixed maturity securities is recognized when earned using an effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared. The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management's case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 7 "-- Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities." For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment ("OTTI") is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions exist, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings ("credit loss"). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors ("noncredit loss") is recorded in OCI. With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security's cost and its estimated fair value. 19
N-4243rd Page of 530TOC1stPreviousNextBottomJust 243rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Mortgage Loans The Company disaggregates its mortgage loan investments into two portfolio segments: commercial and agricultural. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 7. Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. Also included in mortgage loans are commercial mortgage loans held by consolidated securitization entities ("CSEs") for which the FVO was elected. These mortgage loans are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs. Policy Loans Policy loans are stated at unpaid principal balances. Interest income on such loans is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy's anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal or interest on the loan is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy. Real Estate Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income associated with such real estate is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks. Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held for sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated. Real Estate Joint Ventures and Other Limited Partnership Interests The Company uses the equity method of accounting for investments in equity securities when it has significant influence or at least 20% interest and for investments in real estate joint ventures and other limited partnership interests ("investees") when it has more than a minor ownership interest or more than a minor influence over the investee's operations, but does not have a controlling financial interest. The Company 20
N-4244th Page of 530TOC1stPreviousNextBottomJust 244th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) generally recognizes its share of the investee's earnings on a three-month lag in instances where the investee's financial information is not sufficiently timely or when the investee's reporting period differs from the Company's reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee's operations. The Company recognizes distributions on cost method investments as earned or received. Because of the nature and structure of these cost method investments, they do not meet the characteristics of an equity security in accordance with applicable accounting standards. The Company routinely evaluates its equity method and cost method investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value ("NAV"). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Short-term investments also include investments in affiliated money market pools. Other Invested Assets Other invested assets consist principally of the following: . Freestanding derivatives with positive estimated fair values are described in "-- Derivatives" below. . Loans to affiliates are stated at unpaid principal balance, adjusted for any unamortized premium or discount. . Tax credit and renewable energy partnerships derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method. . Leveraged leases are recorded net of non-recourse debt. Income on leveraged leases is recognized by applying the leveraged lease's estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment. . Investments in joint ventures that engage in insurance underwriting activities are accounted for under the equity method. Securities Lending Program Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount 21
N-4245th Page of 530TOC1stPreviousNextBottomJust 245th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with the securities lending transactions may not be sold or repledged, unless the counterparty is in default, and is not reflected in the financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income. Derivatives Freestanding Derivatives Freestanding derivatives are carried in the Company's balance sheets either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities. If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows: ----------------------------------------------------------------------------- Statement of Operations Presentation: Derivative: ----------------------------------------------------------------------------- Policyholder benefits and claims . Economic hedges of variable annuity guarantees included in future policy benefits ----------------------------------------------------------------------------- Net investment income . Economic hedges of equity method investments in joint ventures ----------------------------------------------------------------------------- Hedge Accounting To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows: . Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) -- in net derivative gains (losses), consistent with the change in fair value of the hedged item attributable to the designated risk being hedged. . Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) -- effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company's earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses). 22
N-4246th Page of 530TOC1stPreviousNextBottomJust 246th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the statement of operations within interest income or interest expense to match the location of the hedged item. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statements of operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses). In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value in the balance sheets, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). Embedded Derivatives The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if: . the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings; 23
N-4247th Page of 530TOC1stPreviousNextBottomJust 247th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) . the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and . a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses). If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities. Goodwill Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event. The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit 24
N-4248th Page of 530TOC1stPreviousNextBottomJust 248th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income. On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company's reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill. Employee Benefit Plans Pension, postretirement and postemployment benefits are provided to associates under plans sponsored and administered by MLIC, an affiliate of the Company. The Company's obligation and expense related to these benefits is limited to the amount of associated expense allocated from MLIC. Income Tax MetLife Insurance Company of Connecticut and all of its includable subsidiaries join with MetLife and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended (the "Code"). Current taxes (and the benefits of tax attributes such as losses) are allocated to MetLife Insurance Company of Connecticut and its subsidiaries under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife has elected the "percentage method" (and 100 percent under such method) of reimbursing companies for tax attributes such as losses. As a result, 100 percent of tax attributes such as losses are reimbursed by MetLife to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes such as losses. Profitable subsidiaries pay MetLife each year the federal income tax which such profitable subsidiary would have paid that year based upon that year's taxable income. If MetLife Insurance Company of Connecticut or its includable subsidiaries has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by MetLife Insurance Company of Connecticut and its includable subsidiaries when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if MetLife Insurance Company of Connecticut or its includable subsidiaries would not have realized the attributes on a stand-alone basis under a "wait and see" method. The Company's accounting for income taxes represents management's best estimate of various events and transactions. Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. 25
N-4249th Page of 530TOC1stPreviousNextBottomJust 249th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Factors in management's determination include the performance of the business and its ability to generate capital gains. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following: . future taxable income exclusive of reversing temporary differences and carryforwards; . future reversals of existing taxable temporary differences; . taxable income in prior carryback years; and . tax planning strategies. The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made. The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax. Litigation Contingencies The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company's financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company's financial statements. Other Accounting Policies Cash and Cash Equivalents The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value. 26
N-4250th Page of 530TOC1stPreviousNextBottomJust 250th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Property, Equipment, Leasehold Improvements and Computer Software Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. Estimated lives generally range from five to 10 years for leasehold improvements, and from three to seven years for all other property and equipment. The net book value of the property, equipment and leasehold improvements was insignificant at both December 31, 2013 and 2012. Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $200 million and $185 million at December 31, 2013 and 2012, respectively. Accumulated amortization of capitalized software was $97 million and $92 million at December 31, 2013 and 2012, respectively. Related amortization expense was $5 million, $10 million and $17 million for the years ended December 31, 2013, 2012 and 2011, respectively. Other Revenues Other revenues include, in addition to items described elsewhere herein, advisory fees, broker-dealer commissions and fees and administrative service fees. Such fees and commissions are recognized in the period in which services are performed. Foreign Currency Assets, liabilities and operations of foreign affiliates and subsidiaries are recorded based on the functional currency of each entity. The determination of the functional currency is made based on the appropriate economic and management indicators. The local currencies of foreign operations are the functional currencies. Assets and liabilities of foreign affiliates and subsidiaries are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and income and expense accounts are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur. Adoption of New Accounting Pronouncements Effective July 17, 2013, the Company adopted new guidance regarding derivatives that permits the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to the United States Treasury and London Interbank Offered Rate ("LIBOR"). Also, this new guidance removes the restriction on using different benchmark rates for similar hedges. The new guidance did not have a material impact on the financial statements upon adoption, but may impact the selection of benchmark interest rates for hedging relationships in the future. 27
N-4251st Page of 530TOC1stPreviousNextBottomJust 251st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Effective January 1, 2013, the Company adopted new guidance regarding comprehensive income that requires an entity to provide information about the amounts reclassified out of accumulated OCI ("AOCI") by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The adoption was prospectively applied and resulted in additional disclosures in Note 12. Effective January 1, 2013, the Company adopted new guidance regarding balance sheet offsetting disclosures which requires an entity to disclose information about offsetting and related arrangements for derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities borrowing and lending transactions, to enable users of its financial statements to understand the effects of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The adoption was retrospectively applied and resulted in additional disclosures related to derivatives in Note 8. On January 1, 2012, the Company adopted new guidance regarding accounting for DAC, which was retrospectively applied. The guidance specifies that only costs related directly to successful acquisition of new or renewal contracts can be capitalized as DAC; all other acquisition-related costs must be expensed as incurred. As a result, certain sales manager compensation and administrative costs previously capitalized by the Company will no longer be deferred. On January 1, 2012, the Company adopted new guidance regarding comprehensive income, which was retrospectively applied, that provides companies with the option to present the total of comprehensive income, components of net income, and the components of OCI either in a single continuous statement of comprehensive income or in two separate but consecutive statements in annual financial statements. The standard eliminates the option to present components of OCI as part of the statement of changes in stockholders' equity. The Company adopted the two-statement approach for annual financial statements. Effective January 1, 2012, the Company adopted new guidance on goodwill impairment testing that simplifies how an entity tests goodwill for impairment. This new guidance allows an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value as a basis for determining whether it needs to perform the quantitative two-step goodwill impairment test. Only if an entity determines, based on qualitative assessment, that it is more likely than not that a reporting unit's fair value is less than its carrying value will it be required to calculate the fair value of the reporting unit. The qualitative assessment is optional and the Company is permitted to bypass it for any reporting unit in any period and begin its impairment analysis with the quantitative calculation. The Company is permitted to perform the qualitative assessment in any subsequent period. Effective January 1, 2012, the Company adopted new guidance regarding fair value measurements that establishes common requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Some of the 28
N-4252nd Page of 530TOC1stPreviousNextBottomJust 252nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) amendments clarify the Financial Accounting Standards Board's ("FASB") intent on the application of existing fair value measurement requirements. Other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The adoption did not have a material impact on the Company's financial statements other than the expanded disclosures in Note 9. Future Adoption of New Accounting Pronouncements In March 2013, the FASB issued new guidance regarding foreign currency (Accounting Standards Update ("ASU") 2013-05, Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity), effective prospectively for fiscal years and interim reporting periods within those years beginning after December 15, 2013. The amendments require an entity that ceases to have a controlling financial interest in a subsidiary or group of assets within a foreign entity to apply the guidance in Subtopic 830-30, Foreign Currency Matters -- Translation of Financial Statements, to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. For an equity method investment that is a foreign entity, the partial sale guidance in section 830-30-40, Derecognition, still applies. As such, a pro rata portion of the cumulative translation adjustment should be released into net income upon a partial sale of such an equity method investment. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements. In February 2013, the FASB issued new guidance regarding liabilities (ASU 2013-04, Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date), effective retrospectively for fiscal years beginning after December 15, 2013 and interim periods within those years. The amendments require an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. In addition, the amendments require an entity to disclose the nature and amount of the obligation, as well as other information about the obligation. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements. 2. Segment Information The Company is organized into two segments: Retail and Corporate Benefit Funding. In addition, the Company reports certain of its results of operations in Corporate & Other. Retail The Retail segment offers a broad range of protection products and a variety of annuities primarily to individuals, and is organized into two businesses: Annuities and Life & Other. Annuities includes a variety of variable, fixed and indexed annuities which provide for both asset accumulation and asset distribution needs. Life & Other insurance products and services include variable life, universal life, term life and whole life products, as well as individual disability income products. Additionally, through broker-dealer affiliates, the Company offers a full range of mutual funds and other securities products. 29
N-4253rd Page of 530TOC1stPreviousNextBottomJust 253rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) Corporate Benefit Funding The Corporate Benefit Funding segment offers a broad range of annuity and investment products, including guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets. This segment also includes structured settlements and certain products to fund company-, bank- or trust-owned life insurance used to finance non-qualified benefit programs for executives. Corporate & Other Corporate & Other contains the excess capital not allocated to the segments, various start-up businesses, including direct and digital marketing products, run-off businesses, the Company's ancillary international operations, interest expense related to the majority of the Company's outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts. Financial Measures and Segment Accounting Policies Operating earnings is the measure of segment profit or loss the Company uses to evaluate segment performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is the Company's measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for income (loss) from continuing operations, net of income tax. The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings is defined as operating revenues less operating expenses, both net of income tax. Operating revenues excludes net investment gains (losses) and net derivative gains (losses). Operating expenses excludes goodwill impairments. The following additional adjustments are made to GAAP revenues, in the line items indicated, in calculating operating revenues: . Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees ("GMIB Fees"); and . Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iv) excludes certain amounts related to contractholder-directed unit-linked investments, and (v) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP. 30
N-4254th Page of 530TOC1stPreviousNextBottomJust 254th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) The following additional adjustments are made to GAAP expenses, in the line items indicated, in calculating operating expenses: . Policyholder benefits and claims excludes: (i) amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, (ii) benefits and hedging costs related to GMIBs ("GMIB Costs"), and (iii) market value adjustments associated with surrenders or terminations of contracts ("Market Value Adjustments"); . Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of PABs but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments; . Amortization of DAC and VOBA excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments; . Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and . Other expenses excludes costs related to: (i) implementation of new insurance regulatory requirements, and (ii) acquisition and integration costs. Set forth in the tables below is certain financial information with respect to the Company's segments, as well as Corporate & Other, for the years ended December 31, 2013, 2012 and 2011 and at December 31, 2013 and 2012. The segment accounting policies are the same as those used to prepare the Company's consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below. Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in MetLife's and the Company's business. MetLife's economic capital model aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon and applying an industry standard method for the inclusion of diversification benefits among risk types. Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company's consolidated net investment income, operating earnings or income (loss) from continuing operations, net of income tax. Net investment income is based upon the actual results of each segment's specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company's product pricing. 31
N-4255th Page of 530TOC1stPreviousNextBottomJust 255th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Earnings ------------------------------------- Corporate Benefit Corporate Total Year Ended December 31, 2013 Retail Funding & Other Total Adjustments Consolidated -------------------------------------------------------- -------- --------- --------- -------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 387 $ 184 $ 35 $ 606 $ -- $ 606 Universal life and investment-type product policy fees.. 2,155 35 -- 2,190 146 2,336 Net investment income................................... 1,614 1,162 112 2,888 (36) 2,852 Other revenues.......................................... 587 5 -- 592 -- 592 Net investment gains (losses)........................... -- -- -- -- 82 82 Net derivative gains (losses)........................... -- -- -- -- (1,052) (1,052) -------- ------- ------- -------- ---------- ---------- Total revenues........................................ 4,743 1,386 147 6,276 (860) 5,416 -------- ------- ------- -------- ---------- ---------- Expenses Policyholder benefits and claims........................ 737 749 14 1,500 207 1,707 Interest credited to policyholder account balances...... 906 136 -- 1,042 (5) 1,037 Goodwill impairment..................................... -- -- -- -- 66 66 Capitalization of DAC................................... (475) (2) (27) (504) -- (504) Amortization of DAC and VOBA............................ 552 5 1 558 (508) 50 Interest expense on debt................................ -- -- 68 68 122 190 Other expenses.......................................... 1,816 36 71 1,923 -- 1,923 -------- ------- ------- -------- ---------- ---------- Total expenses........................................ 3,536 924 127 4,587 (118) 4,469 -------- ------- ------- -------- ---------- ---------- Provision for income tax expense (benefit).............. 395 162 (86) 471 (244) 227 -------- ------- ------- -------- ---------- ---------- Operating earnings...................................... $ 812 $ 300 $ 106 1,218 ======== ======= ======= Adjustments to:......................................... Total revenues........................................ (860) Total expenses........................................ 118 Provision for income tax (expense) benefit............ 244 -------- Income (loss) from continuing operations, net of income tax.................................................... $ 720 $ 720 ======== ========== [Download Table] Corporate Benefit Corporate & At December 31, 2013 Retail Funding Other Total ----------------------------- ---------- --------- ----------- ---------- (In millions) Total assets................. $ 146,515 $ 30,822 $ 10,702 $ 188,039 Separate account assets...... $ 95,692 $ 2,088 $ -- $ 97,780 Separate account liabilities. $ 95,692 $ 2,088 $ -- $ 97,780 32
N-4256th Page of 530TOC1stPreviousNextBottomJust 256th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Earnings --------------------------------------- Corporate Benefit Corporate & Total Year Ended December 31, 2012 Retail Funding Other Total Adjustments Consolidated -------------------------------------------------------- -------- --------- ----------- -------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 498 $ 629 $ 134 $ 1,261 $ -- $ 1,261 Universal life and investment-type product policy fees.. 2,081 29 14 2,124 137 2,261 Net investment income................................... 1,525 1,167 185 2,877 75 2,952 Other revenues.......................................... 505 6 -- 511 -- 511 Net investment gains (losses)........................... -- -- -- -- 152 152 Net derivative gains (losses)........................... -- -- -- -- 1,003 1,003 -------- -------- -------- -------- ---------- ----------- Total revenues........................................ 4,609 1,831 333 6,773 1,367 8,140 -------- -------- -------- -------- ---------- ----------- Expenses Policyholder benefits and claims........................ 738 1,161 128 2,027 362 2,389 Interest credited to policyholder account balances...... 943 162 -- 1,105 42 1,147 Goodwill impairment..................................... -- -- -- -- 394 394 Capitalization of DAC................................... (848) (5) (33) (886) -- (886) Amortization of DAC and VOBA............................ 666 10 2 678 357 1,035 Interest expense on debt................................ -- -- 68 68 163 231 Other expenses.......................................... 2,229 39 66 2,334 6 2,340 -------- -------- -------- -------- ---------- ----------- Total expenses........................................ 3,728 1,367 231 5,326 1,324 6,650 -------- -------- -------- -------- ---------- ----------- Provision for income tax expense (benefit).............. 332 162 (30) 464 (92) 372 -------- -------- -------- -------- ----------- Operating earnings...................................... $ 549 $ 302 $ 132 983 ======== ======== ======== Adjustments to: Total revenues........................................ 1,367 Total expenses........................................ (1,324) Provision for income tax (expense) benefit............ 92 -------- Income (loss) from continuing operations, net of income tax.................................................... $ 1,118 $ 1,118 ======== =========== [Download Table] Corporate Benefit Corporate At December 31, 2012 Retail Funding & Other Total ----------------------------- ---------- --------- --------- ---------- (In millions) Total assets................. $ 136,074 $33,140 $ 15,323 $ 184,537 Separate account assets...... $ 84,106 $ 2,008 $ -- $ 86,114 Separate account liabilities. $ 84,106 $ 2,008 $ -- $ 86,114 33
N-4257th Page of 530TOC1stPreviousNextBottomJust 257th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Earnings ----------------------------------------- Corporate Benefit Corporate Total Year Ended December 31, 2011 Retail Funding & Other Total Adjustments Consolidated -------------------------------------------------------- ---------- --------- --------- ---------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 710 $ 1,071 $ 47 $ 1,828 $ -- $ 1,828 Universal life and investment-type product policy fees.. 1,764 34 36 1,834 122 1,956 Net investment income................................... 1,423 1,175 181 2,779 295 3,074 Other revenues.......................................... 502 5 1 508 -- 508 Net investment gains (losses)........................... -- -- -- -- 35 35 Net derivative gains (losses)........................... -- -- -- -- 1,096 1,096 ---------- -------- -------- ---------- ----------- ----------- Total revenues........................................ 4,399 2,285 265 6,949 1,548 8,497 ---------- -------- -------- ---------- ----------- ----------- Expenses Policyholder benefits and claims........................ 896 1,598 46 2,540 120 2,660 Interest credited to policyholder account balances...... 988 180 -- 1,168 21 1,189 Goodwill impairment..................................... -- -- -- -- -- -- Capitalization of DAC................................... (1,301) (7) (57) (1,365) -- (1,365) Amortization of DAC and VOBA............................ 791 4 6 801 358 1,159 Interest expense on debt................................ -- -- 67 67 322 389 Other expenses.......................................... 2,568 42 163 2,773 25 2,798 ---------- -------- -------- ---------- ----------- ----------- Total expenses........................................ 3,942 1,817 225 5,984 846 6,830 ---------- -------- -------- ---------- ----------- ----------- Provision for income tax expense (benefit).............. 161 164 (70) 255 238 493 ---------- -------- -------- ---------- ----------- Operating earnings...................................... $ 296 $ 304 $ 110 710 ========== ======== ======== Adjustments to: Total revenues........................................ 1,548 Total expenses........................................ (846) Provision for income tax (expense) benefit............ (238) ---------- Income (loss) from continuing operations, net of income tax.................................................... $ 1,174 $ 1,174 ========== =========== The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company's segments, as well as Corporate & Other: [Download Table] Years Ended December 31, -------------------------- 2013 2012 2011 -------- -------- -------- (In millions) Life insurance (1)............ $ 3,528 $ 4,026 $ 4,285 Accident and health insurance. 6 7 7 -------- -------- -------- Total........................ $ 3,534 $ 4,033 $ 4,292 ======== ======== ======== -------- (1) Includes annuities and corporate benefit funding products. Revenues derived from any customer did not exceed 10% of consolidated premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2013, 2012 and 2011. 34
N-4258th Page of 530TOC1stPreviousNextBottomJust 258th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) The following table presents total premiums, universal life and investment-type product policy fees and other revenues associated with the Company's U.S. and foreign operations: [Download Table] Years Ended December 31, -------------------------- 2013 2012 2011 -------- -------- -------- (In millions) U.S............. $ 3,442 $ 3,329 $ 3,222 Foreign: United Kingdom. 92 556 986 Other (1)...... -- 148 84 -------- -------- -------- Total........ $ 3,534 $ 4,033 $ 4,292 ======== ======== ======== -------- (1)See Note 3 for information on the disposition of a subsidiary. 3. Dispositions Disposition In June 2012, the Company distributed all of the issued and outstanding shares of common stock of its wholly-owned subsidiary, MetLife Europe Limited ("MetLife Europe") to its stockholders as an in-kind dividend. The net book value of MetLife Europe at the time of the dividend was $290 million which was recorded as a dividend of retained earnings of $347 million and an increase to OCI of $57 million, net of income tax. As of the date of dividend, the Company no longer consolidates the assets, liabilities and operations of MetLife Europe. The net income of MetLife Europe was not material to the Company for the periods prior to the dividend. The results of MetLife Europe were reported in Corporate & Other. See Note 2 for a discussion of Corporate & Other. Discontinued Operations The following table summarizes the amounts that have been reflected as discontinued operations in the consolidated statements of operations. Income (loss) from discontinued operations includes real estate classified as held-for-sale or sold. [Enlarge/Download Table] Year Ended December 31, 2012 ---------------------------- (In millions) Total revenues................................................ $ 12 Total expenses................................................ -- --------------------- Income (loss) before provision for income tax................. 12 Provision for income tax expense (benefit).................... 4 --------------------- Income (loss) from discontinued operations, net of income tax. $ 8 ===================== There was no income (loss) from discontinued operations, net of income tax, for both of the years ended December 31, 2013 and 2011. 35
N-4259th Page of 530TOC1stPreviousNextBottomJust 259th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance Insurance Liabilities Insurance liabilities, including affiliated insurance liabilities on reinsurance assumed and ceded, are comprised of future policy benefits, PABs and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at: [Download Table] December 31, ------------------- 2013 2012 --------- --------- (In millions) Retail.................... $ 35,844 $ 37,642 Corporate Benefit Funding. 22,222 23,766 Corporate & Other......... 6,542 6,289 --------- --------- Total.................... $ 64,608 $ 67,697 ========= ========= See Note 6 for discussion of affiliated reinsurance liabilities included in the table above. Future policy benefits are measured as follows: Product Type: Measurement Assumptions: --------------------------------------------------------------------------- Participating life Aggregate of net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate of 4%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts). --------------------------------------------------------------------------- Nonparticipating life Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company's experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 2% to 7%. --------------------------------------------------------------------------- Individual and group traditional Present value of expected future fixed annuities after annuitization payments. Interest rate assumptions used in establishing such liabilities range from 4% to 8%. --------------------------------------------------------------------------- Non-medical health insurance The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7%. --------------------------------------------------------------------------- Disabled lives Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 3% to 7%. --------------------------------------------------------------------------- Participating business represented 3% and 2% of the Company's life insurance in-force at December 31, 2013 and 2012, respectively. Participating policies represented 32%, 24% and 10% of gross life insurance premiums for the years ended December 31, 2013, 2012 and 2011, respectively. PABs are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from 1% to 8%, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations. 36
N-4260th Page of 530TOC1stPreviousNextBottomJust 260th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) Guarantees The Company issues variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWBs and the portion of certain GMIBs that does not require annuitization are accounted for as embedded derivatives in PABs and are further discussed in Note 8. Guarantees accounted for as insurance liabilities include: [Enlarge/Download Table] Guarantee: Measurement Assumptions: ------------------------------------------------------------------------------------------------- GMDBs . A return of purchase payment upon Present value of expected death benefits in death even if the account value is excess of the projected account balance reduced to zero. recognizing the excess ratably over the accumulation period based on the present value of total expected assessments. . An enhanced death benefit may be Assumptions are consistent with those used available for an additional fee. for amortizing DAC, and are thus subject to the same variability and risk. Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index. Benefit assumptions are based on the average benefits payable over a range of scenarios. ------------------------------------------------------------------------------------------------- GMIBs . After a specified period of time Present value of expected income benefits in determined at the time of issuance excess of the projected account balance at of the variable annuity contract, any future date of annuitization and a minimum accumulation of purchase recognizing the excess ratably over the payments, even if the account accumulation period based on present value value is reduced to zero, that can of total expected assessments. be annuitized to receive a monthly income stream that is not less than a specified amount. . Certain contracts also provide for Assumptions are consistent with those used a guaranteed lump sum return of for estimating GMDB liabilities. purchase premium in lieu of the annuitization benefit. Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder. ------------------------------------------------------------------------------------------------- GMWBs. . A return of purchase payment via Expected value of the life contingent partial withdrawals, even if the payments and expected assessments using account value is reduced to zero, assumptions consistent with those used for provided that cumulative estimating the GMDB liabilities. withdrawals in a contract year do not exceed a certain limit. . Certain contracts include guaranteed withdrawals that are life contingent. 37
N-4261st Page of 530TOC1stPreviousNextBottomJust 261st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows: [Download Table] Universal and Variable Life Annuity Contracts Contracts ----------------- ------------- Secondary GMDBs GMIBs Guarantees Total -------- -------- ------------- --------- (In millions) Direct Balance at January 1, 2011... $ 79 $ 281 $ 896 $ 1,256 Incurred guaranteed benefits. 84 128 140 352 Paid guaranteed benefits..... (25) -- -- (25) -------- -------- --------- --------- Balance at December 31, 2011. 138 409 1,036 1,583 Incurred guaranteed benefits. 108 402 332 842 Paid guaranteed benefits..... (29) -- -- (29) -------- -------- --------- --------- Balance at December 31, 2012. 217 811 1,368 2,396 Incurred guaranteed benefits. 155 127 415 697 Paid guaranteed benefits..... (17) -- -- (17) -------- -------- --------- --------- Balance at December 31, 2013. $ 355 $ 938 $ 1,783 $ 3,076 ======== ======== ========= ========= Ceded Balance at January 1, 2011... $ 76 $ 97 $ 657 $ 830 Incurred guaranteed benefits. 59 42 110 211 Paid guaranteed benefits..... (21) -- -- (21) -------- -------- --------- --------- Balance at December 31, 2011. 114 139 767 1,020 Incurred guaranteed benefits. 56 129 267 452 Paid guaranteed benefits..... (25) -- -- (25) -------- -------- --------- --------- Balance at December 31, 2012. 145 268 1,034 1,447 Incurred guaranteed benefits. 85 31 334 450 Paid guaranteed benefits..... (15) -- -- (15) -------- -------- --------- --------- Balance at December 31, 2013. $ 215 $ 299 $ 1,368 $ 1,882 ======== ======== ========= ========= Net Balance at January 1, 2011... $ 3 $ 184 $ 239 $ 426 Incurred guaranteed benefits. 25 86 30 141 Paid guaranteed benefits..... (4) -- -- (4) -------- -------- --------- --------- Balance at December 31, 2011. 24 270 269 563 Incurred guaranteed benefits. 52 273 65 390 Paid guaranteed benefits..... (4) -- -- (4) -------- -------- --------- --------- Balance at December 31, 2012. 72 543 334 949 Incurred guaranteed benefits. 70 96 81 247 Paid guaranteed benefits..... (2) -- -- (2) -------- -------- --------- --------- Balance at December 31, 2013. $ 140 $ 639 $ 415 $ 1,194 ======== ======== ========= ========= 38
N-4262nd Page of 530TOC1stPreviousNextBottomJust 262nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) Account balances of contracts with insurance guarantees were invested in separate account asset classes as follows at: [Download Table] December 31, ------------------- 2013 2012 --------- --------- (In millions) Fund Groupings: Equity.......... $ 46,559 $ 39,113 Balanced........ 41,894 37,528 Bond............ 4,270 4,678 Money Market.... 789 879 --------- --------- Total.......... $ 93,512 $ 82,198 ========= ========= Based on the type of guarantee, the Company defines net amount at risk ("NAR") as listed below. Variable Annuity Guarantees In the Event of Death Defined as the death benefit less the total contract account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death. At Annuitization Defined as the amount (if any) that would be required to be added to the total contract account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company's potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved. Universal and Variable Life Contracts Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date. The amounts in the table below include direct business, but exclude offsets from hedging or reinsurance, if any. See Note 6 for a discussion of certain living and death benefit guarantees which have been reinsured. Therefore, the NARs presented below reflect the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. 39
N-4263rd Page of 530TOC1stPreviousNextBottomJust 263rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) Information regarding the types of guarantees relating to annuity contracts and universal and variable life contracts was as follows at: [Enlarge/Download Table] December 31, --------------------------------------------------------- 2013 2012 ---------------------------- ---------------------------- In the At In the At Event of Death Annuitization Event of Death Annuitization -------------- ------------- -------------- ------------- (In millions) Annuity Contracts (1) Variable Annuity Guarantees Total contract account value............ $ 100,420 $ 57,041 $ 89,671 $ 51,411 Separate account value.................. $ 95,637 $ 55,805 $ 84,106 $ 49,778 Net amount at risk...................... $ 2,230 $ 562 $ 3,117 $ 2,316 Average attained age of contractholders. 64 years 64 years 63 years 63 years [Download Table] December 31, ----------------------- 2013 2012 ----------- ----------- Secondary Guarantees ----------------------- (In millions) Universal and Variable Life Contracts (1) Account value (general and separate account). $ 6,360 $ 5,812 Net amount at risk........................... $ 91,264 $ 86,468 Average attained age of policyholders........ 58 years 58 years -------- (1)The Company's annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. Obligations Under Funding Agreements The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities ("SPEs") that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the years ended December 31, 2013, 2012 and 2011, the Company issued $10.9 billion, $10.3 billion and $12.5 billion, respectively, and repaid $11.7 billion, $9.6 billion and $13.4 billion, respectively, of such funding agreements. At December 31, 2013 and 2012, liabilities for funding agreements outstanding, which are included in PABs, were $5.3 billion and $6.1 billion, respectively. MetLife Insurance Company of Connecticut and MLI-USA, are members of regional banks in the Federal Home Loan Bank ("FHLB") system ("FHLBanks"). Holdings of common stock of FHLBanks, included in equity securities, were as follows at: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) FHLB of Boston..... $ 64 $ 67 FHLB of Pittsburgh. $ 20 $ 11 40
N-4264th Page of 530TOC1stPreviousNextBottomJust 264th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) The Company has also entered into funding agreements with FHLBanks and the Federal Agricultural Mortgage Corporation, a federally chartered instrumentality of the U.S. ("Farmer Mac"). The liability for such funding agreements is included in PABs. Information related to such funding agreements was as follows at: [Download Table] Liability Collateral ------------------- --------------------- December 31, ----------------------------------------- 2013 2012 2013 2012 --------- --------- ---------- ---------- (In millions) FHLB of Boston (1)..... $ 450 $ 450 $ 808 (2) $ 537 (2) Farmer Mac (3)......... $ 200 $ 200 $ 230 $ 230 FHLB of Pittsburgh (1). $ 200 $ -- $ 602 (2) $ 595 (2) -------- (1)Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities ("RMBS"), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank's recovery on the collateral is limited to the amount of the Company's liability to such FHLBank. (2)Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value. (3)Represents funding agreements issued to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by Farmer Mac. The obligations under these funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans and may, under certain circumstances, be secured by other qualified collateral. The amount of collateral presented is at carrying value. 41
N-4265th Page of 530TOC1stPreviousNextBottomJust 265th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Insurance (continued) Liabilities for Unpaid Claims and Claim Expenses Information regarding the liabilities for unpaid claims and claim expenses relating to group accident and non-medical health policies and contracts, which are reported in future policy benefits and other policy-related balances, was as follows: [Download Table] Years Ended December 31, -------------------------- 2013 2012 2011 -------- -------- -------- (In millions) Balance at January 1,........... $ 1,216 $ 1,079 $ 978 Less: Reinsurance recoverables. 1,124 980 878 -------- -------- -------- Net balance at January 1,....... 92 99 100 -------- -------- -------- Incurred related to: Current year................... 5 5 5 Prior years (1)................ 4 (2) 4 -------- -------- -------- Total incurred............... 9 3 9 -------- -------- -------- Paid related to: Current year................... -- -- -- Prior years.................... (11) (10) (10) -------- -------- -------- Total paid................... (11) (10) (10) -------- -------- -------- Net balance at December 31,..... 90 92 99 Add: Reinsurance recoverables.. 1,235 1,124 980 -------- -------- -------- Balance at December 31,......... $ 1,325 $ 1,216 $ 1,079 ======== ======== ======== -------- (1)During 2013, 2012 and 2011, claims and claim adjustment expenses associated with prior years changed due to differences between the actual benefits paid and expected benefits owed during those periods. Separate Accounts Separate account assets and liabilities primarily include pass-through separate accounts totaling $97.6 billion and $85.9 billion at December 31, 2013 and 2012, respectively, for which the policyholder assumes all investment risk. For the years ended December 31, 2013, 2012 and 2011, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts. 5. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles See Note 1 for a description of capitalized acquisition costs. 42
N-4266th Page of 530TOC1stPreviousNextBottomJust 266th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5.Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) Nonparticipating and Non-Dividend-Paying Traditional Contracts The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the historic actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes. Participating, Dividend-Paying Traditional Contracts The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales are reasonably likely to impact significantly the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances. Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the 43
N-4267th Page of 530TOC1stPreviousNextBottomJust 267th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5.Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances. Factors Impacting Amortization Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company's long-term expectation produce higher account balances, which increases the Company's future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company's long-term expectation. The Company's practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized. 44
N-4268th Page of 530TOC1stPreviousNextBottomJust 268th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5.Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) Information regarding DAC and VOBA was as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2013 2012 2011 -------- -------- -------- (In millions) DAC Balance at January 1,............................................ $ 3,079 $ 3,215 $ 2,718 Capitalizations.................................................. 504 886 1,365 Amortization related to: Net investment gains (losses) and net derivative gains (losses). 484 (331) (339) Other expenses.................................................. (404) (513) (477) -------- -------- -------- Total amortization............................................ 80 (844) (816) -------- -------- -------- Unrealized investment gains (losses)............................. 80 (19) (49) Disposition and other (1), (2)................................... 138 (159) (3) -------- -------- -------- Balance at December 31,.......................................... 3,881 3,079 3,215 -------- -------- -------- VOBA Balance at January 1,............................................ 667 1,006 1,686 Amortization related to: Net investment gains (losses) and net derivative gains (losses). 5 -- (29) Other expenses.................................................. (135) (191) (314) -------- -------- -------- Total amortization............................................ (130) (191) (343) -------- -------- -------- Unrealized investment gains (losses)............................. 312 (148) (337) -------- -------- -------- Balance at December 31,.......................................... 849 667 1,006 -------- -------- -------- Total DAC and VOBA Balance at December 31,.......................................... $ 4,730 $ 3,746 $ 4,221 ======== ======== ======== -------- (1)The year ended December 31, 2013 includes $138 million that was reclassified to DAC from premiums, reinsurance and other receivables. The amounts reclassified relate to an affiliated reinsurance agreement accounted for using the deposit method of accounting and represent the DAC amortization on the expense allowances ceded on the agreement from inception. These amounts were previously included in the calculated value of the deposit receivable on this agreement and recorded within premiums, reinsurance and other receivables. (2)See Note 3 for information on the disposition of a subsidiary. 45
N-4269th Page of 530TOC1stPreviousNextBottomJust 269th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5.Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at: [Download Table] December 31, ----------------- 2013 2012 -------- -------- (In millions) Retail.................... $ 4,698 $ 3,738 Corporate Benefit Funding. 6 8 Corporate & Other......... 26 -- -------- -------- Total.................... $ 4,730 $ 3,746 ======== ======== Information regarding other policy-related intangibles was as follows: [Download Table] Years Ended December 31, ----------------------- 2013 2012 2011 ------- ------- ------- (In millions) Deferred Sales Inducements Balance at January 1,...... $ 509 $ 535 $ 537 Capitalization............. 6 21 79 Amortization............... (32) (47) (81) ------- ------- ------- Balance at December 31,.... $ 483 $ 509 $ 535 ======= ======= ======= VODA and VOCRA Balance at January 1,...... $ 175 $ 190 $ 203 Amortization............... (16) (15) (13) ------- ------- ------- Balance at December 31,.... $ 159 $ 175 $ 190 ======= ======= ======= Accumulated amortization... $ 81 $ 65 $ 50 ======= ======= ======= The estimated future amortization expense to be reported in other expenses for the next five years is as follows: [Download Table] VOBA VODA and VOCRA -------------- -------------- (In millions) 2014.......................... $ 176 $ 17 2015.......................... $ 141 $ 17 2016.......................... $ 114 $ 15 2017.......................... $ 94 $ 14 2018.......................... $ 78 $ 13 6. Reinsurance The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth. 46
N-4270th Page of 530TOC1stPreviousNextBottomJust 270th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 7. Retail The Company's Retail Annuities business reinsures 100% of the living and death benefit guarantees issued in connection with most of its variable annuities issued since 2006 to an affiliated reinsurer and certain portions of the living and death benefit guarantees issued in connection with its variable annuities issued prior to 2006 to affiliated and unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The Company also reinsures 90% of its fixed annuities to an affiliated reinsurer. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. For its Retail Life & Other insurance products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently reinsures 100% of the mortality risk in excess of $100,000 per life for most new policies and reinsures up to 100% of the mortality risk for certain other policies. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. The Company also reinsures the risk associated with secondary death benefit guarantees on certain universal life insurance policies to affiliates. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time. Corporate Benefit Funding The Company's Corporate Benefit Funding segment has periodically engaged in reinsurance activities, on an opportunistic basis. The impact of these activities on the financial results of this segment has not been significant and there were no additional transactions during the periods presented. Corporate & Other The Company also reinsures, through 100% quota share reinsurance agreements, certain run-off LTC and workers' compensation business written by the Company. Catastrophe Coverage The Company has exposure to catastrophes, which could contribute to significant fluctuations in the Company's results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks. 47
N-4271st Page of 530TOC1stPreviousNextBottomJust 271st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) Reinsurance Recoverables The Company reinsures its business through a diversified group of well-capitalized reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at December 31, 2013 and 2012, were not significant. The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $2.0 billion and $2.2 billion of unsecured unaffiliated reinsurance recoverable balances at December 31, 2013 and 2012, respectively. At December 31, 2013, the Company had $7.5 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $6.7 billion, or 89%, were with the Company's five largest unaffiliated ceded reinsurers, including $1.2 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. At December 31, 2012, the Company had $7.2 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $6.5 billion, or 90%, were with the Company's five largest unaffiliated ceded reinsurers, including $1.4 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. 48
N-4272nd Page of 530TOC1stPreviousNextBottomJust 272nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) The amounts in the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2013 2012 2011 -------- -------- -------- (In millions) Premiums Direct premiums............................................... $ 1,561 $ 2,063 $ 2,429 Reinsurance assumed........................................... 10 11 7 Reinsurance ceded............................................. (965) (813) (608) -------- -------- -------- Net premiums................................................ $ 606 $ 1,261 $ 1,828 ======== ======== ======== Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees. $ 3,248 $ 2,972 $ 2,572 Reinsurance assumed........................................... 84 87 92 Reinsurance ceded............................................. (996) (798) (708) -------- -------- -------- Net universal life and investment-type product policy fees.. $ 2,336 $ 2,261 $ 1,956 ======== ======== ======== Other revenues Direct other revenues......................................... $ 259 $ 231 $ 209 Reinsurance assumed........................................... -- -- -- Reinsurance ceded............................................. 333 280 299 -------- -------- -------- Net other revenues.......................................... $ 592 $ 511 $ 508 ======== ======== ======== Policyholder benefits and claims Direct policyholder benefits and claims....................... $ 3,732 $ 4,139 $ 4,277 Reinsurance assumed........................................... 15 23 20 Reinsurance ceded............................................. (2,040) (1,773) (1,637) -------- -------- -------- Net policyholder benefits and claims........................ $ 1,707 $ 2,389 $ 2,660 ======== ======== ======== Interest credited to policyholder account balances Direct interest credited to policyholder account balances..... $ 1,089 $ 1,185 $ 1,206 Reinsurance assumed........................................... 73 71 68 Reinsurance ceded............................................. (125) (109) (85) -------- -------- -------- Net interest credited to policyholder account balances...... $ 1,037 $ 1,147 $ 1,189 ======== ======== ======== Other expenses Direct other expenses......................................... $ 1,568 $ 2,562 $ 2,781 Reinsurance assumed........................................... 28 33 48 Reinsurance ceded............................................. 63 125 152 -------- -------- -------- Net other expenses.......................................... $ 1,659 $ 2,720 $ 2,981 ======== ======== ======== 49
N-4273rd Page of 530TOC1stPreviousNextBottomJust 273rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) The amounts in the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: [Enlarge/Download Table] December 31, --------------------------------------------------------------------------------- 2013 2012 ---------------------------------------- ---------------------------------------- Total Total Balance Balance Direct Assumed Ceded Sheet Direct Assumed Ceded Sheet ---------- -------- --------- --------- ---------- -------- --------- --------- (In millions) Assets Premiums, reinsurance and other receivables........... $ 221 $ 28 $ 20,360 $ 20,609 $ 396 $ 35 $ 21,496 $ 21,927 Deferred policy acquisition costs and value of business acquired.................... 5,191 123 (584) 4,730 4,264 121 (639) 3,746 ---------- -------- --------- --------- ---------- -------- --------- --------- Total assets............... $ 5,412 $ 151 $ 19,776 $ 25,339 $ 4,660 $ 156 $ 20,857 $ 25,673 ========== ======== ========= ========= ========== ======== ========= ========= Liabilities Other policy-related balances.................... $ 712 $ 1,641 $ 811 $ 3,164 $ 691 $ 1,592 $ 855 $ 3,138 Other liabilities............ 1,257 10 5,509 6,776 1,396 11 5,140 6,547 ---------- -------- --------- --------- ---------- -------- --------- --------- Total liabilities.......... $ 1,969 $ 1,651 $ 6,320 $ 9,940 $ 2,087 $ 1,603 $ 5,995 $ 9,685 ========== ======== ========= ========= ========== ======== ========= ========= Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $4.6 billion and $4.7 billion at December 31, 2013 and 2012, respectively. There were no deposit liabilities on reinsurance at both December 31, 2013 and 2012. 50
N-4274th Page of 530TOC1stPreviousNextBottomJust 274th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) Related Party Reinsurance Transactions The Company has reinsurance agreements with certain MetLife subsidiaries, including MLIC, MetLife Reinsurance Company of South Carolina, Exeter, General American Life Insurance Company, MLIIC, MetLife Reinsurance Company of Vermont and MetLife Reinsurance Company of Delaware ("MRD"), all of which are related parties. Information regarding the significant effects of affiliated reinsurance included in the consolidated statements of operations was as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------- 2013 2012 2011 ------- ------- ------- (In millions) Premiums Reinsurance assumed.......................................... $ 10 $ 11 $ 7 Reinsurance ceded............................................ (638) (478) (286) ------- ------- ------- Net premiums............................................... $ (628) $ (467) $ (279) ======= ======= ======= Universal life and investment-type product policy fees Reinsurance assumed.......................................... $ 84 $ 87 $ 92 Reinsurance ceded............................................ (585) (444) (400) ------- ------- ------- Net universal life and investment-type product policy fees. $ (501) $ (357) $ (308) ======= ======= ======= Other revenues Reinsurance assumed.......................................... $ -- $ -- $ -- Reinsurance ceded............................................ 332 280 299 ------- ------- ------- Net other revenues......................................... $ 332 $ 280 $ 299 ======= ======= ======= Policyholder benefits and claims Reinsurance assumed.......................................... $ 13 $ 21 $ 18 Reinsurance ceded............................................ (800) (780) (484) ------- ------- ------- Net policyholder benefits and claims....................... $ (787) $ (759) $ (466) ======= ======= ======= Interest credited to policyholder account balances Reinsurance assumed.......................................... $ 73 $ 71 $ 68 Reinsurance ceded............................................ (125) (109) (84) ------- ------- ------- Net interest credited to policyholder account balances..... $ (52) $ (38) $ (16) ======= ======= ======= Other expenses Reinsurance assumed.......................................... $ 28 $ 33 $ 48 Reinsurance ceded............................................ 92 157 204 ------- ------- ------- Net other expenses......................................... $ 120 $ 190 $ 252 ======= ======= ======= 51
N-4275th Page of 530TOC1stPreviousNextBottomJust 275th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) Information regarding the significant effects of affiliated reinsurance included in the consolidated balance sheets was as follows at: [Enlarge/Download Table] December 31, -------------------------------------- 2013 2012 ------------------ ------------------ Assumed Ceded Assumed Ceded -------- --------- -------- --------- (In millions) Assets Premiums, reinsurance and other receivables............. $ 28 $ 12,710 $ 35 $ 14,171 Deferred policy acquisition costs and value of business acquired.............................................. 122 (579) 121 (642) -------- --------- -------- --------- Total assets........................................... $ 150 $ 12,131 $ 156 $ 13,529 ======== ========= ======== ========= Liabilities Other policy-related balances........................... $ 1,640 $ 811 $ 1,592 $ 855 Other liabilities....................................... 9 5,260 10 4,894 -------- --------- -------- --------- Total liabilities...................................... $ 1,649 $ 6,071 $ 1,602 $ 5,749 ======== ========= ======== ========= Effective October 1, 2012, MLI-USA entered into a reinsurance agreement to cede two blocks of business to MRD, on a 90% coinsurance with funds withheld basis. The agreement covers certain term and certain universal life policies issued in 2012 by MLI-USA and was amended in 2013 to include certain term and universal life policies issued by MLI-USA through December 31, 2013. The agreement transfers risk to MRD and, therefore, is accounted for as reinsurance. As a result of the agreement, affiliated reinsurance recoverables, included in premiums, reinsurance and other receivables, were $917 million and $407 million at December 31, 2013 and 2012, respectively. MLI-USA also recorded a funds withheld liability and other reinsurance payables, included in other liabilities, which were $798 million and $438 million at December 31, 2013 and 2012, respectively. Certain contractual features of this agreement qualify as embedded derivatives, which are separately accounted for at fair value on the Company's consolidated balance sheets. The embedded derivative related to the funds withheld associated with this reinsurance agreement is included within other liabilities and was ($14) million and $6 million at December 31, 2013 and 2012, respectively. The Company's consolidated statements of operations reflected a loss for this agreement of $50 million and $37 million for the years ended December 31, 2013 and 2012, respectively, which included net derivative gains (losses) of $20 million and ($6) million for the years ended December 31, 2013 and 2012, respectively, related to the embedded derivative. The Company ceded risks to affiliates related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in their fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were assets of $912 million and $3.6 billion at December 31, 2013 and 2012, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($3.0) billion, $524 million, and $1.6 billion for the years ended December 31, 2013, 2012 and 2011, respectively. MLI-USA ceded two blocks of business to an affiliate on a 90% coinsurance with funds withheld basis. Certain contractual features of this agreement qualify as embedded derivatives, which are separately accounted for at estimated fair value on the Company's consolidated balance sheets. The embedded derivative related to the 52
N-4276th Page of 530TOC1stPreviousNextBottomJust 276th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Reinsurance (continued) funds withheld associated with this reinsurance agreement is included within other liabilities and increased the funds withheld balance by $48 million and $546 million at December 31, 2013 and 2012, respectively. Net derivative gains (losses) associated with the embedded derivatives were $498 million, ($107) million and ($434) million for the years ended December 31, 2013, 2012 and 2011, respectively. The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $5.9 billion and $6.1 billion of unsecured affiliated reinsurance recoverable balances at December 31, 2013 and 2012, respectively. Affiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on affiliated reinsurance were $4.4 billion and $4.6 billion at December 31, 2013 and 2012, respectively. There were no deposit liabilities on affiliated reinsurance at both December 31, 2013 and 2012. 7. Investments See Note 9 for information about the fair value hierarchy for investments and the related valuation methodologies. Investment Risks and Uncertainties Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the consolidated financial statements. The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available. The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, asset-backed securities ("ABS") and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned. 53
N-4277th Page of 530TOC1stPreviousNextBottomJust 277th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Fixed Maturity and Equity Securities AFS Fixed Maturity and Equity Securities AFS by Sector The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, ABS and commercial mortgage-backed securities ("CMBS"). [Enlarge/Download Table] December 31, 2013 December 31, 2012 --------------------------------------------- --------------------------------------------- Gross Unrealized Gross Unrealized Cost or ------------------------- Estimated Cost or ------------------------- Estimated Amortized Temporary OTTI Fair Amortized Temporary OTTI Fair Cost Gains Losses Losses Value Cost Gains Losses Losses Value --------- -------- --------- ------ --------- --------- -------- --------- ------ --------- (In millions) Fixed maturity securities U.S. corporate.................. $ 15,779 $ 1,130 $ 207 $ -- $ 16,702 $ 16,914 $ 2,063 $ 82 $ -- $ 18,895 Foreign corporate............... 8,111 485 79 -- 8,517 8,618 853 26 -- 9,445 U.S. Treasury and agency........ 8,188 334 228 -- 8,294 7,678 1,186 -- -- 8,864 RMBS............................ 4,587 201 59 41 4,688 5,492 360 50 64 5,738 State and political subdivision. 2,147 139 62 -- 2,224 2,002 354 27 -- 2,329 ABS............................. 2,081 32 12 -- 2,101 2,204 67 18 -- 2,253 CMBS............................ 1,546 62 4 -- 1,604 2,221 141 6 -- 2,356 Foreign government.............. 1,038 103 19 -- 1,122 876 214 2 -- 1,088 --------- -------- --------- ----- --------- --------- -------- --------- ----- --------- Total fixed maturity securities.................... $ 43,477 $ 2,486 $ 670 $ 41 $ 45,252 $ 46,005 $ 5,238 $ 211 $ 64 $ 50,968 ========= ======== ========= ===== ========= ========= ======== ========= ===== ========= Equity securities Non-redeemable preferred stock.......................... $ 236 $ 9 $ 28 $ -- $ 217 $ 151 $ 11 $ 22 $ -- $ 140 Common stock.................... 161 40 -- -- 201 160 18 1 -- 177 --------- -------- --------- ----- --------- --------- -------- --------- ----- --------- Total equity securities........ $ 397 $ 49 $ 28 $ -- $ 418 $ 311 $ 29 $ 23 $ -- $ 317 ========= ======== ========= ===== ========= ========= ======== ========= ===== ========= The Company held non-income producing fixed maturity securities with an estimated fair value of $30 million and $22 million with unrealized gains (losses) of $6 million and $3 million at December 31, 2013 and 2012, respectively. Methodology for Amortization of Premium and Accretion of Discount on Structured Securities Amortization of premium and accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management's knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis. 54
N-4278th Page of 530TOC1stPreviousNextBottomJust 278th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Maturities of Fixed Maturity Securities The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at: [Download Table] December 31, --------------------------------------- 2013 2012 ------------------- ------------------- Estimated Estimated Amortized Fair Amortized Fair Cost Value Cost Value --------- --------- --------- --------- (In millions) Due in one year or less.................... $ 2,934 $ 2,966 $ 4,831 $ 4,875 Due after one year through five years...... 8,895 9,301 8,646 9,192 Due after five years through ten years..... 7,433 7,970 7,967 8,960 Due after ten years........................ 16,001 16,622 14,644 17,594 --------- --------- --------- --------- Subtotal................................ 35,263 36,859 36,088 40,621 Structured securities (RMBS, ABS and CMBS). 8,214 8,393 9,917 10,347 --------- --------- --------- --------- Total fixed maturity securities..... $ 43,477 $ 45,252 $ 46,005 $ 50,968 ========= ========= ========= ========= Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. RMBS, ABS and CMBS are shown separately, as they are not due at a single maturity. 55
N-4279th Page of 530TOC1stPreviousNextBottomJust 279th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position. [Enlarge/Download Table] December 31, 2013 December 31, 2012 ----------------------------------------- ----------------------------------------- Equal to or Greater Equal to or Greater Less than 12 Months than 12 Months Less than 12 Months than 12 Months -------------------- -------------------- -------------------- -------------------- Estimated Gross Estimated Gross Estimated Gross Estimated Gross Fair Unrealized Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Value Losses --------- ---------- --------- ---------- --------- ---------- --------- ---------- (In millions, except number of securities) Fixed maturity securities U.S. corporate................... $ 2,526 $ 141 $ 470 $ 66 $ 784 $ 16 $ 621 $ 66 Foreign corporate................ 1,520 70 135 9 494 8 203 18 U.S. Treasury and agency......... 3,825 228 -- -- 200 -- -- -- RMBS............................. 996 35 457 65 62 6 781 108 State and political subdivision.. 630 44 64 18 44 2 55 25 ABS.............................. 680 5 104 7 208 1 266 17 CMBS............................. 143 4 7 -- 59 1 101 5 Foreign government............... 264 19 1 -- 116 2 -- -- --------- ------- -------- ------ -------- ------ -------- ------ Total fixed maturity securities.................... $ 10,584 $ 546 $ 1,238 $ 165 $ 1,967 $ 36 $ 2,027 $ 239 ========= ======= ======== ====== ======== ====== ======== ====== Equity securities Non-redeemable preferred stock........................... $ 105 $ 21 $ 33 $ 7 $ -- $ -- $ 50 $ 22 Common stock..................... 3 -- 7 -- 10 1 7 -- --------- ------- -------- ------ -------- ------ -------- ------ Total equity securities........ $ 108 $ 21 $ 40 $ 7 $ 10 $ 1 $ 57 $ 22 ========= ======= ======== ====== ======== ====== ======== ====== Total number of securities in an unrealized loss position........ 1,081 297 327 420 ========= ======== ======== ======== Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities Evaluation and Measurement Methodologies Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted 56
N-4280th Page of 530TOC1stPreviousNextBottomJust 280th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: . The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment. . When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management's best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. . Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security. . When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities. With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security's cost and its estimated fair value with a corresponding charge to earnings. 57
N-4281st Page of 530TOC1stPreviousNextBottomJust 281st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value. In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows. Current Period Evaluation Based on the Company's current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company's current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company has concluded that these securities are not other-than-temporarily impaired at December 31, 2013. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods. Gross unrealized losses on fixed maturity securities increased $436 million during the year ended December 31, 2013 from $275 million to $711 million. The increase in gross unrealized losses for the year ended December 31, 2013, was primarily attributable to an increase in interest rates, partially offset by narrowing credit spreads. At December 31, 2013, $61 million of the total $711 million of gross unrealized losses were from 18 fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater. Investment Grade Fixed Maturity Securities Of the $61 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $41 million, or 67%, are related to gross unrealized losses on 13 investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads, and with respect to fixed-rate fixed maturity securities, rising interest rates since purchase. Below Investment Grade Fixed Maturity Securities Of the $61 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $20 million, or 33%, are related to gross unrealized losses on five below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to non-agency RMBS (primarily alternative residential mortgage loans) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over unemployment levels and valuations of residential real estate supporting non-agency RMBS. Management evaluates non-agency RMBS 58
N-4282nd Page of 530TOC1stPreviousNextBottomJust 282nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) based on actual and projected cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security. Equity Securities Gross unrealized losses on equity securities increased $5 million during the year ended December 31, 2013 from $23 million to $28 million. Of the $28 million, $5 million were from two equity securities with gross unrealized losses of 20% or more of cost for 12 months or greater, all of which were financial services industry investment grade non-redeemable preferred stock, of which 40% were rated A or better. Mortgage Loans Mortgage Loans by Portfolio Segment Mortgage loans are summarized as follows at: [Enlarge/Download Table] December 31, -------------------------------------------- 2013 2012 --------------------- ---------------------- Carrying % of Carrying % of Value Total Value Total ------------- ------- ------------- -------- (In millions) (In millions) Mortgage loans: Commercial.................................... $ 4,869 63.1% $ 5,266 57.5% Agricultural.................................. 1,285 16.6 1,260 13.8 -------- ------- -------- -------- Subtotal (1)................................ 6,154 79.7 6,526 71.3 Valuation allowances.......................... (34) (0.4) (35) (0.4) -------- ------- -------- -------- Subtotal mortgage loans, net................ 6,120 79.3 6,491 70.9 Commercial mortgage loans held by CSEs -- FVO. 1,598 20.7 2,666 29.1 -------- ------- -------- -------- Total mortgage loans, net................. $ 7,718 100.0% $ 9,157 100.0% ======== ======= ======== ======== -------- (1)Purchases of mortgage loans were $10 million and $27 million for the years ended December 31, 2013 and 2012, respectively. See "-- Variable Interest Entities" for discussion of CSEs. See "-- Related Party Investment Transactions" for discussion of related party mortgage loans. 59
N-4283rd Page of 530TOC1stPreviousNextBottomJust 283rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Mortgage Loans and Valuation Allowance by Portfolio Segment The carrying value prior to valuation allowance ("recorded investment") in mortgage loans, by portfolio segment, by method of evaluation of credit loss, and the related valuation allowances, by type of credit loss, were as follows at: [Enlarge/Download Table] December 31, --------------------------------------------------------------- 2013 2012 ------------------------------- ------------------------------- Commercial Agricultural Total Commercial Agricultural Total ---------- ------------ ------- ---------- ------------ ------- (In millions) Mortgage loans: Evaluated individually for credit losses.. $ 72 $ 4 $ 76 $ 76 $ -- $ 76 Evaluated collectively for credit losses.. 4,797 1,281 6,078 5,190 1,260 6,450 ------- ------- ------- ------- ------- ------- Total mortgage loans.................... 4,869 1,285 6,154 5,266 1,260 6,526 ------- ------- ------- ------- ------- ------- Valuation allowances: Specific credit losses.................... 7 -- 7 11 -- 11 Non-specifically identified credit losses. 23 4 27 21 3 24 ------- ------- ------- ------- ------- ------- Total valuation allowances.............. 30 4 34 32 3 35 ------- ------- ------- ------- ------- ------- Mortgage loans, net of valuation allowance........................... $ 4,839 $ 1,281 $ 6,120 $ 5,234 $ 1,257 $ 6,491 ======= ======= ======= ======= ======= ======= Valuation Allowance Rollforward by Portfolio Segment The changes in the valuation allowance, by portfolio segment, were as follows: [Download Table] Commercial Agricultural Total ---------- ------------ ------- (In millions) Balance at January 1, 2011..... $ 84 $ 3 $ 87 Provision (release)............ (26) -- (26) Charge-offs, net of recoveries. -- -- -- ------- ------ ------- Balance at December 31, 2011... 58 3 61 Provision (release)............ (26) -- (26) Charge-offs, net of recoveries. -- -- -- ------- ------ ------- Balance at December 31, 2012... 32 3 35 Provision (release)............ (2) 1 (1) Charge-offs, net of recoveries. -- -- -- ------- ------ ------- Balance at December 31, 2013... $ 30 $ 4 $ 34 ======= ====== ======= Valuation Allowance Methodology Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying 60
N-4284th Page of 530TOC1stPreviousNextBottomJust 284th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) value of a loan over either (i) the present value of expected future cash flows discounted at the loan's original effective interest rate, (ii) the estimated fair value of the loan's underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan's observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company's experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available. Commercial and Agricultural Mortgage Loan Portfolio Segments The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans. All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio. For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property's net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated annually, on a rolling basis, with a portion of the loan portfolio updated each quarter. 61
N-4285th Page of 530TOC1stPreviousNextBottomJust 285th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) For agricultural mortgage loans, the Company's primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated. Credit Quality of Commercial Mortgage Loans The credit quality of commercial mortgage loans, were as follows at: [Enlarge/Download Table] Recorded Investment ---------------------------------------------- Debt Service Coverage Ratios ------------------------------ % of Estimated % of > 1.20x 1.00x - 1.20x < 1.00x Total Total Fair Value Total -------- ------------- ------- -------- ------ ------------- ------ (In millions) (In millions) December 31, 2013: Loan-to-value ratios: Less than 65%......... $ 3,754 $ 125 $ 107 $ 3,986 81.9% $ 4,224 82.8% 65% to 75%............ 700 -- 27 727 14.9 736 14.4 76% to 80%............ 80 13 -- 93 1.9 93 1.8 Greater than 80%...... 37 26 -- 63 1.3 53 1.0 -------- ------ ------ -------- ------ -------- ------ Total................ $ 4,571 $ 164 $ 134 $ 4,869 100.0% $ 5,106 100.0% ======== ====== ====== ======== ====== ======== ====== December 31, 2012: Loan-to-value ratios: Less than 65%......... $ 3,888 $ 106 $ 89 $ 4,083 77.5% $ 4,459 78.5% 65% to 75%............ 626 32 27 685 13.0 711 12.5 76% to 80%............ 343 8 57 408 7.8 428 7.6 Greater than 80%...... 39 28 23 90 1.7 81 1.4 -------- ------ ------ -------- ------ -------- ------ Total................ $ 4,896 $ 174 $ 196 $ 5,266 100.0% $ 5,679 100.0% ======== ====== ====== ======== ====== ======== ====== Credit Quality of Agricultural Mortgage Loans The credit quality of agricultural mortgage loans, were as follows at: [Download Table] December 31, --------------------------------------------- 2013 2012 ---------------------- ---------------------- Recorded % of Recorded % of Investment Total Investment Total ------------- -------- ------------- -------- (In millions) (In millions) Loan-to-value ratios: Less than 65%......... $ 1,215 94.6% $ 1,184 94.0% 65% to 75%............ 70 5.4 76 6.0 -------- -------- -------- -------- Total................ $ 1,285 100.0% $ 1,260 100.0% ======== ======== ======== ======== The estimated fair value of agricultural mortgage loans was $1.3 billion at both December 31, 2013 and 2012. 62
N-4286th Page of 530TOC1stPreviousNextBottomJust 286th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Past Due and Interest Accrual Status of Mortgage Loans The Company has a high quality, well performing, mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both December 31, 2013 and 2012. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans -- 60 days and agricultural mortgage loans -- 90 days. The Company had no agricultural mortgage loans past due and one commercial mortgage loan in non-accrual status with a recorded investment of $22 million at December 31, 2013. The Company had no mortgage loans past due and no loans in nonaccrual status at December 31, 2012. Impaired Mortgage Loans Impaired mortgage loans, including those modified in a troubled debt restructuring, by portfolio segment, were as follows at and for the years ended: [Enlarge/Download Table] Loans without Loans with a Valuation Allowance a Valuation Allowance All Impaired Loans ---------------------------------------- -------------------- -------------------------------------- Unpaid Unpaid Unpaid Average Principal Recorded Valuation Carrying Principal Recorded Principal Carrying Recorded Interest Balance Investment Allowances Value Balance Investment Balance Value Investment Income --------- ---------- ---------- -------- --------- ---------- --------- -------- ---------- -------- (In millions) December 31, 2013: Commercial....... $ 22 $ 22 $ 7 $ 15 $ 52 $ 50 $ 74 $ 65 $ 73 $ 3 Agricultural (1). 4 4 -- 4 -- -- 4 4 2 -- ------ -------- -------- ------- ------- ------- ------ ------ ------- ----- Total.......... $ 26 $ 26 $ 7 $ 19 $ 52 $ 50 $ 78 $ 69 $ 75 $ 3 ====== ======== ======== ======= ======= ======= ====== ====== ======= ===== December 31, 2012: Commercial....... $ 76 $ 76 $ 11 $ 65 $ -- $ -- $ 76 $ 65 $ 67 $ 2 Agricultural..... -- -- -- -- -- -- -- -- -- -- ------ -------- -------- ------- ------- ------- ------ ------ ------- ----- Total.......... $ 76 $ 76 $ 11 $ 65 $ -- $ -- $ 76 $ 65 $ 67 $ 2 ====== ======== ======== ======= ======= ======= ====== ====== ======= ===== -------- (1)Valuation allowance on agricultural mortgage loans was less than $1 million for the year ended December 31, 2013. Unpaid principal balance is generally prior to any charge-offs. Interest income recognized is primarily cash basis income. The average recorded investment for commercial and agricultural mortgage loans was $29 million and $4 million, respectively, for the year ended December 31, 2011; and interest income recognized for commercial and agricultural mortgage loans was $2 million and $0, respectively, for the year ended December 31, 2011. Mortgage Loans Modified in a Troubled Debt Restructuring For a small portion of the mortgage loan portfolio, classified as troubled debt restructurings, concessions are granted related to borrowers experiencing financial difficulties. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance recorded 63
N-4287th Page of 530TOC1stPreviousNextBottomJust 287th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) with the restructuring. Through the continuous monitoring process, a specific valuation allowance may have been recorded prior to the quarter when the mortgage loan is modified in a troubled debt restructuring. Accordingly, the carrying value (after specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. The Company had one agricultural mortgage loan modified in a troubled debt restructuring with a pre-modification and post-modification carrying value of $4 million during the year ended December 31, 2013. There were no agricultural mortgage loans modified in a troubled debt restructuring during the year ended December 31, 2012. There were no commercial mortgage loans modified in a troubled debt restructuring during the year ended December 31, 2013. The Company had one commercial mortgage loan modified during the year ended December 31, 2012 in a troubled debt restructuring which had a carrying value after specific valuation allowance of $53 million pre-modification and $48 million post-modification. There were no mortgage loans during the previous 12 months modified in a troubled debt restructuring with a subsequent payment default at December 31, 2013 and 2012. Payment default is determined in the same manner as delinquency status as described above. Other Invested Assets Other invested assets is comprised primarily of freestanding derivatives with positive estimated fair values (see Note 8), loans to affiliates (see "-- Related Party Investment Transactions), tax credit and renewable energy partnerships and leveraged leases. Leveraged Leases Investment in leveraged leases consisted of the following at: [Enlarge/Download Table] December 31, ------------------- 2013 2012 --------- --------- (In millions) Rental receivables, net............................................. $ 92 $ 92 Estimated residual values........................................... 14 14 --------- --------- Subtotal......................................................... 106 106 Unearned income..................................................... (35) (37) --------- --------- Investment in leveraged leases, net of non-recourse debt..... $ 71 $ 69 ========= ========= Rental receivables are generally due in periodic installments. The payment periods range from two to 19 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due. At December 31, 2013 and 2012, all rental receivables were performing. The deferred income tax liability related to leveraged leases was $63 million and $53 million at December 31, 2013 and 2012, respectively. 64
N-4288th Page of 530TOC1stPreviousNextBottomJust 288th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) The components of income from investment in leveraged leases, excluding net investment gains (losses), were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2013 2012 2011 -------- -------- -------- (In millions) Income from investment in leveraged leases...................... $ 2 $ 5 $ 8 Less: Income tax expense on leveraged leases.................... 1 2 3 -------- -------- -------- Investment income after income tax from investment in leveraged leases........................................................ $ 1 $ 3 $ 5 ======== ======== ======== Cash Equivalents The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $469 million and $654 million at December 31, 2013 and 2012, respectively. Net Unrealized Investment Gains (Losses) The components of net unrealized investment gains (losses), included in AOCI, were as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2013 2012 2011 -------- -------- ---------- (In millions) Fixed maturity securities.............................................. $ 1,819 $ 5,019 $ 3,690 Fixed maturity securities with noncredit OTTI losses in AOCI........... (41) (64) (125) -------- -------- ---------- Total fixed maturity securities....................................... 1,778 4,955 3,565 Equity securities...................................................... 15 12 (41) Derivatives............................................................ 39 243 239 Short-term investments................................................. 1 (2) (2) Other.................................................................. (71) (17) (5) -------- -------- ---------- Subtotal.............................................................. 1,762 5,191 3,756 -------- -------- ---------- Amounts allocated from: Insurance liability loss recognition.................................. -- (739) (325) DAC and VOBA related to noncredit OTTI losses recognized in AOCI................................................................ (1) 4 9 DAC and VOBA.......................................................... (274) (671) (509) -------- -------- ---------- Subtotal............................................................ (275) (1,406) (825) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI................................................... 16 22 42 Deferred income tax benefit (expense).................................. (591) (1,358) (1,063) -------- -------- ---------- Net unrealized investment gains (losses)............................... $ 912 $ 2,449 $ 1,910 ======== ======== ========== 65
N-4289th Page of 530TOC1stPreviousNextBottomJust 289th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2013 2012 ------------- -------------- (In millions) Balance at January 1,....................................... $ (64) $ (125) Noncredit OTTI losses and subsequent changes recognized (1). 11 (3) Securities sold with previous noncredit OTTI loss........... 21 35 Subsequent changes in estimated fair value.................. (9) 29 ------------- -------------- Balance at December 31,..................................... $ (41) $ (64) ============= ============== -------- (1)Noncredit OTTI losses and subsequent changes recognized, net of DAC, were $7 million and $5 million for the years ended December 31, 2013 and 2012, respectively. The changes in net unrealized investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------------ 2013 2012 2011 ---------- ---------- -------- (In millions) Balance at January 1,.............................................. $ 2,449 $ 1,910 $ 342 Fixed maturity securities on which noncredit OTTI losses have been recognized....................................................... 23 61 (39) Unrealized investment gains (losses) during the year............... (3,452) 1,374 3,138 Unrealized investment gains (losses) relating to: Insurance liability gain (loss) recognition....................... 739 (414) (292) DAC and VOBA related to noncredit OTTI losses recognized in AOCI............................................................ (5) (5) 4 DAC and VOBA...................................................... 397 (162) (390) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI....................................... (6) (20) 12 Deferred income tax benefit (expense)............................. 767 (295) (865) ---------- ---------- -------- Balance at December 31,............................................ $ 912 $ 2,449 $ 1,910 ========== ========== ======== Change in net unrealized investment gains (losses)................. $ (1,537) $ 539 $ 1,568 ========== ========== ======== Concentrations of Credit Risk There were no investments in any counterparty that were greater than 10% of the Company's stockholders' equity, other than the U.S. government and its agencies, at both December 31, 2013 and 2012. 66
N-4290th Page of 530TOC1stPreviousNextBottomJust 290th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Securities Lending Elements of the securities lending program are presented below at: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) Securities on loan: (1) Amortized cost........................................ $ 5,931 $ 6,154 Estimated fair value.................................. $ 5,984 $ 7,339 Cash collateral on deposit from counterparties (2)..... $ 6,140 $ 7,502 Security collateral on deposit from counterparties (3). $ -- $ 51 Reinvestment portfolio -- estimated fair value......... $ 6,145 $ 7,533 -------- (1)Included within fixed maturity securities, short-term investments, cash and cash equivalents and equity securities. (2)Included within payables for collateral under securities loaned and other transactions. (3)Security collateral on deposit from counterparties may not be sold or repledged, unless the counterparty is in default, and is not reflected in the consolidated financial statements. Invested Assets on Deposit and Pledged as Collateral Invested assets on deposit and pledged as collateral are presented below at estimated fair value for cash and cash equivalents, short-term investments and fixed maturity securities and at carrying value for mortgage loans at: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) Invested assets on deposit (regulatory deposits) (1)........ $ 56 $ 58 Invested assets pledged as collateral (2)................... 1,901 1,569 ---------- ---------- Total invested assets on deposit and pledged as collateral. $ 1,957 $ 1,627 ========== ========== -------- (1)See Note 1 for information about invested assets that became restricted under the MetLife Insurance Company of Connecticut plan to withdraw its New York license on January 1, 2014. (2)The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 4) and derivative transactions (see Note 8). See "-- Securities Lending" for securities on loan. Purchased Credit Impaired Investments Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments 67
N-4291st Page of 530TOC1stPreviousNextBottomJust 291st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) are classified as purchased credit impaired ("PCI") investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI. The Company's PCI fixed maturity securities were as follows at: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) Outstanding principal and interest balance (1). $ 648 $ 560 Carrying value (2)............................. $ 498 $ 459 -------- (1)Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest. (2)Estimated fair value plus accrued interest. The following table presents information about PCI fixed maturity securities acquired during the periods indicated: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) Contractually required payments (including interest). $ 238 $ 172 Cash flows expected to be collected (1).............. $ 183 $ 88 Fair value of investments acquired................... $ 128 $ 55 -------- (1)Represents undiscounted principal and interest cash flow expectations, at the date of acquisition. The following table presents activity for the accretable yield on PCI fixed maturity securities for: [Download Table] December 31, --------------------- 2013 2012 ---------- ---------- (In millions) Accretable yield, January 1,........................ $ 309 $ 320 Investments purchased............................... 55 33 Accretion recognized in earnings.................... (24) (18) Disposals........................................... (8) (4) Reclassification (to) from nonaccretable difference. (24) (22) ---------- ---------- Accretable yield, December 31,...................... $ 308 $ 309 ========== ========== 68
N-4292nd Page of 530TOC1stPreviousNextBottomJust 292nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Collectively Significant Equity Method Investments The Company holds investments in real estate joint ventures, real estate funds and other limited partnership interests consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $2.6 billion at December 31, 2013. The Company's maximum exposure to loss related to these equity method investments is limited to the carrying value of these investments plus unfunded commitments of $862 million at December 31, 2013. Except for certain real estate joint ventures, the Company's investments in real estate funds and other limited partnership interests are generally of a passive nature in that the Company does not participate in the management of the entities. As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company's consolidated pre-tax income (loss) from continuing operations. This aggregated summarized financial data does not represent the Company's proportionate share of the assets, liabilities, or earnings of such entities. The aggregated summarized financial data presented below reflects the latest available financial information and is as of, and for, the years ended December 31, 2013, 2012 and 2011. Aggregate total assets of these entities totaled $217.3 billion and $178.3 billion at December 31, 2013 and 2012, respectively. Aggregate total liabilities of these entities totaled $16.3 billion and $12.4 billion at December 31, 2013 and 2012, respectively. Aggregate net income (loss) of these entities totaled $20.9 billion, $13.1 billion and $7.1 billion for the years ended December 31, 2013, 2012 and 2011, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses). Variable Interest Entities The Company has invested in certain structured transactions that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE's primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party's relationship with or involvement in the entity, an estimate of the entity's expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE's expected losses, receive a majority of a VIE's expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the consolidated financial statements. 69
N-4293rd Page of 530TOC1stPreviousNextBottomJust 293rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Consolidated VIEs The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2013 and 2012. Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company's obligation to the VIEs is limited to the amount of its committed investment. [Download Table] December 31, ----------------- 2013 2012 -------- -------- (In millions) CSEs: (1) Assets: Mortgage loans (commercial mortgage loans). $ 1,598 $ 2,666 Accrued investment income.................. 9 13 -------- -------- Total assets............................. $ 1,607 $ 2,679 ======== ======== Liabilities: Long-term debt............................. $ 1,461 $ 2,559 Other liabilities.......................... 7 13 -------- -------- Total liabilities........................ $ 1,468 $ 2,572 ======== ======== -------- (1)The Company consolidates entities that are structured as CMBS. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company's exposure was limited to that of its remaining investment in these entities of $120 million and $92 million at estimated fair value at December 31, 2013 and 2012, respectively. The long-term debt bears interest primarily at fixed rates ranging from 2.25% to 5.57%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was $122 million, $163 million and $322 million for the years ended December 31, 2013, 2012 and 2011, respectively. 70
N-4294th Page of 530TOC1stPreviousNextBottomJust 294th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Unconsolidated VIEs The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at: [Enlarge/Download Table] December 31, ------------------------------------------- 2013 2012 --------------------- --------------------- Maximum Maximum Carrying Exposure Carrying Exposure Amount to Loss (1) Amount to Loss (1) --------- ----------- --------- ----------- (In millions) Fixed maturity securities AFS: Structured securities (RMBS, ABS and CMBS) (2). $ 8,393 $ 8,393 $ 10,347 $ 10,347 U.S. and foreign corporate..................... 468 468 651 651 Other limited partnership interests............. 1,651 2,077 1,408 1,930 Real estate joint ventures...................... 41 45 71 74 Other invested assets........................... 9 44 -- -- --------- --------- --------- --------- Total.......................................... $ 10,562 $ 11,027 $ 12,477 $ 13,002 ========= ========= ========= ========= -------- (1)The maximum exposure to loss relating to fixed maturity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments of the Company. For its investments in other invested assets, the Company's return is in the form of income tax credits. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitment. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee. (2)For these variable interests, the Company's involvement is limited to that of a passive investor. As described in Note 15, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2013, 2012 and 2011. 71
N-4295th Page of 530TOC1stPreviousNextBottomJust 295th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Net Investment Income The components of net investment income were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------ ------ ------ (In millions) Investment income: Fixed maturity securities.............................................. $2,102 $2,143 $2,147 Equity securities...................................................... 12 9 10 Mortgage loans......................................................... 344 357 347 Policy loans........................................................... 55 59 63 Real estate and real estate joint ventures............................. 56 83 24 Other limited partnership interests.................................... 266 167 176 Cash, cash equivalents and short-term investments...................... 4 5 5 International joint ventures........................................... (5) (2) (5) Other.................................................................. -- (2) 4 ------ ------ ------ Subtotal............................................................. 2,834 2,819 2,771 Less: Investment expenses.............................................. 114 101 100 ------ ------ ------ Subtotal, net........................................................ 2,720 2,718 2,671 ------ ------ ------ FVO securities--FVO contractholder-directed unit-linked investments (1). -- 62 71 FVO CSEs--interest income--commercial mortgage loans................... 132 172 332 ------ ------ ------ Subtotal............................................................. 132 234 403 ------ ------ ------ Net investment income.............................................. $2,852 $2,952 $3,074 ====== ====== ====== -------- (1)There were no changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective years included in net investment income for both the years ended December 31, 2013 and 2012. Changes in estimated fair value subsequent to purchase for securities included in net investment income were ($11) million for the year ended December 31, 2011. See "-- Variable Interest Entities" for discussion of CSEs. See "-- Related Party Investment Transactions" for discussion of affiliated net investment income and investment expenses. 72
N-4296th Page of 530TOC1stPreviousNextBottomJust 296th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Net Investment Gains (Losses) Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2013 2012 2011 ------ ------- ------ (In millions) Total gains (losses) on fixed maturity securities: Total OTTI losses recognized -- by sector and industry: U.S. and foreign corporate securities -- by industry: Transportation........................................................ $ (3) $ (16) $ -- Finance............................................................... (3) (7) (9) Utility............................................................... -- (3) -- Communications........................................................ -- (2) (11) Industrial............................................................ -- (1) (2) ------ ------- ------ Total U.S. and foreign corporate securities......................... (6) (29) (22) RMBS.................................................................... (14) (20) (17) ABS..................................................................... -- -- (5) CMBS.................................................................... -- -- (3) ------ ------- ------ OTTI losses on fixed maturity securities recognized in earnings........... (20) (49) (47) Fixed maturity securities -- net gains (losses) on sales and disposals.... 58 145 81 ------ ------- ------ Total gains (losses) on fixed maturity securities.................. 38 96 34 ------ ------- ------ Total gains (losses) on equity securities: Total OTTI losses recognized -- by sector: Non-redeemable preferred stock.......................................... (3) -- (6) Common stock............................................................ (2) (9) (2) ------ ------- ------ OTTI losses on equity securities recognized in earnings................... (5) (9) (8) Equity securities -- net gains (losses) on sales and disposals............ 10 5 (13) ------ ------- ------ Total gains (losses) on equity securities.......................... 5 (4) (21) ------ ------- ------ Mortgage loans............................................................ 5 27 26 Real estate and real estate joint ventures................................ 2 (3) (1) Other limited partnership interests....................................... (6) (2) (5) Other investment portfolio gains (losses)................................. 8 4 (9) ------ ------- ------ Subtotal -- investment portfolio gains (losses).................... 52 118 24 ------ ------- ------ FVO CSEs: Commercial mortgage loans................................................. (56) 7 (84) Long-term debt -- related to commercial mortgage loans.................... 88 27 93 Non-investment portfolio gains (losses).................................... (2) -- 2 ------ ------- ------ Subtotal FVO CSEs and non-investment portfolio gains (losses)...... 30 34 11 ------ ------- ------ Total net investment gains (losses).............................. $ 82 $ 152 $ 35 ====== ======= ====== See "-- Variable Interest Entities" for discussion of CSEs. 73
N-4297th Page of 530TOC1stPreviousNextBottomJust 297th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) See "-- Related Party Investment Transactions" for discussion of affiliated net investment gains (losses) related to transfers of invested assets to affiliates. Gains (losses) from foreign currency transactions included within net investment gains (losses) was less than $1 million, $2 million and ($7) million for the years ended December 31, 2013, 2012 and 2011, respectively. Sales or Disposals and Impairments of Fixed Maturity and Equity Securities Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis. [Enlarge/Download Table] Years Ended December 31, ------------------------------------------------------------------------- 2013 2012 2011 2013 2012 2011 2013 2012 2011 -------- ------- -------- ------- ------ ------ -------- ------- -------- Fixed Maturity Securities Equity Securities Total ------------------------- --------------------- ------------------------- (In millions) Proceeds.................... $ 11,051 $ 6,690 $ 11,634 $ 75 $ 39 $ 190 $ 11,126 $ 6,729 $ 11,824 ======== ======= ======== ======= ====== ====== ======== ======= ======== Gross investment gains...... $ 189 $ 186 $ 182 $ 19 $ 9 $ 9 $ 208 $ 195 $ 191 -------- ------- -------- ------- ------ ------ -------- ------- -------- Gross investment losses..... (131) (41) (101) (9) (4) (22) (140) (45) (123) -------- ------- -------- ------- ------ ------ -------- ------- -------- Total OTTI losses: Credit-related............ (17) (42) (38) -- -- -- (17) (42) (38) Other (1)................. (3) (7) (9) (5) (9) (8) (8) (16) (17) -------- ------- -------- ------- ------ ------ -------- ------- -------- Total OTTI losses........ (20) (49) (47) (5) (9) (8) (25) (58) (55) -------- ------- -------- ------- ------ ------ -------- ------- -------- Net investment gains (losses)............... $ 38 $ 96 $ 34 $ 5 $ (4) $ (21) $ 43 $ 92 $ 13 ======== ======= ======== ======= ====== ====== ======== ======= ======== -------- (1)Other OTTI losses recognized in earnings include impairments on (i) equity securities, (ii) perpetual hybrid securities classified within fixed maturity securities where the primary reason for the impairment was the severity and/or the duration of an unrealized loss position and (iii) fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value. 74
N-4298th Page of 530TOC1stPreviousNextBottomJust 298th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) Credit Loss Rollforward The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI: [Enlarge/Download Table] Years Ended December 31, --------------------------- 2013 2012 ------------- ------------- (In millions) Balance at January 1,........................................... $ 59 $ 55 Additions: Initial impairments -- credit loss OTTI recognized on securities not previously impaired........................... 1 6 Additional impairments -- credit loss OTTI recognized on securities previously impaired............................... 12 15 Reductions: Sales (maturities, pay downs or prepayments) during the period of securities previously impaired as credit loss OTTI........ (15) (17) ------------- ------------- Balance at December 31,......................................... $ 57 $ 59 ============= ============= Related Party Investment Transactions The Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. Invested assets transferred to and from affiliates were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 -------- ------- ------- (In millions) Estimated fair value of invested assets transferred to affiliates... $ 874 $ -- $ -- Amortized cost of invested assets transferred to affiliates......... $ 827 $ -- $ -- Net investment gains (losses) recognized on transfers............... $ 47 $ -- $ -- Estimated fair value of invested assets transferred from affiliates. $ 834 $ -- $ 33 Included within the transfers to affiliates in 2013 and transfers from affiliates in 2013 was $739 million and $751 million, respectively, related to the establishment of a custodial account to secure certain policyholder liabilities. See Note 1. The Company has affiliated loans outstanding to wholly-owned real estate subsidiaries of an affiliate, MLIC, which are included in mortgage loans, with a carrying value of $364 million and $306 million at December 31, 2013 and 2012, respectively. Two loans issued in 2013 totaling $60 million bear interest at one-month LIBOR + 4.50% with quarterly interest only payments of less than $1 million through January 2017, when the principal balance is due. A loan with a carrying value of $110 million, at both December 31, 2013 and 2012, bears interest at one-month LIBOR + 1.95% with quarterly interest only payments of $1 million through January 2015, when the principal balance is due. A loan with a carrying value of $134 million and $136 million at December 31, 2013 and 2012, respectively, bears interest at 7.26% due in quarterly principal and interest payments of $3 million through January 2020, when the principal balance is due. A loan with a carrying value of $60 million, at both December 31, 2013 and 2012, bears interest at 7.01% with quarterly interest only payments of $1 million through January 2020, when the principal balance is due. These affiliated loans are secured by interests in the real estate 75
N-4299th Page of 530TOC1stPreviousNextBottomJust 299th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Investments (continued) subsidiaries, which own operating real estate with a fair value in excess of the loans. Net investment income from these affiliated loans was $16 million, $17 million and $14 million for the years ended December 31, 2013, 2012 and 2011, respectively. The Company has affiliated loans outstanding, which are included in other invested assets, totaling $430 million at both December 31, 2013 and 2012. At December 31, 2011, the loans were outstanding with Exeter, an affiliate. During 2012, MetLife assumed this affiliated debt from Exeter. The loans of $305 million, issued by MetLife Insurance Company of Connecticut and $125 million, issued by MLI-USA, are due on July 15, 2021 and December 16, 2021, respectively, and bear interest, payable semi-annually, at 5.64% and 5.86%, respectively. Net investment income from these affiliated loans was $25 million, $25 million and $8 million for the years ended December 31, 2013, 2012 and 2011, respectively. In July 2013, the Company committed to lend up to $1.8 billion to Exeter, an affiliate, pursuant to a note purchase agreement. Pursuant to the agreement, MetLife Insurance Company of Connecticut committed to purchase up to $1.3 billion of notes and MLI-USA committed to purchase up to $438 million of notes through December 31, 2014. The notes will be due not later than three years after issuance. The repayment of any notes issued pursuant to this agreement is guaranteed by MetLife. In October 2013, pursuant to this agreement, the Company issued loans to Exeter which are included in other invested assets, totaling $500 million at December 31, 2013. The loans of $375 million, issued by MetLife Insurance Company of Connecticut, and $125 million, issued by MLI-USA, are both due October 15, 2015, and bear interest, payable semi-annually, at 2.47%. Net investment income from this loan was $3 million at December 31, 2013. The remaining total commitment to lend is $1.2 billion with $925 million committed by MetLife Insurance Company of Connecticut and $313 million committed by MLI-USA at December 31, 2013. The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $68 million for both years ended December 31, 2013 and 2012 and $67 million for the year ended December 31, 2011. The Company also had additional affiliated net investment income of $1 million for the year ended December 31, 2013 and less than $1 million for both of the years ended December 31, 2012 and 2011. 8. Derivatives Accounting for Derivatives See Note 1 for a description of the Company's accounting policies for derivatives and Note 9 for information about the fair value hierarchy for derivatives. Derivative Strategies The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives. Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the 76
N-4300th Page of 530TOC1stPreviousNextBottomJust 300th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) over-the-counter ("OTC") market. Certain of the Company's OTC derivatives are cleared and settled through central clearing counterparties ("OTC-cleared"), while others are bilateral contracts between two counterparties ("OTC-bilateral"). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash market. Interest Rate Derivatives The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, caps, floors, futures and forwards. Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and non-qualifying hedging relationships. The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in non-qualifying hedging relationships. In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring and to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in non-qualifying hedging relationships. Inflation swaps are used as an economic hedge to reduce inflation risk generated from inflation-indexed liabilities. Inflation swaps are included in interest rate swaps. The Company utilizes inflation swaps in non-qualifying hedging relationships. The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow hedging relationships. 77
N-4301st Page of 530TOC1stPreviousNextBottomJust 301st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) Foreign Currency Exchange Rate Derivatives The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in fair value, cash flow and non-qualifying hedging relationships. To a lesser extent, the Company uses foreign currency forwards in non-qualifying hedging relationships. Credit Derivatives The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, or involuntary restructuring. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. ("ISDA") deems that a credit event has occurred. The Company utilizes credit default swaps in non-qualifying hedging relationships. The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. Treasury securities, agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments. To a lesser extent, the Company uses credit forwards to lock in the price to be paid for forward purchases of certain securities. The Company utilizes credit forwards in cash flow hedging relationships. Equity Derivatives The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, variance swaps and exchange-traded equity futures. Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in non-qualifying hedging relationships. Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in non-qualifying hedging relationships. 78
N-4302nd Page of 530TOC1stPreviousNextBottomJust 302nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge liabilities embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in non-qualifying hedging relationships. To a lesser extent, the Company also uses total rate of return swaps ("TRRs") to hedge its equity market guarantees in certain of its insurance products. The Company utilizes TRRs in non-qualifying hedging relationships. Primary Risks Managed by Derivatives The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company's derivatives, excluding embedded derivatives, held at: [Enlarge/Download Table] December 31, ------------------------------------------------------------- 2013 2012 ------------------------------ ------------------------------ Estimated Fair Value Estimated Fair Value -------------------- -------------------- Notional Notional Primary Underlying Risk Exposure Amount Assets Liabilities Amount Assets Liabilities -------------------------------- --------- -------- ----------- --------- -------- ----------- (In millions) Derivatives Designated as Hedging Instruments Fair value hedges: Interest rate swaps..... Interest rate.................... $ 436 $ 5 $ 10 $ 538 $ 28 $ 9 Foreign currency swaps.. Foreign currency exchange rate... 122 -- 13 122 -- 14 --------- -------- -------- --------- -------- --------- Subtotal.............................................. 558 5 23 660 28 23 --------- -------- -------- --------- -------- --------- Cash flow hedges: Interest rate swaps..... Interest rate.................... 537 6 32 658 99 -- Interest rate forwards.. Interest rate.................... 245 3 4 410 81 -- Foreign currency swaps.. Foreign currency exchange rate... 544 25 35 524 16 14 --------- -------- -------- --------- -------- --------- Subtotal.............................................. 1,326 34 71 1,592 196 14 --------- -------- -------- --------- -------- --------- Total qualifying hedges............................. 1,884 39 94 2,252 224 37 --------- -------- -------- --------- -------- --------- Derivatives Not Designated or Not Qualifying as Hedging Instruments Interest rate swaps....... Interest rate.................... 22,262 881 441 16,869 1,254 513 Interest rate floors...... Interest rate.................... 17,604 103 99 15,136 318 274 Interest rate caps........ Interest rate.................... 9,651 36 -- 9,031 11 -- Interest rate futures..... Interest rate.................... 1,443 -- 3 2,771 -- 7 Foreign currency swaps.... Foreign currency exchange rate... 882 52 41 811 60 35 Foreign currency forwards. Foreign currency exchange rate... 56 -- 1 139 -- 4 Credit default swaps -- purchased....... Credit........................... 157 -- 1 162 -- 2 Credit default swaps -- written......... Credit........................... 2,243 38 -- 2,456 23 1 Equity futures............ Equity market.................... 778 -- 3 1,075 -- 27 Equity options............ Equity market.................... 3,597 305 42 2,845 469 1 Variance swaps............ Equity market.................... 2,270 6 94 2,346 11 62 TRRs...................... Equity market.................... 462 -- 22 300 -- 7 --------- -------- -------- --------- -------- --------- Total non-designated or non-qualifying derivatives.... 61,405 1,421 747 53,941 2,146 933 --------- -------- -------- --------- -------- --------- Total............................................... $ 63,289 $ 1,460 $ 841 $ 56,193 $ 2,370 $ 970 ========= ======== ======== ========= ======== ========= 79
N-4303rd Page of 530TOC1stPreviousNextBottomJust 303rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) Based on notional amounts, a substantial portion of the Company's derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2013 and 2012. The Company's use of derivatives includes (i) derivatives that serve as macro hedges of the Company's exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these non-qualified derivatives, changes in market factors can lead to the recognition of fair value changes in the consolidated statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged. Net Derivative Gains (Losses) The components of net derivative gains (losses) were as follows: [Download Table] Years Ended December 31, --------------------------------- 2013 2012 2011 ------------- ---------- -------- (In millions) Derivatives and hedging gains (losses) (1). $ (958) $ (289) $ 846 Embedded derivatives....................... (94) 1,292 250 ------------- ---------- -------- Total net derivative gains (losses)....... $ (1,052) $ 1,003 $ 1,096 ============= ========== ======== -------- (1)Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedging relationships, which are not presented elsewhere in this note. The following table presents earned income on derivatives: [Download Table] Years Ended December 31, --------------------------- 2013 2012 2011 --------- -------- -------- (In millions) Qualifying hedges: Net investment income.............................. $ 2 $ 2 $ 2 Interest credited to policyholder account balances. 2 18 41 Non-qualifying hedges: Net derivative gains (losses)...................... 79 127 83 Policyholder benefits and claims................... (17) (6) -- --------- -------- -------- Total............................................ $ 66 $ 141 $ 126 ========= ======== ======== 80
N-4304th Page of 530TOC1stPreviousNextBottomJust 304th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) Non-Qualifying Derivatives and Derivatives for Purposes Other Than Hedging The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments: [Download Table] Net Policyholder Net Derivative Investment Benefits and Gains (Losses) Income (1) Claims (2) -------------- ---------- ------------ (In millions) Year Ended December 31, 2013: Interest rate derivatives.................. $ (558) $ -- $ (26) Foreign currency exchange rate derivatives. (24) -- -- Credit derivatives -- purchased............ -- -- -- Credit derivatives -- written.............. 27 -- -- Equity derivatives......................... (486) (7) (90) ------------ --------- ---------- Total.................................... $ (1,041) $ (7) $ (116) ============ ========= ========== Year Ended December 31, 2012: Interest rate derivatives.................. $ (5) $ -- $ -- Foreign currency exchange rate derivatives. (4) -- -- Credit derivatives -- purchased............ (11) -- -- Credit derivatives -- written.............. 41 -- -- Equity derivatives......................... (413) (4) (51) ------------ --------- ---------- Total.................................... $ (392) $ (4) $ (51) ============ ========= ========== Year Ended December 31, 2011: Interest rate derivatives.................. $ 701 $ -- $ -- Foreign currency exchange rate derivatives. 27 -- -- Credit derivatives -- purchased............ 13 -- -- Credit derivatives -- written.............. (13) -- -- Equity derivatives......................... 45 (7) (4) ------------ --------- ---------- Total.................................... $ 773 $ (7) $ (4) ============ ========= ========== -------- (1)Changes in estimated fair value related to economic hedges of equity method investments in joint ventures. (2)Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits. Fair Value Hedges The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; and (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated liabilities. 81
N-4305th Page of 530TOC1stPreviousNextBottomJust 305th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses): [Enlarge/Download Table] Net Derivative Net Derivative Ineffectiveness Gains (Losses) Gains (Losses) Recognized in Derivatives in Fair Value Hedged Items in Fair Value Recognized Recognized for Net Derivative Hedging Relationships Hedging Relationships for Derivatives Hedged Items Gains (Losses) ------------------------- ----------------------------- --------------- -------------- --------------- (In millions) Year Ended December 31, 2013: Interest rate swaps: Fixed maturity securities.... $ 7 $ (9) $ (2) Policyholder liabilities (1). (30) 28 (2) Foreign currency swaps: Foreign-denominated PABs (2). 2 (2) -- -------------- -------------- -------------- Total............................................... $ (21) $ 17 $ (4) ============== ============== ============== Year Ended December 31, 2012: Interest rate swaps: Fixed maturity securities.... $ (3) $ 1 $ (2) Policyholder liabilities (1). (10) 8 (2) Foreign currency swaps: Foreign-denominated PABs (2). (29) 20 (9) -------------- -------------- -------------- Total............................................... $ (42) $ 29 $ (13) ============== ============== ============== Year Ended December 31, 2011: Interest rate swaps: Fixed maturity securities.... $ (7) $ 5 $ (2) Policyholder liabilities (1). 36 (38) (2) Foreign currency swaps: Foreign-denominated PABs (2). (52) 30 (22) -------------- -------------- -------------- Total............................................... $ (23) $ (3) $ (26) ============== ============== ============== -------- (1)Fixed rate liabilities reported in PABs or future policy benefits. (2)Fixed rate or floating rate liabilities. All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. Cash Flow Hedges The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; and (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments. In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified certain amounts from AOCI into net derivative gains (losses). These amounts were $0 for both years ended December 31, 2013 and 2012 and $1 million for the year ended December 31, 2011. At December 31, 2013 and 2012, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed six years and seven years, respectively. 82
N-4306th Page of 530TOC1stPreviousNextBottomJust 306th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) At December 31, 2013 and 2012, the balance in AOCI associated with cash flow hedges was $39 million and $243 million, respectively. The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and the consolidated statements of stockholders' equity: [Enlarge/Download Table] Amount and Location Amount and Location Amount of Gains of Gains (Losses) of Gains (Losses) Derivatives in Cash Flow (Losses) Deferred in Reclassified from Recognized in Income Hedging Relationships AOCI on Derivatives AOCI into Income (Loss) (Loss) on Derivatives ------------------------ -------------------- ----------------------------- ----------------------- (Effective Portion) (Effective Portion) (Ineffective Portion) - -------------------- ----------------------------- ----------------------- Net Derivative Net Investment Net Derivative Gains (Losses) Income Gains (Losses) -------------- -------------- ----------------------- (In millions) Year Ended December 31, 2013: Interest rate swaps...... $ (120) $ -- $ -- $ -- Interest rate forwards... (57) 9 1 -- Foreign currency swaps... (15) -- -- 1 Credit forwards.......... (1) -- 1 -- -------------------- -------------- -------------- ----------------------- Total.................. $ (193) $ 9 $ 2 $ 1 ==================== ============== ============== ======================= Year Ended December 31, 2012: Interest rate swaps...... $ 21 $ -- $ -- $ 1 Interest rate forwards... 1 1 1 -- Foreign currency swaps... (15) 1 -- (1) Credit forwards.......... -- -- -- -- -------------------- -------------- -------------- ----------------------- Total.................. $ 7 $ 2 $ 1 $ -- ==================== ============== ============== ======================= Year Ended December 31, 2011: Interest rate swaps...... $ 132 $ 1 $ -- $ -- Interest rate forwards... 208 9 -- 1 Foreign currency swaps... 17 (2) -- -- Credit forwards.......... -- 1 -- -- -------------------- -------------- -------------- ----------------------- Total.................. $ 357 $ 9 $ -- $ 1 ==================== ============== ============== ======================= All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. At December 31, 2013, $1 million of deferred net gains (losses) on derivatives in AOCI was expected to be reclassified to earnings within the next 12 months. Credit Derivatives In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the non-qualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company's maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $2.2 billion and $2.5 billion at December 31, 2013 and 2012, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current fair value of the credit default swaps. At December 31, 2013 and 2012, the Company would have received $38 million and $22 million, respectively, to terminate all of these contracts. 83
N-4307th Page of 530TOC1stPreviousNextBottomJust 307th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at: [Enlarge/Download Table] December 31, --------------------------------------------------------------------------------- 2013 2012 ---------------------------------------- ---------------------------------------- Estimated Maximum Estimated Maximum Fair Value Amount of Future Weighted Fair Value Amount of Future Weighted Rating Agency Designation of of Credit Payments under Average of Credit Payments under Average Referenced Default Credit Default Years to Default Credit Default Years to Credit Obligations (1) Swaps Swaps (2) Maturity (3) Swaps Swaps (2) Maturity (3) ---------------------------- ---------- ---------------- ------------ ---------- ---------------- ------------ (In millions) (In millions) Aaa/Aa/A Single name credit default swaps (corporate).......... $ 3 $ 115 2.7 $ 3 $ 167 3.2 Credit default swaps referencing indices........ 6 650 1.1 10 650 2.1 ---------- ---------------- ---------- ---------------- Subtotal.................... 9 765 1.3 13 817 2.3 ---------- ---------------- ---------- ---------------- Baa Single name credit default swaps (corporate).......... 8 446 3.0 4 479 3.8 Credit default swaps referencing indices........ 18 996 4.9 5 1,124 4.8 ---------- ---------------- ---------- ---------------- Subtotal.................... 26 1,442 4.3 9 1,603 4.5 ---------- ---------------- ---------- ---------------- B Single name credit default swaps (corporate).......... -- -- -- -- -- -- Credit default swaps referencing indices........ 3 36 5.0 -- 36 5.0 ---------- ---------------- ---------- ---------------- Subtotal.................... 3 36 5.0 -- 36 5.0 ---------- ---------------- ---------- ---------------- Total..................... $ 38 $ 2,243 3.3 $ 22 $ 2,456 3.8 ========== ================ ========== ================ -------- (1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody's Investors Service ("Moody's"), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used. (2)Assumes the value of the referenced credit obligations is zero. (3)The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts. Credit Risk on Freestanding Derivatives The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company's derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements. 84
N-4308th Page of 530TOC1stPreviousNextBottomJust 308th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company's OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company's ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives. The Company's OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis, and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives. See Note 9 for a description of the impact of credit risk on the valuation of derivatives. The estimated fair value of the Company's net derivative assets and net derivative liabilities after the application of master netting agreements and collateral was as follows at: [Enlarge/Download Table] December 31, 2013 December 31, 2012 Derivatives Subject to a Master Netting Arrangement or a Similar -------------------- -------------------- Arrangement Assets Liabilities Assets Liabilities ---------------------------------------------------------------- -------- ----------- -------- ----------- (In millions) Gross estimated fair value of derivatives: OTC-bilateral (1).............................................. $ 1,450 $ 851 $ 2,436 $ 982 OTC-cleared (1)................................................ 50 9 -- -- Exchange-traded................................................ -- 6 -- 34 -------- -------- -------- -------- Total gross estimated fair value of derivatives (1).......... 1,500 866 2,436 1,016 Amounts offset in the consolidated balance sheets............... -- -- -- -- -------- -------- -------- -------- Estimated fair value of derivatives presented in the consolidated balance sheets (1)............................... 1,500 866 2,436 1,016 Gross amounts not offset in the consolidated balance sheets: Gross estimated fair value of derivatives: (2) OTC-bilateral.................................................. (670) (670) (838) (838) OTC-cleared.................................................... (8) (8) -- -- Exchange-traded................................................ -- -- -- -- Cash collateral: (3) OTC-bilateral.................................................. (216) -- (897) -- OTC-cleared.................................................... (40) (1) -- -- Exchange-traded................................................ -- (5) -- (34) Securities collateral: (4) OTC-bilateral.................................................. (554) (160) (689) (121) OTC-cleared.................................................... -- -- -- -- Exchange-traded................................................ -- (1) -- -- -------- -------- -------- -------- Net amount after application of master netting agreements and collateral.................................................... $ 12 $ 21 $ 12 $ 23 ======== ======== ======== ======== 85
N-4309th Page of 530TOC1stPreviousNextBottomJust 309th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) -------- (1)At December 31, 2013 and 2012, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $40 million and $66 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $25 million and $46 million, respectively. (2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals. (3)Cash collateral received is included in cash and cash equivalents, short-term investments, or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheets. The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables in the consolidated balance sheets. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2013 and 2012, the Company received excess cash collateral of $21 million and $0, respectively, and provided excess cash collateral of $19 million and $53 million, respectively, which is not included in the table above due to the foregoing limitation. (4)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge this collateral, but at December 31, 2013 none of the collateral had been sold or repledged. Securities collateral pledged by the Company is reported in fixed maturity securities in the consolidated balance sheets. Subject to certain constraints, the counterparties are permitted by contract to sell or repledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2013 and 2012, the Company received excess securities collateral with an estimated fair value of $34 million and $0, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At December 31, 2013 and 2012, the Company provided excess securities collateral with an estimated fair value of $1 million and $0, respectively, for its OTC-bilateral derivatives, $29 million and $0, respectively, for its OTC-cleared derivatives and $46 million and $0, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation. The Company's collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the fair value of that counterparty's derivatives reaches a pre-determined threshold. Certain of these arrangements also include financial strength-contingent provisions that provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the financial strength ratings of the Company and/or the credit ratings of the counterparty. In addition, certain of the Company's netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade financial strength or credit rating from each of Moody's and S&P. If a party's financial strength or credit ratings were to fall below that specific investment grade financial strength or credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party's reasonable valuation of the derivatives. 86
N-4310th Page of 530TOC1stPreviousNextBottomJust 310th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) The following table presents the estimated fair value of the Company's OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company's financial strength rating at the reporting date or if the Company's financial strength rating sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table. [Enlarge/Download Table] Estimated Fair Value of Collateral Provided: Fair Value of Incremental Collateral Provided Upon: -------------------- --------------------------------------------------- Downgrade in the Company's Financial Strength One Notch Rating to a Level that Estimated Downgrade in Triggers Full Overnight Fair Value of the Company's Collateralization or Derivatives in Net Fixed Maturity Financial Strength Termination of the Liability Position (1) Securities Rating Derivative Position ---------------------- -------------------- ------------------ ---------------------------- (In millions) December 31, 2013 $ 181 $ 161 $ -- $ 2 December 31, 2012 $ 143 $ 121 $ 2 $ 28 -------- (1)After taking into consideration the existence of netting agreements. Embedded Derivatives The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; affiliated ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; affiliated assumed reinsurance of guaranteed minimum benefits related to GMWBs and certain GMIBs; funds withheld on ceded reinsurance; and certain debt and equity securities. The following table presents the estimated fair value and balance sheet location of the Company's embedded derivatives that have been separated from their host contracts at: [Enlarge/Download Table] December 31, ------------------- Balance Sheet Location 2013 2012 -------------------------- ---------- -------- (In millions) Net embedded derivatives within asset host contracts: Ceded guaranteed minimum benefits... Premiums, reinsurance and other receivables......... $ 912 $ 3,551 Options embedded in debt or equity securities......................... Investments............... (30) (14) ---------- -------- Net embedded derivatives within asset host contracts....... $ 882 $ 3,537 ========== ======== Net embedded derivatives within liability host contracts: Direct guaranteed minimum benefits.. PABs...................... $ (1,232) $ 705 Assumed guaranteed minimum benefits. PABs...................... (13) 4 Funds withheld on ceded reinsurance. Other liabilities......... 34 552 ---------- -------- Net embedded derivatives within liability host contracts... $ (1,211) $ 1,261 ========== ======== 87
N-4311th Page of 530TOC1stPreviousNextBottomJust 311th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Derivatives (continued) The following table presents changes in estimated fair value related to embedded derivatives: [Download Table] Years Ended December 31, ------------------------------------- 2013 2012 2011 ------------- ----------- ----------- (In millions) Net derivative gains (losses) (1) (2). $ (94) $ 1,292 $ 250 -------- (1)The valuation of direct and assumed guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were ($156) million, ($235) million and $354 million for the years ended December 31, 2013, 2012 and 2011, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment, were $76 million, $124 million and ($476) million for the years ended December 31, 2013, 2012 and 2011, respectively. (2)See Note 6 for discussion of affiliated net derivative gains (losses) included in the table above. 9. Fair Value When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability. Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company's ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities. Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. 88
N-4312th Page of 530TOC1stPreviousNextBottomJust 312th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Recurring Fair Value Measurements The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below. [Enlarge/Download Table] December 31, 2013 ---------------------------------------------- Fair Value Hierarchy ------------------------------ Total Estimated Level 1 Level 2 Level 3 Fair Value -------- ---------- ---------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................. $ -- $ 15,454 $ 1,248 $ 16,702 Foreign corporate.......................................... -- 7,783 734 8,517 U.S. Treasury and agency................................... 4,365 3,929 -- 8,294 RMBS....................................................... -- 4,266 422 4,688 State and political subdivision............................ -- 2,224 -- 2,224 ABS........................................................ -- 1,682 419 2,101 CMBS....................................................... -- 1,532 72 1,604 Foreign government......................................... -- 1,122 -- 1,122 -------- ---------- ---------- ------------ Total fixed maturity securities........................... 4,365 37,992 2,895 45,252 -------- ---------- ---------- ------------ Equity securities: Non-redeemable preferred stock............................. -- 136 81 217 Common stock............................................... 86 84 31 201 -------- ---------- ---------- ------------ Total equity securities................................... 86 220 112 418 -------- ---------- ---------- ------------ Short-term investments (1)................................... 391 1,671 -- 2,062 Mortgage loans held by CSEs -- FVO........................... -- 1,598 -- 1,598 Other invested assets: FVO securities............................................. -- 9 -- 9 Derivative assets: (2) Interest rate............................................. -- 1,011 23 1,034 Foreign currency exchange rate............................ -- 77 -- 77 Credit.................................................... -- 32 6 38 Equity market............................................. -- 305 6 311 -------- ---------- ---------- ------------ Total derivative assets................................. -- 1,425 35 1,460 -------- ---------- ---------- ------------ Total other invested assets............................ -- 1,434 35 1,469 Net embedded derivatives within asset host contracts (3)..... -- -- 912 912 Separate account assets (4).................................. 259 97,368 153 97,780 -------- ---------- ---------- ------------ Total assets........................................... $ 5,101 $ 140,283 $ 4,107 $ 149,491 ======== ========== ========== ============ Liabilities Derivative liabilities: (2) Interest rate.............................................. $ 3 $ 574 $ 12 $ 589 Foreign currency exchange rate............................. -- 90 -- 90 Credit..................................................... -- 1 -- 1 Equity market.............................................. 3 64 94 161 -------- ---------- ---------- ------------ Total derivative liabilities.............................. 6 729 106 841 -------- ---------- ---------- ------------ Net embedded derivatives within liability host contracts (3). -- -- (1,211) (1,211) Long-term debt of CSEs....................................... -- 1,461 -- 1,461 -------- ---------- ---------- ------------ Total liabilities...................................... $ 6 $ 2,190 $ (1,105) $ 1,091 ======== ========== ========== ============ 89
N-4313th Page of 530TOC1stPreviousNextBottomJust 313th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] December 31, 2012 -------------------------------------------- Fair Value Hierarchy ---------------------------- Total Estimated Level 1 Level 2 Level 3 Fair Value -------- ---------- -------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................. $ -- $ 17,461 $ 1,434 $ 18,895 Foreign corporate.......................................... -- 8,577 868 9,445 U.S. Treasury and agency................................... 5,082 3,782 -- 8,864 RMBS....................................................... -- 5,460 278 5,738 State and political subdivision............................ -- 2,304 25 2,329 ABS........................................................ -- 1,910 343 2,253 CMBS....................................................... -- 2,231 125 2,356 Foreign government......................................... -- 1,085 3 1,088 -------- ---------- -------- ----------- Total fixed maturity securities.......................... 5,082 42,810 3,076 50,968 -------- ---------- -------- ----------- Equity securities: Non-redeemable preferred stock............................. -- 47 93 140 Common stock............................................... 70 81 26 177 -------- ---------- -------- ----------- Total equity securities.................................. 70 128 119 317 -------- ---------- -------- ----------- Short-term investments (1)................................... 1,233 1,285 13 2,531 Mortgage loans held by CSEs -- FVO........................... -- 2,666 -- 2,666 Other invested assets: FVO securities............................................. -- 9 -- 9 Derivative assets: (2) Interest rate............................................ -- 1,643 148 1,791 Foreign currency exchange rate........................... -- 76 -- 76 Credit................................................... -- 13 10 23 Equity market............................................ -- 469 11 480 -------- ---------- -------- ----------- Total derivative assets................................. -- 2,201 169 2,370 -------- ---------- -------- ----------- Total other invested assets........................... -- 2,210 169 2,379 Net embedded derivatives within asset host contracts (3)..... -- -- 3,551 3,551 Separate account assets (4).................................. 201 85,772 141 86,114 -------- ---------- -------- ----------- Total assets.......................................... $ 6,586 $ 134,871 $ 7,069 $ 148,526 ======== ========== ======== =========== Liabilities Derivative liabilities: (2) Interest rate.............................................. $ 7 $ 767 $ 29 $ 803 Foreign currency exchange rate............................. -- 67 -- 67 Credit..................................................... -- 3 -- 3 Equity market.............................................. 27 8 62 97 -------- ---------- -------- ----------- Total derivative liabilities............................. 34 845 91 970 -------- ---------- -------- ----------- Net embedded derivatives within liability host contracts (3). -- -- 1,261 1,261 Long-term debt of CSEs....................................... -- 2,559 -- 2,559 -------- ---------- -------- ----------- Total liabilities..................................... $ 34 $ 3,404 $ 1,352 $ 4,790 ======== ========== ======== =========== -------- 90
N-4314th Page of 530TOC1stPreviousNextBottomJust 314th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) (1)Short-term investments as presented in the tables above differ from the amounts presented in the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis. (2)Derivative assets are presented within other invested assets in the consolidated balance sheets and derivative liabilities are presented within other liabilities in the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables. (3)Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables in the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within PABs and other liabilities in the consolidated balance sheets. At December 31, 2013 and 2012, equity securities also included embedded derivatives of ($30) million and ($14) million, respectively. (4)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy. Investments Valuation Controls and Procedures On behalf of the Company and MetLife, Inc.'s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to MetLife Insurance Company of Connecticut's Audit Committee regarding compliance with fair value accounting standards. The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the 91
N-4315th Page of 530TOC1stPreviousNextBottomJust 315th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) fair value estimates, comparing fair value estimates to management's knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as "consensus pricing," represent a reasonable estimate of fair value by considering such pricing relative to the Company's knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 11% of the total estimated fair value of Level 3 fixed maturity securities. The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management's best estimate is used. Securities, Short-term Investments and Long-term Debt of CSEs When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company's securities holdings and valuation of these securities does not involve management's judgment. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management's judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances. The estimated fair value of long-term debt of CSEs is determined on a basis consistent with the methodologies described herein for securities. 92
N-4316th Page of 530TOC1stPreviousNextBottomJust 316th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Level 2 Valuation Techniques and Key Inputs: This level includes securities priced principally by independent pricing services using observable inputs. Short-term investments within this level are of a similar nature and class to the Level 2 fixed maturity securities and equity securities. U.S. corporate and foreign corporate securities These securities are principally valued using the market and income approaches. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques that use standard market observable inputs such as benchmark yields, spreads off benchmark yields, new issuances, issuer rating, duration, and trades of identical or comparable securities. Privately-placed securities are valued using matrix pricing methodologies using standard market observable inputs, and inputs derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer, and in certain cases, delta spread adjustments to reflect specific credit-related issues. U.S. Treasury and agency securities These securities are principally valued using the market approach. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques using standard market observable inputs such as a benchmark U.S. Treasury yield curve, the spread off the U.S. Treasury yield curve for the identical security and comparable securities that are actively traded. Structured securities comprised of RMBS, ABS and CMBS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using standard market inputs, including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information, including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans. State and political subdivision and foreign government securities These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques using standard market observable inputs including a benchmark U.S. Treasury yield or other yields, issuer ratings, broker-dealer quotes, issuer spreads and reported trades of similar securities, including those within the same sub-sector or with a similar maturity or credit rating. Common and non-redeemable preferred stock These securities are principally valued using the market approach. Valuations are based principally on observable inputs, including quoted prices in markets that are not considered active. 93
N-4317th Page of 530TOC1stPreviousNextBottomJust 317th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Level 3 Valuation Techniques and Key Inputs: In general, securities classified within Level 3 use many of the same valuation techniques and inputs as described previously for Level 2. However, if key inputs are unobservable, or if the investments are less liquid and there is very limited trading activity, the investments are generally classified as Level 3. The use of independent non-binding broker quotations to value investments generally indicates there is a lack of liquidity or a lack of transparency in the process to develop the valuation estimates, generally causing these investments to be classified in Level 3. Short-term investments within this level are of a similar nature and class to the Level 3 securities described below; accordingly, the valuation techniques and significant market standard observable inputs used in their valuation are also similar to those described below. U.S. corporate and foreign corporate securities These securities, including financial services industry hybrid securities classified within fixed maturity securities, are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques that utilize unobservable inputs or inputs that cannot be derived principally from, or corroborated by, observable market data, including illiquidity premium, delta spread adjustments to reflect specific credit-related issues, credit spreads; and inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on independent non-binding broker quotations. Structured securities comprised of RMBS, ABS and CMBS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads. Below investment grade securities and sub-prime RMBS included in this level are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain of these valuations are based on independent non-binding broker quotations. State and political subdivision and foreign government securities These securities are principally valued using the market approach. Valuations are based primarily on independent non-binding broker quotations and inputs, including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on matrix pricing that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads. Common and non-redeemable preferred stock These securities, including privately-held securities and financial services industry hybrid securities classified within equity securities, are principally valued using the market and income approaches. 94
N-4318th Page of 530TOC1stPreviousNextBottomJust 318th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using inputs such as comparable credit rating and issuance structure. Certain of these securities are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2 and independent non-binding broker quotations. Mortgage Loans Held by CSEs -- FVO The Company consolidates certain securitization entities that hold commercial mortgage loans. Level 2 Valuation Techniques and Key Inputs: These investments are principally valued using the market approach. The principal market for these investments is the securitization market. The Company uses the quoted securitization market price of the obligations of the CSEs to determine the estimated fair value of these commercial loan portfolios. These market prices are determined principally by independent pricing services using observable inputs. Separate Account Assets Separate account assets are carried at estimated fair value and reported as a summarized total on the consolidated balance sheets. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets. Separate account assets include: mutual funds, fixed maturity securities, equity securities, derivatives, other limited partnership interests, short-term investments and cash and cash equivalents. Level 2 Valuation Techniques and Key Inputs: These assets are comprised of investments that are similar in nature to the instruments described under "-- Securities, Short-term Investments and Long-term Debt of CSEs." Also included are certain mutual funds without readily determinable fair values, as prices are not published publicly. Valuation of the mutual funds is based upon quoted prices or reported NAV provided by the fund managers. Level 3 Valuation Techniques and Key Inputs: These assets are comprised of investments that are similar in nature to the instruments described under "-- Securities, Short-term Investments and Long-term Debt of CSEs." Also included are other limited partnership interests, which are valued giving consideration to the value of the underlying holdings of the partnerships and by applying a premium or discount, if appropriate, for factors such as liquidity, bid/ask spreads, the performance record of the fund manager or other relevant variables that may impact the exit value of the particular partnership interest. Derivatives The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard 95
N-4319th Page of 530TOC1stPreviousNextBottomJust 319th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in "-- Investments." The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Significant inputs that are observable generally include: interest rates, foreign currency exchange rates, interest rate curves, credit curves and volatility. However, certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant inputs that are unobservable generally include references to emerging market currencies and inputs that are outside the observable portion of the interest rate curve, credit curve, volatility or other relevant market measure. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company's derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company's ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. Freestanding Derivatives Level 2 Valuation Techniques and Key Inputs: This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. These derivatives are principally valued using the income approach. 96
N-4320th Page of 530TOC1stPreviousNextBottomJust 320th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Interest rate Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and basis curves. Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves and interest rate volatility. Foreign currency exchange rate Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates and cross currency basis curves. Credit Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, credit curves and recovery rates. Equity market Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, spot equity index levels and dividend yield curves. Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, spot equity index levels, dividend yield curves and equity volatility. Level 3 Valuation Techniques and Key Inputs: These derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. These valuation methodologies generally use the same inputs as described in the corresponding sections above for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Interest rate Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve and basis curves. Credit Non-option-based. Significant unobservable inputs may include credit spreads, repurchase rates and the extrapolation beyond observable limits of the swap yield curve and credit curves. Certain of these derivatives are valued based on independent non-binding broker quotations. 97
N-4321st Page of 530TOC1stPreviousNextBottomJust 321st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Equity market Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves and equity volatility. Embedded Derivatives Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees and embedded derivatives related to funds withheld on ceded reinsurance. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs in the consolidated balance sheets. The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company's actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates. Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife's debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income. 98
N-4322nd Page of 530TOC1stPreviousNextBottomJust 322nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) The Company assumed, from an affiliated insurance company, the risk associated with certain GMIBs. These embedded derivatives are included in other policy-related balances in the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on these assumed risks is determined using a methodology consistent with that described previously for the guarantees directly written by the Company. The Company ceded, to an affiliated reinsurance company, the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to the same affiliated reinsurance company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables in the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in "-- Investments -- Securities, Short-term Investments and Long-term Debt of CSEs." The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities in the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income. Embedded Derivatives Within Asset and Liability Host Contracts Level 3 Valuation Techniques and Key Inputs: Direct and assumed guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin. Reinsurance ceded on certain guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in "-- Direct and Assumed Guaranteed Minimum Benefits" and also include counterparty credit spreads. 99
N-4323rd Page of 530TOC1stPreviousNextBottomJust 323rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Transfers between Levels Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period. Transfers between Levels 1 and 2: For assets and liabilities measured at estimated fair value and still held at December 31, 2013 and 2012, transfers between Levels 1 and 2 were not significant. Transfers into or out of Level 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Transfers into Level 3 for fixed maturity securities were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments or credit spreads. Transfers out of Level 3 for fixed maturity securities resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings. 100
N-4324th Page of 530TOC1stPreviousNextBottomJust 324th
Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at: [Enlarge/Download Table] December 31, 2013 --------------------------- Valuation Significant Weighted Techniques Unobservable Inputs Range Average (1) ------------------------ --------------------------- --------------- ----------- Fixed maturity securities: (3) U.S. corporate and Delta spread (10) - 240 51 foreign corporate............ Matrix pricing adjustments (4) Illiquidity premium (4) 30 - 30 30 Credit spreads (4) (112) - 538 208 Offered quotes (5) 99 - 100 100 .. Consensus pricing Offered quotes (5) 33 - 103 87 ----------------------------------------------------------------------------------------- RMBS.......................... Matrix pricing and Credit spreads (4) (96) - 2,406 295 discounted cash flow Market pricing Quoted prices (5) 10 - 100 95 Consensus pricing Offered quotes (5) 78 - 100 95 ----------------------------------------------------------------------------------------- CMBS.......................... Matrix pricing and Credit spreads (4) 341 - 1,879 746 discounted cash flow Market pricing Quoted prices (5) 97 - 104 101 Consensus pricing Offered quotes (5) 101 - 101 101 ----------------------------------------------------------------------------------------- ABS........................... Matrix pricing and Credit spreads (4) 30 - 875 319 discounted cash flow Market pricing Quoted prices (5) -- - 104 101 Consensus pricing Offered quotes (5) 58 - 106 98 ----------------------------------------------------------------------------------------- Derivatives: Interest rate................. Present value Swap yield (7) 248 - 450 techniques ----------------------------------------------------------------------------------------- Credit........................ Present value Credit spreads (8) 98 - 100 techniques Consensus pricing Offered quotes (9) ----------------------------------------------------------------------------------------- Equity market................. Present value Volatility (10) 17% - 28% techniques ----------------------------------------------------------------------------------------- Embedded derivatives: Direct and ceded Option pricing Mortality rates: 0% - 0.10% guaranteed minimum techniques Ages 0 - 40 benefits..................... Ages 41 - 60 0.04% - 0.65% Ages 61 - 115 0.26% - 100% Lapse rates: Durations 1 - 10 0.50% - 100% Durations 11 - 20 3% - 100% Durations 21 - 116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity 17.40% - 25% volatilities Nonperformance 0.03% - 0.44% risk spread ----------------------------------------------------------------------------------------- [Enlarge/Download Table] December 31, 2012 --------------------------- Valuation Significant Weighted Techniques Unobservable Inputs Range Average (1) ------------------------ --------------------------- --------------- ----------- Fixed maturity securities: (3) U.S. corporate and Delta spread 9 - 500 105 foreign corporate............ Matrix pricing adjustments (4) Illiquidity premium (4) 30 - 30 30 Credit spreads (4) (157) - 876 282 Offered quotes (5) 100 - 100 100 .. Consensus pricing Offered quotes (5) 35 - 555 96 ----------------------------------------------------------------------------------------- RMBS.......................... Matrix pricing and Credit spreads (4) 40 - 2,367 436 discounted cash flow Market pricing Quoted prices (5) 100 - 100 100 Consensus pricing Offered quotes (5) ----------------------------------------------------------------------------------------- CMBS.......................... Matrix pricing and Credit spreads (4) 10 - 9,164 413 discounted cash flow Market pricing Quoted prices (5) 100 - 104 102 Consensus pricing Offered quotes (5) ----------------------------------------------------------------------------------------- ABS........................... Matrix pricing and Credit spreads (4) -- - 900 152 discounted cash flow Market pricing Quoted prices (5) 97 - 102 100 Consensus pricing Offered quotes (5) 50 - 111 100 ----------------------------------------------------------------------------------------- Derivatives: Interest rate................. Present value Swap yield (7) 221 - 353 techniques ----------------------------------------------------------------------------------------- Credit........................ Present value Credit spreads (8) 100 - 100 techniques Consensus pricing Offered quotes (9) ----------------------------------------------------------------------------------------- Equity market................. Present value Volatility (10) 18% - 26% techniques ----------------------------------------------------------------------------------------- Embedded derivatives: Direct and ceded Option pricing Mortality rates: 0% - 0.10% guaranteed minimum techniques Ages 0 - 40 benefits..................... Ages 41 - 60 0.05% - 0.64% Ages 61 - 115 0.32% - 100% Lapse rates: Durations 1 - 10 0.50% - 100% Durations 11 - 20 3% - 100% Durations 21 - 116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity 17.40% - 25% volatilities Nonperformance 0.10% - 0.67% risk spread ----------------------------------------------------------------------------------------- [Enlarge/Download Table] Impact of Increase in Input on Valuation Significant Estimated Techniques Unobservable Inputs Fair Value (2) ------------------------ --------------------------- -------------- Fixed maturity securities: (3) U.S. corporate and Delta spread Decrease foreign corporate............ Matrix pricing adjustments (4) Illiquidity premium (4) Decrease Credit spreads (4) Decrease Offered quotes (5) Increase .. Consensus pricing Offered quotes (5) Increase -------------------------------------------------------------------------- RMBS.......................... Matrix pricing and Credit spreads (4) Decrease (6) discounted cash flow Market pricing Quoted prices (5) Increase (6) Consensus pricing Offered quotes (5) Increase (6) -------------------------------------------------------------------------- CMBS.......................... Matrix pricing and Credit spreads (4) Decrease (6) discounted cash flow Market pricing Quoted prices (5) Increase (6) Consensus pricing Offered quotes (5) Increase (6) -------------------------------------------------------------------------- ABS........................... Matrix pricing and Credit spreads (4) Decrease (6) discounted cash flow Market pricing Quoted prices (5) Increase (6) Consensus pricing Offered quotes (5) Increase (6) -------------------------------------------------------------------------- Derivatives: Interest rate................. Present value Swap yield (7) Increase (11) techniques -------------------------------------------------------------------------- Credit........................ Present value Credit spreads (8) Decrease (8) techniques Consensus pricing Offered quotes (9) -------------------------------------------------------------------------- Equity market................. Present value Volatility (10) Increase (11) techniques -------------------------------------------------------------------------- Embedded derivatives: Direct and ceded Option pricing Mortality rates: Decrease (12) guaranteed minimum techniques Ages 0 - 40 benefits..................... Ages 41 - 60 Decrease (12) Ages 61 - 115 Decrease (12) Lapse rates: Durations 1 - 10 Decrease (13) Durations 11 - 20 Decrease (13) Durations 21 - 116 Decrease (13) Utilization rates Increase (14) Withdrawal rates (15) Long-term equity Increase (16) volatilities Nonperformance Decrease (17) risk spread -------------------------------------------------------------------------- -------- (1)The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities. 101
N-4325th Page of 530TOC1stPreviousNextBottomJust 325th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) (2)The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes to direct guaranteed minimum benefits are based on liability positions and changes to ceded guaranteed minimum benefits are based on asset positions. (3)Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations. (4)Range and weighted average are presented in basis points. (5)Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par. (6)Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates. (7)Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation. (8)Represents the risk quoted in basis points of a credit default event on the underlying instrument. The range being provided is a single quoted spread in the valuation model. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps. (9)At both December 31, 2013 and 2012, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value. (10)Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation. (11)Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions. (12)Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (13)Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (14)The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the 102
N-4326th Page of 530TOC1stPreviousNextBottomJust 326th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) contract's withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (15)The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (16)Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (17)Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in "-- Nonrecurring Fair Value Measurements." 103
N-4327th Page of 530TOC1stPreviousNextBottomJust 327th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3): [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) --------------------------------------------------------------------------------- Fixed Maturity Securities: --------------------------------------------------------------------------------- State and U.S. Foreign U.S. Treasury Political Foreign Corporate Corporate and Agency RMBS Subdivision ABS CMBS Government --------- --------- ------------- -------- ----------- ------ ------- ----------- (In millions) Year Ended December 31, 2013: Balance at January 1,.................... $ 1,434 $ 868 $ -- $ 278 $ 25 $ 343 $ 125 $ 3 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 7 -- -- 1 -- 1 1 -- Net investment gains (losses)......... -- (7) -- (1) -- 2 -- -- Net derivative gains (losses)......... -- -- -- -- -- -- -- -- OCI.................................... (39) (5) -- 13 -- (5) 3 -- Purchases (3)............................ 150 53 -- 170 -- 184 37 -- Sales (3)................................ (243) (129) -- (49) (2) (53) (71) (3) Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 218 30 -- 14 -- -- -- -- Transfers out of Level 3 (4)............. (279) (76) -- (4) (23) (53) (23) -- -------- -------- ----------- -------- --------- ------ ------- ----------- Balance at December 31,.................. $ 1,248 $ 734 $ -- $ 422 $ -- $ 419 $ 72 $ -- ======== ======== =========== ======== ========= ====== ======= =========== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 7 $ -- $ -- $ 1 $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ (3) $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- 104
N-4328th Page of 530TOC1stPreviousNextBottomJust 328th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ---------------------------------------------------------------------------------- Equity Securities: Net Derivatives: (6) ------------------- ----------------------- Non- redeemable Net Separate Preferred Common Short-term Interest Equity Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) ---------- -------- ----------- -------- ------ ------- --------------- ---------- (In millions) Year Ended December 31, 2013: Balance at January 1,.................... $ 93 $ 26 $ 13 $ 119 $ 10 $ (51) $ 2,290 $ 141 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. -- -- -- -- -- -- -- -- Net investment gains (losses)......... -- 8 -- -- -- -- -- 6 Net derivative gains (losses)......... -- -- -- (16) (4) (40) 108 -- OCI.................................... 12 7 -- (58) -- -- -- -- Purchases (3)............................ 3 2 -- -- -- -- -- 9 Sales (3)................................ (27) (12) (13) -- -- -- -- (6) Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- (19) -- 3 (59) -- Transfers into Level 3 (4)............... -- -- -- -- -- -- -- 3 Transfers out of Level 3 (4)............. -- -- -- (15) -- -- -- -- ---------- -------- ---------- ------- ------ ------- ------------- -------- Balance at December 31,.................. $ 81 $ 31 $ -- $ 11 $ 6 $ (88) $ 2,123 $ 153 ========== ======== ========== ======= ====== ======= ============= ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ (3) $ (2) $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ (8) $ (4) $ (36) $ (83) $ -- 105
N-4329th Page of 530TOC1stPreviousNextBottomJust 329th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ------------------------------------------------------------------------------- Fixed Maturity Securities: ------------------------------------------------------------------------------- U.S. State and U.S. Foreign Treasury Political Foreign Corporate Corporate and Agency RMBS Subdivision ABS CMBS Government --------- --------- ----------- -------- ----------- ------ ------- ----------- (In millions) Year Ended December 31, 2012: Balance at January 1,.................... $ 1,432 $ 580 $ -- $ 239 $ 23 $ 220 $ 147 $ 2 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 7 -- -- -- -- -- -- -- Net investment gains (losses)......... -- (24) -- (4) -- -- (1) -- Net derivative gains (losses)......... -- -- -- -- -- -- -- -- OCI.................................... 66 44 -- 39 2 8 6 1 Purchases (3)............................ 227 269 -- 61 -- 148 22 -- Sales (3)................................ (183) (56) -- (63) -- (15) (71) -- Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 76 68 -- 6 -- -- 39 -- Transfers out of Level 3 (4)............. (191) (13) -- -- -- (18) (17) -- -------- -------- ----------- -------- --------- ------ ------- ----------- Balance at December 31,.................. $ 1,434 $ 868 $ -- $ 278 $ 25 $ 343 $ 125 $ 3 ======== ======== =========== ======== ========= ====== ======= =========== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 7 $ 1 $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ (16) $ -- $ (2) $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- 106
N-4330th Page of 530TOC1stPreviousNextBottomJust 330th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ----------------------------------------------------------------------------------- Equity Securities: Net Derivatives: (6) ------------------- ------------------------ Non- redeemable Separate Preferred Common Short-term Interest Equity Net Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) ---------- -------- ----------- -------- ------ -------- --------------- ---------- (In millions) Year Ended December 31, 2012: Balance at January 1,.............. $ 76 $ 21 $ 10 $ 174 $ (1) $ 43 $ 1,009 $ 130 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income........... -- -- -- -- -- -- -- -- Net investment gains (losses)... -- (2) -- -- -- -- -- 16 Net derivative gains (losses)... -- -- -- 1 10 (91) 1,296 -- OCI............................... 20 9 -- 1 -- -- -- -- Purchases (3)...................... -- -- 13 -- -- -- -- 1 Sales (3).......................... (3) (2) (10) -- -- -- -- (5) Issuances (3)...................... -- -- -- (10) -- -- -- -- Settlements (3).................... -- -- -- (47) -- (3) (15) -- Transfers into Level 3 (4)......... -- -- -- -- -- -- -- 1 Transfers out of Level 3 (4)....... -- -- -- -- 1 -- -- (2) ---------- -------- ---------- ------ ----- -------- ------------- -------- Balance at December 31,............ $ 93 $ 26 $ 13 $ 119 $ 10 $ (51) $ 2,290 $ 141 ========== ======== ========== ====== ===== ======== ============= ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income............. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses)..... $ -- $ (4) $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses)..... $ -- $ -- $ -- $ 3 $ 11 $ (88) $ 1,305 $ -- 107
N-4331st Page of 530TOC1stPreviousNextBottomJust 331st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) -------------------------------------------------------------------------------- Fixed Maturity Securities: -------------------------------------------------------------------------------- State and U.S. Foreign U.S. Treasury Political Foreign Corporate Corporate and Agency RMBS Subdivision ABS CMBS Government --------- --------- ------------- -------- ----------- ------ ------ ----------- (In millions) Year Ended December 31, 2011: Balance at January 1,.................... $ 1,510 $ 880 $ 34 $ 282 $ 32 $ 321 $ 130 $ 14 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 6 1 -- 1 -- -- -- -- Net investment gains (losses)......... 32 (20) -- (5) -- (6) -- -- Net derivative gains (losses)......... -- -- -- -- -- -- -- -- OCI.................................... 80 22 -- (9) (8) 8 19 -- Purchases (3)............................ 76 282 -- 16 -- 166 17 -- Sales (3)................................ (175) (515) -- (34) (1) (46) (19) (12) Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 40 3 -- 1 -- -- -- -- Transfers out of Level 3 (4)............. (137) (73) (34) (13) -- (223) -- -- -------- -------- ----------- -------- -------- ------ ------ ----------- Balance at December 31,.................. $ 1,432 $ 580 $ -- $ 239 $ 23 $ 220 $ 147 $ 2 ======== ======== =========== ======== ======== ====== ====== =========== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 6 $ 1 $ -- $ 1 $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ (9) $ -- $ (5) $ -- $ (2) $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- 108
N-4332nd Page of 530TOC1stPreviousNextBottomJust 332nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) --------------------------------------------------------------------------------- Equity Securities: Net Derivatives: (6) ------------------ ----------------------- Non- redeemable Separate Preferred Common Short-term Interest Equity Net Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) ---------- ------- ----------- -------- ------- ------ --------------- ---------- (In millions) Year Ended December 31, 2011: Balance at January 1,.................... $ 214 $ 22 $ 173 $ (61) $ 11 $ 12 $ 677 $ 133 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. -- -- -- -- -- -- -- -- Net investment gains (losses)......... (24) 2 (1) -- -- -- -- (7) Net derivative gains (losses)......... -- -- -- 50 (10) 32 254 -- OCI.................................... 1 (6) -- 199 -- -- -- -- Purchases (3)............................ -- 9 10 -- -- 3 -- 5 Sales (3)................................ (115) (6) (172) -- -- -- -- (1) Issuances (3)............................ -- -- -- -- (1) (4) -- -- Settlements (3).......................... -- -- -- (13) (1) -- 78 -- Transfers into Level 3 (4)............... -- -- -- (1) -- -- -- -- Transfers out of Level 3 (4)............. -- -- -- -- -- -- -- -- --------- ------- ---------- ------ ------- ----- ------------ -------- Balance at December 31,.................. $ 76 $ 21 $ 10 $ 174 $ (1) $ 43 $ 1,009 $ 130 ========= ======= ========== ====== ======= ===== ============ ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ (3) $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ 39 $ (10) $ 33 $ 256 $ -- -------- (1)Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). (2)Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (3)Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (4)Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (5)Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. (6)Freestanding derivative assets and liabilities are presented net for purposes of the rollforward. (7)Embedded derivative assets and liabilities are presented net for purposes of the rollforward. (8)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses). 109
N-4333rd Page of 530TOC1stPreviousNextBottomJust 333rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Fair Value Option The following table presents information for certain assets and liabilities of CSEs, which are accounted for under the FVO. These assets and liabilities were initially measured at fair value. [Enlarge/Download Table] December 31, ----------------- 2013 2012 -------- -------- (In millions) Assets: (1) Unpaid principal balance.................................................. $ 1,528 $ 2,539 Difference between estimated fair value and unpaid principal balance...... 70 127 -------- -------- Carrying value at estimated fair value................................... $ 1,598 $ 2,666 ======== ======== Liabilities: (1) Contractual principal balance............................................. $ 1,436 $ 2,444 Difference between estimated fair value and contractual principal balance. 25 115 -------- -------- Carrying value at estimated fair value................................... $ 1,461 $ 2,559 ======== ======== -------- (1)These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs -- FVO is recognized in net investment income. Interest expense from long-term debt of CSEs -- FVO is recognized in other expenses. Nonrecurring Fair Value Measurements The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates; that is, they are not measured at fair value on a recurring basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3). [Enlarge/Download Table] At December 31, Years Ended December 31, -------------------------------- -------------------------- 2013 2012 2011 2013 2012 2011 ------ ------ ------- -------- --------- ------- Carrying Value After Measurement Gains (Losses) -------------------------------- -------------------------- (In millions) Mortgage loans, net (1)................. $ 36 $ 65 $ 8 $ (4) $ 4 $ 8 Other limited partnership interests (2). $ 5 $ 6 $ 5 $ (6) $ (3) $ (2) Real estate joint ventures (3).......... $ 1 $ 2 $ -- $ (1) $ (3) $ -- Goodwill (4)............................ $ -- $ -- $ -- $ (66) $ (394) $ -- -------- (1)Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows. 110
N-4334th Page of 530TOC1stPreviousNextBottomJust 334th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) (2)For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant. (3)For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant. (4)As discussed in Note 10, in 2013, the Company recorded an impairment of goodwill associated with the Retail Life & Other reporting unit. In addition, in 2012, the Company recorded an impairment of goodwill associated with the Retail Annuities reporting unit. These impairments have been categorized as Level 3 due to the significant unobservable inputs used in the determination of the estimated fair value. Fair Value of Financial Instruments Carried at Other Than Fair Value The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the "-- Recurring Fair Value Measurements" section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure. 111
N-4335th Page of 530TOC1stPreviousNextBottomJust 335th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: [Enlarge/Download Table] December 31, 2013 -------------------------------------------------------------- Fair Value Hierarchy ------------------------------------ Carrying Total Estimated Value Level 1 Level 2 Level 3 Fair Value --------- ----------- ----------- ------------ --------------- (In millions) Assets Mortgage loans...................... $ 6,120 $ -- $ -- $ 6,427 $ 6,427 Policy loans........................ $ 1,219 $ -- $ 872 $ 407 $ 1,279 Real estate joint ventures.......... $ 55 $ -- $ -- $ 98 $ 98 Other limited partnership interests. $ 78 $ -- $ -- $ 89 $ 89 Other invested assets............... $ 931 $ -- $ 995 $ -- $ 995 Premiums, reinsurance and other receivables........................ $ 5,928 $ -- $ 24 $ 6,282 $ 6,306 Liabilities PABs................................ $ 20,875 $ -- $ -- $ 21,987 $ 21,987 Long-term debt...................... $ 790 $ -- $ 1,009 $ -- $ 1,009 Other liabilities................... $ 258 $ -- $ 96 $ 162 $ 258 Separate account liabilities........ $ 1,448 $ -- $ 1,448 $ -- $ 1,448 December 31, 2012 -------------------------------------------------------------- Fair Value Hierarchy ------------------------------------ Carrying Total Estimated Value Level 1 Level 2 Level 3 Fair Value --------- ----------- ----------- ------------ --------------- (In millions) Assets Mortgage loans...................... $ 6,491 $ -- $ -- $ 7,009 $ 7,009 Policy loans........................ $ 1,216 $ -- $ 861 $ 450 $ 1,311 Real estate joint ventures.......... $ 59 $ -- $ -- $ 101 $ 101 Other limited partnership interests. $ 94 $ -- $ -- $ 103 $ 103 Other invested assets............... $ 432 $ -- $ 548 $ -- $ 548 Premiums, reinsurance and other receivables........................ $ 6,015 $ -- $ 86 $ 6,914 $ 7,000 Liabilities PABs................................ $ 22,613 $ -- $ -- $ 24,520 $ 24,520 Long-term debt...................... $ 791 $ -- $ 1,076 $ -- $ 1,076 Other liabilities................... $ 237 $ -- $ 81 $ 156 $ 237 Separate account liabilities........ $ 1,296 $ -- $ 1,296 $ -- $ 1,296 The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows: Mortgage Loans For mortgage loans, estimated fair value is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans. 112
N-4336th Page of 530TOC1stPreviousNextBottomJust 336th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) Policy Loans Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates. Real Estate Joint Ventures and Other Limited Partnership Interests The estimated fair values of these cost method investments are generally based on the Company's share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments. Other Invested Assets These other invested assets are principally comprised of loans to affiliates. The estimated fair value of loans to affiliates is determined by discounting the expected future cash flows using market interest rates currently available for instruments with similar terms and remaining maturities. Premiums, Reinsurance and Other Receivables Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled. Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty. The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value. PABs These PABs include investment contracts. Embedded derivatives on investment contracts and certain variable annuity guarantees accounted for as embedded derivatives are excluded from this caption in the preceding tables as they are separately presented in "-- Recurring Fair Value Measurements." 113
N-4337th Page of 530TOC1stPreviousNextBottomJust 337th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Fair Value (continued) The investment contracts primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability. Long-term Debt The estimated fair value of long-term debt is principally determined using market standard valuation methodologies. Valuations are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues. Other Liabilities Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values. Separate Account Liabilities Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts. Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance and certain contracts that provide for benefit funding. Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section "-- Recurring Fair Value Measurements," the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets. 10. Goodwill Goodwill is the excess of cost over the estimated fair value of net assets acquired. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test. Step 1 of the goodwill impairment process requires a comparison of the fair value of a reporting unit to its carrying value. 114
N-4338th Page of 530TOC1stPreviousNextBottomJust 338th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Goodwill (continued) In performing the Company's goodwill impairment tests, the estimated fair values of the reporting units are first determined using a market multiple valuation approach. When further corroboration is required, the Company uses a discounted cash flow valuation approach. For reporting units which are particularly sensitive to market assumptions, the Company may use additional valuation methodologies to estimate the reporting units' fair values. The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting units include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit. The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management's reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of the Company's reporting units could result in goodwill impairments in future periods which could materially adversely affect the Company's results of operations or financial position. During the 2013 annual goodwill impairment tests, the market multiple and discounted cash flow valuation techniques indicated that the fair value of the Retail Life & Other reporting unit was below its carrying value. Due to these results, an actuarial appraisal, which estimates the net worth of the reporting unit, the value of existing business and the value of new business, was also performed. This appraisal also resulted in a fair value of the Retail Life & Other reporting unit that was less than the carrying value, indicating a potential for goodwill impairment. An increase in required reserves on universal life products with secondary guarantees, together with modifications to financial reinsurance treaty terms, was reflected in the fair value estimate. In addition, decreased future sales assumptions reflected in the valuation were driven by the discontinuance of certain sales of universal life products with secondary guarantees by the Company. Accordingly, the Company performed Step 2 of the goodwill impairment process, which compares the implied fair value of goodwill with the carrying value of that goodwill in the reporting unit to calculate the amount of goodwill impairment. The Company determined that all of the recorded goodwill associated with the Retail Life & Other reporting unit was not recoverable and recorded a non-cash charge of $66 million ($57 million, net of income tax) for the impairment of the entire goodwill balance in the consolidated statements of operations for the year ended December 31, 2013. The full amount was impaired at MetLife Insurance Company of Connecticut. In addition, the Company performed its annual goodwill impairment test of its Corporate Benefit Funding reporting unit using a market multiple valuation approach and concluded that the fair value of such reporting unit was in excess of its carrying value and, therefore, goodwill was not impaired. 115
N-4339th Page of 530TOC1stPreviousNextBottomJust 339th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Goodwill (continued) Information regarding goodwill by segment, as well as Corporate & Other, was as follows: [Download Table] Corporate Benefit Corporate Retail Funding & Other (1) Total -------- --------- ----------- -------- (In millions) Balance at January 1, 2012 Goodwill..................... $ 241 $ 307 $ 405 $ 953 Accumulated impairment....... -- -- -- -- -------- ------ -------- -------- Total goodwill, net......... $ 241 $ 307 $ 405 $ 953 Impairments (2).............. (218) -- (176) (394) Balance at December 31, 2012 Goodwill..................... $ 241 $ 307 $ 405 $ 953 Accumulated impairment....... (218) -- (176) (394) -------- ------ -------- -------- Total goodwill, net......... $ 23 $ 307 $ 229 $ 559 Impairments (23) -- (43) (66) Balance at December 31, 2013. Goodwill..................... $ 241 $ 307 $ 405 $ 953 Accumulated impairment....... (241) -- (219) (460) -------- ------ -------- -------- Total goodwill, net......... $ -- $ 307 $ 186 $ 493 ======== ====== ======== ======== -------- (1)For purposes of goodwill impairment testing, the $229 million of net goodwill in Corporate & Other at December 31, 2012, which resulted from goodwill acquired as part of the 2005 Travelers acquisition, was allocated to business units of the Retail and Corporate Benefit Funding segments in the amounts of $43 million and $186 million, respectively. As reflected in the table, the $43 million related to the Retail segment was impaired for the year ended December 31, 2013. (2)In connection with its annual goodwill impairment testing, the Company determined that all of the recorded goodwill associated with the Retail Annuities reporting unit was not recoverable and recorded a non-cash charge of $394 million ($147 million, net of income tax) for the impairment of the entire goodwill balance in the consolidated statements of operations for the year ended December 31, 2012. Of this amount, $327 million ($80 million, net of income tax) was impaired at MetLife Insurance Company of Connecticut. 11. Debt Long-term debt outstanding was as follows: [Download Table] December 31, Interest ----------------- Rate Maturity 2013 2012 -------- -------- -------- -------- (In millions) Surplus notes -- affiliated........ 8.60% 2038 $ 750 $ 750 Long-term debt -- unaffiliated (1). 7.03% 2030 40 41 -------- -------- Total long-term debt (2).......... $ 790 $ 791 ======== ======== -------- (1)Principal and interest is paid quarterly. 116
N-4340th Page of 530TOC1stPreviousNextBottomJust 340th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 11. Debt (continued) (2)Excludes $1.5 billion and $2.6 billion of long-term debt relating to CSEs at December 31, 2013 and 2012, respectively. See Note 7. The aggregate maturities of long-term debt at December 31, 2013 are $1 million in each of 2014, 2015, 2016, and 2017, $2 million in 2018 and $784 million thereafter. Interest expense related to the Company's indebtedness included in other expenses was $68 million, $68 million and $67 million for the years ended December 31, 2013, 2012 and 2011, respectively. Payments of interest and principal on the surplus notes, which are subordinate to all other obligations at the operating company level, may be made only with the prior approval of the insurance department of the state of domicile. 12. Equity Return of Capital During the year ended December 31, 2011, Sino-US MetLife Insurance Company Limited ("Sino"), an insurance underwriting joint venture of the Company accounted for under the equity method, merged with United MetLife Insurance Company Limited ("United"), another insurance underwriting joint venture of an affiliate of the Company. MetLife Insurance Company of Connecticut's ownership interest in the merged entity, Sino-US United MetLife Insurance Company Limited ("Sino-United") was determined based on its contributed capital and share of undistributed earnings of Sino compared to the contributed capital and undistributed earnings of all other investees of Sino and United. Since both of the joint ventures were under common ownership both prior to and subsequent to the merger, MetLife Insurance Company of Connecticut's investment in Sino-United is based on the carrying value of its investment in Sino. Pursuant to the merger, MetLife Insurance Company of Connecticut entered into an agreement to pay the affiliate an amount based on the relative fair values of their respective investments in Sino-United. Accordingly, upon completion of the estimation of fair value, $47 million, representing a return of capital, was paid during the year ended December 31, 2011. MetLife Insurance Company of Connecticut's investment in Sino-United is accounted for under the equity method and is included in other invested assets. Common Stock The Company has 40,000,000 authorized shares of common stock, 34,595,317 shares of which were outstanding at both December 31, 2013 and 2012. Of such outstanding shares, 30,000,000 shares are owned directly by MetLife and the remaining shares are owned by MetLife Investors Group, Inc. Statutory Equity and Income Each U.S. insurance company's state of domicile imposes risk-based capital ("RBC") requirements that were developed by the National Association of Insurance Commissioners ("NAIC"). Regulatory compliance is determined by a ratio of a company's total adjusted capital, calculated in the manner prescribed by the NAIC ("TAC") to its authorized control level RBC, calculated in the manner prescribed by the NAIC ("ACL RBC"). Companies below specific trigger points or ratios are classified within certain levels, each of which requires 117
N-4341st Page of 530TOC1stPreviousNextBottomJust 341st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 12. Equity (continued) specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC. The RBC ratio for MetLife Insurance Company of Connecticut and its U.S. insurance subsidiary, MLI-USA, were in excess of 400% for all periods presented. MetLife Insurance Company of Connecticut and its insurance subsidiaries prepare statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile or applicable foreign jurisdiction. The NAIC has adopted the Codification of Statutory Accounting Principles ("Statutory Codification"). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by the various state insurance departments may impact the effect of Statutory Codification on the statutory capital and surplus of MetLife Insurance Company of Connecticut and MLI-USA. Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt, reporting of reinsurance agreements and valuing securities on a different basis. In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by the Company are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years. Statutory net income (loss) of MetLife Insurance Company of Connecticut, a Connecticut domiciled insurer, was $790 million, $848 million and $46 million for the years ended December 31, 2013, 2012 and 2011, respectively. Statutory capital and surplus was $4.8 billion and $5.3 billion at December 31, 2013 and 2012, respectively. All such amounts are derived from the statutory-basis financial statements as filed with the Connecticut Insurance Department. Statutory net income (loss) of MLI-USA, a Delaware domiciled insurer, was $209 million, $84 million and $178 million for the years ended December 31, 2013, 2012 and 2011, respectively. Statutory capital and surplus was $1.9 billion and $1.7 billion at December 31, 2013 and 2012, respectively. All such amounts are derived from the statutory-basis financial statements as filed with the Delaware Department of Insurance. As of December 31, 2013, MetLife Insurance Company of Connecticut's sole foreign insurance subsidiary, MetLife Assurance Limited ("MAL") was regulated by authorities in the United Kingdom and was subject to minimum capital and solvency requirements before corrective action commences. The required capital and surplus was $165 million and the actual regulatory capital and surplus was $573 million as of the date of the most recent capital adequacy calculation for the jurisdiction. MAL exceeded these minimum capital and solvency requirements for all other periods presented. See Note 17 for additional information on MAL. Dividend Restrictions Under Connecticut State Insurance Law, MetLife Insurance Company of Connecticut is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to its stockholders as long as the amount of such dividends, when aggregated with all other dividends in the preceding 12 months, does not exceed the greater 118
N-4342nd Page of 530TOC1stPreviousNextBottomJust 342nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 12. Equity (continued) of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year or (ii) its statutory net gain from operations for the immediately preceding calendar year. MetLife Insurance Company of Connecticut will be permitted to pay a dividend in excess of the greater of such two amounts only if it files notice of its declaration of such a dividend and the amount thereof with the Connecticut Commissioner of Insurance (the "Connecticut Commissioner") and the Connecticut Commissioner either approves the distribution of the dividend or does not disapprove the payment within 30 days after notice. In addition, any dividend that exceeds earned surplus (defined as "unassigned funds (surplus)" reduced by 25% of unrealized appreciation in value or revaluation of assets or unrealized profits on investments) as of the last filed annual statutory statement requires insurance regulatory approval. Under Connecticut State Insurance Law, the Connecticut Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. During the year ended December 31, 2013, MetLife Insurance Company of Connecticut paid a dividend to its stockholders in the amount of $1.0 billion. During the year ended December 31, 2012, MetLife Insurance Company of Connecticut paid total dividends of $706 million. During June 2012, the Company distributed all of the issued and outstanding shares of common stock of MetLife Europe to its stockholders as an in-kind extraordinary dividend of $202 million, as calculated on a statutory basis. Regulatory approval for this extraordinary dividend was obtained due to the timing of payment. During December 2012, MetLife Insurance Company of Connecticut paid a dividend to its stockholders in the amount of $504 million, which represented its ordinary dividend capacity at year-end 2012. Due to the June 2012 in -kind dividend, a portion of this was extraordinary and regulatory approval was obtained. During the years ended December 31, 2011, MetLife Insurance Company of Connecticut paid a dividend of $517 million. Based on amounts at December 31, 2013, MetLife Insurance Company of Connecticut could pay a stockholder dividend in 2014 of $1.0 billion without prior approval of the Connecticut Commissioner. Under Delaware State Insurance Law, MLI-USA is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to MetLife Insurance Company of Connecticut as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net statutory gain from operations for the immediately preceding calendar year (excluding realized capital gains). MLI-USA will be permitted to pay a dividend to MetLife Insurance Company of Connecticut in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner of Insurance (the "Delaware Commissioner") and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as "unassigned funds (surplus)") as of the immediately preceding calendar year requires insurance regulatory approval. Under Delaware State Insurance Law, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. During the years ended December 31, 2013, 2012 and 2011, MLI-USA did not pay dividends to MetLife Insurance Company of Connecticut. Because MLI-USA's statutory unassigned funds were negative at December 31, 2013, MLI-USA cannot pay any dividends in 2014 without prior regulatory approval. 119
N-4343rd Page of 530TOC1stPreviousNextBottomJust 343rd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 12. Equity (continued) Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI, net of income tax, was as follows: [Enlarge/Download Table] Unrealized Foreign Investment Gains Unrealized Currency (Losses), Net of Gains (Losses) Translation Related Offsets (1) on Derivatives Adjustments Total ------------------- -------------- ----------- ---------- (In millions) Balance at December 31, 2010................... $ 412 $ (70) $ (125) $ 217 OCI before reclassifications................... 2,118 356 (16) 2,458 Income tax expense (benefit)................... (747) (125) 2 (870) -------------- ----------- ---------- ---------- OCI before reclassifications, net of income tax......................................... 1,783 161 (139) 1,805 Amounts reclassified from AOCI................. (44) (9) -- (53) Income tax expense (benefit)................... 16 3 -- 19 -------------- ----------- ---------- ---------- Amounts reclassified from AOCI, net of income tax......................................... (28) (6) -- (34) -------------- ----------- ---------- ---------- Balance at December 31, 2011................... 1,755 155 (139) 1,771 OCI before reclassifications................... 945 7 88 1,040 Income tax expense (benefit)................... (350) (1) 2 (349) -------------- ----------- ---------- ---------- OCI before reclassifications, net of income tax......................................... 2,350 161 (49) 2,462 Amounts reclassified from AOCI................. (95) (3) -- (98) Income tax expense (benefit)................... 35 1 -- 36 -------------- ----------- ---------- ---------- Amounts reclassified from AOCI, net of income tax......................................... (60) (2) -- (62) -------------- ----------- ---------- ---------- Balance at December 31, 2012................... 2,290 159 (49) 2,400 OCI before reclassifications................... (2,039) (193) 28 (2,204) Income tax expense (benefit)................... 671 68 (2) 737 -------------- ----------- ---------- ---------- OCI before reclassifications, net of income tax......................................... 922 34 (23) 933 Amounts reclassified from AOCI................. (55) (11) -- (66) Income tax expense (benefit)................... 18 4 -- 22 -------------- ----------- ---------- ---------- Amounts reclassified from AOCI, net of income tax......................................... (37) (7) -- (44) -------------- ----------- ---------- ---------- Balance at December 31, 2013................... $ 885 $ 27 $ (23) $ 889 ============== =========== ========== ========== -------- (1)See Note 7 for information on offsets to investments related to insurance liabilities and DAC and VOBA. 120
N-4344th Page of 530TOC1stPreviousNextBottomJust 344th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 12. Equity (continued) Information regarding amounts reclassified out of each component of AOCI, was as follows: [Enlarge/Download Table] Statement of Operations and AOCI Components Amounts Reclassified from AOCI Comprehensive Income (Loss) Location -------------------------------------------- ----------------------------- ------------------------------------ Years Ended December 31, ----------------------------- 2013 2012 2011 --------- --------- --------- (In millions) Net unrealized investment gains (losses): Net unrealized investment gains (losses).................................... $ 48 $ 98 $ 14 Other net investment gains (losses) Net unrealized investment gains (losses).................................... 16 6 25 Net investment income Net unrealized investment gains (losses).................................... 2 (12) 10 Net derivative gains (losses) OTTI......................................... (11) 3 (5) OTTI on fixed maturity securities --------- --------- --------- Net unrealized investment gains (losses), before income tax............... 55 95 44 Income tax (expense) benefit............... (18) (35) (16) --------- --------- --------- Net unrealized investment gains (losses), net of income tax............... $ 37 $ 60 $ 28 ========= ========= ========= Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps.......................... -- -- 1 Net derivative gains (losses) Interest rate forwards....................... 9 1 9 Net derivative gains (losses) Interest rate forwards....................... 1 1 -- Net investment income Foreign currency swaps....................... -- 1 (2) Net derivative gains (losses) Credit forwards.............................. -- -- 1 Net derivative gains (losses) Credit forwards.............................. 1 -- -- Net investment income --------- --------- --------- Gains (losses) on cash flow hedges, before income tax......................... 11 3 9 Income tax (expense) benefit............... (4) (1) (3) --------- --------- --------- Gains (losses) on cash flow hedges, net of income tax............................. $ 7 $ 2 $ 6 ========= ========= ========= Total reclassifications, net of income tax..... $ 44 $ 62 $ 34 ========= ========= ========= 121
N-4345th Page of 530TOC1stPreviousNextBottomJust 345th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Other Expenses Information on other expenses was as follows: [Download Table] Years Ended December 31, ---------------------------- 2013 2012 2011 -------- -------- ---------- (In millions) Compensation..................................... $ 352 $ 402 $ 357 Commissions...................................... 639 939 1,418 Volume-related costs............................. 138 159 196 Affiliated interest costs on ceded reinsurance... 212 271 271 Capitalization of DAC............................ (504) (886) (1,365) Amortization of DAC and VOBA..................... 50 1,035 1,159 Interest expense on debt and debt issuance costs. 190 231 389 Premium taxes, licenses and fees................. 57 63 75 Professional services............................ 41 25 50 Rent and related expenses........................ 31 37 29 Other............................................ 453 444 402 -------- -------- ---------- Total other expenses............................ $ 1,659 $ 2,720 $ 2,981 ======== ======== ========== Capitalization of DAC and Amortization of DAC and VOBA See Note 5 for additional information on DAC and VOBA including impacts of capitalization and amortization. Interest Expense on Debt and Debt Issuance Costs Interest expense on debt and debt issuance costs includes interest expense on debt (see Note 11) and interest expense related to CSEs (see Note 7). Affiliated Expenses Commissions, capitalization of DAC and amortization of DAC include the impact of affiliated reinsurance transactions. See Notes 6, 11 and 16 for discussion of affiliated expenses included in the table above. 122
N-4346th Page of 530TOC1stPreviousNextBottomJust 346th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 14. Income Tax The provision for income tax from continuing operations was as follows: [Enlarge/Download Table] Years Ended December 31, --------------------------------------------------- 2013 2012 2011 ------ -------- -------- (In millions) Current: Federal................................................... $ (41) $ (235) $ (157) Foreign................................................... 8 (10) (5) ------ -------- -------- Subtotal................................................ (33) (245) (162) ------ -------- -------- Deferred: Federal................................................... 242 598 613 Foreign................................................... 18 19 42 ------ -------- -------- Subtotal................................................ 260 617 655 ------ -------- -------- Provision for income tax expense (benefit)............ $ 227 $ 372 $ 493 ====== ======== ======== The Company's income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations were as follows: Years Ended December 31, --------------------------------------------------- 2013 2012 2011 ------ -------- -------- (In millions) Income (loss) from continuing operations: Domestic.................................................. $ 869 $ 1,492 $ 1,545 Foreign................................................... 78 (2) 122 ------ -------- -------- Total................................................... $ 947 $ 1,490 $ 1,667 ====== ======== ======== The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported for continuing operations was as follows: Years Ended December 31, --------------------------------------------------- 2013 2012 2011 ------ -------- -------- (In millions) Tax provision at U.S. statutory rate....................... $ 331 $ 522 $ 583 Tax effect of: Dividend received deduction............................... (81) (70) (69) Tax-exempt income......................................... -- (1) (2) Prior year tax............................................ (4) 3 (9) Tax credits............................................... (10) (8) (11) Foreign tax rate differential............................. (2) 13 (1) Change in valuation allowance............................. -- 22 (2) Goodwill impairment....................................... 13 (109) -- Sale of subsidiary........................................ (24) -- -- Other, net................................................ 4 -- 4 ------ -------- -------- Provision for income tax expense (benefit).............. $ 227 $ 372 $ 493 ====== ======== ======== 123
N-4347th Page of 530TOC1stPreviousNextBottomJust 347th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 14. Income Tax (continued) Deferred income tax represents the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: [Enlarge/Download Table] December 31, ----------------------------------------------------- 2013 2012 ---------------- ------------------ (In millions) Deferred income tax assets: Policyholder liabilities and receivables.................. $ 1,282 $ 883 Net operating loss carryforwards.......................... 22 32 Employee benefits......................................... -- 3 Tax credit carryforwards.................................. 125 92 Other..................................................... 7 35 ---------------- ------------------ Total gross deferred income tax assets.................. 1,436 1,045 Less: Valuation allowance................................. -- 25 ---------------- ------------------ Total net deferred income tax assets.................... 1,436 1,020 ---------------- ------------------ Deferred income tax liabilities: Investments, including derivatives........................ 651 258 Net unrealized investment gains........................... 575 1,336 DAC and VOBA.............................................. 1,543 1,281 Other..................................................... 52 15 ---------------- ------------------ Total deferred income tax liabilities................... 2,821 2,890 ---------------- ------------------ Net deferred income tax asset (liability)............. $ (1,385) $ (1,870) ================ ================== The following table sets forth the domestic net operating carryforwards for tax purposes at December 31, 2013: Net Operating Loss Carryforwards ----------------------------------------------------- Amount Expiration ---------------- ------------------ (In millions) Domestic................................................... $ 64 Beginning in 2028 Tax credit carryforwards of $125 million at December 31, 2013 will expire beginning in 2015. Pursuant to Internal Revenue Service ("IRS") rules, the Company was excluded from MetLife's life/non-life consolidated federal tax return for the five years subsequent to MetLife's July 2005 acquisition of the Company. In 2011, MetLife Insurance Company of Connecticut and its subsidiaries joined the consolidated return and became a party to the MetLife tax sharing agreement. Prior to 2011, MetLife Insurance Company of Connecticut filed a consolidated tax return with its includable subsidiaries. Non-includable subsidiaries filed either separate individual corporate tax returns or separate consolidated tax returns. The Company participates in a tax sharing agreement with MetLife, as described in Note 1. Pursuant to this tax sharing agreement, the amounts due from affiliates included $194 million, $135 million, and $151 million at December 31, 2013, 2012, and 2011, respectively. 124
N-4348th Page of 530TOC1stPreviousNextBottomJust 348th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 14. Income Tax (continued) The Company files income tax returns with the U.S. federal government and various state and local jurisdictions, as well as foreign jurisdictions. The Company is under continuous examination by the IRS and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction. The Company is no longer subject to U.S. federal, state or local income tax examinations in major taxing jurisdictions for years prior to 2005. In 2012, the Company and the IRS completed and settled substantially all the issues identified in the audit years of 2005 and 2006. The issues not settled are under review at the IRS Appeals Division. The Company's liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its consolidated financial statements, although the resolution of income tax matters could impact the Company's effective tax rate for a particular future period. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: [Enlarge/Download Table] Years Ended December 31, --------------------------- 2013 2012 2011 ------- --------- --------- (In millions) Balance at January 1,.................................................... $ (1) $ 29 $ 38 Additions for tax positions of prior years............................... 25 46 -- Reductions for tax positions of prior years.............................. (1) (76) (3) Additions for tax positions of current year.............................. 1 9 2 Reductions for tax positions of current year............................. (1) (9) (8) ------- --------- --------- Balance at December 31,.................................................. $23 $ (1) $ 29 ======= ========= ========= Unrecognized tax benefits that, if recognized would impact the effective rate................................................................... $ 23 $ (1) $ (3) ======= ========= ========= The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense. Interest was as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------ ------ ------- (In millions) Interest recognized in the consolidated statements of operations. $ 1 $ (9) $ -- December 31, ---------------- 2013 2012 ------ ------- (In millions) Interest included in other liabilities in the consolidated balance sheets $ 1 $ -- The Company had no penalties for the years ended December 31, 2013, 2012 and 2011. 125
N-4349th Page of 530TOC1stPreviousNextBottomJust 349th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 14. Income Tax (continued) The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction ("DRD"), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2013 and 2012, the Company recognized an income tax benefit of $92 million and $70 million, respectively, related to the separate account DRD. The 2013 benefit included a benefit of $11 million related to a true-up of the 2012 tax return. The 2012 benefit included an expense of less than $1 million related to a true-up of the 2011 tax return. 15. Contingencies, Commitments and Guarantees Contingencies Litigation The Company is a defendant in a number of litigation matters. In some of the matters, large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities have been established for some of the matters below. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at December 31, 2013. 126
N-4350th Page of 530TOC1stPreviousNextBottomJust 350th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Contingencies, Commitments and Guarantees (continued) Matters as to Which an Estimate Can Be Made For some of the matters discussed below, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of December 31, 2013, the aggregate range of reasonably possible losses in excess of amounts accrued for these matters was not material for the Company. Matters as to Which an Estimate Cannot Be Made For other matters disclosed below, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. Unclaimed Property Inquiries In April 2012, MetLife, for itself and on behalf of entities including MetLife Insurance Company of Connecticut, reached agreements with representatives of the U.S. jurisdictions that were conducting audits of MetLife and certain of its affiliates for compliance with unclaimed property laws, and with state insurance regulators directly involved in a multistate targeted market conduct examination relating to claim-payment practices and compliance with unclaimed property laws. On December 28, 2012, the West Virginia Treasurer filed an action (West Virginia ex rel. John D. Perdue v. MetLife Insurance Company of Connecticut, Circuit Court of Putnam County) alleging that the Company violated the West Virginia Uniform Unclaimed Property Act, seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, the Treasurer filed a substantially identical suit against MLI-USA. On December 30, 2013, the court granted defendants' motions to dismiss all of the West Virginia Treasurer's actions. The Treasurer has filed a notice to appeal the dismissal order. At least one other jurisdiction is pursuing a similar market conduct examination. It is possible that other jurisdictions may pursue similar examinations, audits, or lawsuits and that such actions may result in additional payments to beneficiaries, additional escheatment of funds deemed abandoned under state laws, administrative penalties, interest, and/or further changes to the Company's procedures. The Company is not currently able to estimate these additional possible costs. Sales Practices Claims Over the past several years, the Company has faced claims and regulatory inquires and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. The Company continues to vigorously defend against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters. 127
N-4351st Page of 530TOC1stPreviousNextBottomJust 351st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Contingencies, Commitments and Guarantees (continued) Summary Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company's consolidated financial statements, have arisen in the course of the Company's business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company's compliance with applicable insurance and other laws and regulations. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company's financial position, based on information currently known by the Company's management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company's consolidated net income or cash flows in particular quarterly or annual periods. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assets and liabilities held for insolvency assessments were as follows: [Download Table] December 31, --------------- 2013 2012 ------- ------- (In millions) Other Assets: Premium tax offset for future undiscounted assessments....... $ 10 $ 19 Premium tax offsets currently available for paid assessments. 10 2 ------- ------- $ 20 $ 21 ======= ======= Other Liabilities: Insolvency assessments....................................... $ 14 $ 37 ======= ======= On September 1, 2011, the Department of Financial Services filed a liquidation plan for Executive Life Insurance Company of New York ("ELNY"), which had been under rehabilitation by the Liquidation Bureau since 1991. The plan involves the satisfaction of insurers' financial obligations under a number of state life and health insurance guaranty associations and also provides additional industry support for certain ELNY policyholders. 128
N-4352nd Page of 530TOC1stPreviousNextBottomJust 352nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Contingencies, Commitments and Guarantees (continued) Commitments Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commitments were $956 million and $1.0 billion at December 31, 2013 and 2012, respectively. The Company anticipates that these amounts will be invested in partnerships over the next five years. Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $147 million and $181 million at December 31, 2013 and 2012, respectively. Commitments to Fund Bank Credit Facilities and Private Corporate Bond Investments The Company commits to lend funds under bank credit facilities and private corporate bond investments. The amounts of these unfunded commitments were $57 million and $144 million at December 31, 2013 and 2012, respectively. Other Commitments The Company has entered into collateral arrangements with affiliates, which require the transfer of collateral in connection with secured demand notes. At December 31, 2013 and 2012, the Company had agreed to fund up to $61 million and $86 million, respectively, of cash upon the request by these affiliates and had transferred collateral consisting of various securities with a fair market value of $74 million and $106 million, respectively, to custody accounts to secure the demand notes. Each of these affiliates is permitted by contract to sell or repledge this collateral. See Note 7 "-- Related Party Investment Transactions" for additional other commitments. Guarantees In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. The maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, ranging from $36 million to $233 million, with a cumulative maximum of $269 million, in the case of MetLife International Insurance Company, Ltd. ("MLII"), a former affiliate, discussed below. In other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the 129
N-4353rd Page of 530TOC1stPreviousNextBottomJust 353rd
15. Contingencies, Commitments and Guarantees (continued) Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments. The Company has provided a guarantee on behalf of MLII that is triggered if MLII cannot pay claims because of insolvency, liquidation or rehabilitation. Life insurance coverage in-force, representing the maximum potential obligation under this guarantee, was $233 million and $235 million at December 31, 2013 and 2012, respectively. The Company does not hold any collateral related to this guarantee, but has a recorded liability of $1 million that was based on the total account value of the guaranteed policies plus the amounts retained per policy at both December 31, 2013 and 2012. The remainder of the risk was ceded to external reinsurers. In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company's interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future. 16. Related Party Transactions Service Agreements The Company has entered into various agreements with affiliates for services necessary to conduct its activities. Typical services provided under these agreements include management, policy administrative functions, personnel, investment advice and distribution services. For certain agreements, charges are based on various performance measures or activity-based costing. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Expenses incurred with affiliates related to these agreements, recorded in other expenses, were $1.6 billion, $1.7 billion and $1.9 billion for the years ended December 31, 2013, 2012 and 2011, respectively. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $209 million, $179 million and $145 million for the years ended December 31, 2013, 2012 and 2011, respectively. Revenues received from affiliates related to these agreements, recorded in other revenues, were $186 million, $166 million and $136 million for the years ended December 31, 2013, 2012 and 2011, respectively. The Company had net payables to affiliates, related to the items discussed above, of $210 million and $109 million at December 31, 2013 and 2012, respectively. See Notes 6, 7 and 11 for additional information on related party transactions. 17. Subsequent Events Equity In August 2014, in anticipation of the Mergers, MetLife Insurance Company of Connecticut redeemed and retired the 4,595,317 shares of MetLife Insurance Company of Connecticut's common stock owned by MetLife Investors Group, LLC for $1.4 billion; all of the outstanding shares of common stock of MetLife Insurance Company of Connecticut are now directly held by MetLife, Inc. MetLife Insurance Company of Connecticut does not expect to pay a dividend in 2014. 130
N-4354th Page of 530TOC1stPreviousNextBottomJust 354th
17. Subsequent Events (continued) In August 2014, following the common stock redemption, MetLife Insurance Company of Connecticut received a capital contribution from MetLife, Inc. of $231 million. Disposition In May 2014, the Company completed the sale of its wholly-owned subsidiary, MAL, for $702 million ((Pounds)418 million) in net cash consideration. As a result of the sale, a loss of $608 million ($436 million, net of income tax) was recorded, which includes a reduction to goodwill of $112 million ($94 million, net of income tax). The loss on the sale was increased by net income from MAL of $77 million through the date of sale. Following the adoption of new guidance effective January 1, 2014, MAL's results of operations have been included in continuing operations in subsequent quarterly filings. They were historically included in the Corporate Benefit Funding segment. 131
N-4355th Page of 530TOC1stPreviousNextBottomJust 355th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule I Consolidated Summary of Investments -- Other Than Investments in Related Parties December 31, 2013 (In millions) [Enlarge/Download Table] Amount at Cost or Estimated Fair Which Shown on Types of Investments Amortized Cost (1) Value Balance Sheet -------------------- ------------------ -------------- -------------- Fixed maturity securities: Bonds: U.S. Treasury and agency securities........ $ 8,188 $ 8,294 $ 8,294 Public utilities........................... 3,966 4,275 4,275 State and political subdivision securities. 2,147 2,224 2,224 Foreign government securities.............. 1,038 1,122 1,122 All other corporate bonds.................. 19,512 20,478 20,478 --------------- ----------- ------------- Total bonds.............................. 34,851 36,393 36,393 Mortgage-backed and asset-backed securities.. 8,214 8,393 8,393 Redeemable preferred stock................... 412 466 466 --------------- ----------- ------------- Total fixed maturity securities........ 43,477 45,252 45,252 --------------- ----------- ------------- Equity securities: Common stock: Industrial, miscellaneous and all other...... 161 201 201 Non-redeemable preferred stock............... 236 217 217 --------------- ----------- ------------- Total equity securities.................. 397 418 418 --------------- ----------- ------------- Mortgage loans, net.................... 7,718 7,718 Policy loans.................................. 1,219 1,219 Real estate and real estate joint ventures.... 754 754 Other limited partnership interests........... 2,130 2,130 Short-term investments........................ 2,107 2,107 Other invested assets......................... 2,555 2,555 --------------- ------------- Total investments..................... $ 60,357 $ 62,153 =============== ============= -------- (1)Cost or amortized cost for fixed maturity securities and mortgage loans represents original cost reduced by repayments, valuation allowances and impairments from other-than-temporary declines in estimated fair value that are charged to earnings and adjusted for amortization of premiums or discounts; for equity securities, cost represents original cost reduced by impairments from other-than-temporary declines in estimated fair value; for real estate, cost represents original cost reduced by impairments and adjusted for valuation allowances and depreciation; for real estate joint ventures and other limited partnership interests cost represents original cost reduced for other-than-temporary impairments or original cost adjusted for equity in earnings and distributions. 132
N-4356th Page of 530TOC1stPreviousNextBottomJust 356th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule II Condensed Financial Information (Parent Company Only) December 31, 2013 and 2012 (In millions, except share and per share data) [Enlarge/Download Table] 2013 - --------- Condensed Balance Sheets Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $28,548 and $32,018, respectively)............................................................................................... $ 29,690 Equity securities available-for-sale, at estimated fair value (cost: $284 and $273, respectively)............ 319 Mortgage loans (net of valuation allowances of $19 and $22, respectively).................................... 4,224 Policy loans................................................................................................. 1,068 Real estate and real estate joint ventures................................................................... 419 Other limited partnership interests.......................................................................... 1,318 Short-term investments, principally at estimated fair value.................................................. 1,512 Investment in subsidiaries................................................................................... 6,099 Loans to subsidiaries........................................................................................ 680 Other invested assets, principally at estimated fair value................................................... 1,139 --------- Total investments........................................................................................... 46,468 Cash and cash equivalents, principally at estimated fair value................................................. 417 Accrued investment income...................................................................................... 287 Premiums, reinsurance and other receivables.................................................................... 7,195 Receivables from subsidiaries.................................................................................. 858 Deferred policy acquisition costs and value of business acquired............................................... 1,011 Current income tax recoverable................................................................................. 88 Goodwill....................................................................................................... 493 Other assets................................................................................................... 132 Separate account assets........................................................................................ 16,036 --------- Total assets................................................................................................ $ 72,985 ========= Liabilities and Stockholders' Equity Liabilities Future policy benefits......................................................................................... $ 19,099 Policyholder account balances.................................................................................. 22,387 Other policy-related balances.................................................................................. 246 Payables for collateral under securities loaned and other transactions......................................... 4,811 Long-term debt -- affiliated................................................................................... 750 Current income tax payable..................................................................................... -- Deferred income tax liability.................................................................................. 16 Other liabilities.............................................................................................. 852 Separate account liabilities................................................................................... 16,036 --------- Total liabilities........................................................................................... 64,197 --------- Stockholders' Equity Common stock, par value $2.50 per share; 40,000,000 shares authorized; 34,595,317 shares issued and outstanding at December 31, 2013 and 2012..................................................................... 86 Additional paid-in capital..................................................................................... 6,737 Retained earnings.............................................................................................. 1,076 Accumulated other comprehensive income (loss).................................................................. 889 --------- Total stockholders' equity.................................................................................. 8,788 --------- Total liabilities and stockholders' equity.................................................................. $ 72,985 ========= [Enlarge/Download Table] 2012 - --------- Condensed Balance Sheets Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $28,548 and $32,018, respectively)............................................................................................... $ 35,152 Equity securities available-for-sale, at estimated fair value (cost: $284 and $273, respectively)............ 277 Mortgage loans (net of valuation allowances of $19 and $22, respectively).................................... 4,703 Policy loans................................................................................................. 1,086 Real estate and real estate joint ventures................................................................... 371 Other limited partnership interests.......................................................................... 1,181 Short-term investments, principally at estimated fair value.................................................. 1,833 Investment in subsidiaries................................................................................... 6,641 Loans to subsidiaries........................................................................................ 305 Other invested assets, principally at estimated fair value................................................... 1,682 --------- Total investments........................................................................................... 53,231 Cash and cash equivalents, principally at estimated fair value................................................. 553 Accrued investment income...................................................................................... 316 Premiums, reinsurance and other receivables.................................................................... 7,003 Receivables from subsidiaries.................................................................................. 833 Deferred policy acquisition costs and value of business acquired............................................... 789 Current income tax recoverable................................................................................. -- Goodwill....................................................................................................... 558 Other assets................................................................................................... 140 Separate account assets........................................................................................ 15,238 --------- Total assets................................................................................................ $ 78,661 ========= Liabilities and Stockholders' Equity Liabilities Future policy benefits......................................................................................... $ 19,632 Policyholder account balances.................................................................................. 24,039 Other policy-related balances.................................................................................. 872 Payables for collateral under securities loaned and other transactions......................................... 6,477 Long-term debt -- affiliated................................................................................... 750 Current income tax payable..................................................................................... 3 Deferred income tax liability.................................................................................. 266 Other liabilities.............................................................................................. 824 Separate account liabilities................................................................................... 15,238 --------- Total liabilities........................................................................................... 68,101 --------- Stockholders' Equity Common stock, par value $2.50 per share; 40,000,000 shares authorized; 34,595,317 shares issued and outstanding at December 31, 2013 and 2012..................................................................... 86 Additional paid-in capital..................................................................................... 6,718 Retained earnings.............................................................................................. 1,356 Accumulated other comprehensive income (loss).................................................................. 2,400 --------- Total stockholders' equity.................................................................................. 10,560 --------- Total liabilities and stockholders' equity.................................................................. $ 78,661 ========= See accompanying notes to the condensed financial information. 133
N-4357th Page of 530TOC1stPreviousNextBottomJust 357th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule II Condensed Financial Information -- (Continued) (Parent Company Only) For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 --------- --------- --------- Condensed Statements of Operations Revenues Premiums............................................................. $ 181 $ 144 $ 148 Universal life and investment-type product policy fees............... 645 662 632 Net investment income................................................ 1,797 1,854 1,943 Equity in earnings of subsidiaries................................... 287 773 574 Other revenues....................................................... 147 151 154 Net investment gains (losses)........................................ 54 20 14 Net derivative gains (losses)........................................ (105) (140) 241 --------- --------- --------- Total revenues...................................................... 3,006 3,464 3,706 --------- --------- --------- Expenses Policyholder benefits and claims..................................... 916 797 755 Interest credited to policyholder account balances................... 618 666 710 Goodwill impairment.................................................. 66 327 -- Other expenses....................................................... 499 576 772 --------- --------- --------- Total expenses...................................................... 2,099 2,366 2,237 --------- --------- --------- Income (loss) from continuing operations before provision for income tax................................................................ 907 1,098 1,469 Provision for income tax expense (benefit)........................... 187 (20) 295 --------- --------- --------- Income (loss) from continuing operations, net of income tax.......... 720 1,118 1,174 Income (loss) from discontinued operations, net of income tax........ -- 8 -- --------- --------- --------- Net income (loss).................................................... $ 720 $ 1,126 $ 1,174 ========= ========= ========= Comprehensive income (loss).......................................... $ (791) $ 1,755 $ 2,728 ========= ========= ========= See accompanying notes to the condensed financial information. 134
N-4358th Page of 530TOC1stPreviousNextBottomJust 358th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule II Condensed Financial Information -- (Continued) (Parent Company Only) For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ------------ ---------- --------- Condensed Statements of Cash Flows Cash flows from operating activities Net cash provided by (used in) operating activities...................... $ 957 $ 1,184 $ 886 Cash flows from investing activities Sales, maturities, and repayments of: Fixed maturity securities.............................................. 14,647 10,714 13,921 Equity securities...................................................... 56 46 163 Mortgage loans......................................................... 1,154 845 552 Real estate and real estate joint ventures............................. 58 47 12 Other limited partnership interests.................................... 102 154 159 Purchases of: Fixed maturity securities.............................................. (11,000) (10,729) (11,658) Equity securities...................................................... (51) (27) (22) Mortgage loans......................................................... (648) (428) (946) Real estate and real estate joint ventures............................. (129) (77) (83) Other limited partnership interests.................................... (192) (179) (214) Cash received in connection with freestanding derivatives................ 73 362 375 Cash paid in connection with freestanding derivatives.................... (644) (322) (453) Dividends from subsidiaries.............................................. 25 -- -- Returns of capital from subsidiaries..................................... 52 84 49 Capital contributions to subsidiaries.................................... (3) (166) (422) Issuances of loans to affiliates......................................... (375) -- (305) Net change in policy loans............................................... 18 15 26 Net change in short-term investments..................................... 321 (251) (487) Net change in other invested assets...................................... (39) (50) (16) ------------ ---------- --------- Net cash provided by (used in) investing activities........................ 3,425 38 651 ------------ ---------- --------- Cash flows from financing activities Policyholder account balances: Deposits............................................................... 12,156 11,577 14,151 Withdrawals............................................................ (13,987) (12,298) (15,754) Net change in payables for collateral under securities loaned and other transactions............................................................ (1,666) 102 (482) Financing element on certain derivative instruments...................... (21) 75 127 Return of capital........................................................ -- -- (47) Dividends on common stock................................................ (1,000) (504) (517) ------------ ---------- --------- Net cash provided by (used in) financing activities........................ (4,518) (1,048) (2,522) ------------ ---------- --------- Change in cash and cash equivalents........................................ (136) 174 (985) Cash and cash equivalents, beginning of year............................... 553 379 1,364 ------------ ---------- --------- Cash and cash equivalents, end of year..................................... $ 417 $ 553 $ 379 ============ ========== ========= Supplemental disclosures of cash flow information: Net cash paid (received) for: Interest............................................................... $ 64 $ 64 $ 64 ============ ========== ========= Income tax............................................................. $ 120 $ (194) $ (66) ============ ========== ========= Non-cash transactions: Capital contribution from MetLife, Inc................................. $ 19 $ 45 $ -- ============ ========== ========= Returns of capital from subsidiaries................................... $ -- $ 202 $ -- ============ ========== ========= Capital contributions to subsidiaries.................................. $ 16 $ 31 $ -- ============ ========== ========= See accompanying notes to the condensed financial information. 135
N-4359th Page of 530TOC1stPreviousNextBottomJust 359th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule II Notes to the Condensed Financial Information (Parent Company Only) 1. Basis of Presentation The condensed financial information of MetLife Insurance Company of Connecticut (the "Parent Company") should be read in conjunction with the consolidated financial statements of MetLife Insurance Company of Connecticut and its subsidiaries and the notes thereto. These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for the Parent Company. Investments in subsidiaries are accounted for using the equity method of accounting. The preparation of these condensed unconsolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, the accounting for goodwill and identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates. 2. Support Agreement The Parent Company has entered into a net worth maintenance agreement with its indirect subsidiary, MetLife Assurance Limited ("MAL"), a United Kingdom company. Under the agreement, the Parent Company agreed, without limitation as to amount, to cause MAL to have capital and surplus equal to the greater of (a) (Pounds)50 million, (b) such amount that will be sufficient to provide solvency cover equal to 175% of MAL's capital resources requirement as defined by applicable law and regulation as required by the Financial Services Authority of the United Kingdom (the "FSA") or any successor body, or (c) such amount that will be sufficient to provide solvency cover equal to 125% of MAL's individual capital guidance as defined by applicable law and regulation as required by the FSA or any successor body. As described in Note 17 of the Notes to the Consolidated Financial Statements, a subsidiary of MetLife Insurance Company of Connecticut reached an agreement to sell MAL to a third party. Upon the close of such sale, the Parent Company's obligations under this net worth maintenance agreement will terminate. 136
N-4360th Page of 530TOC1stPreviousNextBottomJust 360th
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule III Consolidated Supplementary Insurance Information December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] Future Policy Benefits DAC and Other Policyholder and Policy-Related Account Unearned Unearned Segment VOBA Balances Balances Premiums (1), (2) Revenue (1) -------------------------- -------- ---------------------- ------------ ----------------- ----------- 2013 Retail.................... $ 4,698 $ 10,345 $ 25,499 $ 9 $ 156 Corporate Benefit Funding. 6 14,270 7,952 -- 2 Corporate & Other......... 26 6,540 2 4 -- -------- ---------------- --------- ------------- -------- Total.................... $ 4,730 $ 31,155 $ 33,453 $ 13 $ 158 ======== ================ ========= ============= ======== 2012 Retail.................... $ 3,738 $ 9,355 $ 28,287 $ 9 $ 158 Corporate Benefit Funding. 8 15,078 8,688 -- 2 Corporate & Other......... -- 6,288 1 4 -- -------- ---------------- --------- ------------- -------- Total.................... $ 3,746 $ 30,721 $ 36,976 $ 13 $ 160 ======== ================ ========= ============= ======== 2011 Retail.................... $ 4,080 $ 7,915 $ 30,001 $ 7 $ 184 Corporate Benefit Funding. 13 14,042 8,375 -- 2 Corporate & Other......... 128 6,515 3,699 5 72 -------- ---------------- --------- ------------- -------- Total.................... $ 4,221 $ 28,472 $ 42,075 $ 12 $ 258 ======== ================ ========= ============= ======== -------- (1)Amounts are included within the future policy benefits and other policy-related balances column. (2)Includes premiums received in advance. 137
N-4361st Page of 530TOC1stPreviousNextBottomJust 361st
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule III Consolidated Supplementary Insurance Information -- (Continued) December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] Policyholder Benefits and Premium Claims and Amortization of Revenue Net Interest Credited DAC and VOBA Other and Policy Investment to Policyholder Charged to Operating Segment Charges Income Account Balances Other Expenses Expenses (1) -------------------------- ---------- ---------- ----------------- --------------- ------------ 2013 Retail.................... $ 2,688 $ 1,515 $ 1,875 $ 44 $ 1,341 Corporate Benefit Funding. 219 1,108 855 5 34 Corporate & Other......... 35 229 14 1 234 -------- -------- ------------ ----------- --------- Total.................... $ 2,942 $ 2,852 $ 2,744 $ 50 $ 1,609 ======== ======== ============ =========== ========= 2012 Retail.................... $ 2,716 $ 1,434 $ 2,031 $ 1,023 $ 1,381 Corporate Benefit Funding. 658 1,111 1,318 10 36 Corporate & Other......... 148 407 187 2 268 -------- -------- ------------ ----------- --------- Total.................... $ 3,522 $ 2,952 $ 3,536 $ 1,035 $ 1,685 ======== ======== ============ =========== ========= 2011 Retail.................... $ 2,596 $ 1,360 $ 1,984 $ 1,149 $ 1,268 Corporate Benefit Funding. 1,105 1,142 1,763 4 36 Corporate & Other......... 83 572 102 6 518 -------- -------- ------------ ----------- --------- Total.................... $ 3,784 $ 3,074 $ 3,849 $ 1,159 $ 1,822 ======== ======== ============ =========== ========= -------- (1)Includes other expenses, excluding amortization of deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") charged to other expenses. 138
N-4362nd Page of 530TOC1stPreviousNextBottomJust 362nd
MetLife Insurance Company of Connecticut (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule IV Consolidated Reinsurance December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] % Amount Gross Amount Ceded Assumed Net Amount Assumed to Net ------------ ---------- -------- ---------- -------------- 2013 Life insurance in-force....... $ 466,650 $ 424,836 $ 7,273 $ 49,087 14.8% ========== ========== ======== ========= Insurance premium Life insurance................ $ 1,327 $ 737 $ 10 $ 600 1.7% Accident and health insurance. 234 228 -- 6 -- ---------- ---------- -------- --------- Total insurance premium...... $ 1,561 $ 965 $ 10 $ 606 1.7% ========== ========== ======== ========= 2012 Life insurance in-force....... $ 428,803 $ 391,045 $ 7,750 $ 45,508 17.0% ========== ========== ======== ========= Insurance premium Life insurance................ $ 1,815 $ 572 $ 11 $ 1,254 0.9% Accident and health insurance. 248 241 -- 7 -- ---------- ---------- -------- --------- Total insurance premium...... $ 2,063 $ 813 $ 11 $ 1,261 0.9% ========== ========== ======== ========= 2011 Life insurance in-force....... $ 378,153 $ 340,477 $ 8,085 $ 45,761 17.7% ========== ========== ======== ========= Insurance premium Life insurance................ $ 2,180 $ 366 $ 7 $ 1,821 0.4% Accident and health insurance. 249 242 -- 7 -- ---------- ---------- -------- --------- Total insurance premium...... $ 2,429 $ 608 $ 7 $ 1,828 0.4% ========== ========== ======== ========= For the year ended December 31, 2013, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $269.9 billion and $7.3 billion, respectively, and life insurance premiums of $638 million and $ 10 million, respectively. For the year ended December 31, 2012, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $237.2 billion and $7.8 billion, respectively, and life insurance premiums of $478 million and $11 million, respectively. For the year ended December 31, 2011, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $195.2 billion and $8.1 billion, respectively, and life insurance premiums of $286 million and $ 7 million, respectively. 139
N-4363rd Page of 530TOC1stPreviousNextBottomJust 363rd
MetLife Investors Insurance Company Financial Statements As of December 31, 2013 and 2012 and for the Years Ended December 31, 2013, 2012 and 2011 and Independent Auditors' Report
N-4364th Page of 530TOC1stPreviousNextBottomJust 364th
INDEPENDENT AUDITORS' REPORT To the Board of Directors and Stockholder of MetLife Investors Insurance Company: We have audited the accompanying financial statements of MetLife Investors Insurance Company (a wholly-owned subsidiary of MetLife, Inc.) (the "Company"), which comprise the balance sheets as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2013, and the related notes to the financial statements. Management's Responsibility for the Financial Statements Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error. Auditors' Responsibility Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement. An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion. Opinion In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of MetLife Investors Insurance Company as of December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013 in accordance with accounting principles generally accepted in the United States of America. Other Matter Results of the Company may not be indicative of those of a stand-alone entity, as the Company is a member of a controlled group of affiliated companies. /s/ DELOITTE & TOUCHE LLP Certified Public Accountants Tampa, Florida March 31, 2014 1
N-4365th Page of 530TOC1stPreviousNextBottomJust 365th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Balance Sheets December 31, 2013 and 2012 (In millions, except share and per share data) [Enlarge/Download Table] 2013 2012 ----------- ----------- Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $2,200 and $2,178, respectively).......................................... $ 2,250 $ 2,320 Equity securities available-for-sale, at estimated fair value (cost: $46 and $48, respectively)................................................................... 45 45 Mortgage loans (net of valuation allowances of $1 and $2, respectively)........... 286 284 Policy loans...................................................................... 27 27 Other limited partnership interests............................................... 32 23 Short-term investments, at estimated fair value................................... 75 139 Other invested assets............................................................. 68 93 ----------- ----------- Total investments............................................................... 2,783 2,931 Cash and cash equivalents.......................................................... 24 27 Accrued investment income.......................................................... 26 28 Premiums, reinsurance and other receivables........................................ 1,829 2,485 Deferred policy acquisition costs and value of business acquired................... 291 148 Current income tax recoverable..................................................... 9 9 Other assets....................................................................... 110 115 Separate account assets............................................................ 12,033 11,072 ----------- ----------- Total assets.................................................................... $ 17,105 $ 16,815 =========== =========== Liabilities and Stockholder's Equity Liabilities Future policy benefits............................................................. $ 501 $ 482 Policyholder account balances...................................................... 2,748 3,077 Other policy-related balances...................................................... 102 102 Payables for collateral under securities loaned and other transactions............. 266 238 Deferred income tax liability...................................................... 192 326 Other liabilities.................................................................. 94 78 Separate account liabilities....................................................... 12,033 11,072 ----------- ----------- Total liabilities............................................................... 15,936 15,375 ----------- ----------- Contingencies, Commitments and Guarantees (Note 11) Stockholder's Equity Common stock, par value $2 per share; 5,000,000 shares authorized; 2,899,446 shares issued and outstanding......................................... 6 6 Additional paid-in capital........................................................ 636 636 Retained earnings................................................................. 504 722 Accumulated other comprehensive income (loss)..................................... 23 76 ----------- ----------- Total stockholder's equity...................................................... 1,169 1,440 ----------- ----------- Total liabilities and stockholder's equity...................................... $ 17,105 $ 16,815 =========== =========== See accompanying notes to the financial statements. 2
N-4366th Page of 530TOC1stPreviousNextBottomJust 366th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Statements of Operations For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ---------- -------- -------- Revenues Premiums......................................................... $ 29 $ 11 $ 7 Universal life and investment-type product policy fees........... 202 198 204 Net investment income............................................ 114 113 114 Fees on ceded reinsurance and other.............................. 90 93 104 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities.. -- (2) -- Other net investment gains (losses)............................ 1 (2) (5) ---------- -------- -------- Total net investment gains (losses)........................... 1 (4) (5) Net derivative gains (losses).................................. (442) 329 326 ---------- -------- -------- Total revenues.............................................. (6) 740 750 ---------- -------- -------- Expenses Policyholder benefits and claims................................. 48 100 59 Interest credited to policyholder account balances............... 113 118 127 Other expenses................................................... (11) 229 259 ---------- -------- -------- Total expenses.............................................. 150 447 445 ---------- -------- -------- Income (loss) before provision for income tax.................... (156) 293 305 Provision for income tax expense (benefit)....................... (67) 94 90 ---------- -------- -------- Net income (loss)................................................ $ (89) $ 199 $ 215 ========== ======== ======== See accompanying notes to the financial statements. 3
N-4367th Page of 530TOC1stPreviousNextBottomJust 367th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Statements of Comprehensive Income (Loss) For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ---------- -------- -------- Net income (loss).................................................... $ (89) $ 199 $ 215 Other comprehensive income (loss): Unrealized investment gains (losses), net of related offsets........ (80) 64 23 Unrealized gains (losses) on derivatives............................ (2) (1) -- ---------- -------- -------- Other comprehensive income (loss), before income tax................. (82) 63 23 Income tax (expense) benefit related to items of other comprehensive income (loss)...................................................... 29 (22) (8) ---------- -------- -------- Other comprehensive income (loss), net of income tax................. (53) 41 15 ---------- -------- -------- Comprehensive income (loss).......................................... $ (142) $ 240 $ 230 ========== ======== ======== See accompanying notes to the financial statements. 4
N-4368th Page of 530TOC1stPreviousNextBottomJust 368th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Statements of Stockholder's Equity For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] Accumulated Other Comprehensive Income (Loss) ---------------------- Net Unrealized Additional Investment Other-Than- Total Common Paid-in Retained Gains Temporary Stockholder's Stock Capital Earnings (Losses) Impairments Equity ------ ---------- -------- ---------- ----------- ------------- Balance at December 31, 2010.......................... $6 $636 $ 326 $ 24 $(4) $ 988 Net income (loss)..................................... 215 215 Other comprehensive income (loss), net of income tax.. 16 (1) 15 ------ ---------- -------- ---------- ----------- ------------- Balance at December 31, 2011.......................... 6 636 541 40 (5) 1,218 Dividend on common stock.............................. (18) (18) Net income (loss)..................................... 199 199 Other comprehensive income (loss), net of income tax.. 39 2 41 ------ ---------- -------- ---------- ----------- ------------- Balance at December 31, 2012.......................... 6 636 722 79 (3) 1,440 Dividend on common stock.............................. (129) (129) Net income (loss)..................................... (89) (89) Other comprehensive income (loss), net of income tax.. (54) 1 (53) ------ ---------- -------- ---------- ----------- ------------- Balance at December 31, 2013.......................... $6 $636 $ 504 $ 25 $(2) $1,169 ====== ========== ======== ========== =========== ============= See accompanying notes to the financial statements. 5
N-4369th Page of 530TOC1stPreviousNextBottomJust 369th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Statements of Cash Flows For the Years Ended December 31, 2013, 2012 and 2011 (In millions) [Enlarge/Download Table] 2013 2012 2011 ---------- ------------ ---------- Cash flows from operating activities Net income (loss)................................. $ (89) $ 199 $ 215 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization expenses........... 2 2 2 Amortization of premiums and accretion of discounts associated with investments, net..... 3 (3) (5) (Gains) losses on investments and derivatives, net............................................ 437 (321) (329) (Income) loss from equity method investments, net of dividends or distributions.............. (4) (1) -- Interest credited to policyholder account balances....................................... 113 118 127 Universal life and investment-type product policy fees.................................... (202) (198) (204) Change in accrued investment income.............. 2 1 (4) Change in premiums, reinsurance and other receivables.................................... 71 74 (6) Change in deferred policy acquisition costs and value of business acquired, net................ (135) 130 139 Change in income tax............................. (105) 68 91 Change in other assets........................... 194 193 200 Change in insurance-related liabilities and policy-related balances........................ 19 94 34 Change in other liabilities...................... 10 (12) 14 ---------- ------------ ---------- Net cash provided by operating activities......... 316 344 274 ---------- ------------ ---------- Cash flows from investing activities Sales, maturities and repayments of: Fixed maturity securities........................ 794 909 696 Equity securities................................ 2 6 5 Mortgage loans................................... 47 13 3 Other limited partnership interests.............. 1 1 4 Purchases of: Fixed maturity securities........................ (808) (958) (840) Equity securities................................ -- (13) (13) Mortgage loans................................... (49) (72) (98) Other limited partnership interests.............. (5) (15) (2) Cash received in connection with freestanding derivatives...................................... 1 5 1 Cash paid in connection with freestanding derivatives...................................... (12) (1) -- Issuances of loans to affiliates.................. -- -- (45) Net change in policy loans........................ (1) (1) 1 Net change in short-term investments.............. 64 (70) (12) ---------- ------------ ---------- Net cash provided by (used in) investing activities....................................... 34 (196) (300) ---------- ------------ ---------- Cash flows from financing activities Policyholder account balances: Deposits......................................... 632 1,077 725 Withdrawals...................................... (882) (1,155) (732) Net change in payables for collateral under securities loaned and other transactions......... 28 (87) 46 Dividend on common stock.......................... (129) (18) -- Other, net........................................ (2) 18 -- ---------- ------------ ---------- Net cash provided by (used in) financing activities....................................... (353) (165) 39 ---------- ------------ ---------- Change in cash and cash equivalents............... (3) (17) 13 Cash and cash equivalents, beginning of year...... 27 44 31 ---------- ------------ ---------- Cash and cash equivalents, end of year............ $ 24 $ 27 $ 44 ========== ============ ========== Supplemental disclosures of cash flow information: Net cash paid (received) for: Income tax....................................... $ 34 $ 27 $ (1) ========== ============ ========== See accompanying notes to the financial statements. 6
N-4370th Page of 530TOC1stPreviousNextBottomJust 370th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements 1. Business, Basis of Presentation and Summary of Significant Accounting Policies Business MetLife Investors Insurance Company ("MLIIC"), a Missouri domiciled life insurance company (the "Company") is a wholly-owned subsidiary of MetLife, Inc. ("MetLife"). The Company markets, administers and insures a broad range of term life, universal life and variable and fixed annuity products to individuals. The Company is licensed to conduct business in 49 states and the District of Columbia. Most of the policies issued present no significant mortality or longevity risk to the Company, but rather represent investment deposits by the policyholders. In the second quarter of 2013, MetLife, Inc. announced its plans to merge three U.S.-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company (the "Mergers"). The companies to be merged consist of MetLife Insurance Company of Connecticut ("MICC"), MetLife Investors USA Insurance Company ("MLI-USA") and MLIIC, each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. ("Exeter"), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. MICC, which is expected to be renamed and domiciled in Delaware, will be the surviving entity. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company's business and operations. Actual results could differ from estimates. Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity. Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if: . such separate accounts are legally recognized; . assets supporting the contract liabilities are legally insulated from the Company's general account liabilities; . investments are directed by the contractholder; and 7
N-4371st Page of 530TOC1stPreviousNextBottomJust 371st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) . all investment performance, net of contract fees and assessments, is passed through to the contractholder. The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the statements of operations. The Company's revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees in the statements of operations. Reclassifications Certain amounts in the prior years' financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as discussed throughout the Notes to the Financial Statements. Summary of Significant Accounting Policies The following are the Company's significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies. [Enlarge/Download Table] Accounting Policy Note -------------------------------------------------------------------------------------------------------- Insurance 2 -------------------------------------------------------------------------------------------------------- Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles 3 -------------------------------------------------------------------------------------------------------- Reinsurance 4 -------------------------------------------------------------------------------------------------------- Investments 5 -------------------------------------------------------------------------------------------------------- Derivatives 6 -------------------------------------------------------------------------------------------------------- Fair Value 7 -------------------------------------------------------------------------------------------------------- Income Tax 10 -------------------------------------------------------------------------------------------------------- Litigation Contingencies 11 Insurance Future Policy Benefit Liabilities and Policyholder Account Balances The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial 8
N-4372nd Page of 530TOC1stPreviousNextBottomJust 372nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, policy lapse, renewal, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality and interest rates are "locked in" upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur. Policyholder account balances ("PABs") relate to contract or contract features where the Company has no significant insurance risk. The Company issues certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits ("GMDBs"), the portion of guaranteed minimum income benefits ("GMIBs") that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits ("GMWBs"). Guarantees accounted for as embedded derivatives in PABs include the non life-contingent portion of GMWBs, guaranteed minimum accumulation benefits ("GMABs") and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Other Policy-Related Balances Other policy-related balances include policy and contract claims and unearned revenue liabilities. The liability for policy and contract claims generally relates to incurred but not reported death claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company's estimated ultimate cost of settling all claims. The Company derives estimates for the development 9
N-4373rd Page of 530TOC1stPreviousNextBottomJust 373rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made. The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product's estimated gross profits, similar to deferred policy acquisition costs ("DAC") as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees. Recognition of Insurance Revenues and Deposits Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are provided to recognize profits over the estimated lives of the insurance policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into earnings in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments. Deposits related to universal life-type and investment-type products are credited to PABs. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related PABs. Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include: . incremental direct costs of contract acquisition, such as commissions; . the portion of an employee's total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed; and . other essential direct costs that would not have been incurred had a policy not been acquired or renewed. All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred. 10
N-4374th Page of 530TOC1stPreviousNextBottomJust 374th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Value of business acquired ("VOBA") is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections. DAC and VOBA are amortized as follows: Products: In proportion to the following over estimated lives of the contracts: ----------------------------------------------------------------------------- . Fixed and variable universal life Actual and expected future gross contracts profits. . Fixed and variable deferred annuity contracts See Note 3 for additional information on DAC and VOBA amortization. The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes. The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder's initial account balance is increased by an amount equal to a specified percentage of the customer's deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements to determine the recoverability of the asset. Reinsurance For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company's obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid, and the liabilities ceded related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing the DAC related to the 11
N-4375th Page of 530TOC1stPreviousNextBottomJust 375th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) underlying reinsured contracts. Subsequent amounts paid on the reinsurance of in-force blocks, as well as amounts paid related to new business, are recorded as ceded premiums and ceded premiums, reinsurance and other receivables are established. Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. Premiums, fees and policyholder benefits and claims are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in fees on ceded reinsurance and other. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as fees on ceded reinsurance and other or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through fees on ceded reinsurance and other or other expenses, as appropriate. Investments Net Investment Income and Net Investment Gains (Losses) Income on investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses). Fixed Maturity and Equity Securities The Company's fixed maturity and equity securities are classified as available-for-sale ("AFS") and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) ("OCI"), net of policyholder-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income on fixed maturity securities is recognized when earned using an effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared. 12
N-4376th Page of 530TOC1stPreviousNextBottomJust 376th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management's case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 5 "-- Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities." For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment ("OTTI") is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions exist, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings ("credit loss"). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors is recorded in OCI. With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security's cost and its estimated fair value. Mortgage Loans The Company disaggregates its mortgage loan investments into two portfolio segments: commercial and agricultural. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 5. Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. Policy Loans Policy loans are stated at unpaid principal balances. Interest income on such loans is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy's anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal or interest on the loan is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy. Other Limited Partnership Interests The Company uses the equity method of accounting for investments in equity securities when it has significant influence or at least 20% interest and other limited partnership interests ("investees") when it has 13
N-4377th Page of 530TOC1stPreviousNextBottomJust 377th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) more than a minor ownership interest or more than a minor influence over the investee's operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee's earnings on a three-month lag in instances where the investee's financial information is not sufficiently timely or when the investee's reporting period differs from the Company's reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee's operations. The Company recognizes distributions on cost method investments as earned or received. Because of the nature and structure of these cost method investments, they do not meet the characteristics of an equity security in accordance with applicable accounting standards. The Company routinely evaluates its equity method and cost method investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value ("NAV"). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Other Invested Assets Other invested assets consist principally of the following: . Loans to affiliates are stated at unpaid principal balance, adjusted for any unamortized premium or discount. . Freestanding derivatives with positive estimated fair values are described in "--Derivatives" below. Securities Lending Program Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with the securities lending transactions may not be sold or repledged, unless the counterparty is in default, and is not reflected in the financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income. 14
N-4378th Page of 530TOC1stPreviousNextBottomJust 378th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Derivatives Freestanding Derivatives Freestanding derivatives are carried in the Company's balance sheets either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities. If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses). Hedge Accounting To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows: . Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability)--in net derivative gains (losses), consistent with the change in fair value of the hedged item attributable to the designated risk being hedged. . Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability)--effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company's earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses). The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the statement of operations within interest income or interest expense to match the location of the hedged item. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income. 15
N-4379th Page of 530TOC1stPreviousNextBottomJust 379th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statements of operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses). In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value in the balance sheets, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). Embedded Derivatives The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if: . the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings; . the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and . a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses). If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the 16
N-4380th Page of 530TOC1stPreviousNextBottomJust 380th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities. Goodwill Goodwill, which is included in other assets, is the excess of cost over the estimated fair value of net assets acquired which represents the future economic benefits arising from such net assets acquired that could not be individually identified. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event. Impairment testing is performed using the fair value approach, which requires the use of estimates and judgment, at the "reporting unit" level. A reporting unit is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. Management has concluded that the Company has one reporting unit. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income. In performing the Company's goodwill impairment test, the estimated fair value of the reporting unit is determined using a market multiple approach. When further corroboration is required, the Company uses a discounted cash flow approach. The Company may use additional valuation methodologies when appropriate. 17
N-4381st Page of 530TOC1stPreviousNextBottomJust 381st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting unit include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the reporting unit. The Company applies significant judgment when determining the estimated fair value of its reporting unit. The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management's reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of the Company's reporting unit could result in goodwill impairments in future periods which could adversely affect the Company's results of operations or financial position. In 2013, the Company performed its annual goodwill impairment test using the market multiple valuation approach. The analysis results indicated that the fair value of the reporting unit was in excess of its carrying value and, therefore, goodwill was not impaired. On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company's reporting unit to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions may have an impact on the estimated fair value and could result in future impairments of goodwill. The Company has no accumulated goodwill impairment as of December 31, 2013. Goodwill was $33 million at both December 31, 2013 and 2012. Income Tax The Company joined with MetLife and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to the Company under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife has elected the "percentage method" (and 100 percent under such method) of reimbursing companies for tax attributes such as losses. As a result, 100 percent of tax attributes such as losses are reimbursed by MetLife to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes such as losses. Profitable subsidiaries pay to MetLife each year the federal income tax which such profitable subsidiary would have paid that year based upon that year's taxable income. If the Company has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by the Company when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if the Company would not have realized the attributes on a stand-alone basis under a "wait and see" method. The Company's accounting for income taxes represents management's best estimate of various events and transactions. 18
N-4382nd Page of 530TOC1stPreviousNextBottomJust 382nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Factors in management's determination include the performance of the business and its ability to generate capital gains. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following: . future taxable income exclusive of reversing temporary differences and carryforwards; . future reversals of existing taxable temporary differences; . taxable income in prior carryback years; and . tax planning strategies. The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made. The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax. Litigation Contingencies The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company's financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On an annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company's financial statements. 19
N-4383rd Page of 530TOC1stPreviousNextBottomJust 383rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Other Accounting Policies Cash and Cash Equivalents The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value. Computer Software Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $15 million and $14 million at December 31, 2013 and 2012, respectively. Accumulated amortization of capitalized software was $8 million and $6 million at December 31, 2013 and 2012, respectively. Related amortization expense was $2 million for each of the years ended December 31, 2013, 2012 and 2011. Fees on Ceded Reinsurance and Other Fees on ceded reinsurance and other primarily include, in addition to items described elsewhere herein, fee income on financial reinsurance agreements. Such fees are recognized in the period in which services are performed. Adoption of New Accounting Pronouncements Effective July 17, 2013, the Company adopted new guidance regarding derivatives that permits the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to the United States Treasury and London Interbank Offered Rate. Also, this new guidance removes the restriction on using different benchmark rates for similar hedges. The new guidance did not have a material impact on the financial statements upon adoption, but may impact the selection of benchmark interest rates for hedging relationships in the future. Effective January 1, 2013, the Company adopted new guidance regarding comprehensive income that requires an entity to provide information about the amounts reclassified out of accumulated OCI ("AOCI") by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The adoption was prospectively applied and resulted in additional disclosures in Note 8. Effective January 1, 2013, the Company adopted new guidance regarding balance sheet offsetting disclosures which requires an entity to disclose information about offsetting and related arrangements for derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities 20
N-4384th Page of 530TOC1stPreviousNextBottomJust 384th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) borrowing and lending transactions, to enable users of its financial statements to understand the effects of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The adoption was retrospectively applied and resulted in additional disclosures related to derivatives in Note 6. On January 1, 2012, the Company adopted new guidance regarding accounting for DAC, which was retrospectively applied. The guidance specifies that only costs related directly to successful acquisition of new or renewal contracts can be capitalized as DAC; all other acquisition-related costs must be expensed as incurred. As a result, certain sales manager compensation and administrative costs previously capitalized by the Company will no longer be deferred. On January 1, 2012, the Company adopted new guidance regarding comprehensive income, which was retrospectively applied, that provides companies with the option to present the total of comprehensive income, components of net income, and the components of OCI either in a single continuous statement of comprehensive income or in two separate but consecutive statements in annual financial statements. The standard eliminates the option to present components of OCI as part of the statement of changes in stockholder's equity. The Company adopted the two-statement approach for annual financial statements. Effective January 1, 2012, the Company adopted new guidance regarding fair value measurements that establishes common requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Some of the amendments clarify the Financial Accounting Standards Board's ("FASB") intent on the application of existing fair value measurement requirements. Other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The adoption did not have a material impact on the Company's financial statements other than the expanded disclosures in Note 7. Future Adoption of New Accounting Pronouncements In February 2013, the FASB issued new guidance regarding liabilities (Accounting Standards Update 2013-04, Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date), effective retrospectively for fiscal years beginning after December 15, 2013 and interim periods within those years. The amendments require an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. In addition, the amendments require an entity to disclose the nature and amount of the obligation, as well as other information about the obligation. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements. 21
N-4385th Page of 530TOC1stPreviousNextBottomJust 385th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 2. Insurance Insurance Liabilities Future policy benefits are measured as follows: Product Type: Measurement Assumptions: ------------------------------------------------------------------------- Nonparticipating life Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company's experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities are 5%. ------------------------------------------------------------------------- Traditional fixed annuities after Present value of expected future annuitization payments. Interest rate assumptions used in establishing such liabilities range from 3% to 8%. ------------------------------------------------------------------------- PABs are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; and (ii) credited interest, ranging from 1% to 8%, less expenses, mortality charges and withdrawals. 22
N-4386th Page of 530TOC1stPreviousNextBottomJust 386th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 2. Insurance (continued) Guarantees The Company issues variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWBs and the portion of certain GMIBs that does not require annuitization are accounted for as embedded derivatives in PABs and are further discussed in Note 6. Guarantees accounted for as insurance liabilities include: Guarantee: Measurement Assumptions: ------------------------------------------------------------------------ GMDBs . A return of purchase payment . Present value of expected upon death even if the death benefits in excess of account value is reduced to the projected account zero. balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments. . An enhanced death benefit . Assumptions are consistent may be available for an with those used for additional fee. amortizing DAC, and are thus subject to the same variability and risk. . Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the Standard & Poor's Ratings Services ("S&P") 500 Index. . Benefit assumptions are based on the average benefits payable over a range of scenarios. ------------------------------------------------------------------------ GMIBs . After a specified period of . Present value of expected time determined at the time income benefits in excess of of issuance of the variable the projected account annuity contract, a minimum balance at any future date accumulation of purchase of annuitization and payments, even if the recognizing the excess account value is reduced to ratably over the zero, that can be annuitized accumulation period based on to receive a monthly income present value of total stream that is not less than expected assessments. a specified amount. . Certain contracts also . Assumptions are consistent provide for a guaranteed with those used for lump sum return of purchase estimating GMDB liabilities. premium in lieu of the annuitization benefit. . Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder. ------------------------------------------------------------------------ GMWBs . A return of purchase payment . Expected value of the life via partial withdrawals, contingent payments and even if the account value is expected assessments using reduced to zero, provided assumptions consistent with that cumulative withdrawals those used for estimating in a contract year do not the GMDB liabilities. exceed a certain limit. . Certain contracts include guaranteed withdrawals that are life contingent. 23
N-4387th Page of 530TOC1stPreviousNextBottomJust 387th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 2. Insurance (continued) Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity contracts was as follows: [Download Table] Annuity Contracts ---------------- GMDBs GMIBs Total ------- -------- -------- (In millions) Direct Balance at January 1, 2011...... $ 32 $ 88 $ 120 Incurred guaranteed benefits.... 17 31 48 Paid guaranteed benefits........ (7) -- (7) ------- -------- -------- Balance at December 31, 2011.... 42 119 161 Incurred guaranteed benefits.... 10 98 108 Paid guaranteed benefits........ (9) -- (9) ------- -------- -------- Balance at December 31, 2012.... 43 217 260 Incurred guaranteed benefits.... 11 1 12 Paid guaranteed benefits........ (5) -- (5) ------- -------- -------- Balance at December 31, 2013.... $ 49 $ 218 $ 267 ======= ======== ======== Ceded Balance at January 1, 2011...... $ 32 $ 30 $ 62 Incurred guaranteed benefits.... 17 11 28 Paid guaranteed benefits........ (7) -- (7) ------- -------- -------- Balance at December 31, 2011.... 42 41 83 Incurred guaranteed benefits.... 10 34 44 Paid guaranteed benefits........ (9) -- (9) ------- -------- -------- Balance at December 31, 2012.... 43 75 118 Incurred guaranteed benefits.... 11 1 12 Paid guaranteed benefits........ (5) -- (5) ------- -------- -------- Balance at December 31, 2013.... $ 49 $ 76 $ 125 ======= ======== ======== Net Balance at January 1, 2011...... $ -- $ 58 $ 58 Incurred guaranteed benefits.... -- 20 20 Paid guaranteed benefits........ -- -- -- ------- -------- -------- Balance at December 31, 2011.... -- 78 78 Incurred guaranteed benefits.... -- 64 64 Paid guaranteed benefits........ -- -- -- ------- -------- -------- Balance at December 31, 2012.... -- 142 142 Incurred guaranteed benefits.... -- -- -- Paid guaranteed benefits........ -- -- -- ------- -------- -------- Balance at December 31, 2013.... $ -- $ 142 $ 142 ======= ======== ======== 24
N-4388th Page of 530TOC1stPreviousNextBottomJust 388th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 2. Insurance (continued) Account balances of contracts with insurance guarantees were invested in separate account asset classes as follows at: [Download Table] December 31, ------------------- 2013 2012 --------- --------- (In millions) Fund Groupings: Balanced........ $ 7,255 $ 6,507 Equity.......... 4,086 3,816 Bond............ 551 588 Money Market.... 98 118 --------- --------- Total.......... $ 11,990 $ 11,029 ========= ========= Based on the type of guarantee, the Company defines net amount at risk as listed below. These amounts include direct business, but exclude offsets from hedging or reinsurance, if any. Variable Annuity Guarantees In the Event of Death Defined as the death benefit less the total contract account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death. At Annuitization Defined as the amount (if any) that would be required to be added to the total contract account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company's potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved. Information regarding the types of guarantees relating to annuity contracts was as follows at: [Enlarge/Download Table] December 31, --------------------------------------------------------- 2013 2012 ---------------------------- ---------------------------- In the At In the At Event of Death Annuitization Event of Death Annuitization -------------- ------------- -------------- ------------- (In millions) Annuity Contracts (1) Variable Annuity Guarantees Total contract account value.............. $ 13,348 $ 8,712 $ 12,309 $ 7,963 Separate account value.................... $ 12,841 $ 8,470 $ 11,797 $ 7,715 Net amount at risk........................ $ 327 $ 116 $ 594 $ 554 Average attained age of contractholders... 67 years 66 years 66 years 65 years -------- (1)The Company's annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. 25
N-4389th Page of 530TOC1stPreviousNextBottomJust 389th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 2. Insurance (continued) Obligations Under Funding Agreements MLIIC is a member of the Federal Home Loan Bank ("FHLB") of Des Moines. Holdings of the FHLB of Des Moines common stock, included in equity securities, were as follows at: [Download Table] December 31, ------------- 2013 2012 ----- ----- (In millions) FHLB of Des Moines.... $ 26 $ 28 The Company has also entered into funding agreements with the FHLB of Des Moines. The liability for such funding agreements is included in PABs. Information related to such funding agreements was as follows at: [Download Table] Liability Collateral ------------- --------------------- December 31, ----------------------------------- 2013 2012 2013 2012 ------ ------ ---------- ---------- (In millions) FHLB of Des Moines (1)... $ 405 $ 405 $ 477 (2) $ 604 (2) -------- (1)Represents funding agreements issued to the FHLB of Des Moines in exchange for cash and for which the FHLB of Des Moines has been granted a lien on certain assets, some of which are in the custody of the FHLB of Des Moines, including residential mortgage-backed securities ("RMBS"), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of the FHLB of Des Moines as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, the FHLB of Des Moines' recovery on the collateral is limited to the amount of the Company's liability to the FHLB of Des Moines. (2)Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value. Separate Accounts Separate account assets and liabilities consist of pass-through separate accounts totaling $12.0 billion and $11.1 billion at December 31, 2013 and 2012, respectively, for which the policyholder assumes all investment risk. For the years ended December 31, 2013, 2012 and 2011, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts. 3. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles See Note 1 for a description of capitalized acquisition costs. 26
N-4390th Page of 530TOC1stPreviousNextBottomJust 390th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 3. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances. Factors Impacting Amortization Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company's long-term expectation produce higher account balances, which increases the Company's future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company's long-term expectation. The Company's practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross profits. These assumptions primarily relate to investment returns, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross profits which may have significantly changed. If the update of assumptions causes expected future gross profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross profits to decrease. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage 27
N-4391st Page of 530TOC1stPreviousNextBottomJust 391st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 3. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized. Information regarding DAC and VOBA was as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------ ------ ------ (In millions) DAC Balance at January 1,............................................... $ 97 $ 220 $ 352 Capitalizations..................................................... 6 19 34 Amortization related to: Net investment gains (losses) and net derivative gains (losses)... 122 (96) (84) Other expenses.................................................... (27) (38) (76) ------ ------ ------ Total amortization............................................... 95 (134) (160) ------ ------ ------ Unrealized investment gains (losses)................................ 8 (8) (6) Other (1)........................................................... 38 -- -- ------ ------ ------ Balance at December 31,............................................. 244 97 220 ------ ------ ------ VOBA Balance at January 1,............................................... 51 66 79 Total amortization related to other expenses...................... (6) (14) (12) Unrealized investment gains (losses)................................ 2 (1) (1) ------ ------ ------ Balance at December 31,............................................. 47 51 66 ------ ------ ------ Total DAC and VOBA Balance at December 31,............................................. $ 291 $ 148 $ 286 ====== ====== ====== -------- (1)The year ended December 31, 2013 includes $38 million that was reclassified to DAC from premiums, reinsurance and other receivables. The amounts reclassified relate to an affiliated reinsurance agreement accounted for using the deposit method of accounting and represent the DAC amortization on the expense allowances ceded on the agreement from inception. These amounts were previously included in the calculated value of the deposit receivable on this agreement and recorded within premiums, reinsurance and other receivables. 28
N-4392nd Page of 530TOC1stPreviousNextBottomJust 392nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 3. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (continued) Information regarding other policy-related intangibles was as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ----- ----- ----- (In millions) Deferred Sales Inducements Balance at January 1,...... $ 65 $ 71 $ 84 Capitalization............. -- 1 3 Amortization............... (2) (7) (16) ----- ----- ----- Balance at December 31,.... $ 63 $ 65 $ 71 ===== ===== ===== The estimated future amortization expense to be reported in other expenses for the next five years is as follows: [Download Table] VOBA ------------- (In millions) 2014.......................... $ 12 2015.......................... $ 10 2016.......................... $ 9 2017.......................... $ 6 2018.......................... $ 6 4. Reinsurance The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses and minimize exposure to significant risks. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 5. For its individual life insurance products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. The Company currently reinsures 100% of the living and death benefit guarantees issued in connection with its variable annuities to affiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The Company also reinsures 90% of its fixed annuities to an affiliated reinsurer. The value of the embedded 29
N-4393rd Page of 530TOC1stPreviousNextBottomJust 393rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 4. Reinsurance (continued) derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company's results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks. The Company reinsures its remaining business through a diversified group of well-capitalized reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at December 31, 2013 and 2012, were not significant. The Company had $6 million and $8 million of unsecured unaffiliated ceded reinsurance recoverable balances at December 31, 2013 and 2012, respectively. Of these totals, 100% were with the Company's five largest unaffiliated ceded reinsurers at both December 31, 2013 and 2012. The amounts in the statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: [Enlarge/Download Table] Years Ended December 31, ----------------------- 2013 2012 2011 ------- ------- ------- (In millions) Premiums Direct premiums................................................ $ 30 $ 12 $ 8 Reinsurance ceded.............................................. (1) (1) (1) ------- ------- ------- Net premiums.................................................. $ 29 $ 11 $ 7 ======= ======= ======= Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees.. $ 244 $ 237 $ 240 Reinsurance ceded.............................................. (42) (39) (36) ------- ------- ------- Net universal life and investment-type product policy fees.... $ 202 $ 198 $ 204 ======= ======= ======= Fees on ceded reinsurance and other Direct fees on ceded reinsurance and other..................... $ 25 $ 25 $ 26 Reinsurance ceded.............................................. 65 68 78 ------- ------- ------- Net fees on ceded reinsurance and other....................... $ 90 $ 93 $ 104 ======= ======= ======= Policyholder benefits and claims Direct policyholder benefits and claims........................ $ 61 $ 144 $ 92 Reinsurance ceded.............................................. (13) (44) (33) ------- ------- ------- Net policyholder benefits and claims.......................... $ 48 $ 100 $ 59 ======= ======= ======= 30
N-4394th Page of 530TOC1stPreviousNextBottomJust 394th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 4. Reinsurance (continued) The amounts in the balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: [Enlarge/Download Table] December 31, ------------------------------------------------- 2013 2012 ------------------------ ------------------------ Total Total Balance Balance Direct Ceded Sheet Direct Ceded Sheet ------ -------- -------- ------ -------- -------- (In millions) Assets Premiums, reinsurance and other receivables......................... $ 26 $ 1,803 $ 1,829 $ 26 $ 2,459 $ 2,485 Deferred policy acquisition costs and value of business acquired.......... 311 (20) 291 207 (59) 148 ------ -------- -------- ------ -------- -------- Total assets......................... $ 337 $ 1,783 $ 2,120 $ 233 $ 2,400 $ 2,633 ====== ======== ======== ====== ======== ======== Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. Deposit assets and deposit liabilities, if any, are the result of affiliated reinsurance transactions. See " Related Party Reinsurance Transactions." Related Party Reinsurance Transactions The Company has reinsurance agreements with certain MetLife subsidiaries, including Metropolitan Life Insurance Company, General American Life Insurance Company, Exeter and MICC, all of which are related parties. Information regarding the significant effects of affiliated reinsurance included in the statements of operations was as follows: [Download Table] Years Ended December 31, ----------------------- 2013 2012 2011 ------- ------- ------- (In millions) Premiums Reinsurance ceded...................................... $ -- $ (1) $ -- Universal life and investment-type product policy fees Reinsurance ceded...................................... $ (41) $ (39) $ (35) Fees on ceded reinsurance and other Reinsurance ceded...................................... $ 65 $ 68 $ 78 Policyholder benefits and claims Reinsurance ceded...................................... $ (13) $ (44) $ (31) 31
N-4395th Page of 530TOC1stPreviousNextBottomJust 395th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 4. Reinsurance (continued) Information regarding the significant effects of ceded affiliated reinsurance included in the balance sheets was as follows at: [Enlarge/Download Table] December 31, ----------------- 2013 2012 -------- -------- (In millions) Assets Premiums, reinsurance and other receivables......................... $ 1,798 $ 2,451 Deferred policy acquisition costs and value of business acquired.... (20) (59) -------- -------- Total assets...................................................... $ 1,778 $ 2,392 ======== ======== The Company ceded risks to affiliates related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in their fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were assets of $376 million and $959 million at December 31, 2013 and 2012, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($639) million, $190 million and $380 million for the years ended December 31, 2013, 2012 and 2011, respectively. The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts and irrevocable letters of credit. The Company had $1.3 billion and $1.4 billion of unsecured affiliated reinsurance recoverable balances at December 31, 2013 and 2012, respectively. Affiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on affiliated reinsurance were $1.3 billion and $1.4 billion at December 31, 2013 and 2012, respectively. There were no deposit liabilities on affiliated reinsurance at both December 31, 2013 and 2012. 5. Investments See Note 7 for information about the fair value hierarchy for investments and the related valuation methodologies. Investment Risks and Uncertainties Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of variable interest entities ("VIEs"). The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the financial statements. The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available. 32
N-4396th Page of 530TOC1stPreviousNextBottomJust 396th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, asset-backed securities ("ABS") and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned. Fixed Maturity and Equity Securities AFS Fixed Maturity and Equity Securities AFS by Sector The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities ("CMBS") and ABS. [Enlarge/Download Table] December 31, 2013 December 31, 2012 ------------------------------------------ ------------------------------------------ Gross Unrealized Gross Unrealized Cost or ---------------------- Estimated Cost or ---------------------- Estimated Amortized Temporary OTTI Fair Amortized Temporary OTTI Fair Cost Gains Losses Losses Value Cost Gains Losses Losses Value --------- ----- --------- ------ --------- --------- ----- --------- ------ --------- (In millions) Fixed maturity securities U.S. corporate..................... $ 825 $ 55 $ 8 $ -- $ 872 $ 913 $ 87 $ 1 $ -- $ 999 U.S. Treasury and agency........... 469 2 14 -- 457 391 6 -- -- 397 RMBS............................... 312 12 7 5 312 286 21 4 6 297 CMBS............................... 293 8 4 -- 297 302 17 -- -- 319 Foreign corporate.................. 223 9 3 -- 229 209 14 1 -- 222 ABS................................ 51 2 -- -- 53 51 4 1 -- 54 State and political subdivision.... 17 2 -- -- 19 17 3 -- -- 20 Foreign government................. 10 1 -- -- 11 9 3 -- -- 12 ------- ---- ---- ---- ------- ------- ----- ---- ---- ------- Total fixed maturity securities... $ 2,200 $ 91 $ 36 $ 5 $ 2,250 $ 2,178 $ 155 $ 7 $ 6 $ 2,320 ======= ==== ==== ==== ======= ======= ===== ==== ==== ======= Equity securities Common stock....................... $ 26 $ -- $ -- $ -- $ 26 $ 28 $ -- $ -- $ -- $ 28 Non-redeemable preferred stock..... 20 -- 1 -- 19 20 -- 3 -- 17 ------- ---- ---- ---- ------- ------- ----- ---- ---- ------- Total equity securities........... $ 46 $ -- $ 1 $ -- $ 45 $ 48 $ -- $ 3 $ -- $ 45 ======= ==== ==== ==== ======= ======= ===== ==== ==== ======= The Company held non-income producing fixed maturity securities with an estimated fair value of less than $1 million with unrealized gains (losses) of less than $1 million at both December 31, 2013 and 2012. Methodology for Amortization of Premium and Accretion of Discount on Structured Securities Amortization of premium and accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management's knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis. 33
N-4397th Page of 530TOC1stPreviousNextBottomJust 397th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Maturities of Fixed Maturity Securities The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at: [Enlarge/Download Table] December 31, ----------------------------------------- 2013 2012 -------------------- -------------------- Amortized Estimated Amortized Estimated Cost Fair Value Cost Fair Value --------- ---------- --------- ---------- (In millions) Due in one year or less...................... $ 240 $ 242 $ 306 $ 308 Due after one year through five years........ 487 512 446 476 Due after five years through ten years....... 566 595 588 657 Due after ten years.......................... 251 239 199 209 -------- -------- -------- -------- Subtotal................................... 1,544 1,588 1,539 1,650 Structured securities (RMBS, CMBS and ABS)... 656 662 639 670 -------- -------- -------- -------- Total fixed maturity securities............ $ 2,200 $ 2,250 $ 2,178 $ 2,320 ======== ======== ======== ======== Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. RMBS, CMBS and ABS are shown separately, as they are not due at a single maturity. 34
N-4398th Page of 530TOC1stPreviousNextBottomJust 398th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position. [Enlarge/Download Table] December 31, 2013 December 31, 2012 ----------------------------------------- ----------------------------------------- Equal to or Greater Equal to or Greater Less than 12 Months than 12 Months Less than 12 Months than 12 Months -------------------- -------------------- -------------------- -------------------- Estimated Gross Estimated Gross Estimated Gross Estimated Gross Fair Unrealized Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Value Losses --------- ---------- --------- ---------- --------- ---------- --------- ---------- (In millions, except number of securities) Fixed maturity securities U.S. corporate................... $ 84 $ 7 $ 13 $ 1 $ 20 $ 1 $ 9 $ -- U.S. Treasury and agency......... 169 14 -- -- 60 -- -- -- RMBS............................. 84 4 34 8 -- -- 49 10 CMBS............................. 73 4 -- -- 4 -- 15 -- Foreign corporate................ 27 2 7 1 2 -- 7 1 ABS.............................. 7 -- 5 -- -- -- 5 1 Foreign government............... 1 -- 1 -- 1 -- -- -- ------ ----- ----- ----- ----- ---- ----- ----- Total fixed maturity securities.. $ 445 $ 31 $ 60 $ 10 $ 87 $ 1 $ 85 $ 12 ====== ===== ===== ===== ===== ==== ===== ===== Equity securities Non-redeemable preferred stock........................... $ -- $ -- $ 18 $ 1 $ -- $ -- $ 17 $ 3 ------ ----- ----- ----- ----- ---- ----- ----- Total number of securities in an unrealized loss position........ 87 18 18 22 ====== ===== ===== ===== Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities Evaluation and Measurement Methodologies Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. 35
N-4399th Page of 530TOC1stPreviousNextBottomJust 399th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: . The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment. . When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management's best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. . Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security. . When determining the amount of the credit loss for U.S. and foreign corporate securities, state and political subdivision securities and foreign government securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities. With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security's cost and its estimated fair value with a corresponding charge to earnings. The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value. 36
N-4400th Page of 530TOC1stPreviousNextBottomJust 400th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows. Current Period Evaluation Based on the Company's current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company's current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company has concluded that these securities are not other-than-temporarily impaired at December 31, 2013. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods. Gross unrealized losses on fixed maturity securities increased $28 million during the year ended December 31, 2013 from $13 million to $41 million. The increase in gross unrealized losses for the year ended December 31, 2013, was primarily attributable to an increase in interest rates, partially offset by narrowing credit spreads. At December 31, 2013, $5 million of the total $41 million of gross unrealized losses were from one below investment grade fixed maturity security with an unrealized loss position of 20% or more of amortized cost for six months or greater. Unrealized losses on the below investment grade fixed maturity security are related to non-agency RMBS (alternative residential mortgage loans) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over unemployment levels and valuations of residential real estate supporting non-agency RMBS. Management evaluates non-agency RMBS based on actual and projected cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security. Equity Securities Gross unrealized losses on equity securities decreased $2 million during the year ended December 31, 2013 from $3 million to $1 million. None of the $1 million of gross unrealized losses were from equity securities with gross unrealized losses of 20% or more of cost for 12 months or greater. 37
N-4401st Page of 530TOC1stPreviousNextBottomJust 401st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Mortgage Loans Mortgage Loans by Portfolio Segment Mortgage loans are summarized as follows at: [Download Table] December 31, --------------------------------------------- 2013 2012 ----------------------- -------------------- Carrying Carrying % of Value % of Total Value Total ------------- ---------- ------------- ------ (In millions) (In millions) Mortgage loans: Commercial.................... $ 246 86.0 % $ 238 83.8 % Agricultural.................. 41 14.3 48 16.9 ------ ------ ------ ------ Subtotal (1)................. 287 100.3 286 100.7 Valuation allowances.......... (1) (0.3) (2) (0.7) ------ ------ ------ ------ Total mortgage loans, net.... $ 286 100.0 % $ 284 100.0 % ====== ====== ====== ====== -------- (1)The Company did not purchase any mortgage loans during the year ended December 31, 2013. In 2012, the Company purchased $48 million of mortgage loans, of which $38 million were purchased at estimated fair value from an affiliate, MetLife Bank, National Association. Mortgage Loans and Valuation Allowance by Portfolio Segment All commercial and agricultural mortgage loans held at both December 31, 2013 and 2012 were evaluated collectively for credit losses. The valuation allowances maintained at both December 31, 2013 and 2012 were primarily for the commercial mortgage loan portfolio segment and were for non-specifically identified credit losses. The valuation allowance for agricultural mortgage loans was less than $1 million at both December 31, 2013 and 2012. Valuation Allowance Rollforward by Portfolio Segment The changes in the valuation allowance, by portfolio segment, were as follows: [Download Table] Commercial Agricultural Total ---------- ------------ ------ (In millions) Balance at January 1, 2011...... $ 1 $ -- $ 1 Provision (release)............. 1 -- 1 ------ ------- ------ Balance at December 31, 2011.... 2 -- 2 Provision (release)............. -- -- -- ------ ------- ------ Balance at December 31, 2012.... 2 -- 2 Provision (release)............. (1) -- (1) ------ ------- ------ Balance at December 31, 2013.... $ 1 $ -- $ 1 ====== ======= ====== 38
N-4402nd Page of 530TOC1stPreviousNextBottomJust 402nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Valuation Allowance Methodology Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan's original effective interest rate, (ii) the estimated fair value of the loan's underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan's observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company's experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available. Commercial and Agricultural Mortgage Loan Portfolio Segments The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans. All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio. 39
N-4403rd Page of 530TOC1stPreviousNextBottomJust 403rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property's net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated annually, on a rolling basis, with a portion of the loan portfolio updated each quarter. For agricultural mortgage loans, the Company's primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated. Credit Quality of Commercial Mortgage Loans The credit quality of commercial mortgage loans, were as follows: [Enlarge/Download Table] Recorded Investment ------------------------------------------- Debt Service Coverage Ratios ----------------------------- % of Estimated % of > 1.20x 1.00x - 1.20x < 1.00x Total Total Fair Value Total ------- ------------- ------- ------ ------ ------------- ------ (In millions) (In millions) December 31, 2013: Loan-to-value ratios: Less than 65%......... $ 193 $ 9 $ 15 $ 217 88.2 % $ 228 88.4 % 65% to 75%............ 19 -- 10 29 11.8 30 11.6 ------ ----- ----- ------ ------ ------ ------ Total................ $ 212 $ 9 $ 25 $ 246 100.0 % $ 258 100.0 % ====== ===== ===== ====== ====== ====== ====== December 31, 2012: Loan-to-value ratios: Less than 65%......... $ 194 $ 10 $ 9 $ 213 89.5 % $ 231 90.2 % 65% to 75%............ 15 -- 10 25 10.5 25 9.8 ------ ----- ----- ------ ------ ------ ------ Total................ $ 209 $ 10 $ 19 $ 238 100.0 % $ 256 100.0 % ====== ===== ===== ====== ====== ====== ====== Credit Quality of Agricultural Mortgage Loans All of the agricultural mortgage loans held at both December 31, 2013 and 2012 had loan-to-value ratios of less than 65%. Past Due, Interest Accrual Status and Impaired Mortgage Loans The Company has a high quality, well performing, mortgage loan portfolio, with all mortgage loans classified as performing at both December 31, 2013 and 2012. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans -- 60 days and agricultural mortgage loans -- 90 days. The Company had no impaired mortgage loans, no mortgage loans past due and no mortgage loans in non-accrual status at both December 31, 2013 and 2012. The Company did not recognize interest income on impaired mortgage loans during the years ended December 31, 2013, 2012 and 2011. 40
N-4404th Page of 530TOC1stPreviousNextBottomJust 404th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Mortgage Loans Modified in a Troubled Debt Restructuring The Company may grant concessions related to borrowers experiencing financial difficulties which are classified as troubled debt restructurings. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance recorded with the restructuring. Through the continuous monitoring process, a specific valuation allowance may have been recorded prior to the quarter when the mortgage loan is modified in a troubled debt restructuring. Accordingly, the carrying value (after specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. There were no mortgage loans modified in a troubled debt restructuring during the years ended December 31, 2013 and 2012. Other Invested Assets Other invested assets is comprised of loans to affiliates (see " -- Related Party Investment Transactions") and freestanding derivatives with positive estimated fair values (see Note 6). Cash Equivalents The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $17 million and $23 million at December 31, 2013 and 2012, respectively. 41
N-4405th Page of 530TOC1stPreviousNextBottomJust 405th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Net Unrealized Investment Gains (Losses) The components of net unrealized investment gains (losses), included in AOCI, were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ----- ------ ----- (In millions) Fixed maturity securities......................................................... $ 55 $ 148 $ 88 Fixed maturity securities with noncredit OTTI losses in AOCI...................... (5) (6) (10) ----- ------ ----- Total fixed maturity securities.................................................. 50 142 78 Equity securities................................................................. (1) (3) (5) Derivatives....................................................................... (1) 1 2 Short-term investments............................................................ (1) (1) (1) ----- ------ ----- Subtotal......................................................................... 47 139 74 ----- ------ ----- Amounts allocated from: Insurance liability loss recognition............................................. -- -- (7) DAC and VOBA related to noncredit OTTI losses recognized in AOCI................. 1 1 1 DAC and VOBA..................................................................... (14) (24) (15) ----- ------ ----- Subtotal....................................................................... (13) (23) (21) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI......................................................................... 2 2 4 Deferred income tax benefit (expense)............................................. (13) (42) (22) ----- ------ ----- Net unrealized investment gains (losses).......................................... $ 23 $ 76 $ 35 ===== ====== ===== The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 ---------- ---------- (In millions) Balance at January 1,............................... $ (6) $ (10) Securities sold with previous noncredit OTTI loss... 1 3 Subsequent changes in estimated fair value.......... -- 1 ---------- ---------- Balance at December 31,............................. $ (5) $ (6) ========== ========== 42
N-4406th Page of 530TOC1stPreviousNextBottomJust 406th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) The changes in net unrealized investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------- ------- ----- (In millions) Balance at January 1,........................................................... $ 76 $ 35 $ 20 Fixed maturity securities on which noncredit OTTI losses have been recognized... 1 4 (2) Unrealized investment gains (losses) during the year............................ (93) 61 39 Unrealized investment gains (losses) relating to: Insurance liability gain (loss) recognition................................... -- 7 (7) DAC and VOBA.................................................................. 10 (9) (7) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI........................................................... -- (2) 1 Deferred income tax benefit (expense)......................................... 29 (20) (9) ------- ------- ----- Balance at December 31,......................................................... $ 23 $ 76 $ 35 ======= ======= ===== Change in net unrealized investment gains (losses).............................. $ (53) $ 41 $ 15 ======= ======= ===== Concentrations of Credit Risk There were no investments in any counterparty that were greater than 10% of the Company's stockholder's equity, other than the U.S. government and its agencies, at both December 31, 2013 and 2012. Securities Lending Elements of the securities lending program are presented below at: [Download Table] December 31, ------------- 2013 2012 ------ ------ (In millions) Securities on loan: (1) Amortized cost....................................... $ 249 $ 185 Estimated fair value................................. $ 241 $ 191 Cash collateral on deposit from counterparties (2)..... $ 249 $ 196 Reinvestment portfolio -- estimated fair value......... $ 247 $ 196 ------------- (1)Included within fixed maturity securities and short-term investments. (2)Included within payables for collateral under securities loaned and other transactions. 43
N-4407th Page of 530TOC1stPreviousNextBottomJust 407th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Invested Assets on Deposit and Pledged as Collateral Invested assets on deposit and pledged as collateral are presented below at estimated fair value for fixed maturity securities at: [Download Table] December 31, --------------- 2013 2012 ------- ------- (In millions) Invested assets on deposit (regulatory deposits)............ $ 7 $ 4 Invested assets pledged as collateral (1)................... 505 620 ------- ------- Total invested assets on deposit and pledged as collateral. $ 512 $ 624 ======= ======= -------- (1)The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 2) and derivative transactions (see Note 6). See "-- Securities Lending" for securities on loan. Variable Interest Entities The Company has invested in certain structured transactions that are VIEs. In certain instances, the Company may hold both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, it would be deemed the primary beneficiary or consolidator of the entity. The determination of the VIE's primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party's relationship with or involvement in the entity, an estimate of the entity's expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE's expected losses, receive a majority of a VIE's expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the financial statements. Consolidated VIEs There were no VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2013 and 2012. 44
N-4408th Page of 530TOC1stPreviousNextBottomJust 408th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Unconsolidated VIEs The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at: [Enlarge/Download Table] December 31, ----------------------------------------- 2013 2012 -------------------- -------------------- Maximum Maximum Carrying Exposure Carrying Exposure Amount to Loss (1) Amount to Loss (1) -------- ----------- -------- ----------- (In millions) Fixed maturity securities AFS: Structured securities (RMBS, CMBS, and ABS) (2)...... $ 662 $ 662 $ 670 $ 670 U.S. and foreign corporate........................... 21 21 23 23 Other limited partnership interests.................... 19 20 14 15 Equity securities AFS: Non-redeemable preferred stock....................... 18 18 17 17 ------ ------ ------ ------ Total................................................ $ 720 $ 721 $ 724 $ 725 ====== ====== ====== ====== -------- (1)The maximum exposure to loss relating to fixed maturity and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests is equal to the carrying amounts plus any unfunded commitments of the Company. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee. (2)For these variable interests, the Company's involvement is limited to that of a passive investor. As described in Note 11, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2013, 2012 and 2011. 45
N-4409th Page of 530TOC1stPreviousNextBottomJust 409th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Net Investment Income The components of net investment income were as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------ ------ ------ (In millions) Investment income: Fixed maturity securities.......................... $ 94 $ 98 $ 104 Equity securities.................................. 1 1 2 Mortgage loans..................................... 16 15 10 Policy loans....................................... 2 2 2 Other limited partnership interests................ 4 1 -- Cash, cash equivalents and short-term investments.. 1 -- -- ------ ------ ------ Subtotal.......................................... 118 117 118 Less: Investment expenses.......................... 4 4 4 ------ ------ ------ Net investment income......................... $ 114 $ 113 $ 114 ====== ====== ====== See "-- Related Party Investment Transactions" for discussion of affiliated net investment income and investment expenses. Net Investment Gains (Losses) Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ----- ------ ------ (In millions) Total gains (losses) on fixed maturity securities: Total OTTI losses recognized -- by industry: U.S. and foreign corporate securities -- by industry: Finance................................................................ $ -- $ (1) $ -- Utility................................................................ -- (1) -- ----- ------ ------ Total U.S. and foreign corporate securities.......................... -- (2) -- ----- ------ ------ OTTI losses on fixed maturity securities recognized in earnings........... -- (2) -- Fixed maturity securities -- net gains (losses) on sales and disposals.... 1 (2) (5) ----- ------ ------ Total gains (losses) on fixed maturity securities........................ 1 (4) (5) ----- ------ ------ Total net investment gains (losses).................................. $ 1 $ (4) $ (5) ===== ====== ====== 46
N-4410th Page of 530TOC1stPreviousNextBottomJust 410th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) Sales or Disposals and Impairments of Fixed Maturity and Equity Securities Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis. [Enlarge/Download Table] Years Ended December 31, ---------------------------------------------------------------- 2013 2012 2011 2013 2012 2011 2013 2012 2011 ------ ------ ------ ----- ----- ----- ------ ------ ------ Fixed Maturity Securities Equity Securities Total ------------------------- ----------------- -------------------- (In millions) Proceeds............................ $ 417 $ 576 $ 318 $ -- $ 1 $ 5 $ 417 $ 577 $ 323 ====== ====== ====== ===== ===== ===== ====== ====== ====== Gross investment gains.............. $ 3 $ 2 $ 3 $ -- $ -- $ -- $ 3 $ 2 $ 3 ------ ------ ------ ----- ----- ----- ------ ------ ------ Gross investment losses............. (2) (4) (8) -- -- -- (2) (4) (8) ------ ------ ------ ----- ----- ----- ------ ------ ------ Total OTTI losses: Credit-related.................... -- (1) -- -- -- -- -- (1) -- Other (1)......................... -- (1) -- -- -- -- -- (1) -- ------ ------ ------ ----- ----- ----- ------ ------ ------ Total OTTI losses................ -- (2) -- -- -- -- -- (2) -- ------ ------ ------ ----- ----- ----- ------ ------ ------ Net investment gains (losses)... $ 1 $ (4) $ (5) $ -- $ -- $ -- $ 1 $ (4) $ (5) ====== ====== ====== ===== ===== ===== ====== ====== ====== -------- (1)Other OTTI losses recognized in earnings include impairments on fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value. Credit Loss Rollforward The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2013 2012 ---------- ---------- (In millions) Balance at January 1,........................................... $ 2 $ 3 Reductions: Sales (maturities, pay downs or prepayments) during the period of securities previously impaired as credit loss OTTI........ -- (1) ---------- ---------- Balance at December 31,......................................... $ 2 $ 2 ========== ========== Related Party Investment Transactions The Company has an affiliated loan outstanding, which is included in other invested assets, totaling $45 million at both years ended December 31, 2013 and 2012. At December 31, 2011, the loan was outstanding with Exeter, an affiliate. During 2012, MetLife assumed this affiliated debt from Exeter. The loan is due on July 15, 2021, and bears interest, payable semi-annually, at 5.64%. Net investment income from this loan was $3 million, $3 million and $1 million for the years ended December 31, 2013, 2012 and 2011, respectively. 47
N-4411th Page of 530TOC1stPreviousNextBottomJust 411th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 5. Investments (continued) The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $3 million for each of the years ended December 31, 2013, 2012 and 2011. 6. Derivatives Accounting for Derivatives See Note 1 for a description of the Company's accounting policies for derivatives and Note 7 for information about the fair value hierarchy for derivatives. Derivative Strategies The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity. The Company uses a variety of strategies to manage these risks, including the use of derivatives. Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter ("OTC") market. Certain of the Company's OTC derivatives are cleared and settled through central clearing counterparties ("OTC-cleared"), while others are bilateral contracts between two counterparties ("OTC-bilateral"). The types of derivatives the Company uses include swaps, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash market. Interest Rate Derivatives The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps and floors. Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value and non-qualifying hedging relationships. The Company purchases interest rate floors primarily to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level. In certain instances, the Company locks in the economic impact of existing purchased floors by entering into offsetting written floors. The Company utilizes interest rate floors in non-qualifying hedging relationships. To a lesser extent, the Company uses interest rate futures in non-qualifying hedging relationships. Foreign Currency Exchange Rate Derivatives The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and 48
N-4412th Page of 530TOC1stPreviousNextBottomJust 412th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and non-qualifying hedging relationships. Credit Derivatives The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, or involuntary restructuring. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. ("ISDA") deems that a credit event has occurred. The Company utilizes credit default swaps in non-qualifying hedging relationships. The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. Treasury securities, agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments. Primary Risks Managed by Derivatives The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company's derivatives, excluding embedded derivatives, held at: [Enlarge/Download Table] December 31, ----------------------------------------------------------- 2013 2012 ----------------------------- ----------------------------- Estimated Fair Value Estimated Fair Value -------------------- -------------------- Notional Notional Primary Underlying Risk Exposure Amount Assets Liabilities Amount Assets Liabilities -------------------------------- -------- ------ ----------- -------- ------ ----------- (In millions) Derivatives Designated as Hedging Instruments Fair value hedges: Interest rate swaps............... Interest rate.................... $ 10 $ -- $ -- $ 12 $ -- $ -- Cash flow hedges: Foreign currency swaps............ Foreign currency exchange rate... 30 2 3 27 2 1 -------- ----- ----- -------- ----- ----- Total qualifying hedges...................................... 40 2 3 39 2 1 -------- ----- ----- -------- ----- ----- Derivatives Not Designated or Not Qualifying as Hedging Instruments Interest rate swaps................ Interest rate.................... 741 12 22 741 9 6 Interest rate floors............... Interest rate.................... 2,040 9 4 2,040 36 17 Foreign currency swaps............. Foreign currency exchange rate... 37 -- 5 23 -- 1 Credit default swaps--purchased.... Credit........................... 8 -- -- 9 -- -- Credit default swaps--written...... Credit........................... 20 -- -- 22 -- -- -------- ----- ----- -------- ----- ----- Total non-designated or non-qualifying derivatives............. 2,846 21 31 2,835 45 24 -------- ----- ----- -------- ----- ----- Total........................................................ $ 2,886 $ 23 $ 34 $ 2,874 $ 47 $ 25 ======== ===== ===== ======== ===== ===== 49
N-4413th Page of 530TOC1stPreviousNextBottomJust 413th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) Based on notional amounts, a substantial portion of the Company's derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2013 and 2012. The Company's use of derivatives includes (i) derivatives that serve as macro hedges of the Company's exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; and (iii) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these non-qualified derivatives, changes in market factors can lead to the recognition of fair value changes in the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged. Net Derivative Gains (Losses) The components of net derivative gains (losses) were as follows: [Download Table] Years Ended December 31, ---------------------- 2013 2012 2011 -------- ------ ------ (In millions) Derivatives and hedging gains (losses).. $ (27) $ 26 $ 36 Embedded derivatives.................... (415) 303 290 -------- ------ ------ Total net derivative gains (losses)... $ (442) $ 329 $ 326 ======== ====== ====== The amount the Company recognized in net investment income from settlement payments related to qualifying hedges for the years ended December 31, 2013, 2012 and 2011, was not significant. The Company recognized $26 million, $25 million and $14 million of net derivative gains (losses) from settlement payments related to non-qualifying hedges for the years ended December 31, 2013, 2012 and 2011, respectively. 50
N-4414th Page of 530TOC1stPreviousNextBottomJust 414th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) Non-Qualifying Derivatives and Derivatives for Purposes Other Than Hedging The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments: [Download Table] Net Derivative Gains (Losses) -------------- (In millions) Year Ended December 31, 2013: Interest rate derivatives..................... $ (50) Foreign currency exchange rate derivatives.... (4) Credit derivatives -- purchased............... -- Credit derivatives -- written................. -- ------- Total........................................ $ (54) ======= Year Ended December 31, 2012: Interest rate derivatives..................... $ 2 Foreign currency exchange rate derivatives.... (1) Credit derivatives -- purchased............... -- Credit derivatives -- written................. -- ------- Total........................................ $ 1 ======= Year Ended December 31, 2011: Interest rate derivatives..................... $ 22 Foreign currency exchange rate derivatives.... -- Credit derivatives -- purchased............... -- Credit derivatives -- written................. 1 ------- Total........................................ $ 23 ======= Fair Value Hedges The Company designates and accounts for interest rate swaps to convert fixed rate assets to floating rate assets as fair value hedges when they have met the requirements of fair value hedging. The amounts recognized in net derivative gains (losses) representing the ineffective portion of all fair value hedges for each of the years ended December 31, 2013, 2012 and 2011 were not significant. Changes in the fair value of the derivatives and the hedged items recognized in net derivative gains (losses) were not significant for each of the years ended December 31, 2013, 2012 and 2011. All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. Cash Flow Hedges The Company designates and accounts for foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets as cash flow hedges when they have met the requirements of cash flow hedging. 51
N-4415th Page of 530TOC1stPreviousNextBottomJust 415th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. When such forecasted transactions are not probable of occurring within two months of the anticipated date, the Company reclassifies certain amounts from AOCI into net derivative gains (losses). For the year ended December 31, 2013 the amounts reclassified into net derivative gains (losses) related to such discontinued cash flow hedges were not significant. For both the years ended 2012 and 2011, there were no amounts reclassified into net derivative gains (losses) related to such discontinued cash flow hedges. There were no hedged forecasted transactions, other than the receipt or payment of variable interest payments, for the years ended December 31, 2013, 2012 and 2011. At December 31, 2013 and 2012, the balance in AOCI associated with foreign currency swaps designated and qualifying as cash flow hedges was ($1) million and $1 million, respectively. For the years ended December 31, 2013, 2012 and 2011, there was ($2) million, ($1) million and $1 million of gains (losses) deferred in AOCI related to foreign currency swaps, respectively. For both the years ended December 31, 2013 and 2012, the amounts reclassified to net derivative gains (losses) related to foreign currency swaps were not significant. For the year ended December 31, 2011, there were no amounts reclassified to net derivative gains (losses) related to foreign currency swaps. For the years ended December 31, 2013, 2012 and 2011, there were no amounts reclassified to net investment income related to foreign currency swaps. For both the years ended December 31, 2013 and 2012, the amounts recognized in net derivative gains (losses) which represented the ineffective portion of all cash flow hedges were not significant. For the year ended December 31, 2011, the Company did not recognize any net derivative gains (losses) which represented the ineffective portion of all cash flow hedges. At December 31, 2013, ($1) million of deferred net gains (losses) on derivatives in AOCI was expected to be reclassified to earnings within the next 12 months. All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. Credit Derivatives In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the non-qualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company's maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $20 million and $22 million at December 31, 2013 and 2012, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current fair value of the credit default swaps. At both December 31, 2013 and 2012, the amounts the Company would have received to terminate all of these contracts was not significant. 52
N-4416th Page of 530TOC1stPreviousNextBottomJust 416th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at: [Enlarge/Download Table] December 31, --------------------------------------------------------------------------------- 2013 2012 ---------------------------------------- ---------------------------------------- Estimated Maximum Estimated Maximum Fair Value Amount of Future Weighted Fair Value Amount of Future Weighted Rating Agency Designation of of Credit Payments under Average of Credit Payments under Average Referenced Default Credit Default Years to Default Credit Default Years to Credit Obligations (1) Swaps Swaps (2) Maturity (3) Swaps Swaps (2) Maturity (3) ---------------------------- ---------- ---------------- ------------ ---------- ---------------- ------------ (In millions) (In millions) Aaa/Aa/A Single name credit default swaps (corporate).......... $ -- $ -- -- $ -- $ 2 1.0 Baa Credit default swaps referencing indices........ -- 20 5.0 -- 20 4.5 -------- -------- -------- -------- Total....................... $ -- $ 20 5.0 $ -- $ 22 4.2 ======== ======== ======== ======== -------- (1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody's Investors Service ("Moody's"), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used. (2)Assumes the value of the referenced credit obligations is zero. (3)The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts. Credit Risk on Freestanding Derivatives The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company's derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements. The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company's OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company's ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives. 53
N-4417th Page of 530TOC1stPreviousNextBottomJust 417th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) The Company's OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis, and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives. See Note 7 for a description of the impact of credit risk on the valuation of derivatives. The estimated fair value of the Company's net derivative assets and net derivative liabilities after the application of master netting agreements and collateral was as follows at: [Enlarge/Download Table] December 31, 2013 December 31, 2012 Derivatives Subject to a Master Netting Arrangement or a Similar ------------------ ------------------ Arrangement Assets Liabilities Assets Liabilities ---------------------------------------------------------------- ------ ----------- ------ ----------- (In millions) Gross estimated fair value of derivatives: OTC-bilateral (1)....................................................... $ 25 $ 32 $ 53 $ 27 OTC-cleared (1)......................................................... -- -- -- -- Exchange-traded......................................................... -- -- -- -- ----- ----- ------ ----- Total gross estimated fair value of derivatives (1).................... 25 32 53 27 Amounts offset in the balance sheets...................................... -- -- -- -- ----- ----- ------ ----- Estimated fair value of derivatives presented in the balance sheets (1)... 25 32 53 27 Gross amounts not offset in the balance sheets: Gross estimated fair value of derivatives: (2) OTC-bilateral........................................................... (5) (5) (10) (10) OTC-cleared............................................................. -- -- -- -- Exchange-traded......................................................... -- -- -- -- Cash collateral: (3) OTC-bilateral........................................................... (17) -- (42) -- OTC-cleared............................................................. -- -- -- -- Exchange-traded......................................................... -- -- -- -- Securities collateral: (4) OTC-bilateral........................................................... (2) (26) (1) (16) OTC-cleared............................................................. -- -- -- -- Exchange-traded......................................................... -- -- -- -- ----- ----- ------ ----- Net amount after application of master netting agreements and collateral.. $ 1 $ 1 $ -- $ 1 ===== ===== ====== ===== -------- (1)At December 31, 2013 and 2012, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $2 million and $6 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of ($2) million and $2 million, respectively. (2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals. 54
N-4418th Page of 530TOC1stPreviousNextBottomJust 418th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) (3)Cash collateral received is included in cash and cash equivalents, short-term investments, or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the balance sheets. The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables in the balance sheets. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At both December 31, 2013 and 2012, the Company had not received or paid any excess cash collateral. (4)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge this collateral, but at December 31, 2013 none of the collateral had been sold or repledged. Securities collateral pledged by the Company is reported in fixed maturity securities in the balance sheets. Subject to certain constraints, the counterparties are permitted by contract to sell or repledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At both December 31, 2013 and 2012, the Company received excess securities collateral with an estimated fair value of $1 million for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At both December 31, 2013 and 2012, the Company had provided no excess securities collateral for its OTC-bilateral derivatives, and had provided $1 million and $0, respectively, for its OTC- cleared derivatives, which are not included in the table above due to the foregoing limitation. At both December 31, 2013 and 2012, the Company did not pledge any securities collateral for its exchange-traded derivatives. The Company's collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the fair value of that counterparty's derivatives reaches a pre-determined threshold. Certain of these arrangements also include financial strength-contingent provisions that provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the financial strength ratings of the Company and/or the credit ratings of the counterparty. In addition, certain of the Company's netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade financial strength or credit rating from each of Moody's and S&P. If a party's financial strength or credit ratings were to fall below that specific investment grade financial strength or credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party's reasonable valuation of the derivatives. The following table presents the estimated fair value of the Company's OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company's financial strength rating at the reporting date or if the Company's financial strength rating sustained a downgrade to a level that 55
N-4419th Page of 530TOC1stPreviousNextBottomJust 419th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table. [Enlarge/Download Table] Estimated Fair Value of Fair Value of Incremental Collateral Collateral Provided: Provided Upon: ----------------------- ------------------------------------------- Downgrade in the Company's Financial Strength Rating to a Level that Triggers Estimated One Notch Full Overnight Fair Value of Downgrade in Collateralization or Derivatives in the Company's Termination Net Liability Fixed Maturity Financial Strength of the Derivative Position (1) Securities Rating Position -------------- ----------------------- ------------------ ------------------------ (In millions) December 31, 2013... $ 27 $ 26 $ -- $ 1 December 31, 2012... $ 17 $ 16 $ -- $ 2 -------- (1)After taking into consideration the existence of netting agreements. Embedded Derivatives The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; and affiliated ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs. The following table presents the estimated fair value and balance sheet location of the Company's embedded derivatives that have been separated from their host contracts at: [Download Table] December 31, --------------- Balance Sheet Location 2013 2012 -------------------------- -------- ------ (In millions) Net embedded derivatives within asset host contracts: Ceded guaranteed minimum benefits... Premiums, reinsurance and other receivables......... $ 376 $ 959 Net embedded derivatives within liability host contracts: Direct guaranteed minimum benefits.. PABs...................... $ (131) $ 56 The following table presents changes in estimated fair value related to embedded derivatives: [Download Table] Years Ended December 31, ---------------------- 2013 2012 2011 -------- ------ ------ (In millions) Net derivative gains (losses) (1), (2).. $ (415) $ 303 $ 290 -------- (1)The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were ($6) million, ($26) million and $29 million for the years ended December 31, 2013, 2012 and 2011, respectively. In addition, 56
N-4420th Page of 530TOC1stPreviousNextBottomJust 420th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 6. Derivatives (continued) the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were $42 million, $28 million and ($62) million for the years ended December 31, 2013, 2012 and 2011, respectively. (2)See Note 4 for discussion of affiliated net derivative gains (losses) included in the table above. 7. Fair Value When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability. Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company's ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities. Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. 57
N-4421st Page of 530TOC1stPreviousNextBottomJust 421st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) Recurring Fair Value Measurements The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented below. [Enlarge/Download Table] December 31, 2013 ----------------------------------------- Fair Value Hierarchy ------------------------- Total Estimated Level 1 Level 2 Level 3 Fair Value ------- --------- ------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................... $ -- $ 859 $ 13 $ 872 U.S. Treasury and agency..................................... 408 49 -- 457 RMBS......................................................... -- 285 27 312 CMBS......................................................... -- 297 -- 297 Foreign corporate............................................ -- 185 44 229 ABS.......................................................... -- 46 7 53 State and political subdivision.............................. -- 19 -- 19 Foreign government........................................... -- 11 -- 11 ------ --------- ------ --------- Total fixed maturity securities............................ 408 1,751 91 2,250 ------ --------- ------ --------- Equity securities: Common stock................................................. -- 26 -- 26 Non-redeemable preferred stock............................... -- -- 19 19 ------ --------- ------ --------- Total equity securities.................................... -- 26 19 45 ------ --------- ------ --------- Short-term investments........................................ 14 61 -- 75 Derivative assets: (1) Interest rate.............................................. -- 21 -- 21 Foreign currency exchange rate............................. -- 2 -- 2 ------ --------- ------ --------- Total derivative assets................................... -- 23 -- 23 ------ --------- ------ --------- Net embedded derivatives within asset host contracts (2)...... -- -- 376 376 Separate account assets (3)................................... -- 12,033 -- 12,033 ------ --------- ------ --------- Total assets.............................................. $ 422 $ 13,894 $ 486 $ 14,802 ====== ========= ====== ========= Liabilities Derivative liabilities: (1) Interest rate................................................ $ -- $ 26 $ -- $ 26 Foreign currency exchange rate............................... -- 8 -- 8 ------ --------- ------ --------- Total derivative liabilities............................... -- 34 -- 34 ------ --------- ------ --------- Net embedded derivatives within liability host contracts (2).. -- -- (131) (131) ------ --------- ------ --------- Total liabilities.......................................... $ -- $ 34 $(131) $ (97) ====== ========= ====== ========= 58
N-4422nd Page of 530TOC1stPreviousNextBottomJust 422nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) [Enlarge/Download Table] December 31, 2012 ----------------------------------------------- Fair Value Hierarchy ------------------------------- Total Estimated Level 1 Level 2 Level 3 Fair Value -------- ----------- ---------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................... $ -- $ 944 $ 55 $ 999 U.S. Treasury and agency..................................... 382 15 -- 397 RMBS......................................................... -- 283 14 297 CMBS......................................................... -- 305 14 319 Foreign corporate............................................ -- 180 42 222 ABS.......................................................... -- 54 -- 54 State and political subdivision.............................. -- 20 -- 20 Foreign government........................................... -- 12 -- 12 -------- ----------- ---------- ----------- Total fixed maturity securities............................ 382 1,813 125 2,320 -------- ----------- ---------- ----------- Equity securities: Common stock................................................. -- 28 -- 28 Non-redeemable preferred stock............................... -- -- 17 17 -------- ----------- ---------- ----------- Total equity securities.................................... -- 28 17 45 -------- ----------- ---------- ----------- Short-term investments........................................ 116 23 -- 139 Derivative assets: (1) Interest rate.............................................. -- 45 -- 45 Foreign currency exchange rate............................. -- 2 -- 2 -------- ----------- ---------- ----------- Total derivative assets................................... -- 47 -- 47 -------- ----------- ---------- ----------- Net embedded derivatives within asset host contracts (2)...... -- -- 959 959 Separate account assets (3)................................... -- 11,072 -- 11,072 -------- ----------- ---------- ----------- Total assets.............................................. $ 498 $ 12,983 $ 1,101 $ 14,582 ======== =========== ========== =========== Liabilities Derivative liabilities: (1) Interest rate................................................ $ -- $ 23 $ -- $ 23 Foreign currency exchange rate............................... -- 2 -- 2 -------- ----------- ---------- ----------- Total derivative liabilities.............................. -- 25 -- 25 -------- ----------- ---------- ----------- Net embedded derivatives within liability host contracts (2).. -- -- 56 56 -------- ----------- ---------- ----------- Total liabilities......................................... $ -- $ 25 $ 56 $ 81 ======== =========== ========== =========== -------- (1)Derivative assets are presented within other invested assets in the balance sheets and derivative liabilities are presented within other liabilities in the balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables. (2)Net embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables in the balance sheets. Net embedded derivatives within liability host contracts are presented within PABs in the balance sheets. (3)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. 59
N-4423rd Page of 530TOC1stPreviousNextBottomJust 423rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy. Investments Valuation Controls and Procedures On behalf of the Company and MetLife, Inc.'s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of MetLife, Inc.'s Board of Directors regarding compliance with fair value accounting standards. The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management's knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as "consensus pricing," represent a reasonable estimate of fair value by considering such pricing relative to the Company's knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 2% of the total estimated fair value of Level 3 fixed maturity securities. The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were 60
N-4424th Page of 530TOC1stPreviousNextBottomJust 424th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management's best estimate is used. Securities and Short-term Investments When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company's securities holdings and valuation of these securities does not involve management's judgment. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management's judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances. Level 2 Valuation Techniques and Key Inputs: This level includes securities priced principally by independent pricing services using observable inputs. Short-term investments within this level are of a similar nature and class to the Level 2 fixed maturity securities and equity securities. U.S. corporate and foreign corporate securities These securities are principally valued using the market and income approaches. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques that use standard market observable inputs such as benchmark yields, spreads off benchmark yields, new issuances, issuer rating, duration, and trades of identical or comparable securities. Privately-placed securities are valued using matrix pricing methodologies using standard market observable inputs, and inputs derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer, and in certain cases, delta spread adjustments to reflect specific credit-related issues. U.S. Treasury and agency securities These securities are principally valued using the market approach. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques using standard market observable inputs such as a benchmark U.S. Treasury yield curve, the spread off the U.S. Treasury yield curve for the identical security and comparable securities that are actively traded. 61
N-4425th Page of 530TOC1stPreviousNextBottomJust 425th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) Structured securities comprised of RMBS, CMBS and ABS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using standard market inputs, including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information, including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans. State and political subdivision and foreign government securities These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques using standard market observable inputs, including a benchmark U.S. Treasury yield or other yields, issuer ratings, broker-dealer quotes, issuer spreads and reported trades of similar securities, including those within the same sub-sector or with a similar maturity or credit rating. Common stock These securities are principally valued using the market approach. Valuations are based principally on observable inputs, including quoted prices in markets that are not considered active. Level 3 Valuation Techniques and Key Inputs: In general, securities classified within Level 3 use many of the same valuation techniques and inputs as described previously for Level 2. However, if key inputs are unobservable, or if the investments are less liquid and there is very limited trading activity, the investments are generally classified as Level 3. The use of independent non-binding broker quotations to value investments generally indicates there is a lack of liquidity or a lack of transparency in the process to develop the valuation estimates, generally causing these investments to be classified in Level 3. U.S. corporate and foreign corporate securities These securities, including financial services industry hybrid securities classified within fixed maturity securities, are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques that utilize unobservable inputs or inputs that cannot be derived principally from, or corroborated by, observable market data, including illiquidity premium, delta spread adjustments to reflect specific credit-related issues, credit spreads; and inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on independent non-binding broker quotations. Structured securities comprised of RMBS, CMBS and ABS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques that utilize 62
N-4426th Page of 530TOC1stPreviousNextBottomJust 426th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads. Below investment grade securities and sub-prime RMBS included in this level are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain of these valuations are based on independent non-binding broker quotations. Non-redeemable preferred stock These securities, including financial services industry hybrid securities classified within equity securities, are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using inputs such as comparable credit rating and issuance structure. Certain of these securities are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2 and independent non-binding broker quotations. Separate Account Assets Separate account assets are carried at estimated fair value and reported as a summarized total on the balance sheets. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets. Separate account assets within the Company's separate accounts consist of mutual funds. Level 2 Valuation Techniques and Key Inputs: These assets are comprised of certain mutual funds without readily determinable fair values, as prices are not published publicly. Valuation of the mutual funds is based upon quoted prices or reported NAV provided by the fund managers. Derivatives The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in "-- Investments." The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Significant inputs that are observable generally include: interest rates, foreign currency exchange rates, interest rate curves, credit curves and volatility. However, certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant inputs that are unobservable generally include references to emerging market currencies and inputs that are outside the observable portion of 63
N-4427th Page of 530TOC1stPreviousNextBottomJust 427th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) the interest rate curve, credit curve, volatility or other relevant market measure. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company's derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company's ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. Freestanding Derivatives Level 2 Valuation Techniques and Key Inputs: This level includes all types of derivatives utilized by the Company with the exception of exchange traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. These derivatives are principally valued using the income approach. Interest rate Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and basis curves. Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves and interest rate volatility. Foreign currency exchange rate Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates and cross currency basis curves. Embedded Derivatives Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. 64
N-4428th Page of 530TOC1stPreviousNextBottomJust 428th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs in the balance sheets. The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company's actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates. Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife's debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income. The Company ceded, to an affiliated reinsurance company, the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to the same affiliated reinsurance company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables in the balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. 65
N-4429th Page of 530TOC1stPreviousNextBottomJust 429th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) Embedded Derivatives Within Asset and Liability Host Contracts Level 3 Valuation Techniques and Key Inputs: Direct guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin. Reinsurance ceded on certain guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in "-- Direct Guaranteed Minimum Benefits" and also include counterparty credit spreads. Transfers between Levels Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period. Transfers between Levels 1 and 2: There were no transfers between Levels 1 and 2 for assets and liabilities measured at estimated fair value and still held at December 31, 2013 and 2012. Transfers into or out of Level 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Transfers into Level 3 for fixed maturity securities were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments, or credit spreads. 66
N-4430th Page of 530TOC1stPreviousNextBottomJust 430th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) Transfers out of Level 3 for fixed maturity securities resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings. Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at: [Enlarge/Download Table] December 31, 2013 --------------------- -------------------------- -------------------------- Valuation Significant Weighted Techniques Unobservable Inputs Range Average (1) --------------------- -------------------------- ------------- ----------- Fixed maturity securities: (3) U.S. corporate and Matrix pricing Delta spread foreign corporate... adjustments (4) (10) - 30 6 Illiquidity premium (4) 30 - 30 30 Credit spreads (4) Consensus pricing Offered quotes (5) ------------------------------------------------------------------------------- RMBS Matrix pricing and Credit spreads (4) discounted cash flow 97 - 574 411 Market pricing Quoted prices (5) 100 - 100 100 ------------------------------------------------------------------------------- CMBS Market pricing Quoted prices (5) ------------------------------------------------------------------------------- ABS Market pricing Quoted prices (5) 99 - 99 99 Consensus pricing Offered quotes (5) 99 - 99 99 ------------------------------------------------------------------------------- Embedded derivatives: Direct and ceded Option pricing Mortality rates: guaranteed techniques minimum benefits............ Ages 0 - 40 0% - 0.10% Ages 41 - 60 0.04% - 0.65% Ages 61 - 115 0.26% - 100% Lapse rates: Durations 1 - 10 0.50% - 100% Durations 11 -20 3% - 100% Durations 21 -116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity volatilities 17.40% - 25% Nonperformance risk spread 0.03% - 0.44% ------------------------------------------------------------------------------- [Enlarge/Download Table] December 31, 2012 Impact of --------------------- -------------------------- -------------------------- Increase in Input Valuation Significant Weighted on Estimated Techniques Unobservable Inputs Range Average (1) Fair Value (2) --------------------- -------------------------- ------------- ----------- ----------------- Fixed maturity securities: (3) U.S. corporate and Matrix pricing Delta spread foreign corporate... adjustments (4) 50 - 100 57 Decrease Illiquidity premium (4) 30 - 30 30 Decrease Credit spreads (4) 23 - 421 129 Decrease Consensus pricing Offered quotes (5) 100 - 102 101 Increase ------------------------------------------------------------------------------------------------- RMBS Matrix pricing and Credit spreads (4) discounted cash flow 161 - 657 541 Decrease (6) Market pricing Quoted prices (5) Increase (6) ------------------------------------------------------------------------------------------------- CMBS Market pricing Quoted prices (5) 100 - 100 100 Increase (6) ------------------------------------------------------------------------------------------------- ABS Market pricing Quoted prices (5) Increase (6) Consensus pricing Offered quotes (5) Increase (6) ------------------------------------------------------------------------------------------------- Embedded derivatives: Direct and ceded Option pricing Mortality rates: guaranteed techniques minimum benefits............ Ages 0 - 40 0% - 0.10% Decrease (7) Ages 41 - 60 0.05% - 0.64% Decrease (7) Ages 61 - 115 0.32% - 100% Decrease (7) Lapse rates: Durations 1 - 10 0.50% - 100% Decrease (8) Durations 11 -20 3% - 100% Decrease (8) Durations 21 -116 3% - 100% Decrease (8) Utilization rates 20% - 50% Increase (9) Withdrawal rates 0.07% - 10% (10) Long-term equity volatilities 17.40% - 25% Increase (11) Nonperformance risk spread 0.10% - 0.67% Decrease (12) ------------------------------------------------------------------------------------------------- -------- (1)The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities. (2)The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes to direct guaranteed minimum benefits are based on liability positions and changes to ceded guaranteed minimum benefits are based on asset positions. 67
N-4431st Page of 530TOC1stPreviousNextBottomJust 431st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) (3)Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations. (4)Range and weighted average are presented in basis points. (5)Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par. (6)Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates. (7)Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (8)Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (9)The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract's withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (10)The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (11)Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (12)Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. 68
N-4432nd Page of 530TOC1stPreviousNextBottomJust 432nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3 use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3): [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ----------------------------------------------------------------------------------- Fixed Maturity Securities: Equity Securities: ------------------------------------- ----------------- Non- redeemable Net U.S. Foreign Common Preferred Short-term Embedded Corporate RMBS CMBS Corporate ABS Stock Stock Investments Derivatives (6) --------- ----- ----- --------- ----- ------ ---------- ----------- --------------- (In millions) Year Ended December 31, 2013: Balance at January 1,................... $ 55 $ 14 $ 14 $ 42 $ -- $ -- $ 17 $ -- $ 903 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2)............ Net investment income................. -- -- -- -- -- -- -- -- -- Net investment gains (losses)......... -- -- -- -- -- -- -- -- -- Net derivative gains (losses)......... -- -- -- -- -- -- -- -- (415) OCI.................................... -- -- -- 2 -- -- 2 -- -- Purchases (3)........................... 4 13 -- 10 7 -- -- -- -- Sales (3)............................... (10) -- -- (9) -- -- -- -- -- Issuances (3)........................... -- -- -- -- -- -- -- -- -- Settlements (3)......................... -- -- -- -- -- -- -- -- 19 Transfers into Level 3 (4).............. -- -- -- -- -- -- -- -- -- Transfers out of Level 3 (4)............ (36) -- (14) (1) -- -- -- -- -- ----- ----- ----- ----- ----- ----- ----- ----- ------ Balance at December 31,................. $ 13 $ 27 $ -- $ 44 $ 7 $ -- $ 19 $ -- $ 507 ===== ===== ===== ===== ===== ===== ===== ===== ====== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $(402) 69
N-4433rd Page of 530TOC1stPreviousNextBottomJust 433rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ----------------------------------------------------------------------------------- Fixed Maturity Securities: Equity Securities: ------------------------------------- ----------------- Non- redeemable Net U.S. Foreign Common Preferred Short-term Embedded Corporate RMBS CMBS Corporate ABS Stock Stock Investments Derivatives (6) --------- ----- ----- --------- ----- ------ ---------- ----------- --------------- (In millions) Year Ended December 31, 2012: Balance at January 1,................... $ 16 $ 11 $ -- $ 6 $ 6 $ 19 $ 15 $ -- $ 580 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2)............ Net investment income................. -- -- -- -- -- -- -- -- -- Net investment gains (losses)......... -- -- -- -- -- -- -- -- -- Net derivative gains (losses)......... -- -- -- -- -- -- -- -- 303 OCI.................................... 2 3 -- -- -- -- 2 -- -- Purchases (3)........................... 31 -- 14 36 -- -- -- -- -- Sales (3)............................... (2) -- -- -- (6) -- -- -- -- Issuances (3)........................... -- -- -- -- -- -- -- -- -- Settlements (3)......................... -- -- -- -- -- -- -- -- 20 Transfers into Level 3 (4).............. 11 -- -- -- -- -- -- -- -- Transfers out of Level 3 (4)............ (3) -- -- -- -- (19) -- -- -- ----- ----- ----- ----- ----- ----- ----- ----- ------ Balance at December 31,................. $ 55 $ 14 $ 14 $ 42 $ -- $ -- $ 17 $ -- $ 903 ===== ===== ===== ===== ===== ===== ===== ===== ====== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ 309 [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ----------------------------------------------------------------------------------- Fixed Maturity Securities: Equity Securities: ------------------------------------- ----------------- Non- redeemable Net U.S. Foreign Common Preferred Short-term Embedded Corporate RMBS CMBS Corporate ABS Stock Stock Investments Derivatives (6) --------- ----- ----- --------- ----- ------ ---------- ----------- --------------- (In millions) Year Ended December 31, 2011: Balance at January 1,................. $ 22 $ 11 $ -- $ 25 $ 19 $ 10 $ 15 $ 9 $ 269 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2).......... Net investment income............... -- -- -- -- -- -- -- -- -- Net investment gains (losses)....... -- -- -- (3) -- -- -- -- -- Net derivative gains (losses)....... -- -- -- -- -- -- -- -- 290 OCI.................................. 1 -- -- 2 1 -- -- -- -- Purchases (3)......................... 2 -- -- 6 5 9 -- -- -- Sales (3)............................. (2) -- -- (17) (9) -- -- (9) -- Issuances (3)......................... -- -- -- -- -- -- -- -- -- Settlements (3)....................... -- -- -- -- -- -- -- -- 21 Transfers into Level 3 (4)............ -- -- -- -- -- -- -- -- -- Transfers out of Level 3 (4).......... (7) -- -- (7) (10) -- -- -- -- ----- ----- ----- ----- ----- ----- ----- ----- ------ Balance at December 31,............... $ 16 $ 11 $ -- $ 6 $ 6 $ 19 $ 15 $ -- $ 580 ===== ===== ===== ===== ===== ===== ===== ===== ====== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income................ $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses)........ $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses)........ $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ 293 -------- (1)Amortization of premium/discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). 70
N-4434th Page of 530TOC1stPreviousNextBottomJust 434th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) (2)Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (3)Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (4)Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (5)Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. (6)Embedded derivative assets and liabilities are presented net for purposes of the rollforward. Fair Value of Financial Instruments Carried at Other Than Fair Value The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under securities loaned and other transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure. The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: [Enlarge/Download Table] December 31, 2013 ------------------------------------------------------------- Fair Value Hierarchy - ----------------------------------- Carrying Total Estimated Value Level 1 Level 2 Level 3 Fair Value --------- ----------- ----------- ----------- --------------- (In millions) Assets Mortgage loans.................. $ 286 $ -- $ -- $ 303 $ 303 Policy loans.................... $ 27 $ -- $ 3 $ 39 $ 42 Other limited partnership interests...................... $ 1 $ -- $ -- $ 1 $ 1 Other invested assets........... $ 45 $ -- $ 50 $ -- $ 50 Premiums, reinsurance and other receivables.................... $ 1,258 $ -- $ -- $ 1,359 $ 1,359 Other assets.................... $ 5 $ -- $ 5 $ -- $ 5 Liabilities PABs............................ $ 2,293 $ -- $ -- $ 2,501 $ 2,501 Other liabilities............... $ 1 $ -- $ 1 $ -- $ 1 71
N-4435th Page of 530TOC1stPreviousNextBottomJust 435th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) [Enlarge/Download Table] December 31, 2012 ------------------------------------------------------------- Fair Value Hierarchy ----------------------------------- Carrying Total Estimated Value Level 1 Level 2 Level 3 Fair Value --------- ----------- ----------- ----------- --------------- (In millions) Assets Mortgage loans.................. $ 284 $ -- $ -- $ 307 $ 307 Policy loans.................... $ 27 $ -- $ 2 $ 46 $ 48 Other limited partnership interests...................... $ 1 $ -- $ -- $ 2 $ 2 Other invested assets........... $ 45 $ -- $ 57 $ -- $ 57 Premiums, reinsurance and other receivables.................... $ 1,364 $ -- $ -- $ 1,527 $ 1,527 Other assets.................... $ 6 $ -- $ 6 $ -- $ 6 Liabilities PABs............................ $ 2,431 $ -- $ -- $ 2,788 $ 2,788 Other liabilities............... $ 3 $ -- $ 3 $ -- $ 3 The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows: Mortgage Loans For mortgage loans, estimated fair value is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans. Policy Loans Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates. Other Limited Partnership Interests The estimated fair values of these cost method investments are generally based on the Company's share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments. 72
N-4436th Page of 530TOC1stPreviousNextBottomJust 436th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 7. Fair Value (continued) Other Invested Assets These other invested assets are principally comprised of loans to affiliates. The estimated fair value of loans to affiliates is determined by discounting the expected future cash flows using market interest rates currently available for instruments with similar terms and remaining maturities. Premiums, Reinsurance and Other Receivables Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements. Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty. Other Assets Other assets are comprised of a receivable for the reimbursable portion of the estimated future guaranty liability that pertains to pre-acquisition business. With the exception of the receivable, other assets are not considered financial instruments subject to disclosure. Accordingly, the amount represents the receivable from an unaffiliated institution for which the estimated fair value was determined by discounting the expected future cash flows using a discount rate that reflects the credit standing of the unaffiliated institution. PABs These PABs include investment contracts. Embedded derivatives on investment contracts and certain variable annuity guarantees accounted for as embedded derivatives are excluded from this caption in the preceding tables as they are separately presented in "-- Recurring Fair Value Measurements." The investment contracts primarily include fixed deferred annuities and fixed term payout annuities. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability. Other Liabilities Other liabilities consist of derivative payables and amounts due for securities purchased but not yet settled. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values. 73
N-4437th Page of 530TOC1stPreviousNextBottomJust 437th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 8. Equity Statutory Equity and Income Each U.S. insurance company's state of domicile imposes risk-based capital ("RBC") requirements that were developed by the National Association of Insurance Commissioners ("NAIC"). Regulatory compliance is determined by a ratio of a company's total adjusted capital, calculated in the manner prescribed by the NAIC ("TAC") to its authorized control level RBC, calculated in the manner prescribed by the NAIC ("ACL RBC"). Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC ("Company Action RBC"). The RBC ratio for the Company was in excess of 1,400% for all periods presented. The Company prepares statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of its state of domicile. The NAIC has adopted the Codification of Statutory Accounting Principles ("Statutory Codification"). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by state insurance departments may impact the effect of Statutory Codification on the statutory capital and surplus of the Company. Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting of reinsurance agreements and valuing securities on a different basis. In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by the Company are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years. Statutory net income (loss) of the Company, a Missouri domiciled insurer, was $111 million, $132 million and $94 million for the years ended December 31, 2013, 2012 and 2011, respectively. Statutory capital and surplus was $666 million and $704 million at December 31, 2013 and 2012, respectively. All such amounts are derived from the statutory-basis financial statements as filed with the Missouri State Department of Insurance. Dividend Restrictions Under Missouri State Insurance Law, MLIIC is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to MetLife as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding net realized capital gains). MLIIC will be permitted to pay a dividend to MetLife in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Missouri Director of Insurance (the "Missouri Director") and the Missouri Director either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined by the Company as "unassigned funds (surplus)") as of the last filed annual statutory statement requires insurance regulatory approval. Under Missouri State Insurance Law, the Missouri Director has broad discretion in determining 74
N-4438th Page of 530TOC1stPreviousNextBottomJust 438th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 8. Equity (continued) whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. During the years ended December 31, 2013 and 2012, MLIIC paid a dividend to MetLife of $129 million and $18 million, respectively. During the year ended December 31, 2011, MLIIC did not pay a dividend to MetLife. Based on amounts at December 31, 2013, MLIIC could pay a stockholder dividend in 2014 of $99 million without prior regulatory approval of the Missouri Director. Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI, net of income tax, was as follows: [Enlarge/Download Table] Unrealized Investment Gains Unrealized (Losses), Net of Gains (Losses) Related Offsets (1) on Derivatives Total ------------------- -------------- ------- (In millions) Balance at December 31, 2010....................... $ 19 $ 1 $ 20 OCI before reclassifications....................... 19 -- 19 Income tax expense (benefit)....................... (7) -- (7) ------- ------- ------- OCI before reclassifications, net of income tax... 31 1 32 Amounts reclassified from AOCI..................... 4 -- 4 Income tax expense (benefit)....................... (1) -- (1) ------- ------- ------- Amounts reclassified from AOCI, net of income tax. 3 -- 3 ------- ------- ------- Balance at December 31, 2011....................... 34 1 35 OCI before reclassifications....................... 61 (1) 60 Income tax expense (benefit)....................... (21) -- (21) ------- ------- ------- OCI before reclassifications, net of income tax... 74 -- 74 Amounts reclassified from AOCI..................... 3 -- 3 Income tax expense (benefit)....................... (1) -- (1) ------- ------- ------- Amounts reclassified from AOCI, net of income tax. 2 -- 2 ------- ------- ------- Balance at December 31, 2012....................... 76 -- 76 OCI before reclassifications....................... (78) (2) (80) Income tax expense (benefit)....................... 27 1 28 ------- ------- ------- OCI before reclassifications, net of income tax... 25 (1) 24 Amounts reclassified from AOCI..................... (2) -- (2) Income tax expense (benefit)....................... 1 -- 1 ------- ------- ------- Amounts reclassified from AOCI, net of income tax. (1) -- (1) ------- ------- ------- Balance at December 31, 2013....................... $ 24 $ (1) $ 23 ======= ======= ======= -------- (1)See Note 5 for information on offsets to investments related to insurance liabilities and DAC and VOBA. 75
N-4439th Page of 530TOC1stPreviousNextBottomJust 439th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 8. Equity (continued) Information regarding amounts reclassified out of each component of AOCI, was as follows: [Enlarge/Download Table] Statement of Operations and AOCI Components Amounts Reclassified from AOCI Comprehensive Income (Loss) Location ---------------------------------------------------- ------------------------------ ------------------------------------ Years Ended December 31, ------------------------------ 2013 2012 2011 -------- -------- -------- (In millions) Net unrealized investment gains (losses): Net unrealized investment gains (losses)............ $ 1 $ (5) $ (5) Other net investment gains (losses) Net unrealized investment gains (losses)............ 1 2 1 Net investment income -------- -------- -------- Net unrealized investment gains (losses), before income tax........................................ 2 (3) (4) Income tax (expense) benefit....................... (1) 1 1 -------- -------- -------- Net unrealized investment gains (losses), net of income tax........................................ $ 1 $ (2) $ (3) ======== ======== ======== Total reclassifications, net of income tax............ $ 1 $ (2) $ (3) ======== ======== ======== 9. Other Expenses Information on other expenses was as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ----- ----- ----- (In millions) Compensation..................... $ 5 $ 9 $ 10 Commissions...................... 50 57 68 Volume-related costs............. -- 3 7 Capitalization of DAC............ (6) (19) (34) Amortization of DAC and VOBA..... (89) 148 172 Premium taxes, licenses and fees. 3 1 6 Other............................ 26 30 30 ----- ----- ----- Total other expenses........... $(11) $ 229 $ 259 ===== ===== ===== Capitalization and Amortization of DAC and VOBA See Note 3 for additional information on DAC and VOBA including impacts of capitalization and amortization. Affiliated Expenses See Note 12 for discussion of affiliated expenses included in the table above. 76
N-4440th Page of 530TOC1stPreviousNextBottomJust 440th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 10. Income Tax The provision for income tax was as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------- ----- ----- (In millions) Current: Federal...................................... $ 38 $ 8 $ 24 Deferred: Federal...................................... (105) 86 66 ------- ----- ----- Provision for income tax expense (benefit). $ (67) $ 94 $ 90 ======= ===== ===== The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported was as follows: [Download Table] Years Ended December 31, ------------------------ 2013 2012 2011 ------- ----- ----- (In millions) Tax provision at U.S. statutory rate....... $ (55) $ 103 $ 107 Tax effect of: Dividend received deduction............... (12) (11) (13) Prior year tax............................ (2) 3 (2) Tax credits............................... (1) (1) (2) Other, net................................ 3 -- -- ------- ----- ----- Provision for income tax expense (benefit). $ (67) $ 94 $ 90 ======= ===== ===== Deferred income tax represents the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: [Download Table] December 31, ----------------- 2013 2012 -------- -------- (In millions) Deferred income tax assets: Investments, including derivatives.............. $ 9 $ -- Tax credit carryforwards........................ 5 -- Other, net...................................... 2 -------- -------- Total deferred income tax assets.............. 16 -- Deferred income tax liabilities: Policyholder liabilities and receivables........ 110 234 DAC and VOBA.................................... 86 33 Net unrealized investment gains................. 11 40 Investments, including derivatives.............. -- 18 Other........................................... 1 1 -------- -------- Total deferred income tax liabilities......... 208 326 -------- -------- Net deferred income tax asset (liability)... $ (192) $ (326) ======== ======== 77
N-4441st Page of 530TOC1stPreviousNextBottomJust 441st
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 10. Income Tax (continued) Tax credit carryforwards of $5 million at December 31, 2013 will expire beginning in 2021. The Company participates in a tax sharing agreement with MetLife, as described in Note 1. Pursuant to this tax sharing agreement, the amounts due from affiliates include $18 million and $8 million at December 31, 2013 and 2012, respectively. The amounts due to affiliates include $8 million at December 31, 2011. The Company files income tax returns with the U.S. federal government and various state and local jurisdictions. The Company is under continuous examination by the Internal Revenue Service ("IRS") and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction. The Company is no longer subject to U.S. federal, state or local income tax examinations in major taxing jurisdictions for years prior to 2006. The IRS audit cycle for the year 2006, which began in April 2010, is expected to conclude in 2014. It is not expected that there will be a material change in the Company's liability for unrecognized tax benefits in the next 12 months. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: [Enlarge/Download Table] Year Ended December 31, 2013 ----------------- (In millions) Balance at January 1,......................................................... $ -- Additions for tax positions of prior years.................................... 3 -------- Balance at December 31,....................................................... $ 3 ======== Unrecognized tax benefits that, if recognized would impact the effective rate. $ 3 ======== There were no unrecognized tax benefits at December 31, 2012 and 2011. The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense. Interest was as follows: [Download Table] Year Ended December 31, 2013 ----------------- (In millions) Interest recognized in the statements of operations.......... $ 1 December 31, 2013 ----------------- (In millions) Interest included in other liabilities in the balance sheets. $ 1 78
N-4442nd Page of 530TOC1stPreviousNextBottomJust 442nd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 10. Income Tax (continued) There was no interest recognized in the statements of operations for the years ended December 31, 2012 and 2011. There was no interest included in other liabilities in the balance sheets at December 31, 2012. The Company had no penalties for the years ended December 31, 2013, 2012 and 2011. The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction ("DRD"), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2013 and 2012, the Company recognized an income tax benefit of $14 million and $8 million, respectively, related to the separate account DRD. The 2013 benefit included a benefit of $2 million related to a true-up of the 2012 tax return. The 2012 benefit included an expense of $3 million related to a true-up of the 2011 tax return. 11. Contingencies, Commitments and Guarantees Contingencies Litigation Unclaimed Property Inquiries In April 2012, MetLife, for itself and on behalf of entities including the Company, reached agreements with representatives of the U.S. jurisdictions that were conducting audits of MetLife and certain of its affiliates for compliance with unclaimed property laws, and with state insurance regulators directly involved in a multistate targeted market conduct examination relating to claim-payment practices and compliance with unclaimed property laws. At least one other jurisdiction is pursuing a market conduct examination. It is possible that other jurisdictions may pursue similar examinations or audits and that such actions may result in additional payments to beneficiaries, additional escheatment of funds deemed abandoned under state laws, administrative penalties, interest, and/or further changes to the Company's procedures. The Company is not currently able to estimate these additional possible costs. Sales Practices Claims Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. The Company continues to vigorously defend against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters. 79
N-4443rd Page of 530TOC1stPreviousNextBottomJust 443rd
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 11. Contingencies, Commitments and Guarantees (continued) Summary Various litigation, claims and assessments against the Company, have arisen in the course of the Company's business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor, and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company's compliance with applicable insurance and other laws and regulations. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company's financial position, based on information currently known by the Company's management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company's net income or cash flows in particular annual periods. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assets and liabilities held for insolvency assessments were as follows: [Download Table] December 31, --------------- 2013 2012 ------- ------- (In millions) Other Assets: Premium tax offset for future undiscounted assessments. $ 1 $ 1 Receivable for reimbursement of paid assessments (1)... 5 6 ------- ------- $ 6 $ 7 ======= ======= Other Liabilities: Insolvency assessments................................. $ 6 $ 8 ======= ======= -------- (1)The Company holds a receivable from the seller of a prior acquisition in accordance with the purchase agreement. 80
N-4444th Page of 530TOC1stPreviousNextBottomJust 444th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 11. Contingencies, Commitments and Guarantees (continued) Commitments Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commitments were $7 million and $9 million at December 31, 2013 and 2012, respectively. The Company anticipates that these amounts will be invested in partnerships over the next five years. Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $6 million and $1 million at December 31, 2013 and 2012, respectively. Commitments to Fund Private Corporate Bond Investments The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $14 million and $13 million at December 31, 2013 and 2012, respectively. Guarantees In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities, and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments. In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company's interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future. The Company had no liability for indemnities, guarantees and commitments at both December 31, 2013 and 2012. 81
N-4445th Page of 530TOC1stPreviousNextBottomJust 445th
MetLife Investors Insurance Company (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Financial Statements -- (Continued) 12. Related Party Transactions Service Agreements The Company has entered into various agreements with affiliates for services necessary to conduct its activities. Typical services provided under these agreements include management, policy administrative functions, personnel, investment advice and distribution services. For certain agreements, charges are based on various performance measures or activity-based costing. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Expenses incurred with affiliates related to these agreements, recorded in other expenses, were $78 million, $53 million and $76 million for the years ended December 31, 2013, 2012 and 2011, respectively. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $38 million, $34 million and $32 million for the years ended December 31, 2013, 2012 and 2011, respectively. Revenues received from affiliates related to these agreements, recorded in fees on ceded reinsurance and other, were $25 million, $24 million and $26 million for the years ended December 31, 2013, 2012 and 2011, respectively. The Company had net receivables from affiliates, related to the items discussed above, of $4 million and $2 million at December 31, 2013 and 2012, respectively. See Notes 4 and 5 for additional information on related party transactions. 13. Subsequent Event The Company has evaluated events subsequent to December 31, 2013, through March 31, 2014, which is the date these financial statements were available to be issued, and has determined there are no material subsequent events requiring adjustment to or disclosure in the financial statements. 82
N-4446th Page of 530TOC1stPreviousNextBottomJust 446th
EXETER REASSURANCE COMPANY, LTD. FINANCIAL STATEMENTS AS OF DECEMBER 31, 2013 AND 2012 AND FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 (AS RESTATED) AND INDEPENDENT AUDITORS' REPORT
N-4447th Page of 530TOC1stPreviousNextBottomJust 447th
INDEPENDENT AUDITORS' REPORT To the Board of Directors and Stockholder of Exeter Reassurance Company, Ltd.: We have audited the accompanying financial statements of Exeter Reassurance Company, Ltd. (a wholly-owned subsidiary of MetLife, Inc.) (the "Company"), which comprise the balance sheets as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2013, and the related notes to the financial statements. MANAGEMENT'S RESPONSIBILITY FOR THE FINANCIAL STATEMENTS Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error. AUDITORS' RESPONSIBILITY Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement. An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion. OPINION In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Exeter Reassurance Company, Ltd. as of December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in accordance with accounting principles generally accepted in the United States of America. EMPHASIS OF MATTER As discussed in Note 1 to the financial statements, the accompanying financial statements have been restated to correct misstatements on the 2013, 2012 and 2011 statements of cash flows. Our opinion is not modified with respect to this matter. OTHER MATTERS In our report dated April 2, 2014 on the previously issued 2012 financial statements filed with the Cayman Islands Monetary Authority ("CIMA"), we expressed an opinion that the Company's 2012 balance sheet did not fairly present insurance liabilities and, accordingly, did not conform to the presentation required under accounting principles generally accepted in the United States of America. That presentation was based on practices prescribed or permitted by CIMA. As noted in Note 1, in these general purpose financial statements, the Company has changed its presentation of insurance liabilities to conform to accounting principles generally accepted in the United States of America. Accordingly, our present opinion on the 2012 financial statements, as presented herein, is different from that expressed in our previous report. In addition, results of the Company may not be indicative of those of a stand-alone entity, as the Company is a member of a controlled group of affiliated companies. /s/ DELOITTE & TOUCHE LLP Certified Public Accountants Princeton, New Jersey April 2, 2014 (October 27, 2014 as to Note 1 related to the restatements and November 7, 2014 as to Note 14) F-1
N-4448th Page of 530TOC1stPreviousNextBottomJust 448th
EXETER REASSURANCE COMPANY, LTD. BALANCE SHEETS DECEMBER 31, 2013 AND 2012 (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) [Enlarge/Download Table] 2013 --------------- ASSETS Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $1,311,922 and $1,719,913, respectively)..................................................................... $ 1,321,081 Short-term investments, at estimated fair value.................................................... 2,781,282 Derivative assets.................................................................................. 2,375,499 Funds withheld at interest......................................................................... 2,694,267 --------------- Total investments................................................................................. 9,172,129 Cash and cash equivalents............................................................................ 629,616 Accrued investment income............................................................................ 94,238 Premiums, reinsurance and other receivables.......................................................... 645,814 Deferred policy acquisition costs.................................................................... 159,820 Current income tax recoverable....................................................................... 196,592 Deferred income tax recoverable...................................................................... 1,529,464 --------------- Total assets...................................................................................... $ 12,427,673 =============== LIABILITIES AND STOCKHOLDER'S EQUITY LIABILITIES Future policy benefits............................................................................... $ 2,747,421 Policyholder account balances........................................................................ 2,488,945 Other policy-related balances........................................................................ 2,170,145 Policyholder dividends payable....................................................................... 16,256 Debt -- affiliated................................................................................... 575,118 Derivative liabilities............................................................................... 2,648,454 Other liabilities.................................................................................... 551,170 --------------- Total liabilities................................................................................. 11,197,509 --------------- CONTINGENCIES AND COMMITMENTS (NOTE 12) STOCKHOLDER'S EQUITY Preferred stock, par value $.01 per share; 250,000 shares authorized, 200,000 issued and outstanding at December 31, 2013; par value $1.00 per share; 200,000 shares authorized, issued and outstanding at December 31, 2012; $2,000,000 aggregate liquidation preference at December 31, 2013 and 2012.......................................................................... 2 Common stock, par value $.01 per share; 13,875,000 shares authorized, 13,466,000 issued and outstanding at December 31, 2013; par value $1.00 per share; 14,125,000 shares authorized, 13,466,000 shares issued and outstanding at December 31, 2012....................................... 135 Additional paid-in capital........................................................................... 4,125,653 Retained earnings (accumulated deficit).............................................................. (2,964,638) Accumulated other comprehensive income (loss)........................................................ 69,012 --------------- Total stockholder's equity........................................................................ 1,230,164 --------------- Total liabilities and stockholder's equity........................................................ $ 12,427,673 =============== [Enlarge/Download Table] 2012 --------------- ASSETS Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $1,311,922 and $1,719,913, respectively)..................................................................... $ 1,785,619 Short-term investments, at estimated fair value.................................................... 4,307,652 Derivative assets.................................................................................. 4,652,428 Funds withheld at interest......................................................................... 2,436,815 --------------- Total investments................................................................................. 13,182,514 Cash and cash equivalents............................................................................ 905,519 Accrued investment income............................................................................ 93,501 Premiums, reinsurance and other receivables.......................................................... 775,433 Deferred policy acquisition costs.................................................................... 136,661 Current income tax recoverable....................................................................... 261,720 Deferred income tax recoverable...................................................................... 2,267,071 --------------- Total assets...................................................................................... $ 17,622,419 =============== LIABILITIES AND STOCKHOLDER'S EQUITY LIABILITIES Future policy benefits............................................................................... $ 2,735,580 Policyholder account balances........................................................................ 8,831,285 Other policy-related balances........................................................................ 1,896,818 Policyholder dividends payable....................................................................... 17,438 Debt -- affiliated................................................................................... 75,118 Derivative liabilities............................................................................... 1,665,997 Other liabilities.................................................................................... 1,726,141 --------------- Total liabilities................................................................................. 16,948,377 --------------- CONTINGENCIES AND COMMITMENTS (NOTE 12) STOCKHOLDER'S EQUITY Preferred stock, par value $.01 per share; 250,000 shares authorized, 200,000 issued and outstanding at December 31, 2013; par value $1.00 per share; 200,000 shares authorized, issued and outstanding at December 31, 2012; $2,000,000 aggregate liquidation preference at December 31, 2013 and 2012.......................................................................... 200 Common stock, par value $.01 per share; 13,875,000 shares authorized, 13,466,000 issued and outstanding at December 31, 2013; par value $1.00 per share; 14,125,000 shares authorized, 13,466,000 shares issued and outstanding at December 31, 2012....................................... 13,466 Additional paid-in capital........................................................................... 4,085,299 Retained earnings (accumulated deficit).............................................................. (3,504,200) Accumulated other comprehensive income (loss)........................................................ 79,277 --------------- Total stockholder's equity........................................................................ 674,042 --------------- Total liabilities and stockholder's equity........................................................ $ 17,622,419 =============== SEE ACCOMPANYING NOTES TO THE FINANCIAL STATEMENTS. F-2
N-4449th Page of 530TOC1stPreviousNextBottomJust 449th
EXETER REASSURANCE COMPANY, LTD. STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 (IN THOUSANDS) [Enlarge/Download Table] 2013 2012 2011 ------------- --------------- ----------- REVENUES Premiums............................................... $ 59,372 $ 949,827 $ 71,518 Universal life and investment-type product policy fees. 586,571 548,425 432,722 Net investment income.................................. 35,423 20,695 17,238 Net investment gains (losses).......................... (56,581) 41,793 (1,086) Net derivative gains (losses).......................... 1,935,248 (3,676,589) 230,434 Other revenues......................................... 1,395 22,916 43,740 ------------- --------------- ----------- Total revenues...................................... 2,561,428 (2,092,933) 794,566 ------------- --------------- ----------- EXPENSES Policyholder benefits and claims....................... 1,379,886 1,811,746 309,339 Interest credited to policyholder account balances..... 17,399 16,598 15,831 Policyholder dividends................................. 26,675 30,279 30,722 Other expenses......................................... 101,207 206,841 169,883 ------------- --------------- ----------- Total expenses...................................... 1,525,167 2,065,464 525,775 ------------- --------------- ----------- Income (loss) before provision for income tax.......... 1,036,261 (4,158,397) 268,791 Provision for income tax expense (benefit)............. 364,215 (1,455,499) 94,077 ------------- --------------- ----------- Net income (loss)...................................... $ 672,046 $ (2,702,898) $ 174,714 ============= =============== =========== SEE ACCOMPANYING NOTES TO THE FINANCIAL STATEMENTS. F-3
N-4450th Page of 530TOC1stPreviousNextBottomJust 450th
EXETER REASSURANCE COMPANY, LTD. STATEMENTS OF COMPREHENSIVE INCOME (LOSS) FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 (IN THOUSANDS) [Enlarge/Download Table] 2013 2012 2011 ------------ ---------------- ------------ Net income (loss)....................................... $ 672,046 $ (2,702,898) $ 174,714 Other comprehensive income (loss): Unrealized investment gains (losses), net of related offsets.............................................. (56,634) 25,017 35,549 Foreign currency translation adjustments............... 26,548 13,028 (15,751) ------------ ---------------- ------------ Other comprehensive income (loss), before income tax... (30,086) 38,045 19,798 Income tax (expense) benefit related to items of other comprehensive income (loss).......................... 19,821 (8,756) (12,442) ------------ ---------------- ------------ Other comprehensive income (loss), net of income tax... (10,265) 29,289 7,356 ------------ ---------------- ------------ Comprehensive income (loss)............................. $ 661,781 $ (2,673,609) $ 182,070 ============ ================ ============ SEE ACCOMPANYING NOTES TO THE FINANCIAL STATEMENTS. F-4
N-4451st Page of 530TOC1stPreviousNextBottomJust 451st
EXETER REASSURANCE COMPANY, LTD. STATEMENTS OF STOCKHOLDER'S EQUITY FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 (IN THOUSANDS) [Enlarge/Download Table] RETAINED ADDITIONAL EARNINGS PREFERRED COMMON PAID-IN (ACCUMULATED STOCK STOCK CAPITAL DEFICIT) ---------- ---------- ------------ -------------- Balance at December 31, 2010............................... $ -- $ 13,466 $ 548,218 $ (976,016) Capital contribution from MetLife, Inc. (Note 9)........... 703,860 Comprehensive income (loss): Net income (loss).......................................... 174,714 Other comprehensive income (loss), net of income tax....... -------- ---------- ------------ -------------- Balance at December 31, 2011............................... -- 13,466 1,252,078 (801,302) -------- ---------- ------------ -------------- Capital contribution from MetLife, Inc. (Note 9)........... 833,421 Non-cumulative perpetual preferred stock issuance -- newly issued shares (Note 9).................................... 200 1,999,800 Comprehensive income (loss): Net income (loss).......................................... (2,702,898) Other comprehensive income (loss), net of income tax....... -------- ---------- ------------ -------------- Balance at December 31, 2012............................... 200 13,466 4,085,299 (3,504,200) -------- ---------- ------------ -------------- Capital contribution from MetLife, Inc. (Note 9)........... 26,825 Change in preferred and common stock par value (Note 9).................................................. (198) (13,331) 13,529 Dividends on perpetual preferred stock..................... (132,484) Comprehensive income (loss): Net income (loss).......................................... 672,046 Other comprehensive income (loss), net of income tax....... -------- ---------- ------------ -------------- Balance at December 31, 2013............................... $ 2 $ 135 $ 4,125,653 $ (2,964,638) ======== ========== ============ ============== [Enlarge/Download Table] ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ----------------------------- NET FOREIGN UNREALIZED CURRENCY INVESTMENT TRANSLATION TOTAL GAINS (LOSSES) ADJUSTMENTS STOCKHOLDER'S EQUITY --------------- ------------- --------------------- Balance at December 31, 2010............................... $ 3,341 $ 39,291 $ (371,700) Capital contribution from MetLife, Inc. (Note 9)........... 703,860 Comprehensive income (loss): Net income (loss).......................................... 174,714 Other comprehensive income (loss), net of income tax....... 23,107 (15,751) 7,356 ------------ ------------- ------------ Balance at December 31, 2011............................... 26,448 23,540 514,230 ------------ ------------- ------------ Capital contribution from MetLife, Inc. (Note 9)........... 833,421 Non-cumulative perpetual preferred stock issuance -- newly issued shares (Note 9).................................... 2,000,000 Comprehensive income (loss): Net income (loss).......................................... (2,702,898) Other comprehensive income (loss), net of income tax....... 16,261 13,028 29,289 ------------ ------------- ------------ Balance at December 31, 2012............................... 42,709 36,568 674,042 ------------ ------------- ------------ Capital contribution from MetLife, Inc. (Note 9)........... 26,825 Change in preferred and common stock par value (Note 9).................................................. -- Dividends on perpetual preferred stock..................... (132,484) Comprehensive income (loss): Net income (loss).......................................... 672,046 Other comprehensive income (loss), net of income tax....... (36,813) 26,548 (10,265) ------------ ------------- ------------ Balance at December 31, 2013............................... $ 5,896 $ 63,116 $ 1,230,164 ============ ============= ============ SEE ACCOMPANYING NOTES TO THE FINANCIAL STATEMENTS. F-5
N-4452nd Page of 530TOC1stPreviousNextBottomJust 452nd
EXETER REASSURANCE COMPANY, LTD. STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011 (IN THOUSANDS) [Enlarge/Download Table] 2013 2012 -------------- -------------- AS RESTATED AS RESTATED SEE NOTE 1 SEE NOTE 1 CASH FLOWS FROM OPERATING ACTIVITIES Net income (loss)......................................................................... $ 672,046 $ (2,702,898) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of premiums and accretion of discounts associated with investments, net.... 20,823 5,956 (Gains) losses on investments, net...................................................... 56,581 (41,793) (Gains) losses on derivatives, net...................................................... (204,378) 4,802,934 Universal life and investment-type product policy fees.................................. 11,088 (556) Change in accrued investment income..................................................... 28 (77,901) Change in premiums, reinsurance and other receivables................................... 112,292 155,762 Change in deferred policy acquisition costs, net........................................ (23,159) 41,444 Change in income tax recoverable (payable).............................................. 670,461 (1,675,874) Change in insurance-related liabilities and policy-related balances..................... 272,897 530,400 Change in other liabilities............................................................. 101,876 (96,015) Other, net.............................................................................. 31,681 24,977 -------------- -------------- Net cash provided by (used in) operating activities....................................... 1,722,236 966,436 -------------- -------------- CASH FLOWS FROM INVESTING ACTIVITIES Sales, maturities and repayments of: Fixed maturity securities............................................................... 813,413 1,310,619 Equity securities....................................................................... 128 7,212 Purchases of fixed maturity securities.................................................... (415,825) (1,486,466) Cash received in connection with freestanding derivatives................................. 146,845 415,944 Cash paid in connection with freestanding derivatives..................................... (2,882,508) (1,790,917) Net change in short-term investments...................................................... 1,525,163 1,497,830 Net change in funds withheld at interest.................................................. (336,545) (146,444) Other, net................................................................................ 272,335 24,279 -------------- -------------- Net cash provided by (used in) investing activities....................................... (876,994) (167,943) -------------- -------------- CASH FLOWS FROM FINANCING ACTIVITIES Policyholder account balances: Deposits................................................................................ -- 212 Withdrawals............................................................................. -- (10,330) Change in payables for derivative collateral.............................................. (1,276,847) (1,627,743) Long-term debt issuances -- affiliated.................................................... 500,000 -- Capital contribution from MetLife, Inc.................................................... -- 800,000 Dividend on preferred stock............................................................... (132,484) -- Other, net................................................................................ (166,050) (122,628) -------------- -------------- Net cash provided by (used in) financing activities....................................... (1,075,381) (960,489) -------------- -------------- Effect of change in foreign currency exchange rates on cash and cash equivalents balances. (45,764) (23,555) -------------- -------------- Change in cash and cash equivalents....................................................... (275,903) (185,551) Cash and cash equivalents, beginning of year.............................................. 905,519 1,091,070 -------------- -------------- CASH AND CASH EQUIVALENTS, END OF YEAR.................................................... $ 629,616 $ 905,519 ============== ============== SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Net cash paid for: Interest................................................................................ $ 5,107 $ 134,691 ============== ============== Income tax.............................................................................. $ 304,518 $ 222,025 ============== ============== Non-cash transactions: Purchase of fixed maturity securities associated with business transfer................. $ -- $ 760,628 ============== ============== Purchase of short-term investments associated with business transfer.................... $ -- $ 72,453 ============== ============== Capital contribution from MetLife, Inc.................................................. $ 26,825 $ 33,421 ============== ============== Issuance of non-cumulative perpetual preferred shares................................... $ -- $ 2,000,000 ============== ============== Assignment of senior notes to MetLife, Inc.............................................. $ -- $ (2,000,000) ============== ============== [Enlarge/Download Table] 2011 ------------ AS RESTATED SEE NOTE 1 CASH FLOWS FROM OPERATING ACTIVITIES Net income (loss)......................................................................... $ 174,714 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of premiums and accretion of discounts associated with investments, net.... (62) (Gains) losses on investments, net...................................................... 1,086 (Gains) losses on derivatives, net...................................................... 469,752 Universal life and investment-type product policy fees.................................. (3,781) Change in accrued investment income..................................................... (6,706) Change in premiums, reinsurance and other receivables................................... 358,863 Change in deferred policy acquisition costs, net........................................ 28,571 Change in income tax recoverable (payable).............................................. (19,555) Change in insurance-related liabilities and policy-related balances..................... 256,552 Change in other liabilities............................................................. (355,242) Other, net.............................................................................. 29,195 ------------ Net cash provided by (used in) operating activities....................................... 933,387 ------------ CASH FLOWS FROM INVESTING ACTIVITIES Sales, maturities and repayments of: Fixed maturity securities............................................................... 604,979 Equity securities....................................................................... 2,880 Purchases of fixed maturity securities.................................................... (754,191) Cash received in connection with freestanding derivatives................................. 876,691 Cash paid in connection with freestanding derivatives..................................... (2,032,925) Net change in short-term investments...................................................... (4,538,307) Net change in funds withheld at interest.................................................. (98,811) Other, net................................................................................ 158,928 ------------ Net cash provided by (used in) investing activities....................................... (5,780,756) ------------ CASH FLOWS FROM FINANCING ACTIVITIES Policyholder account balances: Deposits................................................................................ 416 Withdrawals............................................................................. (2,644) Change in payables for derivative collateral.............................................. 2,563,812 Long-term debt issuances -- affiliated.................................................... 1,000,000 Capital contribution from MetLife, Inc.................................................... 673,000 Dividend on preferred stock............................................................... -- Other, net................................................................................ 80,761 ------------ Net cash provided by (used in) financing activities....................................... 4,315,345 ------------ Effect of change in foreign currency exchange rates on cash and cash equivalents balances. 7,065 ------------ Change in cash and cash equivalents....................................................... (524,959) Cash and cash equivalents, beginning of year.............................................. 1,616,029 ------------ CASH AND CASH EQUIVALENTS, END OF YEAR.................................................... $ 1,091,070 ============ SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Net cash paid for: Interest................................................................................ $ 69,232 ============ Income tax.............................................................................. $ 115,497 ============ Non-cash transactions: Purchase of fixed maturity securities associated with business transfer................. $ -- ============ Purchase of short-term investments associated with business transfer.................... $ -- ============ Capital contribution from MetLife, Inc.................................................. $ 30,860 ============ Issuance of non-cumulative perpetual preferred shares................................... $ -- ============ Assignment of senior notes to MetLife, Inc.............................................. $ -- ============ SEE ACCOMPANYING NOTES TO THE FINANCIAL STATEMENTS. F-6
N-4453rd Page of 530TOC1stPreviousNextBottomJust 453rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BUSINESS Exeter Reassurance Company, Ltd. (the "Company" or "Exeter") is a wholly-owned stock life insurance subsidiary of MetLife, Inc. (the "Holding Company"). In 2011, the Company was redomesticated to the Cayman Islands. The Company was licensed as an Unrestricted Class B Insurer under the Insurance Law of the Cayman Islands (the "Law"). Effective October 1, 2013, the Company redomesticated to the state of Delaware ("Delaware"). The Company is licensed as a Delaware pure captive insurance company under the Delaware Captive Insurance Law ("Delaware Law"). The Company engages in traditional and financial reinsurance of life insurance and annuity policies, primarily with affiliates. In the second quarter of 2013, the Holding Company announced its plans to merge three U.S.-based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S.-based and U.S.-regulated life insurance company (the "Mergers"). The companies to be merged consist of MetLife Insurance Company of Connecticut ("MICC"), MetLife Investors USA Insurance Company ("MLI-USA") and MetLife Investors Insurance Company ("MLIIC"), each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter. MICC, which is expected to be renamed and domiciled in Delaware, will be the surviving entity. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. BASIS OF PRESENTATION The Company has previously prepared, and filed, financial statements that comply with the filing requirements of the Cayman Islands Monetary Authority ("CIMA"). The financial statements as of and for the year ended December 31, 2012 presented insurance liabilities in the balance sheet in accordance with practices prescribed or permitted by CIMA, which presentation differs from the presentation requirements under generally accepted accounting principles. The presentation of insurance liabilities in these financial statements has been revised to present such amounts in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company's business and operations. Actual results could differ from estimates. Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity. F-7
N-4454th Page of 530TOC1stPreviousNextBottomJust 454th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) RESTATEMENTS The Company identified the following errors relating to the 2013, 2012 and 2011 statements of cash flows: . Net cash provided by operating activities was overstated and net cash used in investing activities was understated in 2012, as a result of errors relating to the non-cash component of the consideration received for the transfer of business to the Company from an affiliate. . The effects of changes in foreign currency exchange rates on cash and cash equivalents were incorrectly reported in 2013, 2012 and 2011, resulting in offsetting impacts on net cash provided by operating activities and net cash used in investing activities. . Certain transactions relating to fees on embedded derivatives were incorrectly reported in the cash flow statement in 2013, 2012 and 2011 including: (a) cash transactions incorrectly reported in (gains) losses on derivatives, net, resulting in impacts to both net cash provided by operating activities and net cash used in investing activities: and (b) non-cash transactions incorrectly reported in cash flows from investing activities in other, net, resulting in impacts to net cash used in investing activities. . Non-cash transactions relating to funds withheld at interest were incorrectly reported in net cash used in investing activities in 2013, 2012 and 2011. The combined errors resulted in an overstatement/(understatement) of (i) net cash provided by operating activities of $93,333 thousand, $991,168 thousand and ($76,861) thousand in 2013, 2012 and 2011, respectively; (ii) net cash used in investing activities of ($139,097) thousand, ($1,014,723) thousand and $83,926 thousand in 2013, 2012 and 2011, respectively; and (iii) the effect of change in foreign currency exchange rates on cash and cash equivalents of $45,764 thousand, $23,555 thousand and ($7,065) thousand in 2013, 2012 and 2011, respectively. The impact of the 2013, 2012 and 2011 restatements is shown in the tables below: [Enlarge/Download Table] FOR THE YEAR ENDED DECEMBER 31, 2013 ---------------------------------------- AS PREVIOUSLY CORRECTION OF REPORTED ERRORS AS ADJUSTED ------------- ------------- ------------ (IN THOUSANDS) CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: (Gains) losses on derivatives, net............................. $(1,095,691) $ 891,313 $ (204,378) Change in accrued investment income............................ $ (737) $ 765 $ 28 Change in premiums, reinsurance and other receivables.......... $ 130,149 $ (17,857) $ 112,292 Change in income tax recoverable (payable)..................... $ 822,557 $(152,096) $ 670,461 Change in other assets......................................... $ 26,549 $ (26,549) $ -- Change in insurance-related liabilities and policy-related balances..................................................... $ 979,232 $(706,335) $ 272,897 Change in other liabilities.................................... $ 101,875 $ 1 $ 101,876 Other, net..................................................... $ 114,256 $ (82,575) $ 31,681 Net cash provided by (used in) operating activities............. $ 1,815,569 $ (93,333) $ 1,722,236 CASH FLOWS FROM INVESTING ACTIVITIES Sales, maturities and repayments of: Fixed maturity securities.................................... $ 803,256 $ 10,157 $ 813,413 Net change in short-term investments........................... $ 1,528,444 $ (3,281) $ 1,525,163 Net change in funds withheld at interest....................... $ (257,452) $ (79,093) $ (336,545) Other, net..................................................... $ 61,021 $ 211,314 $ 272,335 Net cash provided by (used in) investing activities............. $(1,016,091) $ 139,097 $ (876,994) Effect of change in foreign currency exchange rates on cash and cash equivalents balances..................................... $ -- $ (45,764) $ (45,764) F-8
N-4455th Page of 530TOC1stPreviousNextBottomJust 455th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) [Enlarge/Download Table] FOR THE YEAR ENDED DECEMBER 31, 2012 ---------------------------------------- AS PREVIOUSLY CORRECTION OF REPORTED ERRORS AS ADJUSTED ------------- ------------- ------------ (IN THOUSANDS) CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: (Gains) losses on derivatives, net......................... $ 4,156,565 $ 646,369 $ 4,802,934 Change in premiums, reinsurance and other receivables...... $ 149,271 $ 6,491 $ 155,762 Change in income tax recoverable (payable)................. $(1,617,392) $ (58,482) $(1,675,874) Change in other assets..................................... $ 13,027 $ (13,027) $ -- Change in insurance-related liabilities and policy-related balances................................................. $ 1,932,786 $(1,402,386) $ 530,400 Change in other liabilities................................ $ (31,859) $ (64,156) $ (96,015) Other, net................................................. $ 130,954 $ (105,977) $ 24,977 Net cash provided by (used in) operating activities......... $ 1,957,604 $ (991,168) $ 966,436 CASH FLOWS FROM INVESTING ACTIVITIES Purchases of fixed maturity securities..................... $(2,264,346) $ 777,880 $(1,486,466) Net change in short-term investments....................... $ 1,423,762 $ 74,068 $ 1,497,830 Net change in funds withheld at interest................... $ (218,801) $ 72,357 $ (146,444) Other, net................................................. $ (66,139) $ 90,418 $ 24,279 Net cash provided by (used in) investing activities......... $(1,182,666) $ 1,014,723 $ (167,943) Effect of change in foreign currency exchange rates on cash and cash equivalents balances............................. $ -- $ (23,555) $ (23,555) [Enlarge/Download Table] FOR THE YEAR ENDED DECEMBER 31, 2011 ---------------------------------------- AS PREVIOUSLY CORRECTION OF REPORTED ERRORS AS ADJUSTED ------------- ------------- ------------ (IN THOUSANDS) CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: (Gains) losses on derivatives, net................................ $ (153,956) $ 623,708 $ 469,752 Change in accrued investment income............................... $ (8,031) $ 1,325 $ (6,706) Change in premiums, reinsurance and other receivables............. $ 349,645 $ 9,218 $ 358,863 Change in income tax recoverable (payable)........................ $ (50,030) $ 30,475 $ (19,555) Change in other assets............................................ $ (15,750) $ 15,750 $ -- Change in insurance-related liabilities and policy-related balances........................................................ $ 757,824 $(501,272) $ 256,552 Change in other liabilities....................................... $ (354,977) $ (265) $ (355,242) Other, net........................................................ $ 131,273 $(102,078) $ 29,195 Net cash provided by (used in) operating activities................ $ 856,526 $ 76,861 $ 933,387 CASH FLOWS FROM INVESTING ACTIVITIES Net change in funds withheld at interest........................... $ (91,382) $ (7,429) $ (98,811) Other, net........................................................ $ 235,425 $ (76,497) $ 158,928 Net cash provided by (used in) investing activities................ $(5,696,830) $ (83,926) (5,780,756) Effect of change in foreign currency exchange rates on cash and cash equivalents balances........................................ $ -- $ 7,065 $ 7,065 F-9
N-4456th Page of 530TOC1stPreviousNextBottomJust 456th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following are the Company's significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies. [Download Table] -------------------------------------- ACCOUNTING POLICY NOTE -------------------------------------- Deferred Policy Acquistion Costs 2 -------------------------------------- Reserves 3 -------------------------------------- Reinsurance 4 -------------------------------------- Investments 5 -------------------------------------- Derivatives 6 -------------------------------------- Fair Value 7 -------------------------------------- Income Tax 11 -------------------------------------- Litigation Contingencies 12 -------------------------------------- FUTURE POLICYHOLDER BENEFITS, POLICYHOLDER ACCOUNT BALANCES AND OTHER POLICY-RELATED BALANCES The Company establishes liabilities for insurance policies assumed by the Company. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. For long duration insurance contracts, assumptions such as mortality and interest rates are "locked in" upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. Liabilities for assumed universal secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments. The assumptions used in estimating the secondary liabilities are consistent with those used for amortizing deferred policy acquisition costs ("DAC"), and are thus subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of appropriate underlying equity indices, such as the Standard & Poor's Ratings Services ("S&P") 500 Index. The benefits used in calculating the liabilities assumed are based on the average benefits payable over a range of scenarios. The assumed unearned revenue liability included in other policy-related balances relates to universal life-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product's estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees. The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur. F-10
N-4457th Page of 530TOC1stPreviousNextBottomJust 457th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) The Company assumed and ceded guaranteed minimum benefits associated with certain variable annuity product risks that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Guarantees assumed are accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits ("GMDB"), the portion of guaranteed minimum income benefits ("GMIB") that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits ("GMWB"). Guarantees assumed are accounted for as embedded derivatives in policyholder account balances include the non life-contingent portion of GMWB, guaranteed minimum accumulation benefits ("GMAB") and the portion of GMIB that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Other policy-related balances include policy and contract claims and policyholder dividends due and unpaid. The liability for policy and contract claims generally relates to incurred but not reported death claims, as well as claims which have been reported but not yet settled. DIVIDEND LIABILITY The terminal dividend liability for assumed participating traditional life insurance policies is equal to the liability for dividends paid to policyholders upon termination and after satisfying minimum period in-force requirements. RECOGNITION OF INSURANCE REVENUE AND RELATED BENEFITS Premiums related to assumed traditional life and variable annuity business are recognized as revenues when due. Policyholder benefits and expenses are provided against such revenues to recognize profits over the estimated lives of the policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into operations in a constant relationship to the business assumed. DEFERRED POLICY ACQUISITION COSTS The Company reimburses the direct writer of the reinsured agreements for significant costs in connection with acquiring new and renewal reinsurance business. Costs that are related directly to the successful acquisition or renewal of reinsurance agreements are capitalized as DAC. Such costs primarily include: . incremental direct costs of contract acquisition, such as commissions; F-11
N-4458th Page of 530TOC1stPreviousNextBottomJust 458th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) . other essential direct costs that would not have been incurred had a policy not been acquired or renewed. All other acquisition-related costs, as well as all indirect costs, are expensed as incurred. DAC is amortized as follows: Products reinsured: In proportion to the following over estimated lives of the reinsurance agreements: ----------------------------------------------------------------------------- . Participating, dividend-paying Actual and expected future gross traditional contracts margins. ----------------------------------------------------------------------------- . Variable universal life contracts Actual and expected future gross . Variable deferred annuity contracts profits. See Note 2 for additional information on DAC amortization. The recovery of DAC is dependent upon the future profitability of the related business. REINSURANCE AGREEMENTS For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company's obligations as a reinsurer. The Company reviews all contractual features, particularly those that may limit the amount of insurance risk to which the Company is subject or features that delay the timely reimbursement of claims. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) future policy benefit liabilities are established. Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities and other policy-related balances. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. F-12
N-4459th Page of 530TOC1stPreviousNextBottomJust 459th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. Certain assumed GMWB, GMAB and GMIB are accounted for as embedded derivatives with changes in estimated fair value reported in net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. INVESTMENTS NET INVESTMENT INCOME Income on investments is reported within net investment income, unless otherwise stated herein. FIXED MATURITY SECURITIES The Company's fixed maturity securities are classified as available-for-sale ("AFS") and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) ("OCI"), net of policyholder-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis. Interest income on fixed maturity securities is recognized when earned using an effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. The Company periodically evaluates fixed maturity securities for impairment. The assessment of whether impairments have occurred is based on management's case-by-case evaluation of the underlying reasons for the decline in estimated fair value and an analysis of the gross unrealized losses by severity and/or age. The analysis of gross unrealized losses is described further in Note 5 "--Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities." For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment ("OTTI") is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions exist, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings ("credit loss"). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors ("noncredit loss") is recorded in OCI. Adjustments are not made for subsequent recoveries in value. F-13
N-4460th Page of 530TOC1stPreviousNextBottomJust 460th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) SHORT-TERM INVESTMENTS Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at the estimated fair value or amortized cost, which approximates estimated fair value. DERIVATIVE ASSETS Derivative assets consist principally of freestanding derivatives with positive estimated fair values and are described in " -- Derivatives" below. FUNDS WITHHELD AT INTEREST Funds withheld at interest represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company records a funds withheld asset rather than the underlying investments. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments. DERIVATIVES FREESTANDING DERIVATIVES Freestanding derivatives are carried in the Company's balance sheets either as assets within derivative assets or as liabilities within derivative liabilities at estimated fair value. The Company does not offset the fair value amounts recognized for derivatives executed with the same counterparty absent a master netting agreement. Accruals on derivatives are generally recorded in accrued investment income or within derivative liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in derivative assets or derivative liabilities. The Company's derivatives are not designated as qualifying for hedge accounting. Changes in the estimated fair value of derivatives are generally reported in net derivative gains (losses) except for those in policyholder benefits and claims for economic hedges of variable annuity guarantees included in future policy benefits in the balance sheets. The fluctuations in estimated fair value of derivatives can result in significant volatility in net income. EMBEDDED DERIVATIVES The Company assumes variable annuity guarantees, modified coinsurance contracts and equity indexed deferred annuities that contain embedded derivatives. Additionally, the Company has retroceded certain of these variable annuity guarantees to unaffiliated reinsurance counterparties that also contain embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if: . the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings; F-14
N-4461st Page of 530TOC1stPreviousNextBottomJust 461st
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) . the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and . a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses) for assumed reinsurance or in policyholder benefits and claims for ceded reinsurance. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. FAIR VALUE Certain assets and liabilities are measured at estimated fair value in the Company's balance sheets. In addition, the notes to these financial statements include further disclosures of estimated fair values. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinative, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the fair value of assets and liabilities. INCOME TAX The Company joins with the Holding Company and its includable life insurance and non-life insurance subsidiaries in filing a consolidated U.S. federal income tax return in accordance with the provision of the Internal Revenue Code of 1986 as amended (the "Code"). Current taxes (and the benefits of tax attributes such as losses) are allocated to the Holding Company under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, the Holding Company has elected the "percentage method' (and 100 percent under such method) of reimbursing companies for tax attributes such as losses. As a result, one hundred percent of tax attributes such as losses are reimbursed by the Holding Company to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes such as losses. Profitable subsidiaries pay to the Holding company each year the federal income tax which such profitable subsidiary would have paid that year based upon that year's taxable income. The Holding Company has current or prior deductions and credits (including by not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by the Holding Company when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if the Holding Company would not have realized the attributes on a stand-alone basis under a "wait and see" method. F-15
N-4462nd Page of 530TOC1stPreviousNextBottomJust 462nd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) Deferred income tax assets and liabilities resulting from temporary differences between the financial reporting and tax basis of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The realization of deferred income tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Factors in management's determination include the performance of the business and its ability to generate capital gains. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following: . future taxable income exclusive of reversing temporary differences and carryforwards; . future reversals of existing taxable temporary differences; . taxable income in prior carryback years; and . tax planning strategies. The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included in other liabilities and are charged to earnings in the period that such determination is made. The Company classifies interest recognized as other expense and penalties recognized as a component of income tax expense. OTHER ACCOUNTING POLICIES CASH AND CASH EQUIVALENTS The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value. OTHER REVENUES Other revenues consist of funds withheld investment credit fees associated with financial reinsurance. F-16
N-4463rd Page of 530TOC1stPreviousNextBottomJust 463rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) POLICYHOLDER DIVIDENDS Pursuant to the terms of certain reinsurance agreements, the Company participates in the policyholder dividend scale of the ceding company. Policyholder dividends are approved annually by the ceding company's board of directors. The aggregate amount of policyholder dividends is related to actual interest, mortality, morbidity and expense experience for the year, as well as the judgment of the ceding company's management as to the appropriate level of statutory surplus to be retained by the ceding company. FOREIGN CURRENCY Balance sheet accounts for reinsurance agreements that are settled in foreign currencies are translated at the exchange rate in effect at each year end and income and expense accounts are translated at the average exchange rates during the year. Translation adjustments are charged or credited directly to foreign currency translation adjustments, included in accumulated other comprehensive income or loss, net of applicable taxes. Intercompany receivables (payables) that are held in foreign currencies are translated at the exchange rate in effect at each year end and translation adjustments are charged directly to net investment gains (losses) in the period in which they occur. ADOPTION OF NEW ACCOUNTING PRONOUNCEMENTS Effective January 1, 2013, the Company adopted new guidance regarding comprehensive income that requires an entity to provide information about the amounts reclassified out of Accumulated Other Comprehensive Income ("AOCI") by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The adoption was prospectively applied and resulted in additional disclosures in Note 9. Effective January 1, 2013, the Company adopted new guidance regarding balance sheet offsetting disclosures which requires an entity to disclose information about offsetting and related arrangements for derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities borrowing and lending transactions, to enable users of its financial statements to understand the effects of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The adoption was retrospectively applied and resulted in additional disclosures related to derivatives in Note 6. On January 1, 2012, the Company adopted new guidance regarding accounting for DAC, which was retrospectively applied. The guidance specifies that only costs related directly to successful acquisition of new or renewal contracts can be capitalized as DAC; all other acquisition-related costs must be expensed as incurred. Under the new guidance, advertising costs may only be included in DAC if the capitalization criteria in the direct-response advertising guidance in Subtopic 340-20, OTHER ASSETS AND DEFERRED COSTS--CAPITALIZED ADVERTISING COSTS, are met. As a result, certain direct marketing, sales manager compensation and administrative costs previously capitalized by the Company will no longer be deferred. F-17
N-4464th Page of 530TOC1stPreviousNextBottomJust 464th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) On January 1, 2012, the Company adopted new guidance regarding comprehensive income, which was retrospectively applied, that provides companies with the option to present the total of comprehensive income, components of net income, and the components of OCI either in a single continuous statement of comprehensive income or in two separate but consecutive statements in annual financial statements. The standard eliminates the option to present components of OCI as part of the statement of changes in stockholders' equity. The Company adopted the two-statement approach for annual financial statements. Effective January 1, 2012, the Company adopted new guidance regarding fair value measurements that establishes common requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Some of the amendments clarify the Financial Accounting Standards Board's ("FASB") intent on the application of existing fair value measurement requirements. Other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The adoption did not have a material impact on the Company's financial statements other than the expanded disclosures in Note 7. FUTURE ADOPTION OF NEW ACCOUNTING PRONOUNCEMENTS In March 2013, the FASB issued new guidance regarding foreign currency (Accounting Standards Update ("ASU") 2013-05, FOREIGN CURRENCY MATTERS (TOPIC 830): PARENT'S ACCOUNTING FOR THE CUMULATIVE TRANSLATION ADJUSTMENT UPON DERECOGNITION OF CERTAIN SUBSIDIARIES OR GROUPS OF ASSETS WITHIN A FOREIGN ENTITY OR OF AN INVESTMENT IN A FOREIGN ENTITY), effective prospectively for fiscal years and interim reporting periods within those years beginning after December 15, 2013. The amendments require an entity that ceases to have a controlling financial interest in a subsidiary or group of assets within a foreign entity to apply the guidance in Subtopic 830-30, FOREIGN CURRENCY MATTERS -- TRANSLATION OF FINANCIAL STATEMENTS, to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. For an equity method investment that is a foreign entity, the partial sale guidance in section 830-30-40, DERECOGNITION, still applies. As such, a pro rata portion of the cumulative translation adjustment should be released into net income upon a partial sale of such an equity method investment. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements. In February 2013, the FASB issued new guidance regarding liabilities (ASU 2013-04, LIABILITIES (TOPIC 405): OBLIGATIONS RESULTING FROM JOINT AND SEVERAL LIABILITY ARRANGEMENTS FOR WHICH THE TOTAL AMOUNT OF THE OBLIGATION IS FIXED AT THE REPORTING DATE), effective retrospectively for fiscal years beginning after December 15, 2013 and interim periods within those years. The amendments require an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. In addition, the amendments require an entity to disclose the nature and amount of the obligation, as well as other information about the obligation. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements. F-18
N-4465th Page of 530TOC1stPreviousNextBottomJust 465th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. DEFERRED POLICY ACQUISITION COSTS See Note 1 for a description of capitalized acquisition costs. PARTICIPATING AND DIVIDEND-PAYING TRADITIONAL CONTRACTS The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties, and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency, and other factor changes and policyholder dividend scales are reasonably likely to significantly impact the rate of DAC amortization. On a quarterly basis, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to earnings. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. On a quarterly basis, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Total DAC amortization during a particular period may increase or decrease depending upon the relative size of the amortization change resulting from the adjustment to DAC for the update of actual gross margins and the re-estimation of expected future gross margins. On a quarterly basis, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances. VARIABLE UNIVERSAL LIFE CONTRACTS, VARIABLE DEFERRED ANNUITY CONTRACTS AND EQUITY INDEXED DEFERRED ANNUITY CONTRACTS The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception of the contracts. The amount of expected future gross profits is dependent principally upon investment returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, and persistency are reasonably likely to impact significantly the rate of DAC amortization. On a quarterly basis, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC amortization is re-estimated and adjusted by the cumulated charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. On a quarterly basis, the Company also updates the actual amount of business remaining in-force, which impact expected future gross profits. When expected future gross profits are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC balances. F-19
N-4466th Page of 530TOC1stPreviousNextBottomJust 466th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. DEFERRED POLICY ACQUISITION COSTS (CONTINUED) FACTORS IMPACTING AMORTIZATION The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These include investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease. Amortization of DAC is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC that would have been amortized if such gains and losses had been recognized. Information regarding DAC was as follows: [Enlarge/Download Table] YEARS ENDED DECEMBER 31, -------------------------------- 2013 2012 2011 ---------- ---------- ---------- (IN THOUSANDS) Balance at January 1,...................................... $ 136,661 $ 178,105 $ 206,677 Capitalizations............................................ 2,013 1,760 2,955 Amortization related to: Net investment gains (losses) and net derivative gains (losses).............................................. 23,559 (28,204) (21,453) Other expenses.......................................... (2,413) (15,000) (10,074) ---------- ---------- ---------- Total amortization.................................. 21,146 (43,204) (31,527) ---------- ---------- ---------- Balance at December 31,.................................... $ 159,820 $ 136,661 $ 178,105 ========== ========== ========== 3. RESERVES REINSURANCE LIABILITIES Future policy benefits are measured as follows: Product Type Measurement Assumptions: --------------------------------------------------------------------------- Assumed Participating Life Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate ranging from 4% to 6% and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends. --------------------------------------------------------------------------- Assumed traditional fixed annuities Present value of expected future after annuitization payments. Interest rate assumptions used in establishing such liabilities range from 1% to 7% for domestic business and 2% to 5% for international business. F-20
N-4467th Page of 530TOC1stPreviousNextBottomJust 467th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. RESERVES (CONTINUED) GUARANTEES The Company reinsures variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWB, GMAB and the portion of certain GMIB that does not require annuitization are accounted for as embedded derivatives in policyholder account balances and other policy-related balances which are further discussed in Note 6. Guarantees accounted for as reinsurance liabilities include: [Enlarge/Download Table] Guarantee: Measurement Assumptions: ------------------------------------------------------------------------------------------------- GMDBs . A return of purchase payment upon Present value of expected death benefits in death even if the account value is excess of the projected account balance reduced to zero. recognizing the excess ratably over the accumulation period based on the present value of total expected assessments. . An enhanced death benefit may be Assumptions are consistent with those used available for an additional fee. for amortizing DAC, and are thus subject to the same variability and risk. Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index. Benefit assumptions are based on the average benefits payable over a range of scenarios. ------------------------------------------------------------------------------------------------- GMIBs . After a specified period of time Present value of expected income benefits in determined at the time of issuance excess of the projected account balance at of the variable annuity contract, any future date of annuitization and a minimum accumulation of purchase recognizing the excess ratably over the payments, even if the account accumulation period based on the present value is reduced to zero, that can value of total expected assessments. be annuitized to receive a monthly Assumptions are consistent with those used income stream that is not less for estimating GMDBs liabilities. than a specified amount. Calculation incorporates an assumption for . Certain contracts also provide for the percentage of the potential annuitizations a guaranteed lump sum return of that may be elected by the contractholder. purchase premium in lieu of the annuitization benefit. ------------------------------------------------------------------------------------------------- GMWBs. . A return of purchase payment via Expected value of the life contingent partial withdrawals, even if the payments and expected assessments using account value is reduced to zero, assumptions consistent with those used for provided that cumulative estimating the GMDBs liabilities. withdrawals in a contract year do not exceed a certain limit. . Certain contracts include guaranteed withdrawals that are life contingent. F-21
N-4468th Page of 530TOC1stPreviousNextBottomJust 468th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. RESERVES (CONTINUED) Information regarding the liabilities for guarantees (excluding embedded derivatives) relating to annuity and universal and variable life contracts was as follows: [Download Table] UNIVERSAL AND VARIABLE LIFE ANNUITY CONTRACTS CONTRACTS - ------------------ ------------- SECONDARY GMDBS GMIBS GUARANTEES TOTAL - -------- -------- ------------- ---------- ASSUMED Balance at January 1, 2011... $204,783 $172,260 $41,159 $ 418,202 Incurred guaranteed benefits. 197,432 72,496 (1,514) 268,414 Paid guaranteed benefits..... (74,439) -- -- (74,439) -------- -------- ------- ---------- Balance at December 31, 2011. 327,776 244,756 39,645 612,177 Incurred guaranteed benefits. 169,545 230,988 10,288 410,821 Paid guaranteed benefits..... (79,815) -- -- (79,815) -------- -------- ------- ---------- Balance at December 31, 2012. 417,506 475,744 49,933 943,183 Incurred guaranteed benefits. 125,884 52,561 7,018 185,463 Paid guaranteed benefits..... (59,132) -- -- (59,132) -------- -------- ------- ---------- Balance at December 31, 2013. $484,258 $528,305 $56,951 $1,069,514 ======== ======== ======= ========== CEDED Balance at January 1, 2011... $ 8,210 $ -- $ -- $ 8,210 Incurred guaranteed benefits. (32) -- -- (32) Paid guaranteed benefits..... -- -- -- -- -------- -------- ------- ---------- Balance at December 31, 2011. 8,178 -- -- 8,178 Incurred guaranteed benefits. 2,920 -- -- 2,920 Paid guaranteed benefits..... -- -- -- -- -------- -------- ------- ---------- Balance at December 31, 2012. 11,098 -- -- 11,098 Incurred guaranteed benefits. 3,704 -- -- 3,704 Paid guaranteed benefits..... -- -- -- -- -------- -------- ------- ---------- Balance at December 31, 2013. $ 14,802 $ -- $ -- $ 14,802 ======== ======== ======= ========== NET Balance at January 1, 2011... $196,573 $172,260 $41,159 $ 409,992 Incurred guaranteed benefits. 197,464 72,496 (1,514) 268,446 Paid guaranteed benefits..... (74,439) -- -- (74,439) -------- -------- ------- ---------- Balance at December 31, 2011. 319,598 244,756 39,645 603,999 Incurred guaranteed benefits. 166,625 230,988 10,288 407,901 Paid guaranteed benefits..... (79,815) -- -- (79,815) -------- -------- ------- ---------- Balance at December 31, 2012. 406,408 475,744 49,933 932,085 Incurred guaranteed benefits. 122,180 52,561 7,018 181,759 Paid guaranteed benefits..... (59,132) -- -- (59,132) -------- -------- ------- ---------- Balance at December 31, 2013. $469,456 $528,305 $56,951 $1,054,712 ======== ======== ======= ========== F-22
N-4469th Page of 530TOC1stPreviousNextBottomJust 469th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. REINSURANCE The Company assumes insurance risk from affiliated and unaffiliated insurance companies. The Company also cedes certain assumed insurance risks to unaffiliated reinsurers. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Premiums and policyholder benefits and claims in the statements of operations consist of amounts assumed, partially offset by amounts ceded under reinsurance agreements. The Company assumes risks from an unaffiliated company related to guaranteed minimum benefit guarantees written directly by the unaffiliated company. These assumed reinsurance agreements contain embedded derivatives and changes in their fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within policyholder's account balance and were liabilities of $1,262.3 million and $2,581.9 million at December 31, 2013 and 2012, respectively. For the years ended December 31, 2013, 2012 and 2011, net derivative gains (losses) included $1,126.5 million, ($394.9) million and $80.6 million, respectively, in changes in fair value of such embedded derivatives. At December 31, 2013 and 2012, the Company had $99.2 million and $287.2 million, respectively, of unsecured unaffiliated ceded reinsurance recoverable balances. Certain unaffiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on ceded unaffiliated reinsurance were $3.5 million and $28.9 million, at December 31, 2013 and 2012, respectively. The deposit liabilities on assumed unaffiliated reinsurance were $545 thousand and $335 thousand at December 31, 2013 and 2012, respectively. RELATED PARTY REINSURANCE TRANSACTIONS The Company has reinsurance agreements with certain of the Holding Company's subsidiaries, including Metropolitan Life Insurance Company, First MetLife Investors Insurance Company, MetLife Insurance Company of Connecticut, MetLife Investors USA Insurance Company, MetLife Investors Insurance Company, MetLife Europe Limited ("MEL"), New England Life Insurance Company and Alico Life International Limited, all of which are related parties. F-23
N-4470th Page of 530TOC1stPreviousNextBottomJust 470th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. REINSURANCE (CONTINUED) Information regarding the significant effects of affiliated reinsurance included in the statements of operations was as follows: [Enlarge/Download Table] YEARS ENDED DECEMBER 31, ---------------------------------------- 2013 2012 2011 ------------ ------------ -------------- (IN THOUSANDS) REVENUES Premiums............................................... $ 23,922 $ 909,170 $ 29,894 Universal life and investment-type product policy fees. 450,583 398,509 283,097 Net derivative gain (loss)............................. 5,678,708 (723,305) (2,818,107) Other revenues......................................... 1,396 22,917 43,740 ------------ ------------ -------------- Total revenues........................................ $ 6,154,609 $ 607,291 $ (2,461,376) ============ ============ ============== EXPENSES Policyholder benefits and claims....................... $ 255,205 $ 1,273,113 $ 234,143 Interest credited to policyholder account balances..... 17,399 16,598 15,831 Policyholder dividends................................. 12,295 14,256 14,013 Other expenses......................................... 82,569 16,845 26,466 ------------ ------------ -------------- Total expenses........................................ $ 367,468 $ 1,320,812 $ 290,453 ============ ============ ============== Information regarding the significant effects of affiliated reinsurance included in the balance sheets was as follows at: [Download Table] DECEMBER 31, -------------------------- 2013 2012 ------------ ------------- (IN THOUSANDS) ASSETS Funds withheld at interest.................. $ 2,045,389 $ 1,796,083 Premiums, reinsurance and other receivables. 243,080 160,658 Deferred policy acquisition costs........... 80,831 76,892 ------------ ------------- Total assets............................... $ 2,369,300 $ 2,033,633 ============ ============= LIABILITIES Future policy benefits...................... $ 2,062,320 $ 2,043,905 Other policy-related balances............... 3,561,663 8,130,768 Policyholder dividends payable.............. 16,256 17,438 Other liabilities........................... 250,807 161,603 ------------ ------------- Total liabilities.......................... $ 5,891,046 $ 10,353,714 ============ ============= In September 2012, the Company entered into a reinsurance agreement to assume 100% quota share of certain blocks of indemnity reinsurance from MEL. This agreement covers a portion of liabilities under defined portfolios of living time annuities contracts issued on or after the effective date. This agreement transfers risk to the Company, and therefore, is accounted for as reinsurance. As a result of the agreement, the Company recorded future policy benefits, presented within future policy benefits, of $649.3 million and $792.3 million, other reinsurance liabilities of $16.9 million and $10.7 million, and other reinsurance payables, included in other F-24
N-4471st Page of 530TOC1stPreviousNextBottomJust 471st
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. REINSURANCE (CONTINUED) liabilities, were $43.7 million and $61.1 million at December 31, 2013 and 2012, respectively. The Company's statement of operations reflects a loss for this agreement of $8.6 million and $3.5 million, which includes premiums of $1 thousand and $881.2 million and policyholder benefits of $8.6 million and $884.7 million for the years ended December 31, 2013 and 2012, respectively. The Company assumes risks from affiliates related to guaranteed minimum benefit guarantees written directly by the affiliates. These assumed reinsurance agreements contain embedded derivatives and changes in their fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within policyholder account balances and were liabilities of $1,226.6 million and $6,249.3 million at December 31, 2013 and 2012, respectively. For the years ended December 31, 2013, 2012 and 2011, net derivative gains (losses) included $5,729.1 million, ($729.3) million and ($2,818.1) million, respectively, in changes in fair value of such embedded derivatives. The Company had no ceded affiliated reinsurance recoverable balances at December 31, 2013 and 2012. 5. INVESTMENTS See Note 7 for information about the fair value hierarchy for investments and the related valuation methodologies. INVESTMENT RISKS AND UNCERTAINTIES Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation and currency. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of variable interest entities ("VIEs"). The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the financial statements. The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available. The recognition of income on certain investments (e.g., structured securities, including mortgage-backed securities, asset-backed securities ("ABS") and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned. F-25
N-4472nd Page of 530TOC1stPreviousNextBottomJust 472nd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) FIXED MATURITY SECURITIES AFS FIXED MATURITY SECURITIES AFS BY SECTOR The following table presents the fixed maturity securities AFS by sector. Included within fixed maturity securities are structured securities including commercial mortgage-backed securities ("CMBS"), ABS and residential mortgage-backed securities ("RMBS"). [Enlarge/Download Table] DECEMBER 31, 2013 DECEMBER 31, 2012 ------------------------------------------------- ------------------------------------------------- GROSS UNREALIZED GROSS UNREALIZED COST OR ------------------------- ESTIMATED COST OR ------------------------- ESTIMATED AMORTIZED TEMPORARY OTTI FAIR AMORTIZED TEMPORARY OTTI FAIR COST GAINS LOSSES LOSSES VALUE COST GAINS LOSSES LOSSES VALUE ----------- -------- --------- ------ ----------- ----------- -------- --------- ------ ----------- (IN THOUSANDS) (IN THOUSANDS) FIXED MATURITY SECURITIES: Foreign corporate..... $ 535,332 $ 5,294 $ 7,203 $ -- $ 533,423 $ 621,950 $ 11,286 $ 1,814 $ -- $ 631,422 U.S. corporate........ 255,510 10,478 2,366 -- 263,622 302,993 19,714 241 -- 322,466 CMBS.................. 135,781 1,724 4,941 -- 132,564 82,307 4,019 -- -- 86,326 State and political subdivision.......... 114,310 6,862 916 -- 120,256 115,352 20,220 5 -- 135,567 U.S. Treasury and agency............... 101,947 1,225 3,924 -- 99,248 290,766 2,765 2 -- 293,529 ABS................... 79,461 1,323 264 -- 80,520 195,178 2,707 9 -- 197,876 RMBS.................. 61,322 2,261 794 -- 62,789 76,727 5,179 -- -- 81,906 Foreign government.... 28,259 400 -- -- 28,659 34,640 1,887 -- -- 36,527 ----------- -------- -------- ---- ----------- ----------- -------- ------- ---- ----------- Total fixed maturity securities.......... $ 1,311,922 $ 29,567 $ 20,408 $ -- $ 1,321,081 $ 1,719,913 $ 67,777 $ 2,071 $ -- $ 1,785,619 =========== ======== ======== ==== =========== =========== ======== ======= ==== =========== The Company held no non-income producing fixed maturity securities at December 31, 2013 and 2012. METHODOLOGY FOR AMORTIZATION OF PREMIUM AND ACCRETION OF DISCOUNT ON STRUCTURED SECURITIES Amortization of premium or accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management's knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis. F-26
N-4473rd Page of 530TOC1stPreviousNextBottomJust 473rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) MATURITIES OF FIXED MATURITY SECURITIES The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at: [Enlarge/Download Table] DECEMBER 31, ------------------------------------------- 2013 2012 --------------------- --------------------- ESTIMATED ESTIMATED AMORTIZED FAIR AMORTIZED FAIR COST VALUE COST VALUE ---------- ---------- ---------- ---------- (IN THOUSANDS) Due in one year or less.................... $ 246,228 $ 246,780 $ 273,190 $ 273,472 Due after one year through five years...... 280,090 283,376 520,894 524,882 Due after five years through ten years..... 308,324 311,927 364,081 386,994 Due after ten years........................ 200,716 203,125 207,536 234,163 ---------- ---------- ---------- ---------- Subtotal.................................. 1,035,358 1,045,208 1,365,701 1,419,511 Structured securities (CMBS, ABS and RMBS). 276,564 275,873 354,212 366,108 ---------- ---------- ---------- ---------- Total fixed maturity securities........... $1,311,922 $1,321,081 $1,719,913 $1,785,619 ========== ========== ========== ========== Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. CMBS, ABS and RMBS are shown separately, as they are not due at a single maturity. CONTINUOUS GROSS UNREALIZED LOSSES FOR FIXED MATURITY SECURITIES AFS BY SECTOR The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position. The unrealized loss amounts include the noncredit component of OTTI loss. [Enlarge/Download Table] DECEMBER 31, 2013 DECEMBER 31, 2012 ------------------------------------------ ------------------------------------------ EQUAL TO OR GREATER EQUAL TO OR GREATER LESS THAN 12 MONTHS THAN 12 MONTHS LESS THAN 12 MONTHS THAN 12 MONTHS --------------------- -------------------- --------------------- -------------------- ESTIMATED GROSS ESTIMATED GROSS ESTIMATED GROSS ESTIMATED GROSS FAIR UNREALIZED FAIR UNREALIZED FAIR UNREALIZED FAIR UNREALIZED VALUE LOSSES VALUE LOSSES VALUE LOSSES VALUE LOSSES ---------- ---------- --------- ---------- ---------- ---------- --------- ---------- (IN THOUSANDS, EXCEPT NUMBER OF SECURITIES) FIXED MATURITY SECURITIES: Foreign corporate............. $ 214,876 $ 7,203 $ -- $ -- $ 288,797 $ 1,814 $ -- $ -- U.S. corporate................ 50,458 1,771 4,378 595 54,064 241 -- -- CMBS.......................... 62,872 4,941 -- -- -- -- -- -- State and political subdivision.................. 14,936 916 -- -- 775 5 -- -- U.S. Treasury and agency...... 28,434 3,924 -- -- 2,522 2 -- -- ABS........................... 18,907 264 -- -- 72,441 9 -- -- RMBS.......................... 17,541 794 -- -- -- -- -- -- ---------- --------- -------- ---- ---------- -------- ----- ----- Total fixed maturity securities................. $ 408,024 $ 19,813 $ 4,378 $595 $ 418,599 $ 2,071 $ -- $ -- ========== ========= ======== ==== ========== ======== ===== ===== Total number of securities in an unrealized loss position..................... 79 2 67 -- ========== ======== ========== ===== F-27
N-4474th Page of 530TOC1stPreviousNextBottomJust 474th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) EVALUATION OF AFS SECURITIES FOR OTTI AND EVALUATING TEMPORARILY IMPAIRED AFS SECURITIES EVALUATION AND MEASUREMENT METHODOLOGIES Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: . The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment. . When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management's best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. . Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds; current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security. . When determining the amount of the credit loss for U.S. and foreign corporate securities and state and political subdivision securities, the estimated fair value is considered the recovery value when available F-28
N-4475th Page of 530TOC1stPreviousNextBottomJust 475th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as private and public sector programs to restructure such securities. With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security's cost and its estimated fair value with a corresponding charge to earnings. The amortized cost of fixed maturity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value. In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows. CURRENT PERIOD EVALUATION Based on the Company's current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company's current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company has concluded that these securities are not other-than-temporarily impaired at December 31, 2013. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected) and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods. Gross unrealized losses on fixed maturity securities increased $18.3 million during the year ended December 31, 2013 from $2.1 million to $20.4 million. The increase in gross unrealized losses for the year ended December 31, 2013, was primarily attributable to an increase in interest rates, partially offset by narrowing credit spreads. At December 31, 2013, there were no fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater. FUNDS WITHHELD AT INTEREST Funds withheld at interest represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. At December 31, 2013 and 2012, such amounts consisted of balances withheld in connection with reinsurance agreements with affiliates of the Holding Company, as presented in Note 4, and an unaffiliated company. F-29
N-4476th Page of 530TOC1stPreviousNextBottomJust 476th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) CASH EQUIVALENTS The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $40.8 million and $410.6 million at December 31, 2013 and 2012, respectively. NET UNREALIZED INVESTMENT GAINS (LOSSES) The components of net unrealized investment gains (losses), included in AOCI, were as follows: [Download Table] YEARS ENDED DECEMBER 31, ---------------------------------- 2013 2012 2011 ---------- ----------- ----------- (IN THOUSANDS) Fixed maturity securities................. $ 9,072 $ 65,706 $ 41,752 Equity securities......................... -- -- (1,063) Deferred income tax benefit (expense)..... (3,176) (22,997) (14,241) ---------- ----------- ----------- Net unrealized investment gains (losses). $ 5,896 $ 42,709 $ 26,448 ========== =========== =========== The changes in net unrealized investment gains (losses) were as follows: [Enlarge/Download Table] YEARS ENDED DECEMBER 31, --------------------------------- 2013 2012 2011 ----------- --------- ----------- (IN THOUSANDS) Balance, January 1,.................................. $ 42,709 $ 26,448 $ 3,341 Unrealized investment gains (losses) during the year. (56,634) 25,017 35,549 Deferred income tax benefit (expense)................ 19,821 (8,756) (12,442) ----------- --------- ----------- Balance, December 31,................................ $ 5,896 $ 42,709 $ 26,448 =========== ========= =========== Change in net unrealized investment gains (losses)... $ (36,813) $ 16,261 $ 23,107 =========== ========= =========== CONCENTRATIONS OF CREDIT RISK There were no investments in any counterparty that were greater than 10% of the Company's stockholder's equity, other than the U.S. government and its agencies, at both December 31, 2013 and 2012. INVESTED ASSETS HELD IN TRUST AND PLEDGED AS COLLATERAL Invested assets held in trust and pledged as collateral are presented below at estimated fair value for cash and cash equivalents, short-term investments, and fixed maturity securities at: [Enlarge/Download Table] DECEMBER 31, --------------------- 2013 2012 ---------- ---------- (IN THOUSANDS) Invested assets held in trust (1).............................. $2,754,170 $4,697,418 Invested assets pledged as collateral (2)...................... 1,024,682 289,145 ---------- ---------- Total invested assets held in trust and pledged as collateral. $3,778,852 $4,986,563 ========== ========== -------- (1)The Company has held in trust certain investments, primarily fixed maturity securities, in connection with certain reinsurance transactions. F-30
N-4477th Page of 530TOC1stPreviousNextBottomJust 477th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) (2)Certain of the Company's invested assets are pledged as collateral for various derivative transactions as described in Note 6. VARIABLE INTEREST ENTITIES The Company has invested in certain structured transactions that are VIEs. In certain instances, the Company may hold both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, it would be deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE's primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party's relationship with or involvement in the entity, an estimate of the entity's expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE's expected losses, receive a majority of a VIE's expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the financial statements. CONSOLIDATED VIES There were no VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2013 and 2012. UNCONSOLIDATED VIES The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at: [Enlarge/Download Table] DECEMBER 31, ----------------------------------------- 2013 2012 -------------------- -------------------- MAXIMUM MAXIMUM CARRYING EXPOSURE CARRYING EXPOSURE VALUE TO LOSS (1) VALUE TO LOSS (1) -------- ----------- -------- ----------- (IN THOUSANDS) Fixed maturity securities AFS: Structured securities (ABS, CMBS and RMBS) (2). $275,873 $275,873 $366,108 $366,108 Foreign corporate.............................. 5,186 5,186 5,525 5,525 -------- -------- -------- -------- Total........................................ $281,059 $281,059 $371,633 $371,633 ======== ======== ======== ======== -------- (1)The maximum exposure to loss relating to fixed maturity securities is equal to their carrying amounts or the carrying amounts of retained interests. (2)For these variable interests, the Company's involvement is limited to that of a passive investor. F-31
N-4478th Page of 530TOC1stPreviousNextBottomJust 478th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) NET INVESTMENT INCOME The components of net investment income were as follows: [Download Table] YEARS ENDED DECEMBER 31, -------------------------- 2013 2012 2011 -------- -------- -------- (IN THOUSANDS) Investment Income: Fixed maturity securities......................... $ 41,202 $ 29,831 $ 23,825 Equity securities................................. -- 94 619 Cash, cash equivalents and short-term investments. 3,247 6,415 3,314 Other............................................. (3,155) (4,792) (4,622) -------- -------- -------- Subtotal........................................ 41,294 31,548 23,136 -------- -------- -------- Less: Investment expenses......................... 5,871 10,853 5,898 -------- -------- -------- Net investment income........................... $ 35,423 $ 20,695 $ 17,238 ======== ======== ======== See "-- Related Party Investment Transactions" for discussion of affiliated net investment income and expenses included in the table above. NET INVESTMENT GAINS (LOSSES) COMPONENTS OF NET INVESTMENT GAINS (LOSSES) The components of net investment gains (losses) were as follows: [Download Table] YEARS ENDED DECEMBER 31, -------------------------- 2013 2012 2011 --------- ------- -------- (IN THOUSANDS) Fixed maturity securities................. $ 2,066 $ 711 $ 4,717 Equity securities......................... -- 3,675 (292) Other investment portfolio gains (losses). (58,647) 37,407 (5,511) --------- ------- -------- Total net investment gains (losses)...... $(56,581) $41,793 $(1,086) ========= ======= ======== Gains (losses) from foreign currency transactions included within net investment gains (losses) were ($59.2) million, $37.3 million and ($5.9) million for the years ended December 31, 2013, 2012 and 2011, respectively. F-32
N-4479th Page of 530TOC1stPreviousNextBottomJust 479th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. INVESTMENTS (CONTINUED) SALES OR DISPOSALS OF FIXED MATURITY AND EQUITY SECURITIES Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis. [Enlarge/Download Table] YEARS ENDED DECEMBER 31, YEARS ENDED DECEMBER 31, YEARS ENDED DECEMBER 31, ------------------------------- ----------------------- ------------------------------- 2013 2012 2011 2013 2012 2011 2013 2012 2011 ---------- --------- ---------- ----- -------- -------- ---------- --------- ---------- FIXED MATURITY SECURITIES EQUITY SECURITIES TOTAL ------------------------------- ----------------------- ------------------------------- (IN THOUSANDS) Proceeds................ $ 251,239 $ 34,432 $ 421,298 $ -- $ 7,212 $ 2,880 $ 251,239 $ 41,644 $ 424,178 ========== ========= ========== ===== ======== ======== ========== ========= ========== Gross investment gains.................. $ 2,721 $ 755 $ 5,178 $ -- $ 3,675 $ -- $ 2,721 $ 4,430 $ 5,178 Gross investment losses................. (655) (44) (461) -- -- (292) (655) (44) (753) ---------- --------- ---------- ----- -------- -------- ---------- --------- ---------- Net investment gains (losses)............. $ 2,066 $ 711 $ 4,717 $ -- $ 3,675 $ (292) $ 2,066 $ 4,386 $ 4,425 ========== ========= ========== ===== ======== ======== ========== ========= ========== There were no OTTI losses on fixed maturity securities or equity securities during the years ended December 31, 2013, 2012 and 2011. RELATED PARTY INVESTMENT TRANSACTIONS In the normal course of business, the Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. There were no invested assets transferred to affiliates for the years ended December 31, 2013 and 2012. There were no invested assets transferred from affiliates for the year ended December 31, 2013. The estimated fair value of invested assets transferred from affiliates for the year ended December 31, 2012 was $857.4 million. There were no invested assets transferred from affiliates for the year ended December 31, 2011. The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $4.6 million, $7.2 million and $4.5 million for the years ended December 31, 2013, 2012 and 2011, respectively. 6. DERIVATIVES ACCOUNTING FOR DERIVATIVES See Note 1 for a description of the Company's accounting policies for derivatives and Note 7 for information about the fair value hierarchy for derivatives. DERIVATIVE STRATEGIES The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives. F-33
N-4480th Page of 530TOC1stPreviousNextBottomJust 480th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter ("OTC") market. Certain of the Company's OTC derivatives may be cleared and settled through central clearing counterparties ("OTC-cleared"), while others are bilateral contracts between two counterparties ("OTC-bilateral"). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. The Company also purchases certain securities and engages in certain reinsurance agreements that have embedded derivatives. The Company utilizes all derivatives in non-qualifying hedging relationships. INTEREST RATE DERIVATIVES The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, futures and options. Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. In exchange-traded interest rate Treasury futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate Treasury futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring and to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance. Swaptions are used by the Company to hedge interest rate risk associated with the Company's long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. Swaptions are included in interest rate options. FOREIGN CURRENCY EXCHANGE RATE DERIVATIVES The Company uses foreign currency forwards to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency forward transaction, the Company agrees with another party to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. To a lesser extent, the Company uses exchange-traded currency futures to hedge currency mismatches between assets and liabilities. F-34
N-4481st Page of 530TOC1stPreviousNextBottomJust 481st
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) EQUITY DERIVATIVES The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, variance swaps, exchange-traded equity futures and total rate of return swaps ("TRRs"). Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products assumed by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products reinsured by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge liabilities embedded in certain variable annuity products reinsured by the Company. TRRs are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the London Inter-Bank Offered Rate ("LIBOR"), calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses TRRs to hedge its equity market guarantees in certain of its reinsured products. TRRs can be used as hedges or to synthetically create investments. F-35
N-4482nd Page of 530TOC1stPreviousNextBottomJust 482nd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) PRIMARY RISKS MANAGED BY DERIVATIVES The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company's derivatives, excluding embedded derivatives, held at: [Download Table] DERIVATIVES NOT DESIGNATED OR NOT QUALIFYING AS HEDGING PRIMARY UNDERLYING RISK INSTRUMENTS EXPOSURE --------------------- ------------------------------- Interest rate swaps........ Interest rate.................. Interest rate futures...... Interest rate.................. Interest rate options...... Interest rate.................. Foreign currency forwards.. Foreign currency exchange rate. Currency futures........... Foreign currency exchange rate. Equity futures............. Equity market.................. Equity options............. Equity market.................. Variance swaps............. Equity market.................. Total rate of return swaps. Equity market.................. Total non-designated or non-qualifying derivatives....... [Enlarge/Download Table] DECEMBER 31, 2013 DECEMBER 31, 2012 ----------------------------------- ---------------------------------- ESTIMATED FAIR VALUE ESTIMATED FAIR VALUE ---------------------- ---------------------- PRIMARY UNDERLYING RISK NOTIONAL NOTIONAL EXPOSURE AMOUNT ASSETS LIABILITIES AMOUNT ASSETS LIABILITIES ------------------------------- ------------ ---------- ----------- ----------- ---------- ----------- (IN THOUSANDS) Interest rate.................. $ 23,221,522 $1,040,377 $ 562,851 $22,298,852 $1,867,230 $ 611,572 Interest rate.................. 4,462,013 9,047 6,547 6,437,033 598 20,980 Interest rate.................. 17,690,095 131,341 235,516 11,440,095 302,989 58,486 Foreign currency exchange rate. 2,324,152 728 171,078 2,281,296 1,051 177,496 Foreign currency exchange rate. 364,550 1,169 1,022 518,160 3,864 -- Equity market.................. 4,327,600 1,284 39,600 5,898,717 14,146 105,452 Equity market.................. 31,414,484 1,024,034 1,005,551 18,897,916 2,346,326 355,433 Equity market.................. 18,917,116 167,519 469,330 17,177,849 111,788 241,073 Equity market.................. 3,339,982 -- 156,959 2,791,568 4,436 95,505 ------------ ---------- ---------- ----------- ---------- ---------- $106,061,514 $2,375,499 $2,648,454 $87,741,486 $4,652,428 $1,665,997 ============ ========== ========== =========== ========== ========== NET DERIVATIVE GAINS (LOSSES) The components of net derivative gains (losses) were as follows: [Download Table] YEARS ENDED DECEMBER 31, ------------------------------------------ 2013 2012 2011 -------------- -------------- ------------ (IN THOUSANDS) Derivatives and hedging gains (losses). $ (4,841,296) $ (2,586,885) $ 2,941,895 Embedded derivatives................... 6,776,544 (1,089,704) (2,711,461) -------------- -------------- ------------ Total net derivatives gains (losses).. $ 1,935,248 $ (3,676,589) $ 230,434 ============== ============== ============ The following table presents earned income on derivatives for the: [Download Table] YEARS ENDED DECEMBER 31, ------------------------------------ 2013 2012 2011 ------------ ------------ ---------- (IN THOUSANDS) Net derivative gains (losses).... $ (262,379) $ 20,202 $ 141,929 Policyholder benefits and claims. (274,848) (113,899) 16,833 ------------ ------------ ---------- Total........................... $ (537,227) $ (93,697) $ 158,762 ============ ============ ========== F-36
N-4483rd Page of 530TOC1stPreviousNextBottomJust 483rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) NON-QUALIFYING DERIVATIVES The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments: [Download Table] NET POLICYHOLDER DERIVATIVE BENEFITS AND GAINS (LOSSES) CLAIMS (1) -------------- ------------ (IN THOUSANDS) FOR THE YEAR ENDED DECEMBER 31, 2013: Interest rate derivatives.................. $ (925,139) $ (1,364) Foreign currency exchange rate derivatives. (514,563) -- Equity derivatives......................... (3,139,215) (635,931) -------------- ------------ Total.................................... $ (4,578,917) $ (637,295) ============== ============ FOR THE YEAR ENDED DECEMBER 31, 2012: Interest rate derivatives.................. $ (204,299) $ -- Foreign currency exchange rate derivatives. (284,745) -- Equity derivatives......................... (2,118,043) (367,490) -------------- ------------ Total.................................... $ (2,607,087) $ (367,490) ============== ============ FOR THE YEAR ENDED DECEMBER 31, 2011: Interest rate derivatives.................. $ 1,527,402 $ -- Foreign currency exchange rate derivatives. 143,177 -- Equity derivatives......................... 1,129,387 (82,696) -------------- ------------ Total.................................... $ 2,799,966 $ (82,696) ============== ============ -------- (1)Changes in estimated fair value related to economic hedges of reinsured variable annuity guarantees. CREDIT RISK ON FREESTANDING DERIVATIVES The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company's derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements. The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company's OTC-bilateral derivative transactions are generally governed by International Swaps and Derivatives Association ("ISDA") Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set-off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company's ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives. See Note 7 for a description of the impact of credit risk on the valuation of derivatives. F-37
N-4484th Page of 530TOC1stPreviousNextBottomJust 484th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) The estimated fair value of the Company's net derivative assets and net derivative liabilities after the application of master netting agreements and collateral was as follows at: [Enlarge/Download Table] DECEMBER 31, 2013 DECEMBER 31, 2012 ------------------------- ------------------------- DERIVATIVES SUBJECT TO A MASTER NETTING ARRANGEMENT OR A SIMILAR ARRANGEMENT ASSETS LIABILITIES ASSETS LIABILITIES -------------------------------------------------------- ------------ ------------ ------------ ------------ (IN THOUSANDS) Gross estimated fair value of derivatives: OTC-bilateral.......................................... $ 2,430,173 $ 2,593,152 $ 4,708,762 $ 1,534,233 Exchange-traded........................................ 11,500 47,169 18,608 126,432 ------------ ------------ ------------ ------------ Total gross estimated fair value of derivatives (1).................................... 2,441,673 2,640,321 4,727,370 1,660,665 Amounts offset in the balance sheets.................... -- -- -- -- ------------ ------------ ------------ ------------ Estimated fair value of derivatives presented in the balance sheets (1).................................... 2,441,673 2,640,321 4,727,370 1,660,665 Gross amounts not offset in the balance sheets: Gross estimated fair value of derivatives: (2) OTC-bilateral.......................................... (1,869,869) (1,869,869) (1,518,669) (1,518,669) Exchange-traded........................................ (5,368) (5,368) (18,608) (18,608) Cash collateral (3) OTC-bilateral.......................................... (163,210) -- (1,473,376) -- Exchange-traded........................................ -- (39,008) -- (107,824) Securities collateral (4) OTC-bilateral.......................................... (377,561) (646,079) (1,716,717) (13,667) Exchange-traded........................................ -- (2,793) -- -- ------------ ------------ ------------ ------------ Net amount after application of master netting agreements and collateral............................. $ 25,665 $ 77,204 $ -- $ 1,897 ============ ============ ============ ============ -------- (1)At December 31, 2013 and 2012, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $66,175 thousand and $74,942 thousand, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $8,133 thousand and $5,332 thousand, respectively. (2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals. (3)Cash collateral received is included in cash and cash equivalents and the obligation to return it is included in other liabilities in the balance sheet. The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded derivatives and is included in premiums, reinsurance and other receivables in the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2013 and 2012, the Company received excess cash collateral of $33,319 thousand and $0, respectively, and provided excess cash collateral of $185,299 thousand and $167,655 thousand, respectively, which is not included in the table above due to the foregoing limitation. F-38
N-4485th Page of 530TOC1stPreviousNextBottomJust 485th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) (4)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or repledge this collateral, but at December 31, 2013 none of the collateral had been sold or repledged. Securities collateral pledged by the Company is reported in fixed maturity securities in the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or repledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2013 and 2012, the Company received excess securities collateral of $96,746 thousand and $59,320 thousand, respectively, for its OTC-bilateral derivatives which are not included in the table above due to the foregoing limitation. At December 31, 2013 and 2012, the Company provided excess securities collateral of $0 and $0, respectively, for its OTC-bilateral derivatives and $36,182 thousand and $39,989 thousand, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation. The following table presents the estimated fair value of the Company's OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company's credit rating at the reporting date or if the Company's credit rating sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table. [Enlarge/Download Table] ESTIMATED FAIR VALUE OF FAIR VALUE OF INCREMENTAL COLLATERAL COLLATERAL PROVIDED: PROVIDED UPON: ----------------------- ---------------------------------------- DOWNGRADE IN THE HOLDING COMPANY'S CREDIT RATING ESTIMATED ONE NOTCH TO A LEVEL THAT TRIGGERS FAIR VALUE OF DOWNGRADE IN FULL OVERNIGHT DERIVATIVES IN THE HOLDING COLLATERALIZATION OR NET LIABILITY FIXED MATURITY COMPANY'S TERMINATION POSITION (1) SECURITIES CREDIT RATING OF THE DERIVATIVE POSITION -------------- ----------------------- ------------- -------------------------- (IN THOUSANDS) December 31, 2013. $ 723,283 $ 646,079 $ 20,912 $ 21,353 December 31, 2012. $ 15,564 $ 13,667 $ -- $ -- -------- (1)After taking into consideration the existence of netting agreements. EMBEDDED DERIVATIVES The Company assumes variable annuities, modified coinsurance contracts, equity indexed deferred annuities and purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: assumed variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; ceded reinsurance agreements of guaranteed minimum benefits related to GMABs and certain GMIBs; assumed modified coinsurance contracts; assumed reinsurance on equity indexed deferred annuities; and options embedded in debt and equity securities. F-39
N-4486th Page of 530TOC1stPreviousNextBottomJust 486th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. DERIVATIVES (CONTINUED) The following table presents the estimated fair value and balance sheet location of the Company's embedded derivatives that have been separated from their host contracts at: [Enlarge/Download Table] DECEMBER 31, ------------------------- BALANCE SHEET LOCATION 2013 2012 -------------------------- ------------ ------------ (IN THOUSANDS) Net embedded derivatives within asset host contracts: Ceded guaranteed minimum benefits... Premiums, reinsurance and other receivables......... $ 122,515 $ 257,690 Assumed modified coinsurance Funds withheld at contracts.......................... interest.................. 24,035 72,357 ------------ ------------ Net embedded derivatives within asset host contracts....... $ 146,550 $ 330,047 ============ ============ Net embedded derivatives within liability host contracts: Assumed guaranteed minimum benefits. Other policy-related balances.................. $ 2,488,944 $ 8,831,285 ------------ ------------ Net embedded derivatives within liability host contracts... $ 2,488,944 $ 8,831,285 ============ ============ The following table presents changes in estimated fair value related to embedded derivatives: [Download Table] YEARS ENDED DECEMBER 31, ------------------------------------------ 2013 2012 2011 ------------ -------------- -------------- (IN THOUSANDS) Net derivative gains (losses) (1). $ 6,776,544 $ (1,089,704) $ (2,711,461) Policyholder benefits and claims.. $ (139,134) $ 72,507 $ 70,390 -------- (1)The valuation of reinsured guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were ($996.3) million, ($1,603.0) million and $1,956.9 million, for the years ended December 31, 2013, 2012 and 2011, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were $19.4 million, $2.9 million and ($23.1) million, for the years ended December 31, 2013, 2012 and 2011, respectively. F-40
N-4487th Page of 530TOC1stPreviousNextBottomJust 487th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability. Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company's ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities. Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. F-41
N-4488th Page of 530TOC1stPreviousNextBottomJust 488th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) RECURRING FAIR VALUE MEASUREMENTS The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented below. [Enlarge/Download Table] DECEMBER 31, 2013 ------------------------------------------------------ FAIR VALUE HIERARCHY -------------------------------------- TOTAL ESTIMATED LEVEL 1 LEVEL 2 LEVEL 3 FAIR VALUE ------------ ------------ ------------ --------------- (IN THOUSANDS) ASSETS: Fixed maturity securities: Foreign corporate............................. $ -- $ 533,423 $ -- $ 533,423 U.S. corporate................................ -- 253,705 9,917 263,622 CMBS.......................................... -- 75,017 57,547 132,564 State and political subdivision............... -- 120,256 -- 120,256 U.S. Treasury and agency...................... 99,248 -- -- 99,248 ABS........................................... -- 80,520 -- 80,520 RMBS.......................................... -- 62,789 -- 62,789 Foreign government............................ -- 28,659 -- 28,659 ------------ ------------ ------------ ------------ Total fixed maturity securities............. 99,248 1,154,369 67,464 1,321,081 ------------ ------------ ------------ ------------ Short-term investments (1)..................... 2,630,762 101,270 -- 2,732,032 Derivative assets: (2) Interest rate contracts....................... 9,046 1,171,719 -- 1,180,765 Foreign currency contracts.................... 1,169 728 -- 1,897 Equity market contracts....................... 1,284 917,797 273,756 1,192,837 ------------ ------------ ------------ ------------ Total derivative assets..................... 11,499 2,090,244 273,756 2,375,499 ------------ ------------ ------------ ------------ Net embedded derivatives within asset host contracts (3)................................ -- -- 146,550 146,550 ------------ ------------ ------------ ------------ Total assets................................ $ 2,741,509 $ 3,345,883 $ 487,770 $ 6,575,162 ============ ============ ============ ============ LIABILITIES: Derivative liabilities: (2) Interest rate contracts....................... $ 6,547 $ 798,367 $ -- $ 804,914 Foreign currency contracts.................... 1,022 171,078 -- 172,100 Equity market contracts....................... 39,601 1,136,875 494,964 1,671,440 ------------ ------------ ------------ ------------ Total derivative liabilities................ 47,170 2,106,320 494,964 2,648,454 ------------ ------------ ------------ ------------ Net embedded derivatives within liability host contracts (3)................................ -- -- 2,488,944 2,488,944 ------------ ------------ ------------ ------------ Total liabilities........................... $ 47,170 $ 2,106,320 $ 2,983,908 $ 5,137,398 ============ ============ ============ ============ F-42
N-4489th Page of 530TOC1stPreviousNextBottomJust 489th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) [Enlarge/Download Table] DECEMBER 31, 2012 ------------------------------------------------------ FAIR VALUE HIERARCHY -------------------------------------- TOTAL ESTIMATED LEVEL 1 LEVEL 2 LEVEL 3 FAIR VALUE ------------ ------------ ------------ --------------- (IN THOUSANDS) ASSETS: Fixed maturity securities: Foreign corporate......................... $ -- $ 628,708 $ 2,714 $ 631,422 U.S. corporate............................ -- 307,001 15,465 322,466 CMBS...................................... -- 44,603 41,723 86,326 State and political subdivision........... -- 135,567 -- 135,567 U.S. Treasury and agency.................. 285,259 8,270 -- 293,529 ABS....................................... -- 193,876 4,000 197,876 RMBS...................................... -- 81,906 -- 81,906 Foreign government........................ -- 36,527 -- 36,527 ------------ ------------ ------------ ------------- Total fixed maturity securities......... 285,259 1,436,458 63,902 1,785,619 ------------ ------------ ------------ ------------- Short-term investments (1)................. 3,824,840 425,354 4,996 4,255,190 Derivative assets: (2) Interest rate contracts................... 598 2,170,219 -- 2,170,817 Foreign currency contracts................ 3,864 1,051 -- 4,915 Equity market contracts................... 14,146 2,000,970 461,580 2,476,696 ------------ ------------ ------------ ------------- Total derivative assets................. 18,608 4,172,240 461,580 4,652,428 ------------ ------------ ------------ ------------- Net embedded derivatives within asset host contracts (3)............................ -- -- 330,047 330,047 ------------ ------------ ------------ ------------- Total assets............................ $ 4,128,707 $ 6,034,052 $ 860,525 $ 11,023,284 ============ ============ ============ ============= LIABILITIES: Derivative liabilities: (2) Interest rate contracts................... $ 20,980 $ 670,059 $ -- $ 691,039 Foreign currency contracts................ -- 177,496 -- 177,496 Equity market contracts................... 105,452 416,032 275,979 797,463 ------------ ------------ ------------ ------------- Total derivative liabilities............ 126,432 1,263,587 275,979 1,665,998 ------------ ------------ ------------ ------------- Net embedded derivatives within liability host contracts (3)....................... -- -- 8,831,285 8,831,285 ------------ ------------ ------------ ------------- Total liabilities....................... $ 126,432 $ 1,263,587 $ 9,107,264 $ 10,497,283 ============ ============ ============ ============= -------- (1)Short-term investments as presented in the tables above differ from the amounts presented in the balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis. (2)Derivative amounts are presented gross in the tables above to reflect the presentation in the balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables. F-43
N-4490th Page of 530TOC1stPreviousNextBottomJust 490th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) (3)Net embedded derivatives within asset host contracts are presented within funds withheld at interest and premiums, reinsurance and other receivables in the balance sheets. Net embedded derivatives within liability host contracts are presented within other policy-related balances in the balance sheets. The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy. INVESTMENTS VALUATION CONTROLS AND PROCEDURES On behalf of the Company and the Holding Company's Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management provides oversight of control systems and valuation policies for securities and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of the Holding Company's Board of Directors regarding compliance with fair value accounting standards. The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management's knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as "consensus pricing," represent a reasonable estimate of fair value by considering such pricing relative to the Company's knowledge of the current market dynamics and current pricing for similar financial instruments. The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally F-44
N-4491st Page of 530TOC1stPreviousNextBottomJust 491st
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management's best estimate is used. SECURITIES AND SHORT-TERM INVESTMENTS When available, the estimated fair value of these investments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company's securities holdings and valuation of these securities does not involve management's judgment. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management's judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances. Level 2 Valuation Techniques and Key Inputs: This level includes fixed maturity securities priced principally by independent pricing services using observable inputs. Short-term investments within this level are of a similar nature and class to the Level 2 fixed maturity securities. U.S. CORPORATE AND FOREIGN CORPORATE SECURITIES These securities are principally valued using the market and income approaches. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques that use standard market observable inputs such as benchmark yields, spreads off benchmark yields, new issuances, issuer rating, duration, and trades of identical or comparable securities. Privately placed securities are valued using matrix pricing methodologies using standard market observable inputs, and inputs derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer and in certain cases, delta spread adjustments to reflect specific credit related issues. STRUCTURED SECURITIES COMPRISED OF ABS, CMBS AND RMBS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using standard market inputs including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, F-45
N-4492nd Page of 530TOC1stPreviousNextBottomJust 492nd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans. STATE AND POLITICAL SUBDIVISION AND FOREIGN GOVERNMENT SECURITIES These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques using standard market observable inputs including a benchmark U.S. Treasury yield or other yields, issuer ratings, broker-dealer quotes, issuer spreads and reported trades of similar securities, including those within the same sub-sector or with a similar maturity or credit rating. U.S. TREASURY AND AGENCY SECURITIES These securities are principally valued using the market approach. Valuations are based primarily on quoted prices in markets that are not active or using matrix pricing or other similar techniques using standard market observable inputs such as a benchmark U.S. Treasury yield curve, the spread off the U.S. Treasury yield curve for the identical security and comparable securities that are actively traded. Level 3 Valuation Techniques and Key Inputs: In general, securities classified within Level 3 use many of the same valuation techniques and inputs as described previously for in the Level 2. However, if key inputs are unobservable, or if the investments are less liquid and there is very limited trading activity, the investments are generally classified as Level 3. The use of independent non-binding broker quotations to value investments generally indicates there is a lack of liquidity or a lack of transparency in the process to develop the valuation estimates, generally causing these investments to be classified in Level 3. Short-term investments within this level are of a similar nature and class to the Level 3 securities described below; accordingly, the valuation techniques and significant market standard observable inputs used in their valuation are also similar to those described below. U.S. CORPORATE AND FOREIGN CORPORATE SECURITIES These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques that utilize unobservable inputs or inputs that cannot be derived principally from, or corroborated by, observable market data, including illiquidity premium, delta spread adjustments to reflect specific credit-related issues, credit spreads and inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on independent non-binding broker quotations. STRUCTURED SECURITIES COMPRISED OF ABS AND CMBS These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data including credit spreads. Below investment grade securities and sub-prime RMBS included in this level F-46
N-4493rd Page of 530TOC1stPreviousNextBottomJust 493rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain of these valuations are based on independent non-binding broker quotations. DERIVATIVES The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in "-- Investments." The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Significant inputs that are observable generally include: interest rates, foreign currency exchange rates, interest rate curves, credit curves and volatility. However, certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant inputs that are unobservable generally include references to emerging market currencies and inputs that are outside the observable portion of the interest rate curve, credit curve, volatility or other relevant market measure. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company's derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company's ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. F-47
N-4494th Page of 530TOC1stPreviousNextBottomJust 494th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) FREESTANDING DERIVATIVES Level 2 Valuation Techniques and Key Inputs: This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. These derivatives are principally valued using the income approach. INTEREST RATE NON-OPTION-BASED. -- Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and basis curves. OPTION-BASED. -- Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves and interest rate volatility. FOREIGN CURRENCY EXCHANGE RATE NON-OPTION-BASED. -- Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates and cross currency basis curves. EQUITY MARKET NON-OPTION-BASED. -- Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, spot equity index levels and dividend yield curves. OPTION-BASED. -- Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, spot equity index levels, dividend yield curves and equity volatility. Level 3 Valuation Techniques and Key Inputs: These derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. These valuation methodologies generally use the same inputs as described in the corresponding sections above for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. EQUITY MARKET NON-OPTION-BASED. -- Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves and equity volatility. OPTION-BASED. -- Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves, equity volatility and unobservable correlation between model inputs. F-48
N-4495th Page of 530TOC1stPreviousNextBottomJust 495th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) EMBEDDED DERIVATIVES Embedded derivatives principally include certain assumed and ceded variable annuity guarantees and equity indexed crediting rates within certain funding agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company's actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates. Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for the Holding Company's debt, including related credit default swaps. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income. The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables in the balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. F-49
N-4496th Page of 530TOC1stPreviousNextBottomJust 496th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) The estimated fair value of the embedded derivatives within funds withheld related to certain assumed reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in "-- Investments -- Securities and Short-term Investments." The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in derivative liabilities and funds withheld at interest in the balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income. EMBEDDED DERIVATIVES WITHIN ASSET AND LIABILITY HOST CONTRACTS Level 3 Valuation Techniques and Key Inputs: ASSUMED GUARANTEED MINIMUM BENEFITS These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin. REINSURANCE CEDED ON CERTAIN GUARANTEED MINIMUM BENEFITS These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in " -- Assumed Guaranteed Minimum Benefits" and also include counterparty credit spreads. EMBEDDED DERIVATIVES WITHIN FUNDS WITHHELD RELATED TO CERTAIN ASSUMED REINSURANCE These embedded derivatives are principally valued using an income approach. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and the fair value of assets within the reference portfolio. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the fair value of certain assets within the reference portfolio which are not observable in the market and cannot be derived principally from, or corroborated by, observable market data. TRANSFERS BETWEEN LEVELS Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period. F-50
N-4497th Page of 530TOC1stPreviousNextBottomJust 497th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) TRANSFERS BETWEEN LEVELS 1 AND 2: There were no transfers between Levels 1 and 2 for assets and liabilities measured at estimated fair value and still held at December 31, 2013 and 2012. TRANSFERS INTO OR OUT OF LEVEL 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Transfers into Level 3 for fixed maturity securities were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments, or credit spreads. Transfers out of Level 3 for fixed maturity securities resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings. F-51
N-4498th Page of 530TOC1stPreviousNextBottomJust 498th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) ASSETS AND LIABILITIES MEASURED AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at: [Enlarge/Download Table] DECEMBER 31, 2013 -------------------------- SIGNIFICANT WEIGHTED VALUATION TECHNIQUES UNOBSERVABLE INPUTS RANGE AVERAGE (1) -------------------------------- -------------------------- ------------- ----------- FIXED MATURITY SECURITIES: (3) U.S. corporate and foreign corporate... Matrix pricing Credit spreads (4) 95 - 95 95 Illiquidity premium (4) 30 - 30 30 ------------------------------------------------------------------------------------------ CMBS................. Matrix pricing and discounted Credit spreads (4) cash flow 215 - 215 215 Market pricing Quoted prices (5) 104 - 104 104 Consensus pricing Offered quotes (5) 90 - 92 91 ------------------------------------------------------------------------------------------ DERIVATIVES: Equity market........ Present value techniques Volatility (7) 13% - 28% or option pricing models Correlation (9) 60% - 60% ------------------------------------------------------------------------------------------ EMBEDDED DERIVATIVES: Assumed and ceded Option pricing techniques Mortality rates: 0% - 0.10% guaranteed minimum Ages 0 - 40 benefits............ Ages 41 - 60 0.04% - 0.65% Ages 61 - 115 0.26% - 100% Lapse rates: Durations 1 -10 0.50% - 100% Durations 11 -20 3% - 100% Durations 21 -116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity 17.40% - 25% volatilities Nonperformance 0.03% - 0.44% risk spread ------------------------------------------------------------------------------------------ [Download Table] IMPACT OF DECEMBER 31, 2012 INCREASE IN -------------------------- INPUT ON WEIGHTED ESTIMATED VALUATION TECHNIQUES RANGE AVERAGE (1) FAIR VALUE (2) -------------------------------- ------------- ----------- -------------- Matrix pricing 103 - 499 168 Decrease 30 - 30 30 Decrease ----------------------------------------------------------------------------- Matrix pricing and discounted cash flow Decrease (6) Market pricing 104 - 104 104 Increase (6) Consensus pricing Increase (6) ----------------------------------------------------------------------------- Present value techniques 13% - 32% Increase (8) or option pricing models 65% - 65% ----------------------------------------------------------------------------- Option pricing techniques 0% - 0.14% Decrease (10) 0.05% - 0.75% Decrease (10) 0.26% - 100% Decrease (10) 0.50% - 100% Decrease (11) 3% - 100% Decrease (11) 2.5% - 100% Decrease (11) 20% - 50% Increase (12) 0.07% - 20% (13) 15.18% - 40% Increase (14) 0.10% - 1.72% Decrease (15) ----------------------------------------------------------------------------- -------- (1)The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities. (2)The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes to assumed guaranteed minimum benefits are based on liability positions and changes to ceded guaranteed minimum benefits are based on asset positions. (3)Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations. (4)Range and weighted average are presented in basis points. (5)Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par. (6)Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates. (7)Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation. (8)Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions. F-52
N-4499th Page of 530TOC1stPreviousNextBottomJust 499th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) (9)Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations. (10)Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (11)Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (12)The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract's withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (13)The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (14)Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (15)Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within embedded derivatives within funds withheld related to certain assumed reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 fixed maturity securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. F-53
N-4500th Page of 530TOC1stPreviousNextBottomJust 500th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3): [Enlarge/Download Table] FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) ----------------------------------------------------------------------------- FIXED MATURITY SECURITIES: -------------------------------------- FOREIGN U.S. SHORT-TERM EQUITY NET EMBEDDED CORPORATE CORPORATE CMBS ABS INVESTMENTS MARKET DERIVATIVES (6) --------- --------- --------- -------- ----------- ---------- --------------- (IN THOUSANDS) YEAR ENDED DECEMBER 31, 2013: Balance, January 1,........................... $ 2,714 $ 15,465 $ 41,723 $ 4,000 $ 4,996 $ 185,601 $(8,501,238) Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2)................. Net investment income...................... 11 (63) (242) -- 4 -- -- Net investment gains (losses).............. -- -- -- -- -- -- -- Net derivative gains (losses).............. -- -- -- -- -- (425,674) 6,789,870 Policyholder benefits and claims........... -- -- -- -- -- 18,720 (139,134) OCI......................................... (25) (652) (1,828) -- -- 252 291,536 Purchases (3)................................. -- -- 17,894 -- -- 7,149 -- Sales (3)..................................... (2,700) (8,680) -- -- (5,000) -- -- Settlements (3)............................... -- -- -- -- -- (7,256) (783,428) Transfers into Level 3 (4).................... -- 3,847 -- -- -- -- -- Transfers out of Level 3 (4).................. -- -- -- (4,000) -- -- -- -------- --------- --------- -------- -------- ---------- ------------ Balance, December 31,......................... $ -- $ 9,917 $ 57,547 $ -- $ -- $(221,208) $(2,342,394) ======== ========= ========= ======== ======== ========== ============ Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income....................... $ -- $ 4 $ (242) $ -- $ -- $ -- $ -- Net investment gains (losses)............... $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses)............... $ -- $ -- $ -- $ -- $ -- $(414,667) $ 6,743,952 Policyholder benefits and claims............ $ -- $ -- $ -- $ -- $ -- $ 18,720 $ (134,839) F-54
N-4501st Page of 530TOC1stPreviousNextBottomJust 501st
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) [Enlarge/Download Table] FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) ------------------------------------------------------------------------------------------------ FIXED MATURITY SECURITIES: EQUITY SECURITIES: -------------------------------------- ------------------ FOREIGN U.S. NON-REDEEMABLE SHORT-TERM EQUITY NET EMBEDDED CORPORATE CORPORATE CMBS ABS PREFERRED STOCK INVESTMENTS MARKET DERIVATIVES (6) --------- --------- --------- -------- ------------------ ----------- ---------- --------------- (IN THOUSANDS) YEAR ENDED DECEMBER 31, 2012: Balance, January 1,............. $ 2,533 $ 15,114 $ 41,724 $ -- $ -- $ 39,967 $ 844,062 $(7,033,096) Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income........ 12 (16) (164) -- -- 35 -- -- Net investment gains (losses).................... -- -- -- -- -- -- -- -- Net derivative gains (losses).................... -- -- -- -- -- -- (507,571) (1,085,812) Policyholder benefits and claims...................... -- -- -- -- -- -- 28,895 72,507 OCI........................... 169 (4) 163 -- -- -- (2,565) 259,765 Purchases (3)................... -- 6,501 -- 4,000 -- 4,994 19,056 -- Sales (3)....................... -- (701) -- -- -- (40,000) (43,500) -- Settlements (3)................. -- -- -- -- -- -- (152,776) (714,602) Transfers into Level 3 (4).................... -- -- -- -- -- -- -- -- Transfers out of Level 3 (4).................... -- (5,429) -- -- -- -- -- -- -------- --------- --------- -------- --------- --------- ---------- ------------ Balance, December 31,........... $ 2,714 $ 15,465 $ 41,723 $ 4,000 $ -- $ 4,996 $ 185,601 $(8,501,238) ======== ========= ========= ======== ========= ========= ========== ============ Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income......... $ 11 $ 9 $ (163) $ -- $ -- $ 2 $ -- $ -- Net investment gains (losses)..................... $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses)..................... $ -- $ -- $ -- $ -- $ -- $ -- $(498,377) $(1,139,890) Policyholder benefits and claims....................... $ -- $ -- $ -- $ -- $ -- $ -- $ 28,895 $ 75,146 F-55
N-4502nd Page of 530TOC1stPreviousNextBottomJust 502nd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) [Enlarge/Download Table] FAIR VALUE MEASUREMENTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) ------------------------------------------------------------------------------------------ FIXED MATURITY SECURITIES: EQUITY SECURITIES: ---------------------------------- ------------------ FOREIGN U.S. NON-REDEEMABLE SHORT-TERM EQUITY NET EMBEDDED CORPORATE CORPORATE CMBS ABS PREFERRED STOCK INVESTMENTS MARKET DERIVATIVES (6) --------- --------- ------- ----- ------------------ ----------- -------- --------------- (IN THOUSANDS) YEAR ENDED DECEMBER 31, 2011: Balance, January 1,.............. $2,673 $10,430 $ -- $ -- $ 2,835 $ 49,980 $124,720 $(3,660,494) Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income......... 10 4 (104) -- -- 19 -- -- Net investment gains (losses)..................... -- 1 -- -- (292) -- -- -- Net derivative gains (losses)..................... -- -- -- -- -- -- 563,864 (2,710,927) Policyholder benefits and claims....................... -- -- -- -- -- -- 7,131 70,390 OCI............................ (150) (511) 104 -- 337 -- 409 (120,058) Purchases (3).................... -- -- 41,724 -- -- 39,951 225,211 -- Sales (3)........................ -- (1,974) -- -- (2,880) (49,983) -- -- Settlements (3).................. -- -- -- -- -- -- (2,563) (612,007) Transfers into Level 3 (4)....... -- 7,164 -- -- -- -- -- -- Transfers out of Level 3 (4)..... -- -- -- -- -- -- (74,710) -- ------ ------- ------- ----- ------------ --------- -------- ----------- Balance, December 31,............ $2,533 $15,114 $41,724 $ -- $ -- $ 39,967 $844,062 $(7,033,096) ====== ======= ======= ===== ============ ========= ======== =========== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.......... $ 10 $ 4 $ (104) $ -- $ -- $ 15 $ -- $ -- Net investment gains (losses).. $ -- $ 1 $ -- $ -- $ (292) $ -- $ -- $ -- Net derivative gains (losses).. $ -- $ -- $ -- $ -- $ -- $ -- $566,325 $ 2,735,936 Policyholder benefits and claims........................ $ -- $ -- $ -- $ -- $ -- $ -- $ 7,131 $ 108,678 -------- (1)Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). (2)Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (3)The amount reported within purchases, sales, issuances and settlements is the purchase or issuance price and the sales or settlement proceeds based upon the actual date purchased or issued and sold or settled, respectively. Items purchased/issued and sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (4)Gains and losses, in net income (loss) and other comprehensive income (loss), are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (5)Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. (6)Embedded derivative assets and liabilities are presented net for purposes of the rollforward. F-56
N-4503rd Page of 530TOC1stPreviousNextBottomJust 503rd
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) FAIR VALUE OF FINANCIAL INSTRUMENTS CARRIED AT OTHER THAN FAIR VALUE The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, the obligation to return cash collateral received (included in other liabilities on the balance sheets) and short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the "-- Recurring Fair Value Measurements" section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure. The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: [Enlarge/Download Table] DECEMBER 31, 2013 --------------------------------------------------------- FAIR VALUE HIERARCHY CARRYING ----------------------------- TOTAL ESTIMATED VALUE LEVEL 1 LEVEL 2 LEVEL 3 FAIR VALUE ---------- ------- ---------- ---------- --------------- (IN THOUSANDS) ASSETS Premiums, reinsurance and other receivables. $ 228,140 $ -- $ 224,672 $ (161,249) $ 63,423 LIABILITIES Debt -- affiliated.......................... $ 575,118 $ -- $ 592,278 $ -- $ 592,278 Other liabilities........................... $ 3,836 $ -- $ 3,836 $ -- $ 3,836 DECEMBER 31, 2012 --------------------------------------------------------- FAIR VALUE HIERARCHY CARRYING ----------------------------- TOTAL ESTIMATED VALUE LEVEL 1 LEVEL 2 LEVEL 3 FAIR VALUE ---------- ------- ---------- ---------- --------------- (IN THOUSANDS) ASSETS Premiums, reinsurance and other receivables. $ 304,411 $ -- $ 275,479 $ 174,126 $ 449,605 LIABILITIES Debt -- affiliated.......................... $ 75,118 $ -- $ 82,174 $ -- $ 82,174 Other liabilities........................... $ 72 $ -- $ 72 $ -- $ 72 The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows: PREMIUMS, REINSURANCE AND OTHER RECEIVABLES Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements and amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives. F-57
N-4504th Page of 530TOC1stPreviousNextBottomJust 504th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. FAIR VALUE (CONTINUED) Premiums receivable and those amounts recoverable under reinsurance agreements determined to transfer significant risk are not financial instruments subject to disclosure and thus have been excluded from the amounts presented. Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty. The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value. DEBT -- AFFILIATED The estimated fair value of debt is principally determined using market standard valuation methodologies. Valuations are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues. OTHER LIABILITIES Other liabilities consist primarily of interest payable. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values. 8. DEBT -- AFFILIATED The table below presents information for the Company's long-term and short-term debt-affiliated outstanding at: [Download Table] DECEMBER 31, -------------------- INTEREST RATE MATURITY 2013 2012 ------------- -------- ---------- --------- (IN THOUSANDS) -------------------- SHORT-TERM AND LONG-TERM DEBT Surplus note................. 6.798% 2014 $ 75,118 $ 75,118 Senior notes................. 2.470% 2015 500,000 -- ---------- --------- Total debt-affiliated...... $ 575,118 $ 75,118 ========== ========= On October 15, 2013, the Company issued $500.0 million of guaranteed senior notes, Series A, to various affiliates, maturing in 2015 with an interest rate of 2.47%. On September 27, 2012, the Holding Company assumed $750.0 million of the Company's senior notes with interest rates of 6.440% and 5.330%, payable to an affiliate. In exchange for the assumption of senior notes, the F-58
N-4505th Page of 530TOC1stPreviousNextBottomJust 505th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. DEBT -- AFFILIATED (CONTINUED) Company issued to the Holding Company 75,000 shares of Series A 7.69% non-cumulative perpetual preferred shares with a par value of $1 per share and a liquidity preference of $10,000 per share. The dividend is payable semi-annually. (See Note 9 for additional information on preferred stock). On December 19, 2012, the Holding Company assumed $1,250.0 million of the Company's senior notes with interest rates of 7.440%, 5.640% and 5.860%, payable to various affiliates. In exchange for the assumption of senior notes, the Company issued to the Holding Company 125,000 shares of Series A 7.75% non-cumulative perpetual preferred shares with a par value of $1 per share and a liquidity preference of $10,000 per share. The dividend is payable semi-annually. (See Note 9 for additional information on preferred stock). On July 15, 2011, the Company issued a $500.0 million guaranteed senior note, Series A, to various affiliates, maturing in 2021 with an interest rate of 5.64%. On December 16, 2011, the Company issued a $500.0 million guaranteed senior note, Series B, to various affiliates, maturing in 2021 with an interest rate of 5.86%. Interest expense related to the Company's indebtedness, included in other expenses, was $7.7 million, $112.6 million and $83.3 million for the years ended December 31, 2013, 2012 and 2011, respectively. LETTERS OF CREDIT The Company had access to certain letter of credit agreements totaling $5,450.0 million in letter of credit capacity from various banks, either directly with the bank or indirectly through letters of credit available to the Holding Company for the benefit of the Company and certain other affiliates of the Holding Company. At December 31, 2013, the Company had $802.0 million in outstanding letters of credit. The letters of credit were used to collateralize assumed liabilities. Letters of credit outstanding as of December 31, 2013 were as follows: [Enlarge/Download Table] USED BY USED BY REMAINING BORROWER(S) EXPIRATION CAPACITY THE COMPANY AFFILIATES UNUSED ----------------------------- ------------------ ------------ ----------- ---------- ------------ (IN THOUSANDS) Exeter....................... December 2027 (1) $ 650,000 $ 600,000 $ -- $ 50,000 Holding Company and MetLife Funding, Inc............... September 2017 (1) 1,000,000 -- 59,000 941,000 Holding Company and MetLife Funding, Inc............... August 2016 3,000,000 2,000 130,789 2,867,211 Exeter, Holding Company & Missouri Reinsurance, Inc.. June 2016 500,000 -- 490,000 10,000 Holding Company.............. August 2014 300,000 200,000 100,000 -- ------------ ---------- ---------- ------------ Total....................... $ 5,450,000 $ 802,000 $ 779,789 $ 3,868,211 ============ ========== ========== ============ -------- (1)The Holding Company is a guarantor under this agreement. 9. STOCKHOLDER'S EQUITY Effective October 1, 2013 in conjunction with the Company's redomestication to Delaware the stockholder's equity was restructured. F-59
N-4506th Page of 530TOC1stPreviousNextBottomJust 506th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 9. STOCKHOLDER'S EQUITY (CONTINUED) Information regarding the restructure was as follows at: [Download Table] DECEMBER 31, --------------------- 2013 2012 ---------- ---------- COMMON STOCK Shares authorized................ 13,875,000 14,125,000 Shares issued.................... 13,466,000 13,466,000 Shares outstanding............... 13,466,000 13,466,000 Par value per share.............. $0.01 $1.00 DECEMBER 31, --------------------- 2013 2012 ---------- ---------- PREFERRED STOCK Shares authorized................ 250,000 200,000 Shares issued.................... 200,000 200,000 Shares outstanding............... 200,000 200,000 Par value per share.............. $0.01 $1.00 Liquidation preference per share. $10,000 $10,000 PREFERRED STOCK On September 27, 2012, the Company issued to the Holding Company 75,000 shares of 7.69% Series A non-cumulative perpetual preferred stock in exchange for the assumption of $750.0 million of the Company's senior notes. See Note 8. On December 19, 2012, the Company issued to the Holding Company 125,000 shares of 7.75% Series A non-cumulative perpetual preferred stock in exchange for the assumption of $1,250.0 million of the Company's senior notes. See Note 8. EQUITY Under Delaware Law, the Company is required to maintain minimum capital of $250 thousand. The Company was in compliance with this requirement at December 31, 2013. Under the Law, the Company was required to maintain net worth of $240 thousand. The Company was in compliance with this requirement at September 30, 2013 (prior to redomestication to Delaware) and December 31, 2012. During the year ended December 31, 2013, the Company received no capital contributions from the Holding Company. The Company received capital contributions of $800.0 million and $673.0 million in cash from the Holding Company during the years ended December 31, 2012 and 2011. During the years ended December 31, 2013, 2012 and 2011, the Holding Company paid and contributed, on the Company's behalf, $26.8 million, $33.4 million and $30.9 million, respectively, in the form of letter of credit fees. F-60
N-4507th Page of 530TOC1stPreviousNextBottomJust 507th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 9. STOCKHOLDER'S EQUITY (CONTINUED) DIVIDEND RESTRICTIONS Under the strategic business plan of the company approved by the Delaware Insurance commissioner (the "Commissioner"), the company may not declare or pay dividend in any form to its parent without the approval of the Commissioner and in no event shall the Commissioner grant such approval if the dividend would result in the insolvency or impairment of the Company. The company paid non-cumulative perpetual preferred stock dividend to the Holding company of $132.5 million during the year ended December 31, 2013. The Company did not pay a dividend to the Holding Company during the years ended December 31, 2012 and 2011. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Information regarding changes in the balances of each component of AOCI, net of income tax, was as follows: [Enlarge/Download Table] UNREALIZED FOREIGN INVESTMENT GAINS CURRENCY (LOSSES), NET OF TRANSLATION RELATED OFFSETS ADJUSTMENT TOTAL ---------------- ----------- ----------- (IN THOUSANDS) Balance at December 31, 2010....................... $ 3,341 $ 39,291 $ 42,632 OCI before reclassifications....................... 39,974 (15,751) 24,223 Income tax expense (benefit)....................... (13,991) -- (13,991) ----------- ----------- ----------- OCI before reclassifications, net of income tax... 29,324 23,540 52,864 Amounts reclassified from AOCI..................... (4,425) -- (4,425) Income tax expense (benefit)....................... 1,549 -- 1,549 ----------- ----------- ----------- Amounts reclassified from AOCI, net of income tax. (2,876) -- (2,876) ----------- ----------- ----------- Balance at December 31, 2011....................... 26,448 23,540 49,988 OCI before reclassifications....................... 29,412 13,028 42,440 Income tax expense (benefit)....................... (10,294) -- (10,294) ----------- ----------- ----------- OCI before reclassifications, net of income tax... 45,566 36,568 82,134 Amounts reclassified from AOCI..................... (4,395) -- (4,395) Income tax expense (benefit)....................... 1,538 -- 1,538 ----------- ----------- ----------- Amounts reclassified from AOCI, net of income tax. (2,857) -- (2,857) ----------- ----------- ----------- Balance at December 31, 2012....................... 42,709 36,568 79,277 OCI before reclassifications....................... (54,557) 26,548 (28,009) Income tax expense (benefit)....................... 19,094 -- 19,094 ----------- ----------- ----------- OCI before reclassifications, net of income tax... 7,246 63,116 70,362 Amounts reclassified from AOCI..................... (2,077) -- (2,077) Income tax expense (benefit)....................... 727 -- 727 ----------- ----------- ----------- Amounts reclassified from AOCI, net of income tax. (1,350) -- (1,350) ----------- ----------- ----------- Balance at December 31, 2013....................... $ 5,896 $ 63,116 $ 69,012 =========== =========== =========== F-61
N-4508th Page of 530TOC1stPreviousNextBottomJust 508th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 9. STOCKHOLDER'S EQUITY (CONTINUED) Information regarding amounts reclassified out of each component of AOCI, was as follows: [Enlarge/Download Table] STATEMENT OF OPERATIONS AND AOCI COMPONENTS AMOUNTS RECLASSIFIED FROM AOCI COMPREHENSIVE INCOME (LOSS) LOCATION ------------------------------------------ ------------------------------------------ ------------------------------------ YEARS ENDED DECEMBER 31, ------------------------------------------ 2013 2012 2011 ------------ -------------- -------------- (IN THOUSANDS) Net unrealized investment gains (losses): Net unrealized investment gains (losses)............................... $ 2,066 $ 4,387 $ 4,426 Other net investment gains (losses) Net unrealized investment gains (losses)............................... 11 8 (1) Net investment income ------------ -------------- -------------- Net unrealized investment gains (losses), before income tax........... 2,077 4,395 4,425 Income tax (expense) benefit........... (727) (1,538) (1,549) ------------ -------------- -------------- Net unrealized investment gains (losses), net income tax.............. $ 1,350 $ 2,857 $ 2,876 ============ ============== ============== Total reclassification, net of income tax. $ 1,350 $ 2,857 $ 2,876 ============ ============== ============== 10. OTHER EXPENSES Information on other expenses was as follows: [Download Table] YEARS ENDED DECEMBER 31, -------------------------------- 2013 2012 2011 ---------- ---------- ---------- (IN THOUSANDS) Commissions...................................... $ 11,775 $ 11,116 $ 9,155 Volume-related costs............................. 26,816 33,524 30,929 Affiliated costs of reinsurance.................. 72,517 297 12,073 Capitalization of DAC............................ (2,013) (1,760) (2,955) Amortization of DAC.............................. (21,146) 43,204 31,527 Interest expense on debt and debt issuance costs. 7,714 112,646 83,296 Premium taxes, licenses & fees................... 25 9 34 Professional services............................ 468 858 84 Other............................................ 5,051 6,947 5,740 ---------- ---------- ---------- Total other expenses........................... $ 101,207 $ 206,841 $ 169,883 ========== ========== ========== CAPITALIZATION AND AMORTIZATION OF DAC See Note 2 for additional information on DAC including impacts of capitalization and amortization. AFFILIATED EXPENSES Commissions, volume-related costs and capitalization and amortization of DAC include the impact of affiliated reinsurance transactions. See Notes 4 and 8 for a discussion of affiliated expenses included in the table above. INTEREST EXPENSE ON DEBT See Note 8 for attribution of interest expense by debt issuance. F-62
N-4509th Page of 530TOC1stPreviousNextBottomJust 509th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 11. INCOME TAX The provision for income tax was as follows: [Download Table] YEARS ENDED DECEMBER 31, ------------------------------------ 2013 2012 2011 ---------- -------------- ---------- (IN THOUSANDS) Current: Federal................................... $(267,685) $ (363,174) $ 273,521 Foreign................................... 50 50 -- ---------- -------------- ---------- (267,635) (363,124) 273,521 Deferred: Federal................................... 631,850 (1,092,375) (179,444) ---------- -------------- ---------- Provision for income tax expense (benefit). $ 364,215 $ (1,455,499) $ 94,077 ========== ============== ========== The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported was follows: [Download Table] YEARS ENDED DECEMBER 31, ----------------------------------- 2013 2012 2011 ---------- -------------- --------- (IN THOUSANDS) Tax provision at U.S. statutory rate....... $ 362,691 $ (1,455,439) $ 94,077 Tax effect of: Other...................................... 1,464 -- -- Tax exempt investment income............... -- (60) -- Prior year tax............................. 60 -- -- ---------- -------------- --------- Provision for income tax expense (benefit). $ 364,215 $ (1,455,499) $ 94,077 ========== ============== ========= Deferred income tax represents the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: [Download Table] DECEMBER 31, ------------------------- 2013 2012 ------------ ------------ (IN THOUSANDS) Deferred income tax assets: Benefit, reinsurance and other reserves.. $ 726,167 $ 2,752,083 Investments, including derivatives....... 821,544 -- Net operating loss....................... 67,235 -- Tax credits.............................. 113 -- Other.................................... -- 753 ------------ ------------ 1,615,059 2,752,836 ------------ ------------ Deferred income tax liabilities: Net unrealized investment gains.......... 3,176 22,997 DAC...................................... 35,280 33,288 Investments, including derivatives....... -- 429,480 Other.................................... 47,139 -- ------------ ------------ 85,595 485,765 ------------ ------------ Net deferred income tax asset (liability). $ 1,529,464 $ 2,267,071 ============ ============ F-63
N-4510th Page of 530TOC1stPreviousNextBottomJust 510th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 11. INCOME TAX (CONTINUED) Domestic net operating carryforwards of $192,099 thousand at December 31, 2013 will expire beginning in 2028. Tax credit carryforwards of $113 thousand at December 31, 2013 will expire beginning in 2022. The lack of a valuation allowance reflects management's assessment, based on available information, that it is more likely than not that the deferred income tax asset will be realizable. In 2013, management believes that it is more likely than not that the results of future operations will generate sufficient taxable income to realize gross deferred tax assets. Accordingly, the Company has not recorded a valuation allowance against its gross deferred tax assets. The Company has determined that a valuation allowance against its deferred tax assets is not appropriate as of the year ended December 31, 2012. Prior to October 1, 2013, the Company was registered as an exempted company pursuant to the Companies Law of the Cayman Islands. No local income, profits or capital gains taxes are levied in the Cayman Islands at the current time. As a result, no provision for such taxes is recorded by the Company. Prior to the re-domestication, the Company made an election to be treated as an U.S. Domestic entity under Internal Revenue Code Section ("Sec.") 953(d). The election under Sec. 953(d) is valid through December 31, 2013. The Company joins with the Holding Company and its includable life insurance and non-life insurance subsidiaries in filing a consolidated U.S. federal income tax return in accordance with the provision of the Code. Pursuant to this tax sharing agreement, the amount due from the Holding Company was $196.6 million and $261.7 million at December 31, 2013 and 2012, respectively. The Company files income tax returns with the U.S. federal government and is under continuous examination by the Internal Revenue Service. The Company is no longer subject to U.S. federal income tax examinations for years prior to 2003, with the exception of the period October 31, 2000 through December 31, 2000. The IRS audit cycle for the years 2003 through 2006, which began in April 2010, is expected to conclude in 2014. It is not expected to have a material impact on the financial statements. As of December 31, 2013, the Company had no liability for unrecognized tax benefits. 12. CONTINGENCIES AND COMMITMENTS There is no pending or threatened litigation, claim or assessment against the Company that would constitute a material loss contingency. Various litigation, claims or assessments against the Company may arise in the ordinary course of the Company's business. Liabilities for litigations, claims or assessments are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company regularly reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company's financial statements. Based on information currently known by the Company's management, in its opinion, there are no current legal proceedings, likely to have such an effect. However, it is possible that an adverse outcome in a litigation matter, should such a litigation matter arise in the future, could have a material effect on the Company's net income or cash flows. F-64
N-4511th Page of 530TOC1stPreviousNextBottomJust 511th
EXETER REASSURANCE COMPANY, LTD. NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 13. OTHER RELATED PARTY TRANSACTIONS The Company had net payables to affiliates of $593 thousand and $877 thousand at December 31, 2013 and 2012, respectively. These payables exclude affiliated reinsurance balances discussed in Note 4 and affiliated debt balances discussed in Note 8. See Note 5 for additional related party transactions. 14. SUBSEQUENT EVENTS In anticipation of the Mergers, certain risks formerly reinsured by Exeter were re-directed to affiliates through various forms of transactions. For certain risks that were re-directed in October 2014 and November 2014, the agreement terms included that the initial settlement amounts were to be based upon the reinsurance balances at September 30, 2014. The estimated impacts of these transactions to Exeter were a decrease in cash and invested assets of $2.6 billion, a decrease in future policy benefits of $500 million, a decrease in policyholder account balances of $1.2 billion and a decrease in other policy-related balances of $800 million. Also as a result of these transactions, Exeter recorded an estimated net loss of $100 million during the fourth quarter of 2014. These estimated amounts will be adjusted to actual settlement amounts by January 2015, in accordance with the applicable reinsurance recapture agreements' terms. The Company expects to enter into another affiliated reinsurance transaction on or around November 10, 2014. The estimated impacts, based upon the account balances at September 30, 2014, are a decrease in cash and invested assets of $400 million, a decrease in future policy benefits of $500 million, offset by an increase in other policy-related balances of $100 million. It is likely that the final settlement amounts of these reinsurance transactions, that will consider additional available information, will differ from the estimated amounts and it is possible the differences may be material. F-65
N-4512th Page of 530TOC1stPreviousNextBottomJust 512th
PART C OTHER INFORMATION ITEM 24. FINANCIAL STATEMENTS AND EXHIBITS [Enlarge/Download Table] a. Financial Statements --------------------------------------------------------------------------------------------------- The financial statements and financial highlights of each of the Sub-Accounts of the Separate Account are included in Part B hereof and include: 1. Report of Independent Registered Public Accounting Firm 2. Statements of Assets and Liabilities as of December 31, 2013 3. Statements of Operations for the year ended December 31, 2013 4. Statements of Changes in Net Assets for the years ended December 31, 2013 and 2012 5. Notes to the Financial Statements The unaudited pro forma condensed combined financial statements of MetLife Insurance Company of Connecticut are included in Part B hereof and include: 1. Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31, 2013 2. Unaudited Pro Forma Condensed Combined Statement of Operations for the year end December 31, 2013 3. Unaudited Pro Forma Condensed Combined Statement of Operations for the year end December 31, 2012 4. Unaudited Pro Forma Condensed Combined Statement of Operations for the year end December 31, 2011 5. Notes to the Unaudited Pro Forma Condensed Combined Financial Statements The consolidated financial statements and financial statement schedules of MetLife Insurance Company of Connecticut and subsidiaries are included in Part B hereof and include: 1. Report of Independent Registered Public Accounting Firm 2. Consolidated Balance Sheets as of December 31, 2013 and 2012 3. Consolidated Statements of Operations for the years ended December 31, 2013, 2012 and 2011 4. Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2013, 2012 and 2011 5. Consolidated Statements of Stockholders' Equity for the years ended December 31, 2013, 2012 and 2011 6. Consolidated Statements of Cash Flows for the years ended December 31, 2013, 2012 and 2011 7. Notes to the Consolidated Financial Statements 8. Financial Statement Schedules The financial statements of MetLife Investors Insurance Company are included in Part B hereof and include: 1. Independent Auditors' Report 2. Balance Sheets as of December 31, 2013 and 2012 3. Statements of Operations for the years ended December 31, 2013, 2012 and 2011 4. Statements of Comprehensive Income (Loss) for the years ended December 31, 2013, 2012 and 2011 5. Statements of Stockholder's Equity for the years ended December 31, 2013, 2012 and 2011 6. Statements of Cash Flows for the years ended December 31, 2013, 2012 and 2011 7. Notes to the Financial Statements The financial statements of Exeter Reassurance Company, Ltd. are included in Part B hereof and include: 1. Independent Auditors' Report 2. Balance Sheets as of December 31, 2013 and 2012 3. Statements of Operations for the years ended December 31, 2013, 2012 and 2011
N-4513th Page of 530TOC1stPreviousNextBottomJust 513th
[Enlarge/Download Table] 4. Statements of Comprehensive Income (Loss) for the years ended December 31, 2013, 2012 and 2011 5. Statements of Stockholder's Equity for the years ended December 31, 2013, 2012 and 2011 6. Statements of Cash Flows for the years ended December 31, 2013, 2012 and 2011 7. Notes to the Financial Statements [Enlarge/Download Table] b. Exhibits ----- 1. (i) Certification of Restated Resolution of Board of Directors of the Metlife Investors USA Insurance Company authorizing the establishment of the Separate Account (adopted May 18, 2004) (3) (ii) Resolutions of the Board of Directors of MetLife Investors USA Insurance Company (including Agreement and Plan of Merger attached as Exhibit B to the resolutions) (adopted August 13, 2014) (filed herewith) (iii) Resolutions of the Board of Directors of MetLife Insurance Company of Connecticut authorizing the acceptance of the Separate Account (adopted September 17, 2014) (filed herewith) 2. Not Applicable. 3. (i)(a) Distribution and Principal Underwriting Agreement between MetLife Insurance Company of Connecticut and MetLife Investors Distribution Company (effective November 24, 2009) (i)(b) Amendment to Distribution and Principal Underwriting Agreement between MetLife Insurance Company of Connecticut and MetLife Investors Distribution Company (dated August 18, 2014) (filed herewith) (ii) Form of Enterprise Selling Agreement 09-12 (MetLife Investors Distribution Company Sales Agreement) (7) 4. (i) Form of Individual Flexible Purchase Payment Deferred Variable Annuity Contract (1) (ii) Death Benefit Rider - Principal Protection (1) (iii) Waiver of Withdrawal Charge for Nursing Home or Hospital Confinement Rider (1) (iv) Waiver of Withdrawal Charge for Terminal Illness Rider (1) (v) Unisex Annuity Rates Rider (1) (vi) Endorsement (Name Change - effective March 1, 2001. MetLife Investors USA Insurance Company; formerly Security First Life Insurance Company) MI - 2023 (2) (vii) Individual Retirement Annuity Endorsement 8023.1 (9/02) (3) (viii) Roth Individual Retirement Annuity Endorsement 9024.1 (9/02) (3) (ix) Simple Individual Retirement Annuity Endorsement 8276 (9/02) (3) (x) Designated Beneficiary Non-Qualified Annuity Endorsement MLIU-NQ-1 (11/05)-I (4) (xi) Fixed Account Rider 8012 (11/00) (5) (xii) Form of Spousal Continuation Endorsement MLIU-GMIB (2/10)-E (6) (xiii) Non-qualified Annuity Endorsement MLIU-NQ (11/04) - I (8) (xiv) Form of Contract Schedule [IOVA (L-Share)] 8028-5 (6/06) (8) (xv) Form of Contract Schedule [IOVA (C-Share)] 8028-5 (6/06) (8) (xvi) Merger Endorsement (effective November 14, 2014) (MetLife Investors USA Insurance Company merged into MetLife Insurance Company USA) 6-E118-14 (filed herewith) 5. Form of Variable Annuity Application IOVA-APP (06/14) MIPS (11/14) Fs (filed herewith) 6. (i) Copy of Certificate of Incorporation of the Company and Certificate of Amendment (effective November 14, 2014) (filed herewith) (ii) Copy of the Bylaws of the Company (filed herewith) 7. Not Applicable. 8. (i)(a) Participation Agreement among Met Investors Series Trust, Met Investors Advisory, LLC, MetLife Investors Distribution Company, The Travelers Insurance Company and The Travelers Life and Annuity Company (effective 11-01-05) (9)
N-4514th Page of 530TOC1stPreviousNextBottomJust 514th
[Enlarge/Download Table] (i)(b) First Amendment to Participation Agreement among Met Investors Series Trust, MetLife Advisers, LLC, MetLife Investors Distribution Company and MetLife Insurance Company of Connecticut (effective 05-01-09) (10) (i)(c) Amendment to Participation Agreement among Met Investors Series Trust, MetLife Advisers, LLC, MetLife Investors Distribution Company and MetLife Insurance Company of Connecticut, et al. (effective 4-30-10) (10) (i)(d) Amendment to Participation Agreement with Met Investors Series Trust (effective November 17, 2014) (filed herewith) (ii)(a) Participation Agreement among Metropolitan Series Fund, Inc., MetLife Advisers, LLC, MetLife Investors Distribution Company, MetLife Insurance Company of Connecticut (effective 08-31-07) (11) (ii)(b) Amendment to Participation Agreement among Metropolitan Series Fund, Inc., MetLife Advisers, LLC, MetLife Investors Distribution Company and MetLife Insurance Company of Connecticut, et al. (effective 04-30-10) (10) (iii)(a) Fund Participation Agreement among The Travelers Insurance Company, The Travelers Life and Annuity Company, American Variable Insurance Series, American Funds Distributors, Inc. and Capital Research and Management Company (effective 10-01-99) (12) (iii)(b) Amendment to the Participation Agreement between American Funds Insurance Series, Capital Research and Management Company and MetLife Insurance Company of Connecticut, et al. (effective 04-30-10) (13) (iii)(c) Amendment to the Participation Agreement with American Funds Insurance Series (effective November 17, 2014 (filed herewith) (iv) Participation Agreement among BlackRock Variable Series Funds, Inc. BlackRock Investments, LLC and MetLife Insurance Company USA (effective November 17, 2014) (filed herewith) (v) Participation Agreement Among Ivy Funds Variable Insurance Portfolios, Waddell & Reed, Inc. and MetLife Insurance Company USA (effective November 17, 2014) (filed herewith) (vi)(a) Participation Agreement among Legg Mason Partners Variable Equity Trust, Legg Mason Partners Variable Income Trust, Legg Mason Investors Services, LLC, Legg Mason Partners Fund Advisor, LLC and MetLife Insurance Company of Connecticut (effective 01-01-09) (12) (vi)(b) Amendment to Participation Agreement among Legg Mason Partners Variable Equity Trust, Legg Mason Partners Variable Income Trust, Legg Mason Investors Services, LLC, Legg Mason Partners Fund Advisor, LLC and MetLife Insurance Company of Connecticut, et al. (effective 04-30-10) (14) (vi)(c) Amendment to Participation Agreement with Legg Mason Partners Variable Equity Trust (and Legg Mason Partners Variable Income Trust) (effective November 14, 2014) (filed herewith) (vii)(a) Participation Agreement among The Travelers Insurance Company, The Travelers Life and Annuity Company, PIMCO Variable Insurance Trust and PIMCO Funds Distributors LLC dated May 1, 2001 and amendments. (12) (vii)(b) Amendment dated April 18, 2011 to the PIMCO Variable Insurance Trust Participation Agreement (15) (vii)(c) Amendment to Participation Agreement with PIMCO Variable Insurance Trust (effective November 14, 2014) (filed herewith) (viii)(a) Amended and Restated Participation Agreement among The Travelers Insurance Company, The Travelers Life and Annuity Company, The Universal Institutional Fund, Inc., Morgan Stanley Distribution, Inc. and Morgan Stanley Investment Management Inc. dated May 1, 2005 and amendment (12) (viii)(b) Amendment to Participation Agreement with The Universal Institutional Funds, Inc. (effective November 14, 2014) (filed herewith) (ix) Participation Agreement with Van Eck VIP Trust, Van Eck Securities Corporation, Van Eck Associates Corporation and MetLife Insurance Company USA (effective November 17, 2014) (filed herewith) 9. Opinion of Counsel (filed herewith) 10. Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP) (filed herewith) 11. Not Applicable. 12. Not Applicable. 13. Powers of Attorney for Eric T. Steigerwalt, Elizabeth M. Forget, Gene L. Lunman, Peter M. Carlson and Anant Bhalla (filed herewith)
N-4515th Page of 530TOC1stPreviousNextBottomJust 515th
[Enlarge/Download Table] (1) incorporated herein by reference to Registrant's Form N-4 (File Nos. 333-54464 and 811-03365) filed electronically on January 26, 2001. (2) incorporated herein by reference to Registrant's Post-Effective Amendment No. 1 to Form N-4 (File Nos. 333-54464 and 811-03365) filed electronically on April 13, 2001. (3) incorporated herein by reference to Registrant's Post-Effective Amendment No. 6 to Form N-4 (File Nos. 333-54464 and 811-03365) filed electronically on July 15, 2004. (4) incorporated herein by reference to Registrant's Post-Effective Amendment No. 13 to Form N-4 (File Nos. 333-54464 and 811-03365) filed electronically on September 9, 2005. (5) incorporated herein by reference to Registrant's Post-Effective Amendment No. 18 to Form N-4 (File Nos. 333-54466 and 811-03365) filed electronically on April 16, 2007. (6) incorporated herein by reference to Registrant's Post-Effective Amendment No. 35 to Form N-4 (File Nos. 333-54466 and 811-03365) filed electronically on April 22, 2010. (7) incorporated herein by reference to Registrant's Post-Effective Amendment No. 12 to Form N-4 (File Nos. 333-176374 and 811-03365) filed electronically on April 10, 2013. (8) incorporated herein by reference to Registrant's N-4 (Files Nos. 333-197933 and 811-03365) filed electronically on August 8, 2014. (9) incorporated herein by reference to The Travelers Fund ABD for Variable Annuities' Post-Effective Amendment No. 14 to Form N-4 (File Nos. 033-65343 and 811-07465) filed electronically on April 6, 2006. (10) incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities' Post-Effective Amendment No. 4 to Form N-4 (File Nos. 333-152189 and 811-21262) filed electronically on April 4, 2012. (11) incorporated herein by reference to MetLife of CT Separate Account Nine for Variable Annuities' Post-Effective Amendment No. 11 to Form N-4 (File Nos. 333-65926 and 811-09411) filed electronically on October 31, 2007. (12) incorporated herein by reference to MetLife of CT Fund UL III for Variable Life's Post-Effective Amendment No. 15 to Form N-6 (File Nos. 333-71349 and 811-09215) filed electronically on April 9, 2009. (13) incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities' Post-Effective Amendment No. 3 to Form N-4 (File Nos. 333-152194 and 811-21262) filed electronically on April 5, 2011. (14) incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities' Post-Effective Amendment No. 3 to Form N-4 (Files Nos. 333-152189 and 811-21262) filed electronically on April 5, 2011. (15) incorporated herein by reference to MetLife of CT Fund UL III for Variable Life's Post-Effective Amendment No. 18 to Form N-6 (File Nos. 333-71349 and 811-09215) filed electronically on April 5, 2012. ITEM 25. DIRECTORS AND OFFICERS OF THE DEPOSITOR The following are the Officers and Directors who are engaged directly or indirectly in activities relating to the Registrant or the variable annuity contracts offered by the Registrant and the executive officers of the Company: [Enlarge/Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ------------------------------------- --------------------------------------------------------------- Eric T. Steigerwalt Director, Chairman of the Board, President and Chief Executive Gragg Building Officer 11225 North Community House Road Charlotte, NC 28277 Elizabeth M. Forget Director and Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277
N-4516th Page of 530TOC1stPreviousNextBottomJust 516th
[Enlarge/Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ------------------------------------- -------------------------------------------------------- Gene L. Lunman Director and Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Ricardo A. Anzaldua Executive Vice President and General Counsel 1095 Avenue of the Americas New York, NY 10036 Peter M. Carlson Executive Vice President and Chief Accounting Officer 1095 Avenue of the Americas New York, NY 10036 Steven J. Goulart Executive Vice President and Chief Investment Officer 10 Park Avenue Morristown, NJ 07962 Robin Lenna Executive Vice President 200 Park Avenue 12th Floor New York, NY 10166 Anant Bhalla Senior Vice President and Chief Financial Officer Gragg Building 11225 North Community House Road Charlotte, NC 28277 Marlene B. Debel Senior Vice President and Treasurer 1095 Avenue of the Americas New York, NY 10036 Jason P. Manske Senior Vice President and Chief Hedging Officer 10 Park Avenue Morristown, NJ 07962 Roberto Baron Senior Vice President 1095 Avenue of the Americas New York, NY 10036 Steven J. Brash Senior Vice President 277 Park Avenue 46th Floor New York, NY 10172 Adam M. Hodes Senior Vice President 1095 Avenue of the Americas New York, NY 10036 Stewart M. Ashkenazy Vice President, Senior Actuary and Illustration Actuary 1095 Avenue of the Americas New York, NY 10036 S. Peter Headley Vice President and Assistant Secretary 10801 Mastin Boulevard Suite 930 Overland Park, KS 66210 Andrew Kaniuk Vice President and Senior Actuary 501 Route 22 Bridgewater, NJ 08807 Christopher A. Kremer Vice President and Actuary One Financial Center 21st Floor Boston, MA 02111 Lisa S. Kuklinski Vice President and Senior Actuary 1095 Avenue of the Americas New York, NY 10036
N-4517th Page of 530TOC1stPreviousNextBottomJust 517th
[Enlarge/Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ------------------------------------- ---------------------------------------------- Enid M. Reichert Vice President and Actuary 501 Route 22 Bridgewater, NJ 08807 Mark S. Reilly Vice President and Illustration Actuary Woodward Building 11215 North Community House Road Charlotte, NC 28277 Steven G. Sorrentino Vice President, Actuary and Appointed Actuary 501 Route 22 Bridgewater, NJ 08807 Marian J. Zeldin Vice President and Actuary 501 Route 22 Bridgewater, NJ 08807 Scott E. Andrews Vice President 4700 Westown Pkwy. Suite 200 West Des Moines, IA 50266 Andrew T. Aoyama Vice President 200 Park Avenue 12th Floor New York, NY 10166 Grant Barrans Vice President 600 North King Street Wilmington, DE 19801 Henry W. Blaylock Vice President 200 Park Avenue 12th Floor New York, NY 10166 Timothy J. Brown Vice President 501 Route 22 Bridgewater, NJ 08807 Mark J. Davis Vice President 501 Route 22 Bridgewater, NJ 08807 Lynn A. Dumais Vice President 18210 Crane Nest Drive Tampa, FL 33647 Geoffrey A. Fradkin Vice President 501 Route 22 Bridgewater, NJ 08807 Judith A. Gulotta Vice President 10 Park Avenue Morristown, NJ 07962 Jeffrey P. Halperin Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Regynald Heurtelou Vice President 334 Madison Avenue Morristown, NJ 07960 Gregory E. Illson Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277
N-4518th Page of 530TOC1stPreviousNextBottomJust 518th
[Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ------------------------------------- ------------------------------------- John J. Iwanicki Vice President 18210 Crane Nest Drive Tampa, FL 33647 Karen A. Johnson Vice President One Financial Center 21st Floor Boston, MA 02111 Derrick L. Kelson Vice President 1200 Abernathy Road Suite 1400 Atlanta, GA 30328 James W. Koeger Vice President 13045 Tesson Ferry Road St. Louis, MO 63128 John P. Kyne, III Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Cynthia A. Mallet Kosakowski Vice President One Financial Center 21st Floor Boston, MA 02111 Timothy J. McLinden Vice President 277 Park Avenue 46th Floor New York, NY 10172 James J. Reilly Vice President One Financial Center 21st Floor Boston, MA 02111 Thomas J. Schuster Vice President 200 Park Avenue 12th Floor New York, NY 10166 Robert L. Staffier, Jr. Vice President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Nan D. Tecotzky Vice President 200 Park Avenue 12th Floor New York, NY 10166 Mark H. Wilsmann Vice President 10 Park Avenue Morristown, NJ 07962 Jacob M. Jenkelowitz Secretary 1095 Avenue of the Americas New York, NY 10036 ITEM 26. PERSONS CONTROLLED BY OR UNDER COMMON CONTROL WITH THE DEPOSITOR OR REGISTRANT The Registrant is a separate account of MetLife Insurance Company USA under Delaware insurance law. MetLife Insurance Company USA is a wholly-owned subsidiary of MetLife, Inc., a publicly traded company. The following outline indicates those entities that are controlled by MetLife, Inc. or are under the common control of MetLife, Inc. No person is controlled by the Registrant.
N-4519th Page of 530TOC1stPreviousNextBottomJust 519th
ORGANIZATIONAL STRUCTURE OF METLIFE, INC. AND SUBSIDIARIES AS OF June 30, 2014 The following is a list of subsidiaries of MetLife, Inc. updated as of June 30, 2014. Those entities which are listed at the left margin (labeled with capital letters) are direct subsidiaries of MetLife, Inc. Unless otherwise indicated, each entity which is indented under another entity is a subsidiary of that other entity and, therefore, an indirect subsidiary of MetLife, Inc. Certain inactive subsidiaries have been omitted from the MetLife, Inc. organizational listing. The voting securities (excluding directors' qualifying shares, if any) of the subsidiaries listed are 100% owned by their respective parent corporations, unless otherwise indicated. The jurisdiction of domicile of each subsidiary listed is set forth in the parenthetical following such subsidiary. A. MetLife Group, Inc. (NY) B. MetLife Home Loans LLC (DE) C. Exeter Reassurance Company, Ltd. (DE) D. Metropolitan Tower Life Insurance Company (DE) 1. EntreCap Real Estate II LLC (DE) a) PREFCO Dix-Huit LLC (CT) b) PREFCO X Holdings LLC (CT) c) PREFCO Ten Limited Partnership (CT) - a 99.9% limited partnership interest of PREFCO Ten Limited Partnership is held by EntreCap Real Estate II LLC and 0.1% general partnership is held by PREFCO X Holdings LLC. d) PREFCO Vingt LLC (CT) e) PREFCO Twenty Limited Partnership (CT) - a 99% limited partnership interest of PREFCO Twenty Limited Partnership is held by EntreCap Real Estate II LLC and 1% general partnership is held by PREFCO Vingt LLC. 2. Plaza Drive Properties, LLC (DE) 3. MTL Leasing, LLC (DE) a) PREFCO IX Realty LLC (CT) b) PREFCO XIV Holdings LLC (CT) c) PREFCO Fourteen Limited Partnership (CT) - a 99.9% limited partnership interest of PREFCO Fourteen Limited Partnership is held by MTL Leasing, LLC and 0.1% general partnership is held by PREFCO XIV Holdings LLC. d) 1320 Venture LLC (DE) i) 1320 Owner LP (DE) - a 99.9% limited partnership of 1320 Owner LP is held by 1320 Venture LLC and 0.1% general partnership is held by 1320 GP LLC. e) 1320 GP LLC (DE) E. MetLife Chile Inversiones Limitada (Chile) - 70.4345328853% of MetLife Chile Inversiones Limitada is owned by MetLife, Inc., 26.6071557459% by American Life Insurance Company ("ALICO"), 2.9583113284% is owned by Inversiones MetLife Holdco Dos Limitada and 0.0000000404% is owned by Natilportem Holdings, Inc. 1. MetLife Chile Seguros de Vida S.A. (Chile) - 99.9969% of MetLife Chile Seguros de Vida S.A. is held by MetLife Chile Inversiones Limitada and 0.0031% by International Technical and Advisory Services Limited ("ITAS"). a) MetLife Chile Administradora de Mutuos Hipotecarios S.A. (Chile) - 99.99% of MetLife Chile Administradora de Mutuos Hipotecarios S.A. is held by MetLife Chile Seguros de Vida S.A. and 0.01% is held by MetLife Chile Inversiones Limitada. 2. Legal Chile S.A. (Chile) - 51% of Legal Chile S.A. is owned by MetLife Chile Inversiones Limitada and the remaining interest is owned by a third party. a) Legagroup S.A. (Chile) - 99% of Legagroup S.A. is owned by Legal Chile S.A. and the remaining interest is owned by a third party. 3. Inversiones MetLife Holdco Tres Limitada (Chile) - 99.9% of Inversiones MetLife Holdco Tres Limitada is owned by MetLife Chile Inversiones Limitada and 0.1% is owned by Inversiones MetLife Holdco Dos Limitada. a) MetLife Chile Acquisition Co. S.A. (Chile) - 45% of MetLife Chile Acquisition Co. S.A. is owned by Inversiones MetLife Holdco Dos Limitada, 45% is owned by Inversiones MetLife Holdco Tres Limitada and 10% is owned by MetLife Chile Inversiones Limitada. i) Inversiones Previsionales S.A. (Chile) - 99.999% of Inversiones Previsionales S.A. is owned by MetLife Chile Acquisition Co. S.A. and 0.001% is owned by Inversiones MetLife Holdco Tres Limitada. aa) AFP Provida S.A. (Chile) - 51.62% of AFP Provida S.A. is owned by Inversiones Previsionales S.A., 21.97% is owned indirectly (by means of ADR) by MetLife Chile Acquisition Co. S.A., 17.79% is owned directly by MetLife Chile Acquisition Co. S.A. and the remainder is owned by third parties. 1) Provida Internacional S.A. (Chile) - 99.99% of Provida Internacional S.A. is owned by AFP Provida S.A. and 0.01% by Inversiones Previsionales S.A. ii) AFP Genesis Administradora de Fondos y Fidecomisos S.A. (Ecuador) - 99.9997% of AFP Genesis Administradora de Fondos y Fidecomisos S.A. is owned by Provida Internacional S.A. and 0.0003% is owned by Inversiones Previsionales S.A. 4. MetLife Chile Seguros Generales S.A. (Chile) - 99.9% of MetLife Chile Seguros Generales, S.A. is owned by MetLife Chile Inversiones Limitada and 0.1% is owned by ITAS. F. MetLife Securities, Inc. (DE) G. Enterprise General Insurance Agency, Inc. (DE) 1
N-4520th Page of 530TOC1stPreviousNextBottomJust 520th
H. Metropolitan Property and Casualty Insurance Company (RI) 1. Metropolitan General Insurance Company (RI) 2. Metropolitan Casualty Insurance Company (RI) 3. Metropolitan Direct Property and Casualty Insurance Company (RI) 4. MetLife Auto & Home Insurance Agency, Inc. (RI) 5. Metropolitan Group Property and Casualty Insurance Company (RI) a) Metropolitan Reinsurance Company (U.K.) Limited (United Kingdom) 6. Metropolitan Lloyds, Inc. (TX) a) Metropolitan Lloyds Insurance Company of Texas (TX)- Metropolitan Lloyds Insurance Company of Texas, an affiliated association, provides automobile, homeowner and related insurance for the Texas market. It is an association of individuals designated as underwriters. Metropolitan Lloyds, Inc., a subsidiary of Metropolitan Property and Casualty Insurance Company, serves as the attorney-in-fact and manages the association. 7. Economy Fire & Casualty Company (IL) a) Economy Preferred Insurance Company (IL) b) Economy Premier Assurance Company (IL) I. MetLife Investors Insurance Company (MO) J. First MetLife Investors Insurance Company (NY) K. Newbury Insurance Company, Limited (DE) L. MetLife Investors Group, Inc. (DE) 1. MetLife Investors Distribution Company (MO) 2. MetLife Advisers, LLC (MA) 2
N-4521st Page of 530TOC1stPreviousNextBottomJust 521st
M. MetLife International Holdings, Inc. (DE) 1. MetLife Mexico Cares, S.A. de C.V. (Mexico) a) Fundacion MetLife Mexico, A.C. (Mexico) 2. Natiloportem Holdings, Inc. (DE) a) Excelencia Operativa y Tecnologica, S.A. de C.V. (Mexico) i) MLA Comercial, S.A. de C.V. (Mexico) 99% is owned by Excelencia Operativa y Tecnologica, S.A. de C.V. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. ii) MLA Servicios, S.A. de C.V. (Mexico) 99% is owned by Excelencia Operativa y Tecnologica, S.A. de C.V. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. 3. PNB MetLife India Insurance Company Limited (India)- 26% is owned by MetLife International Holdings, Inc. and 74% is owned by third parties. 4. Metropolitan Life Insurance Company of Hong Kong Limited (Hong Kong)- 99.99935% is owned by MetLife International Holdings, Inc. and 0.00065% is owned by Natiloporterm Holdings, Inc. 5. MetLife Seguros S.A. (Argentina)- 79.3196% is owned by MetLife International Holdings, Inc., 2.6753% is owned by Natiloportem Holdings, Inc., 16.2046% by ALICO and 1.8005% by ITAS. 6. Metropolitan Life Seguros e Previdencia Privada S.A. (Brazil)- 66.662% is owned by MetLife International Holdings, Inc., 33.337% is owned by MetLife Worldwide Holdings, Inc. and 0.001% is owned by Natiloportem Holdings, Inc. 7. MetLife Global, Inc. (DE) 8. MetLife Administradora de Fundos Multipatrocinados Ltda. (Brazil) - 99.99998% of MetLife Administradora de Fundos Multipatrocinados Ltda. is owned by MetLife International Holdings, Inc. and 0.00002% by Natiloportem Holdings, Inc. 9. MetLife Services Limited (United Kingdom) 10. MetLife Seguros de Retiro S.A. (Argentina) - 95.5883% is owned by MetLife International Holdings, Inc., 3.1102% is owned by Natiloportem Holdings, Inc., 1.3014% by ALICO and 0.0001% by ITAS. 11. Best Market S.A. (Argentina) - 5% of the shares are held by Natiloportem Holdings, Inc. and 95% is owned by MetLife International Holdings Inc. 12. Compania Inversora MetLife S.A. (Argentina) - 95.46% is owned by MetLife International Holdings, Inc. and 4.54% is owned by Natiloportem Holdings, Inc. a) MetLife Servicios S.A. (Argentina) - 18.87% of the shares of MetLife Servicios S.A. are held by Compania Inversora MetLife S.A., 79.88% is owned by MetLife Seguros S.A., 0.99% is held by Natiloportem Holdings, Inc. and 0.26% is held by MetLife Seguros de Retiro S.A. 13. MetLife Worldwide Holdings, Inc. (DE) a) MetLife Direct Co., LTD. (Japan) b) MetLife Limited (Hong Kong) 14. MetLife International Limited, LLC (DE) 15. MetLife Planos Odontologicos Ltda. (Brazil) - 99.999% is owned by MetLife International Holdings, Inc. and 0.001% is owned by Natiloportem Holdings, Inc. 16. MetLife Ireland Holdings One Limited (Ireland) a) MetLife Global Holdings Corporation S.A. de C.V. (Mexico/Ireland) - 98.9% is owned by MetLife Ireland Holdings One Limited and 1.1% is owned by MetLife International Limited, LLC. i) MetLife Ireland Treasury Limited (Ireland) a) MetLife General Insurance Limited (Australia) b) MetLife Insurance Limited (Australia) - 91.16468% of MetLife Insurance Limited (Australia) is owned by MetLife Ireland Treasury Limited and 8.83532% is owned by MetLife Global Holdings Corp. S.A. de C.V. 1) The Direct Call Centre PTY Limited (Australia) 2) MetLife Investments PTY Limited (Australia) aa) MetLife Insurance and Investment Trust (Australia) - MetLife Insurance and Investment Trust is a trust vehicle, the trustee of which is MetLife Investments PTY Limited ("MIPL"). MIPL is a wholly owned subsidiary of MetLife Insurance Limited. ii) Metropolitan Global Management, LLC (DE/Ireland) - 99.7% is owned by MetLife Global Holdings Corporation S.A. de C.V. and 0.3% is owned by MetLife International Holdings, Inc. a) MetLife Pensiones Mexico S.A. (Mexico)- 97.4738% is owned by Metropolitan Global Management, LLC and 2.5262% is owned by MetLife International Holdings, Inc. b) MetLife Mexico Servicios, S.A. de C.V. (Mexico) - 98% is owned by Metropolitan Global Management, LLC and 2% is owned by MetLife International Holdings, Inc. c) MetLife Mexico S.A. (Mexico)- 99.050271% is owned by Metropolitan Global Management, LLC and 0.949729% is owned by MetLife International Holdings, Inc. 1) MetLife Afore, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Mexico S.A. and 0.01% is owned by MetLife Pensiones Mexico S.A. aa) Met1 SIEFORE, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. bb) Met2 SIEFORE, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. cc) MetA SIEFORE Adicional, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. dd) Met3 SIEFORE Basica, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ee) Met4 SIEFORE, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ff) Met5 SIEFORE, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. 2) ML Capacitacion Comercial S.A. de C.V.(Mexico) - 99% is owned by MetLife Mexico S.A. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. d) MetLife Saengmyoung Insurance Co. Ltd. (also known as MetLife Insurance Company of Korea Limited) (South Korea)- 14.64% is owned by MetLife Mexico, S.A. and 85.36% is owned by Metropolitan Global Management, LLC. e) GlobalMKT S.A. (Uruguay) 17. MetLife Asia Limited (Hong Kong) 18. AmMetLife Insurance Berhad (Malaysia) - 50.000001% of AmMetLife Insurance Berhad is owned by MetLife International Holdings, Inc. and the remainder is owned by a third party. 19. AmMetLife Takaful Berhad (Malaysia) - 49.999999% of AmMetLife Takaful Berhad is owned by MetLife International Holdings, Inc. and the remainder is owned by a third party. N. Metropolitan Life Insurance Company ("MLIC") (NY) 1. 334 Madison Euro Investments, Inc. (DE) 2. St. James Fleet Investments Two Limited (Cayman Islands) a) Park Twenty Three Investments Company (United Kingdom) i) Convent Station Euro Investments Four Company (United Kingdom) aa) OMI MLIC Investments Limited (Cayman Islands) 3. CRB Co., Inc. (MA) 4. MLIC Asset Holdings II LLC (DE) a) El Conquistador MAH II LLC (DE) b) Mansell Office LLC (DE) - 73.0284% of Mansell Office LLC is owned by MLIC Asset Holdings II LLC and 26.9716% is owned by MLIC CB Holdings LLC. c) Mansell Retail LLC (DE) - 73.0284% of Mansell Retail LLC is owned by MLIC Asset Holdings II LLC and 26.9716% is owned by MLIC CB Holdings LLC. 3
N-4522nd Page of 530TOC1stPreviousNextBottomJust 522nd
5. CC Holdco Manager, LLC (DE) 6. Alternative Fuel I, LLC (DE) 7. Transmountain Land & Livestock Company (MT) 8. MetPark Funding, Inc. (DE) 9. HPZ Assets LLC (DE) 10. Missouri Reinsurance, Inc. (Cayman Islands) 11. Metropolitan Tower Realty Company, Inc. (DE) a) Midtown Heights, LLC (DE) 12. MetLife Real Estate Cayman Company (Cayman Islands) 13. MetLife RC SF Member, LLC (DE) 14. MetLife Private Equity Holdings, LLC (DE) 15. 23rd Street Investments, Inc. (DE) a) MetLife Capital Credit L.P. (DE)- 1% General Partnership interest is held by 23rd Street Investments, Inc. and 99% Limited Partnership interest is held by Metropolitan Life Insurance Company. b) MetLife Capital, Limited Partnership (DE)- 1% General Partnership interest is held by 23rd Street Investments, Inc. and 99% Limited Partnership interest is held by Metropolitan Life Insurance Company. i) Long Island Solar Farm, LLC ("LISF")(DE) - 9.61% membership interest is held by MetLife Renewables Holding, LLC and 90.39% membership interest is held by LISF Solar Trust in which MetLife Capital Limited Partnership has 100% beneficial interest. 16. Hyatt Legal Plans, Inc. (DE) a) Hyatt Legal Plans of Florida, Inc. (FL) 17. MetLife Holdings, Inc. (DE) a) MetLife Credit Corp. (DE) b) MetLife Funding, Inc. (DE) 4
N-4523rd Page of 530TOC1stPreviousNextBottomJust 523rd
18. MetLife Investments Asia Limited (Hong Kong) 19. MetLife Investments Limited (United Kingdom)- 23rd Street Investments, Inc. holds one share of MetLife Investments Limited. 20. MetLife Latin America Asesorias e Inversiones Limitada (Chile)- 23rd Street Investments, Inc. holds 0.01% of MetLife Latin America Asesorias e Inversiones Limitada. 21. New England Life Insurance Company (MA) a) New England Securities Corporation (MA) 22. General American Life Insurance Company (MO) a) GALIC Holdings LLC (DE) 5
N-4524th Page of 530TOC1stPreviousNextBottomJust 524th
23. Corporate Real Estate Holdings, LLC (DE) 24. Ten Park SPC (Cayman Islands) - 1% voting control of Ten Park SPC is held by 23rd Street Investments, Inc. 25. MetLife Tower Resources Group, Inc. (DE) 26. Headland-Pacific Palisades, LLC (CA) 27. Headland Properties Associates (CA) - 99% is owned by Metropolitan Life Insurance Company and 1% is owned by Headland-Pacific Palisades, LLC. 28. WFP 1000 Holding Company GP, LLC (DE) 29. White Oak Royalty Company (OK) 30. 500 Grant Street GP LLC (DE) 31. 500 Grant Street Associates Limited Partnership (CT) - 99% of 500 Grant Street Associates Limited Partnership is held by Metropolitan Life Insurance Company and 1% by 500 Grant Street GP LLC. 32. MetLife Mall Ventures Limited Partnership (DE) - 99% LP interest of MetLife Mall Ventures Limited Partnership is owned by MLIC and 1% GP interest is owned by Metropolitan Tower Realty Company, Inc. a) HMS Master Limited Partnership (DE) - 60% LP interest of HMS Master Limited Partnership is owned by MetLife Mall Ventures Limited Partnership. A 40% LP interest is owned by a third party. Metropolitan Tower Realty Company, Inc. is the GP. i) HMS Southpark Residential LLC (DE) 33. MetLife Retirement Services LLC (NJ) a) MetLife Associates LLC (DE) 34. Euro CL Investments, LLC (DE) 35. MEX DF Properties, LLC (DE) 36. MSV Irvine Property, LLC (DE) - 4% of MSV Irvine Property, LLC is owned by Metropolitan Tower Realty Company, Inc. and 96% is owned by Metropolitan Life Insurance Company 37. MetLife Properties Ventures, LLC (DE) a) Citypoint Holdings II Limited (United Kingdom) 38. Housing Fund Manager, LLC (DE) a) MTC Fund I, LLC (DE) - 0.01% of MTC Fund I, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. b) MTC Fund II, LLC (DE) - 0.01% of MTC Fund II, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. c) MTC Fund III, LLC (DE) - 0.01% of MTC Fund III, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. 39. MLIC Asset Holdings LLC (DE) 40. 85 Broad Street Mezzanine LLC (DE) a) 85 Broad Street LLC (DE) 41. The Building at 575 Fifth Avenue Mezzanine LLC (DE) a) The Building at 575 Fifth LLC (DE) 42. ML Bridgeside Apartments LLC (DE) 43. Para-Met Plaza Associates (FL)- 75% of the General Partnership is held by Metropolitan Life Insurance Company and 25% of the General Partnership is held by Metropolitan Tower Realty Company, Inc. 44. MLIC CB Holdings LLC (DE) 45. Met II Office Mezzanine LLC, (FL) - 10.4167% of the membership interest is owned by Metropolitan Tower Life Insurance Company and 89.5833% is owned by Metropolitan Life Insurance Company. a) Met II Office LLC (FL) 46. The Worthington Series Trust (DE) 47. MetLife CC Member, LLC (DE) - 63.415% of MetLife CC Member, LLC is held by Metropolitan Life Insurance Company, 17.073% by MetLife Investors USA Insurance Company, 14.634% by MetLife Insurance Company of Connecticut and 4.878% by General American Life Insurance Company. 48. Oconee Hotel Company, LLC (DE) 49. Oconee Land Company, LLC (DE) a) Oconee Land Development Company, LLC (DE) b) Oconee Golf Company, LLC (DE) c) Oconee Marina Company, LLC (DE) 50. 1201 TAB Manager, LLC (DE) 51. MetLife 1201 TAB Member, LLC (DE) - 69.66% of MetLife 1201 TAB Member, LLC is owned by Metropolitan Life Insurance Company, 12.07% is owned by MetLife Investors USA Insurance Company, 15.17% is owned by MetLife Insurance Company of Connecticut and 3.1% is owned by Metropolitan Property and Casualty Insurance Company. a) 1201 TAB Owner, LLC (DE) - 50% of 1201 TAB Owner, LLC is owned by Metlife 1201 TAB Member, LLC and the remainder is owned by a third party. Metlife 1201 TAB Manager, LLC is the manager of 1201 TAB Owner, LLC. 52. MetLife LHH Member, LLC (DE) - 69.23% of MetLife LHH Member, LLC is owned by Metropolitan Life Insurance Company, 19.78% is owned by MetLife Investors USA Insurance Company and 10.99% is owned by New England Life Insurance Company. 53. Ashton Southend GP, LLC (DE) 54. Tremont Partners, LP (DE) - 99.9% LP interest of Tremont Partners, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Ashton Southend GP, LLC. 55. Riverway Residential, LP (DE) - 99.9% LP interest of Riverway Residential, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 56. 10420 McKinley Partners, LP (DE) - 99.9% LP interest of 10420 McKinley Partners, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 57. Ardrey Kell Townhomes, LLC (DE) 58. Boulevard Residential, LLC (DE) 59. 465 N. Park Drive, LLC (DE) 60. Ashton Judiciary Square, LLC (DE) 61. Sandpiper Cove Associates, LLC (DE) - 90.59% membership interest of Sandpiper Cove Associates, LLC is owned by MLIC and 9.41% is owned by Metropolitan Tower Realty Company. 62. 1900 McKinney Properties, LP (DE) - 99.9% LP interest of 1900 McKinney Properties, LP is owned by MLIC and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 63. Marketplace Residences, LLC (DE) 64. ML Swan Mezz, LLC (DE) a) ML Swan GP, LLC (DE) 65. ML Dolphin Mezz, LLC (DE) a) ML Dolphin GP, LLC (DE) 66. Haskell East Village, LLC (DE) 67. MetLife Cabo Hilton Member, LLC (DE) - 54.129% of MetLife Cabo Hilton Member, LLC is owned by MLIC, 16.9% by General American Life Insurance Company, 16.9% by MetLife Investors USA Insurance Company and 12.071% by MetLife Insurance Company of Connecticut. 68. ML Terraces, LLC (DE) 69. Chestnut Flats Wind, LLC (DE) 70. MetLife 425 MKT Member, LLC (DE) a) 425 MKT, LLC (DE) - 52.5% of 425 MKT, LLC is owned by MetLife 425 MKT Member, LLC and 47.5% is owned by a third party. MetLife 425 MKT Member, LLC is the managing member of 425 MKT, LLC. i) 425 MKT REIT, LLC (DE) - 99.9% of 425 MKT REIT, LLC is owned by 425 MKT, LLC and the remaining 0.1% by third parties. 71. MetLife OFC Member, LLC (DE) a) OFC Boston, LLC (DE) - 52.5% of OFC Boston, LLC is owned by MetLife OFC Member, LLC and 47.5% is owned by a third party. i) OFC REIT, LLC (DE) - 99.9% of OFC REIT, LLC is owned by OFC Boston and the remaining 0.1% is owned by third parties. 1) Dewey Square Tower Associates, LLC (MA) 72. MetLife THR Investor, LLC (DE) - 85% of MetLife THR Investor, LLC is owned by MLIC and 15% is owned by MICC. 73. ML Southmore, LLC (DE) - 75.12% of ML Southmore, LLC is owned by MLIC and 24.88% is owned by MICC. 74. ML - AI MetLife Member 1, LLC (DE) - 83.675% of the membership interest is owned by MLIC, 5.762% by MICC, 5.762% by MLI USA and 4.801% by Metropolitan Property and Casualty Insurance Company. a) ML - AI Venture 1, LLC (DE) - 51% of ML-AI Venture 1, LLC is owned by ML-AI MetLife Member 1, LLC and 49% is owned by a third party. MetLife Investment Management, LLC is the asset manager. i) ML-AI 125 Wacker, LLC (DE) 75. MetLife CB W/A, LLC (DE) 76. MetLife Camino Ramon Member, LLC (DE) - 78.6% of MetLife Camino Ramon Member, LLC is owned by MLIC and 21.4% is owned by MICC. 77. 10700 Wilshire, LLC (DE) 78. Viridian Miracle Mile, LLC (DE) 79. MetLife Canada Solar ULC (Canada) 80. MetLife 555 12th Member, LLC (DE) - MetLife 555 12th Member, LLC is owned at 69.4% by MLIC, 20.2% by MICC, 5.4% by GALIC and 5% by MLI USA. a) 555 12th, LLC (DE) - 52.5% of 555 12th, LLC is owned by MetLife 555 12th Member, LLC and the remainder by a third party. i) 555 12 REIT, LLC (DE) O. MetLife Capital Trust IV (DE) P. MetLife Insurance Company of Connecticut ("MICC") (CT) - 86.72% is owned by MetLife, Inc. and 13.28% by MetLife Investors Group, Inc. 1. MetLife Property Ventures Canada ULC (Canada) 2. Pilgrim Alternative Investments Opportunity Fund III Associates, LLC (CT) - 67% is owned by MICC and 33% is owned by third party. 3. Metropolitan Connecticut Properties Ventures, LLC (DE) 4. MetLife Canadian Property Ventures LLC (NY) 5. Euro TI Investments LLC (DE) 6. Greenwich Street Investments, L.L.C. (DE) a) Greenwich Street Capital Offshore Fund, Ltd. (Virgin Islands) b) Greenwich Street Investments, L.P. (DE) 7. One Financial Place Corporation (DE) - 100% is owned in the aggregate by MICC. 8. MetLife USA Assignment Company (CT) 9. TIC European Real Estate LP, LLC (DE) 10. MetLife European Holdings, LLC (DE) 11. Travelers International Investments Ltd. (Cayman Islands) 12. Euro TL Investments LLC (DE) 13. Corrigan TLP LLC (DE) 14. TLA Holdings LLC (DE) a) The Prospect Company (DE) 15. TRAL & Co. (CT) - TRAL & Co. is a general partnership. Its partners are MICC and Metropolitan Life Insurance Company. 16. MetLife Investors USA Insurance Company ("MLI USA") (DE) a) MetLife Renewables Holding, LLC (DE) i) Greater Sandhill I, LLC (DE) 17. TLA Holdings II LLC (DE) 18. TLA Holdings III LLC (DE) 19. MetLife Greenstone Southeast Venture, LLC (DE) - 95% of MetLife Greenstone Southeast Venture, LLC is owned by MICC and 5% is owned by Metropolitan Connecticut Properties Ventures, LLC. a) MLGP Lakeside, LLC (DE) 20. Sino-US United MetLife Insurance Co., Ltd. (China) - Sino-US United MetLife Insurance Co., Ltd. is owned at 27.8% by MICC, 22.2% by MLIC and 50% by a third party. Q. MetLife Reinsurance Company of South Carolina (SC) R. MetLife Investment Management, LLC (DE) 1. MetLife Alternatives GP, LLC (DE) a) MetLife International PE Fund I, LP (Cayman Islands) - 92.593% of the Limited Partnership interests of this entity is owned by MetLife Alico Life Insurance K.K., 4.115% is owned by MetLife Mexico S.A., 2.716% is owned by MetLife Limited (Hong Kong) and the remaining 0.576% is owned by Metropolitan Life Insurance Company of Hong Kong Limited. b) MetLife International PE Fund II, LP (Cayman Islands) c) MetLife International HF Partners, LP (Cayman Islands) - The General Partnership Interests of MetLife International HF Partners, LP is held by MetLife Alternatives GP, LLC; 91.49% of the Limited Partnership Interests is owned by MetLife Alico Life Insurance K.K. and 8.51% is owned by MetLife Insurance Company of Korea Limited. 2. MetLife Loan Asset Management LLC (DE) 3. MetLife Core Property Fund GP, LLC (DE) a) MetLife Core Property Fund, LP (DE) - MetLife Core Property Fund GP, LLC is the general partner of MetLife Core Property Fund, LP (the "Fund"). A substantial majority of the limited partnership interests in the Fund are held by third parties. The following affiliates hold a minority share of the limited partnership interests in the Fund: Metropolitan Life Insurance Company owns 23.7%, General American Life Insurance Company owns 0.1% and MetLife Insurance Company of Connecticut owns 0.2%. i) MetLife Core Property REIT, LLC (DE) aa) MetLife Core Property Holdings, LLC (DE) - MetLife Core Property Holdings, LLC holds the following single-property limited liability companies: MCP 7 Riverway, LLC; MCP SoCal Industrial-Redondo, LLC; MCP SoCal Industrial-Springdale, LLC; MCP SoCal Industrial-Concourse, LLC; MCP SoCal Industrial-Kellwood, LLC; MCP SoCal Industrial-Bernado, LLC; MCP SoCal Industrial-Canyon, LLC; MCP SoCal Industrial-Anaheim, LLC; MCP SoCal Industrial-LAX, LLC; MCP SoCal Industrial-Fullerton, LLC; MCP SoCal Industrial-Ontario, LLC; MCP SoCal Industrial-Loker, LLC; MCP Paragon Point, LLC; MCP 4600 South Syracuse, LLC; MCP The Palms Doral, LLC; MCP Waterford Atrium, LLC; MCP EnV Chicago, LLC; MCP 100 Congress, LLC; MCP 1900 McKinney, LLC; MCP 550 West Washington, LLC; MCP Main Street Village, LLC; MCP Lodge At Lakecrest, LLC; MCP Ashton South End, LLC and MCP 3040 Port Oak, LLC S. MetLife Standby I, LLC (DE) 1. MetLife Exchange Trust I (DE) T. MetLife Services and Solutions, LLC (DE) 1. MetLife Solutions Pte. Ltd. (Singapore) a) MetLife Services East Private Limited (India) b) MetLife Global Operations Support Center Private Limited (India) - 99.99999% is owned by MetLife Solutions Pte. Ltd. and 0.00001% is owned by Natiloportem Holdings, Inc. U. SafeGuard Health Enterprises, Inc. (DE) 1. MetLife Health Plans, Inc. (DE) 2. SafeGuard Health Plans, Inc. (CA) 3. SafeHealth Life Insurance Company (CA) 4. SafeGuard Health Plans, Inc. (FL) 5. SafeGuard Health Plans, Inc. (NV) 6. SafeGuard Health Plans, Inc. (TX) V. MetLife Capital Trust X (DE) W. Cova Life Management Company (DE) X. MetLife Reinsurance Company of Charleston (SC) Y. MetLife Reinsurance Company of Vermont (VT) Z. Delaware American Life Insurance Company (DE) AA. Federal Flood Certification LLC (TX) AB. American Life Insurance Company (ALICO) (DE) 1. MetLife ALICO Life Insurance K.K. (Japan) a) Communication One Kabushiki Kaisha (Japan) b) Financial Learning Kabushiki Kaisha (Japan) 2. MetLife Global Holding Company I GmbH (Swiss I) (Switzerland) a) MetLife Global Holding Company II GmbH (Swiss II) (Switzerland) i) MetLife Emeklilik ve Hayat A.S. (Turkey) - 99.98% of MetLife Emeklilik ve Hayat A.S. is owned by Metlife Global Holding Company II GmbH (Swiss II) and the remainder by third parties. ii) ALICO European Holdings Limited (Ireland) aa) ZAO Master D (Russia) 1) Closed Joint Stock Company MetLife Insurance Company (Russia) - 51% of Closed Joint Stock Company MetLife Insurance Company is owned by ZAO Master D and 49% is owned by MetLife Global Holding Company II GmbH. iii) MetLife EU Holding Company Limited (Ireland) aa) MetLife Europe Limited (Ireland) - 93% of MetLife Europe Limited is owned by MetLife EU Holding Company Limited and 7% is owned by ALICO. 1. MetLife Pension Trustees Limited (United Kingdom) bb) Agenvita S.r.l. (Italy) cc) MetLife Europe Insurance Limited (Ireland)- 93% of MetLife Europe Insurance Limited is owned by MetLife EU Holding Company Limited and 7% is owned by ALICO. dd) MetLife Europe Services Limited (Ireland) ee) MetLife Insurance Limited (United Kingdom) ff) MetLife Limited (United Kingdom) gg) MetLife Services, Sociedad Limitada (Spain) hh) MetLife Insurance S.A./NV (Belgium) - 99.999% of MetLife Insurance S.A./NV is owned by MetLife EU Holding Company Limited and 0.001% is owned by Natilportem Holdings, Inc. ii) MetLife Solutions S.A.S. (France) jj) Metlife Biztosito Zrt. (Hungary) 1) First American-Hungarian Insurance Agency Limited (Hungary) kk) Metropolitan Life Asigurari S.A. (Romania) - 99.9982018% of Metropolitan Life Asigurari S.A. is owned by MetLife EU Holding Company Limited and the remaining 0.0017982% is owned by International Technical and Advisory Services Limited. 1) ALICO Societate de Administrare a unui Fond de Pensii Administrat Privat S.A. (Romania) - 99.9836% of ALICO Societate de Administrare a unui Fond de Pensii Administrat Privat S.A. is owned by Metropolitan Life Asigurari S.A. and 0.0164% is owned by MetLife Services Sp z.o.o. 2) Metropolitan Training and Consulting S.R.L. (Romania) 3) APF Societate de Administrare a Fondurilor De Pensii Facultative (APF) (Romania) - 99.99% of APF is owned by Metropolitan Life Asigurari S.A. and 0.01% is owned by ITAS. ll) MetLife AMSLICO poist'ovna, a.s. (Slovakia) 1) ALICO Services Central Europe s.r.o. (Slovakia) 2) ALICO Funds Central Europe sprav. spol., a.s. (Slovakia) mm) MetLife pojist'ovna a.s. (Czech Republic) nn) MetLife Towarzystwo Ubiezpieczen na Zycie I Reasekuracji S.A. (Poland) a) MetLife Services Sp z.o.o. (Poland) b) MetLife Towartzystwo Funduszy Inwestycyjnych, S.A. (Poland) c) AMPLICO Powszechne Towartzystwo Emerytalne S.A. (Poland) - 50% of AMPLICO Powszechne Towarzystwo Emerytalne S.A. is owned by MetLife Towarzystwo Ubiezpieczen na Zycie I Reasekuracji S.A. and the remaining 50% is owned by MetLife EU Holding Company Limited. oo) MetLife Holdings (Cyprus) Limited (Cyprus) a) American Life Insurance Company (Cyprus) Limited (Cyprus) pp) ALICO Bulgaria Zhivotozastrahovatelno Druzhestvo EAD (Bulgaria) qq) MetLife Alico Life Insurance Company S.A. (Greece) a) ALICO Mutual Fund Management Company (Greece) - 90% of ALICO Mutual Fund Management Company is owned by MetLife Alico Life Insurance Company S.A. (Greece) and the remaining interests are owned by third parties. 3. Pharaonic American Life Insurance Company (Egypt) - 84.125% of Pharaonic American Life Insurance Company is owned by ALICO and the remaining interests are owned by third parties. 4. American Life Insurance Company (Pakistan) Ltd. (Pakistan) - 81.96% of American Life Insurance Company (Pakistan) Ltd. is owned by ALICO and the remaining interests are owned by third parties. 5. International Investment Holding Company Limited (Russia) 6. MetLife Akcionarsko Drustvo za Zivotno Osiguranje (Serbia) - 99.98% of MetLife Akcionarska Drustvoza za Zivotno Osiguranje is owned by ALICO and the remaining 0.02% is owned by ITAS. 7. ALICO Management Services Limited (United Kingdom) 8. ALICO Trustees U.K. Ltd. (United Kingdom) - 50% of ALICO Trustees U.K. Ltd. is owned by ALICO and the remaining interest is owned by ITAS. 9. PJSC MetLife (Ukraine) - 99.9988% of PJSC ALICO Ukraine is owned by ALICO 0.0006% is owned by ITAS and the remaining 0.0006% is owned by Borderland Investment Limited. 10. Borderland Investment Limited (USA-Delaware) a) ALICO Hellas Single Member Limited Liability Company (Greece) 11. International Technical and Advisory Services Limited ("ITAS") (USA-Delaware) 12. ALICO Operations Inc. (USA-Delaware) a) MetLife Asset Management Corp. (Japan) 13. MetLife Colombia Seguros de Vida S.A. (Colombia) - 94.9899823% of MetLife Colombia Seguros de Vida S.A. is owned by ALICO, 5.0100106% is owned by ITAS and the remaining interests are owned by third parties. 14. MetLife Mas, S.A. de C.V. (Mexico) - 99.9997546% of MetLife Mas, SA de CV is owned by ALICO and 0.0002454% is owned by ITAS. 15. MetLife Seguros S.A. (Uruguay) - 74.9187% of MetLife Seguros S.A. is owned by ALICO, 25.0798% by MetLife, Inc. and 0.0015% by a third party (Oscar Schmidt). 16. ALICO Properties, Inc. (USA-Delaware) - 51% of ALICO Properties, Inc. is owned by ALICO and the remaining interests are owned by third parties. a) Global Properties, Inc. (USA-Delaware) 17. Alpha Properties, Inc. (USA-Delaware) 18. Beta Properties, Inc. (USA-Delaware) 19. Delta Properties Japan, Inc. (USA-Delaware) 20. Epsilon Properties Japan, Inc. (USA-Delaware) 21. Iris Properties, Inc. (USA-Delaware) 22. Kappa Properties Japan, Inc. (USA-Delaware) AC. MetLife Global Benefits, Ltd. (Cayman Islands) AD. Inversiones Metlife Holdco Dos Limitada (Chile) - 99.999338695% of Inversiones MetLife Holdco Dos Limitada is owned by MetLife, Inc., 0.00065469% is owned by MetLife International Holdings, Inc. and 0.000006613% is owned by Natiloportem. AE. MetLife Consumer Services, Inc. (DE) AF. MetLife Reinsurance Company of Delaware (DE) 1) The voting securities (excluding directors' qualifying shares, if any) of each subsidiary shown on the organizational chart are 100% owned by their respective parent corporation, unless otherwise indicated. 2) The Metropolitan Money Market Pool and MetLife Intermediate Income Pool are pass-through investment pools, of which Metropolitan Life Insurance Company and/or its subsidiaries and/or affiliates are general partners. 3) The MetLife, Inc. organizational chart does not include real estate joint ventures and partnerships of which MetLife, Inc. and/or its subsidiaries is an investment partner. In addition, certain inactive subsidiaries have also been omitted. 4) MetLife Services EEIG is a cost-sharing mechanism used in the EU for EU- affiliated members. 6
N-4525th Page of 530TOC1stPreviousNextBottomJust 525th
ITEM 27. NUMBER OF CONTRACT OWNERS As of September 30, 2014, there were 407,520 owners of qualified contracts and 182,116 owners of non-qualified contracts offered by the Registrant (MetLife Investors USA Separate Account A). ITEM 28. INDEMNIFICATION As described in their respective governing documents, MetLife, Inc.(the ultimate parent of the Depositor and MetLife Investors Distribution Company, the Registrant's underwriter (the "Underwriter")) and the Depositor, each of which is incorporated in the state of Delaware, shall indemnify any person who is made or is threatened to be made a party to any civil or criminal suit, or any administrative or investigative proceeding, by reason of that person's service as a director, officer, or agent of the respective company, under certain circumstances, against liabilities and expenses incurred by such person (except, with respect to the Depositor, as described below regarding MetLife Employees). As described in its governing documents, the Underwriter, which is incorporated in the state of Missouri, may indemnify, under certain circumstances, any person who is made a party to any civil or criminal suit, or made a subject of any administrative or investigative proceeding by reason of the fact that he is or was a director, officer, or agent of the Underwriter. The Underwriter also has such other and further powers of indemnification as are not inconsistent with the laws of Missouri. MetLife, Inc. also has adopted a policy to indemnify employees ("MetLife Employees") of MetLife, Inc. or its affiliates ("MetLife"), including any MetLife Employees serving as directors or officers of the Depositor or the Underwriter. Under the policy, MetLife, Inc. will, under certain circumstances, indemnify MetLife Employees for losses and expenses incurred in connection with legal actions threatened or brought against them as a result of their service to MetLife. The policy excludes MetLife directors and others who are not MetLife Employees, whose rights to indemnification, if any, are as described in the charter, bylaws or other arrangement of the relevant company. MetLife, Inc. also maintains a Directors and Officers Liability and Corporate Reimbursement Insurance Policy under which the Registrant, the Depositor and the Underwriter, as well as certain other subsidiaries of MetLife, are covered. MetLife, Inc. also has secured a Financial Institutions Bond. Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. ITEM 29. PRINCIPAL UNDERWRITERS (a) MetLife Investors Distribution Company is the principal underwriter for the following investment companies (other than Registrant): Met Investors Series Trust MetLife Investors USA Variable Life Account A MetLife Investors Variable Annuity Account One MetLife Investors Variable Life Account One First MetLife Investors Variable Annuity Account One General American Separate Account Eleven General American Separate Account Twenty-Eight General American Separate Account Twenty-Nine General American Separate Account Two Security Equity Separate Account Twenty-Six Security Equity Separate Account Twenty-Seven MetLife of CT Separate Account QPN for Variable Annuities MetLife of CT Fund UL for Variable Life Insurance MetLife of CT Fund UL III for Variable Life Insurance Metropolitan Life Variable Annuity Separate Account II MetLife of CT Separate Account Eleven for Variable Annuities Metropolitan Life Separate Account E
N-4526th Page of 530TOC1stPreviousNextBottomJust 526th
Metropolitan Life Separate Account UL Paragon Separate Account A Paragon Separate Account B Paragon Separate Account C Paragon Separate Account D Metropolitan Series Fund Metropolitan Tower Life Separate Account One Metropolitan Tower Life Separate Account Two New England Life Retirement Investment Account New England Variable Annuity Fund I New England Variable Annuity Separate Account New England Variable Life Separate Account Separate Account No. 13S (b) MetLife Investors Distribution Company is the principal underwriter for the Contracts. The following persons are the officers and directors of MetLife Investors Distribution Company. The principal business address for MetLife Investors Distribution Company is 1095 Avenue of the Americas, New York, NY 10036. [Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH UNDERWRITER ------------------------------------- -------------------------------------------- Elizabeth M. Forget Director Gragg Building 11225 North Community House Road Charlotte, NC 28277 Paul A. LaPiana Director Gragg Building 11225 North Community House Road Charlotte, NC 28277 Gerard J. Nigro Director and Senior Vice President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Lance Carlson President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Kieran R. Mullins Executive Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Barbara A. Dare Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 John P. Kyne, III Vice President and Chief Compliance Officer Gragg Building 11225 North Community House Road Charlotte, NC 28277 Donald Leintz Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 John G. Martinez Vice President and Chief Financial Officer 18210 Crane Nest Drive Tampa, FL 33647 Tyla L. Reynolds Vice President and Secretary 600 North King Street Wilmington, DE 19801
N-4527th Page of 530TOC1stPreviousNextBottomJust 527th
[Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH UNDERWRITER ------------------------------------- --------------------------------------- Marlene B. Debel Treasurer 1095 Avenue of the Americas New York, NY 10036 (c) Compensation from the Registrant. The following commissions and other compensation were received by the Distributor, directly or indirectly, from the Registrant during the Registrant's last fiscal year: [Enlarge/Download Table] (1) (2) (3) (4) (5) NET UNDERWRITING DISCOUNTS AND COMPENSATION BROKERAGE OTHER NAME OF PRINCIPAL UNDERWRITER COMMISSIONS ON REDEMPTION COMMISSIONS COMPENSATION ----------------------------------------- ----------------- --------------- ------------- ------------- MetLife Investors Distribution Company $456,083,088 $0 $0 $0 ITEM 30. LOCATION OF ACCOUNTS AND RECORDS The following companies will maintain possession of the documents required by Section 31(a) of the Investment Company Act of 1940 and the Rules thereunder: (a) Registrant (b) MetLife Annuity Operations, 27000 Westown Parkway, Bldg. 4, Suite 200, West Des Moines, IA 50266 (c) State Street Bank & Trust Company, 225 Franklin Street, Boston, MA 02110 (d) MetLife Investors Distribution Company, 5 Park Plaza, Suite 1900, Irvine, CA 92614 (e) MetLife Investors Insurance Company, 5 Park Plaza, Suite 1900, Irvine, CA 92614 (f) MetLife, 18210 Crane Nest Drive, Tampa, FL 33647 (g) MetLife, 501 Boylston Street, Boston, MA 02116 (h) MetLife, 200 Park Avenue, New York, NY 10166 ITEM 31. MANAGEMENT SERVICES Not Applicable. ITEM 32. UNDERTAKINGS a. Registrant hereby undertakes to file a post-effective amendment to this registration statement as frequently as is necessary to ensure that the audited financial statements in the registration statement are never more than sixteen (16) months old for so long as payment under the variable annuity contracts may be accepted. b. Registrant hereby undertakes to include either (1) as part of any application to purchase a contract offered by the Prospectus, a space that an applicant can check to request a Statement of Additional Information, or (2) a postcard or similar written communication affixed to or included in the Prospectus that the applicant can remove to send for a Statement of Additional Information. c. Registrant hereby undertakes to deliver any Statement of Additional Information and any financial statement required to be made available under this Form promptly upon written or oral request. REPRESENTATIONS MetLife Investors USA Insurance Company ("Company") hereby represents that the fees and charges deducted under the Contracts described in the Prospectus, in the aggregate, are reasonable in relation to the services rendered, the expenses to be incurred and the risks assumed by the Company.
N-4528th Page of 530TOC1stPreviousNextBottomJust 528th
SIGNATURES As required by the Securities Act of 1933 and the Investment Company Act of 1940, the registrant has caused this Registration Statement to be signed on its behalf, in the city of Charlotte, and the state of North Carolina, on the 18th day of November, 2014. [Download Table] METLIFE INVESTORS USA SEPARATE ACCOUNT A (Registrant) By: METLIFE INSURANCE COMPANY USA By: /s/ Elizabeth M. Forget ---------------------------------------- Elizabeth M. Forget Senior Vice President By: METLIFE INSURANCE COMPANY USA (Depositor) By: /s/ Elizabeth M. Forget ---------------------------------------- Elizabeth M. Forget Senior Vice President
N-4529th Page of 530TOC1stPreviousNextBottomJust 529th
As required by the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on November 18, 2014. [Enlarge/Download Table] /s/ Eric T. Steigerwalt* Director, Chairman of the Board, President and Chief -------------------------------- Executive Officer Eric T. Steigerwalt /s/ Anant Bhalla* Senior Vice President and Chief Finanical Officer -------------------------------- Anant Bhalla /s/ Peter M. Carlson* Executive Vice President and Chief Accounting Officer -------------------------------- Peter M. Carlson /s/ Elizabeth M. Forget* Director and Senior Vice President -------------------------------- Elizabeth M. Forget /s/ Gene L. Lunman* Director and Senior Vice President -------------------------------- Gene L. Lunman [Download Table] *By: /s/ Michele H. Abate -------------------------------- Michele H. Abate, Attorney-In-Fact November 18, 2014 *MetLife Investors USA Insurance Company. Executed by Michele H. Abate, Esquire on behalf of those indicated pursuant to powers of attorney filed herewtih.
N-4Last Page of 530TOC1stPreviousNextBottomJust 530th
INDEX TO EXHIBITS 1(ii) Resolutions of the Board of Directors of MetLife Investors USA Insurance Company (including Agreement and Plan of Merger attached as Exhibit B to the resolutions) 1(iii) Resolutions of the Board of Directors of MetLife Insurance Company of Connecticut authorizing the acceptance of the Separate Account 3(i)(b) Amendment to Distribution and Principal Underwriting Agreement 4(xvi) Merger Endorsement 5 Form of Variable Annuity Application 6(i) Copy of Certificate of Incorporation of the Company and Certificate of Amendment 6(ii) Copy of By-Laws of the Company 8(i)(d) Amendment to Participation Agreement with Met Investors Series Trust 8(iii)(c) Amendment to Participation Agreement with American Funds Insurance Series 8(iv) Amendment to Participation Agreement with BlackRock Variable Series Funds, Inc. 8(v) Amendment to Participation Agreement with Ivy Funds Variable Insurance Portfolios 8(vi)(c) Amendment to Participation Agreement with Legg Mason Partners Variable Equity Trust 8(vii)(b) Amendment to Participation Agreement with PIMCO Variable Insurance Trust 8(viii)(b) Amendment to Participation Agreement with The Universal Institutional Funds, Inc. 8(ix) Amendment to Participation Agreement with Van Eck VIP Trust 9 Opinion of Counsel 10 Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP) 13 Powers of Attorney

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘N-4’ Filing    Date First  Last      Other Filings
12/16/21299
7/15/21299410
10/15/15299
12/31/14299
11/19/14261
Filed on:11/18/141529
11/17/1447514N-4
11/14/1447514485APOS,  N-4
11/10/14511N-4/A
11/7/14214447
10/27/14214447497
9/30/14511525
9/17/14513
8/18/14513497
8/13/14513
8/8/14515N-4
6/30/14519N-30D
4/2/14447
3/31/14364445
3/28/14225
3/27/1472
2/14/14223
1/1/14214354
12/31/137251324F-2NT,  N-30D,  NSAR-U
12/30/13350
12/15/13252464
10/15/13504
10/1/13453510
9/30/1350640-OIP,  497
9/18/1347
7/17/13250383
4/29/13103195485BPOS,  497
4/26/13178497
4/10/13515485BPOS
1/1/13251463
12/31/124751324F-2NT,  N-30D,  NSAR-U
12/28/12350497,  497J
12/19/12505506485BPOS
11/14/12350
11/12/12133195
10/1/12275
9/27/12504506
7/23/12133195
4/30/12133195485BPOS,  497
4/5/12515
4/4/12515
1/1/12251464
12/31/1121451324F-2NT,  N-30D,  NSAR-U
12/16/11505
9/1/11351
7/15/11505
4/18/11514
4/5/11515
1/1/11214468
12/31/1022950724F-2NT,  N-30D,  NSAR-U
4/22/10515485BPOS
11/24/09513
4/9/09515N-4
10/31/07515485BPOS,  497
4/16/07515485BPOS
4/6/06515
9/9/05515485BXT,  497
5/1/05514485BPOS
7/15/04515485BPOS
5/18/04513
5/1/01514497J
4/13/01515485BPOS
3/1/01513497J
1/26/01515N-4
12/31/0051024F-2NT,  NSAR-U
10/31/00510
12/31/994324F-2NT,  NSAR-U
 List all Filings


30 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/16/24  Brighthouse Var Annuity Account C 485BPOS     4/29/24    3:9.9M                                   Donnelley … Solutions/FA
 4/12/24  Brighthouse Separate Account A    485BPOS     4/29/24    3:4.3M                                   Donnelley … Solutions/FA
 4/11/24  Brighthouse Separate Account A    485BPOS     4/29/24    3:2.6M                                   Donnelley … Solutions/FA
 4/11/24  Brighthouse Separate Account A    485BPOS     4/29/24    3:4.2M                                   Donnelley … Solutions/FA
 4/10/24  Brighthouse Separate Account A    485BPOS     4/29/24    9:11M                                    Donnelley … Solutions/FA
 4/10/24  Brighthouse Separate Account A    485BPOS     4/29/24    9:12M                                    Donnelley … Solutions/FA
 4/10/24  Brighthouse Separate Account A    485BPOS     4/29/24    9:11M                                    Donnelley … Solutions/FA
 4/19/23  Brighthouse Var Annuity Account C 485BPOS     5/01/23    5:10M                                    Donnelley … Solutions/FA
 4/17/23  Brighthouse Separate Account A    485BPOS     5/01/23    6:4.6M                                   Donnelley … Solutions/FA
 4/14/23  Brighthouse Separate Account A    485BPOS     5/01/23    4:2.7M                                   Donnelley … Solutions/FA
 4/14/23  Brighthouse Separate Account A    485BPOS     5/01/23    6:4.4M                                   Donnelley … Solutions/FA
 4/12/23  Brighthouse Separate Account A    485BPOS     5/01/23   12:9.2M                                   Donnelley … Solutions/FA
 4/12/23  Brighthouse Separate Account A    485BPOS     5/01/23   12:10M                                    Donnelley … Solutions/FA
 4/12/23  Brighthouse Separate Account A    485BPOS     5/01/23   12:9.3M                                   Donnelley … Solutions/FA
 4/27/22  Brighthouse Separate Account A    485BPOS     4/29/22    6:4.2M                                   Donnelley … Solutions/FA
 4/27/22  Brighthouse Separate Account A    485BPOS     4/29/22    5:2.9M                                   Donnelley … Solutions/FA
 4/21/22  Brighthouse Var Annuity Account C 485BPOS     4/29/22    9:8M                                     Donnelley … Solutions/FA
 4/19/22  Brighthouse Separate Account A    485BPOS     4/29/22    6:4.2M                                   Donnelley … Solutions/FA
 4/18/22  Brighthouse Separate Account A    485BPOS     4/29/22    8:2M                                     Donnelley … Solutions/FA
 4/18/22  Brighthouse Separate Account A    485BPOS     4/29/22    5:2.9M                                   Donnelley … Solutions/FA
 4/13/22  Brighthouse Separate Account A    485BPOS     4/29/22    9:2.8M                                   Donnelley … Solutions/FA
 4/13/22  Brighthouse Separate Account A    485BPOS     4/29/22    6:2.4M                                   Donnelley … Solutions/FA
 4/13/22  Brighthouse Separate Account A    485BPOS     4/29/22    6:2.6M                                   Donnelley … Solutions/FA
 4/22/21  Brighthouse Var Annuity Account C 485BPOS     4/30/21    3:26M                                    Donnelley … Solutions/FA
 4/16/21  Brighthouse Separate Account A    485BPOS     4/30/21    3:2.9M                                   Donnelley … Solutions/FA
 4/15/21  Brighthouse Separate Account A    485BPOS     4/30/21    3:1.8M                                   Donnelley … Solutions/FA
 4/15/21  Brighthouse Separate Account A    485BPOS     4/30/21    3:2.8M                                   Donnelley … Solutions/FA
 4/14/21  Brighthouse Separate Account A    485BPOS     4/30/21    4:2.7M                                   Donnelley … Solutions/FA
 4/14/21  Brighthouse Separate Account A    485BPOS     4/30/21    4:2.6M                                   Donnelley … Solutions/FA
 4/14/21  Brighthouse Separate Account A    485BPOS     4/30/21    3:2.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-14-416298   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 12:18:00.4am ET